data_2bbu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bbu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.513 ' CA ' HD12 ' A' ' 4' ' ' LEU . 59.9 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.204 0.526 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -54.96 -45.24 74.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 109.956 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.628 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -54.94 -39.82 69.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.847 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -63.75 -47.2 82.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.836 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.659 ' CG2' ' CE2' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -65.84 -48.35 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 110.012 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.513 ' N ' HG12 ' A' ' 5' ' ' VAL . 39.5 t -59.54 -47.17 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.2 m120 -58.74 -28.07 65.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.581 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . . . -74.13 -44.13 54.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 50.4 t -57.38 -39.72 70.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.357 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -55.87 -49.35 73.58 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.73 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.53 -36.1 45.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 HD22 HG23 ' A' ' 41' ' ' ILE . 46.2 tp -69.48 -42.01 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 5.9 pt20 -67.99 -34.2 76.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.8 tt0 -57.91 -23.7 54.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 110.269 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 1.2 t -70.57 -27.0 63.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.23 -14.12 63.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -76.92 -10.67 59.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -1.108 . . . . 0.0 110.004 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.572 ' CE2' HG21 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -93.41 121.08 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.061 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.67 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 9.0 m95 -110.3 101.86 10.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 110.005 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.23 109.04 20.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 164.98 -4.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.426 -0.796 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.85 -159.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 0.0 109.982 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -99.19 176.2 5.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 110.228 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.597 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.76 -78.25 0.1 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 63' ' ' ASN . . . -79.26 -34.49 32.64 Favored Glycine 0 N--CA 1.492 2.398 0 O-C-N 121.193 -1.18 . . . . 0.0 110.424 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 2.7 mt-10 -59.51 -30.17 68.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.272 . . . . 0.0 110.098 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.62 -47.3 63.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.607 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 38.6 m-80 -68.01 -42.38 80.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.172 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 ' CG2' ' A' ' 61' ' ' THR . 3.4 mp -59.18 -32.01 69.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.799 . . . . 0.0 111.043 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -55.42 -23.81 27.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.973 -1.08 . . . . 0.0 109.943 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 32' ' ' SER . 4.0 pp -61.85 -37.01 82.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.096 -1.002 . . . . 0.0 109.042 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.619 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 96.6 p -69.6 -32.27 70.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -20.6 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.3 mm-40 -122.12 -79.8 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.5 Cg_endo -75.89 69.77 6.1 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.064 1.034 . . . . 0.0 110.184 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.96 141.33 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.21 78.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.4 m -131.0 147.9 52.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -1.04 . . . . 0.0 110.173 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.624 ' CE2' HD13 ' A' ' 149' ' ' LEU . 3.0 m-85 -122.64 141.49 51.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 110.072 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.67 ' CD1' ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -135.49 159.51 41.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.512 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.572 HG21 ' CE2' ' A' ' 18' ' ' TYR . 9.7 tt -115.05 138.56 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.579 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 2.6 tmt_? -112.86 160.71 17.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.0 110.261 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' CZ ' ' A' ' 42' ' ' ARG . 11.6 t0 -85.43 106.47 16.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.346 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.449 ' O ' HG13 ' A' ' 5' ' ' VAL . 54.4 m170 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.48 ' HA ' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -163.58 147.73 10.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.659 ' CE2' ' CG2' ' A' ' 5' ' ' VAL . 12.4 p90 -132.11 146.72 52.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.95 . . . . 0.0 110.533 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.468 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -126.08 140.87 52.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.507 -0.746 . . . . 0.0 109.521 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.624 ' CD2' ' CD1' ' A' ' 98' ' ' TYR . 8.3 tt -120.93 145.32 47.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 111.039 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.558 ' HB3' ' CB ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -139.17 153.82 47.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.715 . . . . 0.0 109.453 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG13 ' CG ' ' A' ' 39' ' ' PHE . 33.5 m -121.35 174.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.662 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.52 ' HB2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -112.43 139.22 48.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.565 ' OG1' ' CD2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -153.17 175.87 12.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.94 4.72 15.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.035 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -13.48 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 110.176 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 57' ' ' THR . . . 130.7 150.3 6.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.53 ' CG2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -79.96 132.04 35.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -1.123 . . . . 0.0 110.227 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HE3' ' CG2' ' A' ' 138' ' ' ILE . 10.6 ttmt -122.41 146.54 47.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.495 ' OD1' ' ND2' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -115.8 145.73 42.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.123 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -138.23 152.74 48.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.506 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -126.48 159.79 32.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.6 HG12 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -86.55 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.496 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -113.19 129.22 56.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.068 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 1' ' ' GLU . 28.1 p -88.03 119.67 28.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.455 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.3 tm-20 -108.7 103.24 12.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.2 -0.937 . . . . 0.0 110.1 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.95 -84.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -138.23 21.95 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 58.6 p -123.08 156.79 34.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -110.96 131.55 54.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 0.0 110.178 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.85 146.86 22.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.057 -1.027 . . . . 0.0 110.514 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.611 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.514 ' O ' HG12 ' A' ' 95' ' ' VAL . 6.1 mp -53.81 -46.2 71.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.527 -1.358 . . . . 0.0 110.342 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -37.36 83.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 108.498 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 7.0 tp -68.31 -34.81 76.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.913 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 96' ' ' HIS . 0.3 OUTLIER -54.43 -36.95 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.905 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.536 ' N ' HG12 ' A' ' 95' ' ' VAL . 20.2 t-160 -53.16 -33.65 53.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 0.0 109.042 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.517 ' NE2' HG12 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -78.18 -37.07 46.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.646 ' CE1' ' OH ' ' A' ' 136' ' ' TYR . 4.3 m-85 -78.7 -21.22 48.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.915 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.515 ' CE ' ' HB3' ' A' ' 152' ' ' PRO . 1.3 mtp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 109.992 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.223 0.535 . . . . 0.0 110.296 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' B' ' 168' ' ' VAL . . . 169.98 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.713 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 0.5 OUTLIER -121.85 123.52 41.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.978 -1.076 . . . . 0.0 109.539 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.781 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 8.3 p90 -154.99 167.74 29.32 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.894 -1.129 . . . . 0.0 111.392 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.517 ' CG2' ' HE3' ' A' ' 62' ' ' LYS . 3.3 mt -102.69 143.24 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.656 0.741 . . . . 0.0 111.05 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.716 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 12.5 m-85 -92.89 132.63 36.86 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.637 0.732 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.549 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 0.9 OUTLIER -84.01 52.59 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.641 -0.662 . . . . 0.0 110.22 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.53 27.06 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 162.95 -30.87 0.28 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mt-10 -116.47 121.8 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.02 105.51 11.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.341 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.781 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -93.01 105.23 14.24 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.8 Cg_endo -73.55 129.64 13.94 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.052 1.554 . . . . 0.0 112.358 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.776 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 mp -125.64 135.28 51.99 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -98.27 116.98 42.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.365 -1.46 . . . . 0.0 109.954 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.624 HD13 ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -121.86 135.52 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.066 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.0 t -167.6 54.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.697 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.87 123.88 22.19 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.077 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.515 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 50.7 Cg_endo -78.75 148.32 22.51 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.143 1.602 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -85.83 133.78 33.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.823 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.828 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.105 0.478 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.4 p -152.58 -179.54 7.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -127.85 143.48 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 137' ' ' TYR . 4.4 m . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.4 0.619 . . . . 0.0 111.126 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.419 ' HA ' HD11 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.254 0.55 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.9 p90 -55.79 -39.02 70.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.525 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 40.0 tp60 -61.16 -42.27 98.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.123 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 73' ' ' PHE . 1.1 mt -67.27 -47.23 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.628 ' CG1' ' CE2' ' A' ' 73' ' ' PHE . 2.4 m -72.56 -44.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.667 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.565 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 p -58.35 -32.55 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.47 ' N ' HG11 ' A' ' 6' ' ' VAL . 55.6 t-20 -67.98 -40.92 83.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.096 -1.003 . . . . 0.0 109.78 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . . . -76.36 -44.99 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 6' ' ' VAL . 4.3 m -57.93 -39.7 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.529 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.9 ttt180 -55.44 -45.9 76.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 109.69 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -32.94 50.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.687 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HG ' ' CZ ' ' A' ' 17' ' ' PHE . 5.9 tp -68.23 -43.98 76.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.455 -0.778 . . . . 0.0 110.286 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 3.4 pt20 -64.65 -33.83 76.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.187 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.554 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 2.9 mt-10 -57.84 -31.03 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -67.29 -41.3 85.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.034 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.75 36.62 3.19 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.599 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 5.6 p90 -145.39 28.17 1.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -1.166 . . . . 0.0 110.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.429 ' HE1' ' HB3' ' A' ' 20' ' ' SER . 3.0 t80 -90.76 136.29 33.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.727 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 69.4 m95 -117.51 149.23 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' TRP . 89.7 p 178.98 -15.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -13.26 4.36 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.714 -0.616 . . . . 0.0 110.533 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.39 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.599 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.58 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -89.16 175.82 7.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.791 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.548 ' HA2' ' CD ' ' A' ' 42' ' ' ARG . . . -46.03 -83.77 0.02 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.34 -30.51 45.32 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 121.398 -1.06 . . . . 0.0 110.681 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.58 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.4 mm-40 -58.27 -26.69 63.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.338 . . . . 0.0 110.422 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.87 -49.97 47.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.016 -1.053 . . . . 0.0 109.117 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.609 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -69.99 -46.39 65.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.0 110.747 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 HD13 ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -59.08 -31.34 68.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.445 -0.784 . . . . 0.0 111.602 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.3 pp -54.63 -23.62 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.789 -1.194 . . . . 0.0 109.442 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.646 HD11 ' N ' ' A' ' 32' ' ' SER . 3.6 pp -68.95 -34.11 74.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.155 -0.966 . . . . 0.0 108.567 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.646 ' N ' HD11 ' A' ' 31' ' ' LEU . 1.4 t -69.97 -32.81 71.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.67 -0.643 . . . . 0.0 110.234 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.66 -20.72 42.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.85 . . . . 0.0 110.488 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.74 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -122.9 -80.59 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.972 -1.08 . . . . 0.0 110.922 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.74 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 53.1 Cg_endo -75.24 68.46 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.015 1.008 . . . . 0.0 110.703 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.92 141.43 10.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.023 . . . . 0.0 110.399 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 78.93 20.58 70.16 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 53.7 m -117.55 148.3 42.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.984 . . . . 0.0 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 8.3 p90 -121.86 138.94 54.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.005 -1.06 . . . . 0.0 109.787 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.727 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.7 OUTLIER -138.95 156.71 47.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.388 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.3 tt -115.37 133.75 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.376 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.604 ' NE ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.89 141.43 46.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.856 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 49.3 t0 -82.08 132.77 35.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.106 -0.996 . . . . 0.0 110.247 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 42' ' ' ARG . 59.4 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.363 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 80.9 m-70 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.301 0.572 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CB ' HG12 ' A' ' 5' ' ' VAL . 16.3 p90 -177.45 175.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.674 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 38.0 p90 -125.73 141.64 51.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.039 -1.038 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.604 ' CG2' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -125.33 144.34 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.686 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -121.99 133.6 54.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.769 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -139.1 154.28 48.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 110.087 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' CG1' HD21 ' A' ' 149' ' ' LEU . 10.7 p -132.98 174.9 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 2.0 ttpp -103.36 135.2 45.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.455 HG23 ' CB ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -97.7 -154.02 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.444 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -66.6 -24.46 66.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 58' ' ' GLN . 2.4 m -177.02 29.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.65 109.8 0.56 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.424 ' C ' ' HD2' ' A' ' 62' ' ' LYS . 32.2 p -98.2 108.94 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.155 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HD3' HG21 ' A' ' 138' ' ' ILE . 2.4 mptp? -116.93 159.28 22.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.994 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.769 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 38.6 m-20 -112.01 134.22 53.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.673 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 1.2 mm? -109.4 117.99 35.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.491 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -117.0 148.38 41.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.258 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.656 ' CG2' ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -76.74 130.57 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.0 OUTLIER -94.74 151.18 19.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.43 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 72' ' ' SER . 27.6 p -97.89 139.08 34.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 72' ' ' SER . 70.5 mt-10 -131.56 113.04 13.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.342 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 46.65 24.27 1.72 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.29 -2.19 40.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m -95.01 153.63 17.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.656 ' CE2' ' CG2' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -113.39 126.78 55.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.8 OUTLIER -155.53 147.59 23.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.521 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.55 ' CD1' HD12 ' A' ' 94' ' ' LEU . 14.7 tp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.674 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 4.6 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.531 HD12 ' CG1' ' A' ' 91' ' ' VAL . 10.9 mp -59.24 -46.08 89.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 108.681 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HA ' ' CD2' ' A' ' 96' ' ' HIS . 7.8 tptt -67.23 -30.7 70.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -58.57 -34.56 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.612 -0.68 . . . . 0.0 109.879 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.539 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 3.0 m -54.83 -37.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 93' ' ' LYS . 18.8 m-70 -55.38 -47.26 76.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.063 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -61.21 -36.74 80.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.476 -0.765 . . . . 0.0 109.258 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.686 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 2.6 m-30 -65.12 -9.38 22.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 109.975 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.483 ' O ' ' CG ' ' A' ' 99' ' ' MET . 2.7 ptt? . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 1.3 mtm180 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.297 0.57 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.623 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 172.93 112.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.67 ' CZ ' ' CG2' ' B' ' 167' ' ' VAL . 0.5 OUTLIER -104.66 122.76 46.33 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.152 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.828 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -156.94 156.39 32.95 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.322 -0.861 . . . . 0.0 110.091 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.872 ' N ' HD23 ' A' ' 147' ' ' LEU . 2.0 mt -103.37 149.4 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.339 -0.851 . . . . 0.0 109.796 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.624 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 81.4 m-85 -85.37 132.05 34.3 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.264 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.526 ' CB ' HD13 ' A' ' 145' ' ' ILE . 2.7 t -95.25 59.06 2.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.245 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.33 54.07 40.31 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.15 1.0 58.33 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 6.4 mm-40 -120.01 123.49 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.86 119.13 14.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.355 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -118.31 115.27 36.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.035 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.828 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 42.7 Cg_endo -69.33 125.23 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.808 1.425 . . . . 0.0 111.349 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.872 HD23 ' N ' ' A' ' 138' ' ' ILE . 1.9 pp -127.03 101.93 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 148' ' ' VAL . 7.6 p -102.45 118.58 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.814 -1.179 . . . . 0.0 111.034 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.554 HD21 ' CG1' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -76.66 114.88 15.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 -30.25 6.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 110.935 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.87 124.47 70.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.987 -1.07 . . . . 0.0 110.203 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 50.0 Cg_endo -78.0 141.09 18.56 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.03 1.542 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.634 ' CD2' ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.55 158.13 15.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.446 ' N ' HD23 ' A' ' 153' ' ' LEU . 45.0 m . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.459 ' O ' ' O ' ' B' ' 166' ' ' THR . 5.3 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.192 0.52 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.459 ' O ' ' O ' ' B' ' 165' ' ' SER . 0.2 OUTLIER 53.5 169.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.67 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 1.8 t -126.82 102.64 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.7 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 2.3 t . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.091 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.42 ' CA ' HD12 ' A' ' 4' ' ' LEU . 5.0 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.258 0.551 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.489 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.5 p90 -54.85 -36.6 65.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.507 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.8 tt0 -54.89 -32.69 61.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.962 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.42 HD12 ' CA ' ' A' ' 1' ' ' GLU . 6.4 mt -59.56 -47.43 85.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 91' ' ' VAL . 2.4 t -64.55 -44.77 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.865 . . . . 0.0 110.775 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.59 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -58.03 -33.5 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.299 -0.876 . . . . 0.0 110.575 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.547 ' N ' HG11 ' A' ' 6' ' ' VAL . 6.6 t-20 -71.44 -40.35 70.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 0.0 110.589 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.1 -44.46 38.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.249 -0.907 . . . . 0.0 110.75 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.671 ' CG1' ' CD2' ' A' ' 51' ' ' PHE . 7.4 m -57.2 -38.37 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -54.23 -49.12 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.862 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -78.44 -40.19 36.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -0.999 . . . . 0.0 109.925 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.489 HD13 ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -72.27 -31.22 65.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.399 -0.813 . . . . 0.0 111.032 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.726 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 22.3 mt-30 -59.44 -41.45 89.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 0.0 111.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.48 -52.56 8.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.889 -1.132 . . . . 0.0 110.598 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 t -73.68 -42.4 61.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 111.746 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' C ' ' A' ' 17' ' ' PHE . . . -90.23 67.57 2.57 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.36 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.702 ' C ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 2.21 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.742 -0.858 . . . . 0.0 110.8 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.726 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 3.8 t80 -90.87 136.23 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.645 ' CD1' HD11 ' A' ' 40' ' ' LEU . 15.9 m95 -116.59 148.24 41.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -142.26 23.73 1.99 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.07 0.13 31.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.784 . . . . 0.0 110.949 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.53 -158.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 110.343 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.567 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.26 166.97 11.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 110.334 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' CA ' ' HG2' ' A' ' 42' ' ' ARG . . . -39.73 -84.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.555 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.05 -31.7 42.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.567 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 7.7 tt0 -59.53 -24.85 64.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.283 . . . . 0.0 109.938 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -72.95 -48.42 36.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.587 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -68.44 -36.16 78.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.326 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD12 ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -58.24 -31.71 67.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 110.976 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.9 pp -55.49 -23.84 28.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.875 -1.141 . . . . 0.0 109.223 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.626 ' CD1' ' O ' ' A' ' 38' ' ' THR . 2.7 pp -70.33 -32.95 70.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 108.648 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.582 ' N ' HD11 ' A' ' 31' ' ' LEU . 61.2 m -69.85 -33.09 71.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.578 -0.701 . . . . 0.0 110.08 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -21.19 41.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.068 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.766 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.4 mm-40 -122.31 -83.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.564 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.766 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.17 69.27 4.87 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 122.923 0.959 . . . . 0.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.59 141.53 37.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.225 -0.922 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 83.31 19.44 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.626 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 4.0 m -122.43 148.33 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.505 -0.997 . . . . 0.0 110.204 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 4.5 p90 -122.21 138.97 54.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.852 -1.155 . . . . 0.0 109.981 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 HD11 ' CD1' ' A' ' 19' ' ' TRP . 0.4 OUTLIER -142.35 159.31 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 0.0 110.276 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.64 ' CG2' ' CD2' ' A' ' 18' ' ' TYR . 2.4 tt -117.01 149.21 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tpt180 -121.62 152.89 38.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.445 -0.784 . . . . 0.0 109.612 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.573 ' CA ' ' OH ' ' A' ' 18' ' ' TYR . 8.8 t0 -90.76 104.31 16.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.956 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 8.3 t . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 0.0 110.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.158 0.504 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.578 ' CZ ' ' O ' ' A' ' 51' ' ' PHE . 20.0 t80 -155.82 156.06 34.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.671 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 8.7 p90 -115.96 151.79 34.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.478 ' C ' HG13 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -126.41 147.62 49.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.634 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -131.1 125.07 32.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.39 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.545 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -122.8 153.74 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 61' ' ' THR . 10.2 m -121.39 174.56 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.372 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.5 tttm -103.47 126.48 50.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.551 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 21.4 p -128.9 169.87 14.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.86 -27.11 67.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 t -86.41 -28.31 23.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.161 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 147.36 156.78 7.12 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 ' CB ' HD13 ' A' ' 29' ' ' LEU . 17.3 p -80.13 138.08 36.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.462 ' CB ' HG12 ' A' ' 138' ' ' ILE . 23.2 mmtm -137.15 160.45 38.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.493 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 5.5 p30 -138.28 154.64 49.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.547 ' CD2' ' HA ' ' B' ' 166' ' ' THR . 8.0 mt -137.45 148.41 46.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 110.01 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -98.25 152.29 19.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.616 HG12 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -79.33 139.6 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -96.4 151.0 19.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 73' ' ' PHE . 18.5 p -99.36 137.03 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 mt-10 -130.63 102.89 6.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 43.24 -95.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -120.53 32.75 4.73 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 5.0 p -139.58 150.91 45.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.292 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.616 ' CD2' HG12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -124.29 144.83 49.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 66' ' ' ILE . 2.2 t -155.18 141.3 18.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.119 -0.988 . . . . 0.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 17.8 tp . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.282 -0.886 . . . . 0.0 110.455 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.545 HG23 ' CZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.074 0.464 . . . . 0.0 111.125 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -54.19 -35.77 62.7 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.907 -1.121 . . . . 0.0 110.058 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.565 ' NZ ' ' CD2' ' A' ' 96' ' ' HIS . 0.3 OUTLIER -62.39 -36.4 82.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.991 -1.068 . . . . 0.0 109.437 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.82 -35.87 75.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.595 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' MET . 78.0 t -56.02 -38.31 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.78 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.565 ' CD2' ' NZ ' ' A' ' 93' ' ' LYS . 26.7 t60 -54.79 -46.55 74.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.573 ' CD2' HG12 ' B' ' 167' ' ' VAL . 0.9 OUTLIER -71.78 -42.95 66.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.634 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 2.0 m-30 -69.31 -22.11 63.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.568 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 6.9 ppt_? . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.23 0.538 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 169.5 129.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.431 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.704 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 2.5 t80 -116.18 121.78 43.12 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.807 -1.183 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.762 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 2.7 p90 -156.99 167.97 28.88 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.878 -1.139 . . . . 0.0 111.185 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.462 HG12 ' CB ' ' A' ' 62' ' ' LYS . 2.8 mp -121.62 149.54 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.95 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.76 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.1 m-30 -84.85 110.47 18.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.729 . . . . 0.0 110.119 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 3.9 m -66.32 56.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.53 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 65.84 82.9 0.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.25 -10.42 49.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.8 tt0 -120.01 121.6 39.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.269 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 2.4 ptpt -89.8 105.5 17.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.762 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.02 109.14 52.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.3 Cg_endo -72.57 128.95 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.996 1.524 . . . . 0.0 111.938 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.712 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -125.83 135.88 52.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 25.3 m -98.04 117.12 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.382 -1.449 . . . . 0.0 110.079 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.581 HD21 ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -117.38 137.91 52.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.047 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.428 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -176.02 41.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.583 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -111.56 124.96 31.31 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.148 -0.97 . . . . 0.0 110.046 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.632 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 45.7 Cg_endo -73.08 147.32 42.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 111.059 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 38' ' ' THR . 0.3 OUTLIER -89.7 128.66 36.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.742 . . . . 0.0 109.778 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.463 ' N ' HD11 ' A' ' 153' ' ' LEU . 49.4 m . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.426 ' C ' HD21 ' A' ' 64' ' ' LEU . 56.6 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.214 0.53 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.579 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.5 OUTLIER 176.87 155.82 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.192 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.704 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 15.3 t -118.62 132.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.61 HG23 ' CE2' ' A' ' 137' ' ' TYR . 5.8 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.188 0.518 . . . . 0.0 110.354 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.527 ' O ' HG22 ' A' ' 5' ' ' VAL . 33.7 p90 -65.31 -37.55 87.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.5 OUTLIER -69.32 -33.65 73.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.218 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 1' ' ' GLU . 3.3 mt -67.09 -47.3 71.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.516 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 34.8 m -72.18 -37.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.449 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.45 -32.97 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.33 -45.65 92.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -67.0 -43.11 83.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 60.1 t -56.93 -39.39 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 15.3 ttt180 -55.47 -48.81 73.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.855 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.37 -33.02 49.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.64 -44.08 71.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.267 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 6.5 pt20 -65.59 -33.77 76.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.01 -32.26 73.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.312 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.6 p -69.68 -27.5 65.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.28 19.97 21.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CD2' ' CD1' ' A' ' 153' ' ' LEU . 3.0 m-85 -108.5 4.22 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -1.129 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.54 ' OH ' ' CB ' ' A' ' 43' ' ' ASP . 21.6 t80 -90.86 136.07 33.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.355 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.604 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -92.23 148.34 22.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' TRP . 2.6 t -40.68 -92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.783 . . . . 0.0 110.321 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . 171.91 61.72 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.527 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -59.53 -137.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -85.32 166.19 16.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 109.551 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.551 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . -39.89 -83.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.29 -30.18 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.593 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 17.0 tt0 -57.78 -34.79 69.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.982 -1.305 . . . . 0.0 110.517 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 22' ' ' VAL . . . -66.84 -48.73 67.96 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.94 -1.1 . . . . 0.0 109.025 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.647 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 29.1 m-80 -69.3 -43.15 74.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.463 -0.773 . . . . 0.0 110.728 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -70.28 -31.78 69.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 111.686 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.565 HD23 ' CZ3' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -54.76 -41.15 70.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.88 -1.138 . . . . 0.0 110.352 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.1 pp -61.02 -34.69 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 108.964 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.578 ' CB ' ' CG ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -69.79 -32.82 71.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -20.62 42.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.504 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.8 mt-10 -114.89 -76.75 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.2 Cg_endo -72.85 65.53 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.299 1.157 . . . . 0.0 110.118 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.91 140.62 11.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 80.15 -2.44 76.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.57 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 3.1 m -104.41 146.38 28.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.432 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 151' ' ' ARG . 39.9 p90 -123.79 138.88 54.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.985 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.604 ' HB2' ' CD1' ' A' ' 19' ' ' TRP . 0.5 OUTLIER -141.4 159.4 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.145 -0.972 . . . . 0.0 110.619 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 53' ' ' LEU . 1.7 tt -115.16 130.58 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.945 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.551 ' NH2' ' HA2' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -112.72 160.5 17.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.032 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' CB ' ' OH ' ' A' ' 18' ' ' TYR . 12.4 t70 -74.0 126.28 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.137 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.547 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 9.4 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 110.101 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.498 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.6 m-70 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.225 0.536 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 44' ' ' SER . 42.7 p90 -177.78 -158.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.659 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 35.5 p90 -133.26 149.14 51.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.377 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.553 HG23 ' CA ' ' A' ' 65' ' ' ARG . 74.7 m -126.22 155.13 42.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.18 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.663 ' CD2' ' CD1' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -137.24 146.44 44.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.697 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.564 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 25.1 p -139.43 153.99 47.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG2' ' HG ' ' A' ' 149' ' ' LEU . 8.8 p -120.13 172.24 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 1.6 tmtp? -123.01 139.19 54.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.524 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -151.65 -173.35 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.66 24.23 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.513 ' CB ' HG21 ' A' ' 145' ' ' ILE . 1.7 p -126.98 -2.62 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.25 139.55 5.6 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 61' ' ' THR . 15.3 t -95.31 109.56 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.308 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -110.65 155.18 22.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 110.04 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 6.7 t-20 -111.53 128.68 56.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.589 ' CD2' HG22 ' B' ' 167' ' ' VAL . 0.9 OUTLIER -130.23 152.06 50.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -0.971 . . . . 0.0 110.33 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' CA ' HG23 ' A' ' 52' ' ' THR . 3.0 ptm180 -121.68 -145.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.777 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.644 ' CG1' ' CD1' ' A' ' 73' ' ' PHE . 1.4 tp -116.75 149.02 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 0.0 110.341 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -110.76 124.71 52.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.57 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 29.4 p -87.81 126.89 35.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.65 103.02 7.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.47 -102.15 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.6 36.19 3.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.06 160.39 40.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -1.18 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.644 ' CD1' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.16 138.44 46.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.855 . . . . 0.0 110.033 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.534 ' N ' HD13 ' A' ' 66' ' ' ILE . 2.3 t -155.32 150.15 26.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.643 HD12 ' CE2' ' A' ' 98' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.052 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.659 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 3.8 p . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.223 0.535 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.29 -34.08 63.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 110.073 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -57.53 -31.76 66.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -59.83 -35.4 74.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.246 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.7 m -55.33 -37.32 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.316 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.512 ' CB ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -53.83 -34.71 60.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.023 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.614 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -78.07 -36.77 47.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 109.986 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.663 ' CD1' ' CD2' ' A' ' 53' ' ' LEU . 3.3 m-85 -63.55 -22.02 66.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 0.0 110.319 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.257 0.551 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.59 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -175.42 111.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.688 ' CZ ' ' CG2' ' B' ' 167' ' ' VAL . 2.1 t80 -103.0 121.42 42.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.936 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.943 ' HA ' ' HB2' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -158.9 165.89 33.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.0 . . . . 0.0 110.423 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.678 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 6.1 mt -123.5 126.73 73.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.012 . . . . 0.0 109.758 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.781 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -83.36 107.63 16.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.832 0.825 . . . . 0.0 109.717 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' TYR . 56.1 p -42.45 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.774 -0.579 . . . . 0.0 110.411 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.84 80.3 0.36 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.38 82.31 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 139' ' ' TYR . 39.8 tt0 -114.06 121.28 43.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.281 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.653 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 21.9 mtmm -76.94 108.45 9.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 110.949 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -104.31 132.47 20.94 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.668 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.56 128.16 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.79 1.416 . . . . 0.0 112.111 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.943 ' HB2' ' HA ' ' A' ' 137' ' ' TYR . 8.3 mp -123.69 101.5 7.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.71 117.81 44.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.874 -1.142 . . . . 0.0 111.207 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.8 mp -79.73 114.83 18.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.283 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.18 -23.93 2.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -85.91 124.9 70.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 110.271 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.581 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 47.9 Cg_endo -74.74 128.26 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.055 1.555 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.633 ' CD2' ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.76 158.22 16.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.519 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.104 -0.997 . . . . 0.0 110.264 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.474 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.1 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.174 0.512 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.567 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 31.0 m -145.16 147.71 32.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.688 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 1.6 t -87.67 102.39 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.677 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.405 -0.81 . . . . 0.0 110.231 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.522 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.336 0.588 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 38.0 p90 -63.38 -36.08 82.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.479 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -55.57 -36.21 66.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.524 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 4.2 mt -64.29 -44.46 91.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' HG21 ' A' ' 9' ' ' VAL . 12.1 t -66.63 -48.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.541 ' O ' HG21 ' A' ' 9' ' ' VAL . 41.8 t -58.82 -41.75 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -71.22 -31.26 67.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 109.833 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.583 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -76.05 -44.28 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.458 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 6' ' ' VAL . 29.9 m -57.11 -38.71 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.241 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.528 ' N ' HG23 ' A' ' 9' ' ' VAL . 4.6 mtp180 -55.04 -40.63 70.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -71.36 -42.39 68.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.959 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.49 HD21 HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -72.04 -40.18 68.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 5.3 pt20 -68.19 -33.73 74.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.511 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 4.0 tm-20 -57.65 -21.45 39.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 110.261 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -26.95 62.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.17 37.8 3.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 25.5 t80 -142.13 7.15 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -1.142 . . . . 0.0 110.235 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.578 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 6.3 t80 -96.28 136.21 37.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.657 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 28.6 m95 -110.6 148.31 32.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.478 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.575 ' CA ' ' HD2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -148.41 109.74 4.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . . . 176.59 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 111.089 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG23 ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -120.88 -160.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.862 -1.149 . . . . 0.0 110.277 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -86.09 166.04 16.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -52.19 -76.45 0.18 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.683 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -60.74 -43.72 98.79 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 29.9 tt0 -59.78 -24.83 64.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 110.01 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . . . -78.12 -45.55 23.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.32 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.683 HD21 ' HA2' ' A' ' 25' ' ' GLY . 1.6 m-80 -69.04 -41.8 77.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.389 -0.819 . . . . 0.0 110.755 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 29' ' ' LEU . 1.4 mp -59.43 -32.14 69.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.766 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.551 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.2 pp -55.21 -23.58 22.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.982 -1.074 . . . . 0.0 109.352 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.66 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 70.9 mt -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 109.096 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.545 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 26.9 p -69.19 -32.43 71.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.716 . . . . 0.0 109.888 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.48 -20.62 43.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.371 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.757 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 12.5 mm-40 -134.06 -83.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.757 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 50.3 Cg_endo -78.01 67.67 8.01 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 122.812 0.901 . . . . 0.0 110.152 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -63.67 141.47 58.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 88.98 15.74 58.88 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -130.63 147.17 52.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -1.05 . . . . 0.0 110.142 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CD1' ' CD2' ' A' ' 149' ' ' LEU . 4.0 p90 -123.11 146.22 47.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 0.0 110.678 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.657 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.08 160.31 43.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 51' ' ' PHE . 3.3 tt -114.0 128.84 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.924 -1.11 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -117.68 150.44 39.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.755 . . . . 0.0 110.122 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 44' ' ' SER . 9.8 t70 -73.87 127.56 33.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 43' ' ' ASP . 25.5 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.324 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 59.4 m170 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.1 0.476 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.565 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 12.4 p90 -152.7 -160.99 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 41' ' ' ILE . 27.1 p90 -115.9 148.72 39.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.529 ' HB ' ' CA ' ' A' ' 24' ' ' GLY . 88.6 m -126.13 139.76 53.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -126.92 124.97 40.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.583 ' CB ' ' CB ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -133.9 154.29 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.476 -0.765 . . . . 0.0 110.049 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' CG1' HD13 ' A' ' 149' ' ' LEU . 12.4 p -130.58 174.08 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -118.86 139.02 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.204 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 26.6 m -115.21 -43.3 3.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' THR . 2.8 pt20 -177.99 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.59 29.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.76 65.46 0.31 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 t -84.96 111.85 20.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -1.144 . . . . 0.0 110.138 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HG3' ' CG2' ' A' ' 138' ' ' ILE . 14.3 mmtt -123.53 166.08 16.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -134.32 154.12 51.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -138.01 118.15 13.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 110.53 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HD2' ' CZ ' ' A' ' 50' ' ' PHE . 10.7 ptm180 -75.32 162.21 28.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.864 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.649 ' CG2' ' CD1' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -78.27 148.78 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 110.263 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -107.53 136.75 46.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 1' ' ' GLU . 27.9 p -87.83 119.97 28.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.28 103.09 8.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.64 -78.27 0.02 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -148.25 30.35 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.44 163.09 33.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.649 ' CD1' ' CG2' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -115.7 141.18 48.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 109.977 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.49 ' N ' ' CD1' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -148.15 138.89 23.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.94 -1.1 . . . . 0.0 110.616 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 HD12 ' CZ ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 109.793 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.703 0.763 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.549 ' O ' ' CG2' ' A' ' 95' ' ' VAL . 2.0 pp -54.41 -33.87 60.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.565 -0.709 . . . . 0.0 111.545 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.514 ' N ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -57.31 -30.41 64.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.596 -1.315 . . . . 0.0 109.741 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 91' ' ' VAL . 1.1 pp -58.78 -33.02 69.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 92' ' ' LEU . 4.3 m -53.39 -34.85 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.429 -0.794 . . . . 0.0 110.353 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -51.29 -30.06 16.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 109.51 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.508 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 2.0 t60 -73.17 -36.3 66.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.166 -0.959 . . . . 0.0 108.825 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.648 ' CE1' ' OH ' ' A' ' 136' ' ' TYR . 1.8 m-85 -63.57 -22.12 66.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.568 -0.707 . . . . 0.0 109.674 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.538 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 10.8 ttm . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.465 -0.772 . . . . 0.0 110.301 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.195 0.521 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -171.97 126.34 0.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 110.058 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.684 ' HA ' HG21 ' B' ' 168' ' ' VAL . 3.7 t80 -128.59 121.81 29.56 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.408 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.745 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 12.6 p90 -156.83 167.33 30.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.203 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.524 ' CD1' HD23 ' A' ' 147' ' ' LEU . 2.6 mp -106.05 149.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.635 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 29.5 m-85 -96.18 133.05 40.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.76 . . . . 0.0 110.992 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -87.46 48.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.636 -0.665 . . . . 0.0 110.217 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 52.49 65.73 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.07 -22.48 15.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.53 121.97 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -1.174 . . . . 0.0 110.162 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.4 ptmt -88.48 105.72 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.27 102.98 10.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.745 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.2 Cg_endo -76.18 126.68 9.37 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.681 1.358 . . . . 0.0 111.981 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.659 ' CG ' ' HA ' ' A' ' 137' ' ' TYR . 0.4 OUTLIER -126.76 136.0 51.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 148' ' ' VAL . 30.2 m -97.08 117.18 41.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.136 -1.603 . . . . 0.0 110.624 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.594 ' CD2' ' CD1' ' A' ' 39' ' ' PHE . 6.3 tt -90.11 114.93 26.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.65 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -148.94 19.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.021 -1.05 . . . . 0.0 110.821 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -105.6 124.49 36.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.03 -1.044 . . . . 0.0 109.976 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.5 Cg_endo -76.57 148.22 29.14 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.954 1.502 . . . . 0.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.07 152.87 30.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 110.089 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 110.192 179.892 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.158 0.504 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.534 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 2.6 t -146.82 175.47 10.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 110.26 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.664 HG11 ' CG ' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -128.73 112.36 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.976 . . . . 0.0 110.272 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.696 HG22 ' CD2' ' A' ' 137' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.238 0.542 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.08 -36.14 80.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.518 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -55.2 -34.21 63.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.167 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -67.26 -45.17 77.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 110.205 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -64.94 -48.4 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.564 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -58.42 -32.62 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.311 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 6' ' ' VAL . 17.6 m-20 -68.11 -42.52 80.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' A' ' 91' ' ' VAL . . . -76.12 -44.91 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 5.4 m -59.01 -39.58 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -55.54 -49.01 73.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -35.94 65.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 109.513 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.13 -44.09 63.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.961 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.507 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 16.7 pt20 -68.21 -33.87 75.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.6 -26.48 61.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.112 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -26.89 62.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.024 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.19 1.61 56.93 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.606 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t80 -88.96 -8.33 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 110.187 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.625 ' CD2' ' CG2' ' A' ' 41' ' ' ILE . 5.7 t80 -90.91 136.23 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.812 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.608 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 46.3 m95 -99.79 148.42 24.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -53.07 -18.7 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.855 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 42' ' ' ARG . . . 75.54 93.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.659 . . . . 0.0 111.16 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 1.8 m -66.41 -90.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.284 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.58 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 1.1 m -103.5 172.99 6.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.003 -1.061 . . . . 0.0 109.219 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.23 -94.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' C ' HD11 ' A' ' 29' ' ' LEU . . . -71.25 -29.5 68.43 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.485 -1.009 . . . . 0.0 110.651 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.58 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -57.56 -24.95 59.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.25 . . . . 0.0 111.204 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . . . -76.46 -47.04 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.825 -1.172 . . . . 0.0 109.66 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.661 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.7 m-80 -70.34 -44.86 67.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 111.066 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 61' ' ' THR . 15.1 mt -70.7 -31.53 68.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 3.7 pp -54.28 -27.41 35.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.535 -1.353 . . . . 0.0 110.561 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.4 pp -74.05 -33.75 63.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.545 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -69.89 -32.72 71.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 110.296 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.07 41.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.352 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.744 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 3.7 mm-40 -113.95 -77.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.057 -1.027 . . . . 0.0 110.063 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.744 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.0 Cg_endo -72.49 71.09 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.271 1.143 . . . . 0.0 110.142 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.09 137.18 47.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.04 0.6 89.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -111.23 147.41 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -1.181 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.619 ' CZ ' HD22 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -122.79 148.75 45.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.0 110.716 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.608 ' HB2' ' CD1' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -147.65 160.02 43.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 109.91 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.625 ' CG2' ' CD2' ' A' ' 18' ' ' TYR . 7.1 tt -113.95 148.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.973 . . . . 0.0 110.46 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.592 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 5.7 ppt_? -127.38 127.59 44.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 24.7 t70 -75.27 138.24 41.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.483 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.578 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 12.9 m . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.228 0.537 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.555 ' CE1' ' HG3' ' A' ' 65' ' ' ARG . 17.2 p90 -154.42 -156.13 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.607 ' CZ ' HG23 ' A' ' 91' ' ' VAL . 14.2 p90 -116.01 152.71 33.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.448 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 24.3 m -118.13 155.54 30.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.831 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 1.2 tm? -142.17 129.68 21.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.301 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.564 ' CB ' ' HB3' ' A' ' 28' ' ' ASN . 3.1 p -138.32 154.13 49.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.642 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' HD23 ' A' ' 149' ' ' LEU . 2.8 m -127.03 173.99 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 110.835 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.534 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 14.5 tptm -113.04 129.58 56.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.887 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.536 ' CG2' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.63 -165.76 1.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.387 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' GLY . 8.4 tt0 -77.93 -59.12 2.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -42.24 -27.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' GLN . . . 130.66 151.92 7.24 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 29' ' ' LEU . 2.4 t -78.87 108.89 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.181 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.553 ' CB ' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -110.37 153.2 25.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.942 . . . . 0.0 110.099 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.543 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 15.0 p30 -121.06 125.84 48.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.532 ' CD1' HG21 ' B' ' 167' ' ' VAL . 2.8 mp -118.65 151.93 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.555 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 1.4 ptt180 -140.36 152.99 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 110.437 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.604 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -76.62 117.86 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 74' ' ' SER . 16.2 tt0 -91.95 151.14 20.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 110.484 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 20.0 p -101.62 127.84 48.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -133.14 117.01 16.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.31 34.15 87.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.22 -14.22 54.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 51.2 p -94.99 162.81 13.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -1.14 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.7 m-30 -110.92 152.01 27.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 67' ' ' GLN . 19.3 m -155.63 138.7 15.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.533 ' CB ' HD21 ' A' ' 94' ' ' LEU . 2.6 tt . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.076 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.607 HG23 ' CZ ' ' A' ' 51' ' ' PHE . 7.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 95' ' ' VAL . 8.6 mt -61.64 -42.07 98.38 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.572 HD13 ' CZ ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -57.86 -34.41 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 110.43 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 92' ' ' LEU . 3.7 m -54.35 -37.67 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.94 -1.1 . . . . 0.0 109.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.459 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 80.1 m-70 -68.16 -37.34 80.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.247 -0.908 . . . . 0.0 109.188 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.705 ' CD2' HG12 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -77.57 -36.87 51.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 109.749 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.831 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 5.6 m-85 -77.1 -22.33 52.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.824 . . . . 0.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.336 -179.777 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.244 0.545 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.588 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -176.31 102.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.734 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 3.0 t80 -102.62 122.51 44.55 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.903 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.808 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 3.5 p90 -155.73 167.9 28.89 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.927 -1.108 . . . . 0.0 110.781 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.553 HG12 ' CB ' ' A' ' 62' ' ' LYS . 3.0 mp -121.09 149.58 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 111.055 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.752 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.0 OUTLIER -84.71 107.94 17.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 110.057 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -91.82 122.02 33.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 110.286 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.14 65.68 2.59 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 51.35 20.59 5.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 140' ' ' SER . 12.8 tt0 -120.38 121.86 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.135 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.16 105.36 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 110.63 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.808 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.98 109.04 54.79 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.763 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.5 Cg_endo -72.53 128.72 13.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.954 1.502 . . . . 0.0 112.277 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.759 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -125.89 135.21 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 148' ' ' VAL . 35.7 m -103.83 117.72 49.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.273 -1.517 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.65 HD12 ' CD2' ' A' ' 136' ' ' TYR . 12.8 mt -76.17 123.5 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -0.963 . . . . 0.0 108.969 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -137.84 -7.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.82 -1.175 . . . . 0.0 111.647 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 ttm-85 -100.23 124.63 42.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.718 -1.239 . . . . 0.0 110.104 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 147.96 32.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.981 1.516 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.655 ' N ' HD11 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -67.13 159.14 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.648 ' C ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.558 -0.713 . . . . 0.0 111.231 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -125.95 163.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.191 -0.943 . . . . 0.0 110.134 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.734 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 37.8 t -114.47 112.89 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.662 HG21 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.225 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.48 ' CA ' HD11 ' A' ' 4' ' ' LEU . 85.3 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.34 0.591 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 22.1 p90 -64.52 -35.88 82.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.564 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 28.1 pt20 -62.88 -40.22 96.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.48 HD11 ' CA ' ' A' ' 1' ' ' GLU . 1.1 mt -67.0 -47.46 71.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.67 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 7.1 p -68.94 -47.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.318 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' N ' HG12 ' A' ' 5' ' ' VAL . 41.9 t -58.68 -50.23 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.82 -38.42 78.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.724 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . . . -72.34 -38.26 68.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 3.0 t -56.94 -39.39 65.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.3 mtp85 -58.45 -49.42 77.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.568 -0.708 . . . . 0.0 110.104 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -78.57 -33.25 47.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.323 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' CG2' ' A' ' 95' ' ' VAL . 2.2 tt -72.0 -44.15 63.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.758 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 4.6 pt20 -61.28 -40.94 96.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 110.371 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 8.3 tt0 -77.16 -51.64 10.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -72.79 -43.18 63.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 17' ' ' PHE . . . -99.98 33.99 5.85 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.221 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 3.1 p90 29.75 44.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -1.039 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.672 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -92.79 122.92 35.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.715 ' CD1' ' N ' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.61 145.94 49.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 110.126 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 107.31 14.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.29 12.82 0.12 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.472 -0.767 . . . . 0.0 110.016 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -121.54 -159.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.693 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.557 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.19 176.17 7.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.523 ' HA2' ' NE ' ' A' ' 42' ' ' ARG . . . -55.21 -75.3 0.25 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -79.39 -31.77 40.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.557 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 1.9 tp10 -59.0 -36.47 74.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.032 -1.275 . . . . 0.0 109.509 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -60.92 -51.43 69.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.719 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 4.1 m-80 -69.82 -42.88 73.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.968 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.1 mp -70.99 -32.75 69.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -0.842 . . . . 0.0 112.321 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.546 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 2.7 pp -55.4 -35.12 64.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.704 -1.247 . . . . 0.0 110.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.6 pp -66.27 -36.24 82.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.826 -1.171 . . . . 0.0 109.265 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.609 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.53 -32.72 71.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 110.324 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.55 -20.71 42.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.67 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -116.84 -76.03 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.9 Cg_endo -73.18 70.9 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.292 1.154 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 141.28 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 79.91 18.21 73.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.577 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.42 147.31 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -1.079 . . . . 0.0 110.023 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.601 ' CD2' HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -123.02 163.08 21.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.016 . . . . 0.0 110.202 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.646 ' CD1' ' CE2' ' A' ' 19' ' ' TRP . 7.6 tt -151.96 159.18 43.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.96 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.659 ' CG1' ' HB2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.24 129.28 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' NH1' ' HA ' ' A' ' 44' ' ' SER . 6.3 ppt_? -112.16 155.06 24.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.34 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 30.3 t0 -100.05 132.14 45.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.536 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.477 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 36.2 m80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.155 0.502 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 12.1 p90 175.44 178.02 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.878 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.677 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 3.3 p90 -115.88 148.66 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.987 . . . . 0.0 110.3 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 65' ' ' ARG . 2.1 p -126.84 155.33 43.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.865 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.695 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 1.9 tt -124.22 154.09 40.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.562 ' CB ' ' HB3' ' A' ' 28' ' ' ASN . 3.2 p -139.03 153.63 48.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.58 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.8 m -130.13 174.11 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.794 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.516 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.8 139.14 52.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.471 -0.768 . . . . 0.0 110.086 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.54 ' HB ' ' CD1' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -175.6 146.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.3 OUTLIER 66.82 -60.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.184 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER 165.89 -22.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 109.817 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' C ' ' NZ ' ' A' ' 62' ' ' LYS . . . -105.77 117.1 5.38 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.453 HG21 HD11 ' A' ' 29' ' ' LEU . 9.7 t -97.61 116.52 29.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.142 -1.211 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HD3' ' CG2' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -106.71 161.37 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.132 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.53 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 1.1 m-80 -118.98 135.82 54.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.619 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 2.1 mm? -104.05 127.09 51.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.587 ' CB ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -118.02 138.28 52.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 91' ' ' VAL . 1.1 tp -82.95 148.42 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.503 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 27.3 tp60 -112.88 151.06 30.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.503 ' N ' ' HG3' ' A' ' 67' ' ' GLN . 45.2 t -102.04 127.84 48.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 110.231 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.4 tt0 -121.26 103.0 8.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.76 -68.95 0.12 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -157.02 28.03 0.52 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -136.45 161.31 36.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 110.161 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG12 ' A' ' 91' ' ' VAL . 1.3 m-30 -112.95 149.96 32.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.47 ' C ' HD11 ' A' ' 66' ' ' ILE . 16.4 t -150.99 138.82 19.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 94' ' ' LEU . 27.0 tp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.141 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.677 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 4.0 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.171 0.51 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.495 ' CD2' ' HB3' ' A' ' 8' ' ' ALA . 16.3 mt -63.51 -46.06 87.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 108.434 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -60.26 -29.9 69.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.582 HD22 ' CZ ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -57.92 -34.24 69.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.785 -0.572 . . . . 0.0 110.095 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 42.0 t -54.05 -42.15 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.089 -1.007 . . . . 0.0 108.948 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.0 OUTLIER -68.26 -31.37 70.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.915 . . . . 0.0 108.735 178.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.565 ' NE2' HG22 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.12 -43.29 29.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.684 -0.635 . . . . 0.0 109.503 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.695 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 4.2 m-85 -64.05 -22.15 66.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.475 -0.766 . . . . 0.0 110.055 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.249 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.239 0.542 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.586 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -173.25 152.82 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.124 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.768 ' O ' ' O ' ' A' ' 147' ' ' LEU . 1.3 t80 -131.11 122.94 27.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.329 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.822 ' HB3' ' H ' ' A' ' 147' ' ' LEU . 9.4 p90 -155.15 168.03 28.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.583 -1.323 . . . . 0.0 111.64 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.528 ' CG2' ' HD3' ' A' ' 62' ' ' LYS . 4.2 mp -102.16 143.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.624 0.726 . . . . 0.0 110.744 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.721 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.2 m-85 -93.3 132.76 37.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.718 0.771 . . . . 0.0 110.925 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 142' ' ' GLY . 12.1 t -101.8 -163.55 1.02 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.088 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.504 ' N ' ' OG ' ' A' ' 140' ' ' SER . . . -55.67 85.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 63.77 12.43 47.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mm-40 -120.2 121.93 39.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.612 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -87.22 105.26 17.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.471 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.789 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -89.52 108.6 26.01 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.741 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.6 Cg_endo -76.35 129.44 11.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.059 1.558 . . . . 0.0 113.35 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.822 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 2.1 mm? -125.12 134.96 52.25 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 148' ' ' VAL . 17.2 m -101.16 116.45 44.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 119.878 -1.764 . . . . 0.0 110.921 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.62 HD11 ' CG ' ' A' ' 136' ' ' TYR . 56.4 mt -84.79 114.96 22.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.135 -0.978 . . . . 0.0 109.241 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 p -147.69 28.55 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 111.375 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 1.2 mtt180 -134.11 123.22 16.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.789 -1.195 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 50.7 Cg_endo -79.3 135.45 12.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.069 1.562 . . . . 0.0 110.822 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.605 ' CD2' ' HB2' ' A' ' 40' ' ' LEU . 16.3 tp -92.39 146.5 23.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.865 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 110.339 -179.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.272 0.558 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 64' ' ' LEU . 41.7 p -131.25 -173.15 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.686 HG11 ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -123.88 -160.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.106 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.699 HG12 ' CD2' ' A' ' 137' ' ' TYR . 2.3 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 2' ' ' TYR . 6.1 pt-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.545 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 30.0 p90 -66.67 -35.9 81.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.4 tt0 -65.18 -44.13 89.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 2.4 mt -67.12 -47.5 70.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.593 HG22 ' CD2' ' A' ' 51' ' ' PHE . 6.8 p -65.32 -47.85 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 0.0 110.353 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.414 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 24.9 t -58.64 -36.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.05 -33.21 70.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . . . -76.05 -44.36 39.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.04 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 82.0 t -57.45 -39.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.446 -0.784 . . . . 0.0 109.295 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.4 mtm180 -55.86 -48.33 75.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.721 . . . . 0.0 109.893 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -34.75 50.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.984 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.554 ' CD2' HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.04 -43.29 65.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 110.055 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 4.8 pt20 -65.74 -33.73 76.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 2.3 mt-10 -57.61 -33.7 68.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.095 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.433 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 3.7 m -56.02 -27.5 53.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.8 42.71 5.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CE2' ' HE2' ' A' ' 99' ' ' MET . 9.2 p90 -152.59 14.5 0.57 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -1.18 . . . . 0.0 110.452 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.677 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -94.93 126.26 40.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.251 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.62 ' CD1' HD13 ' A' ' 40' ' ' LEU . 16.9 m95 -106.04 148.09 28.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 3.6 m -39.12 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.821 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . 166.99 81.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.451 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.1 t -47.22 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.595 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -108.23 173.07 6.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.811 -1.181 . . . . 0.0 109.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.87 -89.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.44 -30.31 45.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.595 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -57.82 -34.93 70.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.268 . . . . 0.0 110.445 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 30' ' ' LEU . . . -66.48 -49.06 67.89 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.012 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.612 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.0 m-80 -69.29 -39.87 78.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 110.535 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.498 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.1 mp -70.39 -31.41 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 111.712 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.511 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 1.8 pp -54.68 -24.02 20.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.825 -1.172 . . . . 0.0 110.794 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.2 pp -75.41 -36.13 60.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.937 -1.102 . . . . 0.0 109.322 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.588 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -69.69 -32.91 71.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.61 41.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.938 . . . . 0.0 110.72 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.737 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.6 mt-10 -114.34 -76.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.737 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 47.3 Cg_endo -72.12 71.31 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.224 1.118 . . . . 0.0 110.268 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.57 141.28 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.497 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.86 20.76 79.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.21 146.93 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 110.178 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.658 ' CD2' ' CD1' ' A' ' 149' ' ' LEU . 4.3 m-85 -123.42 157.41 33.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.916 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.23 159.18 43.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 110.592 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.677 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 13.1 tt -116.33 144.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.81 136.07 52.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 20' ' ' SER . 1.5 p30 -89.58 121.72 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.507 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 10.8 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 13.7 m-70 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.228 0.537 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 65' ' ' ARG . 20.9 p90 -177.44 -159.5 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 110.194 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.593 ' CD2' HG22 ' A' ' 5' ' ' VAL . 8.5 p90 -126.96 155.79 42.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 74.9 m -126.24 138.38 53.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -0.953 . . . . 0.0 110.267 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.72 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -120.93 124.89 46.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.084 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 28' ' ' ASN . 2.5 p -126.02 154.14 43.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' CD1' ' A' ' 149' ' ' LEU . 2.2 m -122.34 174.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.85 . . . . 0.0 110.717 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 25.7 tttt -107.12 124.23 49.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.511 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 8.9 p -127.4 157.13 40.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 110.332 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.73 -24.24 64.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -79.72 -23.13 42.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 152.82 143.47 3.69 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.3 p -78.93 110.52 14.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HG3' HG12 ' A' ' 138' ' ' ILE . 5.3 mmtt -111.99 161.72 16.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.214 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.454 ' CB ' ' HB2' ' A' ' 54' ' ' SER . 12.7 p30 -140.12 125.98 19.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.516 ' CG ' ' OH ' ' A' ' 136' ' ' TYR . 12.9 mt -104.73 152.08 22.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.539 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -125.11 143.13 51.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.538 HG12 ' CG1' ' A' ' 91' ' ' VAL . 3.5 tp -78.58 136.65 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.077 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -102.79 145.31 29.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 1' ' ' GLU . 42.6 t -108.57 127.5 54.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.0 tt0 -124.17 104.29 8.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.04 -71.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -154.22 23.58 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 163.26 24.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 110.182 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.625 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 1.6 m-30 -119.42 157.87 27.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.634 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.516 ' N ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.12 138.68 15.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.14 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.602 ' CD1' ' CE2' ' A' ' 98' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 73' ' ' PHE . 15.5 m . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 8' ' ' ALA . 6.7 mt -65.11 -46.56 80.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -67.5 -31.14 71.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.069 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 98' ' ' TYR . 3.7 mp -59.36 -33.85 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.84 -0.538 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.2 m -52.47 -37.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.98 -1.075 . . . . 0.0 109.651 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.43 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -57.15 -52.49 65.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.909 -1.119 . . . . 0.0 109.161 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.523 ' CE1' ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -79.21 -40.14 31.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 110.097 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.72 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -64.43 -22.36 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.0 109.64 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.577 ' HE2' ' CE2' ' A' ' 17' ' ' PHE . 2.6 ttp . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 0.0 109.816 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.27 0.557 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.59 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 167.44 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.653 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 3.2 t80 -102.47 122.57 44.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.484 -1.286 . . . . 0.0 109.697 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.776 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.6 p90 -156.08 167.18 31.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.464 HG12 ' HG3' ' A' ' 62' ' ' LYS . 2.5 mp -120.25 149.29 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 111.42 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.67 108.08 17.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.986 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 143' ' ' GLU . 2.8 m -66.84 56.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.572 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 67.31 81.8 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.89 -8.59 49.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -120.23 121.8 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.239 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -89.57 105.25 17.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.095 -1.003 . . . . 0.0 110.62 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.53 110.51 51.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.732 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.1 Cg_endo -71.94 129.47 15.36 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.569 . . . . 0.0 112.107 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.762 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.2 mt -125.74 135.83 52.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.46 117.36 42.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.336 -1.478 . . . . 0.0 109.791 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.658 ' CD1' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -116.2 114.88 25.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.061 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -155.13 41.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.23 125.37 24.63 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.286 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.83 148.11 40.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.009 1.531 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.549 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -76.39 150.69 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.207 0.527 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.27 174.38 12.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.653 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 2.4 t -135.87 146.1 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.621 ' C ' ' O ' ' B' ' 167' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.738 -0.601 . . . . 0.0 110.945 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 68' ' ' CYS . 2.7 tm-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 40.1 p90 -64.36 -35.8 82.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.1 tp60 -54.85 -41.08 70.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.599 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -66.14 -47.4 74.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 50' ' ' PHE . 38.9 t -65.31 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.1 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.74 -49.32 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -58.97 -38.23 78.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.895 . . . . 0.0 109.89 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.597 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -76.29 -44.69 35.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.04 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 75.4 t -57.77 -39.87 72.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.404 -0.81 . . . . 0.0 109.163 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -56.05 -41.66 75.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.869 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -76.87 -44.85 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 1.1 mt -62.11 -44.37 96.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 110.013 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 6.0 pt20 -68.27 -33.82 75.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.252 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.86 -45.13 86.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.534 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.534 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 5.6 m -55.9 -38.42 70.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.967 . . . . 0.0 110.096 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.06 35.64 2.7 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.581 ' HB2' HD13 ' A' ' 153' ' ' LEU . 23.3 p90 -139.22 10.72 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -1.137 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 5.2 t80 -90.87 117.45 29.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.67 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 58.6 m95 -82.02 141.58 33.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.612 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -162.86 108.65 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.045 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.612 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 159.62 -2.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.53 -0.731 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.16 -156.65 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.097 . . . . 0.0 110.001 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.57 175.99 6.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -47.98 -86.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -76.48 -31.76 53.35 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 3.5 tt0 -59.63 -24.97 64.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.129 -1.218 . . . . 0.0 110.219 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -74.65 -49.96 19.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.569 HD22 ' HA2' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -70.09 -44.96 67.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.252 -0.905 . . . . 0.0 110.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.4 mp -59.89 -32.26 70.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.565 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.1 pp -55.39 -30.67 60.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.928 -1.107 . . . . 0.0 109.383 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.701 ' CD1' ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.81 -33.99 73.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.701 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 19.7 p -70.44 -32.84 70.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.557 -0.715 . . . . 0.0 110.288 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.78 -20.89 41.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.75 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.9 mt-10 -120.99 -79.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.943 -1.098 . . . . 0.0 110.391 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.1 Cg_endo -75.42 54.83 3.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.072 1.038 . . . . 0.0 110.105 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.562 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . . . -53.03 141.61 22.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.377 -0.827 . . . . 0.0 110.736 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 92.67 15.29 53.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.525 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.44 148.8 43.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.977 . . . . 0.0 110.141 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.612 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -121.59 149.4 43.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.017 . . . . 0.0 110.514 -179.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.67 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -150.37 160.73 43.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.565 -0.709 . . . . 0.0 109.588 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.555 HD13 ' CE1' ' A' ' 51' ' ' PHE . 2.1 tt -113.47 145.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.796 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.556 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 tmt_? -112.28 151.22 29.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.628 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 44' ' ' SER . 9.6 t0 -94.38 133.69 37.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.086 -1.008 . . . . 0.0 110.661 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.527 -0.733 . . . . 0.0 110.635 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.255 0.55 . . . . 0.0 110.33 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.55 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 54.3 p90 -179.52 -176.79 0.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.089 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.639 ' CE2' HG22 ' A' ' 91' ' ' VAL . 5.2 p90 -115.85 155.15 28.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 110.089 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -126.07 150.68 47.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 110.047 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.67 ' CD2' ' CG ' ' A' ' 98' ' ' TYR . 1.4 tt -139.26 131.02 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 111.158 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.728 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -139.71 154.11 47.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.483 -0.761 . . . . 0.0 109.959 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.58 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 1.5 p -129.08 174.2 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 110.585 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.562 ' HE2' ' CB ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -111.74 139.1 47.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.198 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 58' ' ' GLN . 2.3 m -160.33 148.94 16.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 110.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' THR . 7.5 pt20 -41.92 -27.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -66.93 -53.46 31.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.253 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.64 146.55 4.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.458 HG21 ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -83.32 129.06 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -1.098 . . . . 0.0 110.133 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -142.08 140.92 32.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.9 OUTLIER -111.05 141.35 44.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.583 ' CD2' ' HA ' ' B' ' 166' ' ' THR . 0.4 OUTLIER -138.18 152.42 48.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 110.834 -179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.07 165.0 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.813 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.495 ' CD1' HD22 ' A' ' 94' ' ' LEU . 5.0 tp -78.11 131.23 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -97.84 140.33 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 31.0 p -92.32 128.09 38.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 72' ' ' SER . 3.3 tt0 -133.07 104.53 6.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.335 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 54.55 65.42 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.36 24.0 15.03 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 70' ' ' GLY . 0.7 OUTLIER -124.12 157.7 34.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 0.0 110.048 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -124.22 128.91 49.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.089 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -153.97 139.01 17.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.898 . . . . 0.0 110.34 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.566 HD12 ' CZ ' ' A' ' 98' ' ' TYR . 1.8 tt . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 109.885 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.639 HG22 ' CE2' ' A' ' 51' ' ' PHE . 1.2 t . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.281 0.562 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.566 ' C ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -56.04 -38.07 70.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.273 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 -40.56 83.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -68.17 -35.39 77.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.547 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 24.8 t -55.49 -37.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 110.268 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -54.27 -35.77 62.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.676 ' CE1' ' CD1' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -78.17 -41.85 33.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.061 -1.024 . . . . 0.0 110.412 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.676 ' CD1' ' CE1' ' A' ' 97' ' ' HIS . 0.6 OUTLIER -64.68 -22.15 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.205 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.522 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.91 . . . . 0.0 110.29 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 59.1 mmt-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.165 0.507 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 134' ' ' ARG . . . 164.32 82.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 110.17 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.756 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -102.83 125.96 49.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.478 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.759 ' CD2' ' CG2' ' B' ' 168' ' ' VAL . 8.2 p90 -154.11 167.21 30.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.089 . . . . 0.0 110.511 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.566 ' H ' ' CD1' ' A' ' 147' ' ' LEU . 3.0 mt -101.57 149.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 111.298 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.723 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.0 m-85 -98.97 132.82 44.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.709 0.766 . . . . 0.0 110.984 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . 45.0 t -97.06 48.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.618 -0.676 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.02 82.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.61 -22.07 39.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 1.5 mp0 -117.05 122.02 42.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 1.2 pttm -91.68 105.29 17.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.219 -0.926 . . . . 0.0 110.312 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.725 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -87.73 108.24 19.58 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.714 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.2 Cg_endo -76.07 128.8 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.994 1.523 . . . . 0.0 112.346 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.614 ' H ' ' CB ' ' A' ' 137' ' ' TYR . 1.2 mp -125.06 134.19 52.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -117.87 117.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.596 -1.315 . . . . 0.0 111.249 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.622 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.8 tt -92.45 114.86 27.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.11 -15.14 1.51 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 111.063 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.85 124.91 70.2 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.958 -1.088 . . . . 0.0 110.017 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.06 147.88 43.85 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.945 1.497 . . . . 0.0 110.592 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.623 ' O ' HD11 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.48 158.56 14.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 0.0 110.567 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' LEU . 46.2 t . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.315 -0.866 . . . . 0.0 110.815 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.568 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.197 0.522 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.583 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.8 p -112.29 144.64 41.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.852 . . . . 0.0 110.05 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -100.24 114.49 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.759 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 99.6 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.537 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . 7.9 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.568 ' CE1' HG22 ' A' ' 6' ' ' VAL . 11.8 t80 -66.9 -52.39 43.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.907 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -61.09 -39.44 89.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.476 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . 1.2 mt -67.09 -47.25 71.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.663 ' CG2' ' CE2' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -69.58 -47.92 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.245 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.614 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 72.9 t -61.83 -41.27 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -58.93 -41.44 87.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.934 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.539 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . . . -62.01 -44.16 97.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.78 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 41.3 t -57.55 -39.8 71.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.88 78.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.737 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -32.86 56.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -61.91 -43.7 98.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 110.092 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.584 ' HG2' ' CD1' ' A' ' 18' ' ' TYR . 40.2 mt-30 -67.2 -35.89 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -63.42 -39.27 94.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.222 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -38.81 75.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.37 1.17 23.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CD1' HD22 ' A' ' 153' ' ' LEU . 1.6 t80 -94.99 21.85 7.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 13' ' ' GLN . 36.3 t80 -121.25 136.03 55.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 110.258 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.704 ' CE3' ' NH2' ' A' ' 42' ' ' ARG . 9.4 m95 -104.67 148.64 26.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 110.333 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 42.1 m -31.91 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 163.81 69.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' CG2' ' NH1' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -60.9 -135.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.329 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.621 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -88.34 176.16 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.76 -1.213 . . . . 0.0 109.205 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.1 -81.75 0.03 OUTLIER Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.332 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -79.9 -31.12 40.6 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.439 -1.036 . . . . 0.0 111.643 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.621 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 21.2 tp10 -58.63 -24.9 62.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.451 . . . . 0.0 110.955 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.588 ' CB ' ' HD3' ' A' ' 42' ' ' ARG . . . -77.15 -48.19 18.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.992 -1.067 . . . . 0.0 109.544 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.604 ' HA ' HD13 ' A' ' 40' ' ' LEU . 1.8 m-80 -70.62 -49.57 46.16 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.686 0.755 . . . . 0.0 111.142 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 61' ' ' THR . 0.8 OUTLIER -61.88 -31.59 71.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.698 . . . . 0.0 112.162 -178.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 2.2 pp -55.18 -35.15 64.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.75 -1.219 . . . . 0.0 109.853 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.588 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -81.25 -36.18 30.26 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 108.622 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.586 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 52.0 m -70.03 -32.88 71.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.555 -0.716 . . . . 0.0 110.129 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.02 41.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.512 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 10.4 mt-10 -113.87 -76.77 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.041 . . . . 0.0 110.05 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.741 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.8 Cg_endo -73.08 61.32 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.277 1.146 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.73 141.24 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 150' ' ' SER . . . 89.34 13.45 61.66 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 21.2 m -132.66 146.08 51.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.554 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 152' ' ' PRO . 30.5 p90 -126.97 138.84 53.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.838 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -131.4 161.01 33.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.584 HG12 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.41 128.56 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.789 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.704 ' NH2' ' CE3' ' A' ' 19' ' ' TRP . 78.5 mtt-85 -135.73 153.43 51.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.739 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -73.94 122.79 23.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 109.7 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.338 -0.852 . . . . 0.0 110.562 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 50' ' ' PHE . 28.5 p80 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.271 0.558 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 35.9 p90 -92.55 -166.74 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.663 ' CE2' ' CG2' ' A' ' 5' ' ' VAL . 5.9 p90 -130.82 158.21 40.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.84 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 14.5 t -126.28 139.2 53.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.773 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 6.9 tt -121.03 139.45 53.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.585 ' OG ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -139.33 154.39 47.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 ' CG ' ' A' ' 149' ' ' LEU . 2.4 m -130.12 174.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.392 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HB2' ' CB ' ' A' ' 32' ' ' SER . 18.4 tptt -105.93 130.49 53.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.468 HG23 ' HG ' ' A' ' 147' ' ' LEU . 33.7 p -134.86 -169.27 2.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -77.48 -34.95 54.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.3 t -81.73 -22.79 37.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.18 -0.95 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.48 14.62 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.53 HG22 ' CD1' ' A' ' 29' ' ' LEU . 1.8 t -101.04 126.4 47.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -1.123 . . . . 0.0 110.27 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 54' ' ' SER . 8.7 mmpt? -114.07 147.3 38.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.235 -0.916 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' CB ' ' OG ' ' A' ' 54' ' ' SER . 10.7 p30 -112.02 144.07 41.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 110.706 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD1' ' CG2' ' B' ' 167' ' ' VAL . 1.2 mp -138.93 152.26 47.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.594 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HD3' ' CZ ' ' A' ' 50' ' ' PHE . 3.3 ptt180 -123.49 164.04 19.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.581 HG12 ' CD2' ' A' ' 73' ' ' PHE . 6.6 tp -76.78 143.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -113.05 144.66 42.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 1' ' ' GLU . 13.7 t -101.99 118.85 37.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 110.368 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 71' ' ' GLY . 22.9 tt0 -105.21 102.89 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.037 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.21 -83.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -139.87 37.69 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.64 163.07 32.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -1.107 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.617 ' CE1' ' CB ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -122.4 127.97 50.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 3.4 m -155.55 159.91 40.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 94' ' ' LEU . 10.5 tp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.844 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.61 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 p . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.091 0.472 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' N ' HG11 ' A' ' 91' ' ' VAL . 3.8 mt -55.64 -35.98 66.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.723 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -62.53 -46.36 88.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.865 -1.147 . . . . 0.0 109.209 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -68.25 -34.82 76.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.44 -0.787 . . . . 0.0 109.58 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 91' ' ' VAL . 56.0 t -54.74 -36.43 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 110.438 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -52.61 -33.12 44.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.462 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -78.18 -36.79 47.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.156 -0.965 . . . . 0.0 109.476 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.773 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 6.9 m-85 -73.59 -22.05 60.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.316 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 42.0 mtt85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.237 0.542 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.574 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 173.85 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.761 ' OH ' ' CE1' ' A' ' 98' ' ' TYR . 1.3 t80 -102.81 121.52 42.63 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.719 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.814 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -158.24 148.67 20.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 110.137 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 1.0 OUTLIER -102.65 150.18 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.977 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.627 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 76.2 m-85 -86.19 132.71 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 110.435 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 143' ' ' GLU . 1.3 t -98.49 69.23 1.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.65 41.93 75.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.56 2.76 29.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 140' ' ' SER . 2.8 mt-10 -117.8 121.97 42.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -70.92 105.93 3.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.463 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.763 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -101.5 120.1 55.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.866 . . . . 0.0 109.555 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.814 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 43.6 Cg_endo -69.64 129.42 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.349 1.71 . . . . 0.0 112.786 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.788 ' HB2' ' HA ' ' A' ' 137' ' ' TYR . 6.1 mp -121.1 101.29 7.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 148' ' ' VAL . 3.3 p -102.85 117.64 48.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.624 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.567 ' CG ' HG11 ' A' ' 55' ' ' VAL . 3.5 mp -76.02 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 37' ' ' GLY . 2.7 p -172.62 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.74 -1.225 . . . . 0.0 111.495 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -85.68 124.93 70.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.855 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 48.5 Cg_endo -75.7 148.06 32.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.106 1.582 . . . . 0.0 110.093 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -63.21 144.37 56.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.227 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.097 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 1.6 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.152 0.501 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.568 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 2.7 t -105.87 137.52 43.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.709 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -84.63 95.49 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.114 -0.991 . . . . 0.0 109.589 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.652 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.893 . . . . 0.0 109.983 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.513 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.266 0.555 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 30.2 p90 -55.72 -36.48 67.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.7 tt0 -55.03 -32.88 62.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.215 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 73' ' ' PHE . 10.2 mt -62.33 -44.04 97.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.556 ' CG2' ' CB ' ' A' ' 50' ' ' PHE . 61.1 t -63.14 -48.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.158 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.5 -50.53 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -62.36 -44.1 97.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB3' HG12 ' A' ' 91' ' ' VAL . . . -67.01 -44.52 80.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.771 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.1 t -57.93 -40.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.823 . . . . 0.0 109.136 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -55.89 -47.86 76.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.613 -0.68 . . . . 0.0 109.867 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -36.56 63.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.918 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 17' ' ' PHE . 4.2 mt -71.77 -44.05 64.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 110.003 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 6.0 pt20 -67.89 -33.87 75.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -57.9 -34.49 69.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.07 -34.7 66.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.845 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.57 29.19 6.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.617 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 6.7 p90 -145.97 40.24 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 110.631 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 4.9 t80 -120.38 115.81 24.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.853 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.602 ' CD1' HD12 ' A' ' 40' ' ' LEU . 63.5 m95 -77.26 144.08 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 110.329 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 18.6 t -45.77 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.722 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 165.64 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.859 . . . . 0.0 110.568 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 1.4 m -47.04 -97.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.069 -1.02 . . . . 0.0 109.41 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.6 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -108.05 165.88 11.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 109.199 178.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -43.3 -79.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.565 ' HA2' ' OD1' ' A' ' 28' ' ' ASN . . . -79.5 -30.47 44.79 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.369 -1.077 . . . . 0.0 111.254 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.9 mm-40 -58.49 -24.79 61.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.344 . . . . 0.0 110.954 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . . . -76.04 -49.78 16.6 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 109.24 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' OD1' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -71.18 -49.68 41.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 111.244 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' CD1' ' OD1' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -63.37 -31.09 72.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.583 -0.698 . . . . 0.0 111.797 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -53.77 -23.39 11.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.835 -1.166 . . . . 0.0 109.689 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 62.6 mt -61.73 -39.51 91.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 109.191 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.55 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 93.1 p -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.6 -0.688 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.95 -20.39 45.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.7 mm-40 -125.27 -81.16 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.998 -1.064 . . . . 0.0 110.404 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.6 Cg_endo -77.17 68.38 7.41 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 122.92 0.958 . . . . 0.0 110.175 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.67 141.48 9.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.0 110.614 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 71.65 24.0 77.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.584 ' CB ' ' HB2' ' A' ' 35' ' ' PRO . 7.9 m -125.81 147.14 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -1.048 . . . . 0.0 110.474 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 1.2 p90 -122.83 147.1 46.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.613 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -145.29 159.71 42.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.493 -0.754 . . . . 0.0 109.72 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.645 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 5.3 tt -114.31 137.9 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.105 -0.997 . . . . 0.0 110.118 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -112.63 131.82 55.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.0 110.438 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.574 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 35.9 t0 -89.28 118.22 28.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.55 ' CB ' ' CD2' ' A' ' 49' ' ' HIS . 5.7 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.202 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.55 ' CD2' ' CB ' ' A' ' 44' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.214 0.531 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CB ' ' CG2' ' A' ' 5' ' ' VAL . 2.2 p90 176.77 -151.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.114 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.654 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 25.8 p90 -115.37 151.92 33.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -1.0 . . . . 0.0 109.869 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 64' ' ' LEU . 36.2 m -125.9 135.74 52.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.945 . . . . 0.0 110.499 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.619 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -120.75 123.32 42.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.823 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -140.34 155.72 46.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.483 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 2.7 p -134.53 174.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 0.0 110.689 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.42 133.69 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.82 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.508 ' CG2' ' HG ' ' A' ' 147' ' ' LEU . 8.8 t -132.93 -156.96 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.58 -58.36 2.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.455 ' OG ' ' HD2' ' A' ' 146' ' ' PRO . 0.8 OUTLIER -44.63 -61.43 1.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 172.84 45.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 56' ' ' LYS . 49.2 p -99.37 108.97 21.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -1.119 . . . . 0.0 110.238 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HB2' HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -108.43 177.83 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.945 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.823 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 23.8 m-20 -128.42 132.47 48.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 110.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 63' ' ' ASN . 8.2 mt -131.69 152.12 51.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -147.9 168.43 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.0 110.516 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.606 ' CG2' ' CD2' ' A' ' 73' ' ' PHE . 44.0 mm -76.82 146.74 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -114.41 150.82 34.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.513 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 54.1 t -89.01 132.85 34.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.317 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 71' ' ' GLY . 10.3 tm-20 -123.86 102.94 8.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.02 -89.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -133.61 24.62 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -132.93 162.92 30.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.606 ' CD2' ' CG2' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -110.91 136.38 50.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -155.23 150.29 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.299 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.542 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.654 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.972 0.415 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -65.16 -47.25 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 109.537 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 0.2 OUTLIER -68.21 -33.47 74.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 0.0 108.851 178.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.567 ' CD1' HD12 ' A' ' 66' ' ' ILE . 7.5 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.828 -0.545 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -53.04 -36.8 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.399 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 99' ' ' MET . 7.4 m170 -53.42 -45.47 69.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.999 -1.063 . . . . 0.0 108.22 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -78.73 -38.43 38.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.774 . . . . 0.0 108.92 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.619 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.77 -22.11 66.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.546 ' HB2' ' CD2' ' A' ' 149' ' ' LEU . 3.2 ttp . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.898 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.217 0.532 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.576 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 164.41 78.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.741 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -102.8 125.02 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.049 -1.032 . . . . 0.0 109.463 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.769 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 8.2 p90 -155.01 167.62 29.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 110.622 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 64' ' ' LEU . 2.0 mt -101.43 147.43 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.0 110.958 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.703 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -96.66 133.31 41.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -96.64 67.54 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.703 -0.623 . . . . 0.0 110.26 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.54 -65.11 0.17 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -133.25 3.97 4.84 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.3 121.96 40.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -1.196 . . . . 0.0 110.289 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 137' ' ' TYR . 9.7 mttt -82.25 105.53 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -89.45 108.94 28.03 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 0.0 108.947 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.715 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.3 Cg_endo -71.72 129.53 15.68 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.206 1.635 . . . . 0.0 112.191 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 137' ' ' TYR . 5.6 mp -124.64 135.12 52.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.595 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 148' ' ' VAL . 5.7 p -118.51 117.48 54.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.939 -1.1 . . . . 0.0 110.822 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.638 ' CD2' ' CD2' ' A' ' 39' ' ' PHE . 5.2 tt -113.73 115.07 27.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -146.05 11.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.026 -1.046 . . . . 0.0 111.352 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.69 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -118.43 124.62 28.4 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.256 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.72 145.85 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.895 1.471 . . . . 0.0 110.719 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 19' ' ' TRP . 4.2 pp -82.11 139.86 34.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.575 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 3.9 m . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.392 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.535 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 6.4 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.235 0.54 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -82.21 -175.3 5.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.872 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.663 ' CG1' ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -107.64 -158.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.028 . . . . 0.0 110.215 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.746 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 37.5 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 110.29 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 17.9 p90 -67.08 -35.71 80.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.571 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -54.78 -32.97 60.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.103 -0.998 . . . . 0.0 110.523 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.613 ' CB ' ' CE2' ' A' ' 73' ' ' PHE . 1.1 mt -67.32 -48.13 68.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 110.616 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.59 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 2.0 m -72.76 -44.46 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 0.0 110.53 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 9' ' ' VAL . 95.7 t -58.47 -32.46 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -33.06 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.93 -1.106 . . . . 0.0 110.807 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . . . -76.19 -33.59 59.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.153 -0.967 . . . . 0.0 111.143 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 6' ' ' VAL . 1.5 m -56.49 -37.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 108.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' N ' HG22 ' A' ' 9' ' ' VAL . 71.2 mtt180 -55.57 -42.82 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.854 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -46.86 19.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.592 ' HG ' ' CZ ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -65.46 -39.44 92.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.508 ' NE2' HG21 ' A' ' 9' ' ' VAL . 24.9 mt-30 -59.97 -33.96 72.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -72.0 -29.8 64.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 110.027 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.585 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 1.4 t -59.17 -43.05 92.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.97 20.11 22.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.592 ' CZ ' ' HG ' ' A' ' 12' ' ' LEU . 4.1 p90 -130.08 -4.69 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.267 . . . . 0.0 110.472 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -95.46 119.36 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 0.0 109.919 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 19' ' ' TRP . 5.7 m95 -109.22 148.1 31.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.385 -0.822 . . . . 0.0 109.911 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.488 ' C ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -134.95 25.13 3.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.381 -0.824 . . . . 0.0 109.268 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.96 1.13 14.6 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.102 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.6 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.43 -157.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.923 -1.111 . . . . 0.0 109.469 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.589 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -97.5 169.53 9.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 110.074 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -42.67 -81.45 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.15 -31.6 42.12 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.26 -1.141 . . . . 0.0 110.705 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 7.4 mt-10 -58.82 -36.78 75.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.007 -1.29 . . . . 0.0 109.865 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.65 -50.57 71.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.035 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.589 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 m-80 -68.99 -38.96 79.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.371 -0.831 . . . . 0.0 110.669 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 29' ' ' LEU . 1.3 mp -70.51 -31.44 68.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.523 -0.735 . . . . 0.0 112.135 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -54.35 -43.34 71.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.261 . . . . 0.0 110.474 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.617 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -72.01 -34.99 69.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.77 -1.207 . . . . 0.0 108.636 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.579 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 17.2 p -70.05 -32.4 70.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.671 -0.643 . . . . 0.0 110.286 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.19 -20.98 43.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.948 . . . . 0.0 110.142 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.7 mm-40 -115.52 -77.51 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -75.28 62.14 6.02 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.213 1.112 . . . . 0.0 109.818 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.6 141.42 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . 100.03 15.95 29.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 35' ' ' PRO . 16.7 p -134.98 147.27 49.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.659 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' HD11 ' A' ' 149' ' ' LEU . 47.9 p90 -122.76 141.11 52.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.677 ' CD1' ' CD1' ' A' ' 19' ' ' TRP . 0.7 OUTLIER -134.49 158.16 44.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 110.099 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.607 HG22 ' CD1' ' A' ' 18' ' ' TYR . 2.7 tt -114.46 130.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 5.3 tpt180 -112.75 144.06 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 0.6 OUTLIER -92.29 115.67 28.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.222 0.534 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.528 ' HA ' HG11 ' A' ' 5' ' ' VAL . 31.8 p90 -178.63 154.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.12 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 51' ' ' PHE . 9.3 p90 -124.15 141.44 52.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -127.01 148.13 50.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 109.631 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.718 ' HG ' ' CZ ' ' A' ' 98' ' ' TYR . 4.3 pp -120.94 153.12 37.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.793 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.601 ' HB2' ' CA ' ' A' ' 63' ' ' ASN . 4.0 t -139.12 153.9 48.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 109.969 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.543 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 3.3 p -127.03 174.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.53 136.57 43.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.42 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -168.57 169.41 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -44.51 -44.43 8.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.539 ' CB ' ' CG2' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -54.16 -46.18 72.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.177 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.92 161.89 9.59 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.579 ' CG2' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -80.13 111.78 16.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 110.195 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.556 ' HG2' ' CD1' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -142.0 152.87 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.487 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.601 ' CA ' ' HB2' ' A' ' 54' ' ' SER . 7.7 p30 -120.51 156.28 31.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.594 ' O ' ' OH ' ' A' ' 98' ' ' TYR . 23.8 mt -134.34 141.99 47.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -104.29 -177.55 3.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.295 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -105.46 149.04 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.248 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -95.65 132.24 41.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.154 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -106.27 136.84 45.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 71' ' ' GLY . 4.0 tt0 -132.0 102.91 6.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.47 -78.44 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -147.84 34.97 1.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.15 146.61 33.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.108 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.613 ' CE2' ' CB ' ' A' ' 4' ' ' LEU . 9.1 m-30 -110.97 155.85 22.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.461 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.15 165.92 32.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.975 . . . . 0.0 110.586 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.539 HD21 ' CA ' ' A' ' 94' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 109.689 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 5.2 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.462 0.649 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -55.71 -34.87 65.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -57.66 -31.72 66.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.975 -1.078 . . . . 0.0 109.224 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.539 ' CA ' HD21 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.01 -34.62 76.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.603 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.512 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 54.7 t -54.71 -37.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.155 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -53.8 -29.88 42.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.603 ' CE1' ' CE1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -67.56 -40.86 84.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.718 ' CZ ' ' HG ' ' A' ' 53' ' ' LEU . 38.1 m-85 -70.87 -15.74 62.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 97' ' ' HIS . 15.4 mmt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 27.2 mtp85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.287 0.565 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.569 ' O ' HG12 ' B' ' 168' ' ' VAL . . . 165.41 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.729 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -102.72 124.65 48.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.083 -1.01 . . . . 0.0 109.065 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.841 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 7.8 p90 -155.44 167.36 30.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.828 -1.17 . . . . 0.0 111.48 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.561 ' CD1' HD22 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -104.21 149.27 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.624 0.726 . . . . 0.0 111.0 -178.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.629 ' CZ ' ' OH ' ' A' ' 137' ' ' TYR . 16.9 m-85 -96.42 133.34 40.96 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.494 0.664 . . . . 0.0 110.644 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -125.95 126.45 44.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 110.568 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 41.18 68.54 0.63 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.74 22.7 2.0 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 140' ' ' SER . 5.1 tp10 -117.7 121.97 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -1.208 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.563 ' HG3' ' CD2' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -84.64 105.62 15.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -99.17 98.78 6.98 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.841 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.7 Cg_endo -73.08 127.27 11.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 111.792 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.643 ' CD2' ' HA ' ' A' ' 137' ' ' TYR . 0.5 OUTLIER -126.14 133.2 51.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 148' ' ' VAL . 7.1 p -107.53 117.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.765 -1.209 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.667 ' CD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.7 pp -102.34 123.17 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 150' ' ' SER . 0.2 OUTLIER -154.88 14.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.824 -179.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 1.5 tpt180 -101.34 124.22 41.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.987 -1.071 . . . . 0.0 109.976 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.14 138.11 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.946 1.498 . . . . 0.0 110.591 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' PHE . 21.6 tp -91.22 123.55 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.469 ' O ' HD23 ' A' ' 64' ' ' LEU . 11.2 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.187 0.518 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 8.8 t -149.78 154.83 39.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -93.17 173.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.132 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.77 HG11 ' CD2' ' A' ' 137' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.246 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.46 ' HA ' HD13 ' A' ' 4' ' ' LEU . 1.5 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.232 0.539 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.508 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 11.4 p90 -56.73 -35.95 69.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.508 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 2.6 tm0? -67.95 -42.84 80.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 1' ' ' GLU . 1.3 mt -67.1 -47.48 71.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.648 ' CG1' ' CZ ' ' A' ' 73' ' ' PHE . 25.7 m -61.4 -38.64 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.055 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' N ' HG21 ' A' ' 5' ' ' VAL . 25.6 t -58.72 -51.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.47 -45.51 91.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . . . -61.91 -44.04 97.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG21 ' CD2' ' A' ' 51' ' ' PHE . 13.8 t -57.44 -39.82 70.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.351 -0.843 . . . . 0.0 109.327 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.89 72.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.712 . . . . 0.0 109.936 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -41.03 46.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 18' ' ' TYR . 21.4 tp -72.1 -43.99 63.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.509 ' NE2' HG12 ' A' ' 9' ' ' VAL . 12.2 mt-30 -60.12 -33.5 72.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.56 -27.65 62.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.613 ' OG ' ' CD2' ' A' ' 17' ' ' PHE . 96.2 p -60.76 -43.09 98.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 109.843 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.35 26.99 7.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.613 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.9 p90 -132.39 -5.06 3.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 0.0 110.606 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.68 ' CD1' ' CG2' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -106.42 114.91 29.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.014 -1.054 . . . . 0.0 110.004 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.644 ' CE2' HD12 ' A' ' 40' ' ' LEU . 1.7 p-90 -126.46 148.24 49.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 110.025 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.01 107.49 14.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.98 10.19 0.17 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.551 -0.718 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -120.41 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.566 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.32 175.34 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.881 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.42 -81.99 0.04 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.725 ' HA2' ' ND2' ' A' ' 28' ' ' ASN . . . -79.35 -31.57 41.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.7 tt0 -59.22 -24.82 63.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.238 . . . . 0.0 109.94 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.16 -48.58 61.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.885 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.725 ' ND2' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -68.8 -47.26 66.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.396 -0.815 . . . . 0.0 110.899 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 1.5 mp -59.27 -31.92 69.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.797 . . . . 0.0 111.472 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -55.8 -46.08 78.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.9 -1.125 . . . . 0.0 109.665 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD22 ' O ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -73.08 -36.2 66.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 108.579 178.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.574 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 1.9 m -69.8 -32.73 71.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 110.018 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.58 -20.95 42.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.6 mt-10 -113.15 -77.11 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.7 Cg_endo -72.11 64.11 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.33 1.174 . . . . 0.0 110.199 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HB1' ' HD2' ' A' ' 56' ' ' LYS . . . -49.94 141.48 10.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.219 -0.926 . . . . 0.0 110.538 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 90.53 15.74 56.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -135.07 147.23 49.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -1.026 . . . . 0.0 110.252 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' CE1' ' CG ' ' A' ' 99' ' ' MET . 10.4 p90 -122.76 142.22 50.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 0.0 110.094 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.644 HD12 ' CE2' ' A' ' 19' ' ' TRP . 5.5 tt -131.26 151.56 51.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.426 -0.796 . . . . 0.0 110.394 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.68 ' CG2' ' CD1' ' A' ' 18' ' ' TYR . 9.0 tt -114.77 128.07 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.446 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 5.5 tpt180 -119.56 139.56 51.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 1.4 t0 -73.89 138.06 44.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.462 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.311 0.577 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 12.3 p90 -79.71 168.57 19.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.922 . . . . 0.0 110.182 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.615 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 7.8 p90 -123.1 139.26 54.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.494 ' C ' HG13 ' A' ' 41' ' ' ILE . 7.1 t -128.22 154.47 45.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.652 ' CD1' ' CD1' ' A' ' 98' ' ' TYR . 3.9 pp -139.47 151.38 46.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.941 -1.099 . . . . 0.0 110.456 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -139.29 153.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.0 110.262 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG11 HD12 ' A' ' 149' ' ' LEU . 10.7 p -129.01 173.47 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.333 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HB2' ' CA ' ' A' ' 32' ' ' SER . 9.6 tttm -116.92 139.14 50.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.532 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -146.26 -171.76 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.147 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.99 62.44 3.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 p -175.54 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.856 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.97 135.51 2.89 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 61' ' ' THR . 3.0 t -79.12 125.49 29.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.211 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 54' ' ' SER . 14.6 mmtt -123.8 141.96 51.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 110.175 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.56 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 5.1 p30 -116.73 138.87 51.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' B' ' 166' ' ' THR . 0.7 OUTLIER -132.16 131.01 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.419 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HG3' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -96.29 157.08 16.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.576 HG23 ' CD2' ' A' ' 73' ' ' PHE . 4.3 mp -100.6 136.3 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.152 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -119.91 150.98 39.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.276 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 19.9 p -87.95 130.26 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.56 124.37 48.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.4 -74.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -158.53 20.91 0.32 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 24.2 p -134.03 163.41 29.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.56 130.68 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 94' ' ' LEU . 9.5 p -145.52 167.08 23.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 97' ' ' HIS . 2.7 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.615 HG11 ' CZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.197 0.522 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 9.3 mp -57.6 -46.64 83.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.565 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -38.38 84.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.024 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 74' ' ' SER . 7.4 mt -68.09 -34.82 77.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.622 -0.673 . . . . 0.0 109.836 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 91' ' ' VAL . 26.9 t -54.66 -37.71 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 110.042 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -53.49 -35.53 60.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.029 . . . . 0.0 109.339 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.582 ' NE2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -78.16 -34.19 49.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.714 . . . . 0.0 109.776 179.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.652 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -61.88 -22.21 65.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.456 -0.778 . . . . 0.0 111.314 -178.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.542 ' CG ' ' CE1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 120.913 -1.117 . . . . 0.0 111.554 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 5.9 tmm_? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' O ' HG22 ' B' ' 168' ' ' VAL . . . 167.17 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.932 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.774 ' O ' ' O ' ' A' ' 147' ' ' LEU . 5.8 t80 -114.44 120.69 41.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.876 -1.14 . . . . 0.0 109.623 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.853 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.8 p90 -157.15 166.89 31.99 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.954 -1.091 . . . . 0.0 109.998 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 147' ' ' LEU . 1.8 mp -119.24 147.41 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 120.88 -1.137 . . . . 0.0 111.51 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.65 107.77 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.705 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 10.3 t -92.47 124.82 36.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.68 61.54 3.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 57.09 20.28 34.28 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -120.23 121.73 39.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.942 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.06 105.44 11.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.005 -1.059 . . . . 0.0 110.704 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.853 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -97.71 115.09 65.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.677 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.2 Cg_endo -71.81 128.73 14.52 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 112.204 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.774 ' O ' ' O ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -126.1 136.46 52.93 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.4 t -97.41 116.45 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.062 -1.649 . . . . 0.0 109.852 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 1.2 tt -91.47 125.31 36.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 6.9 p -165.55 46.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.78 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 4.4 mtp180 -134.08 124.54 17.53 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.06 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.0 Cg_endo -76.55 148.13 29.12 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.875 1.461 . . . . 0.0 110.771 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.589 ' O ' ' C ' ' A' ' 154' ' ' SER . 4.4 pp -88.18 158.04 18.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.589 ' C ' ' O ' ' A' ' 153' ' ' LEU . 14.0 t . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.704 -0.622 . . . . 0.0 111.067 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' B' ' 166' ' ' THR . 36.6 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.236 0.541 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.603 ' CG2' ' CE2' ' A' ' 139' ' ' TYR . 0.2 OUTLIER 171.67 166.95 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -0.885 . . . . 0.0 110.311 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.636 HG13 ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -123.58 -162.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.384 -0.823 . . . . 0.0 110.274 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.691 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 3.6 t . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.271 -0.893 . . . . 0.0 110.296 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.514 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.515 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -61.46 -47.91 83.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 110.053 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -67.53 -32.96 74.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.368 -0.832 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.566 HD13 ' CD1' ' A' ' 73' ' ' PHE . 63.4 mt -57.01 -47.39 80.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' CA ' ' A' ' 50' ' ' PHE . 3.0 t -61.07 -47.24 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.092 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -43.19 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.134 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -65.0 -39.8 93.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.032 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.28 -44.45 52.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.895 . . . . 0.0 110.026 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 18' ' ' TYR . 94.8 t -57.83 -39.91 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 0.0 109.391 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -55.74 -43.74 76.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.482 -0.762 . . . . 0.0 110.054 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -77.97 -44.33 27.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.546 ' CD2' HG23 ' A' ' 41' ' ' ILE . 44.9 tp -65.98 -42.1 90.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 3.5 pt20 -68.18 -38.86 82.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.257 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.4 tm-20 -57.79 -44.91 86.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -26.91 51.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.48 31.2 8.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.703 ' CZ ' ' CE1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -129.76 8.38 5.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -1.141 . . . . 0.0 110.266 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.554 ' CE2' HG21 ' A' ' 9' ' ' VAL . 2.6 t80 -90.81 136.18 33.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.651 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 12.9 m95 -108.48 143.42 37.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.334 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -149.78 110.99 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.892 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 171.36 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG21 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.66 -161.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 0.0 110.145 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -93.7 165.81 12.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.639 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.51 -84.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.63 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -60.66 -41.93 99.12 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.1 mt-10 -59.56 -27.12 65.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.973 -1.31 . . . . 0.0 110.212 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 42' ' ' ARG . . . -78.3 -44.55 25.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 110.023 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 24' ' ' GLY . 8.8 m-80 -68.78 -48.27 64.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.6 mp -59.19 -32.32 69.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.832 . . . . 0.0 111.038 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -55.98 -26.19 47.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 2.4 pp -68.52 -33.17 73.65 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.396 -0.921 . . . . 0.0 108.599 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.529 ' CA ' ' HD2' ' A' ' 56' ' ' LYS . 7.5 t -69.78 -32.93 71.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.611 -0.681 . . . . 0.0 110.056 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.61 -20.99 41.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 110.013 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.769 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 22.2 mt-10 -122.85 -83.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 110.552 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.769 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.5 69.5 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.894 0.944 . . . . 0.0 110.44 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.34 141.38 41.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 110.287 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 78.6 20.68 70.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.5 m -124.99 147.88 48.71 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -1.041 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.703 ' CE1' ' CZ ' ' A' ' 17' ' ' PHE . 13.0 p90 -122.42 145.71 48.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.542 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.651 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.03 159.47 43.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.466 -0.772 . . . . 0.0 109.964 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.546 HG23 ' CD2' ' A' ' 12' ' ' LEU . 3.1 tt -114.79 143.74 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.283 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.1 tpm_? -129.71 132.04 46.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' A' ' 42' ' ' ARG . 1.9 t0 -77.09 103.95 7.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' N ' ' A' ' 24' ' ' GLY . 64.2 m . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.133 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.513 ' NE2' ' CE1' ' A' ' 2' ' ' TYR . 35.4 m80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.279 0.561 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.544 ' CA ' HG22 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 59.95 108.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.099 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' A' ' 51' ' ' PHE . 14.6 p90 -115.88 143.5 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 64' ' ' LEU . 93.4 m -126.08 155.29 41.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.653 ' CD2' ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -130.84 128.43 40.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.519 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -139.26 154.09 47.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.45 -0.781 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.592 ' CG1' ' CB ' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -135.17 174.22 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD2' ' CA ' ' A' ' 32' ' ' SER . 6.7 tttt -111.03 139.24 46.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.171 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.557 ' HB ' ' CD1' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -131.97 -142.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 110.163 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 59' ' ' SER . 5.4 tt0 -46.09 -27.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.066 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER 163.46 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.522 -0.736 . . . . 0.0 109.77 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 80.5 1.53 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 HG21 ' HG3' ' A' ' 56' ' ' LYS . 13.3 p -94.49 108.88 20.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 0.0 109.872 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -137.11 172.79 12.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' N ' ' ND2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -140.16 155.33 47.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.618 ' CD1' HG21 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -138.31 129.94 27.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 110.655 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -80.22 156.35 26.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.612 HG12 ' CD2' ' A' ' 73' ' ' PHE . 6.8 tp -76.77 140.54 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 110.413 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.8 OUTLIER -91.81 117.77 30.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 42.0 t -98.93 117.15 32.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.02 102.95 14.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.861 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.34 -81.37 0.59 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.474 ' O ' HD11 ' A' ' 4' ' ' LEU . . . -141.45 6.79 2.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.4 OUTLIER -104.02 163.61 12.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 110.299 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.612 ' CD2' HG12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.42 141.33 43.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.404 -0.81 . . . . 0.0 110.202 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 67' ' ' GLN . 4.0 p -155.41 139.99 16.94 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.935 . . . . 0.0 110.753 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.58 HG13 ' CZ ' ' A' ' 51' ' ' PHE . 1.5 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.556 ' O ' ' CG2' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -57.58 -47.35 82.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.999 -1.063 . . . . 0.0 108.899 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 93' ' ' LYS . 26.0 mmtt -68.44 -34.06 75.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 108.714 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.596 ' CD1' ' CB ' ' A' ' 75' ' ' LEU . 19.6 mt -59.82 -33.13 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.201 0.524 . . . . 0.0 110.297 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.692 ' O ' ' N ' ' A' ' 99' ' ' MET . 3.3 m -53.19 -36.43 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.5 OUTLIER -53.68 -52.71 59.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.584 -1.322 . . . . 0.0 108.906 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 19.9 t60 -79.58 -53.12 7.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -0.865 . . . . 0.0 109.692 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.653 ' CD2' ' CD2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.02 -22.25 65.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.726 -0.609 . . . . 0.0 110.344 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.692 ' N ' ' O ' ' A' ' 95' ' ' VAL . 2.3 mtp . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.577 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 8.5 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.253 0.549 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.625 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 162.49 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 109.874 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.784 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -106.73 125.52 51.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.837 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 14.5 p90 -155.04 167.63 29.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.73 -1.231 . . . . 0.0 111.108 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.532 HG21 ' CB ' ' B' ' 165' ' ' SER . 3.0 mp -101.93 149.07 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 110.933 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.713 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.9 m-85 -99.15 133.08 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 110.985 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER -89.91 -162.77 0.92 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.657 -0.652 . . . . 0.0 110.004 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -43.04 -45.93 6.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.0 18.31 0.23 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.34 123.92 44.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.18 . . . . 0.0 110.403 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 23.5 mtpt -75.73 105.33 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.035 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -91.83 110.9 46.83 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.837 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -76.47 128.99 10.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.143 1.602 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.597 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.8 mm? -124.63 123.16 39.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.289 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 148' ' ' VAL . 7.7 p -102.53 117.44 47.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.67 -1.269 . . . . 0.0 110.297 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.667 ' CD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.9 pp -108.65 132.29 54.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.875 . . . . 0.0 110.047 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.2 p -169.9 27.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.026 -1.046 . . . . 0.0 110.73 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.573 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -113.58 124.84 30.48 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 109.943 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 46.6 Cg_endo -73.76 129.82 13.95 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.988 1.52 . . . . 0.0 110.703 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.521 HD21 ' CB ' ' A' ' 40' ' ' LEU . 36.7 tp -91.92 128.57 37.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.105 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.54 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 4.7 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.06 0.457 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.536 ' C ' ' O ' ' B' ' 165' ' ' SER . 46.3 p -30.34 123.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.568 -0.707 . . . . 0.0 110.44 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.677 ' CG1' ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -92.53 84.16 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 110.268 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.765 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 32.8 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.479 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 29.8 p90 -61.19 -35.86 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -55.0 -37.39 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.2 mt -60.9 -47.34 86.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.574 HG12 ' CE1' ' A' ' 51' ' ' PHE . 55.5 t -70.38 -42.72 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.746 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -58.78 -50.73 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.954 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.83 -41.87 87.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.93 -41.49 98.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.817 . . . . 0.0 109.659 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 2.9 t -56.97 -39.53 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.147 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -48.11 75.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -78.18 -38.94 42.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.14 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -65.3 -31.9 73.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.316 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.473 ' HG3' HG11 ' A' ' 9' ' ' VAL . 26.7 mt-30 -66.93 -39.86 87.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -34.28 71.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.262 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 p -72.02 -37.78 69.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.04 -5.18 71.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.589 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 9.0 t80 -93.54 6.04 49.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -1.111 . . . . 0.0 110.007 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 20' ' ' SER . 2.2 t80 -90.92 131.9 36.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.621 ' CG ' HD13 ' A' ' 40' ' ' LEU . 29.1 m95 -124.15 104.18 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 111.146 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -122.44 17.73 10.53 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.873 0.845 . . . . 0.0 108.883 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.98 47.95 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.393 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -113.63 -157.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.889 -1.132 . . . . 0.0 109.974 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.599 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 1.2 p -95.96 176.1 6.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' CG ' ' A' ' 42' ' ' ARG . . . -52.83 -69.51 1.18 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.66 -40.94 13.77 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.087 -1.243 . . . . 0.0 110.94 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 4.6 tp10 -59.59 -28.12 66.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.721 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -77.95 -42.92 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.084 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.617 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -69.28 -44.97 70.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 111.277 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 HD12 ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -70.32 -31.92 69.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.155 -0.966 . . . . 0.0 111.851 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 1.6 pp -55.43 -23.8 27.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.824 -1.173 . . . . 0.0 110.223 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 2.8 pp -78.47 -38.47 40.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.548 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 12.7 p -70.09 -32.71 70.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.85 -20.57 42.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.299 -0.876 . . . . 0.0 110.973 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.715 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 11.8 mm-40 -116.29 -75.08 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.9 -1.125 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.715 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 45.2 Cg_endo -71.64 72.58 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.302 1.159 . . . . 0.0 110.564 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -57.62 141.25 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.952 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.64 19.45 75.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -133.56 148.09 51.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -1.026 . . . . 0.0 109.928 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.679 ' CD1' ' HB3' ' A' ' 98' ' ' TYR . 21.9 p90 -121.84 159.44 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.937 . . . . 0.0 109.945 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.621 HD13 ' CG ' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -152.64 159.86 43.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 110.704 -178.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.649 HG12 ' OH ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -114.45 134.76 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.564 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 13.9 tpt180 -112.71 129.93 56.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.058 -1.026 . . . . 0.0 110.033 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.6 ' OD1' ' CG ' ' A' ' 51' ' ' PHE . 15.0 m-20 -98.59 138.1 36.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.281 -0.887 . . . . 0.0 110.494 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 9.1 t60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.175 0.512 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HB3' ' O ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER 171.01 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.603 ' CE2' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -115.81 139.88 49.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.36 -0.838 . . . . 0.0 109.88 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 16.1 p -123.12 146.63 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.97 -1.081 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.759 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -120.82 122.72 40.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 109.818 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.617 ' CB ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -143.52 155.94 44.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.726 -1.234 . . . . 0.0 112.812 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.558 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 5.3 p -143.66 174.48 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.166 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 2.1 ttpt -115.72 125.45 52.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.862 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.88 -162.62 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.985 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.77 -23.21 42.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -81.73 13.38 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.166 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.06 138.72 3.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.523 ' CG2' HD13 ' A' ' 29' ' ' LEU . 2.9 t -78.85 108.76 12.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -1.139 . . . . 0.0 109.951 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 54' ' ' SER . 6.9 mmtt -109.17 157.94 18.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.213 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 64' ' ' LEU . 1.7 t-20 -111.97 152.28 28.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.877 . . . . 0.0 110.028 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 52' ' ' THR . 15.1 mt -138.52 117.52 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 0.0 110.233 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -81.8 155.71 25.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 0.0 110.586 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -77.28 141.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 110.014 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.3 mt-30 -93.48 132.55 37.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' SER . 30.0 t -109.42 118.82 37.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' O ' ' OG ' ' A' ' 72' ' ' SER . 7.0 mm-40 -133.15 104.77 6.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.442 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.68 36.32 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.18 -0.01 55.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -103.75 163.3 12.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -1.127 . . . . 0.0 109.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.4 m-30 -110.87 148.06 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 19.5 m -144.43 138.59 27.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.808 . . . . 0.0 110.079 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 94' ' ' LEU . 10.0 tp . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 109.94 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.565 HG12 ' CE2' ' A' ' 73' ' ' PHE . 8.6 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.512 ' O ' HG21 ' A' ' 95' ' ' VAL . 13.3 mt -63.41 -46.12 87.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 108.829 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -64.95 -29.42 70.35 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.576 0.703 . . . . 0.0 109.543 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -57.51 -34.55 69.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 110.739 -178.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.542 HG13 ' CD1' ' A' ' 12' ' ' LEU . 3.7 m -54.19 -39.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.928 -1.108 . . . . 0.0 108.825 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -68.62 -30.01 68.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 178.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.648 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -56.73 -38.82 72.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 110.276 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.759 ' CE1' ' HB2' ' A' ' 53' ' ' LEU . 36.3 m-85 -73.8 -0.65 16.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.602 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.035 -1.041 . . . . 0.0 110.471 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 2.8 ttt180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.551 ' O ' ' CG1' ' B' ' 168' ' ' VAL . . . 165.13 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.844 . . . . 0.0 109.997 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.904 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -102.59 124.86 48.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.018 . . . . 0.0 108.993 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.843 ' O ' ' HA ' ' B' ' 167' ' ' VAL . 6.7 p90 -156.02 166.34 33.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.804 -1.185 . . . . 0.0 111.016 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.537 ' CD1' HD23 ' A' ' 147' ' ' LEU . 5.6 mt -102.43 149.53 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.778 0.799 . . . . 0.0 111.377 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -97.79 133.46 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.639 0.733 . . . . 0.0 110.969 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -121.43 119.53 32.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.566 -0.709 . . . . 0.0 110.52 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 42.58 63.41 1.91 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.3 13.84 23.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 140' ' ' SER . 8.3 tp10 -109.97 121.73 45.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 18.2 mttt -79.4 105.65 10.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.833 . . . . 0.0 110.561 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.782 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.2 mp -97.22 109.67 50.71 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.781 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.59 129.38 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.139 1.599 . . . . 0.0 111.838 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.588 HD13 ' CG2' ' A' ' 145' ' ' ILE . 5.6 mp -124.28 134.96 53.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.493 -0.755 . . . . 0.0 109.87 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.93 118.41 53.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.683 ' CD1' ' CE1' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -76.06 157.83 32.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.87 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.4 -74.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 0.0 110.999 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 38' ' ' THR . 2.8 mtt180 -105.19 132.54 20.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.038 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.626 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 49.9 Cg_endo -78.04 148.01 24.33 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.02 1.537 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -85.26 115.9 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.346 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.43 ' C ' HD21 ' A' ' 64' ' ' LEU . 6.9 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.15 0.5 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.558 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.2 t -178.32 147.41 0.42 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.0 t -86.03 145.38 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.758 HG12 ' CD2' ' A' ' 137' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 5.1 mt-10 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.237 0.542 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 4.8 t80 -66.8 -51.51 54.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.219 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -67.3 -40.8 86.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 1' ' ' GLU . 3.0 mt -56.99 -45.89 82.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.158 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.489 HG13 HG11 ' A' ' 9' ' ' VAL . 17.0 t -71.97 -47.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.496 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 81.0 t -58.75 -32.77 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.358 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -70.88 -38.68 73.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -76.14 -44.61 37.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.485 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 10' ' ' ARG . 24.5 m -57.62 -39.81 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.323 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 mmt180 -55.75 -44.44 77.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 109.82 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.09 -41.32 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.921 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.88 -41.93 95.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.543 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 19.6 mt-30 -67.75 -35.27 78.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -69.7 -49.57 52.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -58.53 -28.75 65.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.23 15.84 29.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD2' ' HG ' ' A' ' 153' ' ' LEU . 4.0 m-85 -101.85 -0.94 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.144 . . . . 0.0 110.13 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.543 ' CD2' ' HG3' ' A' ' 13' ' ' GLN . 4.3 t80 -90.77 136.05 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.639 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.532 ' HB3' ' NE ' ' A' ' 42' ' ' ARG . 45.9 m95 -117.35 148.07 42.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 109.651 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -150.66 108.18 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 110.444 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 176.16 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.498 HG22 ' CD ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -119.42 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 110.421 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.529 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -85.61 176.14 8.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.338 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.7 -69.38 1.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -77.64 -36.04 34.52 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 3.1 tt0 -59.66 -24.57 64.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 0.0 109.603 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.6 ' CB ' ' HD3' ' A' ' 42' ' ' ARG . . . -74.35 -46.47 40.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.474 -0.766 . . . . 0.0 110.364 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.604 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -67.96 -36.68 80.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.553 HD13 ' ND2' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -57.71 -32.31 67.27 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.004 -1.06 . . . . 0.0 110.282 -178.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.2 pp -56.39 -23.88 40.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 108.765 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.665 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 1.7 pp -68.06 -33.67 75.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 m -69.56 -33.03 72.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.758 . . . . 0.0 109.777 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.01 41.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 109.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.788 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 45.1 mm-40 -125.93 -86.87 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.788 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.4 Cg_endo -74.46 68.57 5.25 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 122.831 0.911 . . . . 0.0 110.267 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 141.47 48.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 0.0 110.64 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.27 18.65 66.34 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -131.28 148.21 52.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.482 -1.01 . . . . 0.0 110.103 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' CE2' ' HG ' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -121.72 138.74 54.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 110.068 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.56 ' HA ' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -126.13 161.09 28.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.45 -0.781 . . . . 0.0 110.286 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -113.12 128.69 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.108 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -129.14 136.51 50.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.831 . . . . 0.0 109.655 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 2.3 t0 -73.77 127.57 33.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.299 -0.876 . . . . 0.0 110.184 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.23 0.538 . . . . 0.0 110.248 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 18.4 t80 55.04 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.597 ' CE2' HG12 ' A' ' 91' ' ' VAL . 7.3 p90 -126.24 148.79 49.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.034 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 64' ' ' LEU . 3.3 m -126.42 155.03 42.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.663 ' CD2' ' CG ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -126.93 136.52 52.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.603 ' OG ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -127.71 154.29 45.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 109.55 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.584 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 6.6 m -118.02 174.36 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.563 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 0.1 OUTLIER -103.91 138.98 39.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.39 -0.819 . . . . 0.0 110.28 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.1 m -127.32 158.14 38.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 57' ' ' THR . 43.9 mt-30 -38.92 -28.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.0 t -173.55 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.2 62.4 0.46 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.95 108.94 12.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -1.194 . . . . 0.0 109.514 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -137.46 178.0 7.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 0.0 110.67 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.556 ' CA ' ' HB3' ' A' ' 54' ' ' SER . 32.5 p-10 -137.56 156.17 48.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.491 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' OH ' ' A' ' 98' ' ' TYR . 34.5 mt -131.04 152.19 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.11 156.79 18.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 110.178 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.573 HG22 ' CE2' ' A' ' 73' ' ' PHE . 3.5 tp -76.76 134.75 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.96 151.04 20.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.8 t -116.72 116.92 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.6 mm-40 -107.41 102.79 12.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.009 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.38 -79.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -143.7 45.67 0.87 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 t -142.92 163.03 33.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -1.155 . . . . 0.0 110.393 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.573 ' CE2' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.14 126.8 32.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 109.823 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 66' ' ' ILE . 4.1 p -155.24 146.03 22.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.018 . . . . 0.0 110.435 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.001 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 HG12 ' CE2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.427 0.632 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -56.47 -35.37 67.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.485 -0.759 . . . . 0.0 110.154 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -58.25 -38.57 77.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.266 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.16 -35.14 77.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.418 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 93.4 t -55.37 -37.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.749 . . . . 0.0 110.404 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.09 -45.51 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.58 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.425 ' CD2' HG13 ' B' ' 167' ' ' VAL . 1.5 t60 -78.12 -36.74 47.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.84 . . . . 0.0 109.533 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.663 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -69.32 -12.15 61.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 12.5 ttt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.27 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mmt-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.172 0.511 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.629 ' CB ' HG21 ' B' ' 168' ' ' VAL . . . -160.89 132.85 5.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.667 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 1.5 t80 -119.42 123.53 44.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.806 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 3.8 p90 -155.23 166.74 32.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.857 -1.152 . . . . 0.0 111.285 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.413 ' H ' ' CD2' ' A' ' 147' ' ' LEU . 3.0 mt -102.44 149.11 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.388 -0.82 . . . . 0.0 111.207 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.711 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 14.8 m-85 -98.72 133.19 43.39 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.692 0.758 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.457 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -94.88 -162.07 0.91 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.68 . . . . 0.0 110.134 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.37 60.7 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 101.6 2.46 53.12 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -119.97 121.92 40.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.63 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -80.74 105.33 11.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.485 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -82.77 109.13 14.82 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.638 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -74.93 129.42 12.38 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.193 1.628 . . . . 0.0 112.811 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.688 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.8 mm? -125.25 135.86 52.96 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 148' ' ' VAL . 13.0 p -97.43 117.15 41.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.265 -1.522 . . . . 0.0 110.428 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.62 ' HG ' ' CE2' ' A' ' 39' ' ' PHE . 9.5 tp -91.88 114.8 27.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 t -161.77 10.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.892 -1.13 . . . . 0.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 2.9 mtt85 -108.93 123.93 35.62 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.679 -1.263 . . . . 0.0 109.991 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 50.1 Cg_endo -78.65 148.35 22.84 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.98 1.516 . . . . 0.0 111.039 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.625 ' HG ' ' CD2' ' A' ' 17' ' ' PHE . 4.4 pp -83.73 135.63 34.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.914 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 153' ' ' LEU . 12.7 t . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 110.36 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.429 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.235 0.54 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.73 159.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.667 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -113.47 170.61 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.664 ' C ' ' O ' ' B' ' 167' ' ' VAL . 46.8 t . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.195 0.521 . . . . 0.0 111.314 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.531 ' CA ' HD13 ' A' ' 4' ' ' LEU . 3.3 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 55.1 p90 -57.55 -36.04 71.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.9 tt0 -55.03 -37.98 67.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.531 HD13 ' CA ' ' A' ' 1' ' ' GLU . 1.5 mt -58.87 -45.8 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.589 HG21 ' CD2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -71.16 -37.34 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.189 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 2' ' ' TYR . 94.9 t -58.02 -39.43 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.923 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -70.69 -34.67 72.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' CB ' HD12 ' A' ' 92' ' ' LEU . . . -76.27 -44.17 38.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.785 . . . . 0.0 110.119 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.596 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 47.3 t -57.4 -39.85 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.47 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 10.8 ttm180 -55.91 -45.46 78.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.947 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -38.61 43.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.862 . . . . 0.0 109.992 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.555 ' CD2' HG23 ' A' ' 41' ' ' ILE . 18.0 tp -71.0 -40.7 71.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 110.013 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.469 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 4.6 pt20 -68.12 -34.94 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.303 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -57.95 -27.92 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.54 -27.27 69.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.865 . . . . 0.0 110.168 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.3 25.11 24.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -130.11 7.83 5.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.041 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CD2' HG22 ' A' ' 41' ' ' ILE . 4.3 t80 -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.665 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 17.2 m95 -121.1 148.56 44.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.416 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -151.41 24.83 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.02 8.97 20.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.661 -0.649 . . . . 0.0 110.924 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.637 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -116.35 -160.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.049 . . . . 0.0 109.925 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -97.31 176.16 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.319 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.58 -85.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.552 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -70.74 -31.63 67.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -59.09 -39.17 81.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.129 -1.218 . . . . 0.0 109.958 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.637 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -64.44 -47.03 80.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.627 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.706 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 m-80 -68.91 -43.66 74.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -0.94 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.503 ' N ' HD11 ' A' ' 29' ' ' LEU . 1.6 mp -70.53 -32.29 69.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 112.072 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' CD2' HG13 ' A' ' 22' ' ' VAL . 1.8 pp -55.17 -24.42 26.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.709 -1.244 . . . . 0.0 111.032 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.4 pp -77.56 -37.86 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 0.0 109.584 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 21.8 p -69.74 -32.57 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 0.0 110.28 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.65 43.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.615 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.731 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 5.3 mm-40 -115.76 -76.41 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.92 -1.112 . . . . 0.0 110.489 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.731 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.2 Cg_endo -72.69 70.37 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.286 1.151 . . . . 0.0 110.509 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 141.23 13.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 73.46 20.77 79.92 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.3 m -129.59 147.7 51.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -1.074 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.633 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 9.7 m-85 -122.9 158.46 30.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.382 -0.824 . . . . 0.0 109.454 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.665 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.38 160.57 43.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.008 -1.058 . . . . 0.0 111.195 -178.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.592 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.89 129.18 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.541 -0.724 . . . . 0.0 109.906 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -117.36 161.12 20.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.282 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.491 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 7.5 t70 -100.05 138.06 37.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 109.991 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' ASP . 53.1 p . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.291 0.567 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.577 ' CG ' HG22 ' A' ' 66' ' ' ILE . 12.2 p90 -163.8 -165.01 0.96 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.706 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 13.0 p90 -134.33 139.6 45.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 110.628 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.577 ' CG2' ' HA ' ' A' ' 65' ' ' ARG . 2.2 p -126.31 155.29 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.474 -0.767 . . . . 0.0 109.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.754 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -134.37 142.58 47.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.064 -1.023 . . . . 0.0 110.688 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.661 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -124.5 154.17 40.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.633 ' CG1' ' CD1' ' A' ' 39' ' ' PHE . 21.2 m -117.63 174.01 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.114 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' CG ' ' HB2' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.99 130.79 51.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.454 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 80.5 p -141.11 156.6 45.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.76 82.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.2 t -63.0 -10.86 15.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 124.07 153.64 8.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -78.91 140.47 38.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 54' ' ' SER . 69.6 mmtt -139.16 133.18 31.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.563 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 1.5 p-10 -111.91 128.85 56.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.495 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 2.9 mp -102.43 118.14 36.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.972 . . . . 0.0 110.252 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.577 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 0.1 OUTLIER -84.52 152.26 24.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 50' ' ' PHE . 4.5 tp -84.93 149.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -114.58 115.65 27.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.855 . . . . 0.0 110.504 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.564 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 27.5 p -92.04 123.15 35.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 14.9 tt0 -133.19 103.5 6.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.5 32.93 85.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.81 -11.67 69.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 82.9 p -94.74 143.1 26.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.989 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 68' ' ' CYS . 3.4 m-30 -110.82 157.36 19.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.243 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -155.56 138.65 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.153 -0.967 . . . . 0.0 110.486 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.546 ' CD2' ' CD2' ' A' ' 94' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.706 ' CG2' ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 8' ' ' ALA . 4.9 mp -66.36 -46.2 77.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 108.841 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -29.22 69.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.784 0.802 . . . . 0.0 108.869 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.628 ' CD2' ' CZ ' ' A' ' 98' ' ' TYR . 5.0 mt -57.48 -34.23 68.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 0.0 110.096 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -54.27 -38.66 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.879 -1.138 . . . . 0.0 108.686 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.478 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 7.7 m170 -68.64 -51.89 37.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 108.862 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -63.81 -36.95 85.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.358 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.754 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 3.7 m-30 -73.38 -9.16 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.642 -0.661 . . . . 0.0 110.013 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.51 ' HB3' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 110.2 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.442 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 1.2 ptm180 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.59 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.559 ' O ' ' CG1' ' B' ' 168' ' ' VAL . . . 172.23 130.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.671 ' CD2' HG12 ' B' ' 167' ' ' VAL . 1.2 t80 -116.55 122.54 44.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.984 -1.072 . . . . 0.0 109.306 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.733 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 5.4 p90 -156.32 166.95 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.952 -1.092 . . . . 0.0 110.66 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.33 149.17 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.061 . . . . 0.0 111.356 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.71 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.7 m-30 -86.44 107.88 18.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.591 -0.693 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.594 ' CB ' ' CD1' ' A' ' 145' ' ' ILE . 23.0 t -55.78 84.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.018 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 66.9 -64.79 0.19 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -144.7 13.08 1.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 140' ' ' SER . 2.8 tt0 -120.45 123.43 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.093 . . . . 0.0 109.797 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -75.5 105.57 6.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -103.38 112.86 65.94 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.733 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.8 Cg_endo -72.79 127.47 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.76 1.4 . . . . 0.0 111.791 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.66 ' O ' ' O ' ' A' ' 136' ' ' TYR . 1.1 mp -126.42 135.24 51.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 15.0 m -97.88 116.58 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.187 -1.571 . . . . 0.0 109.945 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.619 HD12 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -109.5 123.34 49.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.7 m -158.61 61.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -134.37 124.92 17.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.7 144.17 34.92 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.922 1.485 . . . . 0.0 110.472 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 1.3 tt -92.03 153.74 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.885 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.411 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 50.9 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.495 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -89.61 139.55 30.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.671 HG12 ' CD2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -91.77 106.92 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.067 -1.021 . . . . 0.0 109.829 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.667 ' CG1' ' CD2' ' A' ' 137' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.526 ' CG ' ' N ' ' A' ' 2' ' ' TYR . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.224 0.535 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 7.0 p90 -60.49 -37.17 80.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.18 -41.46 77.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.341 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 1.1 mt -67.44 -47.21 70.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 3.5 p -64.95 -48.36 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.757 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 3' ' ' GLN . 12.4 p -58.7 -43.99 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 109.984 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.9 m120 -59.06 -42.16 89.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.0 109.618 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' HG13 ' A' ' 91' ' ' VAL . . . -68.34 -44.17 75.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.806 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 49.1 t -57.53 -39.8 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.387 -0.821 . . . . 0.0 109.25 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 tpt180 -55.66 -49.0 74.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -34.26 49.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.806 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.588 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 tp -72.16 -44.15 63.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 110.097 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 4.9 pt20 -60.82 -33.91 73.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 25.7 tt0 -57.82 -18.98 25.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.426 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 59.1 m -55.99 -43.01 77.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.044 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.2 34.37 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.588 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 15.5 p90 -153.0 18.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.253 . . . . 0.0 110.56 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 3.0 t80 -90.84 119.86 31.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.756 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.664 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 31.6 m95 -72.69 148.12 45.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.631 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -62.15 -12.67 21.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.901 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 74.1 75.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 110.915 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.572 HG22 ' CB ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -46.42 -92.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 109.091 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.583 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -106.63 165.81 11.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 178.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA2' ' NH1' ' A' ' 42' ' ' ARG . . . -43.51 -81.16 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.614 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.26 -30.15 47.1 Favored Glycine 0 N--CA 1.491 2.349 0 O-C-N 121.41 -1.053 . . . . 0.0 110.705 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.583 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -58.22 -24.46 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.378 . . . . 0.0 110.955 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.572 ' CB ' HG22 ' A' ' 22' ' ' VAL . . . -77.63 -46.61 21.55 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 110.146 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.655 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.3 OUTLIER -70.42 -46.85 63.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 111.2 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.631 HD11 ' OD1' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -70.61 -29.98 66.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 112.069 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -52.96 -23.25 6.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.64 -1.288 . . . . 0.0 109.8 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD11 HD22 ' A' ' 40' ' ' LEU . 45.0 mt -64.05 -41.33 97.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.992 -1.068 . . . . 0.0 109.219 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.577 ' CB ' ' CG ' ' A' ' 56' ' ' LYS . 55.9 p -69.1 -31.6 70.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 -20.13 47.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.787 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 17.8 mm-40 -126.15 -81.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.901 -1.124 . . . . 0.0 110.607 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 55.4 Cg_endo -77.71 68.43 7.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 122.902 0.949 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.39 135.5 33.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.625 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 87.04 7.9 76.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.585 ' OG1' ' HB2' ' A' ' 35' ' ' PRO . 27.4 p -116.11 147.71 41.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -1.136 . . . . 0.0 110.608 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CD2' HD21 ' A' ' 149' ' ' LEU . 7.2 p90 -122.3 147.3 46.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 0.0 110.374 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.664 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -147.21 160.24 42.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.481 -0.762 . . . . 0.0 109.548 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 1.4 tt -113.56 128.47 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 110.001 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 5.7 ppt_? -112.77 122.11 46.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 110.31 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.57 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.9 t70 -73.82 114.97 12.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.239 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 44' ' ' SER . 7.6 m-70 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.187 0.518 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.582 ' CZ ' ' HG3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -143.6 -150.82 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.162 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.65 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 25.6 p90 -115.56 142.79 46.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 110.104 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 2.4 m -126.28 143.5 51.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.765 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 7.2 tt -124.21 135.1 53.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.655 ' CB ' ' OD1' ' A' ' 28' ' ' ASN . 23.1 p -139.26 155.42 47.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.544 ' CG2' HD22 ' A' ' 149' ' ' LEU . 10.3 p -140.94 158.9 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 110.481 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.577 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.76 137.48 41.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' CD1' ' A' ' 147' ' ' LEU . 25.8 p -137.73 -74.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 59' ' ' SER . 2.3 mt-30 -147.43 -78.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.532 ' CB ' HG21 ' A' ' 145' ' ' ILE . 9.8 t -42.69 -53.17 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.32 47.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.521 ' CG2' HD12 ' A' ' 29' ' ' LEU . 5.5 m -99.56 141.02 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.17 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.9 145.86 51.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.25 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.535 ' ND2' ' HB3' ' A' ' 28' ' ' ASN . 13.6 t-20 -111.13 132.34 54.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.776 ' HG ' ' CG2' ' B' ' 167' ' ' VAL . 0.4 OUTLIER -110.97 152.13 27.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.621 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.582 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -140.91 148.05 39.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.258 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.565 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 10.0 tp -76.83 128.29 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 2.7 tp-100 -96.54 151.1 19.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.216 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 1' ' ' GLU . 36.5 t -93.01 139.12 30.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -130.08 102.94 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 44.82 -111.19 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.73 28.11 15.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.18 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 110.145 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.565 ' CZ ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -124.54 144.96 49.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 67' ' ' GLN . 47.4 t -155.54 167.12 31.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.571 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.546 ' CD2' ' CD2' ' A' ' 94' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 109.892 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 7.4 mp -59.52 -47.1 86.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.045 . . . . 0.0 108.974 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -31.86 72.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -59.73 -35.03 73.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.697 -0.627 . . . . 0.0 110.261 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.9 t -54.5 -38.01 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.574 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.284 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.607 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -78.15 -50.51 11.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.932 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.765 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 10.0 m-85 -63.79 -11.73 29.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 4.4 tpt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.138 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.55 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -171.83 143.98 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.684 ' CZ ' ' CG2' ' B' ' 167' ' ' VAL . 1.8 t80 -138.21 121.65 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.579 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.746 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 6.7 p90 -156.11 166.72 32.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.737 -1.227 . . . . 0.0 110.843 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.498 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.5 mt -102.14 149.61 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.289 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.699 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.6 m-85 -99.4 133.37 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.637 0.732 . . . . 0.0 111.007 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -88.31 54.23 3.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.526 -0.734 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.63 31.41 1.73 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.87 -29.56 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 140' ' ' SER . 6.1 mp0 -116.06 121.91 43.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.12 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.66 105.39 8.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -87.56 110.64 35.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.632 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 48.9 Cg_endo -75.72 128.12 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.026 1.54 . . . . 0.0 112.728 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.649 ' O ' ' O ' ' A' ' 136' ' ' TYR . 2.0 mm? -125.49 135.32 52.18 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.521 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 5.6 m -98.68 116.38 41.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.006 -1.684 . . . . 0.0 111.218 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 136' ' ' TYR . 1.6 mt -91.05 125.89 35.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.022 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.475 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 90.9 p -151.23 -24.39 0.21 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.774 -1.204 . . . . 0.0 111.985 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 38' ' ' THR . 47.5 mtp180 -85.85 124.5 70.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.627 -1.296 . . . . 0.0 110.328 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.57 148.23 25.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.104 1.581 . . . . 0.0 110.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.642 ' CD2' ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.54 158.13 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.357 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.264 -179.829 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.31 0.576 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.522 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -94.04 151.43 19.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.291 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.776 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 1.2 t -87.59 -160.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.67 ' CG1' ' CD2' ' A' ' 137' ' ' TYR . 21.4 m . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.215 0.531 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.478 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.18 -35.74 79.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 43.4 tp60 -54.79 -33.85 61.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.168 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.635 ' CD2' ' CD1' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -57.0 -47.02 81.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG21 ' CE2' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -59.89 -44.41 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 73.7 t -58.73 -51.14 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 48.3 m-20 -59.83 -46.08 90.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -63.08 -43.51 98.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -0.801 . . . . 0.0 109.655 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 25.6 t -57.29 -39.31 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.72 . . . . 0.0 109.311 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.7 tpt180 -55.42 -40.92 72.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.445 -0.784 . . . . 0.0 109.887 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -42.15 32.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD22 HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.0 -38.87 69.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 2.6 pt20 -65.77 -33.97 77.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.84 -18.96 25.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -56.6 -43.49 80.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 110.081 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.97 30.9 2.02 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.662 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 15' ' ' SER . 1.6 p90 -159.93 33.79 0.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.43 . . . . 0.0 111.134 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.59 ' CD2' HG21 ' A' ' 41' ' ' ILE . 1.7 t80 -90.89 134.66 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.725 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.663 ' CG ' HD11 ' A' ' 40' ' ' LEU . 24.8 m95 -124.5 148.55 47.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.13 23.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.01 0.15 13.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.546 -0.721 . . . . 0.0 111.004 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -107.24 -158.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.9 -1.125 . . . . 0.0 109.721 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -101.56 170.76 7.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.093 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.75 -79.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.525 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -79.32 -30.92 43.75 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.4 tp10 -58.27 -37.78 75.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -1.225 . . . . 0.0 110.069 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.47 -50.69 71.76 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.031 -1.043 . . . . 0.0 108.825 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.525 HD21 ' HA2' ' A' ' 25' ' ' GLY . 8.4 m-80 -69.79 -49.04 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 1.6 mp -59.77 -31.76 69.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 111.237 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.25 -22.49 11.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.998 -1.064 . . . . 0.0 109.555 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.713 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 80.4 mt -60.13 -35.3 74.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.087 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.66 ' HB2' ' CD ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -69.56 -32.48 71.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.112 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.2 -20.8 43.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.96 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.754 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.6 mt-10 -131.07 -84.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.515 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.754 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.1 Cg_endo -76.77 68.31 7.17 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 122.77 0.879 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.27 141.74 14.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -0.978 . . . . 0.0 110.717 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' ' CD ' ' A' ' 151' ' ' ARG . . . 72.32 25.66 73.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.56 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 79.1 m -119.82 149.19 42.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.933 . . . . 0.0 110.692 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -120.72 138.81 53.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.663 HD11 ' CG ' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -134.08 160.53 37.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.442 -0.786 . . . . 0.0 110.959 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.59 HG21 ' CD2' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -114.07 134.09 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 1.1 ttp-105 -129.32 146.35 51.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.327 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 8.2 t0 -99.08 138.0 36.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.471 ' HB3' ' CB ' ' A' ' 49' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 21.6 m170 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.184 0.516 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.549 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 27.6 p90 -89.78 -177.77 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.197 -0.939 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.643 ' CE2' HG13 ' A' ' 91' ' ' VAL . 6.8 p90 -116.0 155.72 27.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.53 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 64' ' ' LEU . 3.2 m -126.16 154.65 42.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.641 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -135.0 130.86 36.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.54 ' CB ' ' OD1' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -136.43 153.9 50.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.583 -0.698 . . . . 0.0 109.665 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.617 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -127.59 171.18 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 110.447 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.66 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -119.38 135.42 54.74 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 0.0 110.1 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 58' ' ' GLN . 4.4 t -127.51 61.34 1.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER 67.37 -57.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -145.84 47.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.208 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.452 ' HA3' ' CG2' ' A' ' 57' ' ' THR . . . -153.57 74.42 0.24 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.526 HG23 ' CD1' ' A' ' 29' ' ' LEU . 2.7 m -96.17 108.87 21.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -128.97 155.29 45.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.54 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 4.0 m-20 -140.07 149.22 42.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' B' ' 167' ' ' VAL . 17.4 mt -134.87 147.17 49.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -108.38 153.62 23.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.313 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.58 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 20.0 mm -89.06 145.59 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.43 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 66' ' ' ILE . 51.5 mm-40 -122.09 132.96 54.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 72' ' ' SER . 28.1 p -88.61 125.24 34.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.11 112.27 11.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 53.5 65.82 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.36 18.02 9.22 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -122.29 163.15 20.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -1.174 . . . . 0.0 109.882 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 4' ' ' LEU . 5.3 m-85 -131.94 139.8 48.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 110.47 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.551 ' CA ' HD11 ' A' ' 94' ' ' LEU . 8.3 t -147.23 138.98 24.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.0 110.101 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.652 ' CD2' ' CE1' ' A' ' 97' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.643 HG13 ' CE2' ' A' ' 51' ' ' PHE . 2.8 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.655 0.74 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -54.03 -35.07 61.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 110.932 -178.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.615 ' N ' ' HG ' ' A' ' 92' ' ' LEU . 1.5 tptt -58.28 -35.65 72.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.54 -1.35 . . . . 0.0 109.06 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.553 ' O ' ' ND1' ' A' ' 97' ' ' HIS . 63.1 mt -62.86 -34.86 78.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -54.6 -37.07 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.53 ' N ' HG11 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -53.76 -31.54 48.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.02 . . . . 0.0 109.121 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.652 ' CE1' ' CD2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -65.86 -35.94 82.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 0.0 109.411 179.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.641 ' CE2' ' HB3' ' A' ' 53' ' ' LEU . 1.9 m-85 -63.05 -10.54 14.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.612 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.703 -0.623 . . . . 0.0 110.211 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 29.3 mmt-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.188 0.518 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 134' ' ' ARG . . . 163.27 75.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.913 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.661 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -102.7 124.72 48.76 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 109.321 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.826 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 5.6 p90 -155.6 167.06 31.62 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.085 -1.009 . . . . 0.0 110.983 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.651 ' H ' ' CD1' ' A' ' 147' ' ' LEU . 2.2 mp -102.75 149.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 111.11 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.694 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 17.5 m-85 -97.31 133.3 42.1 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.697 0.76 . . . . 0.0 111.096 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 3.2 t -86.48 51.92 2.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.17 27.53 1.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.42 -32.78 0.24 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 14.2 tp10 -120.19 121.98 39.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.234 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 3.9 ptmt -72.03 105.46 3.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.397 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.826 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -85.11 110.54 29.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.695 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.0 Cg_endo -75.38 129.65 12.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.124 1.591 . . . . 0.0 111.828 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.651 ' CD1' ' H ' ' A' ' 138' ' ' ILE . 1.0 OUTLIER -124.02 134.2 53.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.392 -0.818 . . . . 0.0 109.396 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 148' ' ' VAL . 13.5 m -107.61 117.53 53.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.96 -1.087 . . . . 0.0 110.604 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.599 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 6.6 tt -125.08 114.82 19.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.78 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.8 t -168.1 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.038 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.589 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -111.9 124.83 31.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 109.996 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.38 138.26 29.7 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.93 1.49 . . . . 0.0 110.693 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.56 HD21 ' CE2' ' A' ' 19' ' ' TRP . 4.8 tp -91.77 145.66 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 153' ' ' LEU . 1.2 p . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.481 ' HB2' ' CG2' ' A' ' 138' ' ' ILE . 57.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.241 0.543 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.509 ' N ' HD21 ' A' ' 64' ' ' LEU . 1.3 m 58.52 152.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' A' ' 136' ' ' TYR . 2.9 t -108.9 151.08 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.008 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 137' ' ' TYR . 6.5 p . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.955 . . . . 0.0 110.931 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 2' ' ' TYR . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.235 0.54 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 49' ' ' HIS . 3.6 t80 -63.29 -52.06 63.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.473 ' HA ' ' CG1' ' A' ' 6' ' ' VAL . 5.5 tm0? -68.57 -35.77 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 73' ' ' PHE . 2.3 mt -67.13 -42.0 85.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.61 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 56.0 t -72.06 -46.29 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.581 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 14.2 p -58.33 -32.7 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.309 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.513 ' N ' HG11 ' A' ' 6' ' ' VAL . 32.2 t-20 -68.1 -37.88 81.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 110.309 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.25 -45.05 34.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 110.593 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 33.6 m -57.91 -39.65 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.52 ' N ' HG21 ' A' ' 9' ' ' VAL . 2.9 ttt180 -55.75 -46.77 77.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.538 -0.726 . . . . 0.0 109.92 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.06 -35.87 49.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.883 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' A' ' 41' ' ' ILE . 52.0 tp -71.99 -44.32 63.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 110.058 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 1.9 pt20 -68.48 -34.16 75.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.4 mt-10 -57.91 -45.0 87.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -55.91 -26.87 49.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.88 40.4 3.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 152' ' ' PRO . 1.1 m-85 -141.98 44.46 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.17 . . . . 0.0 110.609 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.47 ' HB2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 t80 -126.59 130.36 50.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.61 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 36.3 m95 -102.86 147.66 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 1.2 m -44.64 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . 167.78 79.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.6 t -56.03 -118.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.29 -0.881 . . . . 0.0 109.647 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.594 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.11 168.93 10.79 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.786 -1.196 . . . . 0.0 109.347 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.561 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.32 -85.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' O ' ' CD2' ' A' ' 29' ' ' LEU . . . -79.37 -30.12 46.78 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.384 -1.068 . . . . 0.0 110.465 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.594 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -57.59 -42.9 84.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.242 . . . . 0.0 110.049 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . . . -58.91 -49.28 78.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 109.046 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.61 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.8 m-80 -68.75 -44.17 74.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.425 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.543 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.68 -31.71 68.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 112.091 -178.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 2.0 pp -54.71 -24.07 20.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.712 -1.243 . . . . 0.0 110.692 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.0 pp -78.5 -35.64 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.004 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.87 -32.84 71.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.74 41.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.629 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 24.6 mm-40 -113.64 -76.71 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.004 -1.06 . . . . 0.0 110.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.3 Cg_endo -72.03 65.36 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.287 1.151 . . . . 0.0 110.261 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 141.25 13.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 74.85 20.17 79.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.56 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.78 146.62 49.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -1.1 . . . . 0.0 110.224 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 5.3 p90 -123.39 155.92 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 110.311 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -149.48 159.01 44.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.962 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' A' ' 12' ' ' LEU . 5.5 tt -115.06 128.56 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.069 -1.019 . . . . 0.0 110.324 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.512 ' CG ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -112.89 149.72 32.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.778 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 49' ' ' HIS . 5.2 t0 -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.512 ' CB ' ' HB3' ' A' ' 50' ' ' PHE . 28.2 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.539 ' CE1' ' CE1' ' A' ' 2' ' ' TYR . 2.3 m-70 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.23 0.538 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.579 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.3 OUTLIER 48.12 107.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.395 -0.816 . . . . 0.0 110.898 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.646 ' CZ ' HG13 ' A' ' 91' ' ' VAL . 5.7 p90 -120.47 140.31 51.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.48 HG23 ' HG3' ' A' ' 42' ' ' ARG . 8.2 t -126.85 155.25 43.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.383 -0.823 . . . . 0.0 109.916 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.73 ' HG ' ' CZ ' ' A' ' 98' ' ' TYR . 2.0 pp -143.99 127.24 16.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.025 -1.047 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.579 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . 6.6 t -112.83 154.1 26.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.454 -0.779 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' HB ' ' CD2' ' A' ' 149' ' ' LEU . 14.9 p -127.86 173.78 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.13 -0.981 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.51 ' HD2' ' CB ' ' A' ' 32' ' ' SER . 4.6 tptt -117.55 139.05 51.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 0.0 110.018 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.52 HG22 ' CA ' ' A' ' 147' ' ' LEU . 4.9 p -135.7 -94.08 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.294 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.3 mm-40 -80.02 -29.17 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER 162.8 -18.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.735 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.56 100.81 2.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 56' ' ' LYS . 2.2 t -100.43 121.46 41.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -1.13 . . . . 0.0 109.925 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -139.71 171.81 13.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.076 -1.015 . . . . 0.0 110.518 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 1.4 p-10 -123.6 152.68 41.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.607 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -110.44 117.79 34.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.936 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.479 ' NH2' ' CZ ' ' A' ' 50' ' ' PHE . 9.2 ptm180 -83.13 151.76 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.577 HG13 ' CG2' ' A' ' 91' ' ' VAL . 6.9 mm -84.84 144.2 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.5 OUTLIER -96.08 121.37 37.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 26.8 p -88.07 118.16 27.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -133.04 121.15 22.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.221 -0.924 . . . . 0.0 110.244 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.51 95.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.82 13.06 38.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 69' ' ' GLU . 13.7 p -108.8 163.21 13.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.296 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.61 ' CZ ' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -110.78 128.38 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -155.17 138.98 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.646 HG13 ' CZ ' ' A' ' 51' ' ' PHE . 5.4 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.073 0.463 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.514 ' O ' HG21 ' A' ' 95' ' ' VAL . 8.9 mp -58.06 -47.03 84.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 109.308 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 5.0 mtpp -67.86 -31.46 71.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 108.891 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -59.39 -33.71 71.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.49 -37.21 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.733 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.446 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 5.0 m-70 -53.65 -50.44 65.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.62 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 135' ' ' ALA . 7.3 t60 -78.28 -36.95 46.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.518 -0.739 . . . . 0.0 109.09 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.73 ' CZ ' ' HG ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.11 -12.0 46.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.887 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.498 ' HA ' ' HB2' ' A' ' 149' ' ' LEU . 1.9 ttt . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.456 -0.778 . . . . 0.0 110.079 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.254 0.55 . . . . 0.0 110.336 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.608 ' O ' ' CE1' ' A' ' 97' ' ' HIS . . . 166.2 147.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.416 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.685 ' CD2' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -100.58 162.41 12.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.64 ' CE1' ' CG ' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -152.27 151.6 31.13 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 116.74 -1.984 . . . . 0.0 115.118 -176.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.538 ' N ' ' CD2' ' A' ' 147' ' ' LEU . 13.4 mt -142.17 120.57 8.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 137' ' ' TYR . 7.7 m-85 -84.09 107.96 16.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 143' ' ' GLU . 1.6 t -72.94 66.98 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.341 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.12 89.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.94 2.15 57.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.5 mt-10 -120.04 121.86 39.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -1.147 . . . . 0.0 110.31 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 137' ' ' TYR . 1.1 ttpp -98.23 105.72 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 145' ' ' ILE . 2.8 mp -112.7 119.02 44.06 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.778 . . . . 0.0 109.098 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.609 ' HA ' ' CD2' ' A' ' 137' ' ' TYR . 48.1 Cg_endo -75.13 127.2 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.731 1.385 . . . . 0.0 111.021 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -125.59 134.33 51.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 148' ' ' VAL . 2.2 p -120.72 118.85 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.752 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 136' ' ' TYR . 4.2 mp -76.36 150.62 36.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.218 -0.926 . . . . 0.0 109.886 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -36.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.462 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 6.9 mtp85 -104.78 124.32 37.21 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.602 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 51.2 Cg_endo -78.21 147.29 23.21 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.024 1.539 . . . . 0.0 110.198 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.525 ' HG ' ' NE1' ' A' ' 19' ' ' TRP . 4.3 tp -92.18 115.84 28.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.132 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.587 ' HB3' ' CE1' ' A' ' 17' ' ' PHE . 81.0 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.312 0.577 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.425 ' O ' HG23 ' B' ' 167' ' ' VAL . 45.1 p -65.94 -162.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 136' ' ' TYR . 55.4 t -143.06 167.61 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 137' ' ' TYR . 18.7 m . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.454 -0.779 . . . . 0.0 110.385 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.513 ' CA ' HD12 ' A' ' 4' ' ' LEU . 59.9 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.204 0.526 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -54.96 -45.24 74.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 109.956 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.628 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -54.94 -39.82 69.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.847 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -63.75 -47.2 82.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.836 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.659 ' CG2' ' CE2' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -65.84 -48.35 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 110.012 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.513 ' N ' HG12 ' A' ' 5' ' ' VAL . 39.5 t -59.54 -47.17 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.2 m120 -58.74 -28.07 65.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . . . -74.13 -44.13 54.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 50.4 t -57.38 -39.72 70.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.357 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -55.87 -49.35 73.58 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.73 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.53 -36.1 45.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 HD22 HG23 ' A' ' 41' ' ' ILE . 46.2 tp -69.48 -42.01 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 5.9 pt20 -67.99 -34.2 76.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.8 tt0 -57.91 -23.7 54.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 110.269 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 1.2 t -70.57 -27.0 63.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.23 -14.12 63.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -76.92 -10.67 59.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -1.108 . . . . 0.0 110.004 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.572 ' CE2' HG21 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -93.41 121.08 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.061 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.67 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 9.0 m95 -110.3 101.86 10.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 110.005 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.23 109.04 20.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 164.98 -4.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.426 -0.796 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.85 -159.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 0.0 109.982 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -99.19 176.2 5.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 110.228 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.597 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.76 -78.25 0.1 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' N ' HG21 ' B' ' 162' ' ' VAL . . . -79.26 -34.49 32.64 Favored Glycine 0 N--CA 1.492 2.398 0 O-C-N 121.193 -1.18 . . . . 0.0 110.424 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 2.7 mt-10 -59.51 -30.17 68.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.272 . . . . 0.0 110.098 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.62 -47.3 63.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.607 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 38.6 m-80 -68.01 -42.38 80.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.172 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 ' CG2' ' A' ' 61' ' ' THR . 3.4 mp -59.18 -32.01 69.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.799 . . . . 0.0 111.043 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -55.42 -23.81 27.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.973 -1.08 . . . . 0.0 109.943 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 32' ' ' SER . 4.0 pp -61.85 -37.01 82.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.096 -1.002 . . . . 0.0 109.042 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.619 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 96.6 p -69.6 -32.27 70.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -20.6 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.3 mm-40 -122.12 -79.8 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.5 Cg_endo -75.89 69.77 6.1 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.064 1.034 . . . . 0.0 110.184 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.96 141.33 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.21 78.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.4 m -131.0 147.9 52.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -1.04 . . . . 0.0 110.173 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.624 ' CE2' HD13 ' A' ' 149' ' ' LEU . 3.0 m-85 -122.64 141.49 51.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 110.072 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.67 ' CD1' ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -135.49 159.51 41.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.512 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.572 HG21 ' CE2' ' A' ' 18' ' ' TYR . 9.7 tt -115.05 138.56 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.579 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 2.6 tmt_? -112.86 160.71 17.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.0 110.261 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' CZ ' ' A' ' 42' ' ' ARG . 11.6 t0 -85.43 106.47 16.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t -44.43 145.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.346 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 23.2 t -64.88 -145.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.202 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 45' ' ' SER . 2.5 t70 67.27 -138.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' O ' ' CB ' ' A' ' 48' ' ' ARG . 26.8 mt-30 -67.06 -6.36 16.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.495 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 69.88 19.18 7.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 110.148 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.449 ' O ' HG13 ' A' ' 5' ' ' VAL . 54.4 m170 -102.83 39.54 1.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.117 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.48 ' HA ' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -163.58 147.73 10.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.659 ' CE2' ' CG2' ' A' ' 5' ' ' VAL . 12.4 p90 -132.11 146.72 52.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.95 . . . . 0.0 110.533 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.468 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -126.08 140.87 52.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.507 -0.746 . . . . 0.0 109.521 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.624 ' CD2' ' CD1' ' A' ' 98' ' ' TYR . 8.3 tt -120.93 145.32 47.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 111.039 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.558 ' HB3' ' CB ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -139.17 153.82 47.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.715 . . . . 0.0 109.453 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG13 ' CG ' ' A' ' 39' ' ' PHE . 33.5 m -121.35 174.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.662 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' HB2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -112.43 139.22 48.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.565 ' OG1' ' CD2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -153.17 175.87 12.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.94 4.72 15.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.035 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -13.48 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 110.176 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 57' ' ' THR . . . 130.7 150.3 6.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.53 ' CG2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -79.96 132.04 35.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -1.123 . . . . 0.0 110.227 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HE3' ' CG2' ' A' ' 138' ' ' ILE . 10.6 ttmt -122.41 146.54 47.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.541 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -115.8 145.73 42.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.123 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -138.23 152.74 48.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.506 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -126.48 159.79 32.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.6 HG12 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -86.55 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.496 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -113.19 129.22 56.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.068 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 1' ' ' GLU . 28.1 p -88.03 119.67 28.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.455 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.3 tm-20 -108.7 103.24 12.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.2 -0.937 . . . . 0.0 110.1 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.95 -84.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -138.23 21.95 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 58.6 p -123.08 156.79 34.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.638 ' CD2' ' HB3' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -110.96 131.55 54.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 0.0 110.178 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.85 146.86 22.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.057 -1.027 . . . . 0.0 110.514 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt -76.93 2.27 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.611 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 -157.34 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 110.079 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.65 4.08 8.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.097 -1.002 . . . . 0.0 110.499 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -98.47 121.99 54.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.072 -1.017 . . . . 0.0 110.278 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.67 52.0 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.952 1.501 . . . . 0.0 110.621 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 15.98 9.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.23 56.02 1.3 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.333 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.6 t -86.31 13.05 8.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.566 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -43.81 -53.55 12.5 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 83' ' ' GLN . 44.9 Cg_endo -72.38 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.82 1.432 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.545 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 3.5 m -102.69 168.38 8.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.965 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 43.8 Cg_endo -70.7 134.78 26.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.933 1.491 . . . . 0.0 110.152 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.8 ptt180 73.05 21.41 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.859 . . . . 0.0 109.865 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.652 ' CE1' ' CB ' ' A' ' 93' ' ' LYS . 49.5 p90 -58.66 -154.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.626 ' CB ' ' HB2' ' A' ' 92' ' ' LEU . 1.1 m-20 -72.69 110.42 7.03 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 109.187 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.638 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 61.8 m -37.66 -109.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.667 0.746 . . . . 0.0 112.433 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -49.39 -22.8 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 112.155 -178.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.626 ' HB2' ' CB ' ' A' ' 89' ' ' ASP . 6.1 mp -53.81 -46.2 71.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.527 -1.358 . . . . 0.0 110.342 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -67.06 -37.36 83.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 108.498 178.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 7.0 tp -68.31 -34.81 76.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.913 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 96' ' ' HIS . 0.3 OUTLIER -54.43 -36.95 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.905 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.536 ' N ' HG12 ' A' ' 95' ' ' VAL . 20.2 t-160 -53.16 -33.65 53.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 0.0 109.042 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.517 ' NE2' HG12 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -78.18 -37.07 46.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.646 ' CE1' ' OH ' ' A' ' 136' ' ' TYR . 4.3 m-85 -78.7 -21.22 48.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.915 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.557 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 1.3 mtp -161.86 -177.23 0.68 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 109.992 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 99' ' ' MET . 45.4 Cg_endo -72.4 175.33 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.858 1.452 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 100' ' ' PRO . 43.9 Cg_endo -71.37 160.81 47.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.992 1.522 . . . . 0.0 110.541 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.13 -157.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.075 1.566 . . . . 0.0 110.417 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 104' ' ' THR . . . 80.43 85.05 0.66 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.3 OUTLIER -42.43 159.87 0.19 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -1.13 . . . . 0.0 110.131 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.9 -13.09 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.996 1.524 . . . . 0.0 110.281 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.4 p -75.51 157.62 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' LEU . 25.7 t80 -161.62 92.82 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.12 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 2.9 m 57.81 -81.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.126 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 5.3 tp 173.49 -56.28 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 109' ' ' LEU . 45.1 Cg_endo -71.65 142.63 40.32 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.898 1.473 . . . . 0.0 110.425 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.93 94.13 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.947 1.499 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.56 -35.59 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.286 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -136.26 106.44 9.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.301 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.18 152.57 50.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.028 1.541 . . . . 0.0 110.377 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -128.36 44.86 2.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 118' ' ' VAL . 92.3 p -70.28 -145.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -55.94 104.53 0.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.169 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 116' ' ' SER . 9.7 m -154.25 75.64 5.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 110.275 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.04 165.26 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.997 1.525 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 53.3 71.85 0.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -151.39 134.18 8.71 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.32 112.08 3.44 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.38 66.79 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.81 91.49 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.25 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -91.48 -81.09 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.155 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.76 68.66 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 8.2 tp -155.97 52.68 0.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 127' ' ' LEU . 45.9 Cg_endo -73.0 59.28 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.032 1.543 . . . . 0.0 110.411 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 62.18 47.57 88.9 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -154.78 108.35 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.3 t -155.38 105.65 2.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.168 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 46.2 Cg_endo -73.25 -1.02 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.913 1.48 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER 61.99 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.97 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -131.59 161.01 33.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' B' ' 168' ' ' VAL . . . 169.98 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.713 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 0.5 OUTLIER -121.85 123.52 41.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.978 -1.076 . . . . 0.0 109.539 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.781 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 8.3 p90 -154.99 167.74 29.32 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.894 -1.129 . . . . 0.0 111.392 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.517 ' CG2' ' HE3' ' A' ' 62' ' ' LYS . 3.3 mt -102.69 143.24 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.656 0.741 . . . . 0.0 111.05 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.716 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 12.5 m-85 -92.89 132.63 36.86 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.637 0.732 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.549 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 0.9 OUTLIER -84.01 52.59 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.641 -0.662 . . . . 0.0 110.22 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.53 27.06 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 162.95 -30.87 0.28 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mt-10 -116.47 121.8 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.02 105.51 11.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.341 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.781 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -93.01 105.23 14.24 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.8 Cg_endo -73.55 129.64 13.94 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.052 1.554 . . . . 0.0 112.358 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.776 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 mp -125.64 135.28 51.99 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -98.27 116.98 42.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.365 -1.46 . . . . 0.0 109.954 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.624 HD13 ' CE2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -121.86 135.52 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.066 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.466 ' OG ' ' HD3' ' A' ' 100' ' ' PRO . 29.0 t -167.6 54.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.87 123.88 22.19 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.077 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.515 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 50.7 Cg_endo -78.75 148.32 22.51 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.143 1.602 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -85.83 133.78 33.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.823 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 155' ' ' SER . 36.9 t -117.79 78.77 1.27 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 10.0 m 42.65 -166.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -0.935 . . . . 0.0 110.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' A' ' 155' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.297 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 95.5 m -94.45 74.33 3.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.263 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . 179.63 -88.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.947 . . . . 0.0 110.265 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.16 114.1 9.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -36.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.349 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.531 HG21 ' HA3' ' A' ' 24' ' ' GLY . 97.2 t -73.25 55.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 2.6 mt-10 -96.6 159.17 15.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.541 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 43.3 t -139.47 -105.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.263 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.4 p -152.58 -179.54 7.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.713 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -127.85 143.48 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 137' ' ' TYR . 4.4 m 22.23 76.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.4 0.619 . . . . 0.0 111.126 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.555 ' N ' ' OH ' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -44.72 -78.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 83.5 p -128.64 -76.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.585 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.419 ' HA ' HD11 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.254 0.55 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.9 p90 -55.79 -39.02 70.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.525 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 40.0 tp60 -61.16 -42.27 98.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.123 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 HD22 ' CA ' ' A' ' 89' ' ' ASP . 1.1 mt -67.27 -47.23 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.628 ' CG1' ' CE2' ' A' ' 73' ' ' PHE . 2.4 m -72.56 -44.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.667 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.565 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 p -58.35 -32.55 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.47 ' N ' HG11 ' A' ' 6' ' ' VAL . 55.6 t-20 -67.98 -40.92 83.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.096 -1.003 . . . . 0.0 109.78 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . . . -76.36 -44.99 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 6' ' ' VAL . 4.3 m -57.93 -39.7 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.529 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.9 ttt180 -55.44 -45.9 76.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 109.69 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -32.94 50.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.687 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HG ' ' CZ ' ' A' ' 17' ' ' PHE . 5.9 tp -68.23 -43.98 76.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.455 -0.778 . . . . 0.0 110.286 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 3.4 pt20 -64.65 -33.83 76.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.187 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.554 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 2.9 mt-10 -57.84 -31.03 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -67.29 -41.3 85.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.034 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.75 36.62 3.19 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.599 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 5.6 p90 -145.39 28.17 1.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -1.166 . . . . 0.0 110.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.429 ' HE1' ' HB3' ' A' ' 20' ' ' SER . 3.0 t80 -90.76 136.29 33.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.727 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 69.4 m95 -117.51 149.23 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' TRP . 89.7 p 178.98 -15.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -13.26 4.36 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.714 -0.616 . . . . 0.0 110.533 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.39 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.599 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.58 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -89.16 175.82 7.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.791 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.548 ' HA2' ' CD ' ' A' ' 42' ' ' ARG . . . -46.03 -83.77 0.02 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.34 -30.51 45.32 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 121.398 -1.06 . . . . 0.0 110.681 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.58 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.4 mm-40 -58.27 -26.69 63.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.338 . . . . 0.0 110.422 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.87 -49.97 47.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.016 -1.053 . . . . 0.0 109.117 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.609 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -69.99 -46.39 65.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.0 110.747 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 HD13 ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -59.08 -31.34 68.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.445 -0.784 . . . . 0.0 111.602 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.3 pp -54.63 -23.62 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.789 -1.194 . . . . 0.0 109.442 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.646 HD11 ' N ' ' A' ' 32' ' ' SER . 3.6 pp -68.95 -34.11 74.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.155 -0.966 . . . . 0.0 108.567 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.646 ' N ' HD11 ' A' ' 31' ' ' LEU . 1.4 t -69.97 -32.81 71.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.67 -0.643 . . . . 0.0 110.234 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.66 -20.72 42.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.85 . . . . 0.0 110.488 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.74 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -122.9 -80.59 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.972 -1.08 . . . . 0.0 110.922 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.74 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 53.1 Cg_endo -75.24 68.46 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.015 1.008 . . . . 0.0 110.703 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.92 141.43 10.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.023 . . . . 0.0 110.399 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 78.93 20.58 70.16 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 53.7 m -117.55 148.3 42.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.984 . . . . 0.0 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 8.3 p90 -121.86 138.94 54.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.005 -1.06 . . . . 0.0 109.787 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.727 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.7 OUTLIER -138.95 156.71 47.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.388 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.3 tt -115.37 133.75 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.376 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.604 ' NE ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.89 141.43 46.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.856 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 49.3 t0 -82.08 132.77 35.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.106 -0.996 . . . . 0.0 110.247 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 42' ' ' ARG . 59.4 p -56.54 -63.81 1.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.363 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 69.56 7.43 6.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 0.0 109.93 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 3.9 t70 -102.3 -135.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.575 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -90.71 -26.45 19.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 110.345 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -75.33 -21.98 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.237 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 47' ' ' GLN . 80.9 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.255 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CB ' HG12 ' A' ' 5' ' ' VAL . 16.3 p90 -177.45 175.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.674 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 38.0 p90 -125.73 141.64 51.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.039 -1.038 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.604 ' CG2' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -125.33 144.34 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.686 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -121.99 133.6 54.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.769 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -139.1 154.28 48.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 110.087 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' CG1' HD21 ' A' ' 149' ' ' LEU . 10.7 p -132.98 174.9 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 2.0 ttpp -103.36 135.2 45.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.455 HG23 ' CB ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -97.7 -154.02 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.444 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -66.6 -24.46 66.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 58' ' ' GLN . 2.4 m -177.02 29.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.65 109.8 0.56 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.424 ' C ' ' HD2' ' A' ' 62' ' ' LYS . 32.2 p -98.2 108.94 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.155 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' NZ ' ' OE2' ' B' ' 163' ' ' GLU . 2.4 mptp? -116.93 159.28 22.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.994 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.769 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 38.6 m-20 -112.01 134.22 53.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.673 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 1.2 mm? -109.4 117.99 35.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HB3' ' CE2' ' B' ' 164' ' ' PTR . 0.2 OUTLIER -117.0 148.38 41.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.258 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.656 ' CG2' ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -76.74 130.57 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.0 OUTLIER -94.74 151.18 19.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.43 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 72' ' ' SER . 27.6 p -97.89 139.08 34.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 72' ' ' SER . 70.5 mt-10 -131.56 113.04 13.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.342 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 46.65 24.27 1.72 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.29 -2.19 40.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m -95.01 153.63 17.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.656 ' CE2' ' CG2' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -113.39 126.78 55.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.8 OUTLIER -155.53 147.59 23.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.521 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.55 ' CD1' HD12 ' A' ' 94' ' ' LEU . 14.7 tp -77.48 -13.04 60.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.78 -139.83 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 110.117 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.437 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 45.5 t -164.49 44.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.05 111.89 35.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.4 61.77 4.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.022 1.538 . . . . 0.0 110.343 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' SER . 2.9 tpt180 -67.27 -48.06 68.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.251 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER 174.96 169.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 83' ' ' GLN . 1.9 p -104.75 71.7 0.99 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.528 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -42.18 -56.72 5.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.443 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.624 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 47.3 Cg_endo -71.4 -99.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.979 1.515 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.632 ' CG2' ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -135.59 172.51 7.04 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.541 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.632 ' HD2' ' CG2' ' A' ' 85' ' ' VAL . 42.0 Cg_endo -69.93 132.56 23.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.526 1.277 . . . . 0.0 109.547 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 2.6 mtt180 67.42 34.12 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 0.0 109.77 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.624 ' CG ' ' HG2' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -86.21 -176.29 5.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.615 ' N ' ' CD2' ' A' ' 88' ' ' PHE . 17.8 p-10 -112.42 110.97 21.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.586 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 7.3 t -82.6 -5.63 58.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.476 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.674 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 4.6 p -49.84 -31.53 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.111 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.531 HD12 ' CG1' ' A' ' 91' ' ' VAL . 10.9 mp -59.24 -46.08 89.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 108.681 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HA ' ' CD2' ' A' ' 96' ' ' HIS . 7.8 tptt -67.23 -30.7 70.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -58.57 -34.56 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.612 -0.68 . . . . 0.0 109.879 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.539 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 3.0 m -54.83 -37.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 93' ' ' LYS . 18.8 m-70 -55.38 -47.26 76.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.063 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -61.21 -36.74 80.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.476 -0.765 . . . . 0.0 109.258 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.686 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 2.6 m-30 -65.12 -9.38 22.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 109.975 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.545 ' C ' ' HD2' ' A' ' 101' ' ' PRO . 2.7 ptt? -167.16 114.99 0.68 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.669 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 41.8 Cg_endo -72.09 -29.55 14.55 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.954 1.502 . . . . 0.0 112.22 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 100' ' ' PRO . 48.2 Cg_endo -74.33 159.93 42.81 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.888 0.941 . . . . 0.0 110.312 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.76 126.87 11.75 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.41 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.13 -66.11 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.5 p -139.85 160.5 60.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -1.113 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -91.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.513 . . . . 0.0 110.456 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.21 -41.36 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 30.5 p90 -122.59 130.49 53.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -88.34 -63.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 1.4 pp -131.1 119.4 17.79 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 150.63 50.54 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.942 1.496 . . . . 0.0 110.44 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.407 ' O ' ' HB ' ' A' ' 112' ' ' THR . 46.0 Cg_endo -72.93 -51.02 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 21.1 m 53.79 99.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.544 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . 9.0 tp10 172.34 -55.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.19 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 45.6 Cg_endo -71.54 89.37 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.899 1.473 . . . . 0.0 110.469 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 114' ' ' PRO . 8.6 t 60.47 -178.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 6.4 t -66.9 -63.29 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' C ' ' CG2' ' A' ' 118' ' ' VAL . 6.1 tp10 55.74 94.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.194 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.556 ' N ' ' CD ' ' A' ' 119' ' ' PRO . 23.1 t -151.57 49.48 0.57 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 118' ' ' VAL . 46.1 Cg_endo -73.17 118.91 5.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.953 1.502 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 0.0 OUTLIER 61.69 147.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 6.5 mm-40 -147.58 115.9 4.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.04 142.18 34.12 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.946 1.498 . . . . 0.0 110.51 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.08 -89.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.965 1.508 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.31 -145.45 0.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.151 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -130.11 -70.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 0.0 110.089 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.59 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.42 161.89 74.88 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.94 -50.95 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.961 1.506 . . . . 0.0 110.411 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 130' ' ' SER . . . 103.5 126.23 5.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 72.9 p -178.58 -168.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 110.234 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.18 65.3 69.44 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.94 70.87 3.54 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.122 1.59 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt 48.06 71.26 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.152 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 1.3 mtm180 -159.39 139.31 11.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.19 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.623 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 172.93 112.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.67 ' CZ ' ' CG2' ' B' ' 167' ' ' VAL . 0.5 OUTLIER -104.66 122.76 46.33 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.152 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.828 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -156.94 156.39 32.95 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.322 -0.861 . . . . 0.0 110.091 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.872 ' N ' HD23 ' A' ' 147' ' ' LEU . 2.0 mt -103.37 149.4 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.339 -0.851 . . . . 0.0 109.796 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.624 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 81.4 m-85 -85.37 132.05 34.3 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.264 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.526 ' CB ' HD13 ' A' ' 145' ' ' ILE . 2.7 t -95.25 59.06 2.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.245 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.33 54.07 40.31 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.15 1.0 58.33 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 6.4 mm-40 -120.01 123.49 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.86 119.13 14.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.355 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -118.31 115.27 36.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.035 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.828 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 42.7 Cg_endo -69.33 125.23 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.808 1.425 . . . . 0.0 111.349 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.872 HD23 ' N ' ' A' ' 138' ' ' ILE . 1.9 pp -127.03 101.93 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 148' ' ' VAL . 7.6 p -102.45 118.58 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.814 -1.179 . . . . 0.0 111.034 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.554 HD21 ' CG1' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -76.66 114.88 15.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 -30.25 6.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 110.935 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.87 124.47 70.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.987 -1.07 . . . . 0.0 110.203 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 50.0 Cg_endo -78.0 141.09 18.56 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.03 1.542 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.634 ' CD2' ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.55 158.13 15.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.446 ' N ' HD23 ' A' ' 153' ' ' LEU . 45.0 m -126.93 92.92 3.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.592 ' HB2' ' CE2' ' A' ' 19' ' ' TRP . 4.1 t -114.06 34.21 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.241 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 3.2 p -134.79 80.58 1.85 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.272 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' B' ' 161' ' ' THR . . . -126.46 23.09 6.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.468 ' HA ' ' OE2' ' A' ' 26' ' ' GLU . 1.7 t 66.2 -63.86 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.518 ' N ' ' O ' ' B' ' 159' ' ' ALA . 0.7 OUTLIER 61.23 48.94 5.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.174 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.459 HG12 ' HA3' ' A' ' 25' ' ' GLY . 78.5 t -82.72 50.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 9.6 pt-20 -73.74 -162.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 65' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.459 ' O ' ' O ' ' B' ' 166' ' ' THR . 5.3 m -137.19 10.29 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.459 ' O ' ' O ' ' B' ' 165' ' ' SER . 0.2 OUTLIER 53.5 169.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.67 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 1.8 t -126.82 102.64 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.7 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 2.3 t 67.17 142.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.483 ' O ' ' CG ' ' B' ' 169' ' ' HIS . 6.8 t60 -131.22 14.61 5.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.193 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.416 ' O ' ' O ' ' B' ' 171' ' ' GLY . 85.4 p -150.22 23.94 0.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.189 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' B' ' 170' ' ' SER . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.42 ' CA ' HD12 ' A' ' 4' ' ' LEU . 5.0 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.258 0.551 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.489 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.5 p90 -54.85 -36.6 65.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.507 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.8 tt0 -54.89 -32.69 61.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.962 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.592 ' HB3' ' CB ' ' A' ' 90' ' ' CYS . 6.4 mt -59.56 -47.43 85.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 91' ' ' VAL . 2.4 t -64.55 -44.77 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.865 . . . . 0.0 110.775 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -58.03 -33.5 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.299 -0.876 . . . . 0.0 110.575 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.547 ' N ' HG11 ' A' ' 6' ' ' VAL . 6.6 t-20 -71.44 -40.35 70.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 0.0 110.589 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.1 -44.46 38.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.249 -0.907 . . . . 0.0 110.75 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.671 ' CG1' ' CD2' ' A' ' 51' ' ' PHE . 7.4 m -57.2 -38.37 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -54.23 -49.12 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.862 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -78.44 -40.19 36.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -0.999 . . . . 0.0 109.925 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.489 HD13 ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -72.27 -31.22 65.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.399 -0.813 . . . . 0.0 111.032 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.726 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 22.3 mt-30 -59.44 -41.45 89.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 0.0 111.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.48 -52.56 8.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.889 -1.132 . . . . 0.0 110.598 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 t -73.68 -42.4 61.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 111.746 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' C ' ' A' ' 17' ' ' PHE . . . -90.23 67.57 2.57 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.36 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.702 ' C ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 2.21 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.742 -0.858 . . . . 0.0 110.8 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.726 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 3.8 t80 -90.87 136.23 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.645 ' CD1' HD11 ' A' ' 40' ' ' LEU . 15.9 m95 -116.59 148.24 41.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -142.26 23.73 1.99 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.07 0.13 31.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.784 . . . . 0.0 110.949 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.53 -158.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 110.343 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.567 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.26 166.97 11.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 110.334 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' CA ' ' HG2' ' A' ' 42' ' ' ARG . . . -39.73 -84.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.555 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.05 -31.7 42.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.567 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 7.7 tt0 -59.53 -24.85 64.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.283 . . . . 0.0 109.938 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -72.95 -48.42 36.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.587 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -68.44 -36.16 78.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.326 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD12 ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -58.24 -31.71 67.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 110.976 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.9 pp -55.49 -23.84 28.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.875 -1.141 . . . . 0.0 109.223 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.626 ' CD1' ' O ' ' A' ' 38' ' ' THR . 2.7 pp -70.33 -32.95 70.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 108.648 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.582 ' N ' HD11 ' A' ' 31' ' ' LEU . 61.2 m -69.85 -33.09 71.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.578 -0.701 . . . . 0.0 110.08 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -21.19 41.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.068 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.766 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.4 mm-40 -122.31 -83.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.564 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.766 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.17 69.27 4.87 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 122.923 0.959 . . . . 0.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.59 141.53 37.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.225 -0.922 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 83.31 19.44 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.626 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 4.0 m -122.43 148.33 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.505 -0.997 . . . . 0.0 110.204 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 4.5 p90 -122.21 138.97 54.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.852 -1.155 . . . . 0.0 109.981 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 HD11 ' CD1' ' A' ' 19' ' ' TRP . 0.4 OUTLIER -142.35 159.31 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 0.0 110.276 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.64 ' CG2' ' CD2' ' A' ' 18' ' ' TYR . 2.4 tt -117.01 149.21 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tpt180 -121.62 152.89 38.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.445 -0.784 . . . . 0.0 109.612 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.573 ' CA ' ' OH ' ' A' ' 18' ' ' TYR . 8.8 t0 -90.76 104.31 16.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.956 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 8.3 t -53.94 168.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 0.0 110.139 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 p -115.99 5.41 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 173.36 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -14.68 58.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -82.16 4.38 23.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER 43.34 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.167 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.578 ' CZ ' ' O ' ' A' ' 51' ' ' PHE . 20.0 t80 -155.82 156.06 34.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.671 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 8.7 p90 -115.96 151.79 34.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.478 ' C ' HG13 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -126.41 147.62 49.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.634 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -131.1 125.07 32.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.39 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.545 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -122.8 153.74 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 61' ' ' THR . 10.2 m -121.39 174.56 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.372 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 14.5 tttm -103.47 126.48 50.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.551 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 21.4 p -128.9 169.87 14.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.86 -27.11 67.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 t -86.41 -28.31 23.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.161 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 147.36 156.78 7.12 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 ' CB ' HD13 ' A' ' 29' ' ' LEU . 17.3 p -80.13 138.08 36.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.462 ' CB ' HG12 ' A' ' 138' ' ' ILE . 23.2 mmtm -137.15 160.45 38.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 5.5 p30 -138.28 154.64 49.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.547 ' CD2' ' HA ' ' B' ' 166' ' ' THR . 8.0 mt -137.45 148.41 46.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 110.01 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -98.25 152.29 19.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.616 HG12 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -79.33 139.6 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -96.4 151.0 19.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 73' ' ' PHE . 18.5 p -99.36 137.03 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 mt-10 -130.63 102.89 6.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 43.24 -95.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -120.53 32.75 4.73 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 5.0 p -139.58 150.91 45.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.292 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.616 ' CD2' HG12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -124.29 144.83 49.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 66' ' ' ILE . 2.2 t -155.18 141.3 18.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.119 -0.988 . . . . 0.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 17.8 tp -76.77 1.3 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.282 -0.886 . . . . 0.0 110.455 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 77' ' ' SER . 18.6 pt20 -139.5 -155.43 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 76' ' ' GLN . 93.1 p -60.0 -142.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.453 ' OD2' ' HD3' ' A' ' 80' ' ' ARG . 17.7 p-10 -74.46 126.14 89.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.63 58.93 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.994 1.523 . . . . 0.0 110.366 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.462 ' O ' ' OG1' ' A' ' 82' ' ' THR . 0.0 OUTLIER -71.62 -2.79 18.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.283 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.0 OUTLIER -50.1 -34.16 21.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 69.26 6.35 5.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.566 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 8.7 tt0 -57.53 -59.94 11.38 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 83' ' ' GLN . 46.4 Cg_endo -71.68 -155.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.818 1.43 . . . . 0.0 110.219 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.549 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -118.82 178.3 1.11 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.136 -0.978 . . . . 0.0 109.682 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 40.8 Cg_endo -67.89 132.65 27.05 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.798 1.42 . . . . 0.0 109.434 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 71' ' ' GLY . 1.7 mpp_? 52.91 65.91 1.38 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.147 -0.971 . . . . 0.0 109.248 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG ' ' A' ' 93' ' ' LYS . 53.1 p90 -100.3 -155.97 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.651 ' CB ' ' HB2' ' A' ' 92' ' ' LEU . 72.8 m-20 -72.9 109.77 6.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.057 -1.027 . . . . 0.0 108.716 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.611 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 1.3 p -39.94 -93.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.545 HG23 ' CZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -48.09 -22.6 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.272 -0.892 . . . . 0.0 111.125 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.651 ' HB2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -54.19 -35.77 62.7 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.907 -1.121 . . . . 0.0 110.058 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.604 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -62.39 -36.4 82.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.991 -1.068 . . . . 0.0 109.437 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.82 -35.87 75.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.595 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' MET . 78.0 t -56.02 -38.31 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.78 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.565 ' CD2' ' NZ ' ' A' ' 93' ' ' LYS . 26.7 t60 -54.79 -46.55 74.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.573 ' CD2' HG12 ' B' ' 167' ' ' VAL . 0.9 OUTLIER -71.78 -42.95 66.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.634 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 2.0 m-30 -69.31 -22.11 63.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.568 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -166.12 167.57 8.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 99' ' ' MET . 44.8 Cg_endo -72.57 170.81 18.51 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.462 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 145.68 41.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.046 1.55 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 -12.68 25.48 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.99 1.521 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -165.78 41.18 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.55 75.87 0.42 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.15 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.412 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -172.88 133.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.238 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.574 ' O ' ' CG ' ' A' ' 107' ' ' PHE . 9.2 t80 -126.64 58.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 109' ' ' LEU . 6.8 m 49.9 -137.95 1.0 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.455 ' HG ' ' HD2' ' A' ' 110' ' ' PRO . 2.1 tp -42.17 143.02 1.1 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HD2' ' HG ' ' A' ' 109' ' ' LEU . 46.5 Cg_endo -72.96 118.7 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.948 1.499 . . . . 0.0 110.442 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.03 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.467 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 113' ' ' GLU . 1.4 m 57.62 174.41 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.229 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 112' ' ' THR . 14.5 mt-10 56.85 159.85 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.06 99.88 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -143.83 19.83 1.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.44 -76.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -142.66 -46.43 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.313 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.5 t 51.78 86.33 0.16 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.76 -89.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.033 1.544 . . . . 0.0 110.494 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.83 178.81 6.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.255 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 134.09 25.64 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.17 135.66 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.998 1.525 . . . . 0.0 110.464 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 56.68 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.06 16.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.74 54.89 6.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.414 ' C ' ' HG ' ' A' ' 127' ' ' LEU . . . -147.43 19.34 1.2 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.414 ' HG ' ' C ' ' A' ' 126' ' ' ALA . 10.8 mt -134.66 95.74 15.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.245 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.77 -166.34 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.359 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.96 85.67 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.411 ' C ' ' OG1' ' A' ' 131' ' ' THR . 40.9 t -99.01 -96.86 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -179.92 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 131' ' ' THR . 45.8 Cg_endo -72.26 67.45 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.967 1.509 . . . . 0.0 110.499 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -44.63 -38.08 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 110.12 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 6.9 ppt_? -140.1 176.21 8.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 169.5 129.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.431 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.704 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 2.5 t80 -116.18 121.78 43.12 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.807 -1.183 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.762 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 2.7 p90 -156.99 167.97 28.88 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.878 -1.139 . . . . 0.0 111.185 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.462 HG12 ' CB ' ' A' ' 62' ' ' LYS . 2.8 mp -121.62 149.54 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.95 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.76 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.1 m-30 -84.85 110.47 18.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.729 . . . . 0.0 110.119 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 3.9 m -66.32 56.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.53 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 65.84 82.9 0.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.25 -10.42 49.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.8 tt0 -120.01 121.6 39.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.269 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 2.4 ptpt -89.8 105.5 17.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.762 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.02 109.14 52.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.3 Cg_endo -72.57 128.95 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.996 1.524 . . . . 0.0 111.938 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.712 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -125.83 135.88 52.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 25.3 m -98.04 117.12 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.382 -1.449 . . . . 0.0 110.079 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.581 HD21 ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -117.38 137.91 52.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.047 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.428 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 0.3 OUTLIER -176.02 41.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.583 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -111.56 124.96 31.31 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.148 -0.97 . . . . 0.0 110.046 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.632 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 45.7 Cg_endo -73.08 147.32 42.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 111.059 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 38' ' ' THR . 0.3 OUTLIER -89.7 128.66 36.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.742 . . . . 0.0 109.778 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.463 ' N ' HD11 ' A' ' 153' ' ' LEU . 49.4 m -73.09 88.67 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.329 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.563 ' HB2' ' CE2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -119.23 -38.4 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.152 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.256 0.55 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 8.9 t -124.72 145.92 49.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.72 1.89 11.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.103 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' B' ' 161' ' ' THR . 32.1 m -165.45 -171.66 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.247 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER 66.83 70.67 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.248 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' B' ' 161' ' ' THR . 84.4 t 56.93 54.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.28 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 164' ' ' PTR . 42.3 tt0 -89.12 172.08 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.549 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.426 ' C ' HD21 ' A' ' 64' ' ' LEU . 56.6 m -160.67 -60.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.386 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.579 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.5 OUTLIER 176.87 155.82 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.192 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.704 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 15.3 t -118.62 132.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.61 HG23 ' CE2' ' A' ' 137' ' ' TYR . 5.8 t 40.68 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.444 ' HB2' ' OH ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -91.19 91.54 8.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -72.92 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.922 -1.488 . . . . 0.0 109.497 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.188 0.518 . . . . 0.0 110.354 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.527 ' O ' HG22 ' A' ' 5' ' ' VAL . 33.7 p90 -65.31 -37.55 87.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.5 OUTLIER -69.32 -33.65 73.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.218 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.52 ' CD2' ' SG ' ' A' ' 90' ' ' CYS . 3.3 mt -67.09 -47.3 71.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.516 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 34.8 m -72.18 -37.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.449 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.45 -32.97 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.33 -45.65 92.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -67.0 -43.11 83.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 60.1 t -56.93 -39.39 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 15.3 ttt180 -55.47 -48.81 73.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.855 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.37 -33.02 49.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.64 -44.08 71.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.267 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 6.5 pt20 -65.59 -33.77 76.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -66.01 -32.26 73.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.312 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.6 p -69.68 -27.5 65.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.28 19.97 21.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CD2' ' CD1' ' A' ' 153' ' ' LEU . 3.0 m-85 -108.5 4.22 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -1.129 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.54 ' OH ' ' CB ' ' A' ' 43' ' ' ASP . 21.6 t80 -90.86 136.07 33.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.355 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.604 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -92.23 148.34 22.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' TRP . 2.6 t -40.68 -92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.783 . . . . 0.0 110.321 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . 171.91 61.72 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.527 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -59.53 -137.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -85.32 166.19 16.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 109.551 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.551 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . -39.89 -83.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.29 -30.18 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.593 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 17.0 tt0 -57.78 -34.79 69.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.982 -1.305 . . . . 0.0 110.517 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 22' ' ' VAL . . . -66.84 -48.73 67.96 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.94 -1.1 . . . . 0.0 109.025 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.647 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 29.1 m-80 -69.3 -43.15 74.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.463 -0.773 . . . . 0.0 110.728 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -70.28 -31.78 69.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 111.686 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.565 HD23 ' CZ3' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -54.76 -41.15 70.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.88 -1.138 . . . . 0.0 110.352 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.1 pp -61.02 -34.69 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 108.964 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.578 ' CB ' ' CG ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -69.79 -32.82 71.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -20.62 42.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.504 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.8 mt-10 -114.89 -76.75 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.2 Cg_endo -72.85 65.53 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.299 1.157 . . . . 0.0 110.118 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.91 140.62 11.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 80.15 -2.44 76.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.57 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 3.1 m -104.41 146.38 28.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.432 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' A' ' 151' ' ' ARG . 39.9 p90 -123.79 138.88 54.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.985 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.604 ' HB2' ' CD1' ' A' ' 19' ' ' TRP . 0.5 OUTLIER -141.4 159.4 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.145 -0.972 . . . . 0.0 110.619 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 53' ' ' LEU . 1.7 tt -115.16 130.58 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.945 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.551 ' NH2' ' HA2' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -112.72 160.5 17.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.032 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' CB ' ' OH ' ' A' ' 18' ' ' TYR . 12.4 t70 -74.0 126.28 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.137 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.547 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 9.4 t -57.47 -87.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 110.101 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -119.78 67.76 0.82 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.993 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 69.28 -168.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.091 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -1.93 32.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -92.28 16.54 11.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.893 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.558 ' CD2' ' HB3' ' A' ' 45' ' ' SER . 2.6 m-70 -143.25 -93.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 44' ' ' SER . 42.7 p90 -177.78 -158.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.659 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 35.5 p90 -133.26 149.14 51.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.377 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.553 HG23 ' CA ' ' A' ' 65' ' ' ARG . 74.7 m -126.22 155.13 42.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.18 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.663 ' CD2' ' CD1' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -137.24 146.44 44.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.697 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.564 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 25.1 p -139.43 153.99 47.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG2' ' HG ' ' A' ' 149' ' ' LEU . 8.8 p -120.13 172.24 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 1.6 tmtp? -123.01 139.19 54.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.524 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -151.65 -173.35 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.66 24.23 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.513 ' CB ' HG21 ' A' ' 145' ' ' ILE . 1.7 p -126.98 -2.62 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.25 139.55 5.6 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 61' ' ' THR . 15.3 t -95.31 109.56 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.308 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -110.65 155.18 22.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 110.04 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 6.7 t-20 -111.53 128.68 56.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.589 ' CD2' HG22 ' B' ' 167' ' ' VAL . 0.9 OUTLIER -130.23 152.06 50.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -0.971 . . . . 0.0 110.33 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' CA ' HG23 ' A' ' 52' ' ' THR . 3.0 ptm180 -121.68 -145.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.777 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.644 ' CG1' ' CD1' ' A' ' 73' ' ' PHE . 1.4 tp -116.75 149.02 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 0.0 110.341 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -110.76 124.71 52.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.57 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 29.4 p -87.81 126.89 35.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.65 103.02 7.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.47 -102.15 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.6 36.19 3.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.06 160.39 40.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -1.18 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.644 ' CD1' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.16 138.44 46.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.855 . . . . 0.0 110.033 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.534 ' N ' HD13 ' A' ' 66' ' ' ILE . 2.3 t -155.32 150.15 26.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.643 HD12 ' CE2' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -80.02 49.37 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.052 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.522 ' NE2' ' OG1' ' B' ' 166' ' ' THR . 2.1 tt0 66.71 74.7 0.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -136.52 -169.17 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.498 ' HB3' ' CA ' ' B' ' 171' ' ' GLY . 18.3 p-10 -120.04 149.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.19 54.64 2.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.077 1.567 . . . . 0.0 110.356 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -69.98 -4.27 19.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER 67.83 40.23 2.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.177 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.509 ' N ' ' OE1' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -106.31 33.82 3.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.193 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' OE1' ' N ' ' A' ' 82' ' ' THR . 8.8 mp0 -131.49 163.7 47.79 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.174 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.632 ' HD2' ' CE1' ' A' ' 88' ' ' PHE . 40.5 Cg_endo -66.77 -53.1 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 111.211 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' CG1' ' HD2' ' A' ' 86' ' ' PRO . 55.3 t -116.88 149.34 43.91 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.766 -1.209 . . . . 0.0 110.23 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 85' ' ' VAL . 41.3 Cg_endo -68.21 132.87 27.02 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.922 1.485 . . . . 0.0 109.051 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 88' ' ' PHE . 14.3 mtm180 54.65 85.93 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.955 -1.091 . . . . 0.0 108.513 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.632 ' CE1' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -51.72 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 110.649 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 90' ' ' CYS . 64.1 m-20 -88.47 109.97 20.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.965 -1.085 . . . . 0.0 110.694 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.543 ' C ' ' O ' ' A' ' 89' ' ' ASP . 13.7 m 20.81 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.641 0.734 . . . . 0.0 112.14 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.659 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 3.8 p -49.63 -24.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 110.633 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.29 -34.08 63.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 110.073 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.615 ' HB2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -57.53 -31.76 66.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -59.83 -35.4 74.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.246 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.7 m -55.33 -37.32 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.316 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.512 ' CB ' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -53.83 -34.71 60.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.023 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.614 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -78.07 -36.77 47.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 109.986 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.663 ' CD1' ' CD2' ' A' ' 53' ' ' LEU . 3.3 m-85 -63.55 -22.02 66.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.32 124.73 4.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 0.0 110.319 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.97 162.56 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.925 1.487 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 134' ' ' ARG . 45.7 Cg_endo -72.99 130.89 16.07 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 55.61 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.985 1.518 . . . . 0.0 110.361 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.451 ' C ' ' CG2' ' A' ' 104' ' ' THR . . . 70.64 -174.71 38.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 21.5 p -149.54 164.45 20.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -1.16 . . . . 0.0 110.205 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 45.9 Cg_endo -73.1 -159.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.961 1.506 . . . . 0.0 110.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' SER . 3.3 m -170.87 153.96 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 52.81 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 110.216 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' SER . 0.8 OUTLIER -138.73 164.38 29.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.224 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.536 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 1.4 tp -61.14 -55.46 43.91 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 109' ' ' LEU . 45.8 Cg_endo -72.86 134.91 22.55 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.942 1.496 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 112' ' ' THR . 46.6 Cg_endo -73.16 83.63 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.984 1.518 . . . . 0.0 110.432 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER 48.41 -178.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 2.1 mm-40 -58.7 -57.73 24.56 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.226 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 46.6 Cg_endo -72.93 -177.58 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.991 1.521 . . . . 0.0 110.431 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 115' ' ' SER . 10.2 p -123.89 58.32 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.883 . . . . 0.0 110.163 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.1 m -150.38 17.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.24 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -74.15 61.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.5 ' N ' ' CD ' ' A' ' 119' ' ' PRO . 17.4 m -123.18 52.38 4.53 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.945 . . . . 0.0 110.157 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 118' ' ' VAL . 45.7 Cg_endo -72.92 -164.31 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.961 1.506 . . . . 0.0 110.383 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -150.0 56.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.529 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 10.5 mm-40 -71.59 -57.7 4.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.89 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 47.4 Cg_endo -73.08 159.01 48.56 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.983 1.517 . . . . 0.0 110.458 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.22 -6.94 19.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.054 1.555 . . . . 0.0 110.419 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.14 -163.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -110.76 -59.07 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.61 -50.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.8 102.2 7.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.297 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.31 -16.36 24.85 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.977 1.514 . . . . 0.0 110.363 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.46 -21.7 41.73 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 m -76.87 -30.13 56.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -1.128 . . . . 0.0 110.143 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.525 ' CB ' ' CD ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -57.75 -57.61 24.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 131' ' ' THR . 46.6 Cg_endo -73.08 152.58 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' ARG . 1.2 mmpt? -78.24 -13.14 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -42.68 116.73 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.59 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -175.42 111.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.688 ' CZ ' ' CG2' ' B' ' 167' ' ' VAL . 2.1 t80 -103.0 121.42 42.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.936 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.943 ' HA ' ' HB2' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -158.9 165.89 33.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.0 . . . . 0.0 110.423 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.678 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 6.1 mt -123.5 126.73 73.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.012 . . . . 0.0 109.758 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.781 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -83.36 107.63 16.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.832 0.825 . . . . 0.0 109.717 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' TYR . 56.1 p -42.45 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.774 -0.579 . . . . 0.0 110.411 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.84 80.3 0.36 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.38 82.31 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 139' ' ' TYR . 39.8 tt0 -114.06 121.28 43.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.281 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.653 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 21.9 mtmm -76.94 108.45 9.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 110.949 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -104.31 132.47 20.94 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.668 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.56 128.16 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.79 1.416 . . . . 0.0 112.111 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.943 ' HB2' ' HA ' ' A' ' 137' ' ' TYR . 8.3 mp -123.69 101.5 7.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.71 117.81 44.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.874 -1.142 . . . . 0.0 111.207 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.8 mp -79.73 114.83 18.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.283 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.18 -23.93 2.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -85.91 124.9 70.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 110.271 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.581 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 47.9 Cg_endo -74.74 128.26 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.055 1.555 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.633 ' CD2' ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.76 158.22 16.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.519 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.8 t -113.03 82.47 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.104 -0.997 . . . . 0.0 110.264 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.462 ' OG ' HD21 ' A' ' 153' ' ' LEU . 2.2 m -71.29 95.2 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.432 ' C ' ' OD1' ' A' ' 156' ' ' ASN . 27.5 p30 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.276 0.56 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.8 145.87 18.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.13 -47.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 3.7 t 45.7 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.219 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 69.5 p -145.75 92.64 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.503 HG22 ' CA ' ' A' ' 25' ' ' GLY . 7.2 p -119.97 92.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' B' ' 164' ' ' PTR . 0.4 OUTLIER -71.56 162.84 28.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.561 ' CD2' ' N ' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.474 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.1 t -120.45 -134.87 0.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.567 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 31.0 m -145.16 147.71 32.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.688 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 1.6 t -87.67 102.39 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.677 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 2.5 t 72.7 120.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.405 -0.81 . . . . 0.0 110.231 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' B' ' 168' ' ' VAL . 0.1 OUTLIER -42.26 153.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.15 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' GLN . 4.4 t -102.77 93.84 5.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.498 ' CA ' ' HB3' ' A' ' 78' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.522 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.336 0.588 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 38.0 p90 -63.38 -36.08 82.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.479 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -55.57 -36.21 66.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.524 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 4.2 mt -64.29 -44.46 91.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' HG21 ' A' ' 9' ' ' VAL . 12.1 t -66.63 -48.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.541 ' O ' HG21 ' A' ' 9' ' ' VAL . 41.8 t -58.82 -41.75 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -71.22 -31.26 67.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 109.833 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.583 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -76.05 -44.28 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.458 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 6' ' ' VAL . 29.9 m -57.11 -38.71 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.241 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' N ' HG23 ' A' ' 9' ' ' VAL . 4.6 mtp180 -55.04 -40.63 70.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -71.36 -42.39 68.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.959 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.49 HD21 HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -72.04 -40.18 68.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 5.3 pt20 -68.19 -33.73 74.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.511 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 4.0 tm-20 -57.65 -21.45 39.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 110.261 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -26.95 62.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.17 37.8 3.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 25.5 t80 -142.13 7.15 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -1.142 . . . . 0.0 110.235 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.578 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 6.3 t80 -96.28 136.21 37.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.657 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 28.6 m95 -110.6 148.31 32.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.478 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.575 ' CA ' ' HD2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -148.41 109.74 4.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . . . 176.59 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 111.089 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG23 ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -120.88 -160.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.862 -1.149 . . . . 0.0 110.277 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -86.09 166.04 16.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -52.19 -76.45 0.18 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.683 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -60.74 -43.72 98.79 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 29.9 tt0 -59.78 -24.83 64.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 110.01 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . . . -78.12 -45.55 23.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.32 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.683 HD21 ' HA2' ' A' ' 25' ' ' GLY . 1.6 m-80 -69.04 -41.8 77.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.389 -0.819 . . . . 0.0 110.755 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 29' ' ' LEU . 1.4 mp -59.43 -32.14 69.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.766 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.551 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.2 pp -55.21 -23.58 22.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.982 -1.074 . . . . 0.0 109.352 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.66 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 70.9 mt -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 109.096 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.545 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 26.9 p -69.19 -32.43 71.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.716 . . . . 0.0 109.888 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.48 -20.62 43.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.371 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.757 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 12.5 mm-40 -134.06 -83.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.757 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 50.3 Cg_endo -78.01 67.67 8.01 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 122.812 0.901 . . . . 0.0 110.152 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -63.67 141.47 58.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 88.98 15.74 58.88 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -130.63 147.17 52.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -1.05 . . . . 0.0 110.142 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.594 ' CD1' ' CD2' ' A' ' 149' ' ' LEU . 4.0 p90 -123.11 146.22 47.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 0.0 110.678 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.657 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.08 160.31 43.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 51' ' ' PHE . 3.3 tt -114.0 128.84 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.924 -1.11 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -117.68 150.44 39.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.755 . . . . 0.0 110.122 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 44' ' ' SER . 9.8 t70 -73.87 127.56 33.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 43' ' ' ASP . 25.5 m -41.26 -34.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.324 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.43 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -177.25 -172.12 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -64.97 -10.02 26.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 110.224 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -67.86 -32.53 73.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.261 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -115.29 -123.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.104 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.565 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 12.4 p90 -152.7 -160.99 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 41' ' ' ILE . 27.1 p90 -115.9 148.72 39.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.529 ' HB ' ' CA ' ' A' ' 24' ' ' GLY . 88.6 m -126.13 139.76 53.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -126.92 124.97 40.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.583 ' CB ' ' CB ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -133.9 154.29 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.476 -0.765 . . . . 0.0 110.049 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' CG1' HD13 ' A' ' 149' ' ' LEU . 12.4 p -130.58 174.08 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -118.86 139.02 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.204 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 26.6 m -115.21 -43.3 3.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' THR . 2.8 pt20 -177.99 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.59 29.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.76 65.46 0.31 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 t -84.96 111.85 20.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -1.144 . . . . 0.0 110.138 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HG3' ' CG2' ' A' ' 138' ' ' ILE . 14.3 mmtt -123.53 166.08 16.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.638 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 0.5 OUTLIER -134.32 154.12 51.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -138.01 118.15 13.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 110.53 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HD2' ' CZ ' ' A' ' 50' ' ' PHE . 10.7 ptm180 -75.32 162.21 28.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.864 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.649 ' CG2' ' CD1' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -78.27 148.78 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 110.263 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -107.53 136.75 46.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 1' ' ' GLU . 27.9 p -87.83 119.97 28.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.28 103.09 8.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.64 -78.27 0.02 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -148.25 30.35 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.44 163.09 33.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.649 ' CD1' ' CG2' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -115.7 141.18 48.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 109.977 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.49 ' N ' ' CD1' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -148.15 138.89 23.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.94 -1.1 . . . . 0.0 110.616 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 HD12 ' CZ ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -86.06 -1.14 57.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 109.793 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.491 ' NE2' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -121.12 -130.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.097 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.409 ' O ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.21 -87.86 0.53 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.386 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.414 ' OD1' ' HG3' ' A' ' 80' ' ' ARG . 6.0 t0 -81.28 113.21 39.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HB3' ' HB2' ' A' ' 74' ' ' SER . 47.3 Cg_endo -74.35 -12.64 22.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.043 1.549 . . . . 0.0 110.379 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.414 ' HG3' ' OD1' ' A' ' 78' ' ' ASP . 13.7 mtm-85 -67.79 -6.17 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.309 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 82' ' ' THR . 34.3 t -142.81 -143.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 70.38 -55.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 0.0 110.315 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.511 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 177.02 -57.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.314 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 45.1 Cg_endo -72.01 162.0 43.12 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.905 1.476 . . . . 0.0 110.452 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 20.9 m -97.81 167.08 12.33 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.2 Cg_endo -70.46 132.85 23.02 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.952 1.501 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 3.5 mtt180 63.36 43.11 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.915 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CE2' ' O ' ' A' ' 73' ' ' PHE . 14.4 p90 -61.43 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.037 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 90' ' ' CYS . 74.2 m-20 -103.9 109.97 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.76 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.564 ' O ' ' O ' ' A' ' 89' ' ' ASP . 0.6 OUTLIER 50.92 156.13 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.962 0.887 . . . . 0.0 111.588 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -49.05 -21.11 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.703 0.763 . . . . 0.0 109.32 178.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' O ' ' CG2' ' A' ' 95' ' ' VAL . 2.0 pp -54.41 -33.87 60.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.565 -0.709 . . . . 0.0 111.545 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -57.31 -30.41 64.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.596 -1.315 . . . . 0.0 109.741 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 91' ' ' VAL . 1.1 pp -58.78 -33.02 69.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 92' ' ' LEU . 4.3 m -53.39 -34.85 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.429 -0.794 . . . . 0.0 110.353 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -51.29 -30.06 16.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 109.51 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.508 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 2.0 t60 -73.17 -36.3 66.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.166 -0.959 . . . . 0.0 108.825 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.648 ' CE1' ' OH ' ' A' ' 136' ' ' TYR . 1.8 m-85 -63.57 -22.12 66.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.568 -0.707 . . . . 0.0 109.674 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.542 ' C ' ' HD2' ' A' ' 101' ' ' PRO . 10.8 ttm 71.57 63.31 0.41 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.465 -0.772 . . . . 0.0 110.301 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.67 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 42.1 Cg_endo -72.67 -29.41 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.915 1.481 . . . . 0.0 112.284 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 100' ' ' PRO . 48.3 Cg_endo -74.36 162.76 37.74 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 122.821 0.906 . . . . 0.0 110.415 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HA ' ' OG ' ' A' ' 150' ' ' SER . 45.8 Cg_endo -73.26 -90.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.004 1.528 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 119.93 12.14 6.65 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.6 p -56.16 142.69 66.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 110.237 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.35 -44.28 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.05 1.553 . . . . 0.0 110.412 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.8 t -159.06 -161.92 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.269 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 43.91 75.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -107.86 -174.02 2.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.499 ' N ' ' OG ' ' A' ' 108' ' ' SER . 0.1 OUTLIER -130.83 75.42 78.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.89 139.91 31.02 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.496 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.02 147.45 43.29 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.034 1.544 . . . . 0.0 110.463 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -80.67 91.96 5.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 8.2 pt-20 -64.42 143.18 98.49 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.99 -18.69 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.988 1.52 . . . . 0.0 110.419 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 150.58 21.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 3.4 t -140.7 -136.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 116' ' ' SER . 2.5 mt-10 65.6 9.71 6.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 t -54.6 117.98 15.29 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.101 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 45.9 Cg_endo -72.6 -48.95 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.982 1.517 . . . . 0.0 110.504 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 119' ' ' PRO . 2.1 tt0 177.18 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.238 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 6.6 mt-30 -43.32 127.34 3.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.75 110.56 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 121' ' ' GLN . 46.4 Cg_endo -73.08 -159.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.996 1.524 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 125' ' ' GLN . . . -92.25 -17.73 24.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 124' ' ' ALA . 7.5 tp60 42.35 62.44 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.915 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . 43.31 -99.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.0 110.09 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER 40.21 81.5 0.25 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.935 . . . . 0.0 110.287 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' SER . 46.1 Cg_endo -73.08 -54.63 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 48.08 -94.11 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 128' ' ' PRO . 0.1 OUTLIER -116.66 105.21 12.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -1.124 . . . . 0.0 110.244 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.43 123.13 68.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 133' ' ' LYS . 46.0 Cg_endo -72.7 104.23 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.961 1.506 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 134' ' ' ARG . 2.3 tptt -42.81 -58.61 2.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.319 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 133' ' ' LYS . 1.7 mtp180 57.57 113.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -171.97 126.34 0.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 110.058 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.684 ' HA ' HG21 ' B' ' 168' ' ' VAL . 3.7 t80 -128.59 121.81 29.56 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.408 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.745 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 12.6 p90 -156.83 167.33 30.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.203 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.524 ' CD1' HD23 ' A' ' 147' ' ' LEU . 2.6 mp -106.05 149.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.635 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 29.5 m-85 -96.18 133.05 40.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.76 . . . . 0.0 110.992 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -87.46 48.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.636 -0.665 . . . . 0.0 110.217 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 52.49 65.73 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.07 -22.48 15.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.53 121.97 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -1.174 . . . . 0.0 110.162 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.4 ptmt -88.48 105.72 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.27 102.98 10.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.745 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.2 Cg_endo -76.18 126.68 9.37 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.681 1.358 . . . . 0.0 111.981 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.659 ' CG ' ' HA ' ' A' ' 137' ' ' TYR . 0.4 OUTLIER -126.76 136.0 51.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 148' ' ' VAL . 30.2 m -97.08 117.18 41.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.136 -1.603 . . . . 0.0 110.624 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.594 ' CD2' ' CD1' ' A' ' 39' ' ' PHE . 6.3 tt -90.11 114.93 26.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.65 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -148.94 19.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.021 -1.05 . . . . 0.0 110.821 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -105.6 124.49 36.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.03 -1.044 . . . . 0.0 109.976 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.5 Cg_endo -76.57 148.22 29.14 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.954 1.502 . . . . 0.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.07 152.87 30.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 110.089 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 155' ' ' SER . 17.0 m -91.55 57.57 3.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 110.192 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 38.0 t -41.21 -60.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 110.27 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.228 0.537 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.64 28.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.237 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -176.16 60.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 12.0 t -115.18 174.55 5.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.42 ' O ' ' C ' ' B' ' 162' ' ' VAL . 12.9 m -121.22 42.8 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 25' ' ' GLY . 43.2 t 42.44 64.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.265 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -87.87 153.56 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.638 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 1.6 p -149.03 -98.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.368 -0.833 . . . . 0.0 110.318 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.534 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 2.6 t -146.82 175.47 10.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 110.26 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.664 HG11 ' CG ' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -128.73 112.36 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.976 . . . . 0.0 110.272 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.696 HG22 ' CD2' ' A' ' 137' ' ' TYR . 0.2 OUTLIER 41.46 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -116.53 170.43 8.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.54 -73.34 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.238 0.542 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.08 -36.14 80.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.518 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -55.2 -34.21 63.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.167 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -67.26 -45.17 77.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 110.205 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -64.94 -48.4 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.564 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -58.42 -32.62 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.311 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 6' ' ' VAL . 17.6 m-20 -68.11 -42.52 80.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' A' ' 91' ' ' VAL . . . -76.12 -44.91 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 5.4 m -59.01 -39.58 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' N ' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -55.54 -49.01 73.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -35.94 65.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 109.513 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.13 -44.09 63.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.961 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.507 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 16.7 pt20 -68.21 -33.87 75.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.6 -26.48 61.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.112 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -26.89 62.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.024 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' ' 155' ' ' SER . . . 99.19 1.61 56.93 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t80 -88.96 -8.33 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 110.187 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.625 ' CD2' ' CG2' ' A' ' 41' ' ' ILE . 5.7 t80 -90.91 136.23 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.812 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.608 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 46.3 m95 -99.79 148.42 24.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -53.07 -18.7 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.855 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 42' ' ' ARG . . . 75.54 93.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.659 . . . . 0.0 111.16 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 1.8 m -66.41 -90.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.284 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.58 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 1.1 m -103.5 172.99 6.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.003 -1.061 . . . . 0.0 109.219 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.23 -94.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' CA ' HG23 ' B' ' 162' ' ' VAL . . . -71.25 -29.5 68.43 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.485 -1.009 . . . . 0.0 110.651 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.58 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -57.56 -24.95 59.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.25 . . . . 0.0 111.204 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . . . -76.46 -47.04 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.825 -1.172 . . . . 0.0 109.66 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.661 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.7 m-80 -70.34 -44.86 67.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 111.066 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 61' ' ' THR . 15.1 mt -70.7 -31.53 68.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 3.7 pp -54.28 -27.41 35.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.535 -1.353 . . . . 0.0 110.561 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.4 pp -74.05 -33.75 63.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.545 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -69.89 -32.72 71.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 110.296 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.07 41.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.352 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.744 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 3.7 mm-40 -113.95 -77.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.057 -1.027 . . . . 0.0 110.063 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.744 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.0 Cg_endo -72.49 71.09 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.271 1.143 . . . . 0.0 110.142 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.09 137.18 47.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.04 0.6 89.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -111.23 147.41 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -1.181 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.619 ' CZ ' HD22 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -122.79 148.75 45.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.0 110.716 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.608 ' HB2' ' CD1' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -147.65 160.02 43.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 109.91 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.625 ' CG2' ' CD2' ' A' ' 18' ' ' TYR . 7.1 tt -113.95 148.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.973 . . . . 0.0 110.46 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 5.7 ppt_? -127.38 127.59 44.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 24.7 t70 -75.27 138.24 41.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.483 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.578 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 12.9 m -69.86 64.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -47.98 -24.89 1.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.172 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 45' ' ' SER . 52.5 t0 -49.78 -101.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 13.1 mt-30 -78.11 -1.89 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.991 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 68.77 23.72 6.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -58.66 -70.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.368 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.555 ' CE1' ' HG3' ' A' ' 65' ' ' ARG . 17.2 p90 -154.42 -156.13 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.607 ' CZ ' HG23 ' A' ' 91' ' ' VAL . 14.2 p90 -116.01 152.71 33.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.448 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 24.3 m -118.13 155.54 30.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.831 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 1.2 tm? -142.17 129.68 21.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.301 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.564 ' CB ' ' HB3' ' A' ' 28' ' ' ASN . 3.1 p -138.32 154.13 49.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.642 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' HD23 ' A' ' 149' ' ' LEU . 2.8 m -127.03 173.99 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 110.835 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 14.5 tptm -113.04 129.58 56.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.887 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.536 ' CG2' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.63 -165.76 1.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.387 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' GLY . 8.4 tt0 -77.93 -59.12 2.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -42.24 -27.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' GLN . . . 130.66 151.92 7.24 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 29' ' ' LEU . 2.4 t -78.87 108.89 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.181 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.553 ' CB ' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -110.37 153.2 25.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.942 . . . . 0.0 110.099 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 164' ' ' PTR . 15.0 p30 -121.06 125.84 48.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.532 ' CD1' HG21 ' B' ' 167' ' ' VAL . 2.8 mp -118.65 151.93 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.555 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 1.4 ptt180 -140.36 152.99 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 110.437 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.604 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -76.62 117.86 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 74' ' ' SER . 16.2 tt0 -91.95 151.14 20.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 110.484 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 20.0 p -101.62 127.84 48.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -133.14 117.01 16.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.31 34.15 87.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.22 -14.22 54.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 51.2 p -94.99 162.81 13.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -1.14 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.7 m-30 -110.92 152.01 27.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 67' ' ' GLN . 19.3 m -155.63 138.7 15.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.533 ' CB ' HD21 ' A' ' 94' ' ' LEU . 2.6 tt -123.74 -1.86 8.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.076 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 77' ' ' SER . 13.7 mt-30 -131.37 -136.06 0.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.089 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 76' ' ' GLN . 5.3 t -42.56 139.82 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 110.163 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 80' ' ' ARG . 3.8 p30 -81.56 130.15 62.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.2 -0.938 . . . . 0.0 110.164 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 54.41 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.52 . . . . 0.0 110.416 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HB2' ' OD1' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -85.88 16.08 4.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.466 ' OG ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -108.84 44.26 1.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.876 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 43.79 39.97 2.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.466 ' HG2' ' OG ' ' A' ' 81' ' ' SER . 3.2 pt20 -134.2 70.97 73.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.23 -179.16 4.12 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.979 1.515 . . . . 0.0 110.357 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.74 141.61 40.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 46.7 Cg_endo -72.95 137.66 27.11 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.011 1.532 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.649 ' O ' ' O ' ' A' ' 88' ' ' PHE . 4.3 mtt180 57.54 37.22 27.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 110.15 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 22.2 p90 36.16 109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.727 0.775 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.504 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 0.9 OUTLIER -113.56 110.1 19.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.914 -1.116 . . . . 0.0 109.349 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER 172.79 -65.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.642 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.607 HG23 ' CZ ' ' A' ' 51' ' ' PHE . 7.3 p -49.79 -48.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.82 -1.175 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 95' ' ' VAL . 8.6 mt -61.64 -42.07 98.38 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.572 HD13 ' CZ ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -57.86 -34.41 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 110.43 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 92' ' ' LEU . 3.7 m -54.35 -37.67 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.94 -1.1 . . . . 0.0 109.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.517 ' ND1' ' HB3' ' A' ' 101' ' ' PRO . 80.1 m-70 -68.16 -37.34 80.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.247 -0.908 . . . . 0.0 109.188 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.705 ' CD2' HG12 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -77.57 -36.87 51.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 109.749 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.831 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 5.6 m-85 -77.1 -22.33 52.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.824 . . . . 0.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.429 ' HG2' ' HD2' ' A' ' 100' ' ' PRO . 2.5 mtp -156.89 167.96 13.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.336 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 149' ' ' LEU . 48.9 Cg_endo -76.01 133.96 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.0 110.451 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.517 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 45.4 Cg_endo -73.03 111.8 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.977 1.514 . . . . 0.0 110.344 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 46.3 Cg_endo -72.87 55.12 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.985 1.518 . . . . 0.0 110.383 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.71 117.38 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.5 m -140.73 88.92 10.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.264 -1.139 . . . . 0.0 110.214 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.24 -176.7 2.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.026 1.54 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 t -72.73 -176.26 1.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -83.78 82.03 8.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 109' ' ' LEU . 19.2 t 50.84 -157.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 109' ' ' LEU . 2.5 pt? -149.87 158.57 37.03 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.236 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.446 ' HB2' ' HB2' ' A' ' 113' ' ' GLU . 46.7 Cg_endo -73.0 148.43 45.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.09 -90.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.967 1.509 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.35 67.33 1.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.211 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -155.81 77.09 4.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.205 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 115' ' ' SER . 46.7 Cg_endo -72.83 -53.57 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.477 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 114' ' ' PRO . 0.7 OUTLIER 63.3 20.95 12.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' GLU . 5.7 t 57.95 21.36 7.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' SER . 18.7 mt-10 43.28 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.262 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.6 t -127.57 62.12 53.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -35.01 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.045 1.55 . . . . 0.0 110.458 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 52.68 87.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -150.12 49.26 0.62 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.199 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 121' ' ' GLN . 47.0 Cg_endo -73.42 134.39 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.944 1.497 . . . . 0.0 110.531 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 56.1 3.42 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.974 1.513 . . . . 0.0 110.4 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.56 18.29 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.343 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -135.08 151.88 51.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.04 129.2 9.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.536 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 3.2 mm? -63.36 -57.56 19.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 46.2 Cg_endo -73.1 119.3 5.96 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.542 . . . . 0.0 110.435 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 131' ' ' THR . . . 159.29 -90.29 0.11 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -57.45 84.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -1.146 . . . . 0.0 110.231 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.571 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -127.53 48.29 3.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.228 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 131' ' ' THR . 47.1 Cg_endo -73.42 -0.18 8.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.99 1.521 . . . . 0.0 110.562 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 35.64 3.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.248 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.96 52.25 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.588 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -176.31 102.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.734 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 3.0 t80 -102.62 122.51 44.55 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.903 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.808 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 3.5 p90 -155.73 167.9 28.89 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.927 -1.108 . . . . 0.0 110.781 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.553 HG12 ' CB ' ' A' ' 62' ' ' LYS . 3.0 mp -121.09 149.58 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 111.055 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.752 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.0 OUTLIER -84.71 107.94 17.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 110.057 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -91.82 122.02 33.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 110.286 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.14 65.68 2.59 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 51.35 20.59 5.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 140' ' ' SER . 12.8 tt0 -120.38 121.86 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.135 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.16 105.36 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 110.63 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.808 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.98 109.04 54.79 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.763 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.5 Cg_endo -72.53 128.72 13.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.954 1.502 . . . . 0.0 112.277 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.759 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -125.89 135.21 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 148' ' ' VAL . 35.7 m -103.83 117.72 49.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.273 -1.517 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.65 HD12 ' CD2' ' A' ' 136' ' ' TYR . 12.8 mt -76.17 123.5 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -0.963 . . . . 0.0 108.969 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.483 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 11.0 t -137.84 -7.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.82 -1.175 . . . . 0.0 111.647 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 ttm-85 -100.23 124.63 42.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.718 -1.239 . . . . 0.0 110.104 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 147.96 32.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.981 1.516 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.655 ' N ' HD11 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -67.13 159.14 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.648 ' C ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m -14.09 -86.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.558 -0.713 . . . . 0.0 111.231 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.525 ' N ' HD23 ' A' ' 153' ' ' LEU . 20.0 m -41.09 139.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.218 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.203 0.525 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.73 49.77 6.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -163.82 -51.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.91 148.62 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -0.871 . . . . 0.0 110.175 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -97.56 -51.9 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.547 ' O ' ' CG1' ' B' ' 162' ' ' VAL . 2.6 p -171.03 121.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 110.014 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 0.0 OUTLIER -120.81 -176.5 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.189 -0.944 . . . . 0.0 110.28 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.552 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.488 ' O ' ' CD2' ' B' ' 164' ' ' PTR . 1.4 m -134.83 -138.67 0.17 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -125.95 163.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.191 -0.943 . . . . 0.0 110.134 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.734 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 37.8 t -114.47 112.89 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.662 HG21 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t 58.48 155.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -172.37 128.34 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 5.6 t -131.05 109.19 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.26 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.57 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.48 ' CA ' HD11 ' A' ' 4' ' ' LEU . 85.3 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.34 0.591 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 22.1 p90 -64.52 -35.88 82.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.564 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 28.1 pt20 -62.88 -40.22 96.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.48 HD11 ' CA ' ' A' ' 1' ' ' GLU . 1.1 mt -67.0 -47.46 71.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.67 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 7.1 p -68.94 -47.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.318 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' N ' HG12 ' A' ' 5' ' ' VAL . 41.9 t -58.68 -50.23 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.82 -38.42 78.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.724 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . . . -72.34 -38.26 68.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 3.0 t -56.94 -39.39 65.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.3 mtp85 -58.45 -49.42 77.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.568 -0.708 . . . . 0.0 110.104 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -78.57 -33.25 47.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.323 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' CG2' ' A' ' 95' ' ' VAL . 2.2 tt -72.0 -44.15 63.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.758 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 4.6 pt20 -61.28 -40.94 96.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 110.371 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 8.3 tt0 -77.16 -51.64 10.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -72.79 -43.18 63.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 17' ' ' PHE . . . -99.98 33.99 5.85 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.221 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 3.1 p90 29.75 44.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -1.039 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.672 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -92.79 122.92 35.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.715 ' CD1' ' N ' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.61 145.94 49.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 110.126 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 107.31 14.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.29 12.82 0.12 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.472 -0.767 . . . . 0.0 110.016 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -121.54 -159.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.693 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.557 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.19 176.17 7.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.523 ' HA2' ' NE ' ' A' ' 42' ' ' ARG . . . -55.21 -75.3 0.25 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' N ' HG12 ' B' ' 162' ' ' VAL . . . -79.39 -31.77 40.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.557 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 1.9 tp10 -59.0 -36.47 74.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.032 -1.275 . . . . 0.0 109.509 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -60.92 -51.43 69.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.719 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 4.1 m-80 -69.82 -42.88 73.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.968 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.1 mp -70.99 -32.75 69.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -0.842 . . . . 0.0 112.321 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.546 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 2.7 pp -55.4 -35.12 64.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.704 -1.247 . . . . 0.0 110.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.6 pp -66.27 -36.24 82.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.826 -1.171 . . . . 0.0 109.265 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.609 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.53 -32.72 71.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 110.324 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.55 -20.71 42.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.67 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -116.84 -76.03 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.9 Cg_endo -73.18 70.9 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.292 1.154 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 141.28 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 79.91 18.21 73.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.577 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.42 147.31 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -1.079 . . . . 0.0 110.023 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.601 ' CD2' HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -123.02 163.08 21.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.016 . . . . 0.0 110.202 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.646 ' CD1' ' CE2' ' A' ' 19' ' ' TRP . 7.6 tt -151.96 159.18 43.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.96 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.659 ' CG1' ' HB2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.24 129.28 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' NH1' ' HA ' ' A' ' 44' ' ' SER . 6.3 ppt_? -112.16 155.06 24.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.34 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 30.3 t0 -100.05 132.14 45.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.536 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -55.82 153.98 7.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m -48.17 -51.28 25.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.168 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -79.56 146.14 32.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -90.91 -2.0 57.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.212 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -93.94 44.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 48' ' ' ARG . 36.2 m80 -146.35 -93.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 12.1 p90 175.44 178.02 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.878 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.677 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 3.3 p90 -115.88 148.66 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.987 . . . . 0.0 110.3 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 65' ' ' ARG . 2.1 p -126.84 155.33 43.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.865 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.695 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 1.9 tt -124.22 154.09 40.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.562 ' CB ' ' HB3' ' A' ' 28' ' ' ASN . 3.2 p -139.03 153.63 48.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.58 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.8 m -130.13 174.11 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.794 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.516 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.8 139.14 52.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.471 -0.768 . . . . 0.0 110.086 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.54 ' HB ' ' CD1' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -175.6 146.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.3 OUTLIER 66.82 -60.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.184 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER 165.89 -22.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 109.817 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' C ' ' NZ ' ' A' ' 62' ' ' LYS . . . -105.77 117.1 5.38 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.453 HG21 HD11 ' A' ' 29' ' ' LEU . 9.7 t -97.61 116.52 29.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.142 -1.211 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HD3' ' CG2' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -106.71 161.37 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.132 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.532 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 1.1 m-80 -118.98 135.82 54.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.619 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 2.1 mm? -104.05 127.09 51.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.587 ' CB ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -118.02 138.28 52.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 91' ' ' VAL . 1.1 tp -82.95 148.42 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.503 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 27.3 tp60 -112.88 151.06 30.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.503 ' N ' ' HG3' ' A' ' 67' ' ' GLN . 45.2 t -102.04 127.84 48.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 110.231 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.4 tt0 -121.26 103.0 8.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.76 -68.95 0.12 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -157.02 28.03 0.52 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 4.5 p -136.45 161.31 36.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 110.161 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 90' ' ' CYS . 1.3 m-30 -112.95 149.96 32.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.48 ' HA ' ' SG ' ' A' ' 90' ' ' CYS . 16.4 t -150.99 138.82 19.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 94' ' ' LEU . 27.0 tp -96.41 -23.24 16.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -102.07 142.89 32.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 110.213 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.5 m -92.45 83.48 4.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 40.7 p-10 -109.44 139.86 21.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.18 56.11 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.457 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 81' ' ' SER . 0.0 OUTLIER -85.9 -38.96 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 110.234 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 82' ' ' THR . 12.7 m 55.79 -163.0 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.147 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 81' ' ' SER . 12.6 t 37.79 35.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.297 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.2 tp60 69.66 125.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.65 -62.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.94 1.495 . . . . 0.0 110.524 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 89' ' ' ASP . 2.9 m -126.91 168.13 15.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.4 Cg_endo -70.46 132.87 23.04 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.863 1.454 . . . . 0.0 110.116 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 67.95 -77.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.904 . . . . 0.0 109.938 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 87' ' ' ARG . 10.5 p90 176.39 50.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.858 . . . . 0.0 109.84 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.508 ' N ' HG21 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -72.64 110.09 6.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.158 -0.963 . . . . 0.0 109.896 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.491 ' HB3' HD12 ' A' ' 66' ' ' ILE . 0.5 OUTLIER 168.89 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.677 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 4.0 p -53.43 -50.06 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.525 HD12 ' CE2' ' A' ' 88' ' ' PHE . 16.3 mt -63.51 -46.06 87.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 108.434 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -60.26 -29.9 69.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.582 HD22 ' CZ ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -57.92 -34.24 69.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.785 -0.572 . . . . 0.0 110.095 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 42.0 t -54.05 -42.15 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.089 -1.007 . . . . 0.0 108.948 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.0 OUTLIER -68.26 -31.37 70.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.915 . . . . 0.0 108.735 178.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.565 ' NE2' HG22 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.12 -43.29 29.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.684 -0.635 . . . . 0.0 109.503 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.695 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 4.2 m-85 -64.05 -22.15 66.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.475 -0.766 . . . . 0.0 110.055 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.51 ' CB ' ' HD2' ' A' ' 100' ' ' PRO . 0.2 OUTLIER -129.61 -179.04 0.91 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.249 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 99' ' ' MET . 48.0 Cg_endo -75.41 127.57 10.5 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.04 1.547 . . . . 0.0 110.38 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.26 110.44 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.998 1.525 . . . . 0.0 110.42 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 46.7 Cg_endo -73.56 -90.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.019 1.536 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.74 26.46 7.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.8 t -174.4 140.91 0.75 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.206 -1.173 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 106' ' ' SER . 45.3 Cg_endo -72.99 -89.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.976 1.513 . . . . 0.0 110.427 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 88.5 p -175.61 102.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.237 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -121.08 -164.81 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 110.195 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.73 108.02 5.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.947 . . . . 0.0 110.251 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.96 121.82 86.06 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 132.76 18.64 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.955 1.503 . . . . 0.0 110.492 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 113' ' ' GLU . 46.8 Cg_endo -73.52 -0.51 9.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.974 1.513 . . . . 0.0 110.452 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 111' ' ' PRO . 16.6 p -42.31 -26.82 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 110.251 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 111' ' ' PRO . 2.9 mm-40 -96.87 129.97 31.3 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.131 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.25 170.92 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.932 1.491 . . . . 0.0 110.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 t -160.46 101.93 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 116' ' ' SER . 27.8 p -96.78 100.52 12.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 118' ' ' VAL . 1.0 OUTLIER 179.34 111.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 118' ' ' VAL . 30.6 m -139.0 81.27 21.95 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.24 109.86 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.059 1.557 . . . . 0.0 110.336 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 121' ' ' GLN . 21.0 pt-20 -61.27 -176.81 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 120' ' ' GLU . 8.8 mt-30 44.7 91.05 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.11 154.13 52.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.035 1.545 . . . . 0.0 110.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.18 132.86 18.59 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.047 1.551 . . . . 0.0 110.343 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 125' ' ' GLN . . . -135.56 84.05 2.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 7.1 mt-30 56.43 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.138 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 176.23 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.251 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.52 153.09 85.64 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.0 113.39 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.044 1.549 . . . . 0.0 110.476 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.77 -135.48 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 131' ' ' THR . 0.1 OUTLIER 55.44 28.13 11.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -1.154 . . . . 0.0 110.212 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 130' ' ' SER . 10.7 m 44.27 80.99 0.26 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.85 53.22 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.059 1.557 . . . . 0.0 110.422 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -102.73 -89.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.49 146.07 48.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.586 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -173.25 152.82 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.124 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.768 ' O ' ' O ' ' A' ' 147' ' ' LEU . 1.3 t80 -131.11 122.94 27.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.329 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.822 ' HB3' ' H ' ' A' ' 147' ' ' LEU . 9.4 p90 -155.15 168.03 28.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.583 -1.323 . . . . 0.0 111.64 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.528 ' CG2' ' HD3' ' A' ' 62' ' ' LYS . 4.2 mp -102.16 143.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.624 0.726 . . . . 0.0 110.744 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.721 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.2 m-85 -93.3 132.76 37.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.718 0.771 . . . . 0.0 110.925 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 142' ' ' GLY . 12.1 t -101.8 -163.55 1.02 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.088 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.504 ' N ' ' OG ' ' A' ' 140' ' ' SER . . . -55.67 85.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 63.77 12.43 47.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mm-40 -120.2 121.93 39.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.612 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -87.22 105.26 17.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.471 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.789 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -89.52 108.6 26.01 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.741 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.6 Cg_endo -76.35 129.44 11.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.059 1.558 . . . . 0.0 113.35 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.822 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 2.1 mm? -125.12 134.96 52.25 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 148' ' ' VAL . 17.2 m -101.16 116.45 44.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 119.878 -1.764 . . . . 0.0 110.921 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.62 HD11 ' CG ' ' A' ' 136' ' ' TYR . 56.4 mt -84.79 114.96 22.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.135 -0.978 . . . . 0.0 109.241 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.499 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 1.5 p -147.69 28.55 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 111.375 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 1.2 mtt180 -134.11 123.22 16.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.789 -1.195 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 50.7 Cg_endo -79.3 135.45 12.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.069 1.562 . . . . 0.0 110.822 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.605 ' CD2' ' HB2' ' A' ' 40' ' ' LEU . 16.3 tp -92.39 146.5 23.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.865 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m -61.91 114.03 3.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 110.339 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.584 ' O ' ' CG ' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -45.39 -24.36 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.18 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.183 0.516 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.76 38.53 30.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' B' ' 160' ' ' SER . . . -111.0 -67.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' B' ' 159' ' ' ALA . 3.4 t 65.06 137.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.275 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.13 155.99 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 25' ' ' GLY . 2.8 m -52.55 120.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.49 ' C ' ' CD2' ' B' ' 164' ' ' PTR . 17.2 pt-20 -115.66 174.0 6.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.532 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 t -116.72 -141.17 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.337 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 64' ' ' LEU . 41.7 p -131.25 -173.15 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.686 HG11 ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -123.88 -160.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.106 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.699 HG12 ' CD2' ' A' ' 137' ' ' TYR . 2.3 m -69.87 -157.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.528 ' N ' HG21 ' B' ' 168' ' ' VAL . 1.8 p-80 -133.73 174.06 10.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 110.184 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 1.4 t -176.16 151.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.035 -1.425 . . . . 0.0 109.578 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 2' ' ' TYR . 6.1 pt-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.545 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 30.0 p90 -66.67 -35.9 81.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.4 tt0 -65.18 -44.13 89.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 2.4 mt -67.12 -47.5 70.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.593 HG22 ' CD2' ' A' ' 51' ' ' PHE . 6.8 p -65.32 -47.85 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 0.0 110.353 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.414 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 24.9 t -58.64 -36.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.05 -33.21 70.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . . . -76.05 -44.36 39.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.04 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 82.0 t -57.45 -39.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.446 -0.784 . . . . 0.0 109.295 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.4 mtm180 -55.86 -48.33 75.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.721 . . . . 0.0 109.893 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -34.75 50.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.984 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' CD2' HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.04 -43.29 65.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 110.055 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 4.8 pt20 -65.74 -33.73 76.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 2.3 mt-10 -57.61 -33.7 68.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.095 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.433 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 3.7 m -56.02 -27.5 53.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 155' ' ' SER . . . 87.8 42.71 5.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.577 ' CE2' ' HE2' ' A' ' 99' ' ' MET . 9.2 p90 -152.59 14.5 0.57 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -1.18 . . . . 0.0 110.452 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.677 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -94.93 126.26 40.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.251 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.62 ' CD1' HD13 ' A' ' 40' ' ' LEU . 16.9 m95 -106.04 148.09 28.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 3.6 m -39.12 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.821 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . 166.99 81.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.451 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.1 t -47.22 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.595 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -108.23 173.07 6.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.811 -1.181 . . . . 0.0 109.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.87 -89.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' CA ' ' CG1' ' B' ' 162' ' ' VAL . . . -79.44 -30.31 45.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.595 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -57.82 -34.93 70.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.268 . . . . 0.0 110.445 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 30' ' ' LEU . . . -66.48 -49.06 67.89 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.012 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.612 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.0 m-80 -69.29 -39.87 78.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 110.535 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.1 mp -70.39 -31.41 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 111.712 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 1.8 pp -54.68 -24.02 20.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.825 -1.172 . . . . 0.0 110.794 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.2 pp -75.41 -36.13 60.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.937 -1.102 . . . . 0.0 109.322 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.588 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -69.69 -32.91 71.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.61 41.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.938 . . . . 0.0 110.72 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.737 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.6 mt-10 -114.34 -76.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.737 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 47.3 Cg_endo -72.12 71.31 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.224 1.118 . . . . 0.0 110.268 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.57 141.28 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.497 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.86 20.76 79.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.21 146.93 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 110.178 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.658 ' CD2' ' CD1' ' A' ' 149' ' ' LEU . 4.3 m-85 -123.42 157.41 33.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.916 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.23 159.18 43.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 110.592 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.677 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 13.1 tt -116.33 144.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.527 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.81 136.07 52.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 20' ' ' SER . 1.5 p30 -89.58 121.72 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 10.8 t -48.05 124.63 7.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 8.53 8.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.582 ' CB ' ' CD2' ' A' ' 49' ' ' HIS . 9.6 m-20 -67.21 -143.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 48' ' ' ARG . 3.9 pt20 -90.99 -37.52 13.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HD3' ' CB ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -173.54 37.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.31 -0.869 . . . . 0.0 110.144 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.582 ' CD2' ' CB ' ' A' ' 46' ' ' ASP . 13.7 m-70 -64.48 -93.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.913 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 65' ' ' ARG . 20.9 p90 -177.44 -159.5 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 110.194 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.593 ' CD2' HG22 ' A' ' 5' ' ' VAL . 8.5 p90 -126.96 155.79 42.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 74.9 m -126.24 138.38 53.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -0.953 . . . . 0.0 110.267 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.72 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -120.93 124.89 46.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.084 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 28' ' ' ASN . 2.5 p -126.02 154.14 43.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' CD1' ' A' ' 149' ' ' LEU . 2.2 m -122.34 174.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.85 . . . . 0.0 110.717 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 25.7 tttt -107.12 124.23 49.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.511 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 8.9 p -127.4 157.13 40.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 110.332 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.73 -24.24 64.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -79.72 -23.13 42.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.474 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 152.82 143.47 3.69 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.3 p -78.93 110.52 14.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HG3' HG12 ' A' ' 138' ' ' ILE . 5.3 mmtt -111.99 161.72 16.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.214 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.454 ' CB ' ' HB2' ' A' ' 54' ' ' SER . 12.7 p30 -140.12 125.98 19.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.516 ' CG ' ' OH ' ' A' ' 136' ' ' TYR . 12.9 mt -104.73 152.08 22.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.539 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -125.11 143.13 51.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.538 HG12 ' CG1' ' A' ' 91' ' ' VAL . 3.5 tp -78.58 136.65 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.077 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -102.79 145.31 29.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 1' ' ' GLU . 42.6 t -108.57 127.5 54.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.0 tt0 -124.17 104.29 8.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.04 -71.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -154.22 23.58 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -126.89 163.26 24.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 110.182 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.625 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 1.6 m-30 -119.42 157.87 27.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.634 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.516 ' N ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.12 138.68 15.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.14 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.602 ' CD1' ' CE2' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -127.0 -17.46 4.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.445 ' NE2' HD22 ' A' ' 75' ' ' LEU . 1.1 tp-100 -86.69 -148.14 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.518 ' CB ' ' CG2' ' B' ' 166' ' ' THR . 22.7 t -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.249 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -112.62 117.14 47.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -45.01 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.983 1.517 . . . . 0.0 110.463 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -55.97 -46.33 78.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.66 165.57 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -45.12 -41.7 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 82' ' ' THR . 8.4 mt-30 42.2 84.67 0.18 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.74 -164.07 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.096 1.577 . . . . 0.0 110.516 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 ' O ' ' OG ' ' A' ' 72' ' ' SER . 8.5 m -130.9 154.31 81.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 110.206 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 46.3 Cg_endo -73.44 135.64 22.59 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.943 1.496 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.608 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 59.38 49.44 8.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.622 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.672 ' CD1' ' O ' ' A' ' 88' ' ' PHE . 26.3 p90 35.19 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.402 -0.811 . . . . 0.0 110.535 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 87' ' ' ARG . 15.4 t0 -72.12 109.83 6.17 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.915 -1.116 . . . . 0.0 109.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.646 ' O ' ' N ' ' A' ' 94' ' ' LEU . 9.1 t -175.21 -74.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.669 -0.644 . . . . 0.0 110.211 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 73' ' ' PHE . 15.5 m -50.63 -51.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 8' ' ' ALA . 6.7 mt -65.11 -46.56 80.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -67.5 -31.14 71.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.069 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 90' ' ' CYS . 3.7 mp -59.36 -33.85 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.84 -0.538 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.2 m -52.47 -37.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.98 -1.075 . . . . 0.0 109.651 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.502 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -57.15 -52.49 65.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.909 -1.119 . . . . 0.0 109.161 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.523 ' CE1' ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -79.21 -40.14 31.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 110.097 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.72 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -64.43 -22.36 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.0 109.64 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.577 ' HE2' ' CE2' ' A' ' 17' ' ' PHE . 2.6 ttp 165.63 89.42 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 0.0 109.816 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 149' ' ' LEU . 47.5 Cg_endo -76.06 129.59 11.53 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.848 1.446 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HG2' ' HD3' ' A' ' 102' ' ' PRO . 41.4 Cg_endo -72.24 -29.76 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.025 1.54 . . . . 0.0 112.241 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.671 ' HD3' ' HG2' ' A' ' 101' ' ' PRO . 48.3 Cg_endo -74.96 149.49 36.95 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.824 0.907 . . . . 0.0 110.476 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.29 7.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -44.39 108.27 0.71 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 106' ' ' SER . 47.2 Cg_endo -73.23 -174.55 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 59.12 -163.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 110.19 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -126.63 21.93 7.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -165.85 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.94 . . . . 0.0 110.251 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 tp 49.32 85.34 0.18 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.91 125.06 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.059 1.557 . . . . 0.0 110.469 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.87 -6.19 18.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.965 1.508 . . . . 0.0 110.393 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -52.84 124.86 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -69.83 -57.23 6.7 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 46.2 Cg_endo -73.21 148.18 43.61 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.082 1.569 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 63.1 m -68.01 149.41 49.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.3 m -158.86 150.47 20.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.53 24.76 7.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.5 t -96.47 123.18 55.32 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.883 . . . . 0.0 110.214 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.03 -90.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.0 110.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -135.4 -37.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.288 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.88 143.83 29.07 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.435 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . 46.5 Cg_endo -73.38 173.64 13.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.984 1.518 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 122' ' ' PRO . 46.0 Cg_endo -73.28 -20.11 21.61 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.29 138.97 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.182 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -168.62 -43.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -104.08 100.39 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 129' ' ' GLY . 2.2 pp -168.73 125.82 0.84 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.8 -58.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.006 1.529 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 127' ' ' LEU . . . -88.11 -134.07 4.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t -115.94 103.23 10.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -1.125 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 1.3 m -67.6 -54.22 18.92 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 131' ' ' THR . 45.6 Cg_endo -71.83 105.57 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.879 1.463 . . . . 0.0 110.485 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.2 -46.2 0.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.256 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -63.28 106.4 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.59 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 167.44 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.653 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 3.2 t80 -102.47 122.57 44.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.484 -1.286 . . . . 0.0 109.697 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.776 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.6 p90 -156.08 167.18 31.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.464 HG12 ' HG3' ' A' ' 62' ' ' LYS . 2.5 mp -120.25 149.29 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 111.42 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.67 108.08 17.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.986 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 143' ' ' GLU . 2.8 m -66.84 56.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.572 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 67.31 81.8 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.89 -8.59 49.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -120.23 121.8 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.239 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -89.57 105.25 17.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.095 -1.003 . . . . 0.0 110.62 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.53 110.51 51.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.732 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.1 Cg_endo -71.94 129.47 15.36 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.569 . . . . 0.0 112.107 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.762 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.2 mt -125.74 135.83 52.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.46 117.36 42.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.336 -1.478 . . . . 0.0 109.791 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.658 ' CD1' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -116.2 114.88 25.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.061 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -155.13 41.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.23 125.37 24.63 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.286 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.83 148.11 40.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.009 1.531 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.549 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER -76.39 150.69 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.34 109.57 6.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -171.47 96.71 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.207 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.232 0.539 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' B' ' 158' ' ' THR . 8.1 t -65.13 91.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 160' ' ' SER . . . 49.02 61.61 3.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.287 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.462 ' O ' ' O ' ' B' ' 159' ' ' ALA . 0.2 OUTLIER 60.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 110.24 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' B' ' 160' ' ' SER . 16.6 m -167.29 163.43 15.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 110.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.572 ' CG1' ' CA ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.85 134.69 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.13 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -82.22 -178.09 6.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.533 ' CG ' ' O ' ' B' ' 163' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 15.5 m -92.11 -139.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.518 ' CG2' ' CB ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -148.27 174.38 12.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.653 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 2.4 t -135.87 146.1 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.621 ' C ' ' O ' ' B' ' 167' ' ' VAL . 6.7 m 20.62 93.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.738 -0.601 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' B' ' 170' ' ' SER . 11.5 t-160 -94.37 -76.4 0.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.249 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' B' ' 169' ' ' HIS . 17.5 t -177.12 88.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 68' ' ' CYS . 2.7 tm-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 40.1 p90 -64.36 -35.8 82.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.1 tp60 -54.85 -41.08 70.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.599 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -66.14 -47.4 74.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 50' ' ' PHE . 38.9 t -65.31 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.1 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.74 -49.32 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -58.97 -38.23 78.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.895 . . . . 0.0 109.89 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.597 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -76.29 -44.69 35.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.04 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 75.4 t -57.77 -39.87 72.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.404 -0.81 . . . . 0.0 109.163 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -56.05 -41.66 75.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.869 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -76.87 -44.85 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 1.1 mt -62.11 -44.37 96.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 110.013 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 6.0 pt20 -68.27 -33.82 75.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.252 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.86 -45.13 86.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.534 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.534 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 5.6 m -55.9 -38.42 70.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.967 . . . . 0.0 110.096 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.06 35.64 2.7 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.581 ' HB2' HD13 ' A' ' 153' ' ' LEU . 23.3 p90 -139.22 10.72 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -1.137 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 5.2 t80 -90.87 117.45 29.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.67 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 58.6 m95 -82.02 141.58 33.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.612 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -162.86 108.65 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.045 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.612 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 159.62 -2.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.53 -0.731 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.16 -156.65 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.097 . . . . 0.0 110.001 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.57 175.99 6.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -47.98 -86.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -76.48 -31.76 53.35 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 3.5 tt0 -59.63 -24.97 64.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.129 -1.218 . . . . 0.0 110.219 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -74.65 -49.96 19.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.569 HD22 ' HA2' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -70.09 -44.96 67.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.252 -0.905 . . . . 0.0 110.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.4 mp -59.89 -32.26 70.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.565 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.1 pp -55.39 -30.67 60.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.928 -1.107 . . . . 0.0 109.383 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.701 ' CD1' ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.81 -33.99 73.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.701 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 19.7 p -70.44 -32.84 70.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.557 -0.715 . . . . 0.0 110.288 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.78 -20.89 41.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.75 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.9 mt-10 -120.99 -79.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.943 -1.098 . . . . 0.0 110.391 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.1 Cg_endo -75.42 54.83 3.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.072 1.038 . . . . 0.0 110.105 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' CB ' ' HE2' ' A' ' 56' ' ' LYS . . . -53.03 141.61 22.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.377 -0.827 . . . . 0.0 110.736 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 92.67 15.29 53.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.525 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.44 148.8 43.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.977 . . . . 0.0 110.141 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.612 ' O ' ' CD1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -121.59 149.4 43.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.017 . . . . 0.0 110.514 -179.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.67 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -150.37 160.73 43.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.565 -0.709 . . . . 0.0 109.588 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.555 HD13 ' CE1' ' A' ' 51' ' ' PHE . 2.1 tt -113.47 145.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.796 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.556 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 tmt_? -112.28 151.22 29.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.628 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 44' ' ' SER . 9.6 t0 -94.38 133.69 37.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.086 -1.008 . . . . 0.0 110.661 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER 74.15 135.63 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.527 -0.733 . . . . 0.0 110.635 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 7.5 t -150.35 -43.85 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.731 . . . . 0.0 109.668 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' B' ' 161' ' ' THR . 8.7 m-20 -132.86 -152.96 0.52 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.925 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -91.05 -1.88 57.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.091 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.506 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 6.8 mtt180 -78.75 -15.16 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.498 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER 68.58 98.53 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.33 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.55 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 54.3 p90 -179.52 -176.79 0.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.089 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.639 ' CE2' HG22 ' A' ' 91' ' ' VAL . 5.2 p90 -115.85 155.15 28.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 110.089 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -126.07 150.68 47.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 110.047 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.67 ' CD2' ' CG ' ' A' ' 98' ' ' TYR . 1.4 tt -139.26 131.02 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 111.158 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.728 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -139.71 154.11 47.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.483 -0.761 . . . . 0.0 109.959 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.58 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 1.5 p -129.08 174.2 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 110.585 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' HE2' ' CB ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -111.74 139.1 47.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.198 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 58' ' ' GLN . 2.3 m -160.33 148.94 16.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 110.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' THR . 7.5 pt20 -41.92 -27.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -66.93 -53.46 31.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.253 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.64 146.55 4.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.458 HG21 ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -83.32 129.06 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -1.098 . . . . 0.0 110.133 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.0 OUTLIER -142.08 140.92 32.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.9 OUTLIER -111.05 141.35 44.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.583 ' CD2' ' HA ' ' B' ' 166' ' ' THR . 0.4 OUTLIER -138.18 152.42 48.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 110.834 -179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' HD3' ' O2P' ' B' ' 164' ' ' PTR . 0.0 OUTLIER -121.07 165.0 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.813 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.495 ' CD1' HD22 ' A' ' 94' ' ' LEU . 5.0 tp -78.11 131.23 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -97.84 140.33 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 31.0 p -92.32 128.09 38.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG2' ' NE ' ' A' ' 87' ' ' ARG . 3.3 tt0 -133.07 104.53 6.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.335 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 54.55 65.42 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.36 24.0 15.03 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 70' ' ' GLY . 0.7 OUTLIER -124.12 157.7 34.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 0.0 110.048 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -124.22 128.91 49.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.089 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -153.97 139.01 17.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.898 . . . . 0.0 110.34 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.566 HD12 ' CZ ' ' A' ' 98' ' ' TYR . 1.8 tt -116.29 -17.82 10.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 109.885 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.582 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -178.57 141.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.064 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.459 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 0.1 OUTLIER 60.78 139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -120.0 113.79 34.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HG3' ' HD3' ' A' ' 93' ' ' LYS . 47.4 Cg_endo -73.21 57.9 3.47 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.978 1.515 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 20.08 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' OE1' ' A' ' 83' ' ' GLN . 31.3 p -115.48 134.88 54.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.441 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.486 ' O ' ' NE2' ' A' ' 83' ' ' GLN . 2.9 p 42.35 40.34 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER -133.99 177.28 2.32 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 83' ' ' GLN . 45.6 Cg_endo -72.89 -57.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.093 1.575 . . . . 0.0 110.305 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -144.83 153.2 53.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 110.111 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 44.4 Cg_endo -72.37 152.19 54.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.03 1.542 . . . . 0.0 110.332 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 75.33 -42.36 0.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.788 . . . . 0.0 110.429 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.55 ' CD2' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 71.48 103.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.699 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 5.1 t0 -72.83 109.21 6.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.699 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 10.7 t 149.72 121.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.639 HG22 ' CE2' ' A' ' 51' ' ' PHE . 1.2 t -49.56 -25.06 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.566 ' C ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -56.04 -38.07 70.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.273 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.55 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -58.57 -40.56 83.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -68.17 -35.39 77.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.547 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 24.8 t -55.49 -37.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 110.268 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -54.27 -35.77 62.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.676 ' CE1' ' CD1' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -78.17 -41.85 33.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.061 -1.024 . . . . 0.0 110.412 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.676 ' CD1' ' CE1' ' A' ' 97' ' ' HIS . 0.6 OUTLIER -64.68 -22.15 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.205 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.522 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -124.55 164.23 31.82 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.91 . . . . 0.0 110.29 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 149' ' ' LEU . 45.5 Cg_endo -73.25 174.45 12.05 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.019 1.537 . . . . 0.0 110.282 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 100' ' ' PRO . 44.4 Cg_endo -72.1 166.83 28.48 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.005 1.529 . . . . 0.0 110.395 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 107.46 2.3 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.072 1.564 . . . . 0.0 110.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.39 2.26 7.12 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.478 ' OG1' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -130.33 156.95 78.69 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' OG1' ' A' ' 104' ' ' THR . 43.8 Cg_endo -72.27 -73.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.022 1.538 . . . . 0.0 110.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 107' ' ' PHE . 28.7 t 44.35 -144.66 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.513 ' N ' ' OG ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -135.97 101.66 4.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 t -140.67 176.63 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp 52.25 90.85 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.916 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.97 148.3 45.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.963 1.507 . . . . 0.0 110.388 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 78.75 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.967 1.509 . . . . 0.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 t -163.35 151.1 13.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.167 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.5 138.79 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.15 116.54 4.75 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.089 1.573 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 117' ' ' GLU . 70.6 m -121.11 152.63 38.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 115' ' ' SER . 7.9 m 56.73 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -156.98 138.0 13.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.7 t -46.0 104.71 0.41 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 117' ' ' GLU . 46.6 Cg_endo -73.09 132.69 18.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.045 1.55 . . . . 0.0 110.455 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -109.06 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.141 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.515 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 1.2 mt-30 -64.12 -56.37 24.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 121' ' ' GLN . 46.5 Cg_endo -73.36 173.99 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.944 1.497 . . . . 0.0 110.386 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 122' ' ' PRO . 46.6 Cg_endo -72.95 156.36 52.38 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.017 1.535 . . . . 0.0 110.478 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 178.78 -30.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.218 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -59.68 -15.33 18.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.186 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 125' ' ' GLN . . . 66.76 23.38 10.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER 64.54 131.43 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.231 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' SER . 46.2 Cg_endo -73.09 -7.93 21.36 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.972 1.512 . . . . 0.0 110.514 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.61 89.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' PRO . 0.9 OUTLIER -153.62 65.35 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.127 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -64.24 126.11 89.66 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.238 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 Cg_endo -74.12 -63.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.978 1.515 . . . . 0.0 110.582 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.7 tttp -178.11 66.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 59.1 mmt-85 -59.42 133.58 56.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 134' ' ' ARG . . . 164.32 82.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 110.17 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.756 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -102.83 125.96 49.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.478 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.759 ' CD2' ' CG2' ' B' ' 168' ' ' VAL . 8.2 p90 -154.11 167.21 30.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.089 . . . . 0.0 110.511 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.566 ' H ' ' CD1' ' A' ' 147' ' ' LEU . 3.0 mt -101.57 149.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 111.298 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.723 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.0 m-85 -98.97 132.82 44.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.709 0.766 . . . . 0.0 110.984 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . 45.0 t -97.06 48.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.618 -0.676 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.02 82.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.61 -22.07 39.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 1.5 mp0 -117.05 122.02 42.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 1.2 pttm -91.68 105.29 17.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.219 -0.926 . . . . 0.0 110.312 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.725 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -87.73 108.24 19.58 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.714 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.2 Cg_endo -76.07 128.8 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.994 1.523 . . . . 0.0 112.346 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.614 ' H ' ' CB ' ' A' ' 137' ' ' TYR . 1.2 mp -125.06 134.19 52.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -117.87 117.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.596 -1.315 . . . . 0.0 111.249 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.622 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 3.8 tt -92.45 114.86 27.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 1.0 OUTLIER -137.11 -15.14 1.51 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 111.063 -179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.85 124.91 70.2 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.958 -1.088 . . . . 0.0 110.017 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.06 147.88 43.85 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.945 1.497 . . . . 0.0 110.592 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.623 ' O ' HD11 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.48 158.56 14.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 0.0 110.567 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 155' ' ' SER . 46.2 t -38.04 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.315 -0.866 . . . . 0.0 110.815 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.59 ' CB ' HD23 ' A' ' 153' ' ' LEU . 0.3 OUTLIER 61.32 -84.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.491 ' N ' ' OG ' ' A' ' 155' ' ' SER . 4.0 t-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.17 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.173 0.511 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 1.8 t -163.47 64.04 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . 48.23 -142.04 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.162 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.08 -158.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.51 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 p -89.94 118.84 29.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.293 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.503 ' CG2' ' HA3' ' A' ' 24' ' ' GLY . 16.5 t -46.14 149.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.954 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.474 ' C ' ' HD1' ' B' ' 164' ' ' PTR . 0.4 OUTLIER -93.81 122.38 36.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.565 ' HD2' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.568 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -142.92 -149.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.362 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.583 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.8 p -112.29 144.64 41.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.852 . . . . 0.0 110.05 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -100.24 114.49 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.759 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 99.6 t 40.23 83.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -126.08 107.54 10.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.28 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 3.4 t -167.52 77.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.316 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.548 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.537 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . 7.9 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.568 ' CE1' HG22 ' A' ' 6' ' ' VAL . 11.8 t80 -66.9 -52.39 43.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.907 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -61.09 -39.44 89.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.476 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . 1.2 mt -67.09 -47.25 71.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.663 ' CG2' ' CE2' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -69.58 -47.92 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.245 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.614 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 72.9 t -61.83 -41.27 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -58.93 -41.44 87.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.934 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . . . -62.01 -44.16 97.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.78 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 41.3 t -57.55 -39.8 71.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.88 78.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.737 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -32.86 56.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -61.91 -43.7 98.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 110.092 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.584 ' HG2' ' CD1' ' A' ' 18' ' ' TYR . 40.2 mt-30 -67.2 -35.89 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -63.42 -39.27 94.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.222 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -38.81 75.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.37 1.17 23.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CD1' HD22 ' A' ' 153' ' ' LEU . 1.6 t80 -94.99 21.85 7.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 13' ' ' GLN . 36.3 t80 -121.25 136.03 55.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 110.258 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.704 ' CE3' ' NH2' ' A' ' 42' ' ' ARG . 9.4 m95 -104.67 148.64 26.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 110.333 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 42.1 m -31.91 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 163.81 69.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' CG2' ' NH1' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -60.9 -135.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.329 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.621 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -88.34 176.16 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.76 -1.213 . . . . 0.0 109.205 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.1 -81.75 0.03 OUTLIER Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.332 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -79.9 -31.12 40.6 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.439 -1.036 . . . . 0.0 111.643 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.621 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 21.2 tp10 -58.63 -24.9 62.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.451 . . . . 0.0 110.955 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' CB ' ' HD3' ' A' ' 42' ' ' ARG . . . -77.15 -48.19 18.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.992 -1.067 . . . . 0.0 109.544 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.604 ' HA ' HD13 ' A' ' 40' ' ' LEU . 1.8 m-80 -70.62 -49.57 46.16 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.686 0.755 . . . . 0.0 111.142 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 61' ' ' THR . 0.8 OUTLIER -61.88 -31.59 71.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.698 . . . . 0.0 112.162 -178.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 2.2 pp -55.18 -35.15 64.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.75 -1.219 . . . . 0.0 109.853 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.588 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -81.25 -36.18 30.26 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 108.622 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.586 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 52.0 m -70.03 -32.88 71.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.555 -0.716 . . . . 0.0 110.129 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.02 41.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.512 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 10.4 mt-10 -113.87 -76.77 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.041 . . . . 0.0 110.05 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.741 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.8 Cg_endo -73.08 61.32 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.277 1.146 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.73 141.24 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 150' ' ' SER . . . 89.34 13.45 61.66 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 21.2 m -132.66 146.08 51.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.554 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 152' ' ' PRO . 30.5 p90 -126.97 138.84 53.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.838 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -131.4 161.01 33.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.584 HG12 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.41 128.56 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.789 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.704 ' NH2' ' CE3' ' A' ' 19' ' ' TRP . 78.5 mtt-85 -135.73 153.43 51.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.739 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -73.94 122.79 23.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 109.7 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -36.35 -72.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.338 -0.852 . . . . 0.0 110.562 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 60.5 m -109.42 -31.85 7.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 16.0 t0 -178.08 -178.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.252 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.421 ' HA ' ' OD2' ' A' ' 43' ' ' ASP . 0.8 OUTLIER -78.43 -1.97 36.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -71.16 -2.47 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.295 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 50' ' ' PHE . 28.5 p80 -144.07 -144.42 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 110.271 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 35.9 p90 -92.55 -166.74 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.663 ' CE2' ' CG2' ' A' ' 5' ' ' VAL . 5.9 p90 -130.82 158.21 40.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.84 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 14.5 t -126.28 139.2 53.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.773 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 6.9 tt -121.03 139.45 53.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.585 ' OG ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -139.33 154.39 47.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 ' CG ' ' A' ' 149' ' ' LEU . 2.4 m -130.12 174.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.392 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HB2' ' CB ' ' A' ' 32' ' ' SER . 18.4 tptt -105.93 130.49 53.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.468 HG23 ' HG ' ' A' ' 147' ' ' LEU . 33.7 p -134.86 -169.27 2.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -77.48 -34.95 54.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.3 t -81.73 -22.79 37.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.18 -0.95 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.48 14.62 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.53 HG22 ' CD1' ' A' ' 29' ' ' LEU . 1.8 t -101.04 126.4 47.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -1.123 . . . . 0.0 110.27 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 54' ' ' SER . 8.7 mmpt? -114.07 147.3 38.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.235 -0.916 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.595 ' O ' ' CD1' ' B' ' 164' ' ' PTR . 10.7 p30 -112.02 144.07 41.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 110.706 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD1' ' CG2' ' B' ' 167' ' ' VAL . 1.2 mp -138.93 152.26 47.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.594 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HD3' ' CZ ' ' A' ' 50' ' ' PHE . 3.3 ptt180 -123.49 164.04 19.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG12 ' CD2' ' A' ' 73' ' ' PHE . 6.6 tp -76.78 143.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -113.05 144.66 42.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 1' ' ' GLU . 13.7 t -101.99 118.85 37.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 110.368 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 71' ' ' GLY . 22.9 tt0 -105.21 102.89 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.037 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.21 -83.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -139.87 37.69 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.64 163.07 32.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -1.107 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.617 ' CE1' ' CB ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -122.4 127.97 50.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 3.4 m -155.55 159.91 40.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 94' ' ' LEU . 10.5 tp -94.1 17.15 13.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.844 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 64.05 93.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.184 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.2 t -162.77 -69.01 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.33 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 78' ' ' ASP . 18.5 p-10 -93.96 114.08 62.22 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.04 -56.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.009 1.531 . . . . 0.0 110.439 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' O ' ' CB ' ' A' ' 81' ' ' SER . 15.4 tpt180 -56.21 -48.02 77.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.901 . . . . 0.0 110.249 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER 66.1 53.79 1.04 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.194 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 m -96.89 -43.87 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 110.219 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -55.25 -58.12 16.68 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 110.19 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 46.5 Cg_endo -73.07 -157.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.062 1.559 . . . . 0.0 110.277 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.591 ' CG1' ' HD2' ' A' ' 86' ' ' PRO . 88.9 t -125.17 149.31 63.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.591 ' HD2' ' CG1' ' A' ' 85' ' ' VAL . 40.7 Cg_endo -67.69 132.06 25.93 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.718 1.378 . . . . 0.0 109.821 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 72.82 47.5 0.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.418 -179.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.539 ' CB ' ' HG3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -57.68 -149.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.53 -0.732 . . . . 0.0 110.187 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.628 ' O ' ' C ' ' A' ' 90' ' ' CYS . 47.7 m-20 -100.44 110.34 22.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.957 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.628 ' C ' ' O ' ' A' ' 89' ' ' ASP . 78.8 m 4.07 -121.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.499 0.666 . . . . 0.0 112.083 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.61 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 p -57.07 -24.8 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.51 ' HB2' ' CB ' ' A' ' 89' ' ' ASP . 3.8 mt -55.64 -35.98 66.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.723 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.539 ' HG3' ' CB ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -62.53 -46.36 88.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.865 -1.147 . . . . 0.0 109.209 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -68.25 -34.82 76.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.44 -0.787 . . . . 0.0 109.58 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 91' ' ' VAL . 56.0 t -54.74 -36.43 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 110.438 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -52.61 -33.12 44.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.462 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -78.18 -36.79 47.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.156 -0.965 . . . . 0.0 109.476 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.773 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 6.9 m-85 -73.59 -22.05 60.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.98 78.88 34.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.316 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 45.0 Cg_endo -73.01 142.01 33.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.02 1.537 . . . . 0.0 110.226 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.63 110.22 2.95 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.988 1.52 . . . . 0.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 47.1 Cg_endo -73.43 -55.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.028 1.541 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 106' ' ' SER . . . 157.36 67.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.553 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.36 -58.74 2.91 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.165 -1.197 . . . . 0.0 110.119 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 46.4 Cg_endo -72.64 60.09 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.468 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 103' ' ' GLY . 0.8 OUTLIER -120.16 -62.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER 63.17 77.24 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.155 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 0.4 OUTLIER 61.38 -79.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -76.87 130.06 77.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.255 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 170.56 19.42 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.436 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.04 150.13 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.069 1.563 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 17.8 m -74.55 -53.23 9.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 112' ' ' THR . 2.9 mt-10 58.25 93.63 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.04 118.57 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.978 1.515 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 116' ' ' SER . 29.3 t -114.84 -153.96 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.45 ' N ' ' OG ' ' A' ' 115' ' ' SER . 57.8 m 46.33 64.44 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 1.3 tt0 -94.59 73.45 3.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 61.4 t 57.04 92.33 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.22 -161.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.015 1.534 . . . . 0.0 110.406 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -146.17 -70.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.227 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.609 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -91.13 -63.48 0.19 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 110.35 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 46.2 Cg_endo -73.3 120.15 6.38 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.825 1.434 . . . . 0.0 110.385 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -89.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.965 1.508 . . . . 0.0 110.409 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 125' ' ' GLN . . . -70.56 -62.32 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 124' ' ' ALA . 7.4 tp60 54.46 102.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 127' ' ' LEU . . . -102.61 -89.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.184 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER 56.7 110.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' GLY . 45.8 Cg_endo -72.98 67.46 4.03 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' PRO . . . -45.1 134.55 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -1.127 . . . . 0.0 110.147 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.527 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -55.62 -56.65 27.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 131' ' ' THR . 45.5 Cg_endo -72.86 -19.69 23.32 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.346 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -175.74 1.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 42.0 mtt85 -44.51 129.88 6.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.574 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 173.85 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.761 ' OH ' ' CE1' ' A' ' 98' ' ' TYR . 1.3 t80 -102.81 121.52 42.63 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.719 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.814 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -158.24 148.67 20.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 110.137 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.689 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 1.0 OUTLIER -102.65 150.18 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.977 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.627 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 76.2 m-85 -86.19 132.71 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 110.435 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 143' ' ' GLU . 1.3 t -98.49 69.23 1.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.65 41.93 75.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.56 2.76 29.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 140' ' ' SER . 2.8 mt-10 -117.8 121.97 42.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -70.92 105.93 3.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.463 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.763 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -101.5 120.1 55.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.866 . . . . 0.0 109.555 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.814 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 43.6 Cg_endo -69.64 129.42 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.349 1.71 . . . . 0.0 112.786 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.788 ' HB2' ' HA ' ' A' ' 137' ' ' TYR . 6.1 mp -121.1 101.29 7.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 148' ' ' VAL . 3.3 p -102.85 117.64 48.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.624 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.567 ' CG ' HG11 ' A' ' 55' ' ' VAL . 3.5 mp -76.02 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 37' ' ' GLY . 2.7 p -172.62 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.74 -1.225 . . . . 0.0 111.495 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -85.68 124.93 70.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.855 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 39' ' ' PHE . 48.5 Cg_endo -75.7 148.06 32.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.106 1.582 . . . . 0.0 110.093 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -63.21 144.37 56.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.227 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.1 t -130.88 81.2 1.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.097 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.561 ' HB2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -133.18 151.18 51.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.237 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.256 0.55 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' THR . . . . . 0.433 ' O ' ' N ' ' B' ' 160' ' ' SER . 0.2 OUTLIER 47.69 27.55 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.195 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' B' ' 160' ' ' SER . . . 54.53 -91.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 0.7 OUTLIER 170.31 127.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.277 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -43.92 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 110.024 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.549 ' O ' ' CG1' ' B' ' 162' ' ' VAL . 4.3 t -122.66 74.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.33 116.53 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.875 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.595 ' CD1' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 1.6 m -157.78 -137.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 110.173 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.568 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 2.7 t -105.87 137.52 43.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.709 ' CG2' ' CZ ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -84.63 95.49 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.114 -0.991 . . . . 0.0 109.589 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.652 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 2.2 t 70.66 104.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.893 . . . . 0.0 109.983 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.624 ' CD2' ' N ' ' B' ' 170' ' ' SER . 5.3 p-80 -100.5 -29.36 12.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.624 ' N ' ' CD2' ' B' ' 169' ' ' HIS . 93.0 p -78.0 125.72 29.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.513 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.266 0.555 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 30.2 p90 -55.72 -36.48 67.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.7 tt0 -55.03 -32.88 62.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.215 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 73' ' ' PHE . 10.2 mt -62.33 -44.04 97.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.556 ' CG2' ' CB ' ' A' ' 50' ' ' PHE . 61.1 t -63.14 -48.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.158 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.5 -50.53 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -62.36 -44.1 97.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB3' HG12 ' A' ' 91' ' ' VAL . . . -67.01 -44.52 80.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.771 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.1 t -57.93 -40.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.823 . . . . 0.0 109.136 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -55.89 -47.86 76.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.613 -0.68 . . . . 0.0 109.867 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -36.56 63.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.918 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 17' ' ' PHE . 4.2 mt -71.77 -44.05 64.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 110.003 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 6.0 pt20 -67.89 -33.87 75.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -57.9 -34.49 69.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.07 -34.7 66.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.845 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 155' ' ' SER . . . 100.57 29.19 6.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.617 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 6.7 p90 -145.97 40.24 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 110.631 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 4.9 t80 -120.38 115.81 24.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.853 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.602 ' CD1' HD12 ' A' ' 40' ' ' LEU . 63.5 m95 -77.26 144.08 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 110.329 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 18.6 t -45.77 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.722 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 165.64 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.859 . . . . 0.0 110.568 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 1.4 m -47.04 -97.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.069 -1.02 . . . . 0.0 109.41 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.6 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -108.05 165.88 11.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 109.199 178.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -43.3 -79.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.565 ' HA2' ' OD1' ' A' ' 28' ' ' ASN . . . -79.5 -30.47 44.79 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.369 -1.077 . . . . 0.0 111.254 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.9 mm-40 -58.49 -24.79 61.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.344 . . . . 0.0 110.954 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . . . -76.04 -49.78 16.6 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 109.24 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' OD1' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -71.18 -49.68 41.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 111.244 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' CD1' ' OD1' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -63.37 -31.09 72.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.583 -0.698 . . . . 0.0 111.797 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -53.77 -23.39 11.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.835 -1.166 . . . . 0.0 109.689 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 62.6 mt -61.73 -39.51 91.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 109.191 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.55 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 93.1 p -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.6 -0.688 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.95 -20.39 45.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.7 mm-40 -125.27 -81.16 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.998 -1.064 . . . . 0.0 110.404 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.6 Cg_endo -77.17 68.38 7.41 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 122.92 0.958 . . . . 0.0 110.175 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.67 141.48 9.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.0 110.614 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 71.65 24.0 77.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.584 ' CB ' ' HB2' ' A' ' 35' ' ' PRO . 7.9 m -125.81 147.14 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -1.048 . . . . 0.0 110.474 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.69 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 1.2 p90 -122.83 147.1 46.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.613 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -145.29 159.71 42.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.493 -0.754 . . . . 0.0 109.72 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.645 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 5.3 tt -114.31 137.9 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.105 -0.997 . . . . 0.0 110.118 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -112.63 131.82 55.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.0 110.438 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.574 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 35.9 t0 -89.28 118.22 28.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.55 ' CB ' ' CD2' ' A' ' 49' ' ' HIS . 5.7 t -69.8 -22.05 63.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.202 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 45' ' ' SER . 26.7 p 43.8 81.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -144.82 -156.66 0.72 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.259 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' TYR . 19.9 mm-40 -91.19 -35.27 14.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 110.245 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' OE2' ' A' ' 1' ' ' GLU . 7.5 mtt-85 -136.06 4.3 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.55 ' CD2' ' CB ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -74.43 -144.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.16 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CB ' ' CG2' ' A' ' 5' ' ' VAL . 2.2 p90 176.77 -151.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.114 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.654 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 25.8 p90 -115.37 151.92 33.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -1.0 . . . . 0.0 109.869 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 64' ' ' LEU . 36.2 m -125.9 135.74 52.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.945 . . . . 0.0 110.499 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.619 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -120.75 123.32 42.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.823 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -140.34 155.72 46.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.483 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 2.7 p -134.53 174.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 0.0 110.689 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.42 133.69 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.82 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.508 ' CG2' ' HG ' ' A' ' 147' ' ' LEU . 8.8 t -132.93 -156.96 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.58 -58.36 2.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.455 ' OG ' ' HD2' ' A' ' 146' ' ' PRO . 0.8 OUTLIER -44.63 -61.43 1.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 172.84 45.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 56' ' ' LYS . 49.2 p -99.37 108.97 21.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -1.119 . . . . 0.0 110.238 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HB2' HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -108.43 177.83 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.945 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.823 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 23.8 m-20 -128.42 132.47 48.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 110.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 63' ' ' ASN . 8.2 mt -131.69 152.12 51.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -147.9 168.43 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.0 110.516 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.606 ' CG2' ' CD2' ' A' ' 73' ' ' PHE . 44.0 mm -76.82 146.74 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -114.41 150.82 34.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.513 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 54.1 t -89.01 132.85 34.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.317 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 71' ' ' GLY . 10.3 tm-20 -123.86 102.94 8.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.02 -89.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -133.61 24.62 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -132.93 162.92 30.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.606 ' CD2' ' CG2' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -110.91 136.38 50.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -155.23 150.29 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.299 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.542 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -89.75 -29.83 18.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.096 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -97.93 -165.24 1.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.177 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.9 p -95.6 -0.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.145 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -107.23 112.19 62.99 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.23 -38.46 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.995 1.523 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.8 18.18 4.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.893 . . . . 0.0 110.21 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -72.05 -62.98 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.106 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.535 ' CG2' ' HD3' ' A' ' 84' ' ' PRO . 9.0 t -73.05 -4.08 30.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 57.54 56.98 7.55 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.365 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD3' ' CG2' ' A' ' 82' ' ' THR . 48.1 Cg_endo -75.01 -163.42 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.955 1.503 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.669 ' CG1' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -128.88 -167.94 0.15 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.237 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.669 ' HD2' ' CG1' ' A' ' 85' ' ' VAL . 43.7 Cg_endo -73.55 132.69 17.82 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.33 1.173 . . . . 0.0 109.813 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 57.36 45.72 19.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.645 ' CG ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -116.17 131.74 56.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.366 -0.834 . . . . 0.0 110.726 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.492 ' O ' HD23 ' A' ' 92' ' ' LEU . 52.8 m-20 -88.09 110.47 20.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.294 -0.878 . . . . 0.0 109.263 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.557 ' CB ' HD11 ' A' ' 94' ' ' LEU . 87.3 m -67.21 -4.06 9.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.343 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.654 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 3.3 p -58.44 -45.87 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.036 -1.04 . . . . 0.0 110.099 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -65.16 -47.25 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 109.537 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 0.2 OUTLIER -68.21 -33.47 74.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 0.0 108.851 178.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.567 ' CD1' HD12 ' A' ' 66' ' ' ILE . 7.5 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.828 -0.545 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -53.04 -36.8 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.399 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 99' ' ' MET . 7.4 m170 -53.42 -45.47 69.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.999 -1.063 . . . . 0.0 108.22 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -78.73 -38.43 38.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.774 . . . . 0.0 108.92 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.619 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.77 -22.11 66.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.546 ' HB2' ' CD2' ' A' ' 149' ' ' LEU . 3.2 ttp -152.46 142.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.898 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.546 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 48.3 Cg_endo -75.82 125.05 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.868 1.457 . . . . 0.0 110.497 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.677 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.7 Cg_endo -72.16 -29.57 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.92 1.484 . . . . 0.0 112.154 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 48.4 Cg_endo -74.42 177.67 8.04 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.924 0.96 . . . . 0.0 110.397 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.42 -74.23 2.4 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.0 p -132.42 88.38 39.62 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.262 -1.14 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.72 153.7 54.01 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 107' ' ' PHE . 3.3 m -106.71 146.54 30.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 108' ' ' SER . 1.5 p90 -175.93 177.62 1.61 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.194 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 107' ' ' PHE . 0.4 OUTLIER 171.68 -43.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.207 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 109' ' ' LEU . 4.0 pp -107.74 159.59 29.83 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 121.58 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.977 1.514 . . . . 0.0 110.427 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.96 142.37 34.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.95 1.5 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -131.37 134.23 46.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -166.81 57.91 0.44 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.14 177.87 7.27 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.008 1.531 . . . . 0.0 110.396 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 115' ' ' SER . 3.4 p 57.43 48.98 13.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 110.217 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -167.11 127.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.868 . . . . 0.0 110.147 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.95 108.95 13.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -135.45 142.25 40.57 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.85 -4.57 15.62 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.098 1.578 . . . . 0.0 110.43 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 121' ' ' GLN . 2.4 mt-10 55.51 170.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 120' ' ' GLU . 2.7 mp0 56.23 166.76 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.58 139.98 32.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.031 1.543 . . . . 0.0 110.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.88 -16.4 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.033 1.544 . . . . 0.0 110.485 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.81 23.52 13.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 110.228 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -175.22 130.77 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -145.2 -38.06 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.932 . . . . 0.0 110.179 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -117.66 117.02 36.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 129' ' ' GLY . 45.1 Cg_endo -72.94 158.52 49.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.946 1.498 . . . . 0.0 110.39 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' O ' ' OG ' ' A' ' 130' ' ' SER . . . 62.61 133.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 129' ' ' GLY . 28.2 p 42.54 -165.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER 42.47 75.52 0.62 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.11 -57.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.106 1.582 . . . . 0.0 110.457 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -138.97 -53.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 110.187 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -155.89 142.74 18.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.223 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.576 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 164.41 78.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.741 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -102.8 125.02 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.049 -1.032 . . . . 0.0 109.463 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.769 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 8.2 p90 -155.01 167.62 29.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 110.622 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 64' ' ' LEU . 2.0 mt -101.43 147.43 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.0 110.958 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.703 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -96.66 133.31 41.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -96.64 67.54 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.703 -0.623 . . . . 0.0 110.26 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.54 -65.11 0.17 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -133.25 3.97 4.84 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.3 121.96 40.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -1.196 . . . . 0.0 110.289 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 137' ' ' TYR . 9.7 mttt -82.25 105.53 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -89.45 108.94 28.03 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 0.0 108.947 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.715 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.3 Cg_endo -71.72 129.53 15.68 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.206 1.635 . . . . 0.0 112.191 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 137' ' ' TYR . 5.6 mp -124.64 135.12 52.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.595 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 148' ' ' VAL . 5.7 p -118.51 117.48 54.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.939 -1.1 . . . . 0.0 110.822 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.638 ' CD2' ' CD2' ' A' ' 39' ' ' PHE . 5.2 tt -113.73 115.07 27.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -146.05 11.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.026 -1.046 . . . . 0.0 111.352 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.69 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -118.43 124.62 28.4 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.256 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.72 145.85 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.895 1.471 . . . . 0.0 110.719 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 19' ' ' TRP . 4.2 pp -82.11 139.86 34.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.575 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 3.9 m 38.95 -92.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.392 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER 68.12 124.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.205 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.186 0.517 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' B' ' 159' ' ' ALA . 14.5 t -88.01 -159.38 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.167 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' B' ' 158' ' ' THR . . . 64.8 -173.43 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.166 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 59.6 p -167.69 -145.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -73.93 -63.6 1.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.537 HG23 ' CA ' ' A' ' 25' ' ' GLY . 3.2 p -151.86 130.53 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 1.2 pp20? -109.56 162.43 14.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.157 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.533 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.535 ' O ' ' CD2' ' A' ' 64' ' ' LEU . 6.4 m -145.65 -174.47 4.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.328 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.457 HG21 ' ND1' ' B' ' 169' ' ' HIS . 12.1 t -82.21 -175.3 5.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.872 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.663 ' CG1' ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -107.64 -158.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.028 . . . . 0.0 110.215 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.746 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 37.5 t -57.93 103.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 110.29 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.52 ' CD2' ' HB2' ' B' ' 170' ' ' SER . 54.3 p-80 -135.19 -39.04 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.033 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.52 ' HB2' ' CD2' ' B' ' 169' ' ' HIS . 9.1 m -145.67 133.04 20.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.13 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.553 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.467 ' OE1' ' HB3' ' A' ' 48' ' ' ARG . 5.7 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 17.9 p90 -67.08 -35.71 80.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.571 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -54.78 -32.97 60.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.103 -0.998 . . . . 0.0 110.523 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.613 ' CB ' ' CE2' ' A' ' 73' ' ' PHE . 1.1 mt -67.32 -48.13 68.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 110.616 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.59 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 2.0 m -72.76 -44.46 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 0.0 110.53 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 9' ' ' VAL . 95.7 t -58.47 -32.46 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -33.06 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.93 -1.106 . . . . 0.0 110.807 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . . . -76.19 -33.59 59.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.153 -0.967 . . . . 0.0 111.143 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 6' ' ' VAL . 1.5 m -56.49 -37.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 108.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' N ' HG22 ' A' ' 9' ' ' VAL . 71.2 mtt180 -55.57 -42.82 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.854 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -46.86 19.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.592 ' HG ' ' CZ ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -65.46 -39.44 92.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.508 ' NE2' HG21 ' A' ' 9' ' ' VAL . 24.9 mt-30 -59.97 -33.96 72.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -72.0 -29.8 64.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 110.027 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.585 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 1.4 t -59.17 -43.05 92.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.97 20.11 22.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.592 ' CZ ' ' HG ' ' A' ' 12' ' ' LEU . 4.1 p90 -130.08 -4.69 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.267 . . . . 0.0 110.472 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -95.46 119.36 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 0.0 109.919 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 19' ' ' TRP . 5.7 m95 -109.22 148.1 31.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.385 -0.822 . . . . 0.0 109.911 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.488 ' C ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -134.95 25.13 3.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.381 -0.824 . . . . 0.0 109.268 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.96 1.13 14.6 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.102 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.6 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.43 -157.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.923 -1.111 . . . . 0.0 109.469 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.589 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -97.5 169.53 9.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 110.074 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -42.67 -81.45 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.535 ' N ' HG21 ' B' ' 162' ' ' VAL . . . -79.15 -31.6 42.12 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.26 -1.141 . . . . 0.0 110.705 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 7.4 mt-10 -58.82 -36.78 75.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.007 -1.29 . . . . 0.0 109.865 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.65 -50.57 71.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.035 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.589 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 m-80 -68.99 -38.96 79.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.371 -0.831 . . . . 0.0 110.669 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 29' ' ' LEU . 1.3 mp -70.51 -31.44 68.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.523 -0.735 . . . . 0.0 112.135 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -54.35 -43.34 71.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.261 . . . . 0.0 110.474 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.617 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -72.01 -34.99 69.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.77 -1.207 . . . . 0.0 108.636 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.579 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 17.2 p -70.05 -32.4 70.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.671 -0.643 . . . . 0.0 110.286 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.19 -20.98 43.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.948 . . . . 0.0 110.142 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.7 mm-40 -115.52 -77.51 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -75.28 62.14 6.02 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.213 1.112 . . . . 0.0 109.818 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.6 141.42 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . 100.03 15.95 29.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 35' ' ' PRO . 16.7 p -134.98 147.27 49.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.659 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' CD1' HD11 ' A' ' 149' ' ' LEU . 47.9 p90 -122.76 141.11 52.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.677 ' CD1' ' CD1' ' A' ' 19' ' ' TRP . 0.7 OUTLIER -134.49 158.16 44.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 110.099 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.607 HG22 ' CD1' ' A' ' 18' ' ' TYR . 2.7 tt -114.46 130.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 5.3 tpt180 -112.75 144.06 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 0.6 OUTLIER -92.29 115.67 28.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.99 123.07 34.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 81.82 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -110.54 -163.45 0.85 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.41 -8.53 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.467 ' HB3' ' OE1' ' A' ' 1' ' ' GLU . 5.6 mtt85 -107.7 -14.91 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.114 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 0.7 OUTLIER 60.86 112.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.314 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.528 ' HA ' HG11 ' A' ' 5' ' ' VAL . 31.8 p90 -178.63 154.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.12 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 51' ' ' PHE . 9.3 p90 -124.15 141.44 52.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -127.01 148.13 50.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 109.631 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.718 ' HG ' ' CZ ' ' A' ' 98' ' ' TYR . 4.3 pp -120.94 153.12 37.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.793 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.601 ' HB2' ' CA ' ' A' ' 63' ' ' ASN . 4.0 t -139.12 153.9 48.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 109.969 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.543 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 3.3 p -127.03 174.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.53 136.57 43.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.42 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -168.57 169.41 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -44.51 -44.43 8.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.539 ' CB ' ' CG2' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -54.16 -46.18 72.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.177 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.92 161.89 9.59 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.579 ' CG2' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -80.13 111.78 16.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 110.195 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.556 ' HG2' ' CD1' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -142.0 152.87 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.487 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.601 ' CA ' ' HB2' ' A' ' 54' ' ' SER . 7.7 p30 -120.51 156.28 31.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.594 ' O ' ' OH ' ' A' ' 98' ' ' TYR . 23.8 mt -134.34 141.99 47.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HD3' ' OH ' ' B' ' 164' ' ' PTR . 2.2 ptm180 -104.29 -177.55 3.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -105.46 149.04 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.248 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -95.65 132.24 41.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.154 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -106.27 136.84 45.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 71' ' ' GLY . 4.0 tt0 -132.0 102.91 6.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.47 -78.44 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ASP . . . -147.84 34.97 1.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.47 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -143.15 146.61 33.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.108 . . . . 0.0 110.034 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.613 ' CE2' ' CB ' ' A' ' 4' ' ' LEU . 9.1 m-30 -110.97 155.85 22.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.461 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.15 165.92 32.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.975 . . . . 0.0 110.586 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.539 HD21 ' CA ' ' A' ' 94' ' ' LEU . 4.3 tp 179.03 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 109.689 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.533 ' CG ' ' HA ' ' B' ' 169' ' ' HIS . 0.0 OUTLIER 172.09 -173.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.437 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.538 ' HB3' ' CD2' ' A' ' 96' ' ' HIS . 0.2 OUTLIER 55.84 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.443 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -120.1 150.06 50.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.48 54.84 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.046 1.551 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -24.79 59.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -49.57 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.221 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 1.1 p -113.4 -29.8 7.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.124 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 65.85 48.5 0.6 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.885 . . . . 0.0 110.189 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 46.0 Cg_endo -73.18 -53.51 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.072 1.564 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' CG2' ' HA ' ' A' ' 88' ' ' PHE . 9.9 m -125.54 150.59 68.43 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.622 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 46.3 Cg_endo -72.76 132.95 19.37 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.963 1.507 . . . . 0.0 110.445 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.622 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 78.55 -32.12 0.16 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 0.0 110.566 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.568 ' CB ' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 73.33 94.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.231 -0.918 . . . . 0.0 109.972 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 19.3 p-10 -72.83 109.15 6.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.153 -0.967 . . . . 0.0 109.423 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.5 OUTLIER 157.42 124.3 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.206 0.526 . . . . 0.0 109.862 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 5.2 p -49.52 -24.88 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.759 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -55.71 -34.87 65.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -57.66 -31.72 66.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.975 -1.078 . . . . 0.0 109.224 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.539 ' CA ' HD21 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.01 -34.62 76.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.603 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.512 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 54.7 t -54.71 -37.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.155 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.538 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 1.6 t-80 -53.8 -29.88 42.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.603 ' CE1' ' CE1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -67.56 -40.86 84.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.718 ' CZ ' ' HG ' ' A' ' 53' ' ' LEU . 38.1 m-85 -70.87 -15.74 62.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 97' ' ' HIS . 15.4 mmt 62.93 85.09 0.18 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.533 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 44.8 Cg_endo -72.29 133.92 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.07 1.563 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.664 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.7 Cg_endo -72.36 -29.76 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.094 1.576 . . . . 0.0 112.247 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 48.9 Cg_endo -74.6 155.08 44.91 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 122.809 0.899 . . . . 0.0 110.445 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 104' ' ' THR . . . -122.63 -50.59 0.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 103' ' ' GLY . 41.8 p 43.36 72.7 1.1 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.285 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 106' ' ' SER . 45.9 Cg_endo -73.14 -91.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 107' ' ' PHE . 3.7 t 171.06 -105.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 110.107 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.511 ' N ' ' OG ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 41.54 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.304 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.67 -68.39 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 tt -173.99 85.36 0.36 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.03 122.37 8.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.965 1.508 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.95 175.83 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.944 1.497 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.7 m -62.71 90.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.72 155.29 75.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.91 165.35 33.04 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.956 1.503 . . . . 0.0 110.434 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER 46.4 51.83 11.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m 53.82 -86.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.248 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 115' ' ' SER . 4.7 mp0 -147.13 -167.2 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 110.193 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -115.47 100.82 54.03 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 120' ' ' GLU . 46.6 Cg_endo -72.77 54.44 2.53 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.561 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 119' ' ' PRO . 2.5 tt0 42.61 -159.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.543 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -74.92 -58.19 1.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.183 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 45.8 Cg_endo -73.26 116.07 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.005 1.529 . . . . 0.0 110.35 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.88 115.26 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.97 1.51 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -166.44 158.27 13.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -146.24 90.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -166.59 -143.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.199 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -90.87 126.06 56.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.6 -45.16 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.909 1.478 . . . . 0.0 110.467 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.45 44.54 0.26 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 131' ' ' THR . 0.5 OUTLIER -63.9 -55.83 19.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 130' ' ' SER . 66.4 p 42.86 75.88 0.59 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.249 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 115.06 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.04 1.547 . . . . 0.0 110.335 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' B' ' 169' ' ' HIS . 22.6 tttt -73.11 -72.42 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 27.2 mtp85 59.21 107.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.153 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.569 ' O ' HG12 ' B' ' 168' ' ' VAL . . . 165.41 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.729 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -102.72 124.65 48.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.083 -1.01 . . . . 0.0 109.065 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.841 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 7.8 p90 -155.44 167.36 30.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.828 -1.17 . . . . 0.0 111.48 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.561 ' CD1' HD22 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -104.21 149.27 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.624 0.726 . . . . 0.0 111.0 -178.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.629 ' CZ ' ' OH ' ' A' ' 137' ' ' TYR . 16.9 m-85 -96.42 133.34 40.96 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.494 0.664 . . . . 0.0 110.644 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -125.95 126.45 44.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 110.568 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 41.18 68.54 0.63 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.74 22.7 2.0 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 140' ' ' SER . 5.1 tp10 -117.7 121.97 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -1.208 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.563 ' HG3' ' CD2' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -84.64 105.62 15.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -99.17 98.78 6.98 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.841 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.7 Cg_endo -73.08 127.27 11.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 111.792 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.643 ' CD2' ' HA ' ' A' ' 137' ' ' TYR . 0.5 OUTLIER -126.14 133.2 51.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 148' ' ' VAL . 7.1 p -107.53 117.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.765 -1.209 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.667 ' CD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.7 pp -102.34 123.17 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -154.88 14.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.824 -179.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 1.5 tpt180 -101.34 124.22 41.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.987 -1.071 . . . . 0.0 109.976 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.14 138.11 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.946 1.498 . . . . 0.0 110.591 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' PHE . 21.6 tp -91.22 123.55 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.97 90.23 3.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' CH2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.79 155.41 44.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.188 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' SER . . . . . 0.414 ' HB3' ' HB2' ' B' ' 160' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.172 0.511 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 3.4 m -68.65 -26.63 65.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.42 -29.22 47.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.181 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' B' ' 157' ' ' SER . 4.5 m -51.07 -89.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 1.2 t -138.59 173.25 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.535 HG21 ' N ' ' A' ' 25' ' ' GLY . 7.8 p -97.9 123.25 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 15.4 pt-20 -69.05 156.9 37.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.517 ' HD1' ' N ' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.469 ' O ' HD23 ' A' ' 64' ' ' LEU . 11.2 m -139.89 -132.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 8.8 t -149.78 154.83 39.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -93.17 173.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.132 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.77 HG11 ' CD2' ' A' ' 137' ' ' TYR . 2.8 p -62.88 97.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.246 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.533 ' HA ' ' CG ' ' A' ' 76' ' ' GLN . 14.6 p80 -53.5 -41.81 66.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' B' ' 169' ' ' HIS . 0.1 OUTLIER -168.52 163.35 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.885 . . . . 0.0 110.243 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.529 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.46 ' HA ' HD13 ' A' ' 4' ' ' LEU . 1.5 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.232 0.539 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.508 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 11.4 p90 -56.73 -35.95 69.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.508 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 2.6 tm0? -67.95 -42.84 80.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 1.3 mt -67.1 -47.48 71.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.648 ' CG1' ' CZ ' ' A' ' 73' ' ' PHE . 25.7 m -61.4 -38.64 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.055 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' N ' HG21 ' A' ' 5' ' ' VAL . 25.6 t -58.72 -51.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.47 -45.51 91.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB1' ' OD2' ' A' ' 89' ' ' ASP . . . -61.91 -44.04 97.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG21 ' CD2' ' A' ' 51' ' ' PHE . 13.8 t -57.44 -39.82 70.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.351 -0.843 . . . . 0.0 109.327 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.89 72.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.712 . . . . 0.0 109.936 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -41.03 46.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 18' ' ' TYR . 21.4 tp -72.1 -43.99 63.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.509 ' NE2' HG12 ' A' ' 9' ' ' VAL . 12.2 mt-30 -60.12 -33.5 72.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.56 -27.65 62.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.613 ' OG ' ' CD2' ' A' ' 17' ' ' PHE . 96.2 p -60.76 -43.09 98.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 109.843 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.35 26.99 7.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.613 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.9 p90 -132.39 -5.06 3.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 0.0 110.606 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.68 ' CD1' ' CG2' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -106.42 114.91 29.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.014 -1.054 . . . . 0.0 110.004 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.644 ' CE2' HD12 ' A' ' 40' ' ' LEU . 1.7 p-90 -126.46 148.24 49.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 110.025 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.01 107.49 14.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.98 10.19 0.17 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.551 -0.718 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -120.41 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.566 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.32 175.34 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.881 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.42 -81.99 0.04 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.725 ' HA2' ' ND2' ' A' ' 28' ' ' ASN . . . -79.35 -31.57 41.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.7 tt0 -59.22 -24.82 63.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.238 . . . . 0.0 109.94 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.16 -48.58 61.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.885 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.725 ' ND2' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -68.8 -47.26 66.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.396 -0.815 . . . . 0.0 110.899 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 1.5 mp -59.27 -31.92 69.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.797 . . . . 0.0 111.472 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -55.8 -46.08 78.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.9 -1.125 . . . . 0.0 109.665 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD22 ' O ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -73.08 -36.2 66.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 108.579 178.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.574 ' N ' ' CD2' ' A' ' 31' ' ' LEU . 1.9 m -69.8 -32.73 71.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 110.018 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.58 -20.95 42.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.6 mt-10 -113.15 -77.11 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.7 Cg_endo -72.11 64.11 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.33 1.174 . . . . 0.0 110.199 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HB1' ' HD2' ' A' ' 56' ' ' LYS . . . -49.94 141.48 10.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.219 -0.926 . . . . 0.0 110.538 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 90.53 15.74 56.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -135.07 147.23 49.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -1.026 . . . . 0.0 110.252 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' CE1' ' CG ' ' A' ' 99' ' ' MET . 10.4 p90 -122.76 142.22 50.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 0.0 110.094 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.644 HD12 ' CE2' ' A' ' 19' ' ' TRP . 5.5 tt -131.26 151.56 51.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.426 -0.796 . . . . 0.0 110.394 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.68 ' CG2' ' CD1' ' A' ' 18' ' ' TYR . 9.0 tt -114.77 128.07 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.446 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 5.5 tpt180 -119.56 139.56 51.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 1.4 t0 -73.89 138.06 44.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -38.35 -70.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HG ' ' CD2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -122.37 -72.96 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.67 -170.28 1.92 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.118 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -7.31 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -95.48 26.41 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 110.113 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.462 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.9 177.42 7.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 12.3 p90 -79.71 168.57 19.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.922 . . . . 0.0 110.182 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.615 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 7.8 p90 -123.1 139.26 54.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.494 ' C ' HG13 ' A' ' 41' ' ' ILE . 7.1 t -128.22 154.47 45.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.652 ' CD1' ' CD1' ' A' ' 98' ' ' TYR . 3.9 pp -139.47 151.38 46.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.941 -1.099 . . . . 0.0 110.456 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -139.29 153.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.0 110.262 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG11 HD12 ' A' ' 149' ' ' LEU . 10.7 p -129.01 173.47 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.333 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HB2' ' CA ' ' A' ' 32' ' ' SER . 9.6 tttm -116.92 139.14 50.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.532 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -146.26 -171.76 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.147 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.99 62.44 3.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 p -175.54 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.856 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.97 135.51 2.89 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 61' ' ' THR . 3.0 t -79.12 125.49 29.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.211 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 54' ' ' SER . 14.6 mmtt -123.8 141.96 51.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 110.175 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 5.1 p30 -116.73 138.87 51.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' B' ' 166' ' ' THR . 0.7 OUTLIER -132.16 131.01 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.419 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HG3' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -96.29 157.08 16.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.576 HG23 ' CD2' ' A' ' 73' ' ' PHE . 4.3 mp -100.6 136.3 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.152 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' NE2' ' HD3' ' A' ' 79' ' ' PRO . 52.0 mt-30 -119.91 150.98 39.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.276 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 19.9 p -87.95 130.26 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.56 124.37 48.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.4 -74.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.537 ' CA ' ' CG1' ' A' ' 85' ' ' VAL . . . -158.53 20.91 0.32 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 24.2 p -134.03 163.41 29.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.56 130.68 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 94' ' ' LEU . 9.5 p -145.52 167.08 23.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 97' ' ' HIS . 2.7 mt -67.08 117.12 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 64.37 122.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -176.63 -164.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 110.263 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' A' ' 77' ' ' SER . 0.8 OUTLIER -112.41 112.0 52.02 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.194 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HD3' ' NE2' ' A' ' 67' ' ' GLN . 46.1 Cg_endo -73.5 53.87 2.76 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.992 1.522 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.03 17.02 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.294 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.426 ' C ' ' OG1' ' A' ' 82' ' ' THR . 1.9 t -108.17 -58.51 1.98 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.219 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 41.9 33.25 0.33 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.537 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -150.39 -179.3 0.97 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 83' ' ' GLN . 45.6 Cg_endo -72.8 125.92 10.92 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.962 1.507 . . . . 0.0 110.35 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.574 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -132.91 -177.89 0.77 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 109.709 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 85' ' ' VAL . 40.2 Cg_endo -67.31 153.25 77.62 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.571 1.3 . . . . 0.0 109.544 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.597 ' O ' ' HB3' ' A' ' 88' ' ' PHE . 54.4 mtt180 65.09 -118.94 0.4 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 87' ' ' ARG . 4.8 p90 165.68 -148.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.171 -0.955 . . . . 0.0 109.748 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 73' ' ' PHE . 5.7 p-10 -73.24 110.18 7.33 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 0.0 109.596 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.84 6.85 26.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 110.66 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.615 HG11 ' CZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -50.08 -26.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.78 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 9.3 mp -57.6 -46.64 83.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.565 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -38.38 84.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.024 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 74' ' ' SER . 7.4 mt -68.09 -34.82 77.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.622 -0.673 . . . . 0.0 109.836 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.529 ' O ' ' HD2' ' A' ' 100' ' ' PRO . 26.9 t -54.66 -37.71 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 110.042 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 100' ' ' PRO . 34.3 m170 -53.49 -35.53 60.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.029 . . . . 0.0 109.339 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.582 ' NE2' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -78.16 -34.19 49.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.714 . . . . 0.0 109.776 179.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.652 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -61.88 -22.21 65.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.456 -0.778 . . . . 0.0 111.314 -178.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.551 ' HB3' ' HD3' ' A' ' 100' ' ' PRO . 0.0 OUTLIER 177.63 -56.88 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.913 -1.117 . . . . 0.0 111.554 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.6 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 40.5 Cg_endo -65.77 110.08 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.619 1.326 . . . . 0.0 111.256 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HA ' ' HG3' ' A' ' 134' ' ' ARG . 48.9 Cg_endo -75.84 168.99 23.14 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.94 1.495 . . . . 0.0 110.257 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 134' ' ' ARG . 47.5 Cg_endo -73.87 -5.56 17.22 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.953 1.501 . . . . 0.0 110.275 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.479 ' O ' ' OG1' ' A' ' 104' ' ' THR . . . 147.59 149.95 5.08 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.517 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.1 m -179.25 -58.59 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.224 -1.162 . . . . 0.0 110.171 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 44.6 Cg_endo -71.0 158.55 55.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.862 1.453 . . . . 0.0 110.462 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 107' ' ' PHE . 26.7 t -69.09 -92.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 108' ' ' SER . 53.2 m-85 41.86 64.44 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 4.2 m 56.05 174.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.182 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.514 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 16.8 mt 61.51 51.88 2.24 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 109' ' ' LEU . 46.7 Cg_endo -72.95 118.33 5.52 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.996 1.524 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -9.21 23.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.941 1.495 . . . . 0.0 110.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.411 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 8.3 t -117.2 167.34 11.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 2.1 mt-10 173.72 -57.58 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 45.9 Cg_endo -73.13 -10.0 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.049 1.552 . . . . 0.0 110.485 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.8 t -114.33 170.95 7.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.0 110.189 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.2 171.82 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.78 27.94 1.23 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.557 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 2.8 t -48.52 -54.62 24.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 118' ' ' VAL . 44.8 Cg_endo -71.42 152.53 60.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.881 1.463 . . . . 0.0 110.474 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 1.6 pt-20 -114.59 112.07 22.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.536 ' C ' ' HD2' ' A' ' 123' ' ' PRO . 7.8 mt-30 56.51 107.46 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.245 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.666 ' HG2' ' HD3' ' A' ' 123' ' ' PRO . 42.0 Cg_endo -72.26 -29.56 14.02 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.05 1.553 . . . . 0.0 112.242 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.666 ' HD3' ' HG2' ' A' ' 122' ' ' PRO . 48.7 Cg_endo -74.4 -32.11 6.67 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 122.851 0.922 . . . . 0.0 110.342 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -95.17 89.04 5.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.914 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -127.9 -56.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 0.0 110.292 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.47 -157.06 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.544 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -59.25 -58.11 21.97 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 45.5 Cg_endo -72.71 127.56 12.48 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 130' ' ' SER . . . -101.97 -1.5 51.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 129' ' ' GLY . 4.8 m 62.49 -164.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 130' ' ' SER . 27.3 p 42.48 81.27 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 61.39 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -125.63 -87.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 5.9 tmm_? -76.95 144.76 38.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' O ' HG22 ' B' ' 168' ' ' VAL . . . 167.17 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.932 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.774 ' O ' ' O ' ' A' ' 147' ' ' LEU . 5.8 t80 -114.44 120.69 41.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.876 -1.14 . . . . 0.0 109.623 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.853 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.8 p90 -157.15 166.89 31.99 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.954 -1.091 . . . . 0.0 109.998 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 147' ' ' LEU . 1.8 mp -119.24 147.41 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 120.88 -1.137 . . . . 0.0 111.51 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.65 107.77 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.705 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 10.3 t -92.47 124.82 36.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.68 61.54 3.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 57.09 20.28 34.28 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -120.23 121.73 39.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.942 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.06 105.44 11.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.005 -1.059 . . . . 0.0 110.704 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.853 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -97.71 115.09 65.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.677 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.2 Cg_endo -71.81 128.73 14.52 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 112.204 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.774 ' O ' ' O ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -126.1 136.46 52.93 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.4 t -97.41 116.45 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.062 -1.649 . . . . 0.0 109.852 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 1.2 tt -91.47 125.31 36.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 6.9 p -165.55 46.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.78 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 4.4 mtp180 -134.08 124.54 17.53 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.06 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.0 Cg_endo -76.55 148.13 29.12 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.875 1.461 . . . . 0.0 110.771 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.589 ' O ' ' C ' ' A' ' 154' ' ' SER . 4.4 pp -88.18 158.04 18.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.589 ' C ' ' O ' ' A' ' 153' ' ' LEU . 14.0 t 22.04 -90.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.704 -0.622 . . . . 0.0 111.067 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 153' ' ' LEU . 5.7 t 55.21 -85.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 110.219 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 154' ' ' SER . 2.3 t30 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.234 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.33 86.28 7.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.95 39.54 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 57.8 m -95.71 71.13 3.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 110.215 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.458 ' O ' HG21 ' B' ' 162' ' ' VAL . 68.4 p -68.08 117.64 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.597 ' CG2' ' HA3' ' A' ' 25' ' ' GLY . 1.8 t -158.67 92.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 24.7 mt-10 -119.32 -173.1 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 109.955 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.58 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' B' ' 166' ' ' THR . 36.6 m -123.58 -91.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.438 -0.789 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.603 ' CG2' ' CE2' ' A' ' 139' ' ' TYR . 0.2 OUTLIER 171.67 166.95 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -0.885 . . . . 0.0 110.311 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.636 HG13 ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -123.58 -162.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.384 -0.823 . . . . 0.0 110.274 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.691 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 3.6 t -77.19 132.94 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.271 -0.893 . . . . 0.0 110.296 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -67.17 149.56 50.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.43 ' HB2' HD21 ' A' ' 94' ' ' LEU . 3.8 m -97.81 40.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.499 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.514 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.515 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -61.46 -47.91 83.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 110.053 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -67.53 -32.96 74.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.368 -0.832 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.566 HD13 ' CD1' ' A' ' 73' ' ' PHE . 63.4 mt -57.01 -47.39 80.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' CA ' ' A' ' 50' ' ' PHE . 3.0 t -61.07 -47.24 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.092 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -43.19 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.134 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -65.0 -39.8 93.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.032 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.28 -44.45 52.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.895 . . . . 0.0 110.026 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 18' ' ' TYR . 94.8 t -57.83 -39.91 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 0.0 109.391 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -55.74 -43.74 76.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.482 -0.762 . . . . 0.0 110.054 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -77.97 -44.33 27.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.546 ' CD2' HG23 ' A' ' 41' ' ' ILE . 44.9 tp -65.98 -42.1 90.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 3.5 pt20 -68.18 -38.86 82.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.257 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.4 tm-20 -57.79 -44.91 86.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -26.91 51.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.48 31.2 8.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.703 ' CZ ' ' CE1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -129.76 8.38 5.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -1.141 . . . . 0.0 110.266 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.554 ' CE2' HG21 ' A' ' 9' ' ' VAL . 2.6 t80 -90.81 136.18 33.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.651 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 12.9 m95 -108.48 143.42 37.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.334 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -149.78 110.99 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.892 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 171.36 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG21 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.66 -161.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 0.0 110.145 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -93.7 165.81 12.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.639 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.51 -84.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.63 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -60.66 -41.93 99.12 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.1 mt-10 -59.56 -27.12 65.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.973 -1.31 . . . . 0.0 110.212 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 42' ' ' ARG . . . -78.3 -44.55 25.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 110.023 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 24' ' ' GLY . 8.8 m-80 -68.78 -48.27 64.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 29' ' ' LEU . 1.6 mp -59.19 -32.32 69.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.832 . . . . 0.0 111.038 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -55.98 -26.19 47.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 2.4 pp -68.52 -33.17 73.65 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.396 -0.921 . . . . 0.0 108.599 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.529 ' CA ' ' HD2' ' A' ' 56' ' ' LYS . 7.5 t -69.78 -32.93 71.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.611 -0.681 . . . . 0.0 110.056 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.61 -20.99 41.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 110.013 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.769 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 22.2 mt-10 -122.85 -83.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 110.552 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.769 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.5 69.5 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.894 0.944 . . . . 0.0 110.44 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.34 141.38 41.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 110.287 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 78.6 20.68 70.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.5 m -124.99 147.88 48.71 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -1.041 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.703 ' CE1' ' CZ ' ' A' ' 17' ' ' PHE . 13.0 p90 -122.42 145.71 48.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.542 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.651 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.03 159.47 43.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.466 -0.772 . . . . 0.0 109.964 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.546 HG23 ' CD2' ' A' ' 12' ' ' LEU . 3.1 tt -114.79 143.74 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.283 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.1 tpm_? -129.71 132.04 46.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' A' ' 42' ' ' ARG . 1.9 t0 -77.09 103.95 7.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' N ' ' A' ' 24' ' ' GLY . 64.2 m -166.69 -155.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 67.54 29.68 7.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.2 -153.89 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' A' ' 48' ' ' ARG . 29.9 mt-30 -85.41 -12.94 50.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.359 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 2.8 mtm180 170.68 -27.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.513 ' NE2' ' CE1' ' A' ' 2' ' ' TYR . 35.4 m80 -103.85 -147.59 0.39 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.544 ' CA ' HG22 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 59.95 108.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.099 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' A' ' 51' ' ' PHE . 14.6 p90 -115.88 143.5 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 64' ' ' LEU . 93.4 m -126.08 155.29 41.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.653 ' CD2' ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -130.84 128.43 40.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.519 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -139.26 154.09 47.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.45 -0.781 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.592 ' CG1' ' CB ' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -135.17 174.22 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD2' ' CA ' ' A' ' 32' ' ' SER . 6.7 tttt -111.03 139.24 46.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.171 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.557 ' HB ' ' CD1' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -131.97 -142.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 110.163 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 59' ' ' SER . 5.4 tt0 -46.09 -27.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.066 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER 163.46 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.522 -0.736 . . . . 0.0 109.77 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 80.5 1.53 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 HG21 ' HG3' ' A' ' 56' ' ' LYS . 13.3 p -94.49 108.88 20.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 0.0 109.872 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -137.11 172.79 12.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' N ' ' ND2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -140.16 155.33 47.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.618 ' CD1' HG21 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -138.31 129.94 27.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 110.655 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -80.22 156.35 26.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.612 HG12 ' CD2' ' A' ' 73' ' ' PHE . 6.8 tp -76.77 140.54 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 110.413 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.8 OUTLIER -91.81 117.77 30.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 42.0 t -98.93 117.15 32.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.02 102.95 14.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.861 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.34 -81.37 0.59 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 87' ' ' ARG . . . -141.45 6.79 2.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.4 OUTLIER -104.02 163.61 12.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 110.299 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.612 ' CD2' HG12 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.42 141.33 43.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.404 -0.81 . . . . 0.0 110.202 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 67' ' ' GLN . 4.0 p -155.41 139.99 16.94 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.935 . . . . 0.0 110.753 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt -128.33 57.69 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 62.56 -149.97 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.081 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 62.91 -171.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.176 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 77' ' ' SER . 0.5 OUTLIER -89.8 121.62 68.8 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 0.0 110.201 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.03 59.26 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.965 1.508 . . . . 0.0 110.585 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.34 20.01 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.14 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 82' ' ' THR . 12.4 m -68.46 -5.73 20.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 81' ' ' SER . 33.5 m 59.42 13.41 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.31 92.09 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.602 ' HD2' ' CE1' ' A' ' 88' ' ' PHE . 44.8 Cg_endo -73.68 -81.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.002 1.528 . . . . 0.0 110.479 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.595 ' CG2' ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -110.71 170.22 5.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.083 -1.01 . . . . 0.0 109.547 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.595 ' HD2' ' CG2' ' A' ' 85' ' ' VAL . 41.3 Cg_endo -68.46 132.67 26.07 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.734 1.387 . . . . 0.0 109.66 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 31.7 mtm180 53.57 39.42 30.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 109.316 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.602 ' CE1' ' HD2' ' A' ' 84' ' ' PRO . 9.7 p90 -77.21 164.99 25.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 110.493 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 32.5 p-10 -83.91 110.65 18.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' PHE . 4.4 t -88.73 -18.79 27.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.682 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.58 HG13 ' CZ ' ' A' ' 51' ' ' PHE . 1.5 t -49.64 -25.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.025 -1.047 . . . . 0.0 109.925 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.556 ' O ' ' CG2' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -57.58 -47.35 82.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.999 -1.063 . . . . 0.0 108.899 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HG3' ' OG ' ' A' ' 81' ' ' SER . 26.0 mmtt -68.44 -34.06 75.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 108.714 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.596 ' CD1' ' CB ' ' A' ' 75' ' ' LEU . 19.6 mt -59.82 -33.13 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.201 0.524 . . . . 0.0 110.297 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.692 ' O ' ' N ' ' A' ' 99' ' ' MET . 3.3 m -53.19 -36.43 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.5 OUTLIER -53.68 -52.71 59.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.584 -1.322 . . . . 0.0 108.906 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 19.9 t60 -79.58 -53.12 7.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -0.865 . . . . 0.0 109.692 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.653 ' CD2' ' CD2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.02 -22.25 65.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.726 -0.609 . . . . 0.0 110.344 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.692 ' N ' ' O ' ' A' ' 95' ' ' VAL . 2.3 mtp -137.03 -176.39 0.57 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.104 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.58 ' HD3' ' CZ ' ' A' ' 39' ' ' PHE . 46.5 Cg_endo -74.38 136.88 22.42 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.663 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 42.1 Cg_endo -72.32 -29.79 13.57 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.972 1.512 . . . . 0.0 112.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.663 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 47.6 Cg_endo -73.74 78.6 2.41 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.797 0.893 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.95 -159.59 0.13 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -176.44 86.11 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.246 -1.149 . . . . 0.0 110.286 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 107' ' ' PHE . 46.1 Cg_endo -73.05 55.03 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.997 1.525 . . . . 0.0 110.35 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.91 52.31 9.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.865 . . . . 0.0 110.176 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 107' ' ' PHE . 1.8 p90 -134.2 128.76 34.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.271 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p -59.13 -163.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.54 ' C ' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -141.29 86.83 10.94 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.326 -0.859 . . . . 0.0 110.221 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.663 ' HG2' ' HD3' ' A' ' 111' ' ' PRO . 41.7 Cg_endo -72.18 -29.75 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.983 1.517 . . . . 0.0 112.257 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.663 ' HD3' ' HG2' ' A' ' 110' ' ' PRO . 47.7 Cg_endo -74.54 130.64 13.98 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 122.881 0.937 . . . . 0.0 110.387 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.402 ' O ' ' HD3' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -83.65 -86.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.162 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 110.75 2.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 112' ' ' THR . 45.2 Cg_endo -72.71 64.76 3.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.975 1.513 . . . . 0.0 110.44 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -130.88 91.1 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.55 45.21 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 110.273 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -146.22 -37.75 0.24 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.887 . . . . 0.0 110.153 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.492 ' CG1' ' OE1' ' A' ' 120' ' ' GLU . 11.5 t 60.29 80.08 0.27 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.08 54.61 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.029 1.542 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 118' ' ' VAL . 14.1 pt-20 -103.7 -175.41 2.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.8 75.48 0.65 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.184 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 112.71 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.995 1.524 . . . . 0.0 110.316 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 125' ' ' GLN . 45.6 Cg_endo -72.94 65.62 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.991 1.521 . . . . 0.0 110.413 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 123' ' ' PRO . . . 55.79 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.958 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -98.68 110.62 23.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -125.29 178.71 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.136 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.44 ' HG ' ' HD2' ' A' ' 128' ' ' PRO . 8.4 tt -131.0 130.39 22.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.44 ' HD2' ' HG ' ' A' ' 127' ' ' LEU . 46.7 Cg_endo -73.1 -52.46 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.942 1.496 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.62 173.31 13.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -140.47 -85.59 0.21 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -1.142 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -86.88 114.83 60.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.89 -163.04 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.072 1.564 . . . . 0.0 110.474 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.13 36.15 1.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.21 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.577 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 8.5 mtp180 -152.38 150.41 29.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.625 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . 162.49 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 109.874 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.784 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -106.73 125.52 51.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.837 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 14.5 p90 -155.04 167.63 29.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.73 -1.231 . . . . 0.0 111.108 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.532 HG21 ' CB ' ' B' ' 165' ' ' SER . 3.0 mp -101.93 149.07 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 110.933 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.713 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.9 m-85 -99.15 133.08 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 110.985 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER -89.91 -162.77 0.92 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.657 -0.652 . . . . 0.0 110.004 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -43.04 -45.93 6.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.0 18.31 0.23 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -120.34 123.92 44.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.18 . . . . 0.0 110.403 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 23.5 mtpt -75.73 105.33 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.035 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -91.83 110.9 46.83 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.837 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -76.47 128.99 10.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.143 1.602 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.597 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.8 mm? -124.63 123.16 39.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.289 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 148' ' ' VAL . 7.7 p -102.53 117.44 47.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.67 -1.269 . . . . 0.0 110.297 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.667 ' CD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.9 pp -108.65 132.29 54.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.875 . . . . 0.0 110.047 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 100' ' ' PRO . 4.2 p -169.9 27.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.026 -1.046 . . . . 0.0 110.73 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.573 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -113.58 124.84 30.48 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 109.943 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 46.6 Cg_endo -73.76 129.82 13.95 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.988 1.52 . . . . 0.0 110.703 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.521 HD21 ' CB ' ' A' ' 40' ' ' LEU . 36.7 tp -91.92 128.57 37.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.4 OUTLIER 59.97 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.105 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 153' ' ' LEU . 2.6 m 43.3 -93.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 110.253 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 154' ' ' SER . 5.9 t-20 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 7.3 t -122.75 165.55 16.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -167.39 -177.46 3.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.202 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.59 -157.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.417 ' CG2' ' O ' ' B' ' 161' ' ' THR . 93.9 m -94.5 30.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.169 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.612 HG22 ' HA3' ' A' ' 25' ' ' GLY . 40.5 t -131.09 59.89 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.543 ' O ' ' CD1' ' B' ' 164' ' ' PTR . 3.6 pm0 -58.6 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.779 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.543 ' CD1' ' O ' ' B' ' 163' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.54 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 4.7 t -134.09 96.25 3.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.857 . . . . 0.0 109.955 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.536 ' C ' ' O ' ' B' ' 165' ' ' SER . 46.3 p -30.34 123.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.568 -0.707 . . . . 0.0 110.44 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.677 ' CG1' ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -92.53 84.16 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 110.268 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.765 ' CG2' ' CD2' ' A' ' 137' ' ' TYR . 32.8 t 59.1 138.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' B' ' 170' ' ' SER . 16.0 m170 -102.26 -67.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' B' ' 169' ' ' HIS . 0.2 OUTLIER 173.16 123.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.259 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.479 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 29.8 p90 -61.19 -35.86 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -55.0 -37.39 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.2 mt -60.9 -47.34 86.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.574 HG12 ' CE1' ' A' ' 51' ' ' PHE . 55.5 t -70.38 -42.72 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.746 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -58.78 -50.73 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.954 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.83 -41.87 87.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.93 -41.49 98.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.817 . . . . 0.0 109.659 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 2.9 t -56.97 -39.53 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.147 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -48.11 75.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -78.18 -38.94 42.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.14 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -65.3 -31.9 73.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.316 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.473 ' HG3' HG11 ' A' ' 9' ' ' VAL . 26.7 mt-30 -66.93 -39.86 87.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -34.28 71.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.262 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 p -72.02 -37.78 69.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.04 -5.18 71.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.589 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 9.0 t80 -93.54 6.04 49.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -1.111 . . . . 0.0 110.007 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.656 ' CZ ' ' HB2' ' A' ' 20' ' ' SER . 2.2 t80 -90.92 131.9 36.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.621 ' CG ' HD13 ' A' ' 40' ' ' LEU . 29.1 m95 -124.15 104.18 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 111.146 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.656 ' HB2' ' CZ ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -122.44 17.73 10.53 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.873 0.845 . . . . 0.0 108.883 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.98 47.95 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.393 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -113.63 -157.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.889 -1.132 . . . . 0.0 109.974 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.599 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 1.2 p -95.96 176.1 6.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' CG ' ' A' ' 42' ' ' ARG . . . -52.83 -69.51 1.18 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.66 -40.94 13.77 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.087 -1.243 . . . . 0.0 110.94 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 4.6 tp10 -59.59 -28.12 66.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.721 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -77.95 -42.92 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.084 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.617 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -69.28 -44.97 70.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 111.277 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 HD12 ' ND2' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -70.32 -31.92 69.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.155 -0.966 . . . . 0.0 111.851 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 1.6 pp -55.43 -23.8 27.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.824 -1.173 . . . . 0.0 110.223 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 2.8 pp -78.47 -38.47 40.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.548 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 12.7 p -70.09 -32.71 70.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.85 -20.57 42.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.299 -0.876 . . . . 0.0 110.973 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.715 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 11.8 mm-40 -116.29 -75.08 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.9 -1.125 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.715 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 45.2 Cg_endo -71.64 72.58 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.302 1.159 . . . . 0.0 110.564 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -57.62 141.25 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.952 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.64 19.45 75.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -133.56 148.09 51.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -1.026 . . . . 0.0 109.928 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.679 ' CD1' ' HB3' ' A' ' 98' ' ' TYR . 21.9 p90 -121.84 159.44 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.937 . . . . 0.0 109.945 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.621 HD13 ' CG ' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -152.64 159.86 43.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 110.704 -178.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.649 HG12 ' OH ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -114.45 134.76 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.564 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 13.9 tpt180 -112.71 129.93 56.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.058 -1.026 . . . . 0.0 110.033 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.6 ' OD1' ' CG ' ' A' ' 51' ' ' PHE . 15.0 m-20 -98.59 138.1 36.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER 71.85 152.51 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.281 -0.887 . . . . 0.0 110.494 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.533 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 33.9 t -163.95 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.093 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -135.91 -138.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 110.182 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -86.04 -29.11 23.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.511 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -69.17 -31.29 69.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 9.1 t60 58.03 143.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HB3' ' O ' ' A' ' 49' ' ' HIS . 1.0 OUTLIER 171.01 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.603 ' CE2' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -115.81 139.88 49.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.36 -0.838 . . . . 0.0 109.88 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 16.1 p -123.12 146.63 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.97 -1.081 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.759 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -120.82 122.72 40.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 109.818 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.617 ' CB ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -143.52 155.94 44.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.726 -1.234 . . . . 0.0 112.812 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.558 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 5.3 p -143.66 174.48 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.166 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 2.1 ttpt -115.72 125.45 52.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.862 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.88 -162.62 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.985 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -79.77 -23.21 42.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -81.73 13.38 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.166 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.06 138.72 3.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.523 ' CG2' HD13 ' A' ' 29' ' ' LEU . 2.9 t -78.85 108.76 12.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -1.139 . . . . 0.0 109.951 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 54' ' ' SER . 6.9 mmtt -109.17 157.94 18.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.213 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.57 ' O ' ' CD2' ' B' ' 164' ' ' PTR . 1.7 t-20 -111.97 152.28 28.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.877 . . . . 0.0 110.028 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 52' ' ' THR . 15.1 mt -138.52 117.52 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 0.0 110.233 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -81.8 155.71 25.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 0.0 110.586 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -77.28 141.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 110.014 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.3 mt-30 -93.48 132.55 37.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' SER . 30.0 t -109.42 118.82 37.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' O ' ' OG ' ' A' ' 72' ' ' SER . 7.0 mm-40 -133.15 104.77 6.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.442 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.68 36.32 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.18 -0.01 55.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -103.75 163.3 12.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -1.127 . . . . 0.0 109.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.4 m-30 -110.87 148.06 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.539 ' CA ' ' SG ' ' A' ' 90' ' ' CYS . 19.5 m -144.43 138.59 27.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.808 . . . . 0.0 110.079 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 94' ' ' LEU . 10.0 tp -115.35 -3.46 12.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.553 ' CG ' ' HB3' ' B' ' 169' ' ' HIS . 2.8 mp0 -71.85 -145.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.133 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.532 ' CB ' HG21 ' B' ' 166' ' ' THR . 1.8 t -179.39 30.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.457 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . 1.3 m-20 -120.04 125.04 27.51 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.18 53.93 2.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.947 1.498 . . . . 0.0 110.432 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.457 ' HG3' ' HB3' ' A' ' 78' ' ' ASP . 15.0 mtp180 -87.46 19.01 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.143 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 80' ' ' ARG . 3.9 p 43.81 42.28 4.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 14.1 t -81.85 10.22 6.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' CG ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 61.96 -179.24 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 110.193 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.539 ' HD2' ' CG ' ' A' ' 83' ' ' GLN . 46.9 Cg_endo -72.84 -179.77 4.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.965 1.508 . . . . 0.0 110.38 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 85' ' ' VAL . 20.4 m -110.52 143.02 27.29 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 47.1 Cg_endo -72.88 138.39 28.54 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.011 1.532 . . . . 0.0 110.418 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.597 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 69.22 28.46 4.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.365 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 40.0 p90 35.82 45.42 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.603 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -72.31 110.11 6.51 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.02 -1.05 . . . . 0.0 109.909 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.584 ' O ' ' N ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -177.44 -75.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.625 -0.672 . . . . 0.0 110.044 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.565 HG12 ' CE2' ' A' ' 73' ' ' PHE . 8.6 m -54.88 -51.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.016 . . . . 0.0 109.696 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.512 ' O ' HG21 ' A' ' 95' ' ' VAL . 13.3 mt -63.41 -46.12 87.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 108.829 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -64.95 -29.42 70.35 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.576 0.703 . . . . 0.0 109.543 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -57.51 -34.55 69.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 110.739 -178.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG13 ' CD1' ' A' ' 12' ' ' LEU . 3.7 m -54.19 -39.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.928 -1.108 . . . . 0.0 108.825 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -68.62 -30.01 68.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 178.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.648 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -56.73 -38.82 72.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 110.276 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.759 ' CE1' ' HB2' ' A' ' 53' ' ' LEU . 36.3 m-85 -73.8 -0.65 16.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.602 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 178.52 110.47 0.16 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.035 -1.041 . . . . 0.0 110.471 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.83 138.53 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.905 1.476 . . . . 0.0 110.313 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.567 ' CD ' ' CE1' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.67 164.92 33.6 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.002 1.528 . . . . 0.0 110.428 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.88 169.5 21.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.985 1.519 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.51 -54.85 0.77 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 100.55 1.25 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.25 -1.147 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -53.46 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.12 1.59 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.2 -74.12 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.89 . . . . 0.0 110.245 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.434 ' O ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -72.02 124.31 24.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 m -88.63 81.4 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.942 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -110.82 147.41 36.42 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.96 137.03 26.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.016 1.535 . . . . 0.0 110.452 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.87 76.8 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.062 1.559 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.1 p -78.59 121.15 24.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -142.9 117.62 6.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.31 -44.42 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.381 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 p -63.07 153.75 33.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.3 t -98.96 30.44 3.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -46.75 -53.79 11.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.79 78.96 1.36 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 46.1 Cg_endo -72.78 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.066 1.561 . . . . 0.0 110.427 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER 65.89 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.836 . . . . 0.0 110.233 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 120' ' ' GLU . 22.8 tp60 -162.54 105.45 1.07 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.19 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.98 128.13 12.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.044 1.55 . . . . 0.0 110.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 124' ' ' ALA . 46.4 Cg_endo -73.4 54.18 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 123' ' ' PRO . . . 42.72 -154.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 8.3 mt-30 -93.01 -35.01 13.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 110.228 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 125' ' ' GLN . . . 66.68 50.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.521 ' N ' ' HD2' ' A' ' 128' ' ' PRO . 0.1 OUTLIER -67.86 -55.74 13.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 127' ' ' LEU . 45.5 Cg_endo -73.05 -89.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.923 1.486 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.01 -166.41 38.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 131' ' ' THR . 0.6 OUTLIER -59.17 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 130' ' ' SER . 25.2 p 42.96 88.19 0.11 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 172.97 14.26 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -98.45 77.48 2.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 2.8 ttt180 -120.8 101.59 7.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.0 110.222 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.551 ' O ' ' CG1' ' B' ' 168' ' ' VAL . . . 165.13 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.844 . . . . 0.0 109.997 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.904 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -102.59 124.86 48.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.018 . . . . 0.0 108.993 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.843 ' O ' ' HA ' ' B' ' 167' ' ' VAL . 6.7 p90 -156.02 166.34 33.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.804 -1.185 . . . . 0.0 111.016 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.537 ' CD1' HD23 ' A' ' 147' ' ' LEU . 5.6 mt -102.43 149.53 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.778 0.799 . . . . 0.0 111.377 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -97.79 133.46 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.639 0.733 . . . . 0.0 110.969 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -121.43 119.53 32.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.566 -0.709 . . . . 0.0 110.52 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 42.58 63.41 1.91 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.3 13.84 23.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 140' ' ' SER . 8.3 tp10 -109.97 121.73 45.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 18.2 mttt -79.4 105.65 10.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.833 . . . . 0.0 110.561 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.782 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.2 mp -97.22 109.67 50.71 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.781 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.59 129.38 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.139 1.599 . . . . 0.0 111.838 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.588 HD13 ' CG2' ' A' ' 145' ' ' ILE . 5.6 mp -124.28 134.96 53.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.493 -0.755 . . . . 0.0 109.87 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.93 118.41 53.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.683 ' CD1' ' CE1' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -76.06 157.83 32.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.87 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.4 -74.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 0.0 110.999 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 38' ' ' THR . 2.8 mtt180 -105.19 132.54 20.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.038 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.626 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 49.9 Cg_endo -78.04 148.01 24.33 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.02 1.537 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -85.26 115.9 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.54 142.37 42.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.346 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.585 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -136.74 167.92 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 110.233 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.252 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.218 0.532 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 2.5 m -128.3 157.16 41.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -175.33 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 2.0 t -110.05 88.44 2.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.208 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER -105.5 159.79 15.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.513 ' O ' ' CG1' ' B' ' 162' ' ' VAL . 41.1 t 56.65 67.68 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.394 -0.816 . . . . 0.0 110.319 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 5.2 mt-10 -88.48 154.45 20.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.57 ' CD2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.43 ' C ' HD21 ' A' ' 64' ' ' LEU . 6.9 t -144.54 -96.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.558 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.2 t -178.32 147.41 0.42 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.0 t -86.03 145.38 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.758 HG12 ' CD2' ' A' ' 137' ' ' TYR . 7.7 p -54.5 162.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.553 ' HB3' ' CG ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -101.64 -148.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.327 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.476 ' N ' ' CG ' ' B' ' 169' ' ' HIS . 30.0 m -124.46 -68.43 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 110.195 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 5.1 mt-10 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.237 0.542 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 4.8 t80 -66.8 -51.51 54.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.219 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -67.3 -40.8 86.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' A' ' 90' ' ' CYS . 3.0 mt -56.99 -45.89 82.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.158 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 HG13 HG11 ' A' ' 9' ' ' VAL . 17.0 t -71.97 -47.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.496 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 81.0 t -58.75 -32.77 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.358 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -70.88 -38.68 73.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -76.14 -44.61 37.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.485 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 10' ' ' ARG . 24.5 m -57.62 -39.81 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.323 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 mmt180 -55.75 -44.44 77.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 109.82 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.09 -41.32 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.921 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.88 -41.93 95.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.543 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 19.6 mt-30 -67.75 -35.27 78.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -69.7 -49.57 52.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -58.53 -28.75 65.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.23 15.84 29.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CD2' ' HG ' ' A' ' 153' ' ' LEU . 4.0 m-85 -101.85 -0.94 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.144 . . . . 0.0 110.13 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.543 ' CD2' ' HG3' ' A' ' 13' ' ' GLN . 4.3 t80 -90.77 136.05 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.639 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.532 ' HB3' ' NE ' ' A' ' 42' ' ' ARG . 45.9 m95 -117.35 148.07 42.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 109.651 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -150.66 108.18 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 110.444 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 176.16 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.498 HG22 ' CD ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -119.42 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 110.421 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.529 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -85.61 176.14 8.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.338 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.7 -69.38 1.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.573 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -77.64 -36.04 34.52 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 3.1 tt0 -59.66 -24.57 64.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 0.0 109.603 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.6 ' CB ' ' HD3' ' A' ' 42' ' ' ARG . . . -74.35 -46.47 40.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.474 -0.766 . . . . 0.0 110.364 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.604 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -67.96 -36.68 80.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.553 HD13 ' ND2' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -57.71 -32.31 67.27 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.004 -1.06 . . . . 0.0 110.282 -178.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 1.2 pp -56.39 -23.88 40.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 108.765 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.665 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 1.7 pp -68.06 -33.67 75.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.532 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 m -69.56 -33.03 72.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.758 . . . . 0.0 109.777 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.01 41.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 109.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.788 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 45.1 mm-40 -125.93 -86.87 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.788 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.4 Cg_endo -74.46 68.57 5.25 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 122.831 0.911 . . . . 0.0 110.267 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 141.47 48.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 0.0 110.64 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.27 18.65 66.34 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -131.28 148.21 52.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.482 -1.01 . . . . 0.0 110.103 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' CE2' ' HG ' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -121.72 138.74 54.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 110.068 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.56 ' HA ' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -126.13 161.09 28.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.45 -0.781 . . . . 0.0 110.286 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -113.12 128.69 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.108 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -129.14 136.51 50.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.831 . . . . 0.0 109.655 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 2.3 t0 -73.77 127.57 33.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 45' ' ' SER . 85.8 p -117.05 -177.85 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.299 -0.876 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 4.2 t 42.51 65.23 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 66.44 135.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.891 . . . . 0.0 110.07 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ARG . 7.4 pt20 -66.29 -7.88 21.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -42.37 -47.81 4.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.246 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER 177.74 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 18.4 t80 55.04 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.597 ' CE2' HG12 ' A' ' 91' ' ' VAL . 7.3 p90 -126.24 148.79 49.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.034 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 64' ' ' LEU . 3.3 m -126.42 155.03 42.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.663 ' CD2' ' CG ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -126.93 136.52 52.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.603 ' OG ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -127.71 154.29 45.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 109.55 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.584 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 6.6 m -118.02 174.36 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.563 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 0.1 OUTLIER -103.91 138.98 39.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.39 -0.819 . . . . 0.0 110.28 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.1 m -127.32 158.14 38.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 57' ' ' THR . 43.9 mt-30 -38.92 -28.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.0 t -173.55 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.2 62.4 0.46 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.95 108.94 12.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -1.194 . . . . 0.0 109.514 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -137.46 178.0 7.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 0.0 110.67 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.556 ' CA ' ' HB3' ' A' ' 54' ' ' SER . 32.5 p-10 -137.56 156.17 48.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.491 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' O ' ' OH ' ' A' ' 98' ' ' TYR . 34.5 mt -131.04 152.19 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.11 156.79 18.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 110.178 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.573 HG22 ' CE2' ' A' ' 73' ' ' PHE . 3.5 tp -76.76 134.75 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.96 151.04 20.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.8 t -116.72 116.92 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.6 mm-40 -107.41 102.79 12.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.009 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.38 -79.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -143.7 45.67 0.87 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.458 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 1.2 t -142.92 163.03 33.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -1.155 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.573 ' CE2' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.14 126.8 32.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 109.823 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 66' ' ' ILE . 4.1 p -155.24 146.03 22.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.018 . . . . 0.0 110.435 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -82.9 -9.84 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.001 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -141.91 -135.13 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.469 ' N ' ' CG ' ' A' ' 76' ' ' GLN . 88.9 p -151.17 64.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 32.8 p-10 -119.61 115.0 34.04 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.124 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.13 52.54 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.008 1.531 . . . . 0.0 110.705 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' SER . 22.4 mmm180 -90.11 20.13 4.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -52.1 -172.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.823 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -112.11 18.28 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.302 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.823 ' CB ' ' O ' ' A' ' 82' ' ' THR . 9.8 tt0 113.54 -28.8 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 122.132 -0.355 . . . . 0.0 111.635 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 45.5 Cg_endo -73.41 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.047 1.025 . . . . 0.0 110.61 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.5 OUTLIER -92.82 168.49 12.28 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 0.0 109.616 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 88' ' ' PHE . 42.9 Cg_endo -70.06 132.56 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.912 1.48 . . . . 0.0 109.874 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.585 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.2 mtt-85 60.8 -75.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.846 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 163.83 121.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.322 -0.862 . . . . 0.0 109.631 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.658 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 11.3 t70 -84.72 109.26 17.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 110.052 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.658 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.8 OUTLIER 151.75 134.5 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.037 0.446 . . . . 0.0 109.9 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 HG12 ' CE2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -49.71 -25.4 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.348 179.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -56.47 -35.37 67.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.485 -0.759 . . . . 0.0 110.154 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -58.25 -38.57 77.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.266 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.16 -35.14 77.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.418 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 93.4 t -55.37 -37.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.749 . . . . 0.0 110.404 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.09 -45.51 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.58 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.425 ' CD2' HG13 ' B' ' 167' ' ' VAL . 1.5 t60 -78.12 -36.74 47.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.84 . . . . 0.0 109.533 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.663 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -69.32 -12.15 61.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 12.5 ttt -177.77 79.12 0.24 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.27 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.45 166.86 28.76 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.004 1.529 . . . . 0.0 110.322 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HG2' ' HG2' ' A' ' 132' ' ' PRO . 45.6 Cg_endo -72.61 116.82 4.86 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.039 1.547 . . . . 0.0 110.424 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.84 -174.99 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.925 1.487 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.95 60.77 0.39 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.545 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.63 -58.33 7.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.247 -1.149 . . . . 0.0 110.168 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 46.3 Cg_endo -73.25 165.92 31.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.459 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.507 ' C ' ' CG ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -66.87 -159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.196 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.507 ' CG ' ' C ' ' A' ' 106' ' ' SER . 39.3 m-85 -150.49 174.29 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.94 52.09 1.95 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.22 170.43 9.25 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.195 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.03 155.25 52.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.981 1.516 . . . . 0.0 110.438 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 112' ' ' THR . 46.1 Cg_endo -73.01 156.96 51.75 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.438 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 111' ' ' PRO . 7.6 p 43.26 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.21 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -107.06 137.07 19.43 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.243 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.9 -159.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.0 1.526 . . . . 0.0 110.471 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 116' ' ' SER . 11.1 m -152.3 109.55 3.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -42.98 133.13 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.893 . . . . 0.0 110.221 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.538 ' O ' ' CG2' ' A' ' 118' ' ' VAL . 2.6 mm-40 -163.2 -36.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.559 ' CB ' ' CD ' ' A' ' 119' ' ' PRO . 2.5 t -165.91 -61.45 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 118' ' ' VAL . 45.5 Cg_endo -71.49 -2.8 11.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.719 1.378 . . . . 0.0 110.465 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' CG ' ' A' ' 121' ' ' GLN . 4.3 mt-10 -123.15 -167.76 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.897 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.536 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 176.18 -58.14 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 45.9 Cg_endo -73.07 136.38 24.62 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.6 -49.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.979 1.515 . . . . 0.0 110.464 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 125' ' ' GLN . . . 175.63 -29.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 13.3 mt-30 59.07 -147.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.297 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 125' ' ' GLN . . . -42.54 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.48 132.46 92.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.4 161.5 42.41 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.059 1.557 . . . . 0.0 110.396 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.95 -31.12 7.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.469 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 0.8 OUTLIER -74.0 133.61 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -1.148 . . . . 0.0 110.223 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 130' ' ' SER . 72.9 p -42.73 102.32 0.27 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.248 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 130' ' ' SER . 46.4 Cg_endo -73.02 107.29 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.026 1.54 . . . . 0.0 110.418 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.04 81.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mmt-85 -76.69 -146.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.908 . . . . 0.0 110.213 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.629 ' CB ' HG21 ' B' ' 168' ' ' VAL . . . -160.89 132.85 5.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.667 ' HA ' ' CG1' ' B' ' 167' ' ' VAL . 1.5 t80 -119.42 123.53 44.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.806 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 3.8 p90 -155.23 166.74 32.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.857 -1.152 . . . . 0.0 111.285 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.413 ' H ' ' CD2' ' A' ' 147' ' ' LEU . 3.0 mt -102.44 149.11 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.388 -0.82 . . . . 0.0 111.207 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.711 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 14.8 m-85 -98.72 133.19 43.39 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.692 0.758 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.457 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -94.88 -162.07 0.91 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.68 . . . . 0.0 110.134 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.37 60.7 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 101.6 2.46 53.12 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -119.97 121.92 40.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.63 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -80.74 105.33 11.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.485 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -82.77 109.13 14.82 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.638 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -74.93 129.42 12.38 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.193 1.628 . . . . 0.0 112.811 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.688 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.8 mm? -125.25 135.86 52.96 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 148' ' ' VAL . 13.0 p -97.43 117.15 41.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.265 -1.522 . . . . 0.0 110.428 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.62 ' HG ' ' CE2' ' A' ' 39' ' ' PHE . 9.5 tp -91.88 114.8 27.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 t -161.77 10.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.892 -1.13 . . . . 0.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 2.9 mtt85 -108.93 123.93 35.62 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.679 -1.263 . . . . 0.0 109.991 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 50.1 Cg_endo -78.65 148.35 22.84 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.98 1.516 . . . . 0.0 111.039 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.625 ' HG ' ' CD2' ' A' ' 17' ' ' PHE . 4.4 pp -83.73 135.63 34.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.914 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 153' ' ' LEU . 12.7 t 41.64 -89.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 110.36 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 153' ' ' LEU . 23.0 t -59.24 156.17 12.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 110.169 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.466 ' OXT' ' ND2' ' A' ' 156' ' ' ASN . 9.9 p-10 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.223 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' SER . . . . . 0.502 ' O ' ' N ' ' B' ' 159' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.303 0.573 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' B' ' 157' ' ' SER . 43.8 m 55.98 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 157' ' ' SER . . . -165.32 -161.12 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' B' ' 159' ' ' ALA . 16.2 t -177.06 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 160' ' ' SER . 4.7 t -42.04 155.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.532 ' CG2' ' ND2' ' A' ' 63' ' ' ASN . 17.4 m -78.97 150.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.468 ' C ' ' CD2' ' B' ' 164' ' ' PTR . 0.6 OUTLIER -75.97 177.46 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.532 ' CD2' ' N ' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.429 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -169.54 102.35 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.73 159.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.667 ' CG1' ' HA ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -113.47 170.61 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.664 ' C ' ' O ' ' B' ' 167' ' ' VAL . 46.8 t -6.28 115.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.195 0.521 . . . . 0.0 111.314 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.46 179.6 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 11.6 m -153.57 122.63 6.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.153 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.595 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.531 ' CA ' HD13 ' A' ' 4' ' ' LEU . 3.3 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 55.1 p90 -57.55 -36.04 71.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.9 tt0 -55.03 -37.98 67.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 88' ' ' PHE . 1.5 mt -58.87 -45.8 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.589 HG21 ' CD2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -71.16 -37.34 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.189 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 2' ' ' TYR . 94.9 t -58.02 -39.43 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.923 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -70.69 -34.67 72.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' CB ' HD12 ' A' ' 92' ' ' LEU . . . -76.27 -44.17 38.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.785 . . . . 0.0 110.119 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.596 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 47.3 t -57.4 -39.85 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.47 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 10.8 ttm180 -55.91 -45.46 78.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.947 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -38.61 43.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.862 . . . . 0.0 109.992 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.555 ' CD2' HG23 ' A' ' 41' ' ' ILE . 18.0 tp -71.0 -40.7 71.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 110.013 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.469 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 4.6 pt20 -68.12 -34.94 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.303 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -57.95 -27.92 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.54 -27.27 69.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.865 . . . . 0.0 110.168 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.3 25.11 24.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -130.11 7.83 5.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.041 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.583 ' CD2' HG22 ' A' ' 41' ' ' ILE . 4.3 t80 -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.665 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 17.2 m95 -121.1 148.56 44.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.416 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -151.41 24.83 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.02 8.97 20.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.661 -0.649 . . . . 0.0 110.924 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.637 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -116.35 -160.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.049 . . . . 0.0 109.925 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -97.31 176.16 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.319 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.58 -85.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' CA ' HG11 ' B' ' 162' ' ' VAL . . . -70.74 -31.63 67.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -59.09 -39.17 81.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.129 -1.218 . . . . 0.0 109.958 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.637 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -64.44 -47.03 80.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.627 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.706 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 m-80 -68.91 -43.66 74.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -0.94 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.503 ' N ' HD11 ' A' ' 29' ' ' LEU . 1.6 mp -70.53 -32.29 69.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 112.072 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' CD2' HG13 ' A' ' 22' ' ' VAL . 1.8 pp -55.17 -24.42 26.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.709 -1.244 . . . . 0.0 111.032 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.4 pp -77.56 -37.86 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 0.0 109.584 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.591 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 21.8 p -69.74 -32.57 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 0.0 110.28 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.65 43.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.615 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.731 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 5.3 mm-40 -115.76 -76.41 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.92 -1.112 . . . . 0.0 110.489 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.731 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.2 Cg_endo -72.69 70.37 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.286 1.151 . . . . 0.0 110.509 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 141.23 13.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 73.46 20.77 79.92 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 1.3 m -129.59 147.7 51.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -1.074 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.633 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 9.7 m-85 -122.9 158.46 30.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.382 -0.824 . . . . 0.0 109.454 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.665 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.38 160.57 43.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.008 -1.058 . . . . 0.0 111.195 -178.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.592 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -113.89 129.18 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.541 -0.724 . . . . 0.0 109.906 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -117.36 161.12 20.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.282 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.491 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 7.5 t70 -100.05 138.06 37.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 109.991 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' ASP . 53.1 p -44.97 170.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 t -89.01 -25.05 22.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -166.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -65.07 -26.26 68.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 50' ' ' PHE . 1.9 mtm-85 -176.8 -65.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 51.75 -89.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.248 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.577 ' CG ' HG22 ' A' ' 66' ' ' ILE . 12.2 p90 -163.8 -165.01 0.96 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.706 ' CE1' ' CG2' ' A' ' 91' ' ' VAL . 13.0 p90 -134.33 139.6 45.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 110.628 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.577 ' CG2' ' HA ' ' A' ' 65' ' ' ARG . 2.2 p -126.31 155.29 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.474 -0.767 . . . . 0.0 109.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.754 ' HG ' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -134.37 142.58 47.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.064 -1.023 . . . . 0.0 110.688 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.661 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 1.3 p -124.5 154.17 40.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.633 ' CG1' ' CD1' ' A' ' 39' ' ' PHE . 21.2 m -117.63 174.01 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.114 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' CG ' ' HB2' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.99 130.79 51.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.454 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 80.5 p -141.11 156.6 45.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.76 82.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.2 t -63.0 -10.86 15.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 124.07 153.64 8.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -78.91 140.47 38.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 54' ' ' SER . 69.6 mmtt -139.16 133.18 31.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.563 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 1.5 p-10 -111.91 128.85 56.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' B' ' 164' ' ' PTR . 2.9 mp -102.43 118.14 36.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.972 . . . . 0.0 110.252 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.577 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 0.1 OUTLIER -84.52 152.26 24.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 50' ' ' PHE . 4.5 tp -84.93 149.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -114.58 115.65 27.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.855 . . . . 0.0 110.504 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.564 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 27.5 p -92.04 123.15 35.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 14.9 tt0 -133.19 103.5 6.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.5 32.93 85.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.81 -11.67 69.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 82.9 p -94.74 143.1 26.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.989 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.616 ' CB ' ' SG ' ' A' ' 90' ' ' CYS . 3.4 m-30 -110.82 157.36 19.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.243 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -155.56 138.65 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.153 -0.967 . . . . 0.0 110.486 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.546 ' CD2' ' CD2' ' A' ' 94' ' ' LEU . 1.2 tp -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HA ' ' CG2' ' B' ' 166' ' ' THR . 3.1 mt-30 -113.48 94.28 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 t 44.75 -146.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -103.5 120.47 51.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.53 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 46.8 Cg_endo -73.36 59.86 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 80' ' ' ARG . 1.1 ttm-85 -70.32 -4.0 20.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.42 -64.66 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 83' ' ' GLN . 14.9 t -131.49 27.6 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 43.06 89.62 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.155 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.619 ' O ' ' C ' ' A' ' 85' ' ' VAL . 47.8 Cg_endo -74.06 1.41 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.037 1.546 . . . . 0.0 110.678 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.619 ' C ' ' O ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -22.61 -59.6 0.1 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 85' ' ' VAL . 44.3 Cg_endo -71.54 132.95 21.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.859 1.452 . . . . 0.0 109.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.621 ' O ' ' C ' ' A' ' 88' ' ' PHE . 5.6 mtp85 49.15 26.79 1.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.079 -1.013 . . . . 0.0 109.518 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.621 ' C ' ' O ' ' A' ' 87' ' ' ARG . 11.9 p90 -17.09 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.476 0.655 . . . . 0.0 111.585 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.484 ' HB3' ' HD3' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -96.87 110.81 23.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.009 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.641 ' O ' ' N ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -171.28 -88.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 0.0 110.454 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.706 ' CG2' ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -59.71 -51.19 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.051 -1.03 . . . . 0.0 109.469 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 8' ' ' ALA . 4.9 mp -66.36 -46.2 77.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 108.841 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 89' ' ' ASP . 32.4 ttpt -65.79 -29.22 69.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.784 0.802 . . . . 0.0 108.869 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.641 ' N ' ' O ' ' A' ' 90' ' ' CYS . 5.0 mt -57.48 -34.23 68.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 0.0 110.096 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -54.27 -38.66 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.879 -1.138 . . . . 0.0 108.686 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.478 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 7.7 m170 -68.64 -51.89 37.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 108.862 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -63.81 -36.95 85.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.358 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.754 ' CE1' ' HG ' ' A' ' 53' ' ' LEU . 3.7 m-30 -73.38 -9.16 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.642 -0.661 . . . . 0.0 110.013 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.51 ' HB3' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 171.28 160.33 0.23 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 110.2 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.94 160.83 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.009 1.531 . . . . 0.0 110.452 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.06 154.7 52.62 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.058 1.557 . . . . 0.0 110.422 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.9 136.42 25.09 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.02 1.537 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.05 -150.52 12.42 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 8.8 t -140.86 48.54 1.34 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.195 -1.179 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 104' ' ' THR . 46.7 Cg_endo -72.94 111.51 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.369 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 69.25 -57.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.204 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.5 OUTLIER 68.91 -65.88 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 26.4 t 179.04 34.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -94.26 114.05 62.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.92 111.35 3.25 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.048 1.552 . . . . 0.0 110.407 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 109' ' ' LEU . 46.0 Cg_endo -72.63 55.99 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.03 1.542 . . . . 0.0 110.435 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -82.37 -49.82 9.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 4.6 mt-10 -164.31 52.63 0.31 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.271 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 46.6 Cg_endo -72.96 157.69 50.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.042 1.549 . . . . 0.0 110.452 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 116' ' ' SER . 53.5 p -86.17 -21.62 27.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.227 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 117' ' ' GLU . 37.6 t -177.58 -138.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 116' ' ' SER . 2.0 tt0 67.8 -138.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 117' ' ' GLU . 16.0 m -41.89 146.42 0.62 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.89 156.83 52.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.89 1.468 . . . . 0.0 110.419 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 121' ' ' GLN . 66.6 tt0 -92.65 29.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.952 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' GLU . 34.9 tt0 57.96 122.6 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.35 -0.844 . . . . 0.0 110.313 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.81 128.65 13.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.89 1.468 . . . . 0.0 110.424 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.08 140.63 31.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.001 1.527 . . . . 0.0 110.418 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 125' ' ' GLN . . . -167.13 69.92 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 11.6 mm100 58.93 174.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.1 60.96 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.5 OUTLIER -175.68 71.54 0.27 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.148 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.69 -17.66 25.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.012 1.533 . . . . 0.0 110.505 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' SER . . . -148.5 -79.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER 61.69 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.206 -1.173 . . . . 0.0 110.161 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.578 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 54.4 m 47.64 47.76 5.0 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 131' ' ' THR . 47.2 Cg_endo -73.06 170.8 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.495 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -71.41 -24.32 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.442 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 1.2 ptm180 -109.44 120.9 43.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.137 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.559 ' O ' ' CG1' ' B' ' 168' ' ' VAL . . . 172.23 130.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.671 ' CD2' HG12 ' B' ' 167' ' ' VAL . 1.2 t80 -116.55 122.54 44.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.984 -1.072 . . . . 0.0 109.306 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.733 ' CB ' ' HA ' ' A' ' 146' ' ' PRO . 5.4 p90 -156.32 166.95 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.952 -1.092 . . . . 0.0 110.66 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.33 149.17 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.061 . . . . 0.0 111.356 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.71 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.7 m-30 -86.44 107.88 18.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.591 -0.693 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.594 ' CB ' ' CD1' ' A' ' 145' ' ' ILE . 23.0 t -55.78 84.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.018 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 66.9 -64.79 0.19 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -144.7 13.08 1.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 140' ' ' SER . 2.8 tt0 -120.45 123.43 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.093 . . . . 0.0 109.797 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -75.5 105.57 6.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -103.38 112.86 65.94 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.733 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.8 Cg_endo -72.79 127.47 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.76 1.4 . . . . 0.0 111.791 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.66 ' O ' ' O ' ' A' ' 136' ' ' TYR . 1.1 mp -126.42 135.24 51.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 15.0 m -97.88 116.58 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.187 -1.571 . . . . 0.0 109.945 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.619 HD12 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -109.5 123.34 49.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.7 m -158.61 61.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -134.37 124.92 17.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 46.4 Cg_endo -73.7 144.17 34.92 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.922 1.485 . . . . 0.0 110.472 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 1.3 tt -92.03 153.74 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.885 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 155' ' ' SER . 1.8 t 44.81 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER -107.84 173.25 6.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 152' ' ' PRO . 3.3 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.22 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.29 0.567 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 53.1 p -61.07 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.02 77.85 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.28 -62.69 1.4 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.469 ' O ' ' C ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER -131.71 164.89 24.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 110.163 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.572 HG11 ' CA ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -38.89 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.474 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 81.2 mt-10 -79.07 173.57 12.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.561 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' B' ' 164' ' ' PTR . 50.9 m -130.85 172.98 11.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.407 -0.808 . . . . 0.0 110.074 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -89.61 139.55 30.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.671 HG12 ' CD2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -91.77 106.92 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.067 -1.021 . . . . 0.0 109.829 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.667 ' CG1' ' CD2' ' A' ' 137' ' ' TYR . 1.3 m 50.03 -171.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.543 ' N ' ' CG2' ' B' ' 168' ' ' VAL . 0.3 OUTLIER 66.37 121.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' B' ' 169' ' ' HIS . 2.6 m 63.61 86.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.576 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.526 ' CG ' ' N ' ' A' ' 2' ' ' TYR . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.224 0.535 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 7.0 p90 -60.49 -37.17 80.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.18 -41.46 77.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.341 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 1.1 mt -67.44 -47.21 70.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 3.5 p -64.95 -48.36 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.757 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 3' ' ' GLN . 12.4 p -58.7 -43.99 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 109.984 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.9 m120 -59.06 -42.16 89.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.0 109.618 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' HG13 ' A' ' 91' ' ' VAL . . . -68.34 -44.17 75.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.806 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 49.1 t -57.53 -39.8 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.387 -0.821 . . . . 0.0 109.25 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 tpt180 -55.66 -49.0 74.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -34.26 49.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.806 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.588 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 tp -72.16 -44.15 63.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 110.097 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 4.9 pt20 -60.82 -33.91 73.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 25.7 tt0 -57.82 -18.98 25.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.426 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 59.1 m -55.99 -43.01 77.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.044 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.2 34.37 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.588 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 15.5 p90 -153.0 18.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.253 . . . . 0.0 110.56 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 3.0 t80 -90.84 119.86 31.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.756 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.664 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 31.6 m95 -72.69 148.12 45.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.631 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -62.15 -12.67 21.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.901 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 20' ' ' SER . . . 74.1 75.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 110.915 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.572 HG22 ' CB ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -46.42 -92.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 109.091 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.583 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -106.63 165.81 11.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 178.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.511 ' HA2' ' NH1' ' A' ' 42' ' ' ARG . . . -43.51 -81.16 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.614 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.26 -30.15 47.1 Favored Glycine 0 N--CA 1.491 2.349 0 O-C-N 121.41 -1.053 . . . . 0.0 110.705 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.583 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -58.22 -24.46 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.378 . . . . 0.0 110.955 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.572 ' CB ' HG22 ' A' ' 22' ' ' VAL . . . -77.63 -46.61 21.55 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 110.146 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.655 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.3 OUTLIER -70.42 -46.85 63.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 111.2 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.631 HD11 ' OD1' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -70.61 -29.98 66.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 112.069 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -52.96 -23.25 6.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.64 -1.288 . . . . 0.0 109.8 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD11 HD22 ' A' ' 40' ' ' LEU . 45.0 mt -64.05 -41.33 97.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.992 -1.068 . . . . 0.0 109.219 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.577 ' CB ' ' CG ' ' A' ' 56' ' ' LYS . 55.9 p -69.1 -31.6 70.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 -20.13 47.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.787 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 17.8 mm-40 -126.15 -81.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.901 -1.124 . . . . 0.0 110.607 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 55.4 Cg_endo -77.71 68.43 7.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 122.902 0.949 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.39 135.5 33.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.625 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 87.04 7.9 76.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.585 ' OG1' ' HB2' ' A' ' 35' ' ' PRO . 27.4 p -116.11 147.71 41.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -1.136 . . . . 0.0 110.608 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.597 ' CD2' HD21 ' A' ' 149' ' ' LEU . 7.2 p90 -122.3 147.3 46.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 0.0 110.374 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.664 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -147.21 160.24 42.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.481 -0.762 . . . . 0.0 109.548 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 1.4 tt -113.56 128.47 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 110.001 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 5.7 ppt_? -112.77 122.11 46.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 110.31 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.57 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.9 t70 -73.82 114.97 12.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -44.77 146.81 0.71 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.239 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -73.65 -52.9 11.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.54 135.89 8.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -67.24 -18.18 65.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -97.35 50.18 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.237 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.531 ' HB3' ' CB ' ' A' ' 44' ' ' SER . 7.6 m-70 -147.7 -160.86 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.582 ' CZ ' ' HG3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -143.6 -150.82 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.162 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.65 ' CZ ' ' CG2' ' A' ' 91' ' ' VAL . 25.6 p90 -115.56 142.79 46.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 110.104 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 2.4 m -126.28 143.5 51.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.765 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 7.2 tt -124.21 135.1 53.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.655 ' CB ' ' OD1' ' A' ' 28' ' ' ASN . 23.1 p -139.26 155.42 47.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.544 ' CG2' HD22 ' A' ' 149' ' ' LEU . 10.3 p -140.94 158.9 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 110.481 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.577 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.76 137.48 41.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' CD1' ' A' ' 147' ' ' LEU . 25.8 p -137.73 -74.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 59' ' ' SER . 2.3 mt-30 -147.43 -78.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.532 ' CB ' HG21 ' A' ' 145' ' ' ILE . 9.8 t -42.69 -53.17 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.32 47.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.521 ' CG2' HD12 ' A' ' 29' ' ' LEU . 5.5 m -99.56 141.02 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.17 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.9 145.86 51.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.25 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.538 ' O ' ' CD1' ' B' ' 164' ' ' PTR . 13.6 t-20 -111.13 132.34 54.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.776 ' HG ' ' CG2' ' B' ' 167' ' ' VAL . 0.4 OUTLIER -110.97 152.13 27.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.621 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.582 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -140.91 148.05 39.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.258 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.581 ' CD1' ' HB2' ' A' ' 90' ' ' CYS . 10.0 tp -76.83 128.29 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 2.7 tp-100 -96.54 151.1 19.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.216 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 1' ' ' GLU . 36.5 t -93.01 139.12 30.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -130.08 102.94 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 44.82 -111.19 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.73 28.11 15.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.552 ' OG ' ' CB ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -136.72 163.18 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 110.145 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.565 ' CZ ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -124.54 144.96 49.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.485 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 47.4 t -155.54 167.12 31.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.571 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.546 ' CD2' ' CD2' ' A' ' 94' ' ' LEU . 6.1 tp -107.42 -45.04 4.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.465 ' OE1' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.89 155.57 30.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.283 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -115.34 132.81 22.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.08 -3.07 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.935 1.492 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.437 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -56.43 -40.51 74.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.206 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 83' ' ' GLN . 79.0 p -162.96 -160.4 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.03 27.95 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HG3' ' OG ' ' A' ' 81' ' ' SER . 3.7 mt-30 -82.57 126.71 72.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.182 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.552 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 47.0 Cg_endo -73.35 -158.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 73' ' ' PHE . 31.3 m -109.52 148.81 38.85 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.202 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 45.7 Cg_endo -73.08 133.48 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.965 1.508 . . . . 0.0 110.493 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER 66.54 41.36 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.633 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 23.4 p90 34.54 50.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 0.0 110.835 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 74' ' ' SER . 91.5 m-20 -71.87 110.01 6.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.986 -1.071 . . . . 0.0 109.195 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 66' ' ' ILE . 7.1 p -148.31 -117.53 0.06 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.533 -0.729 . . . . 0.0 110.477 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -49.91 -45.56 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.168 -0.958 . . . . 0.0 110.046 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 7.4 mp -59.52 -47.1 86.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.045 . . . . 0.0 108.974 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -31.86 72.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -59.73 -35.03 73.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.697 -0.627 . . . . 0.0 110.261 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.483 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 62.9 t -54.5 -38.01 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.574 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.284 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.607 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -78.15 -50.51 11.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.932 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.765 ' CZ ' ' HB3' ' A' ' 53' ' ' LEU . 10.0 m-85 -63.79 -11.73 29.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 4.4 tpt 71.21 103.69 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.138 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 95' ' ' VAL . 46.4 Cg_endo -74.04 159.39 44.58 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.043 1.549 . . . . 0.0 110.374 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HB3' ' CB ' ' A' ' 152' ' ' PRO . 46.7 Cg_endo -73.16 151.38 49.26 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.16 1.61 . . . . 0.0 110.423 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.62 91.96 0.78 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.073 1.565 . . . . 0.0 110.472 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.42 -115.82 0.57 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -112.7 100.32 50.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.253 -1.145 . . . . 0.0 110.263 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 106' ' ' SER . 47.2 Cg_endo -73.0 -40.1 1.93 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.489 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 62.28 51.37 3.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -146.98 -52.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 0.2 OUTLIER 174.56 -44.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 110.11 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 108' ' ' SER . 0.7 OUTLIER -43.09 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 108' ' ' SER . 46.7 Cg_endo -73.54 114.87 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.962 1.506 . . . . 0.0 110.353 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' THR . 47.2 Cg_endo -72.64 -92.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 73.2 p 40.79 -139.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.08 161.19 53.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 115' ' ' SER . 45.2 Cg_endo -72.82 173.81 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.977 1.514 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' PRO . 12.8 p -42.98 135.14 3.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.222 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.43 149.61 46.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 mt-10 -67.32 -140.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 61.64 117.19 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 44.3 Cg_endo -73.04 -88.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.946 1.498 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 3.3 tt0 69.15 -67.96 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.62 124.52 0.91 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.206 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.07 119.26 5.94 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.894 1.47 . . . . 0.0 110.474 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 124' ' ' ALA . 46.5 Cg_endo -72.94 126.36 11.21 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.022 1.538 . . . . 0.0 110.473 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 123' ' ' PRO . . . 59.72 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.33 95.75 5.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.203 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 56.52 23.2 7.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.541 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 1.5 mt -132.24 50.03 5.28 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 127' ' ' LEU . 46.6 Cg_endo -73.0 55.98 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.06 1.558 . . . . 0.0 110.413 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.91 -174.82 45.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.3 162.95 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.262 -1.14 . . . . 0.0 110.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -43.71 110.4 0.95 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.31 53.71 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.532 . . . . 0.0 110.431 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.85 47.17 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.83 171.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.55 ' O ' ' CG2' ' B' ' 168' ' ' VAL . . . -171.83 143.98 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.684 ' CZ ' ' CG2' ' B' ' 167' ' ' VAL . 1.8 t80 -138.21 121.65 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.579 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.746 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 6.7 p90 -156.11 166.72 32.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.737 -1.227 . . . . 0.0 110.843 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.498 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.5 mt -102.14 149.61 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.289 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.699 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.6 m-85 -99.4 133.37 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.637 0.732 . . . . 0.0 111.007 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -88.31 54.23 3.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.526 -0.734 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.63 31.41 1.73 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.87 -29.56 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 140' ' ' SER . 6.1 mp0 -116.06 121.91 43.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.12 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.66 105.39 8.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -87.56 110.64 35.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.632 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 48.9 Cg_endo -75.72 128.12 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.026 1.54 . . . . 0.0 112.728 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.649 ' O ' ' O ' ' A' ' 136' ' ' TYR . 2.0 mm? -125.49 135.32 52.18 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.521 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 5.6 m -98.68 116.38 41.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.006 -1.684 . . . . 0.0 111.218 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 136' ' ' TYR . 1.6 mt -91.05 125.89 35.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.022 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.475 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 90.9 p -151.23 -24.39 0.21 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.774 -1.204 . . . . 0.0 111.985 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 38' ' ' THR . 47.5 mtp180 -85.85 124.5 70.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.627 -1.296 . . . . 0.0 110.328 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.514 ' CB ' ' HB3' ' A' ' 101' ' ' PRO . 49.5 Cg_endo -77.57 148.23 25.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.104 1.581 . . . . 0.0 110.397 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.642 ' CD2' ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.54 158.13 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.357 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.7 t -133.91 98.88 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -107.72 -30.81 8.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 155' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.213 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.218 0.532 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 6.3 t -81.99 -146.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.136 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.89 127.84 33.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.48 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.464 ' OG1' ' N ' ' B' ' 162' ' ' VAL . 4.4 t -176.19 -143.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.464 ' N ' ' OG1' ' B' ' 161' ' ' THR . 13.1 m -117.7 159.48 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.246 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -152.85 175.75 12.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.538 ' CD1' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.76 -168.16 2.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.522 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -94.04 151.43 19.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.291 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.776 ' CG2' ' HG ' ' A' ' 64' ' ' LEU . 1.2 t -87.59 -160.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.67 ' CG1' ' CD2' ' A' ' 137' ' ' TYR . 21.4 m -42.36 153.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.424 ' O ' ' C ' ' B' ' 170' ' ' SER . 16.7 t-160 -150.67 82.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.424 ' C ' ' O ' ' B' ' 169' ' ' HIS . 4.8 p 42.42 -153.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.294 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.215 0.531 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.478 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.18 -35.74 79.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 43.4 tp60 -54.79 -33.85 61.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.168 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.635 ' CD2' ' CD1' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -57.0 -47.02 81.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG21 ' CE2' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -59.89 -44.41 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 73.7 t -58.73 -51.14 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 48.3 m-20 -59.83 -46.08 90.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -63.08 -43.51 98.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -0.801 . . . . 0.0 109.655 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 25.6 t -57.29 -39.31 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.72 . . . . 0.0 109.311 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.7 tpt180 -55.42 -40.92 72.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.445 -0.784 . . . . 0.0 109.887 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -42.15 32.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD22 HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.0 -38.87 69.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 2.6 pt20 -65.77 -33.97 77.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.84 -18.96 25.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -56.6 -43.49 80.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 110.081 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.97 30.9 2.02 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.662 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 15' ' ' SER . 1.6 p90 -159.93 33.79 0.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.43 . . . . 0.0 111.134 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.59 ' CD2' HG21 ' A' ' 41' ' ' ILE . 1.7 t80 -90.89 134.66 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.725 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.663 ' CG ' HD11 ' A' ' 40' ' ' LEU . 24.8 m95 -124.5 148.55 47.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.13 23.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.01 0.15 13.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.546 -0.721 . . . . 0.0 111.004 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -107.24 -158.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.9 -1.125 . . . . 0.0 109.721 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -101.56 170.76 7.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.093 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.75 -79.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA3' ' CG1' ' B' ' 162' ' ' VAL . . . -79.32 -30.92 43.75 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.4 tp10 -58.27 -37.78 75.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -1.225 . . . . 0.0 110.069 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.47 -50.69 71.76 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.031 -1.043 . . . . 0.0 108.825 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.525 HD21 ' HA2' ' A' ' 25' ' ' GLY . 8.4 m-80 -69.79 -49.04 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HA ' ' CD ' ' A' ' 56' ' ' LYS . 1.6 mp -59.77 -31.76 69.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 111.237 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.25 -22.49 11.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.998 -1.064 . . . . 0.0 109.555 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.713 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 80.4 mt -60.13 -35.3 74.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.087 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.66 ' HB2' ' CD ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -69.56 -32.48 71.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.112 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.2 -20.8 43.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.96 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.754 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.6 mt-10 -131.07 -84.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.515 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.754 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.1 Cg_endo -76.77 68.31 7.17 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 122.77 0.879 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.27 141.74 14.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -0.978 . . . . 0.0 110.717 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' ' CD ' ' A' ' 151' ' ' ARG . . . 72.32 25.66 73.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.56 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 79.1 m -119.82 149.19 42.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.933 . . . . 0.0 110.692 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -120.72 138.81 53.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.663 HD11 ' CG ' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -134.08 160.53 37.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.442 -0.786 . . . . 0.0 110.959 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.59 HG21 ' CD2' ' A' ' 18' ' ' TYR . 0.3 OUTLIER -114.07 134.09 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 1.1 ttp-105 -129.32 146.35 51.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.327 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 8.2 t0 -99.08 138.0 36.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.471 ' HB3' ' CB ' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -45.27 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 1.2 t -52.43 -86.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' N ' ' OG ' ' A' ' 45' ' ' SER . 2.3 t0 -43.3 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -14.22 39.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.19 21.5 2.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 21.6 m170 -116.26 170.92 8.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.549 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 27.6 p90 -89.78 -177.77 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.197 -0.939 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.643 ' CE2' HG13 ' A' ' 91' ' ' VAL . 6.8 p90 -116.0 155.72 27.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.53 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 64' ' ' LEU . 3.2 m -126.16 154.65 42.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.641 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -135.0 130.86 36.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.54 ' CB ' ' OD1' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -136.43 153.9 50.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.583 -0.698 . . . . 0.0 109.665 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.617 ' CG1' ' OH ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -127.59 171.18 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 110.447 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.66 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -119.38 135.42 54.74 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 0.0 110.1 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 58' ' ' GLN . 4.4 t -127.51 61.34 1.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER 67.37 -57.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -145.84 47.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.208 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' HA3' ' CG2' ' A' ' 57' ' ' THR . . . -153.57 74.42 0.24 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.526 HG23 ' CD1' ' A' ' 29' ' ' LEU . 2.7 m -96.17 108.87 21.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -128.97 155.29 45.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.54 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 4.0 m-20 -140.07 149.22 42.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' B' ' 167' ' ' VAL . 17.4 mt -134.87 147.17 49.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' HG2' ' CG ' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -108.38 153.62 23.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.313 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.58 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 20.0 mm -89.06 145.59 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.43 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 66' ' ' ILE . 51.5 mm-40 -122.09 132.96 54.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 72' ' ' SER . 28.1 p -88.61 125.24 34.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.11 112.27 11.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 53.5 65.82 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.36 18.02 9.22 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.49 ' CB ' ' HD3' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -122.29 163.15 20.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -1.174 . . . . 0.0 109.882 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 4' ' ' LEU . 5.3 m-85 -131.94 139.8 48.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 110.47 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.551 ' CA ' HD11 ' A' ' 94' ' ' LEU . 8.3 t -147.23 138.98 24.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.0 110.101 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.652 ' CD2' ' CE1' ' A' ' 97' ' ' HIS . 0.5 OUTLIER -83.2 71.45 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' B' ' 164' ' ' PTR . 8.2 mm-40 56.53 21.01 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 110.261 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.445 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 57.8 m -84.71 170.87 12.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.197 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.39 149.39 38.21 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.196 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 54.61 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.055 1.555 . . . . 0.0 110.444 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 81' ' ' SER . 3.0 mtt180 -62.77 -47.94 81.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER 65.18 66.64 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.17 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' GLN . 9.7 t -92.41 -12.76 31.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.586 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -175.61 -60.84 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 46.2 Cg_endo -72.57 -170.16 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.887 1.467 . . . . 0.0 110.419 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.547 ' CG1' ' HD2' ' A' ' 86' ' ' PRO . 54.6 t -97.31 148.6 34.65 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 43.4 Cg_endo -70.04 132.97 23.97 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.939 1.494 . . . . 0.0 110.088 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 4.3 mtt180 75.25 -48.78 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.64 ' CG ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER 74.38 -174.84 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.431 -0.793 . . . . 0.0 110.536 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.687 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 1.5 t70 -101.96 113.94 27.61 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.449 -0.782 . . . . 0.0 109.78 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.687 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 27.8 m 89.6 123.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.709 0.766 . . . . 0.0 110.362 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.643 HG13 ' CE2' ' A' ' 51' ' ' PHE . 2.8 p -48.45 -20.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.655 0.74 . . . . 0.0 109.385 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -54.03 -35.07 61.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 110.932 -178.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.64 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 1.5 tptt -58.28 -35.65 72.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.54 -1.35 . . . . 0.0 109.06 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.553 ' O ' ' ND1' ' A' ' 97' ' ' HIS . 63.1 mt -62.86 -34.86 78.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 96' ' ' HIS . 0.5 OUTLIER -54.6 -37.07 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.53 ' N ' HG11 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -53.76 -31.54 48.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.02 . . . . 0.0 109.121 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.652 ' CE1' ' CD2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -65.86 -35.94 82.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 0.0 109.411 179.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.641 ' CE2' ' HB3' ' A' ' 53' ' ' LEU . 1.9 m-85 -63.05 -10.54 14.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.612 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 78.69 78.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.703 -0.623 . . . . 0.0 110.211 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.463 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 45.5 Cg_endo -72.32 173.97 12.24 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.976 1.514 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 100' ' ' PRO . 46.1 Cg_endo -72.75 122.86 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.456 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.57 135.13 21.5 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.998 1.525 . . . . 0.0 110.364 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.5 141.61 3.84 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -45.14 118.85 3.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 106' ' ' SER . 46.3 Cg_endo -72.93 -55.02 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.91 1.479 . . . . 0.0 110.416 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER 172.96 -62.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 106' ' ' SER . 1.9 m-85 60.5 126.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 p -49.98 -28.49 6.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.153 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.69 126.81 30.3 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 140.76 31.57 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.972 1.512 . . . . 0.0 110.431 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.12 -89.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.063 1.56 . . . . 0.0 110.383 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -74.7 0.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 116.43 51.08 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 110.195 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -1.78 11.02 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.43 103.73 4.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.72 46.88 1.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 110.233 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 118' ' ' VAL . 4.5 pt-20 -78.76 -139.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.518 ' N ' ' HG3' ' A' ' 117' ' ' GLU . 39.3 t 55.66 97.55 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.16 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 73.8 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.038 1.546 . . . . 0.0 110.469 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' GLN . 4.5 tp10 -152.03 132.99 14.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER 55.65 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.252 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 123.57 8.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.951 1.5 . . . . 0.0 110.45 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 45.4 Cg_endo -73.01 -87.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.99 1.521 . . . . 0.0 110.461 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 123' ' ' PRO . . . 68.82 126.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.177 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' ALA . 81.1 mt-30 -43.09 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.21 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -162.43 54.25 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.938 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.9 83.52 3.67 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.21 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.0 57.37 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 110.404 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.46 104.12 0.85 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -44.64 127.25 6.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -1.144 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.66 -55.29 12.8 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.266 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 131' ' ' THR . 45.3 Cg_endo -73.01 -30.43 10.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.917 1.483 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 132' ' ' PRO . 27.2 tttt 61.16 133.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 29.3 mmt-85 -79.02 -165.57 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 134' ' ' ARG . . . 163.27 75.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.913 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.661 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -102.7 124.72 48.76 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 109.321 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.826 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 5.6 p90 -155.6 167.06 31.62 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.085 -1.009 . . . . 0.0 110.983 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.651 ' H ' ' CD1' ' A' ' 147' ' ' LEU . 2.2 mp -102.75 149.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 111.11 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.694 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 17.5 m-85 -97.31 133.3 42.1 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.697 0.76 . . . . 0.0 111.096 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 3.2 t -86.48 51.92 2.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.17 27.53 1.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.42 -32.78 0.24 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 14.2 tp10 -120.19 121.98 39.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.234 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 3.9 ptmt -72.03 105.46 3.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.397 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.826 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -85.11 110.54 29.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.695 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.0 Cg_endo -75.38 129.65 12.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.124 1.591 . . . . 0.0 111.828 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.651 ' CD1' ' H ' ' A' ' 138' ' ' ILE . 1.0 OUTLIER -124.02 134.2 53.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.392 -0.818 . . . . 0.0 109.396 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 148' ' ' VAL . 13.5 m -107.61 117.53 53.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.96 -1.087 . . . . 0.0 110.604 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.599 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 6.6 tt -125.08 114.82 19.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.78 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.8 t -168.1 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.038 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.589 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -111.9 124.83 31.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 109.996 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.38 138.26 29.7 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.93 1.49 . . . . 0.0 110.693 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.56 HD21 ' CE2' ' A' ' 19' ' ' TRP . 4.8 tp -91.77 145.66 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 153' ' ' LEU . 1.2 p -83.07 92.05 7.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 154' ' ' SER . 2.1 m -42.79 -36.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 0.0 110.211 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.189 -179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.175 0.512 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' THR . . . . . 0.488 HG22 ' N ' ' B' ' 159' ' ' ALA . 22.4 m -88.05 170.74 10.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.488 ' N ' HG22 ' B' ' 158' ' ' THR . . . -179.19 120.3 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' B' ' 161' ' ' THR . 30.9 m -94.86 156.75 16.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.244 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' B' ' 160' ' ' SER . 1.1 t 176.94 137.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.222 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.568 ' CG1' ' HA3' ' A' ' 25' ' ' GLY . 2.6 m -117.72 104.62 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -43.7 155.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.068 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.531 ' CZ ' ' O ' ' B' ' 162' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.481 ' HB2' ' CG2' ' A' ' 138' ' ' ILE . 57.9 m -128.56 12.56 6.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.509 ' N ' HD21 ' A' ' 64' ' ' LEU . 1.3 m 58.52 152.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' A' ' 136' ' ' TYR . 2.9 t -108.9 151.08 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.008 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 137' ' ' TYR . 6.5 p -51.92 -16.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.955 . . . . 0.0 110.931 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . 0.633 ' CD2' ' CD2' ' A' ' 97' ' ' HIS . 7.2 m170 58.14 119.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 0.0 110.318 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 134' ' ' ARG . 1.5 p -84.88 -49.24 8.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.543 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 2' ' ' TYR . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.235 0.54 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 49' ' ' HIS . 3.6 t80 -63.29 -52.06 63.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.473 ' HA ' ' CG1' ' A' ' 6' ' ' VAL . 5.5 tm0? -68.57 -35.77 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 2.3 mt -67.13 -42.0 85.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.61 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 56.0 t -72.06 -46.29 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.581 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 14.2 p -58.33 -32.7 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.309 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.513 ' N ' HG11 ' A' ' 6' ' ' VAL . 32.2 t-20 -68.1 -37.88 81.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 110.309 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.472 ' HB1' ' OD2' ' A' ' 89' ' ' ASP . . . -76.25 -45.05 34.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 110.593 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 33.6 m -57.91 -39.65 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.52 ' N ' HG21 ' A' ' 9' ' ' VAL . 2.9 ttt180 -55.75 -46.77 77.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.538 -0.726 . . . . 0.0 109.92 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.06 -35.87 49.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.883 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' A' ' 41' ' ' ILE . 52.0 tp -71.99 -44.32 63.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 110.058 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 1.9 pt20 -68.48 -34.16 75.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.4 mt-10 -57.91 -45.0 87.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -55.91 -26.87 49.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.88 40.4 3.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 152' ' ' PRO . 1.1 m-85 -141.98 44.46 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.17 . . . . 0.0 110.609 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.47 ' HB2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 t80 -126.59 130.36 50.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.61 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 36.3 m95 -102.86 147.66 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 1.2 m -44.64 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . 167.78 79.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.6 t -56.03 -118.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.29 -0.881 . . . . 0.0 109.647 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.594 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.11 168.93 10.79 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.786 -1.196 . . . . 0.0 109.347 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.561 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.32 -85.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.583 ' CA ' ' CG2' ' B' ' 162' ' ' VAL . . . -79.37 -30.12 46.78 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.384 -1.068 . . . . 0.0 110.465 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.594 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -57.59 -42.9 84.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.242 . . . . 0.0 110.049 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . . . -58.91 -49.28 78.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 109.046 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.61 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.8 m-80 -68.75 -44.17 74.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.425 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.543 ' N ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.68 -31.71 68.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 112.091 -178.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 2.0 pp -54.71 -24.07 20.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.712 -1.243 . . . . 0.0 110.692 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 28' ' ' ASN . 4.0 pp -78.5 -35.64 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.004 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.87 -32.84 71.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.74 41.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.629 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 24.6 mm-40 -113.64 -76.71 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.004 -1.06 . . . . 0.0 110.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.3 Cg_endo -72.03 65.36 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.287 1.151 . . . . 0.0 110.261 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 141.25 13.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 74.85 20.17 79.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.56 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.78 146.62 49.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -1.1 . . . . 0.0 110.224 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 5.3 p90 -123.39 155.92 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 110.311 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CD1' ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -149.48 159.01 44.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.962 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' A' ' 12' ' ' LEU . 5.5 tt -115.06 128.56 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.069 -1.019 . . . . 0.0 110.324 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.512 ' CG ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -112.89 149.72 32.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.778 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 45' ' ' SER . 5.2 t0 -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.512 ' CB ' ' HB3' ' A' ' 50' ' ' PHE . 28.2 m -53.77 -49.77 67.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -174.04 -153.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.142 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 51.4 -140.57 0.86 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 0.8 OUTLIER -91.0 -38.11 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 110.226 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.495 ' NH1' ' HG2' ' A' ' 47' ' ' GLN . 8.0 ptp85 -177.02 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.539 ' CE1' ' CE1' ' A' ' 2' ' ' TYR . 2.3 m-70 -92.48 151.9 19.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.579 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.3 OUTLIER 48.12 107.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.395 -0.816 . . . . 0.0 110.898 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.646 ' CZ ' HG13 ' A' ' 91' ' ' VAL . 5.7 p90 -120.47 140.31 51.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.48 HG23 ' HG3' ' A' ' 42' ' ' ARG . 8.2 t -126.85 155.25 43.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.383 -0.823 . . . . 0.0 109.916 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.73 ' HG ' ' CZ ' ' A' ' 98' ' ' TYR . 2.0 pp -143.99 127.24 16.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.025 -1.047 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.579 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . 6.6 t -112.83 154.1 26.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.454 -0.779 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' HB ' ' CD2' ' A' ' 149' ' ' LEU . 14.9 p -127.86 173.78 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.13 -0.981 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.51 ' HD2' ' CB ' ' A' ' 32' ' ' SER . 4.6 tptt -117.55 139.05 51.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 0.0 110.018 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.52 HG22 ' CA ' ' A' ' 147' ' ' LEU . 4.9 p -135.7 -94.08 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.294 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.3 mm-40 -80.02 -29.17 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER 162.8 -18.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.735 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.56 100.81 2.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 56' ' ' LYS . 2.2 t -100.43 121.46 41.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -1.13 . . . . 0.0 109.925 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -139.71 171.81 13.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.076 -1.015 . . . . 0.0 110.518 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 1.4 p-10 -123.6 152.68 41.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.607 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -110.44 117.79 34.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.936 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' HB3' ' CE1' ' B' ' 164' ' ' PTR . 9.2 ptm180 -83.13 151.76 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.577 HG13 ' CG2' ' A' ' 91' ' ' VAL . 6.9 mm -84.84 144.2 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.5 OUTLIER -96.08 121.37 37.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 26.8 p -88.07 118.16 27.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -133.04 121.15 22.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.221 -0.924 . . . . 0.0 110.244 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.51 95.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.513 ' O ' ' CD ' ' A' ' 87' ' ' ARG . . . 61.82 13.06 38.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 69' ' ' GLU . 13.7 p -108.8 163.21 13.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.296 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.61 ' CZ ' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -110.78 128.38 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -155.17 138.98 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -91.9 -51.19 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 78' ' ' ASP . 65.4 mt-30 -135.49 128.41 31.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 t -57.18 82.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 76' ' ' GLN . 59.2 t0 -120.04 114.0 33.92 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.875 . . . . 0.0 110.215 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.09 61.51 3.98 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 93' ' ' LYS . 4.8 ptp180 -65.07 -9.04 19.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.191 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER 71.71 96.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.286 -0.884 . . . . 0.0 110.423 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.495 ' OG1' ' HG3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -167.76 -52.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.881 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' THR . 5.2 mt-30 41.12 84.85 0.18 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 47.6 Cg_endo -73.52 -92.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 110.298 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.59 ' CG2' ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -120.99 170.06 7.92 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.59 ' HD2' ' CG2' ' A' ' 85' ' ' VAL . 42.0 Cg_endo -69.0 132.78 25.3 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.633 1.333 . . . . 0.0 109.698 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER 54.75 39.68 31.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.545 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.634 ' CE2' ' HA ' ' A' ' 90' ' ' CYS . 1.2 p90 -74.68 -175.18 2.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.436 -0.79 . . . . 0.0 110.236 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.624 ' N ' ' CD2' ' A' ' 88' ' ' PHE . 3.1 t0 -107.71 110.84 22.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.634 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 11.8 t -71.7 -20.5 61.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 110.488 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.646 HG13 ' CZ ' ' A' ' 51' ' ' PHE . 5.4 t -49.88 -36.25 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.046 -1.033 . . . . 0.0 109.795 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.514 ' O ' HG21 ' A' ' 95' ' ' VAL . 8.9 mp -58.06 -47.03 84.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 109.308 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.536 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 5.0 mtpp -67.86 -31.46 71.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 108.891 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -59.39 -33.71 71.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.49 -37.21 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.733 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.446 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 5.0 m-70 -53.65 -50.44 65.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.62 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 135' ' ' ALA . 7.3 t60 -78.28 -36.95 46.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.518 -0.739 . . . . 0.0 109.09 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.73 ' CZ ' ' HG ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.11 -12.0 46.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.887 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.498 ' HA ' ' HB2' ' A' ' 149' ' ' LEU . 1.9 ttt 178.7 68.53 0.12 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.456 -0.778 . . . . 0.0 110.079 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.531 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 45.9 Cg_endo -72.66 111.92 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.903 1.475 . . . . 0.0 110.467 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.673 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.6 Cg_endo -72.22 -29.77 13.9 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.038 1.546 . . . . 0.0 112.212 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 48.5 Cg_endo -74.58 95.26 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 122.879 0.936 . . . . 0.0 110.337 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 102' ' ' PRO . . . -43.79 -28.77 1.21 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.567 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -178.24 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.251 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 45.5 Cg_endo -72.54 -167.86 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.935 1.492 . . . . 0.0 110.4 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.59 ' C ' ' CG ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER 66.19 -63.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.167 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.59 ' CG ' ' C ' ' A' ' 106' ' ' SER . 17.4 p90 34.17 57.96 0.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.493 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' PHE . 1.2 m 65.09 141.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.19 123.94 89.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.174 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.12 138.75 28.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.884 1.466 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.07 -41.62 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.009 1.531 . . . . 0.0 110.466 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.467 ' OG1' ' N ' ' A' ' 113' ' ' GLU . 4.4 t -175.44 -147.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.467 ' N ' ' OG1' ' A' ' 112' ' ' THR . 0.2 OUTLIER -118.88 110.27 38.56 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' O ' ' OG ' ' A' ' 115' ' ' SER . 46.0 Cg_endo -72.84 56.25 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.031 1.543 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 114' ' ' PRO . 54.1 p 42.77 89.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -121.58 104.33 9.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.14 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 116' ' ' SER . 1.7 mm-40 55.72 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.185 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 116' ' ' SER . 33.5 m -138.77 160.65 62.28 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.04 56.71 3.12 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.049 1.552 . . . . 0.0 110.46 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -110.99 -163.25 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.501 ' N ' ' CD ' ' A' ' 122' ' ' PRO . 0.9 OUTLIER -138.25 52.32 4.68 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 121' ' ' GLN . 46.4 Cg_endo -73.09 113.59 3.81 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.1 1.579 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' ALA . 46.3 Cg_endo -73.12 -54.99 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.018 1.536 . . . . 0.0 110.389 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 123' ' ' PRO . . . 42.79 63.92 1.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 110.253 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 175.43 52.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.166 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 127' ' ' LEU . . . -136.33 14.85 3.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.533 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER 176.22 -57.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 46.0 Cg_endo -72.95 -37.46 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.117 1.588 . . . . 0.0 110.398 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.76 -150.41 1.7 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 p -94.74 111.45 23.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.543 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -59.86 -55.09 49.14 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 131' ' ' THR . 46.4 Cg_endo -73.13 -177.05 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.861 1.453 . . . . 0.0 110.419 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 134' ' ' ARG . 23.4 tttp -153.81 -132.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -47.63 176.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.608 ' O ' ' CE1' ' A' ' 97' ' ' HIS . . . 166.2 147.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.416 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.685 ' CD2' ' CD1' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -100.58 162.41 12.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.64 ' CE1' ' CG ' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -152.27 151.6 31.13 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 116.74 -1.984 . . . . 0.0 115.118 -176.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.538 ' N ' ' CD2' ' A' ' 147' ' ' LEU . 13.4 mt -142.17 120.57 8.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 137' ' ' TYR . 7.7 m-85 -84.09 107.96 16.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 143' ' ' GLU . 1.6 t -72.94 66.98 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.341 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.12 89.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.94 2.15 57.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.5 mt-10 -120.04 121.86 39.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -1.147 . . . . 0.0 110.31 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 137' ' ' TYR . 1.1 ttpp -98.23 105.72 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 145' ' ' ILE . 2.8 mp -112.7 119.02 44.06 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.778 . . . . 0.0 109.098 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.609 ' HA ' ' CD2' ' A' ' 137' ' ' TYR . 48.1 Cg_endo -75.13 127.2 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.731 1.385 . . . . 0.0 111.021 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -125.59 134.33 51.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.221 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 148' ' ' VAL . 2.2 p -120.72 118.85 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.752 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 136' ' ' TYR . 4.2 mp -76.36 150.62 36.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.218 -0.926 . . . . 0.0 109.886 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -36.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.462 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 6.9 mtp85 -104.78 124.32 37.21 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.602 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 51.2 Cg_endo -78.21 147.29 23.21 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.024 1.539 . . . . 0.0 110.198 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.525 ' HG ' ' NE1' ' A' ' 19' ' ' TRP . 4.3 tp -92.18 115.84 28.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.132 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.587 ' HB3' ' CE1' ' A' ' 17' ' ' PHE . 81.0 p -100.01 151.96 20.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 0.9 OUTLIER -95.96 -46.54 6.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.222 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.263 0.554 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 53.0 m -120.07 -26.03 5.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 0.0 110.176 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.4 155.07 17.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.55 -56.62 4.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 110.179 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.53 160.12 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.184 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . 0.583 ' CG2' ' CA ' ' A' ' 25' ' ' GLY . 12.3 p -59.97 123.61 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.2 129.12 42.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' PTR . . . . . 0.59 ' CD2' ' N ' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.5 t -109.21 158.79 17.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.13 -0.982 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.425 ' O ' HG23 ' B' ' 167' ' ' VAL . 45.1 p -65.94 -162.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 136' ' ' TYR . 55.4 t -143.06 167.61 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 137' ' ' TYR . 18.7 m -38.98 135.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.454 -0.779 . . . . 0.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -121.02 -29.93 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 31.1 t -124.03 22.88 8.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.644 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.9 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.204 0.526 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -54.96 -45.24 74.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 109.956 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.628 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -54.94 -39.82 69.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.847 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.0 OUTLIER -63.75 -47.2 82.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.836 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.16 HG22 ' CE2' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -65.84 -48.35 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 110.012 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.631 ' N ' HG12 ' A' ' 5' ' ' VAL . 39.5 t -59.54 -47.17 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.2 m120 -58.74 -28.07 65.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -74.13 -44.13 54.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 50.4 t -57.38 -39.72 70.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.357 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -55.87 -49.35 73.58 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.73 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.53 -36.1 45.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 41' ' ' ILE . 46.2 tp -69.48 -42.01 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 18.0 pt20 -67.99 -34.2 76.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.8 tt0 -57.91 -23.7 54.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 110.269 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 1.2 t -70.57 -27.0 63.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.23 -14.12 63.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -76.92 -10.67 59.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -1.108 . . . . 0.0 110.004 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -93.41 121.08 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.061 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 1.017 ' CD1' HD12 ' A' ' 40' ' ' LEU . 9.0 m95 -110.3 101.86 10.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 110.005 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.23 109.04 20.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 164.98 -4.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.426 -0.796 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.85 -159.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 0.0 109.982 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -99.19 176.2 5.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 110.228 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 28' ' ' ASN . . . -49.76 -78.25 0.1 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.623 ' HA2' ' ND2' ' A' ' 63' ' ' ASN . . . -79.26 -34.49 32.64 Favored Glycine 0 N--CA 1.492 2.398 0 O-C-N 121.193 -1.18 . . . . 0.0 110.424 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 2.7 mt-10 -59.51 -30.17 68.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.272 . . . . 0.0 110.098 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' O ' HD23 ' A' ' 30' ' ' LEU . . . -69.62 -47.3 63.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.665 ' O ' HD23 ' A' ' 31' ' ' LEU . 24.3 m120 -68.01 -42.38 80.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.172 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' A' ' 61' ' ' THR . 3.4 mp -59.18 -32.01 69.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.799 . . . . 0.0 111.043 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -55.42 -23.81 27.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.973 -1.08 . . . . 0.0 109.943 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 38' ' ' THR . 4.0 pp -61.85 -37.01 82.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.096 -1.002 . . . . 0.0 109.042 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.875 ' N ' HD12 ' A' ' 31' ' ' LEU . 96.6 p -69.6 -32.27 70.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -20.6 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.3 mm-40 -122.12 -79.8 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.5 Cg_endo -75.89 69.77 6.1 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.064 1.034 . . . . 0.0 110.184 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.96 141.33 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.21 78.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 1.061 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.4 m -131.0 147.9 52.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -1.04 . . . . 0.0 110.173 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.92 ' HA ' HD22 ' A' ' 31' ' ' LEU . 3.0 m-85 -122.64 141.49 51.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 110.072 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -135.49 159.51 41.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.512 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.558 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 9.7 tt -115.05 138.56 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 2.6 tmt_? -112.86 160.71 17.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.0 110.261 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' CZ ' ' A' ' 42' ' ' ARG . 11.6 t0 -85.43 106.47 16.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.346 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.535 ' O ' HG11 ' A' ' 5' ' ' VAL . 54.4 m170 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -163.58 147.73 10.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 1.16 ' CE2' HG22 ' A' ' 5' ' ' VAL . 12.4 p90 -132.11 146.72 52.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.95 . . . . 0.0 110.533 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -126.08 140.87 52.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.507 -0.746 . . . . 0.0 109.521 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.153 HD22 ' CD1' ' A' ' 98' ' ' TYR . 8.3 tt -120.93 145.32 47.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 111.039 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.63 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -139.17 153.82 47.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.715 . . . . 0.0 109.453 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.055 HG11 HD22 ' A' ' 149' ' ' LEU . 33.5 m -121.35 174.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.662 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.918 ' HB2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -112.43 139.22 48.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.565 ' OG1' ' CD2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -153.17 175.87 12.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.94 4.72 15.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.035 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -13.48 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 110.176 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 57' ' ' THR . . . 130.7 150.3 6.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -79.96 132.04 35.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -1.123 . . . . 0.0 110.227 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.868 ' HE3' HG23 ' A' ' 138' ' ' ILE . 10.6 ttmt -122.41 146.54 47.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.623 ' ND2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -115.8 145.73 42.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.123 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.973 HD21 ' HA ' ' B' ' 166' ' ' THR . 0.4 OUTLIER -138.23 152.74 48.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.506 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 52' ' ' THR . 30.9 ptt85 -126.48 159.79 32.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 110.398 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.847 ' HB ' HD22 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -86.55 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -113.19 129.22 56.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.068 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 28.1 p -88.03 119.67 28.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.455 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.3 tm-20 -108.7 103.24 12.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.2 -0.937 . . . . 0.0 110.1 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.95 -84.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -138.23 21.95 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 58.6 p -123.08 156.79 34.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HZ ' HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -110.96 131.55 54.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 0.0 110.178 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.85 146.86 22.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.057 -1.027 . . . . 0.0 110.514 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.883 HD12 ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.611 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.743 HG22 HD23 ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.727 ' O ' HG12 ' A' ' 95' ' ' VAL . 6.1 mp -53.81 -46.2 71.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.527 -1.358 . . . . 0.0 110.342 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -37.36 83.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 108.498 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.883 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.0 tp -68.31 -34.81 76.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.913 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -54.43 -36.95 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.905 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 99' ' ' MET . 20.2 t-160 -53.16 -33.65 53.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 0.0 109.042 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.537 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -78.18 -37.07 46.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.153 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.3 m-85 -78.7 -21.22 48.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.915 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.511 ' CE ' ' HB3' ' A' ' 152' ' ' PRO . 1.3 mtp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 109.992 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.223 0.535 . . . . 0.0 110.296 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 169.98 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -121.85 123.52 41.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.978 -1.076 . . . . 0.0 109.539 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.916 ' H ' HG22 ' B' ' 167' ' ' VAL . 8.3 p90 -154.99 167.74 29.32 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.894 -1.129 . . . . 0.0 111.392 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.868 HG23 ' HE3' ' A' ' 62' ' ' LYS . 3.3 mt -102.69 143.24 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.656 0.741 . . . . 0.0 111.05 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.716 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 12.5 m-85 -92.89 132.63 36.86 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.637 0.732 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -84.01 52.59 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.641 -0.662 . . . . 0.0 110.22 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.53 27.06 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 162.95 -30.87 0.28 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mt-10 -116.47 121.8 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.02 105.51 11.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.341 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -93.01 105.23 14.24 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.817 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.8 Cg_endo -73.55 129.64 13.94 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.052 1.554 . . . . 0.0 112.358 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.804 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 mp -125.64 135.28 51.99 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -98.27 116.98 42.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.365 -1.46 . . . . 0.0 109.954 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.055 HD22 HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -121.86 135.52 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.066 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.0 t -167.6 54.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.697 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.87 123.88 22.19 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.077 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 50.7 Cg_endo -78.75 148.32 22.51 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.143 1.602 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.977 HD13 ' HB2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -85.83 133.78 33.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.823 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.828 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.465 ' O ' HG23 ' B' ' 166' ' ' THR . 43.3 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.105 0.478 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.973 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.4 p -152.58 -179.54 7.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.921 HG12 HG22 ' B' ' 168' ' ' VAL . 1.0 OUTLIER -127.85 143.48 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.921 HG22 HG12 ' B' ' 167' ' ' VAL . 4.4 m . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.4 0.619 . . . . 0.0 111.126 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.596 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.254 0.55 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.9 p90 -55.79 -39.02 70.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.578 ' O ' HG12 ' A' ' 6' ' ' VAL . 40.0 tp60 -61.16 -42.27 98.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.123 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.1 mt -67.27 -47.23 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.987 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.4 m -72.56 -44.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.667 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 3' ' ' GLN . 5.2 p -58.35 -32.55 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -67.98 -40.92 83.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.096 -1.003 . . . . 0.0 109.78 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . . . -76.36 -44.99 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 5' ' ' VAL . 4.3 m -57.93 -39.7 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.9 ttt180 -55.44 -45.9 76.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 109.69 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -32.94 50.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.687 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 5.9 tp -68.23 -43.98 76.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.455 -0.778 . . . . 0.0 110.286 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 3.4 pt20 -64.65 -33.83 76.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.187 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 2.9 mt-10 -57.84 -31.03 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -67.29 -41.3 85.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.034 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.75 36.62 3.19 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.903 ' HB2' HD21 ' A' ' 153' ' ' LEU . 5.6 p90 -145.39 28.17 1.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -1.166 . . . . 0.0 110.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 20' ' ' SER . 3.0 t80 -90.76 136.29 33.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.831 ' HE1' HD23 ' A' ' 153' ' ' LEU . 69.4 m95 -117.51 149.23 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 89.7 p 178.98 -15.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -13.26 4.36 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.714 -0.616 . . . . 0.0 110.533 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.39 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.599 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.588 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -89.16 175.82 7.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.791 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' CD ' ' A' ' 42' ' ' ARG . . . -46.03 -83.77 0.02 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.34 -30.51 45.32 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 121.398 -1.06 . . . . 0.0 110.681 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.588 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.4 mm-40 -58.27 -26.69 63.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.338 . . . . 0.0 110.422 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.87 -49.97 47.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.016 -1.053 . . . . 0.0 109.117 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.927 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -69.99 -46.39 65.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.0 110.747 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.883 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -59.08 -31.34 68.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.445 -0.784 . . . . 0.0 111.602 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 pp -54.63 -23.62 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.789 -1.194 . . . . 0.0 109.442 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.996 HD13 ' O ' ' A' ' 38' ' ' THR . 3.6 pp -68.95 -34.11 74.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.155 -0.966 . . . . 0.0 108.567 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.684 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t -69.97 -32.81 71.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.67 -0.643 . . . . 0.0 110.234 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.66 -20.72 42.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.85 . . . . 0.0 110.488 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.74 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -122.9 -80.59 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.972 -1.08 . . . . 0.0 110.922 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.74 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 53.1 Cg_endo -75.24 68.46 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.015 1.008 . . . . 0.0 110.703 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.92 141.43 10.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.023 . . . . 0.0 110.399 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 78.93 20.58 70.16 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 53.7 m -117.55 148.3 42.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.984 . . . . 0.0 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 8.3 p90 -121.86 138.94 54.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.005 -1.06 . . . . 0.0 109.787 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -138.95 156.71 47.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.388 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.569 HD11 ' CD1' ' A' ' 51' ' ' PHE . 4.3 tt -115.37 133.75 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.376 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -112.89 141.43 46.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.856 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 49.3 t0 -82.08 132.77 35.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.106 -0.996 . . . . 0.0 110.247 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . 59.4 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.363 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.563 ' O ' HG11 ' A' ' 5' ' ' VAL . 80.9 m-70 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.301 0.572 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' HA ' ' CB ' ' A' ' 5' ' ' VAL . 16.3 p90 -177.45 175.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 38.0 p90 -125.73 141.64 51.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.039 -1.038 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.604 ' CG2' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -125.33 144.34 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.104 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -121.99 133.6 54.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.104 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -139.1 154.28 48.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 110.087 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 149' ' ' LEU . 10.7 p -132.98 174.9 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.667 ' HG3' HG22 ' A' ' 61' ' ' THR . 2.0 ttpp -103.36 135.2 45.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -97.7 -154.02 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -24.46 66.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 m -177.02 29.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.65 109.8 0.56 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.667 HG22 ' HG3' ' A' ' 56' ' ' LYS . 32.2 p -98.2 108.94 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.155 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.523 ' HD3' HG21 ' A' ' 138' ' ' ILE . 2.4 mptp? -116.93 159.28 22.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.994 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.81 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 38.6 m-20 -112.01 134.22 53.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.2 mm? -109.4 117.99 35.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -117.0 148.38 41.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.258 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.931 HG21 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -76.74 130.57 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.0 OUTLIER -94.74 151.18 19.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.43 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 72' ' ' SER . 27.6 p -97.89 139.08 34.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' SER . 70.5 mt-10 -131.56 113.04 13.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.342 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 46.65 24.27 1.72 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.29 -2.19 40.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -95.01 153.63 17.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.931 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -113.39 126.78 55.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.8 OUTLIER -155.53 147.59 23.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.521 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.872 HD13 HD12 ' A' ' 94' ' ' LEU . 14.7 tp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.948 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 4.6 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.836 ' O ' HG22 ' A' ' 95' ' ' VAL . 10.9 mp -59.24 -46.08 89.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 108.681 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -67.23 -30.7 70.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -58.57 -34.56 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.612 -0.68 . . . . 0.0 109.879 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.026 ' N ' HD23 ' A' ' 94' ' ' LEU . 3.0 m -54.83 -37.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.453 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 24.6 m170 -55.38 -47.26 76.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.063 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -61.21 -36.74 80.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.476 -0.765 . . . . 0.0 109.258 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.955 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.6 m-30 -65.12 -9.38 22.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 109.975 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 99' ' ' MET . 2.7 ptt? . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.3 mtm180 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.297 0.57 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.075 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 172.93 112.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.116 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 0.5 OUTLIER -104.66 122.76 46.33 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.152 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.2 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -156.94 156.39 32.95 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.322 -0.861 . . . . 0.0 110.091 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.132 ' N ' HD23 ' A' ' 147' ' ' LEU . 2.0 mt -103.37 149.4 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.339 -0.851 . . . . 0.0 109.796 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.589 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 81.4 m-85 -85.37 132.05 34.3 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.264 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.714 ' HB3' HD13 ' A' ' 145' ' ' ILE . 2.7 t -95.25 59.06 2.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.245 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.33 54.07 40.31 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.15 1.0 58.33 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 6.4 mm-40 -120.01 123.49 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 145' ' ' ILE . 12.9 mtmt -70.86 119.13 14.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -118.31 115.27 36.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.035 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.905 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 42.7 Cg_endo -69.33 125.23 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.808 1.425 . . . . 0.0 111.349 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.132 HD23 ' N ' ' A' ' 138' ' ' ILE . 1.9 pp -127.03 101.93 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.6 p -102.45 118.58 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.814 -1.179 . . . . 0.0 111.034 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 98' ' ' TYR . 0.9 OUTLIER -76.66 114.88 15.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 -30.25 6.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 110.935 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.87 124.47 70.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.987 -1.07 . . . . 0.0 110.203 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.584 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 50.0 Cg_endo -78.0 141.09 18.56 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.03 1.542 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.931 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.55 158.13 15.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.508 ' N ' HD22 ' A' ' 153' ' ' LEU . 45.0 m . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 5.3 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.192 0.52 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.459 ' O ' ' O ' ' B' ' 165' ' ' SER . 0.2 OUTLIER 53.5 169.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.116 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.8 t -126.82 102.64 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.2 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.3 t . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.091 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.699 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.0 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.258 0.551 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.489 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.5 p90 -54.85 -36.6 65.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.659 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.8 tt0 -54.89 -32.69 61.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.962 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 1' ' ' GLU . 6.4 mt -59.56 -47.43 85.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.4 t -64.55 -44.77 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.865 . . . . 0.0 110.775 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -58.03 -33.5 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.299 -0.876 . . . . 0.0 110.575 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -71.44 -40.35 70.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.1 -44.46 38.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.249 -0.907 . . . . 0.0 110.75 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 5' ' ' VAL . 7.4 m -57.2 -38.37 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -54.23 -49.12 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.862 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -78.44 -40.19 36.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -0.999 . . . . 0.0 109.925 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -72.27 -31.22 65.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.399 -0.813 . . . . 0.0 111.032 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.74 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 51.6 mt-30 -59.44 -41.45 89.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 0.0 111.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.48 -52.56 8.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.889 -1.132 . . . . 0.0 110.598 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 t -73.68 -42.4 61.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 111.746 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' C ' ' A' ' 17' ' ' PHE . . . -90.23 67.57 2.57 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.36 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.702 ' C ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 2.21 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.742 -0.858 . . . . 0.0 110.8 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.74 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 3.8 t80 -90.87 136.23 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.756 ' CG ' HD11 ' A' ' 40' ' ' LEU . 15.9 m95 -116.59 148.24 41.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -142.26 23.73 1.99 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.07 0.13 31.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.784 . . . . 0.0 110.949 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.53 -158.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 110.343 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.577 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.26 166.97 11.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 110.334 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.49 ' CA ' ' HG2' ' A' ' 42' ' ' ARG . . . -39.73 -84.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 28' ' ' ASN . . . -79.05 -31.7 42.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 7.7 tt0 -59.53 -24.85 64.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.283 . . . . 0.0 109.938 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -72.95 -48.42 36.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.587 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.689 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -68.44 -36.16 78.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.326 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.815 HD11 ' OG1' ' A' ' 61' ' ' THR . 0.6 OUTLIER -58.24 -31.71 67.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 110.976 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp -55.49 -23.84 28.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.875 -1.141 . . . . 0.0 109.223 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 38' ' ' THR . 2.7 pp -70.33 -32.95 70.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 108.648 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 61.2 m -69.85 -33.09 71.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.578 -0.701 . . . . 0.0 110.08 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -21.19 41.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.068 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.766 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.4 mm-40 -122.31 -83.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.564 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.766 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.17 69.27 4.87 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 122.923 0.959 . . . . 0.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.59 141.53 37.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.225 -0.922 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 83.31 19.44 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.926 ' O ' HD13 ' A' ' 31' ' ' LEU . 4.0 m -122.43 148.33 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.505 -0.997 . . . . 0.0 110.204 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HB2' HG12 ' A' ' 55' ' ' VAL . 4.5 p90 -122.21 138.97 54.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.852 -1.155 . . . . 0.0 109.981 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.35 159.31 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 0.0 110.276 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.838 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.4 tt -117.01 149.21 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 3.0 tpt180 -121.62 152.89 38.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.445 -0.784 . . . . 0.0 109.612 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.573 ' CA ' ' OH ' ' A' ' 18' ' ' TYR . 8.8 t0 -90.76 104.31 16.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.956 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 8.3 t . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 0.0 110.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.158 0.504 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.871 ' HD1' HG21 ' A' ' 5' ' ' VAL . 20.0 t80 -155.82 156.06 34.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.855 ' CD2' HG13 ' A' ' 5' ' ' VAL . 8.7 p90 -115.96 151.79 34.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.5 ' C ' HG13 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -126.41 147.62 49.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.916 HD12 ' N ' ' A' ' 54' ' ' SER . 0.3 OUTLIER -131.1 125.07 32.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.39 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.916 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -122.8 153.74 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.02 HG11 HD22 ' A' ' 149' ' ' LEU . 10.2 m -121.39 174.56 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.372 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HA ' HG22 ' A' ' 61' ' ' THR . 14.5 tttm -103.47 126.48 50.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.986 ' HB ' HD22 ' A' ' 147' ' ' LEU . 21.4 p -128.9 169.87 14.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.86 -27.11 67.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 t -86.41 -28.31 23.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.161 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 147.36 156.78 7.12 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 56' ' ' LYS . 17.3 p -80.13 138.08 36.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' CB ' HG12 ' A' ' 138' ' ' ILE . 23.2 mmtm -137.15 160.45 38.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.506 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 5.5 p30 -138.28 154.64 49.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.704 HD11 ' CA ' ' B' ' 166' ' ' THR . 8.0 mt -137.45 148.41 46.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 110.01 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HA ' ' HZ ' ' A' ' 50' ' ' PHE . 4.7 mtt180 -98.25 152.29 19.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.33 139.6 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -96.4 151.0 19.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.403 ' HA ' ' CD1' ' A' ' 73' ' ' PHE . 18.5 p -99.36 137.03 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 mt-10 -130.63 102.89 6.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 43.24 -95.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -120.53 32.75 4.73 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 5.0 p -139.58 150.91 45.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.292 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -124.29 144.83 49.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 66' ' ' ILE . 2.2 t -155.18 141.3 18.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.119 -0.988 . . . . 0.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 94' ' ' LEU . 17.8 tp . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.282 -0.886 . . . . 0.0 110.455 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.786 HG21 HG22 ' A' ' 5' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.074 0.464 . . . . 0.0 111.125 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -54.19 -35.77 62.7 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.907 -1.121 . . . . 0.0 110.058 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -62.39 -36.4 82.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.991 -1.068 . . . . 0.0 109.437 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.82 -35.87 75.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.595 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' MET . 78.0 t -56.02 -38.31 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.78 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 99' ' ' MET . 9.8 t-80 -54.79 -46.55 74.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -71.78 -42.95 66.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.069 ' O ' HD11 ' A' ' 149' ' ' LEU . 2.0 m-30 -69.31 -22.11 63.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.571 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 6.9 ppt_? . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.23 0.538 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.854 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 169.5 129.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.431 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.122 ' CD1' HG11 ' B' ' 167' ' ' VAL . 2.5 t80 -116.18 121.78 43.12 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.807 -1.183 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.904 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.7 p90 -156.99 167.97 28.88 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.878 -1.139 . . . . 0.0 111.185 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.468 HG12 ' CB ' ' A' ' 62' ' ' LYS . 2.8 mp -121.62 149.54 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.95 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.76 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.1 m-30 -84.85 110.47 18.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.729 . . . . 0.0 110.119 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 3.9 m -66.32 56.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.53 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 65.84 82.9 0.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.25 -10.42 49.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.8 tt0 -120.01 121.6 39.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.269 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 2.4 ptpt -89.8 105.5 17.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.02 109.14 52.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.032 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.823 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.3 Cg_endo -72.57 128.95 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.996 1.524 . . . . 0.0 111.938 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.986 HD22 ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -125.83 135.88 52.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 148' ' ' VAL . 25.3 m -98.04 117.12 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.382 -1.449 . . . . 0.0 110.079 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.069 HD11 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -117.38 137.91 52.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.047 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.502 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -176.02 41.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.583 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -111.56 124.96 31.31 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.148 -0.97 . . . . 0.0 110.046 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.632 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 45.7 Cg_endo -73.08 147.32 42.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 111.059 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.795 HD22 HG21 ' A' ' 38' ' ' THR . 0.3 OUTLIER -89.7 128.66 36.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.742 . . . . 0.0 109.778 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.759 ' N ' HD13 ' A' ' 153' ' ' LEU . 49.4 m . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.443 ' C ' HD21 ' A' ' 64' ' ' LEU . 56.6 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.214 0.53 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.745 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.5 OUTLIER 176.87 155.82 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.192 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.122 HG11 ' CD1' ' A' ' 136' ' ' TYR . 15.3 t -118.62 132.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 135' ' ' ALA . 5.8 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.188 0.518 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 6' ' ' VAL . 33.7 p90 -65.31 -37.55 87.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.5 OUTLIER -69.32 -33.65 73.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.218 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.09 -47.3 71.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.516 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 49' ' ' HIS . 34.8 m -72.18 -37.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.449 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 2' ' ' TYR . 24.8 t -58.45 -32.97 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.33 -45.65 92.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -67.0 -43.11 83.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.724 HG13 ' CE2' ' A' ' 18' ' ' TYR . 60.1 t -56.93 -39.39 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 15.3 ttt180 -55.47 -48.81 73.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.855 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.37 -33.02 49.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.64 -44.08 71.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.267 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.6 pt20 -65.59 -33.77 76.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 1.2 tt0 -66.01 -32.26 73.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.312 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.6 p -69.68 -27.5 65.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.28 19.97 21.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CD2' ' CD1' ' A' ' 153' ' ' LEU . 3.0 m-85 -108.5 4.22 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -1.129 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.724 ' CE2' HG13 ' A' ' 9' ' ' VAL . 21.6 t80 -90.86 136.07 33.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.355 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.94 ' CG ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -92.23 148.34 22.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.667 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 2.6 t -40.68 -92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.783 . . . . 0.0 110.321 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.91 61.72 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -59.53 -137.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -85.32 166.19 16.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 109.551 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . -39.89 -83.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.29 -30.18 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 17.0 tt0 -57.78 -34.79 69.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.982 -1.305 . . . . 0.0 110.517 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -66.84 -48.73 67.96 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.94 -1.1 . . . . 0.0 109.025 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.657 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 19.2 m120 -69.3 -43.15 74.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.463 -0.773 . . . . 0.0 110.728 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -70.28 -31.78 69.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 111.686 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.756 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.76 -41.15 70.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.88 -1.138 . . . . 0.0 110.352 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.063 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.1 pp -61.02 -34.69 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 108.964 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.79 -32.82 71.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -20.62 42.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.504 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.8 mt-10 -114.89 -76.75 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.2 Cg_endo -72.85 65.53 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.299 1.157 . . . . 0.0 110.118 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.91 140.62 11.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 80.15 -2.44 76.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.916 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 m -104.41 146.38 28.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.432 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.787 ' HB2' HD23 ' A' ' 149' ' ' LEU . 39.9 p90 -123.79 138.88 54.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.985 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.063 HD23 ' HB3' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -141.4 159.4 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.145 -0.972 . . . . 0.0 110.619 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.919 ' N ' HD12 ' A' ' 40' ' ' LEU . 1.7 tt -115.16 130.58 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.945 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' NH2' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -112.72 160.5 17.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.032 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' CB ' ' OH ' ' A' ' 18' ' ' TYR . 12.4 t70 -74.0 126.28 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.137 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.602 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 9.4 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 110.101 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.667 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.6 m-70 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.225 0.536 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 44' ' ' SER . 42.7 p90 -177.78 -158.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 35.5 p90 -133.26 149.14 51.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.377 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 64' ' ' LEU . 74.7 m -126.22 155.13 42.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.18 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -137.24 146.44 44.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.697 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 25.1 p -139.43 153.99 47.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' CG2' ' HG ' ' A' ' 149' ' ' LEU . 8.8 p -120.13 172.24 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 1.6 tmtp? -123.01 139.19 54.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.537 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -151.65 -173.35 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.66 24.23 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.511 ' HB3' HG21 ' A' ' 145' ' ' ILE . 1.7 p -126.98 -2.62 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.25 139.55 5.6 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 61' ' ' THR . 15.3 t -95.31 109.56 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.308 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -110.65 155.18 22.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 110.04 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 4.5 t30 -111.53 128.68 56.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.019 HD13 ' CG2' ' B' ' 167' ' ' VAL . 0.9 OUTLIER -130.23 152.06 50.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -0.971 . . . . 0.0 110.33 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.58 ' CA ' HG23 ' A' ' 52' ' ' THR . 3.0 ptm180 -121.68 -145.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.777 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 94' ' ' LEU . 1.4 tp -116.75 149.02 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 0.0 110.341 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -110.76 124.71 52.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.575 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 29.4 p -87.81 126.89 35.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.65 103.02 7.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.47 -102.15 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.6 36.19 3.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.06 160.39 40.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -1.18 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.644 ' CD1' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.16 138.44 46.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.855 . . . . 0.0 110.033 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.3 t -155.32 150.15 26.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.052 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.662 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.8 p . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.223 0.535 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.872 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.29 -34.08 63.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 110.073 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -57.53 -31.76 66.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.799 ' HB2' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -59.83 -35.4 74.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.246 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.7 m -55.33 -37.32 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.316 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.54 ' HB2' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -53.83 -34.71 60.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.023 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.614 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -78.07 -36.77 47.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 109.986 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.741 ' CE1' HD23 ' A' ' 53' ' ' LEU . 3.3 m-85 -63.55 -22.02 66.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 0.0 110.319 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.257 0.551 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -175.42 111.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.154 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 2.1 t80 -103.0 121.42 42.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.936 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.18 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.9 165.89 33.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.0 . . . . 0.0 110.423 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.096 HD12 ' CD2' ' A' ' 147' ' ' LEU . 6.1 mt -123.5 126.73 73.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.012 . . . . 0.0 109.758 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.781 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -83.36 107.63 16.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.832 0.825 . . . . 0.0 109.717 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' TYR . 56.1 p -42.45 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.774 -0.579 . . . . 0.0 110.411 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.84 80.3 0.36 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.38 82.31 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 145' ' ' ILE . 39.8 tt0 -114.06 121.28 43.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.281 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 21.9 mtmm -76.94 108.45 9.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 110.949 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.834 HG22 HD11 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -104.31 132.47 20.94 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.927 ' C ' HD12 ' A' ' 147' ' ' LEU . 45.2 Cg_endo -71.56 128.16 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.79 1.416 . . . . 0.0 112.111 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.096 ' CD2' HD12 ' A' ' 138' ' ' ILE . 8.3 mp -123.69 101.5 7.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.71 117.81 44.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.874 -1.142 . . . . 0.0 111.207 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 39' ' ' PHE . 8.8 mp -79.73 114.83 18.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.283 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.18 -23.93 2.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -85.91 124.9 70.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 110.271 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.581 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 47.9 Cg_endo -74.74 128.26 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.055 1.555 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.937 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.76 158.22 16.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.519 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.556 ' N ' HD22 ' A' ' 153' ' ' LEU . 47.8 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.104 -0.997 . . . . 0.0 110.264 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.1 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.174 0.512 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.607 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 31.0 m -145.16 147.71 32.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.154 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.6 t -87.67 102.39 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.18 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.405 -0.81 . . . . 0.0 110.231 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.522 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.336 0.588 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 38.0 p90 -63.38 -36.08 82.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.479 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -55.57 -36.21 66.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 4.2 mt -64.29 -44.46 91.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 51' ' ' PHE . 12.1 t -66.63 -48.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.8 t -58.82 -41.75 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -71.22 -31.26 67.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 109.833 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' HG12 ' A' ' 91' ' ' VAL . . . -76.05 -44.28 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.458 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 6' ' ' VAL . 29.9 m -57.11 -38.71 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.241 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 4.6 mtp180 -55.04 -40.63 70.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -71.36 -42.39 68.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.959 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -72.04 -40.18 68.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 5.3 pt20 -68.19 -33.73 74.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 4.0 tm-20 -57.65 -21.45 39.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 110.261 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -26.95 62.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.17 37.8 3.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 25.5 t80 -142.13 7.15 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -1.142 . . . . 0.0 110.235 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 6.3 t80 -96.28 136.21 37.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 1.102 ' CG ' HD12 ' A' ' 40' ' ' LEU . 28.6 m95 -110.6 148.31 32.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.478 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -148.41 109.74 4.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 176.59 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 111.089 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' CG2' ' CZ ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -120.88 -160.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.862 -1.149 . . . . 0.0 110.277 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -86.09 166.04 16.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' CA ' ' HB ' ' A' ' 52' ' ' THR . . . -52.19 -76.45 0.18 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.74 -43.72 98.79 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.457 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 29.9 tt0 -59.78 -24.83 64.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 110.01 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.676 ' HB1' ' HE ' ' A' ' 42' ' ' ARG . . . -78.12 -45.55 23.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.32 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.583 ' CB ' ' CB ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -69.04 -41.8 77.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.389 -0.819 . . . . 0.0 110.755 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 1.4 mp -59.43 -32.14 69.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.766 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.751 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -55.21 -23.58 22.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.982 -1.074 . . . . 0.0 109.352 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 38' ' ' THR . 70.9 mt -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 109.096 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.549 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 26.9 p -69.19 -32.43 71.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.716 . . . . 0.0 109.888 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.48 -20.62 43.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.371 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.762 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 12.5 mm-40 -134.06 -83.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.762 ' HD3' ' CB ' ' A' ' 34' ' ' GLU . 50.3 Cg_endo -78.01 67.67 8.01 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 122.812 0.901 . . . . 0.0 110.152 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -63.67 141.47 58.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 88.98 15.74 58.88 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.754 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -130.63 147.17 52.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -1.05 . . . . 0.0 110.142 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 149' ' ' LEU . 4.0 p90 -123.11 146.22 47.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 0.0 110.678 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.102 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.08 160.31 43.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 12' ' ' LEU . 3.3 tt -114.0 128.84 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.924 -1.11 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.676 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -117.68 150.44 39.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.755 . . . . 0.0 110.122 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 44' ' ' SER . 9.8 t70 -73.87 127.56 33.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 44' ' ' SER . 25.5 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.324 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 59.4 m170 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.1 0.476 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.617 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.4 p90 -152.7 -160.99 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.838 ' CD2' HG13 ' A' ' 5' ' ' VAL . 27.1 p90 -115.9 148.72 39.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' CA ' ' A' ' 24' ' ' GLY . 88.6 m -126.13 139.76 53.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.055 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -126.92 124.97 40.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.918 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -133.9 154.29 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.476 -0.765 . . . . 0.0 110.049 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 149' ' ' LEU . 12.4 p -130.58 174.08 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -118.86 139.02 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.204 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.796 HG21 ' HB3' ' A' ' 147' ' ' LEU . 26.6 m -115.21 -43.3 3.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 57' ' ' THR . 27.0 pt20 -177.99 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.59 29.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.626 ' O ' HD13 ' A' ' 138' ' ' ILE . . . -155.76 65.46 0.31 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 61' ' ' THR . 3.8 t -84.96 111.85 20.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -1.144 . . . . 0.0 110.138 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HG3' HG21 ' A' ' 138' ' ' ILE . 14.3 mmtt -123.53 166.08 16.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 9.3 p30 -134.32 154.12 51.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.027 HD21 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.01 118.15 13.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 110.53 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.555 ' HD2' ' CZ ' ' A' ' 50' ' ' PHE . 10.7 ptm180 -75.32 162.21 28.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.864 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.914 ' CG1' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -78.27 148.78 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 110.263 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -107.53 136.75 46.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 1' ' ' GLU . 27.9 p -87.83 119.97 28.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.28 103.09 8.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.64 -78.27 0.02 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -148.25 30.35 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.44 163.09 33.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.956 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -115.7 141.18 48.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 109.977 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.631 ' C ' HD13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -148.15 138.89 23.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.94 -1.1 . . . . 0.0 110.616 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.702 HD21 ' CB ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 109.793 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.956 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.703 0.763 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.0 pp -54.41 -33.87 60.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.565 -0.709 . . . . 0.0 111.545 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -57.31 -30.41 64.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.596 -1.315 . . . . 0.0 109.741 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.914 HD22 ' CG1' ' A' ' 66' ' ' ILE . 1.1 pp -58.78 -33.02 69.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.3 m -53.39 -34.85 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.429 -0.794 . . . . 0.0 110.353 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' N ' HG23 ' A' ' 95' ' ' VAL . 8.3 m80 -51.29 -30.06 16.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 109.51 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.508 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 t-80 -73.17 -36.3 66.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.166 -0.959 . . . . 0.0 108.825 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.055 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.8 m-85 -63.57 -22.12 66.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.568 -0.707 . . . . 0.0 109.674 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.569 ' HE1' ' HA ' ' A' ' 135' ' ' ALA . 10.8 ttm . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.465 -0.772 . . . . 0.0 110.301 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.195 0.521 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.889 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.97 126.34 0.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 110.058 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.921 ' CD2' HG11 ' B' ' 167' ' ' VAL . 3.7 t80 -128.59 121.81 29.56 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.408 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.029 ' CD2' HG22 ' B' ' 168' ' ' VAL . 12.6 p90 -156.83 167.33 30.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.203 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.705 HD12 HD21 ' A' ' 147' ' ' LEU . 2.6 mp -106.05 149.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.635 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 29.5 m-85 -96.18 133.05 40.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.76 . . . . 0.0 110.992 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.48 ' OG ' HD13 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -87.46 48.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.636 -0.665 . . . . 0.0 110.217 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 52.49 65.73 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.07 -22.48 15.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.53 121.97 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -1.174 . . . . 0.0 110.162 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.4 ptmt -88.48 105.72 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.27 102.98 10.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.791 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.2 Cg_endo -76.18 126.68 9.37 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.681 1.358 . . . . 0.0 111.981 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.796 ' HB3' HG21 ' A' ' 57' ' ' THR . 0.4 OUTLIER -126.76 136.0 51.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 148' ' ' VAL . 30.2 m -97.08 117.18 41.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.136 -1.603 . . . . 0.0 110.624 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 39' ' ' PHE . 6.3 tt -90.11 114.93 26.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.65 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -148.94 19.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.021 -1.05 . . . . 0.0 110.821 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -105.6 124.49 36.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.03 -1.044 . . . . 0.0 109.976 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.5 Cg_endo -76.57 148.22 29.14 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.954 1.502 . . . . 0.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.709 HD21 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -79.07 152.87 30.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 110.089 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.677 ' H ' HD13 ' A' ' 153' ' ' LEU . 17.0 m . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' SER . . . . . 1.027 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.158 0.504 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.638 ' CA ' HD11 ' A' ' 64' ' ' LEU . 2.6 t -146.82 175.47 10.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 110.26 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.921 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -128.73 112.36 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.976 . . . . 0.0 110.272 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 137' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.238 0.542 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.08 -36.14 80.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -55.2 -34.21 63.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.167 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -67.26 -45.17 77.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 110.205 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.94 ' O ' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -64.94 -48.4 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -58.42 -32.62 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.311 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.11 -42.52 80.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 91' ' ' VAL . . . -76.12 -44.91 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.94 HG13 ' O ' ' A' ' 5' ' ' VAL . 5.4 m -59.01 -39.58 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -55.54 -49.01 73.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -35.94 65.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 109.513 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 12' ' ' LEU . 14.0 tp -72.13 -44.09 63.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 16.7 pt20 -68.21 -33.87 75.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.6 -26.48 61.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.112 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -26.89 62.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.024 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.19 1.61 56.93 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HD2' HD12 ' A' ' 153' ' ' LEU . 1.6 t80 -88.96 -8.33 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 110.187 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 41' ' ' ILE . 5.7 t80 -90.91 136.23 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.812 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 1.034 ' CD1' HD13 ' A' ' 40' ' ' LEU . 46.3 m95 -99.79 148.42 24.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.795 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -53.07 -18.7 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.855 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 75.54 93.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.659 . . . . 0.0 111.16 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 23' ' ' THR . 1.8 m -66.41 -90.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.284 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.678 ' H ' HG23 ' A' ' 22' ' ' VAL . 1.1 m -103.5 172.99 6.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.003 -1.061 . . . . 0.0 109.219 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.599 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.23 -94.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -71.25 -29.5 68.43 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.485 -1.009 . . . . 0.0 110.651 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.594 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -57.56 -24.95 59.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.25 . . . . 0.0 111.204 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.918 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -76.46 -47.04 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.825 -1.172 . . . . 0.0 109.66 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.669 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.7 m-80 -70.34 -44.86 67.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 111.066 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' OG1' ' A' ' 61' ' ' THR . 15.1 mt -70.7 -31.53 68.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.7 pp -54.28 -27.41 35.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.535 -1.353 . . . . 0.0 110.561 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.033 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.4 pp -74.05 -33.75 63.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.81 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -69.89 -32.72 71.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 110.296 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.07 41.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.352 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.744 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 3.7 mm-40 -113.95 -77.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.057 -1.027 . . . . 0.0 110.063 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.744 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.0 Cg_endo -72.49 71.09 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.271 1.143 . . . . 0.0 110.142 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.09 137.18 47.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.04 0.6 89.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -111.23 147.41 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -1.181 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -122.79 148.75 45.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.0 110.716 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' CD1' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -147.65 160.02 43.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 109.91 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.021 ' N ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -113.95 148.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.973 . . . . 0.0 110.46 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.599 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 5.7 ppt_? -127.38 127.59 44.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.705 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 24.7 t70 -75.27 138.24 41.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.483 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.568 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 12.9 m . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.228 0.537 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.843 ' CB ' HG21 ' A' ' 5' ' ' VAL . 17.2 p90 -154.42 -156.13 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.857 ' CE1' HG22 ' A' ' 5' ' ' VAL . 14.2 p90 -116.01 152.71 33.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 24.3 m -118.13 155.54 30.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.904 HD13 ' N ' ' A' ' 54' ' ' SER . 1.2 tm? -142.17 129.68 21.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.301 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.904 ' N ' HD13 ' A' ' 53' ' ' LEU . 3.1 p -138.32 154.13 49.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.642 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG11 HD21 ' A' ' 149' ' ' LEU . 2.8 m -127.03 173.99 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 110.835 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 14.5 tptm -113.04 129.58 56.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.887 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.965 ' HB ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.63 -165.76 1.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.387 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' GLY . 8.4 tt0 -77.93 -59.12 2.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.473 ' OG ' ' HB ' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -42.24 -27.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' GLN . . . 130.66 151.92 7.24 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 61' ' ' THR . 2.4 t -78.87 108.89 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.181 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -110.37 153.2 25.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.942 . . . . 0.0 110.099 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 15.0 p30 -121.06 125.84 48.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -118.65 151.93 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.633 ' C ' HD12 ' A' ' 75' ' ' LEU . 1.4 ptt180 -140.36 152.99 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 110.437 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.73 HD13 ' C ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -76.62 117.86 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 74' ' ' SER . 16.2 tt0 -91.95 151.14 20.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 110.484 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 20.0 p -101.62 127.84 48.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -133.14 117.01 16.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.31 34.15 87.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.22 -14.22 54.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 51.2 p -94.99 162.81 13.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -1.14 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.7 m-30 -110.92 152.01 27.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.73 ' C ' HD13 ' A' ' 66' ' ' ILE . 19.3 m -155.63 138.7 15.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.031 HD13 ' HG ' ' A' ' 94' ' ' LEU . 2.6 tt . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.076 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 92' ' ' LEU . 7.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.722 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.6 mt -61.64 -42.07 98.38 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -57.86 -34.41 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 110.43 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.7 m -54.35 -37.67 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.94 -1.1 . . . . 0.0 109.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.471 ' N ' HG23 ' A' ' 95' ' ' VAL . 77.9 m80 -68.16 -37.34 80.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.247 -0.908 . . . . 0.0 109.188 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.53 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -77.57 -36.87 51.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 109.749 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.913 ' OH ' HD11 ' A' ' 75' ' ' LEU . 5.6 m-85 -77.1 -22.33 52.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.824 . . . . 0.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.336 -179.777 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.244 0.545 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.068 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -176.31 102.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.143 ' CE2' HG21 ' B' ' 167' ' ' VAL . 3.0 t80 -102.62 122.51 44.55 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.903 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.165 ' CD2' HG22 ' B' ' 168' ' ' VAL . 3.5 p90 -155.73 167.9 28.89 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.927 -1.108 . . . . 0.0 110.781 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.566 HG12 ' CB ' ' A' ' 62' ' ' LYS . 3.0 mp -121.09 149.58 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 111.055 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.752 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.0 OUTLIER -84.71 107.94 17.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 110.057 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.851 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -91.82 122.02 33.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 110.286 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.14 65.68 2.59 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 51.35 20.59 5.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 140' ' ' SER . 12.8 tt0 -120.38 121.86 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.135 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.16 105.36 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 110.63 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.851 HD13 ' HB3' ' A' ' 140' ' ' SER . 0.9 OUTLIER -99.98 109.04 54.79 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.831 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.5 Cg_endo -72.53 128.72 13.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.954 1.502 . . . . 0.0 112.277 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -125.89 135.21 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 148' ' ' VAL . 35.7 m -103.83 117.72 49.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.273 -1.517 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.823 HD21 HG11 ' A' ' 55' ' ' VAL . 12.8 mt -76.17 123.5 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -0.963 . . . . 0.0 108.969 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -137.84 -7.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.82 -1.175 . . . . 0.0 111.647 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 ttm-85 -100.23 124.63 42.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.718 -1.239 . . . . 0.0 110.104 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 147.96 32.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.981 1.516 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 1.119 HD13 ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -67.13 159.14 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.964 ' N ' HD22 ' A' ' 153' ' ' LEU . 5.0 m . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.558 -0.713 . . . . 0.0 111.231 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.511 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -125.95 163.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.191 -0.943 . . . . 0.0 110.134 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.143 HG21 ' CE2' ' A' ' 136' ' ' TYR . 37.8 t -114.47 112.89 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.165 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.225 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.61 ' N ' HD12 ' A' ' 4' ' ' LEU . 85.3 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.34 0.591 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 22.1 p90 -64.52 -35.88 82.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.564 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 28.1 pt20 -62.88 -40.22 96.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.1 mt -67.0 -47.46 71.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 50' ' ' PHE . 7.1 p -68.94 -47.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.318 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.608 ' N ' HG13 ' A' ' 5' ' ' VAL . 41.9 t -58.68 -50.23 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -58.82 -38.42 78.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.724 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.59 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -72.34 -38.26 68.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.791 HG13 ' CE2' ' A' ' 18' ' ' TYR . 3.0 t -56.94 -39.39 65.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.3 mtp85 -58.45 -49.42 77.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.568 -0.708 . . . . 0.0 110.104 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -78.57 -33.25 47.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.323 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' CG2' ' A' ' 95' ' ' VAL . 2.2 tt -72.0 -44.15 63.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.758 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 17.3 pt20 -61.28 -40.94 96.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 110.371 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 8.3 tt0 -77.16 -51.64 10.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -72.79 -43.18 63.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 17' ' ' PHE . . . -99.98 33.99 5.85 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.221 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 3.1 p90 29.75 44.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -1.039 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.791 ' CE2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -92.79 122.92 35.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.721 ' CE2' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -125.61 145.94 49.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 110.126 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 107.31 14.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.29 12.82 0.12 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.472 -0.767 . . . . 0.0 110.016 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.54 -159.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.693 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.19 176.17 7.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 42' ' ' ARG . . . -55.21 -75.3 0.25 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -79.39 -31.77 40.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.564 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 1.9 tp10 -59.0 -36.47 74.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.032 -1.275 . . . . 0.0 109.509 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.938 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -60.92 -51.43 69.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.729 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 4.1 m-80 -69.82 -42.88 73.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.968 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.99 -32.75 69.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -0.842 . . . . 0.0 112.321 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.938 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.7 pp -55.4 -35.12 64.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.704 -1.247 . . . . 0.0 110.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.043 HD13 ' O ' ' A' ' 38' ' ' THR . 4.6 pp -66.27 -36.24 82.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.826 -1.171 . . . . 0.0 109.265 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.922 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.53 -32.72 71.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 110.324 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.55 -20.71 42.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.67 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -116.84 -76.03 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.9 Cg_endo -73.18 70.9 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.292 1.154 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 141.28 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 79.91 18.21 73.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 1.043 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.42 147.31 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -1.079 . . . . 0.0 110.023 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.763 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.02 163.08 21.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.016 . . . . 0.0 110.202 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.97 ' HB2' HD23 ' A' ' 153' ' ' LEU . 7.6 tt -151.96 159.18 43.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.96 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.858 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -119.24 129.28 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 24' ' ' GLY . 6.3 ppt_? -112.16 155.06 24.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.34 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 30.3 t0 -100.05 132.14 45.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 36.2 m80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.155 0.502 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.911 ' HA ' HG21 ' A' ' 5' ' ' VAL . 12.1 p90 175.44 178.02 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.878 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.894 ' CD2' HG23 ' A' ' 5' ' ' VAL . 3.3 p90 -115.88 148.66 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.987 . . . . 0.0 110.3 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 65' ' ' ARG . 2.1 p -126.84 155.33 43.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.865 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.12 HD22 ' CD1' ' A' ' 98' ' ' TYR . 1.9 tt -124.22 154.09 40.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.796 ' N ' HD23 ' A' ' 53' ' ' LEU . 3.2 p -139.03 153.63 48.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' HB3' ' A' ' 39' ' ' PHE . 2.8 m -130.13 174.11 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.794 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.8 139.14 52.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.471 -0.768 . . . . 0.0 110.086 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -175.6 146.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.3 OUTLIER 66.82 -60.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.184 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER 165.89 -22.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 109.817 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' C ' ' NZ ' ' A' ' 62' ' ' LYS . . . -105.77 117.1 5.38 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' THR . 9.7 t -97.61 116.52 29.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.142 -1.211 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -106.71 161.37 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.132 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' C ' HD22 ' A' ' 64' ' ' LEU . 1.1 m-80 -118.98 135.82 54.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.904 ' HB3' HD11 ' A' ' 75' ' ' LEU . 2.1 mm? -104.05 127.09 51.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.587 ' CB ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -118.02 138.28 52.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 91' ' ' VAL . 1.1 tp -82.95 148.42 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 27.3 tp60 -112.88 151.06 30.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 67' ' ' GLN . 45.2 t -102.04 127.84 48.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 110.231 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.4 tt0 -121.26 103.0 8.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.76 -68.95 0.12 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -157.02 28.03 0.52 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -136.45 161.31 36.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 110.161 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 5' ' ' VAL . 1.3 m-30 -112.95 149.96 32.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 67' ' ' GLN . 16.4 t -150.99 138.82 19.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD21 ' A' ' 94' ' ' LEU . 27.0 tp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.141 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.734 ' CA ' HD13 ' A' ' 66' ' ' ILE . 4.0 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.171 0.51 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 8' ' ' ALA . 16.3 mt -63.51 -46.06 87.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 108.434 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -60.26 -29.9 69.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.033 HD21 HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.92 -34.24 69.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.785 -0.572 . . . . 0.0 110.095 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 42.0 t -54.05 -42.15 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.089 -1.007 . . . . 0.0 108.948 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.0 OUTLIER -68.26 -31.37 70.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.915 . . . . 0.0 108.735 178.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.12 -43.29 29.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.684 -0.635 . . . . 0.0 109.503 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.12 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.2 m-85 -64.05 -22.15 66.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.475 -0.766 . . . . 0.0 110.055 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.249 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.239 0.542 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . -173.25 152.82 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.124 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CG ' HG11 ' B' ' 167' ' ' VAL . 1.3 t80 -131.11 122.94 27.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.329 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.113 ' CE2' HG12 ' B' ' 168' ' ' VAL . 9.4 p90 -155.15 168.03 28.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.583 -1.323 . . . . 0.0 111.64 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.737 HG21 ' HD3' ' A' ' 62' ' ' LYS . 4.2 mp -102.16 143.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.624 0.726 . . . . 0.0 110.744 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.721 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.2 m-85 -93.3 132.76 37.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.718 0.771 . . . . 0.0 110.925 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.531 ' HB2' HD13 ' A' ' 145' ' ' ILE . 12.1 t -101.8 -163.55 1.02 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.088 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.504 ' N ' ' OG ' ' A' ' 140' ' ' SER . . . -55.67 85.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 63.77 12.43 47.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mm-40 -120.2 121.93 39.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -87.22 105.26 17.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.471 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.948 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -89.52 108.6 26.01 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.828 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.6 Cg_endo -76.35 129.44 11.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.059 1.558 . . . . 0.0 113.35 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.948 HD21 HG22 ' A' ' 145' ' ' ILE . 2.1 mm? -125.12 134.96 52.25 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 148' ' ' VAL . 17.2 m -101.16 116.45 44.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 119.878 -1.764 . . . . 0.0 110.921 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.762 ' CD1' HG11 ' A' ' 55' ' ' VAL . 56.4 mt -84.79 114.96 22.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.135 -0.978 . . . . 0.0 109.241 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 p -147.69 28.55 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 111.375 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 1.2 mtt180 -134.11 123.22 16.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.789 -1.195 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 50.7 Cg_endo -79.3 135.45 12.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.069 1.562 . . . . 0.0 110.822 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 ' HB2' ' A' ' 40' ' ' LEU . 16.3 tp -92.39 146.5 23.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.865 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.479 ' H ' HD12 ' A' ' 153' ' ' LEU . 19.0 m . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 110.339 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.272 0.558 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.581 ' HA ' HD11 ' A' ' 64' ' ' LEU . 41.7 p -131.25 -173.15 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.992 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.88 -160.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.106 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.113 HG12 ' CE2' ' A' ' 137' ' ' TYR . 2.3 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.775 ' HA ' HD12 ' A' ' 4' ' ' LEU . 6.1 pt-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.602 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 30.0 p90 -66.67 -35.9 81.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.4 tt0 -65.18 -44.13 89.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 1' ' ' GLU . 2.4 mt -67.12 -47.5 70.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.937 HG21 ' HA ' ' A' ' 50' ' ' PHE . 6.8 p -65.32 -47.85 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 0.0 110.353 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' HG13 ' A' ' 5' ' ' VAL . 24.9 t -58.64 -36.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.05 -33.21 70.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -76.05 -44.36 39.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.04 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 82.0 t -57.45 -39.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.446 -0.784 . . . . 0.0 109.295 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.4 mtm180 -55.86 -48.33 75.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.721 . . . . 0.0 109.893 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -34.75 50.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.984 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.941 HD23 HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.04 -43.29 65.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 110.055 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 16.8 pt20 -65.74 -33.73 76.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 2.3 mt-10 -57.61 -33.7 68.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.095 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.461 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 3.7 m -56.02 -27.5 53.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.8 42.71 5.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 9.2 p90 -152.59 14.5 0.57 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -1.18 . . . . 0.0 110.452 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.677 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -94.93 126.26 40.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.251 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.981 ' CD1' HD12 ' A' ' 40' ' ' LEU . 16.9 m95 -106.04 148.09 28.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 3.6 m -39.12 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.821 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 166.99 81.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.451 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.1 t -47.22 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -108.23 173.07 6.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.811 -1.181 . . . . 0.0 109.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.87 -89.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.44 -30.31 45.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -57.82 -34.93 70.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.268 . . . . 0.0 110.445 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -66.48 -49.06 67.89 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.012 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.0 m-80 -69.29 -39.87 78.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 110.535 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.39 -31.41 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 111.712 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -54.68 -24.02 20.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.825 -1.172 . . . . 0.0 110.794 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 38' ' ' THR . 4.2 pp -75.41 -36.13 60.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.937 -1.102 . . . . 0.0 109.322 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.85 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -69.69 -32.91 71.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.61 41.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.938 . . . . 0.0 110.72 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.737 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.6 mt-10 -114.34 -76.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.737 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 47.3 Cg_endo -72.12 71.31 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.224 1.118 . . . . 0.0 110.268 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.57 141.28 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.497 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.86 20.76 79.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.963 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.21 146.93 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 110.178 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.995 ' CG ' HD12 ' A' ' 149' ' ' LEU . 4.3 m-85 -123.42 157.41 33.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.916 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.981 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.23 159.18 43.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 110.592 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.017 HD11 ' CD1' ' A' ' 51' ' ' PHE . 13.1 tt -116.33 144.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.81 136.07 52.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 20' ' ' SER . 1.5 p30 -89.58 121.72 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 10.8 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.464 ' HB2' ' CB ' ' A' ' 44' ' ' SER . 13.7 m-70 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.228 0.537 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.937 ' HA ' HG21 ' A' ' 5' ' ' VAL . 20.9 p90 -177.44 -159.5 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 110.194 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 1.017 ' CD1' HD11 ' A' ' 41' ' ' ILE . 8.5 p90 -126.96 155.79 42.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 74.9 m -126.24 138.38 53.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -0.953 . . . . 0.0 110.267 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.03 HD23 ' CG ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -120.93 124.89 46.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.084 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.956 ' N ' HD12 ' A' ' 53' ' ' LEU . 2.5 p -126.02 154.14 43.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.971 HG11 HD13 ' A' ' 149' ' ' LEU . 2.2 m -122.34 174.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.85 . . . . 0.0 110.717 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 25.7 tttt -107.12 124.23 49.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.707 HG21 ' CD1' ' A' ' 138' ' ' ILE . 8.9 p -127.4 157.13 40.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 110.332 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.73 -24.24 64.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -79.72 -23.13 42.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 152.82 143.47 3.69 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.3 p -78.93 110.52 14.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 138' ' ' ILE . 5.3 mmtt -111.99 161.72 16.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.214 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.486 ' CB ' ' HB2' ' A' ' 54' ' ' SER . 12.7 p30 -140.12 125.98 19.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.609 HD12 ' OH ' ' A' ' 136' ' ' TYR . 12.9 mt -104.73 152.08 22.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -125.11 143.13 51.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.647 HD13 HD22 ' A' ' 94' ' ' LEU . 3.5 tp -78.58 136.65 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.077 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.0 tt0 -102.79 145.31 29.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 1' ' ' GLU . 42.6 t -108.57 127.5 54.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.0 tt0 -124.17 104.29 8.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.04 -71.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -154.22 23.58 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 163.26 24.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 110.182 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.6 m-30 -119.42 157.87 27.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.634 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.12 138.68 15.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.14 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.887 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 73' ' ' PHE . 15.5 m . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.7 mt -65.11 -46.56 80.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -67.5 -31.14 71.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.069 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.887 HD21 ' CB ' ' A' ' 75' ' ' LEU . 3.7 mp -59.36 -33.85 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.84 -0.538 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.2 m -52.47 -37.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.98 -1.075 . . . . 0.0 109.651 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.461 ' N ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -57.15 -52.49 65.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.909 -1.119 . . . . 0.0 109.161 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.58 ' CE1' HD22 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -79.21 -40.14 31.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 110.097 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.03 ' CG ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -64.43 -22.36 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.0 109.64 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 17' ' ' PHE . 2.6 ttp . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 0.0 109.816 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.743 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.27 0.557 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 167.44 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CD1' HG21 ' B' ' 167' ' ' VAL . 3.2 t80 -102.47 122.57 44.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.484 -1.286 . . . . 0.0 109.697 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.786 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.6 p90 -156.08 167.18 31.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.707 ' CD1' HG21 ' A' ' 57' ' ' THR . 2.5 mp -120.25 149.29 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 111.42 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.67 108.08 17.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.986 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.627 ' HB2' HD13 ' A' ' 145' ' ' ILE . 2.8 m -66.84 56.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.572 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 67.31 81.8 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.89 -8.59 49.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -120.23 121.8 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.239 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -89.57 105.25 17.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.095 -1.003 . . . . 0.0 110.62 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.786 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.53 110.51 51.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.78 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.1 Cg_endo -71.94 129.47 15.36 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.569 . . . . 0.0 112.107 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.784 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.2 mt -125.74 135.83 52.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.46 117.36 42.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.336 -1.478 . . . . 0.0 109.791 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.996 HD21 ' C ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -116.2 114.88 25.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.061 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -155.13 41.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.23 125.37 24.63 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.286 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.83 148.11 40.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.009 1.531 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.39 150.69 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.207 0.527 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.27 174.38 12.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.032 HG12 HG22 ' B' ' 168' ' ' VAL . 2.4 t -135.87 146.1 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.032 HG22 HG12 ' B' ' 167' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.738 -0.601 . . . . 0.0 110.945 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 68' ' ' CYS . 2.7 tm-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 40.1 p90 -64.36 -35.8 82.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.1 tp60 -54.85 -41.08 70.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.683 HD13 ' CE1' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -66.14 -47.4 74.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.08 HG11 ' HA ' ' A' ' 50' ' ' PHE . 38.9 t -65.31 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.1 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.74 -49.32 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -58.97 -38.23 78.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.895 . . . . 0.0 109.89 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.019 ' O ' HD12 ' A' ' 12' ' ' LEU . . . -76.29 -44.69 35.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.04 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 75.4 t -57.77 -39.87 72.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.404 -0.81 . . . . 0.0 109.163 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -56.05 -41.66 75.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.869 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -76.87 -44.85 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.019 HD12 ' O ' ' A' ' 8' ' ' ALA . 1.1 mt -62.11 -44.37 96.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 110.013 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 18.1 pt20 -68.27 -33.82 75.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.252 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.86 -45.13 86.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.534 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.554 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 5.6 m -55.9 -38.42 70.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.967 . . . . 0.0 110.096 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.06 35.64 2.7 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HZ ' HD23 ' A' ' 12' ' ' LEU . 23.3 p90 -139.22 10.72 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -1.137 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 9' ' ' VAL . 5.2 t80 -90.87 117.45 29.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.6 m95 -82.02 141.58 33.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -162.86 108.65 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.045 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 159.62 -2.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.53 -0.731 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.16 -156.65 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.097 . . . . 0.0 110.001 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -95.57 175.99 6.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -47.98 -86.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.595 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -76.48 -31.76 53.35 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 3.5 tt0 -59.63 -24.97 64.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.129 -1.218 . . . . 0.0 110.219 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -74.65 -49.96 19.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.8 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -70.09 -44.96 67.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.252 -0.905 . . . . 0.0 110.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.4 mp -59.89 -32.26 70.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.744 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp -55.39 -30.67 60.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.928 -1.107 . . . . 0.0 109.383 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.224 HD13 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.81 -33.99 73.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 1.224 ' N ' HD13 ' A' ' 31' ' ' LEU . 19.7 p -70.44 -32.84 70.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.557 -0.715 . . . . 0.0 110.288 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.78 -20.89 41.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.75 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.9 mt-10 -120.99 -79.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.943 -1.098 . . . . 0.0 110.391 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.1 Cg_endo -75.42 54.83 3.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.072 1.038 . . . . 0.0 110.105 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB1' ' HE2' ' A' ' 56' ' ' LYS . . . -53.03 141.61 22.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.377 -0.827 . . . . 0.0 110.736 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 92.67 15.29 53.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.64 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.44 148.8 43.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.977 . . . . 0.0 110.141 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 1.102 ' CG ' HD21 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -121.59 149.4 43.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.017 . . . . 0.0 110.514 -179.368 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -150.37 160.73 43.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.565 -0.709 . . . . 0.0 109.588 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.1 tt -113.47 145.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.796 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 tmt_? -112.28 151.22 29.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.628 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.571 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 9.6 t0 -94.38 133.69 37.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.086 -1.008 . . . . 0.0 110.661 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.527 -0.733 . . . . 0.0 110.635 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.255 0.55 . . . . 0.0 110.33 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 1.08 ' HA ' HG11 ' A' ' 5' ' ' VAL . 54.3 p90 -179.52 -176.79 0.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.089 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.931 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.2 p90 -115.85 155.15 28.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 110.089 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -126.07 150.68 47.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 110.047 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.091 HD22 ' CG ' ' A' ' 98' ' ' TYR . 1.4 tt -139.26 131.02 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 111.158 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.73 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -139.71 154.11 47.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.483 -0.761 . . . . 0.0 109.959 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 39' ' ' PHE . 1.5 p -129.08 174.2 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 110.585 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.808 ' HE2' ' HB1' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -111.74 139.1 47.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.198 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 58' ' ' GLN . 2.3 m -160.33 148.94 16.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 110.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' THR . 7.5 pt20 -41.92 -27.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -66.93 -53.46 31.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.253 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.64 146.55 4.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.43 HG21 ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -83.32 129.06 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -1.098 . . . . 0.0 110.133 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.797 ' NZ ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -142.08 140.92 32.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.9 OUTLIER -111.05 141.35 44.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.992 HD22 HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -138.18 152.42 48.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 110.834 -179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -121.07 165.0 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.813 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.676 HD13 ' CB ' ' A' ' 94' ' ' LEU . 5.0 tp -78.11 131.23 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -97.84 140.33 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 1' ' ' GLU . 31.0 p -92.32 128.09 38.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 72' ' ' SER . 3.3 tt0 -133.07 104.53 6.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.335 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 54.55 65.42 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.36 24.0 15.03 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 70' ' ' GLY . 0.7 OUTLIER -124.12 157.7 34.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 0.0 110.048 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -124.22 128.91 49.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.089 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -153.97 139.01 17.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.898 . . . . 0.0 110.34 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.943 HD22 ' NE2' ' A' ' 97' ' ' HIS . 1.8 tt . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 109.885 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.741 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 t . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.281 0.562 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -56.04 -38.07 70.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.273 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 -40.56 83.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -68.17 -35.39 77.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.555 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 24.8 t -55.49 -37.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 110.268 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -54.27 -35.77 62.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.943 ' NE2' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.17 -41.85 33.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.061 -1.024 . . . . 0.0 110.412 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.091 ' CG ' HD22 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -64.68 -22.15 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.205 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.522 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.91 . . . . 0.0 110.29 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.767 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 59.1 mmt-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.165 0.507 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.982 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.32 82.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 110.17 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.984 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.83 125.96 49.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.478 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.037 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -154.11 167.21 30.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.089 . . . . 0.0 110.511 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 62' ' ' LYS . 3.0 mt -101.57 149.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 111.298 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.723 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.0 m-85 -98.97 132.82 44.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.709 0.766 . . . . 0.0 110.984 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 145' ' ' ILE . 45.0 t -97.06 48.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.618 -0.676 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.02 82.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.61 -22.07 39.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 1.5 mp0 -117.05 122.02 42.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 1.2 pttm -91.68 105.29 17.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.219 -0.926 . . . . 0.0 110.312 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.732 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -87.73 108.24 19.58 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.2 Cg_endo -76.07 128.8 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.994 1.523 . . . . 0.0 112.346 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' NZ ' ' A' ' 62' ' ' LYS . 1.2 mp -125.06 134.19 52.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -117.87 117.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.596 -1.315 . . . . 0.0 111.249 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 39' ' ' PHE . 3.8 tt -92.45 114.86 27.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.11 -15.14 1.51 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 111.063 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.85 124.91 70.2 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.958 -1.088 . . . . 0.0 110.017 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.06 147.88 43.85 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.945 1.497 . . . . 0.0 110.592 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.902 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.48 158.56 14.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 0.0 110.567 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.509 ' N ' HD22 ' A' ' 153' ' ' LEU . 46.2 t . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.315 -0.866 . . . . 0.0 110.815 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.68 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.197 0.522 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.8 p -112.29 144.64 41.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.852 . . . . 0.0 110.05 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.037 HG12 ' N ' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -100.24 114.49 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.982 HG21 ' O ' ' A' ' 135' ' ' ALA . 99.6 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.559 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . 7.9 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 6' ' ' VAL . 11.8 t80 -66.9 -52.39 43.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.907 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -61.09 -39.44 89.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.476 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . 1.2 mt -67.09 -47.25 71.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.063 HG23 HG21 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -69.58 -47.92 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.245 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 2' ' ' TYR . 72.9 t -61.83 -41.27 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -58.93 -41.44 87.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.934 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.936 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -62.01 -44.16 97.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.78 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 ' HE2' ' A' ' 18' ' ' TYR . 41.3 t -57.55 -39.8 71.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.88 78.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.737 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -32.86 56.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -61.91 -43.7 98.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 110.092 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.603 ' HG2' ' CD1' ' A' ' 18' ' ' TYR . 63.6 mt-30 -67.2 -35.89 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -63.42 -39.27 94.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.222 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -38.81 75.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.37 1.17 23.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 1.027 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.6 t80 -94.99 21.85 7.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.659 ' HE2' HG22 ' A' ' 9' ' ' VAL . 36.3 t80 -121.25 136.03 55.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 110.258 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.704 ' CE3' ' NH2' ' A' ' 42' ' ' ARG . 9.4 m95 -104.67 148.64 26.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 110.333 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 42.1 m -31.91 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 163.81 69.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG23 HH11 ' A' ' 42' ' ' ARG . 0.5 OUTLIER -60.9 -135.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.329 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.621 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -88.34 176.16 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.76 -1.213 . . . . 0.0 109.205 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' THR . . . -44.1 -81.75 0.03 OUTLIER Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.332 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.9 -31.12 40.6 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.439 -1.036 . . . . 0.0 111.643 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.621 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 21.2 tp10 -58.63 -24.9 62.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.451 . . . . 0.0 110.955 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.012 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -77.15 -48.19 18.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.992 -1.067 . . . . 0.0 109.544 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.962 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.2 m120 -70.62 -49.57 46.16 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.686 0.755 . . . . 0.0 111.142 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.465 HD11 HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -61.88 -31.59 71.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.698 . . . . 0.0 112.162 -178.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.2 pp -55.18 -35.15 64.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.75 -1.219 . . . . 0.0 109.853 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -81.25 -36.18 30.26 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 108.622 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 1.046 ' N ' HD23 ' A' ' 31' ' ' LEU . 52.0 m -70.03 -32.88 71.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.555 -0.716 . . . . 0.0 110.129 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.02 41.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.512 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 10.4 mt-10 -113.87 -76.77 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.041 . . . . 0.0 110.05 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.741 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.8 Cg_endo -73.08 61.32 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.277 1.146 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.73 141.24 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.421 ' C ' ' HG ' ' A' ' 150' ' ' SER . . . 89.34 13.45 61.66 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.883 ' C ' HD11 ' A' ' 31' ' ' LEU . 21.2 m -132.66 146.08 51.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.554 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.747 ' CG ' HD23 ' A' ' 149' ' ' LEU . 30.5 p90 -126.97 138.84 53.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.838 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -131.4 161.01 33.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.913 HG12 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.41 128.56 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.789 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 1.012 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 78.5 mtt-85 -135.73 153.43 51.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.739 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -73.94 122.79 23.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 109.7 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.338 -0.852 . . . . 0.0 110.562 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 50' ' ' PHE . 28.5 p80 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.271 0.558 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.763 ' CB ' HG21 ' A' ' 5' ' ' VAL . 35.9 p90 -92.55 -166.74 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.916 ' CE2' HG22 ' A' ' 5' ' ' VAL . 5.9 p90 -130.82 158.21 40.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.84 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 14.5 t -126.28 139.2 53.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.067 HD22 ' CD1' ' A' ' 98' ' ' TYR . 6.9 tt -121.03 139.45 53.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.698 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -139.33 154.39 47.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.839 HG11 ' CG ' ' A' ' 149' ' ' LEU . 2.4 m -130.12 174.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.392 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' SER . 18.4 tptt -105.93 130.49 53.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.715 HG21 ' HA ' ' A' ' 147' ' ' LEU . 33.7 p -134.86 -169.27 2.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -77.48 -34.95 54.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.3 t -81.73 -22.79 37.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.18 -0.95 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.48 14.62 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 1.8 t -101.04 126.4 47.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -1.123 . . . . 0.0 110.27 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.524 ' CG ' HG12 ' A' ' 138' ' ' ILE . 8.7 mmpt? -114.07 147.3 38.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.235 -0.916 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' CB ' ' OG ' ' A' ' 54' ' ' SER . 10.7 p30 -112.02 144.07 41.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 110.706 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.995 HD22 HG23 ' B' ' 167' ' ' VAL . 1.2 mp -138.93 152.26 47.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.594 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 50' ' ' PHE . 3.3 ptt180 -123.49 164.04 19.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.063 HG21 HG23 ' A' ' 5' ' ' VAL . 6.6 tp -76.78 143.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -113.05 144.66 42.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.559 ' CB ' ' HB3' ' A' ' 1' ' ' GLU . 13.7 t -101.99 118.85 37.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 110.368 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 71' ' ' GLY . 22.9 tt0 -105.21 102.89 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.037 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.21 -83.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -139.87 37.69 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.64 163.07 32.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -1.107 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.617 ' CE1' ' CB ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -122.4 127.97 50.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 3.4 m -155.55 159.91 40.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.856 HD13 HD12 ' A' ' 94' ' ' LEU . 10.5 tp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.844 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB1' ' A' ' 8' ' ' ALA . 7.8 p . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.091 0.472 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.8 mt -55.64 -35.98 66.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.723 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -62.53 -46.36 88.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.865 -1.147 . . . . 0.0 109.209 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -68.25 -34.82 76.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.44 -0.787 . . . . 0.0 109.58 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 91' ' ' VAL . 56.0 t -54.74 -36.43 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 110.438 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -52.61 -33.12 44.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -78.18 -36.79 47.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.156 -0.965 . . . . 0.0 109.476 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.067 ' CD1' HD22 ' A' ' 53' ' ' LEU . 6.9 m-85 -73.59 -22.05 60.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.316 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.0 mtt85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.237 0.542 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 173.85 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.13 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.3 t80 -102.81 121.52 42.63 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.719 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.158 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.24 148.67 20.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 110.137 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.013 HD13 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -102.65 150.18 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.977 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.594 ' CZ ' ' OH ' ' A' ' 137' ' ' TYR . 76.2 m-85 -86.19 132.71 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 110.435 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.641 ' HB3' HD13 ' A' ' 145' ' ' ILE . 1.3 t -98.49 69.23 1.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.65 41.93 75.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.56 2.76 29.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 140' ' ' SER . 2.8 mt-10 -117.8 121.97 42.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -70.92 105.93 3.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.463 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.75 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -101.5 120.1 55.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.866 . . . . 0.0 109.555 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.876 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 43.6 Cg_endo -69.64 129.42 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.349 1.71 . . . . 0.0 112.786 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.013 ' CD2' HD13 ' A' ' 138' ' ' ILE . 6.1 mp -121.1 101.29 7.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.3 p -102.85 117.64 48.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.624 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.945 HD22 ' O ' ' A' ' 98' ' ' TYR . 3.5 mp -76.02 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 37' ' ' GLY . 2.7 p -172.62 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.74 -1.225 . . . . 0.0 111.495 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -85.68 124.93 70.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.855 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 48.5 Cg_endo -75.7 148.06 32.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.106 1.582 . . . . 0.0 110.093 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 1.027 HD21 ' O ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -63.21 144.37 56.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.227 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.465 ' N ' HD12 ' A' ' 153' ' ' LEU . 1.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.097 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.553 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.152 0.501 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.686 ' HA ' HD21 ' A' ' 64' ' ' LEU . 2.7 t -105.87 137.52 43.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.13 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -84.63 95.49 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.114 -0.991 . . . . 0.0 109.589 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.158 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.893 . . . . 0.0 109.983 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 4' ' ' LEU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.266 0.555 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 30.2 p90 -55.72 -36.48 67.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.7 tt0 -55.03 -32.88 62.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.215 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.887 HD13 ' CD1' ' A' ' 73' ' ' PHE . 10.2 mt -62.33 -44.04 97.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.867 HG13 ' HD2' ' A' ' 51' ' ' PHE . 61.1 t -63.14 -48.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.158 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 6' ' ' VAL . 15.5 t -61.5 -50.53 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.884 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 2.0 t-20 -62.36 -44.1 97.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -67.01 -44.52 80.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.771 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' VAL . 23.1 t -57.93 -40.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.823 . . . . 0.0 109.136 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -55.89 -47.86 76.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.613 -0.68 . . . . 0.0 109.867 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -36.56 63.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.918 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD22 ' CZ ' ' A' ' 17' ' ' PHE . 4.2 mt -71.77 -44.05 64.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 110.003 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' OE1' HG12 ' A' ' 9' ' ' VAL . 17.6 pt20 -67.89 -33.87 75.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -57.9 -34.49 69.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.07 -34.7 66.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.845 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.57 29.19 6.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.997 ' C ' HD11 ' A' ' 153' ' ' LEU . 6.7 p90 -145.97 40.24 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 110.631 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 4.9 t80 -120.38 115.81 24.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.853 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CD1' HD13 ' A' ' 153' ' ' LEU . 63.5 m95 -77.26 144.08 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 110.329 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 18.6 t -45.77 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.722 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 165.64 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.859 . . . . 0.0 110.568 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 27' ' ' ALA . 1.4 m -47.04 -97.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.069 -1.02 . . . . 0.0 109.41 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.606 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -108.05 165.88 11.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 109.199 178.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -43.3 -79.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' HA2' ' OD1' ' A' ' 28' ' ' ASN . . . -79.5 -30.47 44.79 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.369 -1.077 . . . . 0.0 111.254 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.9 mm-40 -58.49 -24.79 61.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.344 . . . . 0.0 110.954 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 22' ' ' VAL . . . -76.04 -49.78 16.6 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 109.24 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -71.18 -49.68 41.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 111.244 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.673 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -63.37 -31.09 72.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.583 -0.698 . . . . 0.0 111.797 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.924 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -53.77 -23.39 11.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.835 -1.166 . . . . 0.0 109.689 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 40' ' ' LEU . 62.6 mt -61.73 -39.51 91.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 109.191 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 93.1 p -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.6 -0.688 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.95 -20.39 45.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.7 mm-40 -125.27 -81.16 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.998 -1.064 . . . . 0.0 110.404 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.6 Cg_endo -77.17 68.38 7.41 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 122.92 0.958 . . . . 0.0 110.175 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.67 141.48 9.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.0 110.614 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 71.65 24.0 77.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.586 ' CB ' ' HB2' ' A' ' 35' ' ' PRO . 7.9 m -125.81 147.14 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -1.048 . . . . 0.0 110.474 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.784 ' CE2' HD21 ' A' ' 149' ' ' LEU . 1.2 p90 -122.83 147.1 46.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.995 HD23 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -145.29 159.71 42.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.493 -0.754 . . . . 0.0 109.72 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.645 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 5.3 tt -114.31 137.9 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.105 -0.997 . . . . 0.0 110.118 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -112.63 131.82 55.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.0 110.438 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 35.9 t0 -89.28 118.22 28.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 5.7 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.202 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.52 ' HE1' HH22 ' A' ' 42' ' ' ARG . 2.5 t-80 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.214 0.531 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.851 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.2 p90 176.77 -151.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.114 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.867 ' HD2' HG13 ' A' ' 5' ' ' VAL . 25.8 p90 -115.37 151.92 33.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -1.0 . . . . 0.0 109.869 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' LEU . 36.2 m -125.9 135.74 52.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.945 . . . . 0.0 110.499 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.949 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -120.75 123.32 42.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.871 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -140.34 155.72 46.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.483 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.743 HG12 ' OH ' ' A' ' 136' ' ' TYR . 2.7 p -134.53 174.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 0.0 110.689 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.42 133.69 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.82 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.849 HG21 ' HG ' ' A' ' 147' ' ' LEU . 8.8 t -132.93 -156.96 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.58 -58.36 2.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.899 ' HB2' HG23 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -44.63 -61.43 1.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 57' ' ' THR . . . -179.05 172.84 45.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 56' ' ' LYS . 49.2 p -99.37 108.97 21.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -1.119 . . . . 0.0 110.238 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.843 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -108.43 177.83 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.945 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 1.091 ' O ' HD23 ' A' ' 64' ' ' LEU . 23.8 m-20 -128.42 132.47 48.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 110.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.091 HD23 ' O ' ' A' ' 63' ' ' ASN . 8.2 mt -131.69 152.12 51.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -147.9 168.43 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.0 110.516 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.0 HG21 ' CD2' ' A' ' 73' ' ' PHE . 44.0 mm -76.82 146.74 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -114.41 150.82 34.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.513 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 54.1 t -89.01 132.85 34.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.317 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 71' ' ' GLY . 10.3 tm-20 -123.86 102.94 8.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.02 -89.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -133.61 24.62 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -132.93 162.92 30.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 1.0 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -110.91 136.38 50.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -155.23 150.29 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.299 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.808 ' CB ' HD22 ' A' ' 94' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.972 0.415 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -65.16 -47.25 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 109.537 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 0.2 OUTLIER -68.21 -33.47 74.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 0.0 108.851 178.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.984 HD13 ' CD1' ' A' ' 66' ' ' ILE . 7.5 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.828 -0.545 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -53.04 -36.8 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.399 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 99' ' ' MET . 7.4 m170 -53.42 -45.47 69.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.999 -1.063 . . . . 0.0 108.22 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -78.73 -38.43 38.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.774 . . . . 0.0 108.92 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.949 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.77 -22.11 66.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.689 ' HG3' HD23 ' A' ' 149' ' ' LEU . 3.2 ttp . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.898 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.785 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.217 0.532 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.41 78.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.175 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.8 125.02 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.049 -1.032 . . . . 0.0 109.463 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.992 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -155.01 167.62 29.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 110.622 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 mt -101.43 147.43 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.0 110.958 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.703 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -96.66 133.31 41.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -96.64 67.54 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.703 -0.623 . . . . 0.0 110.26 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.54 -65.11 0.17 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -133.25 3.97 4.84 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.3 121.96 40.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -1.196 . . . . 0.0 110.289 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 9.7 mttt -82.25 105.53 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 147' ' ' LEU . 1.1 mp -89.45 108.94 28.03 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 0.0 108.947 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.3 Cg_endo -71.72 129.53 15.68 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.206 1.635 . . . . 0.0 112.191 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.64 135.12 52.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.595 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 5.7 p -118.51 117.48 54.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.939 -1.1 . . . . 0.0 110.822 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.792 ' C ' HD23 ' A' ' 149' ' ' LEU . 5.2 tt -113.73 115.07 27.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.519 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -146.05 11.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.026 -1.046 . . . . 0.0 111.352 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.69 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -118.43 124.62 28.4 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.256 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.72 145.85 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.895 1.471 . . . . 0.0 110.719 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 1.094 HD13 ' CD1' ' A' ' 19' ' ' TRP . 4.2 pp -82.11 139.86 34.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.563 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 3.9 m . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.392 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.945 ' O ' HD22 ' A' ' 64' ' ' LEU . 6.4 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.235 0.54 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -82.21 -175.3 5.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.872 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.175 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -107.64 -158.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.028 . . . . 0.0 110.215 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.942 HG21 ' O ' ' A' ' 135' ' ' ALA . 37.5 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 110.29 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.584 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.7 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 17.9 p90 -67.08 -35.71 80.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.571 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -54.78 -32.97 60.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.103 -0.998 . . . . 0.0 110.523 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.1 mt -67.32 -48.13 68.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 110.616 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 49' ' ' HIS . 2.0 m -72.76 -44.46 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 0.0 110.53 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 9' ' ' VAL . 95.7 t -58.47 -32.46 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.21 -33.06 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.93 -1.106 . . . . 0.0 110.807 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.688 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . . . -76.19 -33.59 59.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.153 -0.967 . . . . 0.0 111.143 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 6' ' ' VAL . 1.5 m -56.49 -37.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 108.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 71.2 mtt180 -55.57 -42.82 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.854 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -46.86 19.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -65.46 -39.44 92.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 73.0 mt-30 -59.97 -33.96 72.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -72.0 -29.8 64.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 110.027 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 1.4 t -59.17 -43.05 92.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.97 20.11 22.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 12' ' ' LEU . 4.1 p90 -130.08 -4.69 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.267 . . . . 0.0 110.472 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -95.46 119.36 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 0.0 109.919 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CD1' HD12 ' A' ' 40' ' ' LEU . 5.7 m95 -109.22 148.1 31.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.385 -0.822 . . . . 0.0 109.911 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.488 ' C ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -134.95 25.13 3.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.381 -0.824 . . . . 0.0 109.268 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.96 1.13 14.6 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.102 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.6 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.43 -157.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.923 -1.111 . . . . 0.0 109.469 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.593 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -97.5 169.53 9.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 110.074 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -42.67 -81.45 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.15 -31.6 42.12 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.26 -1.141 . . . . 0.0 110.705 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 7.4 mt-10 -58.82 -36.78 75.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.007 -1.29 . . . . 0.0 109.865 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 42' ' ' ARG . . . -61.65 -50.57 71.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.035 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.596 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 m-80 -68.99 -38.96 79.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.371 -0.831 . . . . 0.0 110.669 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.3 mp -70.51 -31.44 68.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.523 -0.735 . . . . 0.0 112.135 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.713 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.35 -43.34 71.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.261 . . . . 0.0 110.474 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -72.01 -34.99 69.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.77 -1.207 . . . . 0.0 108.636 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.859 ' OG ' HG21 ' A' ' 61' ' ' THR . 17.2 p -70.05 -32.4 70.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.671 -0.643 . . . . 0.0 110.286 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.19 -20.98 43.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.948 . . . . 0.0 110.142 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.7 mm-40 -115.52 -77.51 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -75.28 62.14 6.02 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.213 1.112 . . . . 0.0 109.818 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.6 141.42 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . 100.03 15.95 29.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.674 ' C ' HG23 ' A' ' 55' ' ' VAL . 16.7 p -134.98 147.27 49.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.659 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.573 ' CG ' HD13 ' A' ' 149' ' ' LEU . 47.9 p90 -122.76 141.11 52.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -134.49 158.16 44.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 110.099 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.88 HD12 HD23 ' A' ' 53' ' ' LEU . 2.7 tt -114.46 130.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 5.3 tpt180 -112.75 144.06 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' OG ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -92.29 115.67 28.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.832 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.222 0.534 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' HIS . 31.8 p90 -178.63 154.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.12 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.605 ' O ' ' CD1' ' A' ' 51' ' ' PHE . 9.3 p90 -124.15 141.44 52.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.507 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -127.01 148.13 50.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 109.631 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.038 HD11 ' CD1' ' A' ' 98' ' ' TYR . 4.3 pp -120.94 153.12 37.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.793 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.615 ' HB2' ' CA ' ' A' ' 63' ' ' ASN . 4.0 t -139.12 153.9 48.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 109.969 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG23 ' C ' ' A' ' 38' ' ' THR . 3.3 p -127.03 174.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -103.53 136.57 43.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -168.57 169.41 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -44.51 -44.43 8.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.628 ' CB ' HG21 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -54.16 -46.18 72.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.177 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.92 161.89 9.59 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.859 HG21 ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -80.13 111.78 16.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 110.195 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -142.0 152.87 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.487 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.615 ' CA ' ' HB2' ' A' ' 54' ' ' SER . 7.7 p30 -120.51 156.28 31.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.967 HD22 ' HA ' ' B' ' 166' ' ' THR . 23.8 mt -134.34 141.99 47.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -104.29 -177.55 3.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.295 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -105.46 149.04 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.248 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -95.65 132.24 41.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.154 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -106.27 136.84 45.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 71' ' ' GLY . 4.0 tt0 -132.0 102.91 6.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.47 -78.44 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -147.84 34.97 1.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.15 146.61 33.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.108 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 9.1 m-30 -110.97 155.85 22.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.15 165.92 32.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.975 . . . . 0.0 110.586 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 109.689 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' A' ' 8' ' ' ALA . 5.2 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.462 0.649 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -55.71 -34.87 65.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -57.66 -31.72 66.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.975 -1.078 . . . . 0.0 109.224 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.97 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -68.01 -34.62 76.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.603 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.97 ' N ' HD23 ' A' ' 94' ' ' LEU . 54.7 t -54.71 -37.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.155 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -53.8 -29.88 42.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.787 ' CE1' HD12 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -67.56 -40.86 84.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.038 ' CD1' HD11 ' A' ' 53' ' ' LEU . 38.1 m-85 -70.87 -15.74 62.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 97' ' ' HIS . 15.4 mmt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 27.2 mtp85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.287 0.565 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.41 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.083 ' CZ ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -102.72 124.65 48.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.083 -1.01 . . . . 0.0 109.065 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.901 ' H ' HG12 ' B' ' 168' ' ' VAL . 7.8 p90 -155.44 167.36 30.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.828 -1.17 . . . . 0.0 111.48 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.809 HD12 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -104.21 149.27 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.624 0.726 . . . . 0.0 111.0 -178.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.765 ' OH ' HG23 ' B' ' 168' ' ' VAL . 16.9 m-85 -96.42 133.34 40.96 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.494 0.664 . . . . 0.0 110.644 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.609 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -125.95 126.45 44.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 110.568 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 41.18 68.54 0.63 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.74 22.7 2.0 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 140' ' ' SER . 5.1 tp10 -117.7 121.97 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -1.208 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -84.64 105.62 15.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.663 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -99.17 98.78 6.98 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.893 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.7 Cg_endo -73.08 127.27 11.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 111.792 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.809 ' CD2' HD12 ' A' ' 138' ' ' ILE . 0.5 OUTLIER -126.14 133.2 51.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.1 p -107.53 117.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.765 -1.209 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.083 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.7 pp -102.34 123.17 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.2 OUTLIER -154.88 14.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.824 -179.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 37' ' ' GLY . 1.5 tpt180 -101.34 124.22 41.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.987 -1.071 . . . . 0.0 109.976 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.14 138.11 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.946 1.498 . . . . 0.0 110.591 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 40' ' ' LEU . 21.6 tp -91.22 123.55 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.187 0.518 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.967 ' HA ' HD22 ' A' ' 64' ' ' LEU . 8.8 t -149.78 154.83 39.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.945 HG21 ' CD2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -93.17 173.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.132 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.901 HG12 ' H ' ' A' ' 137' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.246 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 4' ' ' LEU . 1.5 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.232 0.539 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.4 p90 -56.73 -35.95 69.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.508 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 2.6 tm0? -67.95 -42.84 80.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.3 mt -67.1 -47.48 71.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.72 HG12 ' CZ ' ' A' ' 73' ' ' PHE . 25.7 m -61.4 -38.64 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.055 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 2' ' ' TYR . 25.6 t -58.72 -51.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.47 -45.51 91.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.04 97.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.683 HG23 ' CD2' ' A' ' 51' ' ' PHE . 13.8 t -57.44 -39.82 70.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.351 -0.843 . . . . 0.0 109.327 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.89 72.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.712 . . . . 0.0 109.936 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -41.03 46.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 21.4 tp -72.1 -43.99 63.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 9' ' ' VAL . 37.9 mt-30 -60.12 -33.5 72.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.56 -27.65 62.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.595 ' OG ' ' CD2' ' A' ' 17' ' ' PHE . 96.2 p -60.76 -43.09 98.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 109.843 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.35 26.99 7.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.91 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.9 p90 -132.39 -5.06 3.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 0.0 110.606 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.68 ' CD1' ' CG2' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -106.42 114.91 29.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.014 -1.054 . . . . 0.0 110.004 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.788 ' CE2' HD11 ' A' ' 40' ' ' LEU . 1.7 p-90 -126.46 148.24 49.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 110.025 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.01 107.49 14.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.98 10.19 0.17 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.551 -0.718 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -120.41 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -93.32 175.34 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.881 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.42 -81.99 0.04 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.592 ' HA2' ' OD1' ' A' ' 28' ' ' ASN . . . -79.35 -31.57 41.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.575 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.7 tt0 -59.22 -24.82 63.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.238 . . . . 0.0 109.94 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 23' ' ' THR . . . -69.16 -48.58 61.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.885 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.592 ' OD1' ' HA2' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -68.8 -47.26 66.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.396 -0.815 . . . . 0.0 110.899 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 1.5 mp -59.27 -31.92 69.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.797 . . . . 0.0 111.472 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -55.8 -46.08 78.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.9 -1.125 . . . . 0.0 109.665 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.023 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -73.08 -36.2 66.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 108.579 178.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 1.023 ' N ' HD23 ' A' ' 31' ' ' LEU . 1.9 m -69.8 -32.73 71.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 110.018 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.58 -20.95 42.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.6 mt-10 -113.15 -77.11 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.7 Cg_endo -72.11 64.11 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.33 1.174 . . . . 0.0 110.199 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 141.48 10.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.219 -0.926 . . . . 0.0 110.538 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 90.53 15.74 56.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.873 ' O ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -135.07 147.23 49.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -1.026 . . . . 0.0 110.252 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 149' ' ' LEU . 10.4 p90 -122.76 142.22 50.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 0.0 110.094 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 41' ' ' ILE . 5.5 tt -131.26 151.56 51.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.426 -0.796 . . . . 0.0 110.394 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.885 HD12 HD23 ' A' ' 53' ' ' LEU . 9.0 tt -114.77 128.07 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.446 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 5.5 tpt180 -119.56 139.56 51.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 1.4 t0 -73.89 138.06 44.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.443 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.311 0.577 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.55 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.3 p90 -79.71 168.57 19.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.922 . . . . 0.0 110.182 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.843 ' CE1' HG21 ' A' ' 91' ' ' VAL . 7.8 p90 -123.1 139.26 54.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 7.1 t -128.22 154.47 45.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.155 HD21 ' CG ' ' A' ' 98' ' ' TYR . 3.9 pp -139.47 151.38 46.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.941 -1.099 . . . . 0.0 110.456 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.579 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 0.8 OUTLIER -139.29 153.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.0 110.262 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 56' ' ' LYS . 10.7 p -129.01 173.47 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.333 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HB2' ' CA ' ' A' ' 32' ' ' SER . 9.6 tttm -116.92 139.14 50.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.606 HG21 HD22 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -146.26 -171.76 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.147 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.99 62.44 3.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 p -175.54 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.856 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.97 135.51 2.89 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 t -79.12 125.49 29.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.211 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' SER . 14.6 mmtt -123.8 141.96 51.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 110.175 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 4.3 p-10 -116.73 138.87 51.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.574 HD13 HG22 ' B' ' 167' ' ' VAL . 0.7 OUTLIER -132.16 131.01 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.419 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.504 ' HG3' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -96.29 157.08 16.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -100.6 136.3 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.152 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -119.91 150.98 39.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.276 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 72' ' ' SER . 19.9 p -87.95 130.26 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.56 124.37 48.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.4 -74.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -158.53 20.91 0.32 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 24.2 p -134.03 163.41 29.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.72 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.56 130.68 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.819 ' HA ' HD11 ' A' ' 94' ' ' LEU . 9.5 p -145.52 167.08 23.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.777 HD11 ' CE1' ' A' ' 97' ' ' HIS . 2.7 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' A' ' 51' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.197 0.522 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 9.3 mp -57.6 -46.64 83.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.565 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -38.38 84.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.024 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.819 HD11 ' HA ' ' A' ' 74' ' ' SER . 7.4 mt -68.09 -34.82 77.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.622 -0.673 . . . . 0.0 109.836 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 91' ' ' VAL . 26.9 t -54.66 -37.71 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 110.042 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -53.49 -35.53 60.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.029 . . . . 0.0 109.339 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.777 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -78.16 -34.19 49.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.714 . . . . 0.0 109.776 179.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.155 ' CG ' HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -61.88 -22.21 65.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.456 -0.778 . . . . 0.0 111.314 -178.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.865 ' HB2' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 120.913 -1.117 . . . . 0.0 111.554 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.741 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 5.9 tmm_? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 167.17 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.932 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.916 ' CD2' HG11 ' B' ' 167' ' ' VAL . 5.8 t80 -114.44 120.69 41.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.876 -1.14 . . . . 0.0 109.623 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.962 ' H ' HG12 ' B' ' 167' ' ' VAL . 1.8 p90 -157.15 166.89 31.99 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.954 -1.091 . . . . 0.0 109.998 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 147' ' ' LEU . 1.8 mp -119.24 147.41 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 120.88 -1.137 . . . . 0.0 111.51 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.833 ' CE2' HG23 ' B' ' 166' ' ' THR . 1.2 m-30 -84.65 107.77 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.705 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.762 ' HB3' HD13 ' A' ' 145' ' ' ILE . 10.3 t -92.47 124.82 36.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.68 61.54 3.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 57.09 20.28 34.28 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -120.23 121.73 39.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.942 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.62 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.06 105.44 11.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.005 -1.059 . . . . 0.0 110.704 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.863 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -97.71 115.09 65.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.2 Cg_endo -71.81 128.73 14.52 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 112.204 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.774 ' O ' ' O ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -126.1 136.46 52.93 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.4 t -97.41 116.45 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.062 -1.649 . . . . 0.0 109.852 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 98' ' ' TYR . 1.2 tt -91.47 125.31 36.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 6.9 p -165.55 46.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.78 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 4.4 mtp180 -134.08 124.54 17.53 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.06 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.0 Cg_endo -76.55 148.13 29.12 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.875 1.461 . . . . 0.0 110.771 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.91 HD21 ' O ' ' A' ' 17' ' ' PHE . 4.4 pp -88.18 158.04 18.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.589 ' C ' ' O ' ' A' ' 153' ' ' LEU . 14.0 t . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.704 -0.622 . . . . 0.0 111.067 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.573 ' C ' HG22 ' B' ' 166' ' ' THR . 36.6 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.236 0.541 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.833 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.2 OUTLIER 171.67 166.95 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -0.885 . . . . 0.0 110.311 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.962 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.58 -162.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.384 -0.823 . . . . 0.0 110.274 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.936 HG22 ' CE2' ' A' ' 137' ' ' TYR . 3.6 t . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.271 -0.893 . . . . 0.0 110.296 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.514 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.515 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -61.46 -47.91 83.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 110.053 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -67.53 -32.96 74.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.368 -0.832 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 71' ' ' GLY . 63.4 mt -57.01 -47.39 80.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.868 HG21 ' CA ' ' A' ' 50' ' ' PHE . 3.0 t -61.07 -47.24 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.092 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -43.19 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.134 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -65.0 -39.8 93.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.032 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.28 -44.45 52.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.895 . . . . 0.0 110.026 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.785 HG22 ' HE2' ' A' ' 18' ' ' TYR . 94.8 t -57.83 -39.91 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 0.0 109.391 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -55.74 -43.74 76.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.482 -0.762 . . . . 0.0 110.054 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -77.97 -44.33 27.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' HG21 ' A' ' 41' ' ' ILE . 44.9 tp -65.98 -42.1 90.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 12.8 pt20 -68.18 -38.86 82.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.257 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.4 tm-20 -57.79 -44.91 86.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -26.91 51.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.48 31.2 8.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.703 ' CZ ' ' CE1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -129.76 8.38 5.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -1.141 . . . . 0.0 110.266 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.785 ' HE2' HG22 ' A' ' 9' ' ' VAL . 2.6 t80 -90.81 136.18 33.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.972 ' CG ' HD12 ' A' ' 40' ' ' LEU . 12.9 m95 -108.48 143.42 37.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.334 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.687 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -149.78 110.99 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.892 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.36 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.66 -161.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 0.0 110.145 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -93.7 165.81 12.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 44' ' ' SER . . . -44.51 -84.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.66 -41.93 99.12 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.1 mt-10 -59.56 -27.12 65.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.973 -1.31 . . . . 0.0 110.212 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -78.3 -44.55 25.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 110.023 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.689 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.7 m120 -68.78 -48.27 64.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.465 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.6 mp -59.19 -32.32 69.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.832 . . . . 0.0 111.038 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -55.98 -26.19 47.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 38' ' ' THR . 2.4 pp -68.52 -33.17 73.65 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.396 -0.921 . . . . 0.0 108.599 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.535 ' CA ' ' HD2' ' A' ' 56' ' ' LYS . 7.5 t -69.78 -32.93 71.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.611 -0.681 . . . . 0.0 110.056 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.61 -20.99 41.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 110.013 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.769 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 22.2 mt-10 -122.85 -83.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 110.552 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.769 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.5 69.5 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.894 0.944 . . . . 0.0 110.44 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.34 141.38 41.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 110.287 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 78.6 20.68 70.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.985 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.5 m -124.99 147.88 48.71 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -1.041 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.715 ' HB2' HG12 ' A' ' 55' ' ' VAL . 13.0 p90 -122.42 145.71 48.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.542 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.972 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.03 159.47 43.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.466 -0.772 . . . . 0.0 109.964 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.578 HG21 ' CD2' ' A' ' 12' ' ' LEU . 3.1 tt -114.79 143.74 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.283 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.1 tpm_? -129.71 132.04 46.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' A' ' 42' ' ' ARG . 1.9 t0 -77.09 103.95 7.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.515 ' HB2' ' N ' ' A' ' 24' ' ' GLY . 64.2 m . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.133 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.513 ' NE2' ' CE1' ' A' ' 2' ' ' TYR . 35.4 m80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.279 0.561 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.868 ' CA ' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 59.95 108.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.099 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 14.6 p90 -115.88 143.5 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.4 m -126.08 155.29 41.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.89 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -130.84 128.43 40.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.519 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -139.26 154.09 47.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.45 -0.781 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.815 ' HA ' HD21 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -135.17 174.22 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HD2' ' CA ' ' A' ' 32' ' ' SER . 6.7 tttt -111.03 139.24 46.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.171 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.958 ' HB ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -131.97 -142.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 110.163 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 59' ' ' SER . 27.7 tt0 -46.09 -27.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.066 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER 163.46 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.522 -0.736 . . . . 0.0 109.77 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 80.5 1.53 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 56' ' ' LYS . 13.3 p -94.49 108.88 20.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 0.0 109.872 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.926 ' HD2' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -137.11 172.79 12.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -140.16 155.33 47.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.998 HD11 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.31 129.94 27.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 110.655 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -80.22 156.35 26.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' CE2' ' A' ' 73' ' ' PHE . 6.8 tp -76.77 140.54 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 110.413 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 74' ' ' SER . 2.8 mt-30 -91.81 117.77 30.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.658 ' SG ' HD12 ' A' ' 4' ' ' LEU . 42.0 t -98.93 117.15 32.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.02 102.95 14.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.861 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.34 -81.37 0.59 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.733 ' O ' HD11 ' A' ' 4' ' ' LEU . . . -141.45 6.79 2.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.4 OUTLIER -104.02 163.61 12.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 110.299 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.42 141.33 43.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.404 -0.81 . . . . 0.0 110.202 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 67' ' ' GLN . 4.0 p -155.41 139.99 16.94 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.935 . . . . 0.0 110.753 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.084 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 1.5 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.904 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -57.58 -47.35 82.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.999 -1.063 . . . . 0.0 108.899 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 93' ' ' LYS . 26.0 mmtt -68.44 -34.06 75.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 108.714 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.084 HD13 ' CB ' ' A' ' 75' ' ' LEU . 19.6 mt -59.82 -33.13 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.201 0.524 . . . . 0.0 110.297 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.19 -36.43 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.5 OUTLIER -53.68 -52.71 59.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.584 -1.322 . . . . 0.0 108.906 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.682 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 19.9 t60 -79.58 -53.12 7.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -0.865 . . . . 0.0 109.692 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.89 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.02 -22.25 65.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.726 -0.609 . . . . 0.0 110.344 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.733 ' HA ' HD11 ' A' ' 149' ' ' LEU . 2.3 mtp . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.768 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 8.5 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.253 0.549 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.88 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 162.49 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 109.874 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.132 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -106.73 125.52 51.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.977 ' N ' HG12 ' B' ' 167' ' ' VAL . 14.5 p90 -155.04 167.63 29.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.73 -1.231 . . . . 0.0 111.108 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.926 HG21 ' HD2' ' A' ' 62' ' ' LYS . 3.0 mp -101.93 149.07 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 110.933 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.713 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.9 m-85 -99.15 133.08 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 110.985 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER -89.91 -162.77 0.92 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.657 -0.652 . . . . 0.0 110.004 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -43.04 -45.93 6.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.0 18.31 0.23 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 145' ' ' ILE . 4.1 mm-40 -120.34 123.92 44.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.18 . . . . 0.0 110.403 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 23.5 mtpt -75.73 105.33 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.035 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.07 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -91.83 110.9 46.83 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.897 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -76.47 128.99 10.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.143 1.602 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.07 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -124.63 123.16 39.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.289 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.7 p -102.53 117.44 47.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.67 -1.269 . . . . 0.0 110.297 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.993 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.9 pp -108.65 132.29 54.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.875 . . . . 0.0 110.047 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.2 p -169.9 27.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.026 -1.046 . . . . 0.0 110.73 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.573 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -113.58 124.84 30.48 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 109.943 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 46.6 Cg_endo -73.76 129.82 13.95 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.988 1.52 . . . . 0.0 110.703 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.773 ' HB2' HG22 ' A' ' 38' ' ' THR . 36.7 tp -91.92 128.57 37.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.105 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.998 ' O ' HD11 ' A' ' 64' ' ' LEU . 4.7 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.06 0.457 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.536 ' C ' ' O ' ' B' ' 165' ' ' SER . 46.3 p -30.34 123.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.568 -0.707 . . . . 0.0 110.44 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.132 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -92.53 84.16 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 110.268 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 135' ' ' ALA . 32.8 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.592 ' CA ' HD12 ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.652 ' O ' HG23 ' A' ' 6' ' ' VAL . 29.8 p90 -61.19 -35.86 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.6 tt0 -55.0 -37.39 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.172 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.2 mt -60.9 -47.34 86.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 50' ' ' PHE . 55.5 t -70.38 -42.72 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.746 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 2' ' ' TYR . 73.2 t -58.78 -50.73 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.954 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.83 -41.87 87.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.93 -41.49 98.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.817 . . . . 0.0 109.659 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.15 HG22 ' CE2' ' A' ' 18' ' ' TYR . 2.9 t -56.97 -39.53 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.147 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -48.11 75.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -78.18 -38.94 42.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.14 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -65.3 -31.9 73.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.316 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.449 ' OE1' HG12 ' A' ' 9' ' ' VAL . 39.5 mt-30 -66.93 -39.86 87.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -34.28 71.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.262 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 p -72.02 -37.78 69.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 154' ' ' SER . . . 94.04 -5.18 71.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 9.0 t80 -93.54 6.04 49.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -1.111 . . . . 0.0 110.007 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 1.15 ' CE2' HG22 ' A' ' 9' ' ' VAL . 2.2 t80 -90.92 131.9 36.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 40' ' ' LEU . 29.1 m95 -124.15 104.18 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 111.146 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -122.44 17.73 10.53 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.873 0.845 . . . . 0.0 108.883 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.98 47.95 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.393 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.638 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -113.63 -157.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.889 -1.132 . . . . 0.0 109.974 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.599 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 1.2 p -95.96 176.1 6.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 42' ' ' ARG . . . -52.83 -69.51 1.18 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.66 -40.94 13.77 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.087 -1.243 . . . . 0.0 110.94 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 4.6 tp10 -59.59 -28.12 66.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.721 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.026 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -77.95 -42.92 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.084 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.952 HD21 HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.28 -44.97 70.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 111.277 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.952 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -70.32 -31.92 69.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.155 -0.966 . . . . 0.0 111.851 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.026 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.6 pp -55.43 -23.8 27.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.824 -1.173 . . . . 0.0 110.223 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.767 HD13 ' O ' ' A' ' 38' ' ' THR . 2.8 pp -78.47 -38.47 40.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.715 ' OG ' HG21 ' A' ' 61' ' ' THR . 12.7 p -70.09 -32.71 70.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.85 -20.57 42.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.299 -0.876 . . . . 0.0 110.973 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.715 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 11.8 mm-40 -116.29 -75.08 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.9 -1.125 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.715 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 45.2 Cg_endo -71.64 72.58 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.302 1.159 . . . . 0.0 110.564 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -57.62 141.25 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.952 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' H ' ' CE ' ' A' ' 56' ' ' LYS . . . 77.64 19.45 75.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -133.56 148.09 51.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -1.026 . . . . 0.0 109.928 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.905 ' HB3' HG23 ' A' ' 55' ' ' VAL . 21.9 p90 -121.84 159.44 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.937 . . . . 0.0 109.945 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.816 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -152.64 159.86 43.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 110.704 -178.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.679 HG12 ' OH ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -114.45 134.76 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 13.9 tpt180 -112.71 129.93 56.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.058 -1.026 . . . . 0.0 110.033 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.6 ' OD1' ' CG ' ' A' ' 51' ' ' PHE . 15.0 m-20 -98.59 138.1 36.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.281 -0.887 . . . . 0.0 110.494 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 9.1 t60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.175 0.512 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.826 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER 171.01 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.705 ' CD1' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -115.81 139.88 49.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.36 -0.838 . . . . 0.0 109.88 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 16.1 p -123.12 146.63 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.97 -1.081 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' B' ' 167' ' ' VAL . 0.2 OUTLIER -120.82 122.72 40.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 109.818 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.621 ' CB ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -143.52 155.94 44.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.726 -1.234 . . . . 0.0 112.812 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 39' ' ' PHE . 5.3 p -143.66 174.48 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.166 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 2.1 ttpt -115.72 125.45 52.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.862 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -153.88 -162.62 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.985 . . . . 0.0 110.498 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 57' ' ' THR . 5.1 mt-30 -79.77 -23.21 42.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -81.73 13.38 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.166 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.06 138.72 3.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.924 ' O ' HD11 ' A' ' 29' ' ' LEU . 2.9 t -78.85 108.76 12.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -1.139 . . . . 0.0 109.951 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 54' ' ' SER . 6.9 mmtt -109.17 157.94 18.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.213 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 64' ' ' LEU . 59.8 t30 -111.97 152.28 28.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.877 . . . . 0.0 110.028 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.98 ' CD1' HG23 ' B' ' 167' ' ' VAL . 15.1 mt -138.52 117.52 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 0.0 110.233 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -81.8 155.71 25.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 0.0 110.586 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.851 HD13 ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -77.28 141.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 110.014 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.3 mt-30 -93.48 132.55 37.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' SER . 30.0 t -109.42 118.82 37.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 72' ' ' SER . 7.0 mm-40 -133.15 104.77 6.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.442 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.68 36.32 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.18 -0.01 55.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -103.75 163.3 12.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -1.127 . . . . 0.0 109.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.4 m-30 -110.87 148.06 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.851 ' O ' HD13 ' A' ' 66' ' ' ILE . 19.5 m -144.43 138.59 27.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.808 . . . . 0.0 110.079 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.956 ' CD1' HD11 ' A' ' 94' ' ' LEU . 10.0 tp . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 109.94 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 92' ' ' LEU . 8.6 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 13.3 mt -63.41 -46.12 87.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 108.829 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -64.95 -29.42 70.35 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.576 0.703 . . . . 0.0 109.543 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.956 HD11 ' CD1' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.51 -34.55 69.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 110.739 -178.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.872 HG12 HD11 ' A' ' 12' ' ' LEU . 3.7 m -54.19 -39.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.928 -1.108 . . . . 0.0 108.825 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.51 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -68.62 -30.01 68.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 178.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.668 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -56.73 -38.82 72.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 110.276 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.864 ' HA ' HD13 ' A' ' 149' ' ' LEU . 36.3 m-85 -73.8 -0.65 16.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.602 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.035 -1.041 . . . . 0.0 110.471 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.761 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 2.8 ttt180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.13 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.844 . . . . 0.0 109.997 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.904 ' CD1' ' O ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -102.59 124.86 48.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.018 . . . . 0.0 108.993 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.931 ' N ' HG13 ' B' ' 167' ' ' VAL . 6.7 p90 -156.02 166.34 33.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.804 -1.185 . . . . 0.0 111.016 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.889 ' H ' HD13 ' A' ' 147' ' ' LEU . 5.6 mt -102.43 149.53 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.778 0.799 . . . . 0.0 111.377 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -97.79 133.46 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.639 0.733 . . . . 0.0 110.969 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.972 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -121.43 119.53 32.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.566 -0.709 . . . . 0.0 110.52 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 42.58 63.41 1.91 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.3 13.84 23.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 140' ' ' SER . 8.3 tp10 -109.97 121.73 45.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 18.2 mttt -79.4 105.65 10.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.833 . . . . 0.0 110.561 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 147' ' ' LEU . 1.2 mp -97.22 109.67 50.71 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.846 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.59 129.38 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.139 1.599 . . . . 0.0 111.838 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.002 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.28 134.96 53.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.493 -0.755 . . . . 0.0 109.87 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.93 118.41 53.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER -76.06 157.83 32.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.87 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.4 -74.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 0.0 110.999 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 38' ' ' THR . 2.8 mtt180 -105.19 132.54 20.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.038 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 49.9 Cg_endo -78.04 148.01 24.33 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.02 1.537 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -85.26 115.9 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.346 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.723 ' C ' HD22 ' A' ' 64' ' ' LEU . 6.9 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.15 0.5 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.854 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.2 t -178.32 147.41 0.42 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.98 HG23 ' CD1' ' A' ' 64' ' ' LEU . 5.0 t -86.03 145.38 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 137' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.1 mt-10 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.237 0.542 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.577 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 t80 -66.8 -51.51 54.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.219 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -67.3 -40.8 86.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.723 HD12 ' HA ' ' A' ' 1' ' ' GLU . 3.0 mt -56.99 -45.89 82.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.158 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.887 HG21 ' HA ' ' A' ' 50' ' ' PHE . 17.0 t -71.97 -47.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 2' ' ' TYR . 81.0 t -58.75 -32.77 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.358 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -70.88 -38.68 73.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 91' ' ' VAL . . . -76.14 -44.61 37.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.485 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.696 HG12 ' HE2' ' A' ' 18' ' ' TYR . 24.5 m -57.62 -39.81 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.323 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 mmt180 -55.75 -44.44 77.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 109.82 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.09 -41.32 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.921 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.88 -41.93 95.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 19.6 mt-30 -67.75 -35.27 78.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -69.7 -49.57 52.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -58.53 -28.75 65.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.23 15.84 29.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . 4.0 m-85 -101.85 -0.94 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.144 . . . . 0.0 110.13 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.696 ' HE2' HG12 ' A' ' 9' ' ' VAL . 4.3 t80 -90.77 136.05 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.639 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.861 ' HE1' HD13 ' A' ' 153' ' ' LEU . 45.9 m95 -117.35 148.07 42.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 109.651 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -150.66 108.18 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 110.444 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.737 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . . . 176.16 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -119.42 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 110.421 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -85.61 176.14 8.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.338 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.7 -69.38 1.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' HG ' ' A' ' 54' ' ' SER . . . -77.64 -36.04 34.52 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 3.1 tt0 -59.66 -24.57 64.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 0.0 109.603 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.002 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -74.35 -46.47 40.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.474 -0.766 . . . . 0.0 110.364 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.904 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -67.96 -36.68 80.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.765 HD11 ' HB ' ' A' ' 61' ' ' THR . 0.4 OUTLIER -57.71 -32.31 67.27 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.004 -1.06 . . . . 0.0 110.282 -178.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -56.39 -23.88 40.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 108.765 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.965 HD11 ' CB ' ' A' ' 56' ' ' LYS . 1.7 pp -68.06 -33.67 75.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 m -69.56 -33.03 72.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.758 . . . . 0.0 109.777 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.01 41.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 109.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.788 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 45.1 mm-40 -125.93 -86.87 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.788 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.4 Cg_endo -74.46 68.57 5.25 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 122.831 0.911 . . . . 0.0 110.267 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 141.47 48.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 0.0 110.64 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.27 18.65 66.34 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.866 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -131.28 148.21 52.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.482 -1.01 . . . . 0.0 110.103 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.758 ' CZ ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -121.72 138.74 54.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 110.068 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.13 161.09 28.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.45 -0.781 . . . . 0.0 110.286 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -113.12 128.69 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.108 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 1.002 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -129.14 136.51 50.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.831 . . . . 0.0 109.655 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 2.3 t0 -73.77 127.57 33.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.299 -0.876 . . . . 0.0 110.184 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.23 0.538 . . . . 0.0 110.248 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.887 ' HA ' HG21 ' A' ' 5' ' ' VAL . 18.4 t80 55.04 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.878 ' HD2' HG13 ' A' ' 5' ' ' VAL . 7.3 p90 -126.24 148.79 49.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.034 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.3 m -126.42 155.03 42.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -126.93 136.52 52.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.004 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.71 154.29 45.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 109.55 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 149' ' ' LEU . 6.6 m -118.02 174.36 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.563 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.965 ' CB ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -103.91 138.98 39.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.39 -0.819 . . . . 0.0 110.28 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.724 HG23 HD11 ' A' ' 147' ' ' LEU . 21.1 m -127.32 158.14 38.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 57' ' ' THR . 43.9 mt-30 -38.92 -28.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.0 t -173.55 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.2 62.4 0.46 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.765 ' HB ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -78.95 108.94 12.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -1.194 . . . . 0.0 109.514 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -137.46 178.0 7.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 0.0 110.67 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.56 ' CA ' ' HB3' ' A' ' 54' ' ' SER . 32.5 p-10 -137.56 156.17 48.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.491 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 52' ' ' THR . 34.5 mt -131.04 152.19 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.11 156.79 18.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 110.178 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.83 HD13 ' HB2' ' A' ' 94' ' ' LEU . 3.5 tp -76.76 134.75 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.96 151.04 20.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.8 t -116.72 116.92 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.6 mm-40 -107.41 102.79 12.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.009 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.38 -79.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -143.7 45.67 0.87 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 t -142.92 163.03 33.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -1.155 . . . . 0.0 110.393 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -133.14 126.8 32.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 109.823 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.787 ' N ' HD11 ' A' ' 66' ' ' ILE . 4.1 p -155.24 146.03 22.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.018 . . . . 0.0 110.435 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.863 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.001 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.853 HG23 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.427 0.632 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.965 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -56.47 -35.37 67.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.485 -0.759 . . . . 0.0 110.154 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -58.25 -38.57 77.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.266 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.959 HD21 ' CD2' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -68.16 -35.14 77.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.418 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 94' ' ' LEU . 93.4 t -55.37 -37.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.749 . . . . 0.0 110.404 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.09 -45.51 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.58 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.456 ' HE1' HG12 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -78.12 -36.74 47.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.84 . . . . 0.0 109.533 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.959 ' CD2' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -69.32 -12.15 61.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 12.5 ttt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.27 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mmt-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.172 0.511 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' HG21 ' B' ' 168' ' ' VAL . . . -160.89 132.85 5.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' B' ' 167' ' ' VAL . 1.5 t80 -119.42 123.53 44.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.838 ' H ' HG22 ' B' ' 167' ' ' VAL . 3.8 p90 -155.23 166.74 32.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.857 -1.152 . . . . 0.0 111.285 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.663 ' H ' HD23 ' A' ' 147' ' ' LEU . 3.0 mt -102.44 149.11 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.388 -0.82 . . . . 0.0 111.207 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.711 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 14.8 m-85 -98.72 133.19 43.39 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.692 0.758 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.72 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -94.88 -162.07 0.91 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.68 . . . . 0.0 110.134 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.37 60.7 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 101.6 2.46 53.12 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -119.97 121.92 40.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.644 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -80.74 105.33 11.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.485 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.996 HG22 HD21 ' A' ' 147' ' ' LEU . 1.5 mp -82.77 109.13 14.82 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -74.93 129.42 12.38 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.193 1.628 . . . . 0.0 112.811 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.996 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -125.25 135.86 52.96 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 148' ' ' VAL . 13.0 p -97.43 117.15 41.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.265 -1.522 . . . . 0.0 110.428 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 98' ' ' TYR . 9.5 tp -91.88 114.8 27.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 t -161.77 10.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.892 -1.13 . . . . 0.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 2.9 mtt85 -108.93 123.93 35.62 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.679 -1.263 . . . . 0.0 109.991 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 50.1 Cg_endo -78.65 148.35 22.84 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.98 1.516 . . . . 0.0 111.039 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.861 HD13 ' HE1' ' A' ' 19' ' ' TRP . 4.4 pp -83.73 135.63 34.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.914 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.531 ' HB3' HD12 ' A' ' 153' ' ' LEU . 12.7 t . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 110.36 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.235 0.54 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.73 159.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -113.47 170.61 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 135' ' ' ALA . 46.8 t . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.195 0.521 . . . . 0.0 111.314 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.779 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.3 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 6' ' ' VAL . 55.1 p90 -57.55 -36.04 71.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.9 tt0 -55.03 -37.98 67.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 1' ' ' GLU . 1.5 mt -58.87 -45.8 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.995 HG22 ' CE2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -71.16 -37.34 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.189 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 2' ' ' TYR . 94.9 t -58.02 -39.43 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.923 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -70.69 -34.67 72.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.797 ' HB2' HD11 ' A' ' 92' ' ' LEU . . . -76.27 -44.17 38.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.785 . . . . 0.0 110.119 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.656 HG23 ' CE2' ' A' ' 51' ' ' PHE . 47.3 t -57.4 -39.85 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.47 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.8 ttm180 -55.91 -45.46 78.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.947 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -38.61 43.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.862 . . . . 0.0 109.992 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 41' ' ' ILE . 18.0 tp -71.0 -40.7 71.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 110.013 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 15.4 pt20 -68.12 -34.94 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.303 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -57.95 -27.92 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.54 -27.27 69.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.865 . . . . 0.0 110.168 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.3 25.11 24.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -130.11 7.83 5.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.041 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.558 ' HD2' HD23 ' A' ' 12' ' ' LEU . 4.3 t80 -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.813 ' CG ' HD11 ' A' ' 40' ' ' LEU . 17.2 m95 -121.1 148.56 44.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.416 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -151.41 24.83 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.02 8.97 20.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.661 -0.649 . . . . 0.0 110.924 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.785 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -116.35 -160.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.049 . . . . 0.0 109.925 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.54 ' CB ' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -97.31 176.16 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.319 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.58 -85.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.593 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -70.74 -31.63 67.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -59.09 -39.17 81.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.129 -1.218 . . . . 0.0 109.958 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -64.44 -47.03 80.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.627 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.713 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 m-80 -68.91 -43.66 74.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -0.94 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.468 ' O ' ' OG ' ' A' ' 32' ' ' SER . 1.6 mp -70.53 -32.29 69.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 112.072 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -55.17 -24.42 26.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.709 -1.244 . . . . 0.0 111.032 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.016 HD13 ' O ' ' A' ' 38' ' ' THR . 4.4 pp -77.56 -37.86 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 0.0 109.584 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.884 ' N ' HD12 ' A' ' 31' ' ' LEU . 21.8 p -69.74 -32.57 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 0.0 110.28 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.65 43.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.615 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.731 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 5.3 mm-40 -115.76 -76.41 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.92 -1.112 . . . . 0.0 110.489 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.731 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.2 Cg_endo -72.69 70.37 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.286 1.151 . . . . 0.0 110.509 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 141.23 13.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 73.46 20.77 79.92 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 1.016 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.3 m -129.59 147.7 51.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -1.074 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.782 ' CD1' HG12 ' A' ' 55' ' ' VAL . 9.7 m-85 -122.9 158.46 30.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.382 -0.824 . . . . 0.0 109.454 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.006 ' HB2' HD13 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -152.38 160.57 43.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.008 -1.058 . . . . 0.0 111.195 -178.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.704 HG21 ' CD2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -113.89 129.18 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.541 -0.724 . . . . 0.0 109.906 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -117.36 161.12 20.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.282 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.486 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 7.5 t70 -100.05 138.06 37.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 109.991 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' ASP . 53.1 p . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.291 0.567 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.939 ' CA ' HG21 ' A' ' 5' ' ' VAL . 12.2 p90 -163.8 -165.01 0.96 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 1.107 ' CE1' HG22 ' A' ' 91' ' ' VAL . 13.0 p90 -134.33 139.6 45.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 110.628 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.59 ' CG2' ' HA ' ' A' ' 65' ' ' ARG . 2.2 p -126.31 155.29 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.474 -0.767 . . . . 0.0 109.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.18 HD12 ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -134.37 142.58 47.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.064 -1.023 . . . . 0.0 110.688 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.18 ' N ' HD12 ' A' ' 53' ' ' LEU . 1.3 p -124.5 154.17 40.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.097 HG11 HD22 ' A' ' 149' ' ' LEU . 21.2 m -117.63 174.01 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.114 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.99 130.79 51.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.465 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 80.5 p -141.11 156.6 45.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.76 82.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.2 t -63.0 -10.86 15.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 124.07 153.64 8.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -78.91 140.47 38.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' SER . 69.6 mmtt -139.16 133.18 31.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.585 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 11.2 p30 -111.91 128.85 56.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 HG23 ' B' ' 167' ' ' VAL . 2.9 mp -102.43 118.14 36.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.972 . . . . 0.0 110.252 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 0.1 OUTLIER -84.52 152.26 24.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.664 HG22 ' CD1' ' A' ' 50' ' ' PHE . 4.5 tp -84.93 149.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -114.58 115.65 27.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.855 . . . . 0.0 110.504 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 27.5 p -92.04 123.15 35.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 14.9 tt0 -133.19 103.5 6.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.5 32.93 85.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.81 -11.67 69.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 82.9 p -94.74 143.1 26.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.989 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.667 ' HE2' HG23 ' A' ' 5' ' ' VAL . 3.4 m-30 -110.82 157.36 19.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.243 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -155.56 138.65 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.153 -0.967 . . . . 0.0 110.486 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.06 ' CD2' HD21 ' A' ' 94' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.107 HG22 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 8' ' ' ALA . 4.9 mp -66.36 -46.2 77.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 108.841 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -29.22 69.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.784 0.802 . . . . 0.0 108.869 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.145 HD22 ' CZ ' ' A' ' 98' ' ' TYR . 5.0 mt -57.48 -34.23 68.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 0.0 110.096 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -54.27 -38.66 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.879 -1.138 . . . . 0.0 108.686 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.478 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 7.7 m170 -68.64 -51.89 37.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 108.862 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -63.81 -36.95 85.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.358 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 3.7 m-30 -73.38 -9.16 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.642 -0.661 . . . . 0.0 110.013 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 110.2 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 ptm180 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.59 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG11 ' B' ' 168' ' ' VAL . . . 172.23 130.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.023 ' CD2' HG11 ' B' ' 167' ' ' VAL . 1.2 t80 -116.55 122.54 44.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.984 -1.072 . . . . 0.0 109.306 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.042 ' CD2' HG12 ' B' ' 168' ' ' VAL . 5.4 p90 -156.32 166.95 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.952 -1.092 . . . . 0.0 110.66 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.33 149.17 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.061 . . . . 0.0 111.356 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.71 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.7 m-30 -86.44 107.88 18.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.591 -0.693 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.947 ' HB2' HD13 ' A' ' 145' ' ' ILE . 23.0 t -55.78 84.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.018 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 66.9 -64.79 0.19 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -144.7 13.08 1.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 145' ' ' ILE . 2.8 tt0 -120.45 123.43 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.093 . . . . 0.0 109.797 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -75.5 105.57 6.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 140' ' ' SER . 0.9 OUTLIER -103.38 112.86 65.94 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.8 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.8 Cg_endo -72.79 127.47 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.76 1.4 . . . . 0.0 111.791 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.66 ' O ' ' O ' ' A' ' 136' ' ' TYR . 1.1 mp -126.42 135.24 51.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.689 ' O ' HG23 ' A' ' 148' ' ' VAL . 15.0 m -97.88 116.58 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.187 -1.571 . . . . 0.0 109.945 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.097 HD22 HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -109.5 123.34 49.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.7 m -158.61 61.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -134.37 124.92 17.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.7 144.17 34.92 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.922 1.485 . . . . 0.0 110.472 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 1.006 HD13 ' HB2' ' A' ' 40' ' ' LEU . 1.3 tt -92.03 153.74 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.885 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 64' ' ' LEU . 50.9 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.742 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -89.61 139.55 30.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.023 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -91.77 106.92 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.067 -1.021 . . . . 0.0 109.829 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.042 HG12 ' CD2' ' A' ' 137' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.791 ' O ' HG12 ' A' ' 5' ' ' VAL . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.224 0.535 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.0 p90 -60.49 -37.17 80.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.18 -41.46 77.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.341 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' SG ' ' A' ' 68' ' ' CYS . 1.1 mt -67.44 -47.21 70.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.123 HG23 ' CE2' ' A' ' 51' ' ' PHE . 3.5 p -64.95 -48.36 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.757 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 2' ' ' TYR . 12.4 p -58.7 -43.99 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 109.984 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.598 ' N ' HG13 ' A' ' 6' ' ' VAL . 6.5 m-80 -59.06 -42.16 89.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.0 109.618 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.859 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -68.34 -44.17 75.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.806 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 49.1 t -57.53 -39.8 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.387 -0.821 . . . . 0.0 109.25 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 tpt180 -55.66 -49.0 74.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -34.26 49.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.806 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 tp -72.16 -44.15 63.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 110.097 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 15.7 pt20 -60.82 -33.91 73.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 25.7 tt0 -57.82 -18.98 25.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.426 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 59.1 m -55.99 -43.01 77.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.044 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.2 34.37 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 12' ' ' LEU . 15.5 p90 -153.0 18.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.253 . . . . 0.0 110.56 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 3.0 t80 -90.84 119.86 31.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.756 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 1.044 ' CG ' HD12 ' A' ' 40' ' ' LEU . 31.6 m95 -72.69 148.12 45.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.631 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.804 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -62.15 -12.67 21.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.901 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 74.1 75.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 110.915 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -46.42 -92.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 109.091 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.595 ' H ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -106.63 165.81 11.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 178.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.526 ' HA2' ' NH1' ' A' ' 42' ' ' ARG . . . -43.51 -81.16 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.614 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.26 -30.15 47.1 Favored Glycine 0 N--CA 1.491 2.349 0 O-C-N 121.41 -1.053 . . . . 0.0 110.705 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.592 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -58.22 -24.46 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.378 . . . . 0.0 110.955 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 42' ' ' ARG . . . -77.63 -46.61 21.55 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 110.146 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.758 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -70.42 -46.85 63.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 111.2 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.758 HD13 ' OD1' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -70.61 -29.98 66.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 112.069 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.952 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -52.96 -23.25 6.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.64 -1.288 . . . . 0.0 109.8 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 40' ' ' LEU . 45.0 mt -64.05 -41.33 97.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.992 -1.068 . . . . 0.0 109.219 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 55.9 p -69.1 -31.6 70.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 -20.13 47.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.787 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 17.8 mm-40 -126.15 -81.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.901 -1.124 . . . . 0.0 110.607 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 55.4 Cg_endo -77.71 68.43 7.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 122.902 0.949 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.39 135.5 33.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.625 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 87.04 7.9 76.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 35' ' ' PRO . 27.4 p -116.11 147.71 41.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -1.136 . . . . 0.0 110.608 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.957 ' CD1' HD11 ' A' ' 53' ' ' LEU . 7.2 p90 -122.3 147.3 46.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 0.0 110.374 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.044 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -147.21 160.24 42.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.481 -0.762 . . . . 0.0 109.548 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 1.4 tt -113.56 128.47 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 110.001 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.564 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 5.7 ppt_? -112.77 122.11 46.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 110.31 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.773 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 4.9 t70 -73.82 114.97 12.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.239 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 44' ' ' SER . 7.6 m-70 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.187 0.518 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.755 ' CB ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -143.6 -150.82 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.162 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 1.123 ' CE2' HG23 ' A' ' 5' ' ' VAL . 25.6 p90 -115.56 142.79 46.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 110.104 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.638 HG22 ' CG ' ' A' ' 63' ' ' ASN . 2.4 m -126.28 143.5 51.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.089 HD22 ' CD1' ' A' ' 98' ' ' TYR . 7.2 tt -124.21 135.1 53.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.655 ' CB ' ' OD1' ' A' ' 28' ' ' ASN . 23.1 p -139.26 155.42 47.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 61' ' ' THR . 10.3 p -140.94 158.9 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 110.481 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.76 137.48 41.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 147' ' ' LEU . 25.8 p -137.73 -74.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 59' ' ' SER . 2.3 mt-30 -147.43 -78.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 58' ' ' GLN . 9.8 t -42.69 -53.17 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.32 47.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 55' ' ' VAL . 5.5 m -99.56 141.02 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.17 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.9 145.86 51.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.25 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.638 ' CG ' HG22 ' A' ' 52' ' ' THR . 13.6 t-20 -111.13 132.34 54.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.92 ' CD1' HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -110.97 152.13 27.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.621 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -140.91 148.05 39.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.258 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.576 HG12 ' CD2' ' A' ' 73' ' ' PHE . 10.0 tp -76.83 128.29 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 74' ' ' SER . 2.7 tp-100 -96.54 151.1 19.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.216 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.708 ' SG ' HD13 ' A' ' 4' ' ' LEU . 36.5 t -93.01 139.12 30.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -130.08 102.94 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 44.82 -111.19 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.73 28.11 15.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.18 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 110.145 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.576 ' CD2' HG12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -124.54 144.96 49.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 67' ' ' GLN . 47.4 t -155.54 167.12 31.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.571 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 ' CD1' ' A' ' 94' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 109.892 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG11 ' HB1' ' A' ' 8' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 91' ' ' VAL . 7.4 mp -59.52 -47.1 86.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.045 . . . . 0.0 108.974 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -31.86 72.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -59.73 -35.03 73.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.697 -0.627 . . . . 0.0 110.261 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 91' ' ' VAL . 62.9 t -54.5 -38.01 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.574 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 51.7 m170 -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.284 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.649 ' NE2' HG23 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.15 -50.51 11.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.932 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.089 ' CD1' HD22 ' A' ' 53' ' ' LEU . 10.0 m-85 -63.79 -11.73 29.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 4.4 tpt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.138 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.851 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.83 143.98 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.208 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.8 t80 -138.21 121.65 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.579 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.121 ' CD2' HG12 ' B' ' 168' ' ' VAL . 6.7 p90 -156.11 166.72 32.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.737 -1.227 . . . . 0.0 110.843 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.721 ' H ' HD23 ' A' ' 147' ' ' LEU . 2.5 mt -102.14 149.61 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.289 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.699 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.6 m-85 -99.4 133.37 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.637 0.732 . . . . 0.0 111.007 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -88.31 54.23 3.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.526 -0.734 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.63 31.41 1.73 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.87 -29.56 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 140' ' ' SER . 6.1 mp0 -116.06 121.91 43.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.12 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.66 105.39 8.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.096 HG22 HD21 ' A' ' 147' ' ' LEU . 1.3 mp -87.56 110.64 35.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.711 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 48.9 Cg_endo -75.72 128.12 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.026 1.54 . . . . 0.0 112.728 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.096 HD21 HG22 ' A' ' 145' ' ' ILE . 2.0 mm? -125.49 135.32 52.18 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 148' ' ' VAL . 5.6 m -98.68 116.38 41.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.006 -1.684 . . . . 0.0 111.218 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.961 HD12 ' CD2' ' A' ' 136' ' ' TYR . 1.6 mt -91.05 125.89 35.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.022 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 90.9 p -151.23 -24.39 0.21 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.774 -1.204 . . . . 0.0 111.985 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 38' ' ' THR . 47.5 mtp180 -85.85 124.5 70.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.627 -1.296 . . . . 0.0 110.328 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.57 148.23 25.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.104 1.581 . . . . 0.0 110.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.941 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.54 158.13 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.357 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 153' ' ' LEU . 7.7 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.31 0.576 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.436 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -94.04 151.43 19.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.291 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.208 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.2 t -87.59 -160.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 1.121 HG12 ' CD2' ' A' ' 137' ' ' TYR . 21.4 m . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.215 0.531 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.478 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.18 -35.74 79.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 43.4 tp60 -54.79 -33.85 61.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.168 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.098 HD22 ' CD1' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -57.0 -47.02 81.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.035 HG22 ' CD2' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -59.89 -44.41 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 73.7 t -58.73 -51.14 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 48.3 m-20 -59.83 -46.08 90.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -63.08 -43.51 98.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -0.801 . . . . 0.0 109.655 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 18' ' ' TYR . 25.6 t -57.29 -39.31 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.72 . . . . 0.0 109.311 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.7 tpt180 -55.42 -40.92 72.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.445 -0.784 . . . . 0.0 109.887 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -42.15 32.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 41' ' ' ILE . 1.2 tp -72.0 -38.87 69.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 8.6 pt20 -65.77 -33.97 77.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.84 -18.96 25.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -56.6 -43.49 80.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 110.081 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.97 30.9 2.02 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.662 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 15' ' ' SER . 1.6 p90 -159.93 33.79 0.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.43 . . . . 0.0 111.134 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.786 ' CE2' HG13 ' A' ' 9' ' ' VAL . 1.7 t80 -90.89 134.66 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.725 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.727 ' CB ' HD11 ' A' ' 40' ' ' LEU . 24.8 m95 -124.5 148.55 47.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.13 23.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.01 0.15 13.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.546 -0.721 . . . . 0.0 111.004 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -107.24 -158.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.9 -1.125 . . . . 0.0 109.721 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.54 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -101.56 170.76 7.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.093 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.75 -79.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.32 -30.92 43.75 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.4 tp10 -58.27 -37.78 75.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -1.225 . . . . 0.0 110.069 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.47 -50.69 71.76 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.031 -1.043 . . . . 0.0 108.825 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.547 HD21 HD23 ' A' ' 40' ' ' LEU . 5.2 m120 -69.79 -49.04 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 61' ' ' THR . 1.6 mp -59.77 -31.76 69.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 111.237 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.93 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.25 -22.49 11.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.998 -1.064 . . . . 0.0 109.555 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 38' ' ' THR . 80.4 mt -60.13 -35.3 74.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.087 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.672 ' HB2' ' CD ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -69.56 -32.48 71.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.112 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.2 -20.8 43.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.96 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.754 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.6 mt-10 -131.07 -84.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.515 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.754 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.1 Cg_endo -76.77 68.31 7.17 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 122.77 0.879 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.27 141.74 14.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -0.978 . . . . 0.0 110.717 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' ' CD ' ' A' ' 151' ' ' ARG . . . 72.32 25.66 73.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.855 ' O ' HD13 ' A' ' 31' ' ' LEU . 79.1 m -119.82 149.19 42.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.933 . . . . 0.0 110.692 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.845 ' CB ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.72 138.81 53.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.795 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -134.08 160.53 37.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.442 -0.786 . . . . 0.0 110.959 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.763 HG13 HD21 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -114.07 134.09 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 1.1 ttp-105 -129.32 146.35 51.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.327 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 8.2 t0 -99.08 138.0 36.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 21.6 m170 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.184 0.516 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 1.013 ' HA ' HG21 ' A' ' 5' ' ' VAL . 27.6 p90 -89.78 -177.77 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.197 -0.939 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 1.035 ' CD2' HG22 ' A' ' 5' ' ' VAL . 6.8 p90 -116.0 155.72 27.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.53 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.2 m -126.16 154.65 42.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.028 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -135.0 130.86 36.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 1.028 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.43 153.9 50.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.583 -0.698 . . . . 0.0 109.665 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.845 HG23 ' CB ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -127.59 171.18 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 110.447 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -119.38 135.42 54.74 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 0.0 110.1 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 4.4 t -127.51 61.34 1.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER 67.37 -57.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -145.84 47.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.208 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' HG22 ' A' ' 57' ' ' THR . . . -153.57 74.42 0.24 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.749 HG23 HD11 ' A' ' 29' ' ' LEU . 2.7 m -96.17 108.87 21.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.672 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.7 OUTLIER -128.97 155.29 45.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 1.049 ' O ' HD23 ' A' ' 64' ' ' LEU . 4.0 m-20 -140.07 149.22 42.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 63' ' ' ASN . 17.4 mt -134.87 147.17 49.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -108.38 153.62 23.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.313 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.087 ' CD1' HD12 ' A' ' 75' ' ' LEU . 20.0 mm -89.06 145.59 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.43 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 66' ' ' ILE . 51.5 mm-40 -122.09 132.96 54.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 72' ' ' SER . 28.1 p -88.61 125.24 34.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.11 112.27 11.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 53.5 65.82 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.36 18.02 9.22 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.8 OUTLIER -122.29 163.15 20.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -1.174 . . . . 0.0 109.882 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 1.098 ' CD1' HD22 ' A' ' 4' ' ' LEU . 5.3 m-85 -131.94 139.8 48.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 110.47 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.422 ' CA ' HD11 ' A' ' 94' ' ' LEU . 8.3 t -147.23 138.98 24.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.0 110.101 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.11 HD22 ' CE1' ' A' ' 97' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 51' ' ' PHE . 2.8 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.655 0.74 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.766 ' O ' HG12 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -54.03 -35.07 61.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 110.932 -178.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.62 ' N ' ' HG ' ' A' ' 92' ' ' LEU . 1.5 tptt -58.28 -35.65 72.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.54 -1.35 . . . . 0.0 109.06 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.624 HD12 HD12 ' A' ' 66' ' ' ILE . 63.1 mt -62.86 -34.86 78.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -54.6 -37.07 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.448 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -53.76 -31.54 48.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.02 . . . . 0.0 109.121 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 1.11 ' CE1' HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -65.86 -35.94 82.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 0.0 109.411 179.173 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.841 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.9 m-85 -63.05 -10.54 14.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.612 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.703 -0.623 . . . . 0.0 110.211 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.774 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 29.3 mmt-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.188 0.518 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 163.27 75.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.913 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.867 ' HB2' HG11 ' B' ' 167' ' ' VAL . 0.2 OUTLIER -102.7 124.72 48.76 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 109.321 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.972 ' N ' HG13 ' B' ' 167' ' ' VAL . 5.6 p90 -155.6 167.06 31.62 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.085 -1.009 . . . . 0.0 110.983 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.672 HD13 ' CB ' ' A' ' 62' ' ' LYS . 2.2 mp -102.75 149.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 111.11 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.694 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 17.5 m-85 -97.31 133.3 42.1 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.697 0.76 . . . . 0.0 111.096 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 3.2 t -86.48 51.92 2.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.17 27.53 1.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.42 -32.78 0.24 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 14.2 tp10 -120.19 121.98 39.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.234 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 3.9 ptmt -72.03 105.46 3.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.397 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.833 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -85.11 110.54 29.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.0 Cg_endo -75.38 129.65 12.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.124 1.591 . . . . 0.0 111.828 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 138' ' ' ILE . 1.0 OUTLIER -124.02 134.2 53.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.392 -0.818 . . . . 0.0 109.396 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 148' ' ' VAL . 13.5 m -107.61 117.53 53.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.96 -1.087 . . . . 0.0 110.604 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 55' ' ' VAL . 6.6 tt -125.08 114.82 19.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.78 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.8 t -168.1 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.038 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.589 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -111.9 124.83 31.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 109.996 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.38 138.26 29.7 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.93 1.49 . . . . 0.0 110.693 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 154' ' ' SER . 4.8 tp -91.77 145.66 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.868 ' H ' HD12 ' A' ' 153' ' ' LEU . 1.2 p . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.636 ' CB ' HG23 ' A' ' 138' ' ' ILE . 57.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.241 0.543 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.775 ' H ' HD22 ' A' ' 64' ' ' LEU . 1.3 m 58.52 152.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 64' ' ' LEU . 2.9 t -108.9 151.08 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.008 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.956 HG12 ' H ' ' A' ' 137' ' ' TYR . 6.5 p . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.955 . . . . 0.0 110.931 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.53 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.235 0.54 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 49' ' ' HIS . 3.6 t80 -63.29 -52.06 63.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.542 ' O ' HG12 ' A' ' 6' ' ' VAL . 5.5 tm0? -68.57 -35.77 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 73' ' ' PHE . 2.3 mt -67.13 -42.0 85.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.067 HG13 ' CD2' ' A' ' 51' ' ' PHE . 56.0 t -72.06 -46.29 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.581 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.609 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 14.2 p -58.33 -32.7 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.309 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 t-20 -68.1 -37.88 81.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 110.309 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.476 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . . . -76.25 -45.05 34.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 110.593 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 33.6 m -57.91 -39.65 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' VAL . 2.9 ttt180 -55.75 -46.77 77.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.538 -0.726 . . . . 0.0 109.92 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.06 -35.87 49.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.883 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.548 ' CD2' HG21 ' A' ' 41' ' ' ILE . 52.0 tp -71.99 -44.32 63.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 110.058 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 10.9 pt20 -68.48 -34.16 75.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.4 mt-10 -57.91 -45.0 87.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -55.91 -26.87 49.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.88 40.4 3.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 152' ' ' PRO . 1.1 m-85 -141.98 44.46 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.17 . . . . 0.0 110.609 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.589 ' HE2' HG12 ' A' ' 9' ' ' VAL . 2.8 t80 -126.59 130.36 50.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.945 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.3 m95 -102.86 147.66 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 m -44.64 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 167.78 79.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.659 HG21 ' CD2' ' A' ' 30' ' ' LEU . 2.6 t -56.03 -118.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.29 -0.881 . . . . 0.0 109.647 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.11 168.93 10.79 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.786 -1.196 . . . . 0.0 109.347 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.561 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.32 -85.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.885 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -79.37 -30.12 46.78 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.384 -1.068 . . . . 0.0 110.465 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -57.59 -42.9 84.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.242 . . . . 0.0 110.049 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -58.91 -49.28 78.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 109.046 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 52' ' ' THR . 34.8 m-80 -68.75 -44.17 74.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.425 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -70.68 -31.71 68.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 112.091 -178.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.0 pp -54.71 -24.07 20.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.712 -1.243 . . . . 0.0 110.692 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.924 HD23 HD22 ' A' ' 40' ' ' LEU . 4.0 pp -78.5 -35.64 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.004 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.665 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.87 -32.84 71.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.74 41.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.629 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 24.6 mm-40 -113.64 -76.71 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.004 -1.06 . . . . 0.0 110.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.3 Cg_endo -72.03 65.36 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.287 1.151 . . . . 0.0 110.261 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 141.25 13.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 74.85 20.17 79.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.869 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.78 146.62 49.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -1.1 . . . . 0.0 110.224 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 5.3 p90 -123.39 155.92 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 110.311 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.945 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -149.48 159.01 44.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.962 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.74 HD12 ' CD2' ' A' ' 53' ' ' LEU . 5.5 tt -115.06 128.56 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.069 -1.019 . . . . 0.0 110.324 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.89 149.72 32.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.778 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 49' ' ' HIS . 5.2 t0 -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 50' ' ' PHE . 28.2 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.555 ' C ' HG11 ' A' ' 5' ' ' VAL . 2.3 m-70 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.23 0.538 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 1.048 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 48.12 107.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.395 -0.816 . . . . 0.0 110.898 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 1.067 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.7 p90 -120.47 140.31 51.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 28' ' ' ASN . 8.2 t -126.85 155.25 43.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.383 -0.823 . . . . 0.0 109.916 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.145 HD11 ' CD1' ' A' ' 98' ' ' TYR . 2.0 pp -143.99 127.24 16.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.025 -1.047 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.743 ' O ' HD21 ' A' ' 31' ' ' LEU . 6.6 t -112.83 154.1 26.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.454 -0.779 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.977 HG11 ' HG ' ' A' ' 149' ' ' LEU . 14.9 p -127.86 173.78 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.13 -0.981 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' N ' HG22 ' A' ' 55' ' ' VAL . 4.6 tptt -117.55 139.05 51.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 0.0 110.018 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.778 HG21 ' CB ' ' A' ' 147' ' ' LEU . 4.9 p -135.7 -94.08 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.294 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.3 mm-40 -80.02 -29.17 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER 162.8 -18.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.735 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.56 100.81 2.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 56' ' ' LYS . 2.2 t -100.43 121.46 41.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -1.13 . . . . 0.0 109.925 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -139.71 171.81 13.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.076 -1.015 . . . . 0.0 110.518 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 1.4 p-10 -123.6 152.68 41.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 167' ' ' VAL . 1.0 OUTLIER -110.44 117.79 34.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.936 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.479 ' NH2' ' CZ ' ' A' ' 50' ' ' PHE . 9.2 ptm180 -83.13 151.76 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.903 HG21 ' CD2' ' A' ' 73' ' ' PHE . 6.9 mm -84.84 144.2 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.5 OUTLIER -96.08 121.37 37.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 26.8 p -88.07 118.16 27.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -133.04 121.15 22.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.221 -0.924 . . . . 0.0 110.244 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.51 95.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 4' ' ' LEU . . . 61.82 13.06 38.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 69' ' ' GLU . 13.7 p -108.8 163.21 13.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.296 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.903 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.78 128.38 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -155.17 138.98 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.997 ' CD2' HD11 ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 5.4 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.073 0.463 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.9 mp -58.06 -47.03 84.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 109.308 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 5.0 mtpp -67.86 -31.46 71.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 108.891 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -59.39 -33.71 71.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.49 -37.21 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.733 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.446 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 5.0 m-70 -53.65 -50.44 65.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.62 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 135' ' ' ALA . 7.3 t60 -78.28 -36.95 46.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.518 -0.739 . . . . 0.0 109.09 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CD1' HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.11 -12.0 46.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.887 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 149' ' ' LEU . 1.9 ttt . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.456 -0.778 . . . . 0.0 110.079 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.254 0.55 . . . . 0.0 110.336 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 166.2 147.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.416 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 1.048 ' CD2' HD11 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -100.58 162.41 12.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.851 ' C ' HD21 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -152.27 151.6 31.13 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 116.74 -1.984 . . . . 0.0 115.118 -176.215 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.852 ' N ' HD21 ' A' ' 147' ' ' LEU . 13.4 mt -142.17 120.57 8.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 7.7 m-85 -84.09 107.96 16.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 143' ' ' GLU . 1.6 t -72.94 66.98 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.341 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.12 89.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.94 2.15 57.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.658 ' HB3' HD11 ' A' ' 145' ' ' ILE . 1.5 mt-10 -120.04 121.86 39.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -1.147 . . . . 0.0 110.31 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.727 ' C ' HD12 ' A' ' 145' ' ' ILE . 1.1 ttpp -98.23 105.72 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.808 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.8 mp -112.7 119.02 44.06 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.778 . . . . 0.0 109.098 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 137' ' ' TYR . 48.1 Cg_endo -75.13 127.2 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.731 1.385 . . . . 0.0 111.021 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.852 HD21 ' N ' ' A' ' 138' ' ' ILE . 0.4 OUTLIER -125.59 134.33 51.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.221 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 p -120.72 118.85 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.752 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.048 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mp -76.36 150.62 36.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.218 -0.926 . . . . 0.0 109.886 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -36.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.462 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 6.9 mtp85 -104.78 124.32 37.21 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 51.2 Cg_endo -78.21 147.29 23.21 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.024 1.539 . . . . 0.0 110.198 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 40' ' ' LEU . 4.3 tp -92.18 115.84 28.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.132 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' PHE . 81.0 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.312 0.577 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 45.1 p -65.94 -162.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 167' ' ' VAL . . . . . 0.781 HG13 ' N ' ' A' ' 137' ' ' TYR . 55.4 t -143.06 167.61 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 168' ' ' VAL . . . . . 0.703 HG22 HG12 ' B' ' 167' ' ' VAL . 18.7 m . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.454 -0.779 . . . . 0.0 110.385 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.644 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.9 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.204 0.526 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -54.96 -45.24 74.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 109.956 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.628 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -54.94 -39.82 69.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.847 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.931 HD23 ' SG ' ' A' ' 90' ' ' CYS . 1.0 OUTLIER -63.75 -47.2 82.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.836 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.16 HG22 ' CE2' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -65.84 -48.35 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 110.012 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.631 ' N ' HG12 ' A' ' 5' ' ' VAL . 39.5 t -59.54 -47.17 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.2 m120 -58.74 -28.07 65.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -74.13 -44.13 54.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 50.4 t -57.38 -39.72 70.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.357 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -55.87 -49.35 73.58 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.73 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.53 -36.1 45.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 41' ' ' ILE . 46.2 tp -69.48 -42.01 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 18.0 pt20 -67.99 -34.2 76.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.8 tt0 -57.91 -23.7 54.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 110.269 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 1.2 t -70.57 -27.0 63.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.23 -14.12 63.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -76.92 -10.67 59.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -1.108 . . . . 0.0 110.004 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -93.41 121.08 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.061 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 1.017 ' CD1' HD12 ' A' ' 40' ' ' LEU . 9.0 m95 -110.3 101.86 10.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 110.005 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.23 109.04 20.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 164.98 -4.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.426 -0.796 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.85 -159.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 0.0 109.982 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -99.19 176.2 5.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 110.228 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.536 ' HA3' HG21 ' B' ' 162' ' ' VAL . . . -49.76 -78.25 0.1 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.761 ' N ' HG22 ' B' ' 162' ' ' VAL . . . -79.26 -34.49 32.64 Favored Glycine 0 N--CA 1.492 2.398 0 O-C-N 121.193 -1.18 . . . . 0.0 110.424 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 2.7 mt-10 -59.51 -30.17 68.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.272 . . . . 0.0 110.098 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' O ' HD23 ' A' ' 30' ' ' LEU . . . -69.62 -47.3 63.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.665 ' O ' HD23 ' A' ' 31' ' ' LEU . 24.3 m120 -68.01 -42.38 80.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.172 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' A' ' 61' ' ' THR . 3.4 mp -59.18 -32.01 69.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.799 . . . . 0.0 111.043 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -55.42 -23.81 27.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.973 -1.08 . . . . 0.0 109.943 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 38' ' ' THR . 4.0 pp -61.85 -37.01 82.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.096 -1.002 . . . . 0.0 109.042 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.875 ' N ' HD12 ' A' ' 31' ' ' LEU . 96.6 p -69.6 -32.27 70.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -20.6 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.3 mm-40 -122.12 -79.8 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.5 Cg_endo -75.89 69.77 6.1 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.064 1.034 . . . . 0.0 110.184 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.96 141.33 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.21 78.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 1.061 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.4 m -131.0 147.9 52.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -1.04 . . . . 0.0 110.173 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.92 ' HA ' HD22 ' A' ' 31' ' ' LEU . 3.0 m-85 -122.64 141.49 51.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 110.072 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -135.49 159.51 41.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.512 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.558 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 9.7 tt -115.05 138.56 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 2.6 tmt_? -112.86 160.71 17.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.0 110.261 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' CZ ' ' A' ' 42' ' ' ARG . 11.6 t0 -85.43 106.47 16.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t -44.43 145.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.346 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 23.2 t -64.88 -145.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.202 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 45' ' ' SER . 2.5 t70 67.27 -138.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' O ' ' CB ' ' A' ' 48' ' ' ARG . 75.8 mt-30 -67.06 -6.36 16.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.495 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 69.88 19.18 7.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 110.148 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.535 ' O ' HG11 ' A' ' 5' ' ' VAL . 3.7 m-70 -102.83 39.54 1.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.117 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -163.58 147.73 10.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 1.16 ' CE2' HG22 ' A' ' 5' ' ' VAL . 12.4 p90 -132.11 146.72 52.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.95 . . . . 0.0 110.533 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -126.08 140.87 52.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.507 -0.746 . . . . 0.0 109.521 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.153 HD22 ' CD1' ' A' ' 98' ' ' TYR . 8.3 tt -120.93 145.32 47.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 111.039 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.63 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -139.17 153.82 47.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.715 . . . . 0.0 109.453 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.055 HG11 HD22 ' A' ' 149' ' ' LEU . 33.5 m -121.35 174.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.662 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.918 ' HB2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -112.43 139.22 48.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.565 ' OG1' ' CD2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -153.17 175.87 12.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.94 4.72 15.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.035 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -13.48 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 110.176 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 57' ' ' THR . . . 130.7 150.3 6.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -79.96 132.04 35.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -1.123 . . . . 0.0 110.227 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.868 ' HE3' HG23 ' A' ' 138' ' ' ILE . 10.6 ttmt -122.41 146.54 47.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.623 ' ND2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -115.8 145.73 42.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.123 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.973 HD21 ' HA ' ' B' ' 166' ' ' THR . 0.4 OUTLIER -138.23 152.74 48.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.506 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 52' ' ' THR . 30.9 ptt85 -126.48 159.79 32.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 110.398 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.847 ' HB ' HD22 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -86.55 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -113.19 129.22 56.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.068 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 28.1 p -88.03 119.67 28.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.455 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.3 tm-20 -108.7 103.24 12.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.2 -0.937 . . . . 0.0 110.1 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.95 -84.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -138.23 21.95 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 58.6 p -123.08 156.79 34.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HZ ' HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -110.96 131.55 54.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 0.0 110.178 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.85 146.86 22.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.057 -1.027 . . . . 0.0 110.514 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.883 HD12 ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt -76.93 2.27 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.611 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 -157.34 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 110.079 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.65 4.08 8.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.097 -1.002 . . . . 0.0 110.499 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -98.47 121.99 54.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.072 -1.017 . . . . 0.0 110.278 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.67 52.0 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.952 1.501 . . . . 0.0 110.621 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 15.98 9.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.23 56.02 1.3 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.333 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.6 t -86.31 13.05 8.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.581 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -43.81 -53.55 12.5 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 83' ' ' GLN . 44.9 Cg_endo -72.38 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.82 1.432 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.562 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 3.5 m -102.69 168.38 8.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.965 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.8 Cg_endo -70.7 134.78 26.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.933 1.491 . . . . 0.0 110.152 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.8 ptt180 73.05 21.41 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.859 . . . . 0.0 109.865 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.652 ' CE1' ' CB ' ' A' ' 93' ' ' LYS . 49.5 p90 -58.66 -154.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.826 ' HB3' HD22 ' A' ' 92' ' ' LEU . 1.1 m-20 -72.69 110.42 7.03 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 109.187 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.931 ' SG ' HD23 ' A' ' 4' ' ' LEU . 61.8 m -37.66 -109.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.667 0.746 . . . . 0.0 112.433 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.743 HG22 HD23 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -49.39 -22.8 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 112.155 -178.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.826 HD22 ' HB3' ' A' ' 89' ' ' ASP . 6.1 mp -53.81 -46.2 71.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.527 -1.358 . . . . 0.0 110.342 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -67.06 -37.36 83.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 108.498 178.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.883 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.0 tp -68.31 -34.81 76.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.913 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -54.43 -36.95 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.905 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 99' ' ' MET . 20.2 t-160 -53.16 -33.65 53.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 0.0 109.042 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.537 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -78.18 -37.07 46.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.153 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.3 m-85 -78.7 -21.22 48.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.915 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.566 ' CB ' ' HD2' ' A' ' 100' ' ' PRO . 1.3 mtp -161.86 -177.23 0.68 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 109.992 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 99' ' ' MET . 45.4 Cg_endo -72.4 175.33 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.858 1.452 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 100' ' ' PRO . 43.9 Cg_endo -71.37 160.81 47.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.992 1.522 . . . . 0.0 110.541 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.13 -157.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.075 1.566 . . . . 0.0 110.417 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 104' ' ' THR . . . 80.43 85.05 0.66 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.3 OUTLIER -42.43 159.87 0.19 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -1.13 . . . . 0.0 110.131 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.9 -13.09 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.996 1.524 . . . . 0.0 110.281 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.4 p -75.51 157.62 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' LEU . 25.7 t80 -161.62 92.82 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.12 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 2.9 m 57.81 -81.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.126 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.583 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 5.3 tp 173.49 -56.28 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 109' ' ' LEU . 45.1 Cg_endo -71.65 142.63 40.32 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.898 1.473 . . . . 0.0 110.425 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.93 94.13 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.947 1.499 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.56 -35.59 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.286 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -136.26 106.44 9.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.301 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.18 152.57 50.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.028 1.541 . . . . 0.0 110.377 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -128.36 44.86 2.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.946 ' O ' HG22 ' A' ' 118' ' ' VAL . 92.3 p -70.28 -145.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 118' ' ' VAL . 5.3 tm-20 -55.94 104.53 0.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.946 HG22 ' O ' ' A' ' 116' ' ' SER . 9.7 m -154.25 75.64 5.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 110.275 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.04 165.26 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.997 1.525 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 53.3 71.85 0.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -151.39 134.18 8.71 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.32 112.08 3.44 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.38 66.79 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.81 91.49 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.25 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -91.48 -81.09 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.155 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.76 68.66 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 8.2 tp -155.97 52.68 0.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 127' ' ' LEU . 45.9 Cg_endo -73.0 59.28 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.032 1.543 . . . . 0.0 110.411 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 62.18 47.57 88.9 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -154.78 108.35 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 131' ' ' THR . 1.3 t -155.38 105.65 2.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 46.2 Cg_endo -73.25 -1.02 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.913 1.48 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER 61.99 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.97 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -131.59 161.01 33.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 169.98 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -121.85 123.52 41.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.978 -1.076 . . . . 0.0 109.539 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.916 ' H ' HG22 ' B' ' 167' ' ' VAL . 8.3 p90 -154.99 167.74 29.32 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.894 -1.129 . . . . 0.0 111.392 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.868 HG23 ' HE3' ' A' ' 62' ' ' LYS . 3.3 mt -102.69 143.24 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.656 0.741 . . . . 0.0 111.05 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.716 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 12.5 m-85 -92.89 132.63 36.86 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.637 0.732 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -84.01 52.59 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.641 -0.662 . . . . 0.0 110.22 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.53 27.06 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 162.95 -30.87 0.28 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mt-10 -116.47 121.8 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.02 105.51 11.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.341 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -93.01 105.23 14.24 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.817 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.8 Cg_endo -73.55 129.64 13.94 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.052 1.554 . . . . 0.0 112.358 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.804 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 mp -125.64 135.28 51.99 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -98.27 116.98 42.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.365 -1.46 . . . . 0.0 109.954 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.055 HD22 HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -121.86 135.52 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.066 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 29.0 t -167.6 54.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.87 123.88 22.19 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.077 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 50.7 Cg_endo -78.75 148.32 22.51 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.143 1.602 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.977 HD13 ' HB2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -85.83 133.78 33.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.823 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 155' ' ' SER . 36.9 t -117.79 78.77 1.27 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.63 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 10.0 m 42.65 -166.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -0.935 . . . . 0.0 110.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' A' ' 155' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.297 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' B' ' 159' ' ' ALA . 95.5 m -94.45 74.33 3.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.263 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' B' ' 158' ' ' THR . . . 179.63 -88.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.947 . . . . 0.0 110.265 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.16 114.1 9.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -36.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.349 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.975 HG12 ' HE1' ' B' ' 164' ' ' PTR . 97.2 t -73.25 55.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 2.6 mt-10 -96.6 159.17 15.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.975 ' HE1' HG12 ' B' ' 162' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.465 ' O ' HG23 ' B' ' 166' ' ' THR . 43.3 t -139.47 -105.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.263 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.973 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.4 p -152.58 -179.54 7.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.921 HG12 HG22 ' B' ' 168' ' ' VAL . 1.0 OUTLIER -127.85 143.48 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.921 HG22 HG12 ' B' ' 167' ' ' VAL . 4.4 m 22.23 76.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.4 0.619 . . . . 0.0 111.126 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.555 ' N ' ' OH ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -44.72 -78.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' B' ' 171' ' ' GLY . 83.5 p -128.64 -76.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.43 ' N ' ' OG ' ' B' ' 170' ' ' SER . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.585 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.254 0.55 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.9 p90 -55.79 -39.02 70.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' O ' HG12 ' A' ' 6' ' ' VAL . 40.0 tp60 -61.16 -42.27 98.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.123 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 89' ' ' ASP . 1.1 mt -67.27 -47.23 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.987 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.4 m -72.56 -44.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.667 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 3' ' ' GLN . 5.2 p -58.35 -32.55 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -67.98 -40.92 83.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.096 -1.003 . . . . 0.0 109.78 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . . . -76.36 -44.99 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 5' ' ' VAL . 4.3 m -57.93 -39.7 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.9 ttt180 -55.44 -45.9 76.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 109.69 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -32.94 50.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.687 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 5.9 tp -68.23 -43.98 76.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.455 -0.778 . . . . 0.0 110.286 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 3.4 pt20 -64.65 -33.83 76.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.187 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 2.9 mt-10 -57.84 -31.03 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -67.29 -41.3 85.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.034 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.75 36.62 3.19 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.903 ' HB2' HD21 ' A' ' 153' ' ' LEU . 5.6 p90 -145.39 28.17 1.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -1.166 . . . . 0.0 110.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 20' ' ' SER . 3.0 t80 -90.76 136.29 33.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.831 ' HE1' HD23 ' A' ' 153' ' ' LEU . 69.4 m95 -117.51 149.23 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 89.7 p 178.98 -15.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -13.26 4.36 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.714 -0.616 . . . . 0.0 110.533 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.39 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.599 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.588 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -89.16 175.82 7.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.791 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' CD ' ' A' ' 42' ' ' ARG . . . -46.03 -83.77 0.02 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.34 -30.51 45.32 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 121.398 -1.06 . . . . 0.0 110.681 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.588 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.4 mm-40 -58.27 -26.69 63.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.338 . . . . 0.0 110.422 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.87 -49.97 47.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.016 -1.053 . . . . 0.0 109.117 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.927 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -69.99 -46.39 65.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.0 110.747 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.883 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -59.08 -31.34 68.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.445 -0.784 . . . . 0.0 111.602 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 pp -54.63 -23.62 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.789 -1.194 . . . . 0.0 109.442 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.996 HD13 ' O ' ' A' ' 38' ' ' THR . 3.6 pp -68.95 -34.11 74.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.155 -0.966 . . . . 0.0 108.567 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.684 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t -69.97 -32.81 71.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.67 -0.643 . . . . 0.0 110.234 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.66 -20.72 42.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.85 . . . . 0.0 110.488 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.74 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -122.9 -80.59 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.972 -1.08 . . . . 0.0 110.922 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.74 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 53.1 Cg_endo -75.24 68.46 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.015 1.008 . . . . 0.0 110.703 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.92 141.43 10.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.023 . . . . 0.0 110.399 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 78.93 20.58 70.16 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 53.7 m -117.55 148.3 42.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.984 . . . . 0.0 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 8.3 p90 -121.86 138.94 54.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.005 -1.06 . . . . 0.0 109.787 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -138.95 156.71 47.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.388 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.569 HD11 ' CD1' ' A' ' 51' ' ' PHE . 4.3 tt -115.37 133.75 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.376 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -112.89 141.43 46.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.856 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 49.3 t0 -82.08 132.77 35.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.106 -0.996 . . . . 0.0 110.247 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . 59.4 p -56.54 -63.81 1.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.363 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 69.56 7.43 6.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 0.0 109.93 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -102.3 -135.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.71 -26.45 19.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 110.345 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -75.33 -21.98 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.237 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.563 ' O ' HG11 ' A' ' 5' ' ' VAL . 28.9 m80 46.99 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.255 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 48' ' ' ARG . 16.3 p90 -177.45 175.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 38.0 p90 -125.73 141.64 51.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.039 -1.038 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.604 ' CG2' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -125.33 144.34 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.104 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -121.99 133.6 54.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.104 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -139.1 154.28 48.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 110.087 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 149' ' ' LEU . 10.7 p -132.98 174.9 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.667 ' HG3' HG22 ' A' ' 61' ' ' THR . 2.0 ttpp -103.36 135.2 45.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -97.7 -154.02 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -24.46 66.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 m -177.02 29.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.65 109.8 0.56 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.667 HG22 ' HG3' ' A' ' 56' ' ' LYS . 32.2 p -98.2 108.94 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.155 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' B' ' 163' ' ' GLU . 2.4 mptp? -116.93 159.28 22.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.994 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.81 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 38.6 m-20 -112.01 134.22 53.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.2 mm? -109.4 117.99 35.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' CE2' ' B' ' 164' ' ' PTR . 0.2 OUTLIER -117.0 148.38 41.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.258 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.931 HG21 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -76.74 130.57 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.0 OUTLIER -94.74 151.18 19.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.43 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 72' ' ' SER . 27.6 p -97.89 139.08 34.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' SER . 70.5 mt-10 -131.56 113.04 13.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.342 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 46.65 24.27 1.72 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.29 -2.19 40.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -95.01 153.63 17.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.931 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -113.39 126.78 55.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.8 OUTLIER -155.53 147.59 23.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.521 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.872 HD13 HD12 ' A' ' 94' ' ' LEU . 14.7 tp -77.48 -13.04 60.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.78 -139.83 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 110.117 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.46 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 45.5 t -164.49 44.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.05 111.89 35.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.4 61.77 4.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.022 1.538 . . . . 0.0 110.343 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' SER . 2.9 tpt180 -67.27 -48.06 68.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.251 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER 174.96 169.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 83' ' ' GLN . 1.9 p -104.75 71.7 0.99 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -42.18 -56.72 5.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.443 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.652 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 47.3 Cg_endo -71.4 -99.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.979 1.515 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.004 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -135.59 172.51 7.04 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.541 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 1.004 ' HD2' HG22 ' A' ' 85' ' ' VAL . 42.0 Cg_endo -69.93 132.56 23.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.526 1.277 . . . . 0.0 109.547 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 2.6 mtt180 67.42 34.12 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 0.0 109.77 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.652 ' CG ' ' HG2' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -86.21 -176.29 5.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.615 ' N ' ' CD2' ' A' ' 88' ' ' PHE . 17.8 p-10 -112.42 110.97 21.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' PHE . 7.3 t -82.6 -5.63 58.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.476 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.948 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 4.6 p -49.84 -31.53 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.111 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.836 ' O ' HG22 ' A' ' 95' ' ' VAL . 10.9 mp -59.24 -46.08 89.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 108.681 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -67.23 -30.7 70.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -58.57 -34.56 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.612 -0.68 . . . . 0.0 109.879 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.026 ' N ' HD23 ' A' ' 94' ' ' LEU . 3.0 m -54.83 -37.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.453 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 24.6 m170 -55.38 -47.26 76.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.063 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -61.21 -36.74 80.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.476 -0.765 . . . . 0.0 109.258 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.955 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.6 m-30 -65.12 -9.38 22.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 109.975 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.563 ' C ' ' HD2' ' A' ' 101' ' ' PRO . 2.7 ptt? -167.16 114.99 0.68 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.681 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 41.8 Cg_endo -72.09 -29.55 14.55 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.954 1.502 . . . . 0.0 112.22 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 100' ' ' PRO . 48.2 Cg_endo -74.33 159.93 42.81 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.888 0.941 . . . . 0.0 110.312 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.76 126.87 11.75 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.41 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.13 -66.11 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.5 p -139.85 160.5 60.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -1.113 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -91.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.513 . . . . 0.0 110.456 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.21 -41.36 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 30.5 p90 -122.59 130.49 53.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -88.34 -63.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 1.4 pp -131.1 119.4 17.79 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 150.63 50.54 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.942 1.496 . . . . 0.0 110.44 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 112' ' ' THR . 46.0 Cg_endo -72.93 -51.02 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 21.1 m 53.79 99.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . 9.0 tp10 172.34 -55.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.19 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 45.6 Cg_endo -71.54 89.37 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.899 1.473 . . . . 0.0 110.469 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 114' ' ' PRO . 8.6 t 60.47 -178.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 6.4 t -66.9 -63.29 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.536 ' C ' HG23 ' A' ' 118' ' ' VAL . 6.1 tp10 55.74 94.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.194 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.556 ' N ' ' CD ' ' A' ' 119' ' ' PRO . 23.1 t -151.57 49.48 0.57 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 118' ' ' VAL . 46.1 Cg_endo -73.17 118.91 5.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.953 1.502 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 0.0 OUTLIER 61.69 147.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 6.5 mm-40 -147.58 115.9 4.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.04 142.18 34.12 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.946 1.498 . . . . 0.0 110.51 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.08 -89.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.965 1.508 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.31 -145.45 0.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.151 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.11 -70.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 0.0 110.089 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.59 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 129' ' ' GLY . 1.1 pp -75.42 161.89 74.88 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.94 -50.95 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.961 1.506 . . . . 0.0 110.411 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' N ' HD12 ' A' ' 127' ' ' LEU . . . 103.5 126.23 5.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 72.9 p -178.58 -168.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 110.234 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.18 65.3 69.44 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.94 70.87 3.54 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.122 1.59 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt 48.06 71.26 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.152 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.3 mtm180 -159.39 139.31 11.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.19 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.075 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 172.93 112.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.116 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 0.5 OUTLIER -104.66 122.76 46.33 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.152 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.2 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -156.94 156.39 32.95 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.322 -0.861 . . . . 0.0 110.091 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.132 ' N ' HD23 ' A' ' 147' ' ' LEU . 2.0 mt -103.37 149.4 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.339 -0.851 . . . . 0.0 109.796 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.589 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 81.4 m-85 -85.37 132.05 34.3 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.264 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.714 ' HB3' HD13 ' A' ' 145' ' ' ILE . 2.7 t -95.25 59.06 2.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.245 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.33 54.07 40.31 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.15 1.0 58.33 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 6.4 mm-40 -120.01 123.49 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 145' ' ' ILE . 12.9 mtmt -70.86 119.13 14.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -118.31 115.27 36.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.035 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.905 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 42.7 Cg_endo -69.33 125.23 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.808 1.425 . . . . 0.0 111.349 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.132 HD23 ' N ' ' A' ' 138' ' ' ILE . 1.9 pp -127.03 101.93 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.6 p -102.45 118.58 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.814 -1.179 . . . . 0.0 111.034 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 98' ' ' TYR . 0.9 OUTLIER -76.66 114.88 15.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 -30.25 6.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 110.935 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.87 124.47 70.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.987 -1.07 . . . . 0.0 110.203 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.584 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 50.0 Cg_endo -78.0 141.09 18.56 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.03 1.542 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.931 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.55 158.13 15.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.508 ' N ' HD22 ' A' ' 153' ' ' LEU . 45.0 m -126.93 92.92 3.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.601 ' HB2' ' CE2' ' A' ' 19' ' ' TRP . 4.1 t -114.06 34.21 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.241 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 3.2 p -134.79 80.58 1.85 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.272 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' B' ' 161' ' ' THR . . . -126.46 23.09 6.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 1.7 t 66.2 -63.86 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.518 ' N ' ' O ' ' B' ' 159' ' ' ALA . 0.7 OUTLIER 61.23 48.94 5.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.174 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.653 HG12 ' O ' ' B' ' 162' ' ' VAL . 78.5 t -82.72 50.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 9.6 pt-20 -73.74 -162.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 65' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 5.3 m -137.19 10.29 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.459 ' O ' ' O ' ' B' ' 165' ' ' SER . 0.2 OUTLIER 53.5 169.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.116 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.8 t -126.82 102.64 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.2 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.3 t 67.17 142.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.483 ' O ' ' CG ' ' B' ' 169' ' ' HIS . 6.8 t60 -131.22 14.61 5.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.193 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.416 ' O ' ' O ' ' B' ' 171' ' ' GLY . 85.4 p -150.22 23.94 0.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.189 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' B' ' 170' ' ' SER . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.699 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.0 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.258 0.551 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.489 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.5 p90 -54.85 -36.6 65.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.659 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.8 tt0 -54.89 -32.69 61.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.962 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.892 HD22 ' HB3' ' A' ' 90' ' ' CYS . 6.4 mt -59.56 -47.43 85.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.4 t -64.55 -44.77 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.865 . . . . 0.0 110.775 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -58.03 -33.5 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.299 -0.876 . . . . 0.0 110.575 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -71.44 -40.35 70.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.1 -44.46 38.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.249 -0.907 . . . . 0.0 110.75 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 5' ' ' VAL . 7.4 m -57.2 -38.37 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -54.23 -49.12 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.862 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -78.44 -40.19 36.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -0.999 . . . . 0.0 109.925 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -72.27 -31.22 65.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.399 -0.813 . . . . 0.0 111.032 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.74 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 51.6 mt-30 -59.44 -41.45 89.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 0.0 111.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.48 -52.56 8.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.889 -1.132 . . . . 0.0 110.598 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 t -73.68 -42.4 61.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 111.746 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' C ' ' A' ' 17' ' ' PHE . . . -90.23 67.57 2.57 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.36 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.702 ' C ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 2.21 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.742 -0.858 . . . . 0.0 110.8 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.74 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 3.8 t80 -90.87 136.23 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.756 ' CG ' HD11 ' A' ' 40' ' ' LEU . 15.9 m95 -116.59 148.24 41.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -142.26 23.73 1.99 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.07 0.13 31.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.784 . . . . 0.0 110.949 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.53 -158.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 110.343 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.577 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.26 166.97 11.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 110.334 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.49 ' CA ' ' HG2' ' A' ' 42' ' ' ARG . . . -39.73 -84.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 28' ' ' ASN . . . -79.05 -31.7 42.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 7.7 tt0 -59.53 -24.85 64.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.283 . . . . 0.0 109.938 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -72.95 -48.42 36.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.587 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.689 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -68.44 -36.16 78.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.326 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.815 HD11 ' OG1' ' A' ' 61' ' ' THR . 0.6 OUTLIER -58.24 -31.71 67.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 110.976 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp -55.49 -23.84 28.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.875 -1.141 . . . . 0.0 109.223 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 38' ' ' THR . 2.7 pp -70.33 -32.95 70.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 108.648 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 61.2 m -69.85 -33.09 71.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.578 -0.701 . . . . 0.0 110.08 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -21.19 41.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.068 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.766 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.4 mm-40 -122.31 -83.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.564 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.766 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.17 69.27 4.87 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 122.923 0.959 . . . . 0.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.59 141.53 37.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.225 -0.922 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 83.31 19.44 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.926 ' O ' HD13 ' A' ' 31' ' ' LEU . 4.0 m -122.43 148.33 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.505 -0.997 . . . . 0.0 110.204 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HB2' HG12 ' A' ' 55' ' ' VAL . 4.5 p90 -122.21 138.97 54.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.852 -1.155 . . . . 0.0 109.981 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.35 159.31 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 0.0 110.276 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.838 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.4 tt -117.01 149.21 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 3.0 tpt180 -121.62 152.89 38.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.445 -0.784 . . . . 0.0 109.612 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.573 ' CA ' ' OH ' ' A' ' 18' ' ' TYR . 8.8 t0 -90.76 104.31 16.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.956 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 8.3 t -53.94 168.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 0.0 110.139 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 p -115.99 5.41 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 173.36 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -79.19 -14.68 58.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -82.16 4.38 23.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER 43.34 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.167 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.871 ' HD1' HG21 ' A' ' 5' ' ' VAL . 20.0 t80 -155.82 156.06 34.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.855 ' CD2' HG13 ' A' ' 5' ' ' VAL . 8.7 p90 -115.96 151.79 34.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.5 ' C ' HG13 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -126.41 147.62 49.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.916 HD12 ' N ' ' A' ' 54' ' ' SER . 0.3 OUTLIER -131.1 125.07 32.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.39 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.916 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -122.8 153.74 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.02 HG11 HD22 ' A' ' 149' ' ' LEU . 10.2 m -121.39 174.56 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.372 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HA ' HG22 ' A' ' 61' ' ' THR . 14.5 tttm -103.47 126.48 50.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.986 ' HB ' HD22 ' A' ' 147' ' ' LEU . 21.4 p -128.9 169.87 14.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.86 -27.11 67.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 t -86.41 -28.31 23.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.161 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 147.36 156.78 7.12 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 56' ' ' LYS . 17.3 p -80.13 138.08 36.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' CB ' HG12 ' A' ' 138' ' ' ILE . 23.2 mmtm -137.15 160.45 38.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 5.5 p30 -138.28 154.64 49.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.704 HD11 ' CA ' ' B' ' 166' ' ' THR . 8.0 mt -137.45 148.41 46.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 110.01 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HA ' ' HZ ' ' A' ' 50' ' ' PHE . 4.7 mtt180 -98.25 152.29 19.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.33 139.6 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -96.4 151.0 19.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.403 ' HA ' ' CD1' ' A' ' 73' ' ' PHE . 18.5 p -99.36 137.03 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 mt-10 -130.63 102.89 6.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 43.24 -95.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -120.53 32.75 4.73 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 5.0 p -139.58 150.91 45.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.292 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -124.29 144.83 49.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 66' ' ' ILE . 2.2 t -155.18 141.3 18.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.119 -0.988 . . . . 0.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 94' ' ' LEU . 17.8 tp -76.77 1.3 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.282 -0.886 . . . . 0.0 110.455 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 77' ' ' SER . 18.6 pt20 -139.5 -155.43 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 76' ' ' GLN . 93.1 p -60.0 -142.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 80' ' ' ARG . 17.7 p-10 -74.46 126.14 89.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.63 58.93 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.994 1.523 . . . . 0.0 110.366 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' O ' ' OG1' ' A' ' 82' ' ' THR . 0.0 OUTLIER -71.62 -2.79 18.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.283 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.0 OUTLIER -50.1 -34.16 21.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 69.26 6.35 5.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.582 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 3.1 tt0 -57.53 -59.94 11.38 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 83' ' ' GLN . 46.4 Cg_endo -71.68 -155.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.818 1.43 . . . . 0.0 110.219 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -118.82 178.3 1.11 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.136 -0.978 . . . . 0.0 109.682 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 40.8 Cg_endo -67.89 132.65 27.05 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.798 1.42 . . . . 0.0 109.434 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 71' ' ' GLY . 1.7 mpp_? 52.91 65.91 1.38 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.147 -0.971 . . . . 0.0 109.248 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG ' ' A' ' 93' ' ' LYS . 53.1 p90 -100.3 -155.97 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.674 ' CB ' ' HB2' ' A' ' 92' ' ' LEU . 72.8 m-20 -72.9 109.77 6.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.057 -1.027 . . . . 0.0 108.716 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.892 ' HB3' HD22 ' A' ' 4' ' ' LEU . 1.3 p -39.94 -93.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.786 HG21 HG22 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -48.09 -22.6 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.272 -0.892 . . . . 0.0 111.125 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.674 ' HB2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -54.19 -35.77 62.7 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.907 -1.121 . . . . 0.0 110.058 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.604 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -62.39 -36.4 82.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.991 -1.068 . . . . 0.0 109.437 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.82 -35.87 75.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.595 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' MET . 78.0 t -56.02 -38.31 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.78 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 99' ' ' MET . 9.8 t-80 -54.79 -46.55 74.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -71.78 -42.95 66.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.069 ' O ' HD11 ' A' ' 149' ' ' LEU . 2.0 m-30 -69.31 -22.11 63.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.571 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -166.12 167.57 8.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 99' ' ' MET . 44.8 Cg_endo -72.57 170.81 18.51 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.462 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 145.68 41.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.046 1.55 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 -12.68 25.48 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.99 1.521 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -165.78 41.18 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.55 75.87 0.42 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.15 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.412 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -172.88 133.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.238 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 9.2 t80 -126.64 58.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 109' ' ' LEU . 6.8 m 49.9 -137.95 1.0 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 110' ' ' PRO . 2.1 tp -42.17 143.02 1.1 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.45 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 46.5 Cg_endo -72.96 118.7 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.948 1.499 . . . . 0.0 110.442 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.03 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.467 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 113' ' ' GLU . 1.4 m 57.62 174.41 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.229 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 112' ' ' THR . 14.5 mt-10 56.85 159.85 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.06 99.88 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -143.83 19.83 1.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.44 -76.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -142.66 -46.43 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.313 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.5 t 51.78 86.33 0.16 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.76 -89.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.033 1.544 . . . . 0.0 110.494 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.83 178.81 6.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.255 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 134.09 25.64 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.17 135.66 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.998 1.525 . . . . 0.0 110.464 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 56.68 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.06 16.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.74 54.89 6.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.422 ' C ' ' HG ' ' A' ' 127' ' ' LEU . . . -147.43 19.34 1.2 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 126' ' ' ALA . 10.8 mt -134.66 95.74 15.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.245 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.77 -166.34 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.359 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.96 85.67 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 131' ' ' THR . 40.9 t -99.01 -96.86 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -179.92 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 131' ' ' THR . 45.8 Cg_endo -72.26 67.45 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.967 1.509 . . . . 0.0 110.499 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -44.63 -38.08 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 110.12 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 6.9 ppt_? -140.1 176.21 8.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.854 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 169.5 129.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.431 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.122 ' CD1' HG11 ' B' ' 167' ' ' VAL . 2.5 t80 -116.18 121.78 43.12 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.807 -1.183 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.904 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.7 p90 -156.99 167.97 28.88 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.878 -1.139 . . . . 0.0 111.185 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.468 HG12 ' CB ' ' A' ' 62' ' ' LYS . 2.8 mp -121.62 149.54 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.95 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.76 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.1 m-30 -84.85 110.47 18.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.729 . . . . 0.0 110.119 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 3.9 m -66.32 56.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.53 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 65.84 82.9 0.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.25 -10.42 49.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.8 tt0 -120.01 121.6 39.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.269 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 2.4 ptpt -89.8 105.5 17.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.02 109.14 52.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.823 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.3 Cg_endo -72.57 128.95 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.996 1.524 . . . . 0.0 111.938 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.986 HD22 ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -125.83 135.88 52.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 148' ' ' VAL . 25.3 m -98.04 117.12 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.382 -1.449 . . . . 0.0 110.079 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.069 HD11 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -117.38 137.91 52.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.047 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.502 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -176.02 41.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.583 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -111.56 124.96 31.31 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.148 -0.97 . . . . 0.0 110.046 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.632 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 45.7 Cg_endo -73.08 147.32 42.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 111.059 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.795 HD22 HG21 ' A' ' 38' ' ' THR . 0.3 OUTLIER -89.7 128.66 36.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.742 . . . . 0.0 109.778 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.759 ' N ' HD13 ' A' ' 153' ' ' LEU . 49.4 m -73.09 88.67 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.329 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.589 ' HB2' ' CE2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -119.23 -38.4 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.152 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 155' ' ' SER . 19.6 t-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.218 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.256 0.55 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 8.9 t -124.72 145.92 49.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.72 1.89 11.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.103 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' B' ' 161' ' ' THR . 32.1 m -165.45 -171.66 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.247 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER 66.83 70.67 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.248 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.65 HG12 ' O ' ' B' ' 162' ' ' VAL . 84.4 t 56.93 54.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.28 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 164' ' ' PTR . 42.3 tt0 -89.12 172.08 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.549 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.443 ' C ' HD21 ' A' ' 64' ' ' LEU . 56.6 m -160.67 -60.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.386 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.745 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.5 OUTLIER 176.87 155.82 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.192 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.122 HG11 ' CD1' ' A' ' 136' ' ' TYR . 15.3 t -118.62 132.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 135' ' ' ALA . 5.8 t 40.68 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.434 ' HB2' ' OH ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -91.19 91.54 8.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -72.92 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.922 -1.488 . . . . 0.0 109.497 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.188 0.518 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 6' ' ' VAL . 33.7 p90 -65.31 -37.55 87.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.5 OUTLIER -69.32 -33.65 73.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.218 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.928 HD23 ' SG ' ' A' ' 90' ' ' CYS . 3.3 mt -67.09 -47.3 71.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.516 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 49' ' ' HIS . 34.8 m -72.18 -37.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.449 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 2' ' ' TYR . 24.8 t -58.45 -32.97 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.33 -45.65 92.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -67.0 -43.11 83.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.724 HG13 ' CE2' ' A' ' 18' ' ' TYR . 60.1 t -56.93 -39.39 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 15.3 ttt180 -55.47 -48.81 73.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.855 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.37 -33.02 49.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.64 -44.08 71.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.267 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.6 pt20 -65.59 -33.77 76.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 1.2 tt0 -66.01 -32.26 73.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.312 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.6 p -69.68 -27.5 65.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.28 19.97 21.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CD2' ' CD1' ' A' ' 153' ' ' LEU . 3.0 m-85 -108.5 4.22 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -1.129 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.724 ' CE2' HG13 ' A' ' 9' ' ' VAL . 21.6 t80 -90.86 136.07 33.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.355 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.94 ' CG ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -92.23 148.34 22.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.667 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 2.6 t -40.68 -92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.783 . . . . 0.0 110.321 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.91 61.72 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -59.53 -137.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -85.32 166.19 16.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 109.551 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . -39.89 -83.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.827 ' CA ' HG21 ' B' ' 162' ' ' VAL . . . -79.29 -30.18 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 17.0 tt0 -57.78 -34.79 69.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.982 -1.305 . . . . 0.0 110.517 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -66.84 -48.73 67.96 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.94 -1.1 . . . . 0.0 109.025 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.657 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 19.2 m120 -69.3 -43.15 74.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.463 -0.773 . . . . 0.0 110.728 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -70.28 -31.78 69.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 111.686 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.756 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.76 -41.15 70.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.88 -1.138 . . . . 0.0 110.352 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.063 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.1 pp -61.02 -34.69 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 108.964 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.79 -32.82 71.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -20.62 42.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.504 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.8 mt-10 -114.89 -76.75 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.2 Cg_endo -72.85 65.53 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.299 1.157 . . . . 0.0 110.118 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.91 140.62 11.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 80.15 -2.44 76.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.916 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 m -104.41 146.38 28.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.432 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.787 ' HB2' HD23 ' A' ' 149' ' ' LEU . 39.9 p90 -123.79 138.88 54.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.985 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.063 HD23 ' HB3' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -141.4 159.4 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.145 -0.972 . . . . 0.0 110.619 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.919 ' N ' HD12 ' A' ' 40' ' ' LEU . 1.7 tt -115.16 130.58 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.945 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' NH2' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -112.72 160.5 17.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.032 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' CB ' ' OH ' ' A' ' 18' ' ' TYR . 12.4 t70 -74.0 126.28 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.137 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.602 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 9.4 t -57.47 -87.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 110.101 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.517 ' HB2' ' CG ' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -119.78 67.76 0.82 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.993 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 69.28 -168.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.091 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -1.93 32.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -92.28 16.54 11.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.893 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.667 ' O ' HG21 ' A' ' 5' ' ' VAL . 7.3 m80 -143.25 -93.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 44' ' ' SER . 42.7 p90 -177.78 -158.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 35.5 p90 -133.26 149.14 51.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.377 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 64' ' ' LEU . 74.7 m -126.22 155.13 42.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.18 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -137.24 146.44 44.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.697 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 25.1 p -139.43 153.99 47.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' CG2' ' HG ' ' A' ' 149' ' ' LEU . 8.8 p -120.13 172.24 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 1.6 tmtp? -123.01 139.19 54.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.537 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -151.65 -173.35 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.66 24.23 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.511 ' HB3' HG21 ' A' ' 145' ' ' ILE . 1.7 p -126.98 -2.62 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.25 139.55 5.6 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 61' ' ' THR . 15.3 t -95.31 109.56 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.308 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -110.65 155.18 22.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 110.04 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 4.5 t30 -111.53 128.68 56.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.019 HD13 ' CG2' ' B' ' 167' ' ' VAL . 0.9 OUTLIER -130.23 152.06 50.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -0.971 . . . . 0.0 110.33 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.58 ' CA ' HG23 ' A' ' 52' ' ' THR . 3.0 ptm180 -121.68 -145.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.777 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 94' ' ' LEU . 1.4 tp -116.75 149.02 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 0.0 110.341 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -110.76 124.71 52.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.575 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 29.4 p -87.81 126.89 35.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.65 103.02 7.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.47 -102.15 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.6 36.19 3.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.06 160.39 40.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -1.18 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.644 ' CD1' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.16 138.44 46.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.855 . . . . 0.0 110.033 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.3 t -155.32 150.15 26.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -80.02 49.37 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.052 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.522 ' NE2' ' OG1' ' B' ' 166' ' ' THR . 2.1 tt0 66.71 74.7 0.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -136.52 -169.17 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' HB3' ' CA ' ' B' ' 171' ' ' GLY . 18.3 p-10 -120.04 149.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.19 54.64 2.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.077 1.567 . . . . 0.0 110.356 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -69.98 -4.27 19.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER 67.83 40.23 2.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.177 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.509 ' N ' ' OE1' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -106.31 33.82 3.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.193 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' OE1' ' N ' ' A' ' 82' ' ' THR . 8.8 mp0 -131.49 163.7 47.79 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.174 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.619 ' HD2' ' CE1' ' A' ' 88' ' ' PHE . 40.5 Cg_endo -66.77 -53.1 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 111.211 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.768 HG13 ' HD2' ' A' ' 86' ' ' PRO . 55.3 t -116.88 149.34 43.91 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.766 -1.209 . . . . 0.0 110.23 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.768 ' HD2' HG13 ' A' ' 85' ' ' VAL . 41.3 Cg_endo -68.21 132.87 27.02 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.922 1.485 . . . . 0.0 109.051 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 88' ' ' PHE . 14.3 mtm180 54.65 85.93 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.955 -1.091 . . . . 0.0 108.513 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.619 ' CE1' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -51.72 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 110.649 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 90' ' ' CYS . 64.1 m-20 -88.47 109.97 20.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.965 -1.085 . . . . 0.0 110.694 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.928 ' SG ' HD23 ' A' ' 4' ' ' LEU . 13.7 m 20.81 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.641 0.734 . . . . 0.0 112.14 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.662 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.8 p -49.63 -24.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 110.633 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.872 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.29 -34.08 63.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 110.073 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.609 ' HB2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -57.53 -31.76 66.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.799 ' HB2' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -59.83 -35.4 74.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.246 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.7 m -55.33 -37.32 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.316 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.54 ' HB2' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -53.83 -34.71 60.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.023 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.614 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -78.07 -36.77 47.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 109.986 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.741 ' CE1' HD23 ' A' ' 53' ' ' LEU . 3.3 m-85 -63.55 -22.02 66.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.32 124.73 4.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 0.0 110.319 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.97 162.56 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.925 1.487 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HD3' ' HG2' ' A' ' 134' ' ' ARG . 45.7 Cg_endo -72.99 130.89 16.07 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 55.61 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.985 1.518 . . . . 0.0 110.361 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.492 ' C ' HG23 ' A' ' 104' ' ' THR . . . 70.64 -174.71 38.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 103' ' ' GLY . 21.5 p -149.54 164.45 20.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -1.16 . . . . 0.0 110.205 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 45.9 Cg_endo -73.1 -159.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.961 1.506 . . . . 0.0 110.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' SER . 3.3 m -170.87 153.96 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 52.81 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 110.216 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' SER . 0.8 OUTLIER -138.73 164.38 29.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.224 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.544 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 1.4 tp -61.14 -55.46 43.91 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 109' ' ' LEU . 45.8 Cg_endo -72.86 134.91 22.55 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.942 1.496 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 117' ' ' GLU . 46.6 Cg_endo -73.16 83.63 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.984 1.518 . . . . 0.0 110.432 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER 48.41 -178.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 2.1 mm-40 -58.7 -57.73 24.56 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.226 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 46.6 Cg_endo -72.93 -177.58 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.991 1.521 . . . . 0.0 110.431 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.2 p -123.89 58.32 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.883 . . . . 0.0 110.163 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.1 m -150.38 17.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.24 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -74.15 61.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 118' ' ' VAL . 17.4 m -123.18 52.38 4.53 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.945 . . . . 0.0 110.157 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 118' ' ' VAL . 45.7 Cg_endo -72.92 -164.31 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.961 1.506 . . . . 0.0 110.383 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -150.0 56.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.53 ' CB ' ' HD3' ' A' ' 122' ' ' PRO . 10.5 mm-40 -71.59 -57.7 4.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.89 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 121' ' ' GLN . 47.4 Cg_endo -73.08 159.01 48.56 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.983 1.517 . . . . 0.0 110.458 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.22 -6.94 19.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.054 1.555 . . . . 0.0 110.419 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.14 -163.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -110.76 -59.07 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.61 -50.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.433 HD21 ' HG3' ' A' ' 132' ' ' PRO . 0.5 OUTLIER -139.8 102.2 7.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.297 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.31 -16.36 24.85 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.977 1.514 . . . . 0.0 110.363 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.46 -21.7 41.73 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 m -76.87 -30.13 56.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -1.128 . . . . 0.0 110.143 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.527 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -57.75 -57.61 24.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 131' ' ' THR . 46.6 Cg_endo -73.08 152.58 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' ARG . 1.2 mmpt? -78.24 -13.14 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.467 ' HG2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -42.68 116.73 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -175.42 111.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.154 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 2.1 t80 -103.0 121.42 42.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.936 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.18 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.9 165.89 33.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.0 . . . . 0.0 110.423 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.096 HD12 ' CD2' ' A' ' 147' ' ' LEU . 6.1 mt -123.5 126.73 73.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.012 . . . . 0.0 109.758 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.781 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -83.36 107.63 16.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.832 0.825 . . . . 0.0 109.717 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' TYR . 56.1 p -42.45 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.774 -0.579 . . . . 0.0 110.411 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.84 80.3 0.36 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.38 82.31 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 145' ' ' ILE . 39.8 tt0 -114.06 121.28 43.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.281 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 21.9 mtmm -76.94 108.45 9.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 110.949 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.834 HG22 HD11 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -104.31 132.47 20.94 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.927 ' C ' HD12 ' A' ' 147' ' ' LEU . 45.2 Cg_endo -71.56 128.16 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.79 1.416 . . . . 0.0 112.111 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.096 ' CD2' HD12 ' A' ' 138' ' ' ILE . 8.3 mp -123.69 101.5 7.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.71 117.81 44.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.874 -1.142 . . . . 0.0 111.207 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 39' ' ' PHE . 8.8 mp -79.73 114.83 18.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.283 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.18 -23.93 2.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -85.91 124.9 70.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 110.271 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.581 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 47.9 Cg_endo -74.74 128.26 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.055 1.555 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.937 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.76 158.22 16.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.519 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.556 ' N ' HD22 ' A' ' 153' ' ' LEU . 47.8 t -113.03 82.47 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.104 -0.997 . . . . 0.0 110.264 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.2 m -71.29 95.2 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 156' ' ' ASN . 27.5 p30 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.276 0.56 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.8 145.87 18.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.494 ' O ' HG23 ' B' ' 161' ' ' THR . . . -126.13 -47.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.412 ' C ' HG23 ' B' ' 161' ' ' THR . 3.7 t 45.7 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.219 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.494 HG23 ' O ' ' B' ' 159' ' ' ALA . 69.5 p -145.75 92.64 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.827 HG21 ' CA ' ' A' ' 25' ' ' GLY . 7.2 p -119.97 92.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' B' ' 164' ' ' PTR . 0.4 OUTLIER -71.56 162.84 28.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.561 ' N ' ' CD2' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.1 t -120.45 -134.87 0.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.607 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 31.0 m -145.16 147.71 32.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.154 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.6 t -87.67 102.39 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.18 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t 72.7 120.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.405 -0.81 . . . . 0.0 110.231 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' B' ' 168' ' ' VAL . 0.1 OUTLIER -42.26 153.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.15 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' GLN . 4.4 t -102.77 93.84 5.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.509 ' CA ' ' HB3' ' A' ' 78' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.522 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.336 0.588 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 38.0 p90 -63.38 -36.08 82.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.479 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -55.57 -36.21 66.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 4.2 mt -64.29 -44.46 91.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 51' ' ' PHE . 12.1 t -66.63 -48.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.8 t -58.82 -41.75 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -71.22 -31.26 67.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 109.833 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' HG12 ' A' ' 91' ' ' VAL . . . -76.05 -44.28 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.458 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 6' ' ' VAL . 29.9 m -57.11 -38.71 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.241 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 4.6 mtp180 -55.04 -40.63 70.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -71.36 -42.39 68.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.959 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -72.04 -40.18 68.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 5.3 pt20 -68.19 -33.73 74.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 4.0 tm-20 -57.65 -21.45 39.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 110.261 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -26.95 62.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.17 37.8 3.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 25.5 t80 -142.13 7.15 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -1.142 . . . . 0.0 110.235 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 6.3 t80 -96.28 136.21 37.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 1.102 ' CG ' HD12 ' A' ' 40' ' ' LEU . 28.6 m95 -110.6 148.31 32.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.478 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -148.41 109.74 4.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 176.59 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 111.089 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' CG2' ' CZ ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -120.88 -160.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.862 -1.149 . . . . 0.0 110.277 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -86.09 166.04 16.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' CA ' ' HB ' ' A' ' 52' ' ' THR . . . -52.19 -76.45 0.18 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.683 ' HA3' HG22 ' B' ' 162' ' ' VAL . . . -60.74 -43.72 98.79 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.457 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 29.9 tt0 -59.78 -24.83 64.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 110.01 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.676 ' HB1' ' HE ' ' A' ' 42' ' ' ARG . . . -78.12 -45.55 23.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.32 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.583 ' CB ' ' CB ' ' A' ' 54' ' ' SER . 1.0 OUTLIER -69.04 -41.8 77.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.389 -0.819 . . . . 0.0 110.755 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 1.4 mp -59.43 -32.14 69.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.766 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.751 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -55.21 -23.58 22.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.982 -1.074 . . . . 0.0 109.352 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 38' ' ' THR . 70.9 mt -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 109.096 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.549 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 26.9 p -69.19 -32.43 71.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.716 . . . . 0.0 109.888 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.48 -20.62 43.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.371 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.762 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 12.5 mm-40 -134.06 -83.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.762 ' HD3' ' CB ' ' A' ' 34' ' ' GLU . 50.3 Cg_endo -78.01 67.67 8.01 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 122.812 0.901 . . . . 0.0 110.152 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -63.67 141.47 58.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 88.98 15.74 58.88 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.754 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -130.63 147.17 52.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -1.05 . . . . 0.0 110.142 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 149' ' ' LEU . 4.0 p90 -123.11 146.22 47.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 0.0 110.678 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.102 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.08 160.31 43.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 12' ' ' LEU . 3.3 tt -114.0 128.84 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.924 -1.11 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.676 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -117.68 150.44 39.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.755 . . . . 0.0 110.122 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 44' ' ' SER . 9.8 t70 -73.87 127.56 33.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 44' ' ' SER . 25.5 m -41.26 -34.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.324 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.43 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -177.25 -172.12 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -64.97 -10.02 26.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 110.224 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -67.86 -32.53 73.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.261 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 3.2 m-70 -115.29 -123.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.104 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.617 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.4 p90 -152.7 -160.99 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.838 ' CD2' HG13 ' A' ' 5' ' ' VAL . 27.1 p90 -115.9 148.72 39.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' CA ' ' A' ' 24' ' ' GLY . 88.6 m -126.13 139.76 53.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.055 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -126.92 124.97 40.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.918 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -133.9 154.29 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.476 -0.765 . . . . 0.0 110.049 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 149' ' ' LEU . 12.4 p -130.58 174.08 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -118.86 139.02 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.204 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.796 HG21 ' HB3' ' A' ' 147' ' ' LEU . 26.6 m -115.21 -43.3 3.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 57' ' ' THR . 27.0 pt20 -177.99 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.59 29.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.626 ' O ' HD13 ' A' ' 138' ' ' ILE . . . -155.76 65.46 0.31 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 61' ' ' THR . 3.8 t -84.96 111.85 20.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -1.144 . . . . 0.0 110.138 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HG3' HG21 ' A' ' 138' ' ' ILE . 14.3 mmtt -123.53 166.08 16.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.804 ' OD1' HG13 ' B' ' 162' ' ' VAL . 0.5 OUTLIER -134.32 154.12 51.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.027 HD21 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.01 118.15 13.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 110.53 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.555 ' HD2' ' CZ ' ' A' ' 50' ' ' PHE . 10.7 ptm180 -75.32 162.21 28.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.864 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.914 ' CG1' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -78.27 148.78 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 110.263 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -107.53 136.75 46.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 1' ' ' GLU . 27.9 p -87.83 119.97 28.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.28 103.09 8.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.64 -78.27 0.02 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -148.25 30.35 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.44 163.09 33.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.956 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -115.7 141.18 48.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 109.977 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.631 ' C ' HD13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -148.15 138.89 23.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.94 -1.1 . . . . 0.0 110.616 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.702 HD21 ' CB ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -86.06 -1.14 57.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 109.793 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.67 HE21 HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -121.12 -130.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.097 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.21 -87.86 0.53 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.386 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' OD1' ' HG3' ' A' ' 80' ' ' ARG . 6.0 t0 -81.28 113.21 39.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HB3' ' HB2' ' A' ' 74' ' ' SER . 47.3 Cg_endo -74.35 -12.64 22.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.043 1.549 . . . . 0.0 110.379 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.42 ' HG3' ' OD1' ' A' ' 78' ' ' ASP . 13.7 mtm-85 -67.79 -6.17 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.309 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 82' ' ' THR . 34.3 t -142.81 -143.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.67 HG21 HE21 ' A' ' 76' ' ' GLN . 0.2 OUTLIER 70.38 -55.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 0.0 110.315 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 177.02 -57.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.314 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 83' ' ' GLN . 45.1 Cg_endo -72.01 162.0 43.12 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.905 1.476 . . . . 0.0 110.452 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 20.9 m -97.81 167.08 12.33 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.2 Cg_endo -70.46 132.85 23.02 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.952 1.501 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 3.5 mtt180 63.36 43.11 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.915 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 14.4 p90 -61.43 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.037 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 90' ' ' CYS . 74.2 m-20 -103.9 109.97 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.76 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.779 ' CB ' HD23 ' A' ' 92' ' ' LEU . 0.6 OUTLIER 50.92 156.13 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.962 0.887 . . . . 0.0 111.588 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.956 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -49.05 -21.11 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.703 0.763 . . . . 0.0 109.32 178.379 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.0 pp -54.41 -33.87 60.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.565 -0.709 . . . . 0.0 111.545 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HB2' ' CD1' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -57.31 -30.41 64.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.596 -1.315 . . . . 0.0 109.741 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.914 HD22 ' CG1' ' A' ' 66' ' ' ILE . 1.1 pp -58.78 -33.02 69.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.3 m -53.39 -34.85 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.429 -0.794 . . . . 0.0 110.353 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' N ' HG23 ' A' ' 95' ' ' VAL . 8.3 m80 -51.29 -30.06 16.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 109.51 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.508 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 t-80 -73.17 -36.3 66.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.166 -0.959 . . . . 0.0 108.825 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.055 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.8 m-85 -63.57 -22.12 66.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.568 -0.707 . . . . 0.0 109.674 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.569 ' HE1' ' HA ' ' A' ' 135' ' ' ALA . 10.8 ttm 71.57 63.31 0.41 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.465 -0.772 . . . . 0.0 110.301 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 42.1 Cg_endo -72.67 -29.41 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.915 1.481 . . . . 0.0 112.284 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 100' ' ' PRO . 48.3 Cg_endo -74.36 162.76 37.74 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 122.821 0.906 . . . . 0.0 110.415 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' HA ' ' HG ' ' A' ' 150' ' ' SER . 45.8 Cg_endo -73.26 -90.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.004 1.528 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 119.93 12.14 6.65 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.6 p -56.16 142.69 66.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 110.237 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.35 -44.28 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.05 1.553 . . . . 0.0 110.412 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.8 t -159.06 -161.92 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.269 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 43.91 75.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -107.86 -174.02 2.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.499 ' N ' ' OG ' ' A' ' 108' ' ' SER . 0.1 OUTLIER -130.83 75.42 78.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.89 139.91 31.02 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.496 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.02 147.45 43.29 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.034 1.544 . . . . 0.0 110.463 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -80.67 91.96 5.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 8.2 pt-20 -64.42 143.18 98.49 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.99 -18.69 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.988 1.52 . . . . 0.0 110.419 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 150.58 21.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 3.4 t -140.7 -136.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 2.5 mt-10 65.6 9.71 6.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 t -54.6 117.98 15.29 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.101 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 45.9 Cg_endo -72.6 -48.95 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.982 1.517 . . . . 0.0 110.504 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 119' ' ' PRO . 2.1 tt0 177.18 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.238 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 6.6 mt-30 -43.32 127.34 3.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.75 110.56 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 121' ' ' GLN . 46.4 Cg_endo -73.08 -159.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.996 1.524 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 125' ' ' GLN . . . -92.25 -17.73 24.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 124' ' ' ALA . 7.5 tp60 42.35 62.44 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.915 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . 43.31 -99.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.0 110.09 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER 40.21 81.5 0.25 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.935 . . . . 0.0 110.287 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' SER . 46.1 Cg_endo -73.08 -54.63 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 48.08 -94.11 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 128' ' ' PRO . 0.1 OUTLIER -116.66 105.21 12.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -1.124 . . . . 0.0 110.244 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.43 123.13 68.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 133' ' ' LYS . 46.0 Cg_endo -72.7 104.23 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.961 1.506 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 134' ' ' ARG . 2.3 tptt -42.81 -58.61 2.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.319 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 133' ' ' LYS . 1.7 mtp180 57.57 113.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.889 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.97 126.34 0.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 110.058 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.921 ' CD2' HG11 ' B' ' 167' ' ' VAL . 3.7 t80 -128.59 121.81 29.56 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.408 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.029 ' CD2' HG22 ' B' ' 168' ' ' VAL . 12.6 p90 -156.83 167.33 30.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.203 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.705 HD12 HD21 ' A' ' 147' ' ' LEU . 2.6 mp -106.05 149.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.635 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 29.5 m-85 -96.18 133.05 40.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.76 . . . . 0.0 110.992 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.48 ' OG ' HD13 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -87.46 48.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.636 -0.665 . . . . 0.0 110.217 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 52.49 65.73 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.07 -22.48 15.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.53 121.97 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -1.174 . . . . 0.0 110.162 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.4 ptmt -88.48 105.72 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.27 102.98 10.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.791 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.2 Cg_endo -76.18 126.68 9.37 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.681 1.358 . . . . 0.0 111.981 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.796 ' HB3' HG21 ' A' ' 57' ' ' THR . 0.4 OUTLIER -126.76 136.0 51.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 148' ' ' VAL . 30.2 m -97.08 117.18 41.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.136 -1.603 . . . . 0.0 110.624 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 39' ' ' PHE . 6.3 tt -90.11 114.93 26.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.65 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.52 ' HG ' ' HA ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -148.94 19.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.021 -1.05 . . . . 0.0 110.821 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -105.6 124.49 36.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.03 -1.044 . . . . 0.0 109.976 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.5 Cg_endo -76.57 148.22 29.14 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.954 1.502 . . . . 0.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.709 HD21 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -79.07 152.87 30.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 110.089 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.677 ' H ' HD13 ' A' ' 153' ' ' LEU . 17.0 m -91.55 57.57 3.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 110.192 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 38.0 t -41.21 -60.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 110.27 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' SER . . . . . 0.659 ' O ' HG23 ' B' ' 158' ' ' THR . 37.3 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.228 0.537 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.659 HG23 ' O ' ' B' ' 157' ' ' SER . 0.7 OUTLIER -159.64 28.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.237 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 158' ' ' THR . . . -176.16 60.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 12.0 t -115.18 174.55 5.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.42 ' O ' ' C ' ' B' ' 162' ' ' VAL . 12.9 m -121.22 42.8 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.804 HG13 ' OD1' ' A' ' 63' ' ' ASN . 43.2 t 42.44 64.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.265 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -87.87 153.56 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.638 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' SER . . . . . 1.027 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 p -149.03 -98.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.368 -0.833 . . . . 0.0 110.318 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.638 ' CA ' HD11 ' A' ' 64' ' ' LEU . 2.6 t -146.82 175.47 10.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 110.26 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.921 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -128.73 112.36 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.976 . . . . 0.0 110.272 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 137' ' ' TYR . 0.2 OUTLIER 41.46 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -116.53 170.43 8.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.54 -73.34 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.238 0.542 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.505 ' HB2' ' HD2' ' A' ' 48' ' ' ARG . 36.8 p90 -62.08 -36.14 80.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -55.2 -34.21 63.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.167 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -67.26 -45.17 77.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 110.205 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.94 ' O ' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -64.94 -48.4 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -58.42 -32.62 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.311 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.11 -42.52 80.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 91' ' ' VAL . . . -76.12 -44.91 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.94 HG13 ' O ' ' A' ' 5' ' ' VAL . 5.4 m -59.01 -39.58 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -55.54 -49.01 73.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -35.94 65.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 109.513 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 12' ' ' LEU . 14.0 tp -72.13 -44.09 63.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 16.7 pt20 -68.21 -33.87 75.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.6 -26.48 61.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.112 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -26.89 62.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.024 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' ' 155' ' ' SER . . . 99.19 1.61 56.93 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HD2' HD12 ' A' ' 153' ' ' LEU . 1.6 t80 -88.96 -8.33 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 110.187 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 41' ' ' ILE . 5.7 t80 -90.91 136.23 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.812 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 1.034 ' CD1' HD13 ' A' ' 40' ' ' LEU . 46.3 m95 -99.79 148.42 24.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.795 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -53.07 -18.7 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.855 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 75.54 93.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.659 . . . . 0.0 111.16 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 23' ' ' THR . 1.8 m -66.41 -90.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.284 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.678 ' H ' HG23 ' A' ' 22' ' ' VAL . 1.1 m -103.5 172.99 6.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.003 -1.061 . . . . 0.0 109.219 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.599 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.23 -94.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.644 ' CA ' HG21 ' B' ' 162' ' ' VAL . . . -71.25 -29.5 68.43 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.485 -1.009 . . . . 0.0 110.651 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.594 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -57.56 -24.95 59.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.25 . . . . 0.0 111.204 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.918 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -76.46 -47.04 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.825 -1.172 . . . . 0.0 109.66 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.669 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.7 m-80 -70.34 -44.86 67.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 111.066 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' OG1' ' A' ' 61' ' ' THR . 15.1 mt -70.7 -31.53 68.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.7 pp -54.28 -27.41 35.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.535 -1.353 . . . . 0.0 110.561 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.033 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.4 pp -74.05 -33.75 63.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.81 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -69.89 -32.72 71.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 110.296 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.07 41.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.352 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.744 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 3.7 mm-40 -113.95 -77.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.057 -1.027 . . . . 0.0 110.063 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.744 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.0 Cg_endo -72.49 71.09 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.271 1.143 . . . . 0.0 110.142 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.09 137.18 47.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.04 0.6 89.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -111.23 147.41 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -1.181 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -122.79 148.75 45.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.0 110.716 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' CD1' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -147.65 160.02 43.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 109.91 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.021 ' N ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -113.95 148.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.973 . . . . 0.0 110.46 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.599 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 5.7 ppt_? -127.38 127.59 44.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.705 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 24.7 t70 -75.27 138.24 41.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.483 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.568 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 12.9 m -69.86 64.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -47.98 -24.89 1.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.172 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 45' ' ' SER . 52.5 t0 -49.78 -101.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 13.1 mt-30 -78.11 -1.89 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.991 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 68.77 23.72 6.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -58.66 -70.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.368 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.843 ' CB ' HG21 ' A' ' 5' ' ' VAL . 17.2 p90 -154.42 -156.13 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.857 ' CE1' HG22 ' A' ' 5' ' ' VAL . 14.2 p90 -116.01 152.71 33.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 24.3 m -118.13 155.54 30.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.904 HD13 ' N ' ' A' ' 54' ' ' SER . 1.2 tm? -142.17 129.68 21.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.301 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.904 ' N ' HD13 ' A' ' 53' ' ' LEU . 3.1 p -138.32 154.13 49.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.642 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG11 HD21 ' A' ' 149' ' ' LEU . 2.8 m -127.03 173.99 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 110.835 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 14.5 tptm -113.04 129.58 56.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.887 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.965 ' HB ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.63 -165.76 1.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.387 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' GLY . 8.4 tt0 -77.93 -59.12 2.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.473 ' OG ' ' HB ' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -42.24 -27.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' GLN . . . 130.66 151.92 7.24 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 61' ' ' THR . 2.4 t -78.87 108.89 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.181 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -110.37 153.2 25.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.942 . . . . 0.0 110.099 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 164' ' ' PTR . 15.0 p30 -121.06 125.84 48.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -118.65 151.93 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.633 ' C ' HD12 ' A' ' 75' ' ' LEU . 1.4 ptt180 -140.36 152.99 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 110.437 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.911 HD11 ' HB2' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -76.62 117.86 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 74' ' ' SER . 16.2 tt0 -91.95 151.14 20.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 110.484 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 20.0 p -101.62 127.84 48.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -133.14 117.01 16.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.31 34.15 87.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.22 -14.22 54.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 51.2 p -94.99 162.81 13.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -1.14 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.7 m-30 -110.92 152.01 27.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.73 ' C ' HD13 ' A' ' 66' ' ' ILE . 19.3 m -155.63 138.7 15.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.031 HD13 ' HG ' ' A' ' 94' ' ' LEU . 2.6 tt -123.74 -1.86 8.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.076 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 77' ' ' SER . 13.7 mt-30 -131.37 -136.06 0.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.089 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 76' ' ' GLN . 5.3 t -42.56 139.82 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 110.163 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 80' ' ' ARG . 3.8 p30 -81.56 130.15 62.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.2 -0.938 . . . . 0.0 110.164 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 54.41 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.52 . . . . 0.0 110.416 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' HB2' ' OD1' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -85.88 16.08 4.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -108.84 44.26 1.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.876 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 43.79 39.97 2.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.471 ' HG2' ' OG ' ' A' ' 81' ' ' SER . 3.2 pt20 -134.2 70.97 73.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.23 -179.16 4.12 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.979 1.515 . . . . 0.0 110.357 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.74 141.61 40.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.452 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 46.7 Cg_endo -72.95 137.66 27.11 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.011 1.532 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.649 ' O ' ' O ' ' A' ' 88' ' ' PHE . 4.3 mtt180 57.54 37.22 27.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 110.15 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.2 p90 36.16 109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.727 0.775 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.504 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 0.9 OUTLIER -113.56 110.1 19.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.914 -1.116 . . . . 0.0 109.349 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.911 ' HB2' HD11 ' A' ' 66' ' ' ILE . 0.8 OUTLIER 172.79 -65.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.642 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 92' ' ' LEU . 7.3 p -49.79 -48.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.82 -1.175 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.722 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.6 mt -61.64 -42.07 98.38 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -57.86 -34.41 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 110.43 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.7 m -54.35 -37.67 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.94 -1.1 . . . . 0.0 109.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.723 ' CD2' ' HB3' ' A' ' 101' ' ' PRO . 77.9 m80 -68.16 -37.34 80.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.247 -0.908 . . . . 0.0 109.188 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.53 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -77.57 -36.87 51.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 109.749 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.913 ' OH ' HD11 ' A' ' 75' ' ' LEU . 5.6 m-85 -77.1 -22.33 52.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.824 . . . . 0.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' HD2' ' A' ' 100' ' ' PRO . 2.5 mtp -156.89 167.96 13.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.336 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.498 ' HG3' ' HA ' ' A' ' 150' ' ' SER . 48.9 Cg_endo -76.01 133.96 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.0 110.451 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.723 ' HB3' ' CD2' ' A' ' 96' ' ' HIS . 45.4 Cg_endo -73.03 111.8 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.977 1.514 . . . . 0.0 110.344 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 46.3 Cg_endo -72.87 55.12 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.985 1.518 . . . . 0.0 110.383 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.71 117.38 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.5 m -140.73 88.92 10.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.264 -1.139 . . . . 0.0 110.214 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.24 -176.7 2.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.026 1.54 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 t -72.73 -176.26 1.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -83.78 82.03 8.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 109' ' ' LEU . 19.2 t 50.84 -157.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.84 HD23 ' H ' ' A' ' 109' ' ' LEU . 2.5 pt? -149.87 158.57 37.03 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.236 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HB2' ' HB2' ' A' ' 113' ' ' GLU . 46.7 Cg_endo -73.0 148.43 45.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.09 -90.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.967 1.509 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.35 67.33 1.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.211 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -155.81 77.09 4.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.205 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 115' ' ' SER . 46.7 Cg_endo -72.83 -53.57 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.477 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 114' ' ' PRO . 0.7 OUTLIER 63.3 20.95 12.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' GLU . 5.7 t 57.95 21.36 7.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' SER . 18.7 mt-10 43.28 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.262 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 118' ' ' VAL . 50.6 t -127.57 62.12 53.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -35.01 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.045 1.55 . . . . 0.0 110.458 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 52.68 87.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -150.12 49.26 0.62 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.199 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 121' ' ' GLN . 47.0 Cg_endo -73.42 134.39 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.944 1.497 . . . . 0.0 110.531 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 56.1 3.42 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.974 1.513 . . . . 0.0 110.4 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.56 18.29 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.343 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -135.08 151.88 51.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.04 129.2 9.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.536 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 3.2 mm? -63.36 -57.56 19.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 46.2 Cg_endo -73.1 119.3 5.96 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.542 . . . . 0.0 110.435 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 131' ' ' THR . . . 159.29 -90.29 0.11 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -57.45 84.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -1.146 . . . . 0.0 110.231 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.571 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -127.53 48.29 3.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.228 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 131' ' ' THR . 47.1 Cg_endo -73.42 -0.18 8.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.99 1.521 . . . . 0.0 110.562 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 35.64 3.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.248 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.425 ' HB3' HG22 ' A' ' 131' ' ' THR . 0.1 OUTLIER -162.96 52.25 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.068 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -176.31 102.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.143 ' CE2' HG21 ' B' ' 167' ' ' VAL . 3.0 t80 -102.62 122.51 44.55 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.903 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.165 ' CD2' HG22 ' B' ' 168' ' ' VAL . 3.5 p90 -155.73 167.9 28.89 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.927 -1.108 . . . . 0.0 110.781 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.566 HG12 ' CB ' ' A' ' 62' ' ' LYS . 3.0 mp -121.09 149.58 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 111.055 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.752 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.0 OUTLIER -84.71 107.94 17.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 110.057 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.851 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -91.82 122.02 33.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 110.286 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.14 65.68 2.59 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 51.35 20.59 5.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 140' ' ' SER . 12.8 tt0 -120.38 121.86 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.135 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.16 105.36 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 110.63 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.851 HD13 ' HB3' ' A' ' 140' ' ' SER . 0.9 OUTLIER -99.98 109.04 54.79 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.831 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.5 Cg_endo -72.53 128.72 13.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.954 1.502 . . . . 0.0 112.277 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -125.89 135.21 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 148' ' ' VAL . 35.7 m -103.83 117.72 49.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.273 -1.517 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.823 HD21 HG11 ' A' ' 55' ' ' VAL . 12.8 mt -76.17 123.5 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -0.963 . . . . 0.0 108.969 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.498 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 11.0 t -137.84 -7.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.82 -1.175 . . . . 0.0 111.647 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 ttm-85 -100.23 124.63 42.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.718 -1.239 . . . . 0.0 110.104 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 147.96 32.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.981 1.516 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 1.119 HD13 ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -67.13 159.14 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.964 ' N ' HD22 ' A' ' 153' ' ' LEU . 5.0 m -14.09 -86.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.558 -0.713 . . . . 0.0 111.231 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 20.0 m -41.09 139.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.218 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.203 0.525 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.73 49.77 6.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -163.82 -51.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.91 148.62 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -0.871 . . . . 0.0 110.175 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -97.56 -51.9 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.644 HG21 ' CA ' ' A' ' 25' ' ' GLY . 2.6 p -171.03 121.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 110.014 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 0.0 OUTLIER -120.81 -176.5 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.189 -0.944 . . . . 0.0 110.28 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.552 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.488 ' O ' ' CD2' ' B' ' 164' ' ' PTR . 1.4 m -134.83 -138.67 0.17 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.511 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -125.95 163.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.191 -0.943 . . . . 0.0 110.134 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.143 HG21 ' CE2' ' A' ' 136' ' ' TYR . 37.8 t -114.47 112.89 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.165 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t 58.48 155.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -172.37 128.34 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 5.6 t -131.05 109.19 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.26 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.57 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.61 ' N ' HD12 ' A' ' 4' ' ' LEU . 85.3 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.34 0.591 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 22.1 p90 -64.52 -35.88 82.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.564 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 28.1 pt20 -62.88 -40.22 96.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.1 mt -67.0 -47.46 71.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 50' ' ' PHE . 7.1 p -68.94 -47.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.318 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.608 ' N ' HG13 ' A' ' 5' ' ' VAL . 41.9 t -58.68 -50.23 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -58.82 -38.42 78.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.724 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.59 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -72.34 -38.26 68.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.791 HG13 ' CE2' ' A' ' 18' ' ' TYR . 3.0 t -56.94 -39.39 65.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.3 mtp85 -58.45 -49.42 77.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.568 -0.708 . . . . 0.0 110.104 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -78.57 -33.25 47.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.323 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' CG2' ' A' ' 95' ' ' VAL . 2.2 tt -72.0 -44.15 63.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.758 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 17.3 pt20 -61.28 -40.94 96.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 110.371 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 8.3 tt0 -77.16 -51.64 10.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -72.79 -43.18 63.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 17' ' ' PHE . . . -99.98 33.99 5.85 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.221 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 3.1 p90 29.75 44.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -1.039 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.791 ' CE2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -92.79 122.92 35.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.721 ' CE2' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -125.61 145.94 49.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 110.126 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 107.31 14.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.29 12.82 0.12 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.472 -0.767 . . . . 0.0 110.016 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.54 -159.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.693 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.19 176.17 7.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 42' ' ' ARG . . . -55.21 -75.3 0.25 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.742 ' CA ' HG11 ' B' ' 162' ' ' VAL . . . -79.39 -31.77 40.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.564 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 1.9 tp10 -59.0 -36.47 74.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.032 -1.275 . . . . 0.0 109.509 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.938 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -60.92 -51.43 69.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.729 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 4.1 m-80 -69.82 -42.88 73.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.968 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.99 -32.75 69.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -0.842 . . . . 0.0 112.321 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.938 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.7 pp -55.4 -35.12 64.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.704 -1.247 . . . . 0.0 110.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.043 HD13 ' O ' ' A' ' 38' ' ' THR . 4.6 pp -66.27 -36.24 82.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.826 -1.171 . . . . 0.0 109.265 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.922 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.53 -32.72 71.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 110.324 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.55 -20.71 42.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.67 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -116.84 -76.03 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.9 Cg_endo -73.18 70.9 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.292 1.154 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 141.28 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 79.91 18.21 73.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 1.043 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.42 147.31 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -1.079 . . . . 0.0 110.023 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.763 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.02 163.08 21.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.016 . . . . 0.0 110.202 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.97 ' HB2' HD23 ' A' ' 153' ' ' LEU . 7.6 tt -151.96 159.18 43.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.96 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.858 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -119.24 129.28 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 24' ' ' GLY . 6.3 ppt_? -112.16 155.06 24.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.34 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 30.3 t0 -100.05 132.14 45.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -55.82 153.98 7.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m -48.17 -51.28 25.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.168 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -79.56 146.14 32.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -90.91 -2.0 57.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.212 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -93.94 44.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 48' ' ' ARG . 36.2 m80 -146.35 -93.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.911 ' HA ' HG21 ' A' ' 5' ' ' VAL . 12.1 p90 175.44 178.02 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.878 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.894 ' CD2' HG23 ' A' ' 5' ' ' VAL . 3.3 p90 -115.88 148.66 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.987 . . . . 0.0 110.3 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 65' ' ' ARG . 2.1 p -126.84 155.33 43.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.865 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.12 HD22 ' CD1' ' A' ' 98' ' ' TYR . 1.9 tt -124.22 154.09 40.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.796 ' N ' HD23 ' A' ' 53' ' ' LEU . 3.2 p -139.03 153.63 48.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' HB3' ' A' ' 39' ' ' PHE . 2.8 m -130.13 174.11 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.794 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.8 139.14 52.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.471 -0.768 . . . . 0.0 110.086 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -175.6 146.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.3 OUTLIER 66.82 -60.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.184 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER 165.89 -22.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 109.817 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' C ' ' NZ ' ' A' ' 62' ' ' LYS . . . -105.77 117.1 5.38 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' THR . 9.7 t -97.61 116.52 29.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.142 -1.211 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -106.71 161.37 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.132 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' C ' HD22 ' A' ' 64' ' ' LEU . 1.1 m-80 -118.98 135.82 54.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.904 ' HB3' HD11 ' A' ' 75' ' ' LEU . 2.1 mm? -104.05 127.09 51.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.587 ' CB ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -118.02 138.28 52.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 91' ' ' VAL . 1.1 tp -82.95 148.42 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 27.3 tp60 -112.88 151.06 30.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 67' ' ' GLN . 45.2 t -102.04 127.84 48.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 110.231 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.4 tt0 -121.26 103.0 8.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.76 -68.95 0.12 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -157.02 28.03 0.52 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 4.5 p -136.45 161.31 36.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 110.161 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 90' ' ' CYS . 1.3 m-30 -112.95 149.96 32.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.485 ' HA ' ' SG ' ' A' ' 90' ' ' CYS . 16.4 t -150.99 138.82 19.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD21 ' A' ' 94' ' ' LEU . 27.0 tp -96.41 -23.24 16.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -102.07 142.89 32.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 110.213 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.5 m -92.45 83.48 4.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 40.7 p-10 -109.44 139.86 21.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.18 56.11 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.457 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 81' ' ' SER . 0.0 OUTLIER -85.9 -38.96 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 110.234 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.666 ' O ' HG22 ' A' ' 82' ' ' THR . 12.7 m 55.79 -163.0 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.147 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 81' ' ' SER . 12.6 t 37.79 35.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.297 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.2 tp60 69.66 125.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.65 -62.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.94 1.495 . . . . 0.0 110.524 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.64 HG21 ' O ' ' A' ' 89' ' ' ASP . 2.9 m -126.91 168.13 15.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.4 Cg_endo -70.46 132.87 23.04 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.863 1.454 . . . . 0.0 110.116 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.552 ' O ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 67.95 -77.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.904 . . . . 0.0 109.938 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB3' ' O ' ' A' ' 87' ' ' ARG . 10.5 p90 176.39 50.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.858 . . . . 0.0 109.84 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.64 ' O ' HG21 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -72.64 110.09 6.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.158 -0.963 . . . . 0.0 109.896 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HB3' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER 168.89 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.734 ' CA ' HD13 ' A' ' 66' ' ' ILE . 4.0 p -53.43 -50.06 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 8' ' ' ALA . 16.3 mt -63.51 -46.06 87.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 108.434 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -60.26 -29.9 69.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.033 HD21 HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.92 -34.24 69.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.785 -0.572 . . . . 0.0 110.095 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 42.0 t -54.05 -42.15 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.089 -1.007 . . . . 0.0 108.948 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.0 OUTLIER -68.26 -31.37 70.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.915 . . . . 0.0 108.735 178.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.12 -43.29 29.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.684 -0.635 . . . . 0.0 109.503 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.12 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.2 m-85 -64.05 -22.15 66.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.475 -0.766 . . . . 0.0 110.055 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.523 ' CB ' ' HD2' ' A' ' 100' ' ' PRO . 0.2 OUTLIER -129.61 -179.04 0.91 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.249 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 150' ' ' SER . 48.0 Cg_endo -75.41 127.57 10.5 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.04 1.547 . . . . 0.0 110.38 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.404 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 46.3 Cg_endo -73.26 110.44 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.998 1.525 . . . . 0.0 110.42 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 46.7 Cg_endo -73.56 -90.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.019 1.536 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.74 26.46 7.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.8 t -174.4 140.91 0.75 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.206 -1.173 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.99 -89.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.976 1.513 . . . . 0.0 110.427 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 88.5 p -175.61 102.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -121.08 -164.81 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 110.195 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.73 108.02 5.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.947 . . . . 0.0 110.251 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.96 121.82 86.06 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 132.76 18.64 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.955 1.503 . . . . 0.0 110.492 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 113' ' ' GLU . 46.8 Cg_endo -73.52 -0.51 9.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.974 1.513 . . . . 0.0 110.452 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 111' ' ' PRO . 16.6 p -42.31 -26.82 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 110.251 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 111' ' ' PRO . 2.9 mm-40 -96.87 129.97 31.3 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.131 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.25 170.92 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.932 1.491 . . . . 0.0 110.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 t -160.46 101.93 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 116' ' ' SER . 27.8 p -96.78 100.52 12.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.34 111.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 118' ' ' VAL . 30.6 m -139.0 81.27 21.95 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.24 109.86 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.059 1.557 . . . . 0.0 110.336 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 121' ' ' GLN . 21.0 pt-20 -61.27 -176.81 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 120' ' ' GLU . 8.8 mt-30 44.7 91.05 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.11 154.13 52.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.035 1.545 . . . . 0.0 110.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.18 132.86 18.59 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.047 1.551 . . . . 0.0 110.343 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 125' ' ' GLN . . . -135.56 84.05 2.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 7.1 mt-30 56.43 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.138 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 125' ' ' GLN . . . 176.23 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.251 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.52 153.09 85.64 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.0 113.39 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.044 1.549 . . . . 0.0 110.476 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.77 -135.48 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 131' ' ' THR . 0.1 OUTLIER 55.44 28.13 11.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -1.154 . . . . 0.0 110.212 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.62 ' O ' HG22 ' A' ' 131' ' ' THR . 10.7 m 44.27 80.99 0.26 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.85 53.22 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.059 1.557 . . . . 0.0 110.422 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -102.73 -89.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.404 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -71.49 146.07 48.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . -173.25 152.82 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.124 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CG ' HG11 ' B' ' 167' ' ' VAL . 1.3 t80 -131.11 122.94 27.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.329 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.113 ' CE2' HG12 ' B' ' 168' ' ' VAL . 9.4 p90 -155.15 168.03 28.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.583 -1.323 . . . . 0.0 111.64 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.737 HG21 ' HD3' ' A' ' 62' ' ' LYS . 4.2 mp -102.16 143.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.624 0.726 . . . . 0.0 110.744 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.721 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.2 m-85 -93.3 132.76 37.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.718 0.771 . . . . 0.0 110.925 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.531 ' HB2' HD13 ' A' ' 145' ' ' ILE . 12.1 t -101.8 -163.55 1.02 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.088 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.504 ' N ' ' OG ' ' A' ' 140' ' ' SER . . . -55.67 85.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 63.77 12.43 47.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mm-40 -120.2 121.93 39.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -87.22 105.26 17.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.471 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.948 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -89.52 108.6 26.01 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.828 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.6 Cg_endo -76.35 129.44 11.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.059 1.558 . . . . 0.0 113.35 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.948 HD21 HG22 ' A' ' 145' ' ' ILE . 2.1 mm? -125.12 134.96 52.25 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 148' ' ' VAL . 17.2 m -101.16 116.45 44.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 119.878 -1.764 . . . . 0.0 110.921 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.762 ' CD1' HG11 ' A' ' 55' ' ' VAL . 56.4 mt -84.79 114.96 22.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.135 -0.978 . . . . 0.0 109.241 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 1.5 p -147.69 28.55 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 111.375 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 1.2 mtt180 -134.11 123.22 16.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.789 -1.195 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 50.7 Cg_endo -79.3 135.45 12.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.069 1.562 . . . . 0.0 110.822 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 ' HB2' ' A' ' 40' ' ' LEU . 16.3 tp -92.39 146.5 23.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.865 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.479 ' H ' HD12 ' A' ' 153' ' ' LEU . 19.0 m -61.91 114.03 3.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 110.339 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.63 ' HA ' ' CD1' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -45.39 -24.36 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.18 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.183 0.516 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.76 38.53 30.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' B' ' 160' ' ' SER . . . -111.0 -67.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' B' ' 159' ' ' ALA . 3.4 t 65.06 137.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.275 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.13 155.99 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.786 HG23 ' O3P' ' B' ' 164' ' ' PTR . 2.8 m -52.55 120.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.49 ' C ' ' CD2' ' B' ' 164' ' ' PTR . 17.2 pt-20 -115.66 174.0 6.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.786 ' O3P' HG23 ' B' ' 162' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 t -116.72 -141.17 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.337 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.581 ' HA ' HD11 ' A' ' 64' ' ' LEU . 41.7 p -131.25 -173.15 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.992 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.88 -160.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.106 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.113 HG12 ' CE2' ' A' ' 137' ' ' TYR . 2.3 m -69.87 -157.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.593 ' N ' HG23 ' B' ' 168' ' ' VAL . 1.3 p80 -133.73 174.06 10.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 110.184 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 1.4 t -176.16 151.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.035 -1.425 . . . . 0.0 109.578 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.775 ' HA ' HD12 ' A' ' 4' ' ' LEU . 6.1 pt-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.602 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 30.0 p90 -66.67 -35.9 81.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.4 tt0 -65.18 -44.13 89.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.888 HD22 ' CB ' ' A' ' 88' ' ' PHE . 2.4 mt -67.12 -47.5 70.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.937 HG21 ' HA ' ' A' ' 50' ' ' PHE . 6.8 p -65.32 -47.85 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 0.0 110.353 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' HG13 ' A' ' 5' ' ' VAL . 24.9 t -58.64 -36.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.05 -33.21 70.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -76.05 -44.36 39.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.04 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 82.0 t -57.45 -39.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.446 -0.784 . . . . 0.0 109.295 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.4 mtm180 -55.86 -48.33 75.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.721 . . . . 0.0 109.893 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -34.75 50.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.984 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.941 HD23 HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.04 -43.29 65.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 110.055 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 16.8 pt20 -65.74 -33.73 76.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 2.3 mt-10 -57.61 -33.7 68.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.095 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.461 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 3.7 m -56.02 -27.5 53.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 155' ' ' SER . . . 87.8 42.71 5.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 9.2 p90 -152.59 14.5 0.57 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -1.18 . . . . 0.0 110.452 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.677 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -94.93 126.26 40.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.251 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.981 ' CD1' HD12 ' A' ' 40' ' ' LEU . 16.9 m95 -106.04 148.09 28.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 3.6 m -39.12 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.821 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 166.99 81.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.451 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.1 t -47.22 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -108.23 173.07 6.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.811 -1.181 . . . . 0.0 109.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.87 -89.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.584 ' CA ' HG11 ' B' ' 162' ' ' VAL . . . -79.44 -30.31 45.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -57.82 -34.93 70.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.268 . . . . 0.0 110.445 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -66.48 -49.06 67.89 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.012 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.0 m-80 -69.29 -39.87 78.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 110.535 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.39 -31.41 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 111.712 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -54.68 -24.02 20.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.825 -1.172 . . . . 0.0 110.794 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 38' ' ' THR . 4.2 pp -75.41 -36.13 60.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.937 -1.102 . . . . 0.0 109.322 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.85 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -69.69 -32.91 71.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.61 41.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.938 . . . . 0.0 110.72 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.737 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.6 mt-10 -114.34 -76.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.737 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 47.3 Cg_endo -72.12 71.31 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.224 1.118 . . . . 0.0 110.268 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.57 141.28 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.497 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.86 20.76 79.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.963 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.21 146.93 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 110.178 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.995 ' CG ' HD12 ' A' ' 149' ' ' LEU . 4.3 m-85 -123.42 157.41 33.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.916 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.981 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.23 159.18 43.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 110.592 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.017 HD11 ' CD1' ' A' ' 51' ' ' PHE . 13.1 tt -116.33 144.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.81 136.07 52.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 20' ' ' SER . 1.5 p30 -89.58 121.72 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 10.8 t -48.05 124.63 7.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 8.53 8.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 9.6 m-20 -67.21 -143.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 48' ' ' ARG . 13.1 pt20 -90.99 -37.52 13.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -173.54 37.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.31 -0.869 . . . . 0.0 110.144 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.464 ' HB2' ' CB ' ' A' ' 44' ' ' SER . 23.3 m80 -64.48 -93.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.913 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.937 ' HA ' HG21 ' A' ' 5' ' ' VAL . 20.9 p90 -177.44 -159.5 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 110.194 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 1.017 ' CD1' HD11 ' A' ' 41' ' ' ILE . 8.5 p90 -126.96 155.79 42.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 74.9 m -126.24 138.38 53.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -0.953 . . . . 0.0 110.267 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.03 HD23 ' CG ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -120.93 124.89 46.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.084 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.956 ' N ' HD12 ' A' ' 53' ' ' LEU . 2.5 p -126.02 154.14 43.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.971 HG11 HD13 ' A' ' 149' ' ' LEU . 2.2 m -122.34 174.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.85 . . . . 0.0 110.717 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 25.7 tttt -107.12 124.23 49.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.707 HG21 ' CD1' ' A' ' 138' ' ' ILE . 8.9 p -127.4 157.13 40.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 110.332 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.73 -24.24 64.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -79.72 -23.13 42.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 152.82 143.47 3.69 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.3 p -78.93 110.52 14.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 138' ' ' ILE . 5.3 mmtt -111.99 161.72 16.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.214 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.486 ' CB ' ' HB2' ' A' ' 54' ' ' SER . 12.7 p30 -140.12 125.98 19.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.609 HD12 ' OH ' ' A' ' 136' ' ' TYR . 12.9 mt -104.73 152.08 22.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -125.11 143.13 51.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.705 HD11 ' SG ' ' A' ' 90' ' ' CYS . 3.5 tp -78.58 136.65 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.077 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.0 tt0 -102.79 145.31 29.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 1' ' ' GLU . 42.6 t -108.57 127.5 54.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.0 tt0 -124.17 104.29 8.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.04 -71.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -154.22 23.58 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -126.89 163.26 24.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 110.182 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.6 m-30 -119.42 157.87 27.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.634 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.12 138.68 15.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.14 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.887 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -127.0 -17.46 4.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.54 ' NE2' HD23 ' A' ' 75' ' ' LEU . 1.1 tp-100 -86.69 -148.14 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.942 ' HB3' HG21 ' B' ' 166' ' ' THR . 22.7 t -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.249 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -112.62 117.14 47.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -45.01 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.983 1.517 . . . . 0.0 110.463 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -55.97 -46.33 78.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.66 165.57 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -45.12 -41.7 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 82' ' ' THR . 8.4 mt-30 42.2 84.67 0.18 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.74 -164.07 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.096 1.577 . . . . 0.0 110.516 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 89' ' ' ASP . 8.5 m -130.9 154.31 81.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 110.206 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 46.3 Cg_endo -73.44 135.64 22.59 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.943 1.496 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.608 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 59.38 49.44 8.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.622 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.888 ' CB ' HD22 ' A' ' 4' ' ' LEU . 26.3 p90 35.19 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.402 -0.811 . . . . 0.0 110.535 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 87' ' ' ARG . 15.4 t0 -72.12 109.83 6.17 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.915 -1.116 . . . . 0.0 109.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.896 ' O ' HD13 ' A' ' 94' ' ' LEU . 9.1 t -175.21 -74.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.669 -0.644 . . . . 0.0 110.211 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 73' ' ' PHE . 15.5 m -50.63 -51.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.7 mt -65.11 -46.56 80.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -67.5 -31.14 71.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.069 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 90' ' ' CYS . 3.7 mp -59.36 -33.85 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.84 -0.538 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.2 m -52.47 -37.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.98 -1.075 . . . . 0.0 109.651 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -57.15 -52.49 65.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.909 -1.119 . . . . 0.0 109.161 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.58 ' CE1' HD22 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -79.21 -40.14 31.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 110.097 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.03 ' CG ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -64.43 -22.36 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.0 109.64 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 17' ' ' PHE . 2.6 ttp 165.63 89.42 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 0.0 109.816 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 149' ' ' LEU . 47.5 Cg_endo -76.06 129.59 11.53 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.848 1.446 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HG2' ' HD3' ' A' ' 102' ' ' PRO . 41.4 Cg_endo -72.24 -29.76 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.025 1.54 . . . . 0.0 112.241 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.671 ' HD3' ' HG2' ' A' ' 101' ' ' PRO . 48.3 Cg_endo -74.96 149.49 36.95 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.824 0.907 . . . . 0.0 110.476 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.29 7.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.682 HG21 HD22 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -44.39 108.27 0.71 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' SER . 47.2 Cg_endo -73.23 -174.55 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 59.12 -163.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 110.19 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -126.63 21.93 7.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -165.85 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.94 . . . . 0.0 110.251 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 104' ' ' THR . 2.5 tp 49.32 85.34 0.18 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.91 125.06 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.059 1.557 . . . . 0.0 110.469 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.87 -6.19 18.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.965 1.508 . . . . 0.0 110.393 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -52.84 124.86 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -69.83 -57.23 6.7 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 46.2 Cg_endo -73.21 148.18 43.61 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.082 1.569 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 63.1 m -68.01 149.41 49.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 118' ' ' VAL . 15.3 m -158.86 150.47 20.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.53 24.76 7.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 116' ' ' SER . 17.5 t -96.47 123.18 55.32 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.883 . . . . 0.0 110.214 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.03 -90.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.0 110.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -135.4 -37.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.288 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.88 143.83 29.07 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . 46.5 Cg_endo -73.38 173.64 13.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.984 1.518 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 122' ' ' PRO . 46.0 Cg_endo -73.28 -20.11 21.61 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.29 138.97 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.182 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -168.62 -43.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -104.08 100.39 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 127' ' ' LEU . 2.2 pp -168.73 125.82 0.84 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.8 -58.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.006 1.529 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -88.11 -134.07 4.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t -115.94 103.23 10.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -1.125 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' A' ' 132' ' ' PRO . 1.3 m -67.6 -54.22 18.92 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 131' ' ' THR . 45.6 Cg_endo -71.83 105.57 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.879 1.463 . . . . 0.0 110.485 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.638 ' O ' HG21 ' B' ' 168' ' ' VAL . 0.0 OUTLIER -145.2 -46.2 0.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.256 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.743 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -63.28 106.4 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 167.44 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CD1' HG21 ' B' ' 167' ' ' VAL . 3.2 t80 -102.47 122.57 44.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.484 -1.286 . . . . 0.0 109.697 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.786 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.6 p90 -156.08 167.18 31.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.707 ' CD1' HG21 ' A' ' 57' ' ' THR . 2.5 mp -120.25 149.29 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 111.42 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.67 108.08 17.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.986 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.627 ' HB2' HD13 ' A' ' 145' ' ' ILE . 2.8 m -66.84 56.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.572 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 67.31 81.8 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.89 -8.59 49.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -120.23 121.8 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.239 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -89.57 105.25 17.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.095 -1.003 . . . . 0.0 110.62 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.786 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.53 110.51 51.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.78 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.1 Cg_endo -71.94 129.47 15.36 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.569 . . . . 0.0 112.107 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.784 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.2 mt -125.74 135.83 52.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.46 117.36 42.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.336 -1.478 . . . . 0.0 109.791 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.996 HD21 ' C ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -116.2 114.88 25.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.061 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -155.13 41.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.23 125.37 24.63 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.286 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.83 148.11 40.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.009 1.531 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.39 150.69 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.34 109.57 6.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -171.47 96.71 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.207 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.232 0.539 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.705 HG23 ' O ' ' B' ' 158' ' ' THR . 8.1 t -65.13 91.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 160' ' ' SER . . . 49.02 61.61 3.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.287 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.462 ' O ' ' O ' ' B' ' 159' ' ' ALA . 0.2 OUTLIER 60.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 110.24 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.438 HG22 ' N ' ' B' ' 162' ' ' VAL . 16.6 m -167.29 163.43 15.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 110.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.584 HG11 ' CA ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.85 134.69 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.13 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -82.22 -178.09 6.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.533 ' CG ' ' O ' ' B' ' 163' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 15.5 m -92.11 -139.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.942 HG21 ' HB3' ' A' ' 77' ' ' SER . 0.9 OUTLIER -148.27 174.38 12.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.032 HG12 HG22 ' B' ' 168' ' ' VAL . 2.4 t -135.87 146.1 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.032 HG22 HG12 ' B' ' 167' ' ' VAL . 6.7 m 20.62 93.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.738 -0.601 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' B' ' 170' ' ' SER . 11.5 t-160 -94.37 -76.4 0.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.249 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' B' ' 169' ' ' HIS . 17.5 t -177.12 88.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 68' ' ' CYS . 2.7 tm-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 40.1 p90 -64.36 -35.8 82.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.1 tp60 -54.85 -41.08 70.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.683 HD13 ' CE1' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -66.14 -47.4 74.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.08 HG11 ' HA ' ' A' ' 50' ' ' PHE . 38.9 t -65.31 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.1 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.74 -49.32 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -58.97 -38.23 78.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.895 . . . . 0.0 109.89 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.019 ' O ' HD12 ' A' ' 12' ' ' LEU . . . -76.29 -44.69 35.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.04 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 75.4 t -57.77 -39.87 72.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.404 -0.81 . . . . 0.0 109.163 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -56.05 -41.66 75.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.869 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -76.87 -44.85 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.019 HD12 ' O ' ' A' ' 8' ' ' ALA . 1.1 mt -62.11 -44.37 96.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 110.013 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 18.1 pt20 -68.27 -33.82 75.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.252 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.86 -45.13 86.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.534 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.554 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 5.6 m -55.9 -38.42 70.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.967 . . . . 0.0 110.096 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.06 35.64 2.7 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HZ ' HD23 ' A' ' 12' ' ' LEU . 23.3 p90 -139.22 10.72 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -1.137 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 9' ' ' VAL . 5.2 t80 -90.87 117.45 29.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.6 m95 -82.02 141.58 33.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -162.86 108.65 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.045 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 159.62 -2.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.53 -0.731 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.16 -156.65 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.097 . . . . 0.0 110.001 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -95.57 175.99 6.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -47.98 -86.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.595 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -76.48 -31.76 53.35 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 3.5 tt0 -59.63 -24.97 64.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.129 -1.218 . . . . 0.0 110.219 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -74.65 -49.96 19.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.8 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -70.09 -44.96 67.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.252 -0.905 . . . . 0.0 110.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.4 mp -59.89 -32.26 70.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.744 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp -55.39 -30.67 60.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.928 -1.107 . . . . 0.0 109.383 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.224 HD13 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.81 -33.99 73.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 1.224 ' N ' HD13 ' A' ' 31' ' ' LEU . 19.7 p -70.44 -32.84 70.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.557 -0.715 . . . . 0.0 110.288 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.78 -20.89 41.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.75 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.9 mt-10 -120.99 -79.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.943 -1.098 . . . . 0.0 110.391 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.1 Cg_endo -75.42 54.83 3.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.072 1.038 . . . . 0.0 110.105 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB1' ' HE2' ' A' ' 56' ' ' LYS . . . -53.03 141.61 22.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.377 -0.827 . . . . 0.0 110.736 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 92.67 15.29 53.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.64 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.44 148.8 43.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.977 . . . . 0.0 110.141 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 1.102 ' CG ' HD21 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -121.59 149.4 43.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.017 . . . . 0.0 110.514 -179.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -150.37 160.73 43.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.565 -0.709 . . . . 0.0 109.588 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.1 tt -113.47 145.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.796 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 tmt_? -112.28 151.22 29.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.628 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.571 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 9.6 t0 -94.38 133.69 37.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.086 -1.008 . . . . 0.0 110.661 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER 74.15 135.63 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.527 -0.733 . . . . 0.0 110.635 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 7.5 t -150.35 -43.85 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.731 . . . . 0.0 109.668 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.519 ' OD1' ' HA ' ' B' ' 161' ' ' THR . 8.7 m-20 -132.86 -152.96 0.52 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.925 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -91.05 -1.88 57.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.091 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 6.8 mtt180 -78.75 -15.16 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.498 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER 68.58 98.53 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.33 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.08 ' HA ' HG11 ' A' ' 5' ' ' VAL . 54.3 p90 -179.52 -176.79 0.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.089 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.931 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.2 p90 -115.85 155.15 28.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 110.089 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -126.07 150.68 47.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 110.047 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.091 HD22 ' CG ' ' A' ' 98' ' ' TYR . 1.4 tt -139.26 131.02 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 111.158 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.73 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -139.71 154.11 47.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.483 -0.761 . . . . 0.0 109.959 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 39' ' ' PHE . 1.5 p -129.08 174.2 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 110.585 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.808 ' HE2' ' HB1' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -111.74 139.1 47.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.198 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 58' ' ' GLN . 2.3 m -160.33 148.94 16.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 110.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' THR . 7.5 pt20 -41.92 -27.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -66.93 -53.46 31.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.253 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.64 146.55 4.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.43 HG21 ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -83.32 129.06 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -1.098 . . . . 0.0 110.133 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.797 ' NZ ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -142.08 140.92 32.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.9 OUTLIER -111.05 141.35 44.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.992 HD22 HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -138.18 152.42 48.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 110.834 -179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -121.07 165.0 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.813 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.676 HD13 ' CB ' ' A' ' 94' ' ' LEU . 5.0 tp -78.11 131.23 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -97.84 140.33 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 1' ' ' GLU . 31.0 p -92.32 128.09 38.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HG2' ' NE ' ' A' ' 87' ' ' ARG . 3.3 tt0 -133.07 104.53 6.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.335 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 54.55 65.42 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.36 24.0 15.03 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 70' ' ' GLY . 0.7 OUTLIER -124.12 157.7 34.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 0.0 110.048 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -124.22 128.91 49.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.089 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -153.97 139.01 17.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.898 . . . . 0.0 110.34 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.943 HD22 ' NE2' ' A' ' 97' ' ' HIS . 1.8 tt -116.29 -17.82 10.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 109.885 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.596 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -178.57 141.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.064 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.47 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 0.1 OUTLIER 60.78 139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -120.0 113.79 34.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HG3' ' HD3' ' A' ' 93' ' ' LYS . 47.4 Cg_endo -73.21 57.9 3.47 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.978 1.515 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 20.08 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' OE1' ' A' ' 83' ' ' GLN . 31.3 p -115.48 134.88 54.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.441 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.486 ' O ' ' NE2' ' A' ' 83' ' ' GLN . 2.9 p 42.35 40.34 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.508 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -133.99 177.28 2.32 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' HG3' ' A' ' 83' ' ' GLN . 45.6 Cg_endo -72.89 -57.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.093 1.575 . . . . 0.0 110.305 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -144.83 153.2 53.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 110.111 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 44.4 Cg_endo -72.37 152.19 54.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.03 1.542 . . . . 0.0 110.332 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 75.33 -42.36 0.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.788 . . . . 0.0 110.429 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' CD2' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 71.48 103.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.705 ' O ' ' HB2' ' A' ' 90' ' ' CYS . 5.1 t0 -72.83 109.21 6.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.705 ' HB2' ' O ' ' A' ' 89' ' ' ASP . 10.7 t 149.72 121.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.741 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 t -49.56 -25.06 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -56.04 -38.07 70.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.273 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.569 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -58.57 -40.56 83.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -68.17 -35.39 77.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.555 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 24.8 t -55.49 -37.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 110.268 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -54.27 -35.77 62.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.943 ' NE2' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.17 -41.85 33.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.061 -1.024 . . . . 0.0 110.412 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.091 ' CG ' HD22 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -64.68 -22.15 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.205 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.522 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -124.55 164.23 31.82 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.91 . . . . 0.0 110.29 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 45.5 Cg_endo -73.25 174.45 12.05 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.019 1.537 . . . . 0.0 110.282 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 131' ' ' THR . 44.4 Cg_endo -72.1 166.83 28.48 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.005 1.529 . . . . 0.0 110.395 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 107.46 2.3 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.072 1.564 . . . . 0.0 110.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.39 2.26 7.12 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.475 ' OG1' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -130.33 156.95 78.69 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' OG1' ' A' ' 104' ' ' THR . 43.8 Cg_endo -72.27 -73.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.022 1.538 . . . . 0.0 110.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 107' ' ' PHE . 28.7 t 44.35 -144.66 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.513 ' N ' ' OG ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -135.97 101.66 4.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 t -140.67 176.63 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp 52.25 90.85 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.916 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.97 148.3 45.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.963 1.507 . . . . 0.0 110.388 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 78.75 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.967 1.509 . . . . 0.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 t -163.35 151.1 13.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.167 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.5 138.79 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.15 116.54 4.75 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.089 1.573 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 117' ' ' GLU . 70.6 m -121.11 152.63 38.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 115' ' ' SER . 7.9 m 56.73 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -156.98 138.0 13.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 118' ' ' VAL . 35.7 t -46.0 104.71 0.41 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 117' ' ' GLU . 46.6 Cg_endo -73.09 132.69 18.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.045 1.55 . . . . 0.0 110.455 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -109.06 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.141 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.526 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 1.2 mt-30 -64.12 -56.37 24.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 121' ' ' GLN . 46.5 Cg_endo -73.36 173.99 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.944 1.497 . . . . 0.0 110.386 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 46.6 Cg_endo -72.95 156.36 52.38 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.017 1.535 . . . . 0.0 110.478 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 123' ' ' PRO . . . 178.78 -30.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.676 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -59.68 -15.33 18.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.186 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.676 ' HB3' ' O ' ' A' ' 125' ' ' GLN . . . 66.76 23.38 10.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER 64.54 131.43 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.231 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' SER . 46.2 Cg_endo -73.09 -7.93 21.36 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.972 1.512 . . . . 0.0 110.514 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.61 89.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' PRO . 0.9 OUTLIER -153.62 65.35 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.127 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -64.24 126.11 89.66 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.238 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 Cg_endo -74.12 -63.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.978 1.515 . . . . 0.0 110.582 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.7 tttp -178.11 66.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.767 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 59.1 mmt-85 -59.42 133.58 56.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.982 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.32 82.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 110.17 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.984 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.83 125.96 49.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.478 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.037 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -154.11 167.21 30.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.089 . . . . 0.0 110.511 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 62' ' ' LYS . 3.0 mt -101.57 149.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 111.298 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.723 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.0 m-85 -98.97 132.82 44.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.709 0.766 . . . . 0.0 110.984 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 145' ' ' ILE . 45.0 t -97.06 48.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.618 -0.676 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.02 82.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.61 -22.07 39.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 1.5 mp0 -117.05 122.02 42.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 1.2 pttm -91.68 105.29 17.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.219 -0.926 . . . . 0.0 110.312 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.732 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -87.73 108.24 19.58 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.2 Cg_endo -76.07 128.8 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.994 1.523 . . . . 0.0 112.346 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' NZ ' ' A' ' 62' ' ' LYS . 1.2 mp -125.06 134.19 52.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -117.87 117.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.596 -1.315 . . . . 0.0 111.249 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 39' ' ' PHE . 3.8 tt -92.45 114.86 27.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.443 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 1.0 OUTLIER -137.11 -15.14 1.51 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 111.063 -179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.85 124.91 70.2 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.958 -1.088 . . . . 0.0 110.017 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.06 147.88 43.85 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.945 1.497 . . . . 0.0 110.592 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.902 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.48 158.56 14.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 0.0 110.567 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.509 ' N ' HD22 ' A' ' 153' ' ' LEU . 46.2 t -38.04 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.315 -0.866 . . . . 0.0 110.815 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.3 OUTLIER 61.32 -84.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.491 ' N ' ' OG ' ' A' ' 155' ' ' SER . 4.0 t-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.17 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.173 0.511 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 1.8 t -163.47 64.04 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . 48.23 -142.04 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.162 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.08 -158.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.519 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 p -89.94 118.84 29.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.293 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.52 HG22 ' HA3' ' A' ' 24' ' ' GLY . 16.5 t -46.14 149.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.954 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.481 ' C ' ' HD1' ' B' ' 164' ' ' PTR . 0.4 OUTLIER -93.81 122.38 36.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.585 ' HD2' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.68 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -142.92 -149.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.362 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.8 p -112.29 144.64 41.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.852 . . . . 0.0 110.05 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.037 HG12 ' N ' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -100.24 114.49 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.982 HG21 ' O ' ' A' ' 135' ' ' ALA . 99.6 t 40.23 83.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -126.08 107.54 10.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.28 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 3.4 t -167.52 77.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.316 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.548 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.559 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . 7.9 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 6' ' ' VAL . 11.8 t80 -66.9 -52.39 43.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.907 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -61.09 -39.44 89.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.476 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . 1.2 mt -67.09 -47.25 71.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.063 HG23 HG21 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -69.58 -47.92 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.245 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 2' ' ' TYR . 72.9 t -61.83 -41.27 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -58.93 -41.44 87.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.934 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.936 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -62.01 -44.16 97.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.78 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 ' HE2' ' A' ' 18' ' ' TYR . 41.3 t -57.55 -39.8 71.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.88 78.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.737 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -32.86 56.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -61.91 -43.7 98.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 110.092 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.603 ' HG2' ' CD1' ' A' ' 18' ' ' TYR . 63.6 mt-30 -67.2 -35.89 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -63.42 -39.27 94.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.222 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -38.81 75.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.37 1.17 23.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 1.027 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.6 t80 -94.99 21.85 7.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.659 ' HE2' HG22 ' A' ' 9' ' ' VAL . 36.3 t80 -121.25 136.03 55.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 110.258 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.704 ' CE3' ' NH2' ' A' ' 42' ' ' ARG . 9.4 m95 -104.67 148.64 26.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 110.333 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 42.1 m -31.91 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 163.81 69.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG23 HH11 ' A' ' 42' ' ' ARG . 0.5 OUTLIER -60.9 -135.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.329 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.621 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -88.34 176.16 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.76 -1.213 . . . . 0.0 109.205 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' THR . . . -44.1 -81.75 0.03 OUTLIER Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.332 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.758 ' H ' HG21 ' B' ' 162' ' ' VAL . . . -79.9 -31.12 40.6 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.439 -1.036 . . . . 0.0 111.643 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.621 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 21.2 tp10 -58.63 -24.9 62.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.451 . . . . 0.0 110.955 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.012 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -77.15 -48.19 18.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.992 -1.067 . . . . 0.0 109.544 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.962 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.2 m120 -70.62 -49.57 46.16 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.686 0.755 . . . . 0.0 111.142 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.465 HD11 HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -61.88 -31.59 71.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.698 . . . . 0.0 112.162 -178.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.2 pp -55.18 -35.15 64.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.75 -1.219 . . . . 0.0 109.853 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -81.25 -36.18 30.26 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 108.622 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 1.046 ' N ' HD23 ' A' ' 31' ' ' LEU . 52.0 m -70.03 -32.88 71.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.555 -0.716 . . . . 0.0 110.129 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.02 41.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.512 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 10.4 mt-10 -113.87 -76.77 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.041 . . . . 0.0 110.05 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.741 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.8 Cg_endo -73.08 61.32 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.277 1.146 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.73 141.24 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.421 ' C ' ' HG ' ' A' ' 150' ' ' SER . . . 89.34 13.45 61.66 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.883 ' C ' HD11 ' A' ' 31' ' ' LEU . 21.2 m -132.66 146.08 51.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.554 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.747 ' CG ' HD23 ' A' ' 149' ' ' LEU . 30.5 p90 -126.97 138.84 53.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.838 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -131.4 161.01 33.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.913 HG12 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.41 128.56 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.789 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 1.012 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 78.5 mtt-85 -135.73 153.43 51.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.739 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -73.94 122.79 23.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 109.7 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -36.35 -72.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.338 -0.852 . . . . 0.0 110.562 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.45 ' H ' ' CE1' ' A' ' 49' ' ' HIS . 60.5 m -109.42 -31.85 7.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 16.0 t0 -178.08 -178.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.252 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.43 -1.97 36.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -71.16 -2.47 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.295 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 50' ' ' PHE . 28.5 p80 -144.07 -144.42 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 110.271 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.763 ' CB ' HG21 ' A' ' 5' ' ' VAL . 35.9 p90 -92.55 -166.74 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.916 ' CE2' HG22 ' A' ' 5' ' ' VAL . 5.9 p90 -130.82 158.21 40.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.84 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 14.5 t -126.28 139.2 53.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.067 HD22 ' CD1' ' A' ' 98' ' ' TYR . 6.9 tt -121.03 139.45 53.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.698 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -139.33 154.39 47.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.839 HG11 ' CG ' ' A' ' 149' ' ' LEU . 2.4 m -130.12 174.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.392 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' SER . 18.4 tptt -105.93 130.49 53.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.715 HG21 ' HA ' ' A' ' 147' ' ' LEU . 33.7 p -134.86 -169.27 2.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -77.48 -34.95 54.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.3 t -81.73 -22.79 37.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.18 -0.95 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.48 14.62 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 1.8 t -101.04 126.4 47.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -1.123 . . . . 0.0 110.27 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.524 ' CG ' HG12 ' A' ' 138' ' ' ILE . 8.7 mmpt? -114.07 147.3 38.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.235 -0.916 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.595 ' O ' ' CD1' ' B' ' 164' ' ' PTR . 10.7 p30 -112.02 144.07 41.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 110.706 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.995 HD22 HG23 ' B' ' 167' ' ' VAL . 1.2 mp -138.93 152.26 47.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.594 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 50' ' ' PHE . 3.3 ptt180 -123.49 164.04 19.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.063 HG21 HG23 ' A' ' 5' ' ' VAL . 6.6 tp -76.78 143.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -113.05 144.66 42.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.559 ' CB ' ' HB3' ' A' ' 1' ' ' GLU . 13.7 t -101.99 118.85 37.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 110.368 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 71' ' ' GLY . 22.9 tt0 -105.21 102.89 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.037 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.21 -83.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -139.87 37.69 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.64 163.07 32.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -1.107 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.617 ' CE1' ' CB ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -122.4 127.97 50.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 3.4 m -155.55 159.91 40.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.856 HD13 HD12 ' A' ' 94' ' ' LEU . 10.5 tp -94.1 17.15 13.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.844 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER 64.05 93.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.184 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.2 t -162.77 -69.01 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.33 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 78' ' ' ASP . 18.5 p-10 -93.96 114.08 62.22 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.04 -56.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.009 1.531 . . . . 0.0 110.439 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' O ' ' CB ' ' A' ' 81' ' ' SER . 15.4 tpt180 -56.21 -48.02 77.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.901 . . . . 0.0 110.249 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER 66.1 53.79 1.04 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.194 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 m -96.89 -43.87 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 110.219 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -55.25 -58.12 16.68 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 110.19 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 46.5 Cg_endo -73.07 -157.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.062 1.559 . . . . 0.0 110.277 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.729 HG13 ' HD2' ' A' ' 86' ' ' PRO . 88.9 t -125.17 149.31 63.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.729 ' HD2' HG13 ' A' ' 85' ' ' VAL . 40.7 Cg_endo -67.69 132.06 25.93 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.718 1.378 . . . . 0.0 109.821 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 72.82 47.5 0.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.418 -179.241 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.543 ' CB ' ' HG3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -57.68 -149.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.53 -0.732 . . . . 0.0 110.187 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.628 ' O ' ' C ' ' A' ' 90' ' ' CYS . 47.7 m-20 -100.44 110.34 22.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.957 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.628 ' C ' ' O ' ' A' ' 89' ' ' ASP . 78.8 m 4.07 -121.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.499 0.666 . . . . 0.0 112.083 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB1' ' A' ' 8' ' ' ALA . 7.8 p -57.07 -24.8 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 89' ' ' ASP . 3.8 mt -55.64 -35.98 66.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.723 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.543 ' HG3' ' CB ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -62.53 -46.36 88.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.865 -1.147 . . . . 0.0 109.209 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -68.25 -34.82 76.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.44 -0.787 . . . . 0.0 109.58 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 91' ' ' VAL . 56.0 t -54.74 -36.43 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 110.438 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -52.61 -33.12 44.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -78.18 -36.79 47.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.156 -0.965 . . . . 0.0 109.476 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.067 ' CD1' HD22 ' A' ' 53' ' ' LEU . 6.9 m-85 -73.59 -22.05 60.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.98 78.88 34.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.316 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 45.0 Cg_endo -73.01 142.01 33.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.02 1.537 . . . . 0.0 110.226 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.63 110.22 2.95 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.988 1.52 . . . . 0.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 47.1 Cg_endo -73.43 -55.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.028 1.541 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 106' ' ' SER . . . 157.36 67.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.553 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.36 -58.74 2.91 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.165 -1.197 . . . . 0.0 110.119 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 46.4 Cg_endo -72.64 60.09 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.468 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 103' ' ' GLY . 0.8 OUTLIER -120.16 -62.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER 63.17 77.24 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.155 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 0.4 OUTLIER 61.38 -79.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -76.87 130.06 77.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.255 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 170.56 19.42 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.436 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.04 150.13 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.069 1.563 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 17.8 m -74.55 -53.23 9.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 112' ' ' THR . 2.9 mt-10 58.25 93.63 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.04 118.57 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.978 1.515 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 116' ' ' SER . 29.3 t -114.84 -153.96 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.45 ' N ' ' OG ' ' A' ' 115' ' ' SER . 57.8 m 46.33 64.44 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 1.3 tt0 -94.59 73.45 3.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 61.4 t 57.04 92.33 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.22 -161.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.015 1.534 . . . . 0.0 110.406 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -146.17 -70.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.227 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.609 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -91.13 -63.48 0.19 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 110.35 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 46.2 Cg_endo -73.3 120.15 6.38 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.825 1.434 . . . . 0.0 110.385 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -89.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.965 1.508 . . . . 0.0 110.409 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 125' ' ' GLN . . . -70.56 -62.32 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 122' ' ' PRO . 7.4 tp60 54.46 102.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 127' ' ' LEU . . . -102.61 -89.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.184 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER 56.7 110.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' GLY . 45.8 Cg_endo -72.98 67.46 4.03 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' PRO . . . -45.1 134.55 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -1.127 . . . . 0.0 110.147 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.541 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -55.62 -56.65 27.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 131' ' ' THR . 45.5 Cg_endo -72.86 -19.69 23.32 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.346 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -175.74 1.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.0 mtt85 -44.51 129.88 6.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 173.85 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.13 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.3 t80 -102.81 121.52 42.63 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.719 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.158 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.24 148.67 20.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 110.137 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.013 HD13 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -102.65 150.18 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.977 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.594 ' CZ ' ' OH ' ' A' ' 137' ' ' TYR . 76.2 m-85 -86.19 132.71 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 110.435 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.641 ' HB3' HD13 ' A' ' 145' ' ' ILE . 1.3 t -98.49 69.23 1.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.65 41.93 75.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.56 2.76 29.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 140' ' ' SER . 2.8 mt-10 -117.8 121.97 42.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -70.92 105.93 3.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.463 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.75 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -101.5 120.1 55.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.866 . . . . 0.0 109.555 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.876 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 43.6 Cg_endo -69.64 129.42 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.349 1.71 . . . . 0.0 112.786 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.013 ' CD2' HD13 ' A' ' 138' ' ' ILE . 6.1 mp -121.1 101.29 7.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.3 p -102.85 117.64 48.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.624 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.945 HD22 ' O ' ' A' ' 98' ' ' TYR . 3.5 mp -76.02 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 37' ' ' GLY . 2.7 p -172.62 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.74 -1.225 . . . . 0.0 111.495 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -85.68 124.93 70.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.855 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 48.5 Cg_endo -75.7 148.06 32.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.106 1.582 . . . . 0.0 110.093 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 1.027 HD21 ' O ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -63.21 144.37 56.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.227 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.465 ' N ' HD12 ' A' ' 153' ' ' LEU . 1.1 t -130.88 81.2 1.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.097 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -133.18 151.18 51.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.237 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.256 0.55 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.433 ' O ' ' N ' ' B' ' 160' ' ' SER . 0.2 OUTLIER 47.69 27.55 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.195 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' B' ' 160' ' ' SER . . . 54.53 -91.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 0.7 OUTLIER 170.31 127.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.277 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -43.92 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 110.024 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.834 HG12 ' O ' ' B' ' 162' ' ' VAL . 4.3 t -122.66 74.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.33 116.53 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.875 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.595 ' CD1' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.553 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 m -157.78 -137.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 110.173 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.686 ' HA ' HD21 ' A' ' 64' ' ' LEU . 2.7 t -105.87 137.52 43.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.13 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -84.63 95.49 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.114 -0.991 . . . . 0.0 109.589 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.158 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.2 t 70.66 104.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.893 . . . . 0.0 109.983 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.624 ' CD2' ' N ' ' B' ' 170' ' ' SER . 5.3 p-80 -100.5 -29.36 12.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.624 ' N ' ' CD2' ' B' ' 169' ' ' HIS . 93.0 p -78.0 125.72 29.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 4' ' ' LEU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.266 0.555 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 30.2 p90 -55.72 -36.48 67.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.7 tt0 -55.03 -32.88 62.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.215 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.887 HD13 ' CD1' ' A' ' 73' ' ' PHE . 10.2 mt -62.33 -44.04 97.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.867 HG13 ' HD2' ' A' ' 51' ' ' PHE . 61.1 t -63.14 -48.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.158 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 6' ' ' VAL . 15.5 t -61.5 -50.53 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.884 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 2.0 t-20 -62.36 -44.1 97.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -67.01 -44.52 80.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.771 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' VAL . 23.1 t -57.93 -40.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.823 . . . . 0.0 109.136 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -55.89 -47.86 76.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.613 -0.68 . . . . 0.0 109.867 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -36.56 63.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.918 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD22 ' CZ ' ' A' ' 17' ' ' PHE . 4.2 mt -71.77 -44.05 64.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 110.003 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' OE1' HG12 ' A' ' 9' ' ' VAL . 17.6 pt20 -67.89 -33.87 75.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -57.9 -34.49 69.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.07 -34.7 66.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.845 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 155' ' ' SER . . . 100.57 29.19 6.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.997 ' C ' HD11 ' A' ' 153' ' ' LEU . 6.7 p90 -145.97 40.24 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 110.631 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 4.9 t80 -120.38 115.81 24.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.853 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CD1' HD13 ' A' ' 153' ' ' LEU . 63.5 m95 -77.26 144.08 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 110.329 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 18.6 t -45.77 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.722 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 165.64 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.859 . . . . 0.0 110.568 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 27' ' ' ALA . 1.4 m -47.04 -97.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.069 -1.02 . . . . 0.0 109.41 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.606 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -108.05 165.88 11.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 109.199 178.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -43.3 -79.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.865 ' CA ' HG21 ' B' ' 162' ' ' VAL . . . -79.5 -30.47 44.79 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.369 -1.077 . . . . 0.0 111.254 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.9 mm-40 -58.49 -24.79 61.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.344 . . . . 0.0 110.954 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 22' ' ' VAL . . . -76.04 -49.78 16.6 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 109.24 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -71.18 -49.68 41.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 111.244 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.673 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -63.37 -31.09 72.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.583 -0.698 . . . . 0.0 111.797 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.924 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -53.77 -23.39 11.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.835 -1.166 . . . . 0.0 109.689 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 40' ' ' LEU . 62.6 mt -61.73 -39.51 91.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 109.191 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 93.1 p -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.6 -0.688 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.95 -20.39 45.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.7 mm-40 -125.27 -81.16 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.998 -1.064 . . . . 0.0 110.404 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.6 Cg_endo -77.17 68.38 7.41 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 122.92 0.958 . . . . 0.0 110.175 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.67 141.48 9.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.0 110.614 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 71.65 24.0 77.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.586 ' CB ' ' HB2' ' A' ' 35' ' ' PRO . 7.9 m -125.81 147.14 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -1.048 . . . . 0.0 110.474 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.784 ' CE2' HD21 ' A' ' 149' ' ' LEU . 1.2 p90 -122.83 147.1 46.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.995 HD23 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -145.29 159.71 42.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.493 -0.754 . . . . 0.0 109.72 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.645 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 5.3 tt -114.31 137.9 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.105 -0.997 . . . . 0.0 110.118 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -112.63 131.82 55.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.0 110.438 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 35.9 t0 -89.28 118.22 28.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 5.7 t -69.8 -22.05 63.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.202 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 45' ' ' SER . 26.7 p 43.8 81.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.526 ' CB ' ' HB2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -144.82 -156.66 0.72 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.259 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 2' ' ' TYR . 19.9 mm-40 -91.19 -35.27 14.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 110.245 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' OE2' ' A' ' 1' ' ' GLU . 7.5 mtt-85 -136.06 4.3 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 46' ' ' ASP . 2.5 t-80 -74.43 -144.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.16 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.851 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.2 p90 176.77 -151.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.114 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.867 ' HD2' HG13 ' A' ' 5' ' ' VAL . 25.8 p90 -115.37 151.92 33.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -1.0 . . . . 0.0 109.869 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' LEU . 36.2 m -125.9 135.74 52.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.945 . . . . 0.0 110.499 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.949 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -120.75 123.32 42.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.871 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -140.34 155.72 46.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.483 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.743 HG12 ' OH ' ' A' ' 136' ' ' TYR . 2.7 p -134.53 174.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 0.0 110.689 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.42 133.69 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.82 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.849 HG21 ' HG ' ' A' ' 147' ' ' LEU . 8.8 t -132.93 -156.96 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.58 -58.36 2.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.899 ' HB2' HG23 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -44.63 -61.43 1.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 57' ' ' THR . . . -179.05 172.84 45.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 56' ' ' LYS . 49.2 p -99.37 108.97 21.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -1.119 . . . . 0.0 110.238 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.843 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -108.43 177.83 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.945 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 1.091 ' O ' HD23 ' A' ' 64' ' ' LEU . 23.8 m-20 -128.42 132.47 48.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 110.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.091 HD23 ' O ' ' A' ' 63' ' ' ASN . 8.2 mt -131.69 152.12 51.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -147.9 168.43 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.0 110.516 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.0 HG21 ' CD2' ' A' ' 73' ' ' PHE . 44.0 mm -76.82 146.74 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -114.41 150.82 34.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.513 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 54.1 t -89.01 132.85 34.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.317 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 71' ' ' GLY . 10.3 tm-20 -123.86 102.94 8.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.02 -89.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -133.61 24.62 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -132.93 162.92 30.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 1.0 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -110.91 136.38 50.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -155.23 150.29 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.299 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.808 ' CB ' HD22 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -89.75 -29.83 18.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.096 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HG2' ' HB3' ' B' ' 169' ' ' HIS . 31.6 mt-30 -97.93 -165.24 1.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.9 p -95.6 -0.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.145 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -107.23 112.19 62.99 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.23 -38.46 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.995 1.523 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.8 18.18 4.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.893 . . . . 0.0 110.21 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -72.05 -62.98 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.106 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.586 HG23 ' HD3' ' A' ' 84' ' ' PRO . 9.0 t -73.05 -4.08 30.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.43 ' N ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 57.54 56.98 7.55 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.365 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 82' ' ' THR . 48.1 Cg_endo -75.01 -163.42 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.955 1.503 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.839 HG12 ' CD ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -128.88 -167.94 0.15 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.237 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.839 ' CD ' HG12 ' A' ' 85' ' ' VAL . 43.7 Cg_endo -73.55 132.69 17.82 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.33 1.173 . . . . 0.0 109.813 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 57.36 45.72 19.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.749 ' CG ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -116.17 131.74 56.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.366 -0.834 . . . . 0.0 110.726 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.8 m-20 -88.09 110.47 20.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.294 -0.878 . . . . 0.0 109.263 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.757 ' C ' HD12 ' A' ' 94' ' ' LEU . 87.3 m -67.21 -4.06 9.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.343 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.3 p -58.44 -45.87 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.036 -1.04 . . . . 0.0 110.099 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -65.16 -47.25 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 109.537 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 0.2 OUTLIER -68.21 -33.47 74.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 0.0 108.851 178.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.984 HD13 ' CD1' ' A' ' 66' ' ' ILE . 7.5 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.828 -0.545 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -53.04 -36.8 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.399 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 99' ' ' MET . 7.4 m170 -53.42 -45.47 69.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.999 -1.063 . . . . 0.0 108.22 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -78.73 -38.43 38.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.774 . . . . 0.0 108.92 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.949 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.77 -22.11 66.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.689 ' HG3' HD23 ' A' ' 149' ' ' LEU . 3.2 ttp -152.46 142.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.898 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 149' ' ' LEU . 48.3 Cg_endo -75.82 125.05 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.868 1.457 . . . . 0.0 110.497 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.681 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.7 Cg_endo -72.16 -29.57 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.92 1.484 . . . . 0.0 112.154 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 48.4 Cg_endo -74.42 177.67 8.04 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.924 0.96 . . . . 0.0 110.397 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.42 -74.23 2.4 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.0 p -132.42 88.38 39.62 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.262 -1.14 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.72 153.7 54.01 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 107' ' ' PHE . 3.3 m -106.71 146.54 30.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 108' ' ' SER . 1.5 p90 -175.93 177.62 1.61 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.194 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 107' ' ' PHE . 0.4 OUTLIER 171.68 -43.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.207 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 109' ' ' LEU . 4.0 pp -107.74 159.59 29.83 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 121.58 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.977 1.514 . . . . 0.0 110.427 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.96 142.37 34.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.95 1.5 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -131.37 134.23 46.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -166.81 57.91 0.44 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.14 177.87 7.27 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.008 1.531 . . . . 0.0 110.396 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 115' ' ' SER . 3.4 p 57.43 48.98 13.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 110.217 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -167.11 127.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.868 . . . . 0.0 110.147 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.95 108.95 13.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -135.45 142.25 40.57 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.85 -4.57 15.62 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.098 1.578 . . . . 0.0 110.43 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 121' ' ' GLN . 2.4 mt-10 55.51 170.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 120' ' ' GLU . 2.9 mp0 56.23 166.76 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.58 139.98 32.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.031 1.543 . . . . 0.0 110.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 46.2 Cg_endo -72.88 -16.4 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.033 1.544 . . . . 0.0 110.485 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 61.81 23.52 13.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 110.228 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -175.22 130.77 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -145.2 -38.06 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.932 . . . . 0.0 110.179 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 127' ' ' LEU . 7.1 mt -117.66 117.02 36.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 129' ' ' GLY . 45.1 Cg_endo -72.94 158.52 49.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.946 1.498 . . . . 0.0 110.39 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' O ' ' OG ' ' A' ' 130' ' ' SER . . . 62.61 133.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 129' ' ' GLY . 28.2 p 42.54 -165.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER 42.47 75.52 0.62 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.11 -57.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.106 1.582 . . . . 0.0 110.457 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -138.97 -53.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 110.187 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.785 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -155.89 142.74 18.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.223 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.41 78.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.175 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.8 125.02 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.049 -1.032 . . . . 0.0 109.463 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.992 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -155.01 167.62 29.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 110.622 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 mt -101.43 147.43 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.0 110.958 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.703 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -96.66 133.31 41.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -96.64 67.54 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.703 -0.623 . . . . 0.0 110.26 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.54 -65.11 0.17 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -133.25 3.97 4.84 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.3 121.96 40.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -1.196 . . . . 0.0 110.289 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 9.7 mttt -82.25 105.53 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 147' ' ' LEU . 1.1 mp -89.45 108.94 28.03 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 0.0 108.947 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.3 Cg_endo -71.72 129.53 15.68 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.206 1.635 . . . . 0.0 112.191 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.64 135.12 52.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.595 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 5.7 p -118.51 117.48 54.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.939 -1.1 . . . . 0.0 110.822 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.792 ' C ' HD23 ' A' ' 149' ' ' LEU . 5.2 tt -113.73 115.07 27.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.519 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -146.05 11.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.026 -1.046 . . . . 0.0 111.352 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.69 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -118.43 124.62 28.4 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.256 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.72 145.85 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.895 1.471 . . . . 0.0 110.719 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 1.094 HD13 ' CD1' ' A' ' 19' ' ' TRP . 4.2 pp -82.11 139.86 34.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.563 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 3.9 m 38.95 -92.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.392 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER 68.12 124.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.205 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.186 0.517 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.654 ' O ' ' HB3' ' B' ' 159' ' ' ALA . 14.5 t -88.01 -159.38 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.167 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' B' ' 158' ' ' THR . . . 64.8 -173.43 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.166 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 59.6 p -167.69 -145.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -73.93 -63.6 1.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.865 HG21 ' CA ' ' A' ' 25' ' ' GLY . 3.2 p -151.86 130.53 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.448 ' C ' ' HD1' ' B' ' 164' ' ' PTR . 1.2 pp20? -109.56 162.43 14.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.157 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.533 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.945 ' O ' HD22 ' A' ' 64' ' ' LEU . 6.4 m -145.65 -174.47 4.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.328 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -82.21 -175.3 5.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.872 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.175 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -107.64 -158.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.028 . . . . 0.0 110.215 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.942 HG21 ' O ' ' A' ' 135' ' ' ALA . 37.5 t -57.93 103.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 110.29 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.507 ' CD2' ' HB2' ' B' ' 170' ' ' SER . 54.3 p-80 -135.19 -39.04 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.033 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.507 ' HB2' ' CD2' ' B' ' 169' ' ' HIS . 9.1 m -145.67 133.04 20.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.13 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.553 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.584 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.7 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 17.9 p90 -67.08 -35.71 80.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.571 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -54.78 -32.97 60.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.103 -0.998 . . . . 0.0 110.523 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.1 mt -67.32 -48.13 68.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 110.616 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 49' ' ' HIS . 2.0 m -72.76 -44.46 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 0.0 110.53 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 9' ' ' VAL . 95.7 t -58.47 -32.46 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.21 -33.06 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.93 -1.106 . . . . 0.0 110.807 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.688 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . . . -76.19 -33.59 59.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.153 -0.967 . . . . 0.0 111.143 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 6' ' ' VAL . 1.5 m -56.49 -37.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 108.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 71.2 mtt180 -55.57 -42.82 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.854 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -46.86 19.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -65.46 -39.44 92.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 73.0 mt-30 -59.97 -33.96 72.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -72.0 -29.8 64.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 110.027 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 1.4 t -59.17 -43.05 92.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.97 20.11 22.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 12' ' ' LEU . 4.1 p90 -130.08 -4.69 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.267 . . . . 0.0 110.472 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -95.46 119.36 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 0.0 109.919 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CD1' HD12 ' A' ' 40' ' ' LEU . 5.7 m95 -109.22 148.1 31.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.385 -0.822 . . . . 0.0 109.911 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.488 ' C ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -134.95 25.13 3.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.381 -0.824 . . . . 0.0 109.268 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.96 1.13 14.6 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.102 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.6 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.43 -157.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.923 -1.111 . . . . 0.0 109.469 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.593 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -97.5 169.53 9.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 110.074 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -42.67 -81.45 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.684 ' N ' HG21 ' B' ' 162' ' ' VAL . . . -79.15 -31.6 42.12 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.26 -1.141 . . . . 0.0 110.705 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 7.4 mt-10 -58.82 -36.78 75.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.007 -1.29 . . . . 0.0 109.865 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 42' ' ' ARG . . . -61.65 -50.57 71.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.035 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.596 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 m-80 -68.99 -38.96 79.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.371 -0.831 . . . . 0.0 110.669 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.3 mp -70.51 -31.44 68.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.523 -0.735 . . . . 0.0 112.135 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.713 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.35 -43.34 71.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.261 . . . . 0.0 110.474 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -72.01 -34.99 69.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.77 -1.207 . . . . 0.0 108.636 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.859 ' OG ' HG21 ' A' ' 61' ' ' THR . 17.2 p -70.05 -32.4 70.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.671 -0.643 . . . . 0.0 110.286 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.19 -20.98 43.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.948 . . . . 0.0 110.142 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.7 mm-40 -115.52 -77.51 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -75.28 62.14 6.02 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.213 1.112 . . . . 0.0 109.818 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.6 141.42 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . 100.03 15.95 29.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.674 ' C ' HG23 ' A' ' 55' ' ' VAL . 16.7 p -134.98 147.27 49.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.659 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.573 ' CG ' HD13 ' A' ' 149' ' ' LEU . 47.9 p90 -122.76 141.11 52.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -134.49 158.16 44.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 110.099 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.88 HD12 HD23 ' A' ' 53' ' ' LEU . 2.7 tt -114.46 130.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 5.3 tpt180 -112.75 144.06 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' OG ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -92.29 115.67 28.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.99 123.07 34.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 81.82 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -110.54 -163.45 0.85 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.41 -8.53 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 1' ' ' GLU . 5.6 mtt85 -107.7 -14.91 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.114 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.832 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER 60.86 112.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.314 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' HIS . 31.8 p90 -178.63 154.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.12 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.605 ' O ' ' CD1' ' A' ' 51' ' ' PHE . 9.3 p90 -124.15 141.44 52.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.507 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -127.01 148.13 50.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 109.631 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.038 HD11 ' CD1' ' A' ' 98' ' ' TYR . 4.3 pp -120.94 153.12 37.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.793 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.615 ' HB2' ' CA ' ' A' ' 63' ' ' ASN . 4.0 t -139.12 153.9 48.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 109.969 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG23 ' C ' ' A' ' 38' ' ' THR . 3.3 p -127.03 174.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -103.53 136.57 43.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -168.57 169.41 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -44.51 -44.43 8.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.628 ' CB ' HG21 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -54.16 -46.18 72.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.177 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.92 161.89 9.59 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.859 HG21 ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -80.13 111.78 16.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 110.195 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -142.0 152.87 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.487 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.615 ' CA ' ' HB2' ' A' ' 54' ' ' SER . 7.7 p30 -120.51 156.28 31.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.967 HD22 ' HA ' ' B' ' 166' ' ' THR . 23.8 mt -134.34 141.99 47.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HD3' ' OH ' ' B' ' 164' ' ' PTR . 2.2 ptm180 -104.29 -177.55 3.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -105.46 149.04 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.248 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -95.65 132.24 41.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.154 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -106.27 136.84 45.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 71' ' ' GLY . 4.0 tt0 -132.0 102.91 6.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.47 -78.44 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 89' ' ' ASP . . . -147.84 34.97 1.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.488 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -143.15 146.61 33.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.108 . . . . 0.0 110.034 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 9.1 m-30 -110.97 155.85 22.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.47 ' HB3' ' HG3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -151.15 165.92 32.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.975 . . . . 0.0 110.586 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.3 tp 179.03 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 109.689 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.571 ' CG ' ' HA ' ' B' ' 169' ' ' HIS . 0.0 OUTLIER 172.09 -173.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.437 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.56 ' HB3' ' CD2' ' A' ' 96' ' ' HIS . 0.2 OUTLIER 55.84 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.443 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -120.1 150.06 50.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.48 54.84 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.046 1.551 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -24.79 59.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 82' ' ' THR . 78.6 p -49.57 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.221 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 1.1 p -113.4 -29.8 7.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.124 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 65.85 48.5 0.6 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.885 . . . . 0.0 110.189 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 46.0 Cg_endo -73.18 -53.51 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.072 1.564 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 88' ' ' PHE . 9.9 m -125.54 150.59 68.43 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.622 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 46.3 Cg_endo -72.76 132.95 19.37 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.963 1.507 . . . . 0.0 110.445 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.622 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 78.55 -32.12 0.16 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 0.0 110.566 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.568 ' CB ' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 73.33 94.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.231 -0.918 . . . . 0.0 109.972 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 19.3 p-10 -72.83 109.15 6.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.153 -0.967 . . . . 0.0 109.423 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.663 ' HA ' HD23 ' A' ' 4' ' ' LEU . 0.5 OUTLIER 157.42 124.3 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.206 0.526 . . . . 0.0 109.862 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' A' ' 8' ' ' ALA . 5.2 p -49.52 -24.88 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.759 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -55.71 -34.87 65.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -57.66 -31.72 66.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.975 -1.078 . . . . 0.0 109.224 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.97 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -68.01 -34.62 76.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.603 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.97 ' N ' HD23 ' A' ' 94' ' ' LEU . 54.7 t -54.71 -37.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.155 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.56 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 1.6 t-80 -53.8 -29.88 42.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.787 ' CE1' HD12 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -67.56 -40.86 84.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.038 ' CD1' HD11 ' A' ' 53' ' ' LEU . 38.1 m-85 -70.87 -15.74 62.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 97' ' ' HIS . 15.4 mmt 62.93 85.09 0.18 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.546 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 44.8 Cg_endo -72.29 133.92 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.07 1.563 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.7 Cg_endo -72.36 -29.76 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.094 1.576 . . . . 0.0 112.247 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 48.9 Cg_endo -74.6 155.08 44.91 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 122.809 0.899 . . . . 0.0 110.445 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 104' ' ' THR . . . -122.63 -50.59 0.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 103' ' ' GLY . 41.8 p 43.36 72.7 1.1 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.285 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 106' ' ' SER . 45.9 Cg_endo -73.14 -91.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 107' ' ' PHE . 3.7 t 171.06 -105.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 110.107 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.511 ' N ' ' OG ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 41.54 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.304 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.67 -68.39 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 109' ' ' LEU . 3.3 tt -173.99 85.36 0.36 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.03 122.37 8.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.965 1.508 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.95 175.83 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.944 1.497 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' THR . 18.7 m -62.71 90.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 110.177 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.72 155.29 75.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.91 165.35 33.04 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.956 1.503 . . . . 0.0 110.434 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER 46.4 51.83 11.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m 53.82 -86.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.248 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 115' ' ' SER . 4.7 mp0 -147.13 -167.2 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 110.193 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 10.6 t -115.47 100.82 54.03 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 120' ' ' GLU . 46.6 Cg_endo -72.77 54.44 2.53 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.561 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 119' ' ' PRO . 2.5 tt0 42.61 -159.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.543 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -74.92 -58.19 1.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.183 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 45.8 Cg_endo -73.26 116.07 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.005 1.529 . . . . 0.0 110.35 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.88 115.26 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.97 1.51 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -166.44 158.27 13.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -146.24 90.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -166.59 -143.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.199 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -90.87 126.06 56.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.6 -45.16 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.909 1.478 . . . . 0.0 110.467 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.45 44.54 0.26 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 131' ' ' THR . 0.5 OUTLIER -63.9 -55.83 19.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 130' ' ' SER . 66.4 p 42.86 75.88 0.59 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.249 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 115.06 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.04 1.547 . . . . 0.0 110.335 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' B' ' 169' ' ' HIS . 22.6 tttt -73.11 -72.42 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 27.2 mtp85 59.21 107.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.153 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.41 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.083 ' CZ ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -102.72 124.65 48.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.083 -1.01 . . . . 0.0 109.065 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.901 ' H ' HG12 ' B' ' 168' ' ' VAL . 7.8 p90 -155.44 167.36 30.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.828 -1.17 . . . . 0.0 111.48 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.809 HD12 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -104.21 149.27 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.624 0.726 . . . . 0.0 111.0 -178.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.765 ' OH ' HG23 ' B' ' 168' ' ' VAL . 16.9 m-85 -96.42 133.34 40.96 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.494 0.664 . . . . 0.0 110.644 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.609 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -125.95 126.45 44.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 110.568 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 41.18 68.54 0.63 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.74 22.7 2.0 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 140' ' ' SER . 5.1 tp10 -117.7 121.97 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -1.208 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -84.64 105.62 15.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.663 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -99.17 98.78 6.98 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.893 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.7 Cg_endo -73.08 127.27 11.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 111.792 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.809 ' CD2' HD12 ' A' ' 138' ' ' ILE . 0.5 OUTLIER -126.14 133.2 51.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.1 p -107.53 117.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.765 -1.209 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.083 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.7 pp -102.34 123.17 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -154.88 14.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.824 -179.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 37' ' ' GLY . 1.5 tpt180 -101.34 124.22 41.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.987 -1.071 . . . . 0.0 109.976 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.14 138.11 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.946 1.498 . . . . 0.0 110.591 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 40' ' ' LEU . 21.6 tp -91.22 123.55 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.97 90.23 3.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' CH2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.79 155.41 44.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.188 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 157' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' B' ' 160' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.172 0.511 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 3.4 m -68.65 -26.63 65.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.42 -29.22 47.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.181 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' B' ' 157' ' ' SER . 4.5 m -51.07 -89.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 1.2 t -138.59 173.25 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.684 HG21 ' N ' ' A' ' 25' ' ' GLY . 7.8 p -97.9 123.25 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 15.4 pt-20 -69.05 156.9 37.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.564 ' HD2' HD23 ' A' ' 64' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 11.2 m -139.89 -132.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.967 ' HA ' HD22 ' A' ' 64' ' ' LEU . 8.8 t -149.78 154.83 39.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.945 HG21 ' CD2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -93.17 173.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.132 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.901 HG12 ' H ' ' A' ' 137' ' ' TYR . 2.8 p -62.88 97.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.246 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.571 ' HA ' ' CG ' ' A' ' 76' ' ' GLN . 14.6 p80 -53.5 -41.81 66.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' B' ' 169' ' ' HIS . 0.1 OUTLIER -168.52 163.35 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.885 . . . . 0.0 110.243 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.529 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.706 ' H2 ' HD12 ' A' ' 4' ' ' LEU . 1.5 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.232 0.539 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.4 p90 -56.73 -35.95 69.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.508 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 2.6 tm0? -67.95 -42.84 80.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.706 HD12 ' H2 ' ' A' ' 1' ' ' GLU . 1.3 mt -67.1 -47.48 71.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.72 HG12 ' CZ ' ' A' ' 73' ' ' PHE . 25.7 m -61.4 -38.64 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.055 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 2' ' ' TYR . 25.6 t -58.72 -51.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.47 -45.51 91.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.684 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . . . -61.91 -44.04 97.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.683 HG23 ' CD2' ' A' ' 51' ' ' PHE . 13.8 t -57.44 -39.82 70.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.351 -0.843 . . . . 0.0 109.327 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.89 72.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.712 . . . . 0.0 109.936 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -41.03 46.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 21.4 tp -72.1 -43.99 63.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 9' ' ' VAL . 37.9 mt-30 -60.12 -33.5 72.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.56 -27.65 62.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.595 ' OG ' ' CD2' ' A' ' 17' ' ' PHE . 96.2 p -60.76 -43.09 98.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 109.843 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.35 26.99 7.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.91 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.9 p90 -132.39 -5.06 3.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 0.0 110.606 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.68 ' CD1' ' CG2' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -106.42 114.91 29.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.014 -1.054 . . . . 0.0 110.004 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.788 ' CE2' HD11 ' A' ' 40' ' ' LEU . 1.7 p-90 -126.46 148.24 49.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 110.025 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.01 107.49 14.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.98 10.19 0.17 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.551 -0.718 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -120.41 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -93.32 175.34 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.881 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.42 -81.99 0.04 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.592 ' HA2' ' OD1' ' A' ' 28' ' ' ASN . . . -79.35 -31.57 41.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.575 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.7 tt0 -59.22 -24.82 63.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.238 . . . . 0.0 109.94 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 23' ' ' THR . . . -69.16 -48.58 61.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.885 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.592 ' OD1' ' HA2' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -68.8 -47.26 66.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.396 -0.815 . . . . 0.0 110.899 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 1.5 mp -59.27 -31.92 69.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.797 . . . . 0.0 111.472 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -55.8 -46.08 78.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.9 -1.125 . . . . 0.0 109.665 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.023 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -73.08 -36.2 66.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 108.579 178.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 1.023 ' N ' HD23 ' A' ' 31' ' ' LEU . 1.9 m -69.8 -32.73 71.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 110.018 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.58 -20.95 42.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.6 mt-10 -113.15 -77.11 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.7 Cg_endo -72.11 64.11 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.33 1.174 . . . . 0.0 110.199 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 141.48 10.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.219 -0.926 . . . . 0.0 110.538 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 90.53 15.74 56.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.873 ' O ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -135.07 147.23 49.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -1.026 . . . . 0.0 110.252 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 149' ' ' LEU . 10.4 p90 -122.76 142.22 50.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 0.0 110.094 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 41' ' ' ILE . 5.5 tt -131.26 151.56 51.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.426 -0.796 . . . . 0.0 110.394 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.885 HD12 HD23 ' A' ' 53' ' ' LEU . 9.0 tt -114.77 128.07 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.446 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 5.5 tpt180 -119.56 139.56 51.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 1.4 t0 -73.89 138.06 44.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -38.35 -70.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.37 -72.96 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.67 -170.28 1.92 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.118 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 -7.31 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.154 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -95.48 26.41 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 110.113 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.443 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -135.9 177.42 7.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.55 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.3 p90 -79.71 168.57 19.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.922 . . . . 0.0 110.182 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.843 ' CE1' HG21 ' A' ' 91' ' ' VAL . 7.8 p90 -123.1 139.26 54.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 7.1 t -128.22 154.47 45.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.155 HD21 ' CG ' ' A' ' 98' ' ' TYR . 3.9 pp -139.47 151.38 46.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.941 -1.099 . . . . 0.0 110.456 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.579 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 0.8 OUTLIER -139.29 153.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.0 110.262 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 56' ' ' LYS . 10.7 p -129.01 173.47 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.333 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HB2' ' CA ' ' A' ' 32' ' ' SER . 9.6 tttm -116.92 139.14 50.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.606 HG21 HD22 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -146.26 -171.76 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.147 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.99 62.44 3.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 p -175.54 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.856 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.97 135.51 2.89 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 t -79.12 125.49 29.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.211 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' SER . 14.6 mmtt -123.8 141.96 51.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 110.175 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 4.3 p-10 -116.73 138.87 51.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.574 HD13 HG22 ' B' ' 167' ' ' VAL . 0.7 OUTLIER -132.16 131.01 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.419 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.504 ' HG3' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -96.29 157.08 16.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -100.6 136.3 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.152 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' NE2' ' HD3' ' A' ' 79' ' ' PRO . 52.0 mt-30 -119.91 150.98 39.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.276 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 72' ' ' SER . 19.9 p -87.95 130.26 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.56 124.37 48.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.659 ' O ' HG11 ' A' ' 85' ' ' VAL . . . 65.4 -74.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.766 ' HA2' HG11 ' A' ' 85' ' ' VAL . . . -158.53 20.91 0.32 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 24.2 p -134.03 163.41 29.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.72 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.56 130.68 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.819 ' HA ' HD11 ' A' ' 94' ' ' LEU . 9.5 p -145.52 167.08 23.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.777 HD11 ' CE1' ' A' ' 97' ' ' HIS . 2.7 mt -67.08 117.12 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 64.37 122.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -176.63 -164.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 110.263 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' A' ' 77' ' ' SER . 0.8 OUTLIER -112.41 112.0 52.02 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.194 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HD3' ' NE2' ' A' ' 67' ' ' GLN . 46.1 Cg_endo -73.5 53.87 2.76 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.992 1.522 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.03 17.02 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.294 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.426 ' C ' ' OG1' ' A' ' 82' ' ' THR . 1.9 t -108.17 -58.51 1.98 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.219 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 41.9 33.25 0.33 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.551 ' CG ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -150.39 -179.3 0.97 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 83' ' ' GLN . 45.6 Cg_endo -72.8 125.92 10.92 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.962 1.507 . . . . 0.0 110.35 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.766 HG11 ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -132.91 -177.89 0.77 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 109.709 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.584 ' HD2' ' CB ' ' A' ' 85' ' ' VAL . 40.2 Cg_endo -67.31 153.25 77.62 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.571 1.3 . . . . 0.0 109.544 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.581 ' O ' ' HB3' ' A' ' 88' ' ' PHE . 54.4 mtt180 65.09 -118.94 0.4 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' HB3' ' O ' ' A' ' 87' ' ' ARG . 4.8 p90 165.68 -148.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.171 -0.955 . . . . 0.0 109.748 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.684 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 5.7 p-10 -73.24 110.18 7.33 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 0.0 109.596 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.84 6.85 26.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 110.66 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -50.08 -26.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.78 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 9.3 mp -57.6 -46.64 83.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.565 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -38.38 84.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.024 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.819 HD11 ' HA ' ' A' ' 74' ' ' SER . 7.4 mt -68.09 -34.82 77.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.622 -0.673 . . . . 0.0 109.836 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 91' ' ' VAL . 26.9 t -54.66 -37.71 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 110.042 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 100' ' ' PRO . 34.3 m170 -53.49 -35.53 60.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.029 . . . . 0.0 109.339 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.777 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -78.16 -34.19 49.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.714 . . . . 0.0 109.776 179.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.155 ' CG ' HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -61.88 -22.21 65.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.456 -0.778 . . . . 0.0 111.314 -178.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.865 ' HB2' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER 177.63 -56.88 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.913 -1.117 . . . . 0.0 111.554 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.657 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 40.5 Cg_endo -65.77 110.08 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.619 1.326 . . . . 0.0 111.256 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 99' ' ' MET . 48.9 Cg_endo -75.84 168.99 23.14 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.94 1.495 . . . . 0.0 110.257 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 134' ' ' ARG . 47.5 Cg_endo -73.87 -5.56 17.22 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.953 1.501 . . . . 0.0 110.275 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.59 149.95 5.08 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 105' ' ' PRO . 1.1 m -179.25 -58.59 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.224 -1.162 . . . . 0.0 110.171 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 104' ' ' THR . 44.6 Cg_endo -71.0 158.55 55.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.862 1.453 . . . . 0.0 110.462 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 107' ' ' PHE . 26.7 t -69.09 -92.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 108' ' ' SER . 53.2 m-85 41.86 64.44 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 4.2 m 56.05 174.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.182 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.514 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 16.8 mt 61.51 51.88 2.24 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 109' ' ' LEU . 46.7 Cg_endo -72.95 118.33 5.52 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.996 1.524 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -9.21 23.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.941 1.495 . . . . 0.0 110.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.411 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 8.3 t -117.2 167.34 11.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 2.1 mt-10 173.72 -57.58 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 45.9 Cg_endo -73.13 -10.0 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.049 1.552 . . . . 0.0 110.485 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.8 t -114.33 170.95 7.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.0 110.189 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.2 171.82 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.78 27.94 1.23 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.582 ' HB ' ' HD3' ' A' ' 119' ' ' PRO . 2.8 t -48.52 -54.62 24.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 118' ' ' VAL . 44.8 Cg_endo -71.42 152.53 60.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.881 1.463 . . . . 0.0 110.474 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.6 pt-20 -114.59 112.07 22.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.554 ' C ' ' HD2' ' A' ' 123' ' ' PRO . 7.8 mt-30 56.51 107.46 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.245 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 42.0 Cg_endo -72.26 -29.56 14.02 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.05 1.553 . . . . 0.0 112.242 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 48.7 Cg_endo -74.4 -32.11 6.67 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 122.851 0.922 . . . . 0.0 110.342 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -95.17 89.04 5.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.914 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -127.9 -56.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 0.0 110.292 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.47 -157.06 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.544 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -59.25 -58.11 21.97 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 45.5 Cg_endo -72.71 127.56 12.48 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 130' ' ' SER . . . -101.97 -1.5 51.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 129' ' ' GLY . 4.8 m 62.49 -164.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 130' ' ' SER . 27.3 p 42.48 81.27 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 61.39 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -125.63 -87.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.741 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 5.9 tmm_? -76.95 144.76 38.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 167.17 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.932 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.916 ' CD2' HG11 ' B' ' 167' ' ' VAL . 5.8 t80 -114.44 120.69 41.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.876 -1.14 . . . . 0.0 109.623 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.962 ' H ' HG12 ' B' ' 167' ' ' VAL . 1.8 p90 -157.15 166.89 31.99 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.954 -1.091 . . . . 0.0 109.998 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 147' ' ' LEU . 1.8 mp -119.24 147.41 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 120.88 -1.137 . . . . 0.0 111.51 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.833 ' CE2' HG23 ' B' ' 166' ' ' THR . 1.2 m-30 -84.65 107.77 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.705 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.762 ' HB3' HD13 ' A' ' 145' ' ' ILE . 10.3 t -92.47 124.82 36.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.68 61.54 3.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 57.09 20.28 34.28 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -120.23 121.73 39.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.942 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.62 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.06 105.44 11.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.005 -1.059 . . . . 0.0 110.704 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.863 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -97.71 115.09 65.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.2 Cg_endo -71.81 128.73 14.52 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 112.204 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.774 ' O ' ' O ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -126.1 136.46 52.93 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.4 t -97.41 116.45 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.062 -1.649 . . . . 0.0 109.852 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 98' ' ' TYR . 1.2 tt -91.47 125.31 36.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 6.9 p -165.55 46.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.78 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 4.4 mtp180 -134.08 124.54 17.53 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.06 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.0 Cg_endo -76.55 148.13 29.12 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.875 1.461 . . . . 0.0 110.771 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.91 HD21 ' O ' ' A' ' 17' ' ' PHE . 4.4 pp -88.18 158.04 18.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.589 ' C ' ' O ' ' A' ' 153' ' ' LEU . 14.0 t 22.04 -90.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.704 -0.622 . . . . 0.0 111.067 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 153' ' ' LEU . 5.7 t 55.21 -85.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 110.219 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 154' ' ' SER . 2.3 t30 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.234 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.33 86.28 7.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.95 39.54 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 57.8 m -95.71 71.13 3.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 110.215 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.605 ' O ' HG23 ' B' ' 162' ' ' VAL . 68.4 p -68.08 117.64 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.778 HG12 ' O ' ' B' ' 162' ' ' VAL . 1.8 t -158.67 92.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 24.7 mt-10 -119.32 -173.1 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 109.955 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.58 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.573 ' C ' HG22 ' B' ' 166' ' ' THR . 36.6 m -123.58 -91.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.438 -0.789 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.833 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.2 OUTLIER 171.67 166.95 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -0.885 . . . . 0.0 110.311 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.962 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.58 -162.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.384 -0.823 . . . . 0.0 110.274 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.936 HG22 ' CE2' ' A' ' 137' ' ' TYR . 3.6 t -77.19 132.94 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.271 -0.893 . . . . 0.0 110.296 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -67.17 149.56 50.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 97' ' ' HIS . 3.8 m -97.81 40.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.499 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.514 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.515 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -61.46 -47.91 83.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 110.053 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -67.53 -32.96 74.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.368 -0.832 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 71' ' ' GLY . 63.4 mt -57.01 -47.39 80.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.868 HG21 ' CA ' ' A' ' 50' ' ' PHE . 3.0 t -61.07 -47.24 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.092 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -43.19 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.134 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -65.0 -39.8 93.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.032 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.28 -44.45 52.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.895 . . . . 0.0 110.026 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.785 HG22 ' HE2' ' A' ' 18' ' ' TYR . 94.8 t -57.83 -39.91 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 0.0 109.391 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -55.74 -43.74 76.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.482 -0.762 . . . . 0.0 110.054 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -77.97 -44.33 27.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' HG21 ' A' ' 41' ' ' ILE . 44.9 tp -65.98 -42.1 90.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 12.8 pt20 -68.18 -38.86 82.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.257 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.4 tm-20 -57.79 -44.91 86.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -26.91 51.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.48 31.2 8.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.703 ' CZ ' ' CE1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -129.76 8.38 5.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -1.141 . . . . 0.0 110.266 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.785 ' HE2' HG22 ' A' ' 9' ' ' VAL . 2.6 t80 -90.81 136.18 33.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.972 ' CG ' HD12 ' A' ' 40' ' ' LEU . 12.9 m95 -108.48 143.42 37.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.334 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.687 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -149.78 110.99 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.892 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.36 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.66 -161.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 0.0 110.145 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -93.7 165.81 12.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 44' ' ' SER . . . -44.51 -84.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.73 ' HA3' HG22 ' B' ' 162' ' ' VAL . . . -60.66 -41.93 99.12 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.1 mt-10 -59.56 -27.12 65.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.973 -1.31 . . . . 0.0 110.212 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -78.3 -44.55 25.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 110.023 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.689 ' O ' HD23 ' A' ' 31' ' ' LEU . 4.7 m120 -68.78 -48.27 64.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.465 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.6 mp -59.19 -32.32 69.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.832 . . . . 0.0 111.038 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -55.98 -26.19 47.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 38' ' ' THR . 2.4 pp -68.52 -33.17 73.65 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.396 -0.921 . . . . 0.0 108.599 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.535 ' CA ' ' HD2' ' A' ' 56' ' ' LYS . 7.5 t -69.78 -32.93 71.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.611 -0.681 . . . . 0.0 110.056 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.61 -20.99 41.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 110.013 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.769 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 22.2 mt-10 -122.85 -83.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 110.552 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.769 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.5 69.5 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.894 0.944 . . . . 0.0 110.44 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.34 141.38 41.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 110.287 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 78.6 20.68 70.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.985 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.5 m -124.99 147.88 48.71 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -1.041 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.715 ' HB2' HG12 ' A' ' 55' ' ' VAL . 13.0 p90 -122.42 145.71 48.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.542 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.972 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.03 159.47 43.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.466 -0.772 . . . . 0.0 109.964 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.578 HG21 ' CD2' ' A' ' 12' ' ' LEU . 3.1 tt -114.79 143.74 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.283 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.1 tpm_? -129.71 132.04 46.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' A' ' 42' ' ' ARG . 1.9 t0 -77.09 103.95 7.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.515 ' HB2' ' N ' ' A' ' 24' ' ' GLY . 64.2 m -166.69 -155.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 67.54 29.68 7.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.2 -153.89 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' A' ' 48' ' ' ARG . 29.9 mt-30 -85.41 -12.94 50.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.359 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 2.8 mtm180 170.68 -27.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.513 ' NE2' ' CE1' ' A' ' 2' ' ' TYR . 35.4 m80 -103.85 -147.59 0.39 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.868 ' CA ' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 59.95 108.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.099 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 14.6 p90 -115.88 143.5 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.4 m -126.08 155.29 41.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.89 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -130.84 128.43 40.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.519 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -139.26 154.09 47.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.45 -0.781 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.815 ' HA ' HD21 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -135.17 174.22 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HD2' ' CA ' ' A' ' 32' ' ' SER . 6.7 tttt -111.03 139.24 46.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.171 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.958 ' HB ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -131.97 -142.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 110.163 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 59' ' ' SER . 27.7 tt0 -46.09 -27.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.066 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER 163.46 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.522 -0.736 . . . . 0.0 109.77 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 80.5 1.53 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 56' ' ' LYS . 13.3 p -94.49 108.88 20.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 0.0 109.872 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.926 ' HD2' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -137.11 172.79 12.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -140.16 155.33 47.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.998 HD11 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.31 129.94 27.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 110.655 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -80.22 156.35 26.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' CE2' ' A' ' 73' ' ' PHE . 6.8 tp -76.77 140.54 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 110.413 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.8 OUTLIER -91.81 117.77 30.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.658 ' SG ' HD12 ' A' ' 4' ' ' LEU . 42.0 t -98.93 117.15 32.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.02 102.95 14.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.861 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.34 -81.37 0.59 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.733 ' O ' HD11 ' A' ' 4' ' ' LEU . . . -141.45 6.79 2.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.4 OUTLIER -104.02 163.61 12.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 110.299 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.42 141.33 43.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.404 -0.81 . . . . 0.0 110.202 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 67' ' ' GLN . 4.0 p -155.41 139.99 16.94 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.935 . . . . 0.0 110.753 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.084 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.1 tt -128.33 57.69 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 2.3 mm-40 62.56 -149.97 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.081 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 62.91 -171.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.176 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 77' ' ' SER . 0.5 OUTLIER -89.8 121.62 68.8 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 0.0 110.201 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.03 59.26 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.965 1.508 . . . . 0.0 110.585 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.34 20.01 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.14 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 93' ' ' LYS . 12.4 m -68.46 -5.73 20.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 82' ' ' THR . 33.5 m 59.42 13.41 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.31 92.09 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.617 ' HD2' ' CE1' ' A' ' 88' ' ' PHE . 44.8 Cg_endo -73.68 -81.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.002 1.528 . . . . 0.0 110.479 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.97 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -110.71 170.22 5.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.083 -1.01 . . . . 0.0 109.547 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.97 ' HD2' HG22 ' A' ' 85' ' ' VAL . 41.3 Cg_endo -68.46 132.67 26.07 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.734 1.387 . . . . 0.0 109.66 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.609 ' O ' HD21 ' A' ' 4' ' ' LEU . 31.7 mtm180 53.57 39.42 30.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 109.316 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.617 ' CE1' ' HD2' ' A' ' 84' ' ' PRO . 9.7 p90 -77.21 164.99 25.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 110.493 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.666 ' OD1' HD11 ' A' ' 92' ' ' LEU . 32.5 p-10 -83.91 110.65 18.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' PHE . 4.4 t -88.73 -18.79 27.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.682 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 1.5 t -49.64 -25.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.025 -1.047 . . . . 0.0 109.925 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.904 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -57.58 -47.35 82.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.999 -1.063 . . . . 0.0 108.899 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.482 ' HG3' ' OG ' ' A' ' 81' ' ' SER . 26.0 mmtt -68.44 -34.06 75.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 108.714 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.084 HD13 ' CB ' ' A' ' 75' ' ' LEU . 19.6 mt -59.82 -33.13 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.201 0.524 . . . . 0.0 110.297 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.19 -36.43 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.5 OUTLIER -53.68 -52.71 59.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.584 -1.322 . . . . 0.0 108.906 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.682 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 19.9 t60 -79.58 -53.12 7.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -0.865 . . . . 0.0 109.692 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.89 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.02 -22.25 65.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.726 -0.609 . . . . 0.0 110.344 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.733 ' HA ' HD11 ' A' ' 149' ' ' LEU . 2.3 mtp -137.03 -176.39 0.57 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.104 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.602 ' HD3' ' CZ ' ' A' ' 39' ' ' PHE . 46.5 Cg_endo -74.38 136.88 22.42 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.689 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 42.1 Cg_endo -72.32 -29.79 13.57 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.972 1.512 . . . . 0.0 112.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 47.6 Cg_endo -73.74 78.6 2.41 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.797 0.893 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.95 -159.59 0.13 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -176.44 86.11 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.246 -1.149 . . . . 0.0 110.286 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 107' ' ' PHE . 46.1 Cg_endo -73.05 55.03 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.997 1.525 . . . . 0.0 110.35 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.91 52.31 9.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.865 . . . . 0.0 110.176 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 107' ' ' PHE . 1.8 p90 -134.2 128.76 34.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.271 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p -59.13 -163.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.555 ' C ' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -141.29 86.83 10.94 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.326 -0.859 . . . . 0.0 110.221 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 111' ' ' PRO . 41.7 Cg_endo -72.18 -29.75 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.983 1.517 . . . . 0.0 112.257 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 110' ' ' PRO . 47.7 Cg_endo -74.54 130.64 13.98 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 122.881 0.937 . . . . 0.0 110.387 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -86.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.162 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 110.75 2.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.71 64.76 3.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.975 1.513 . . . . 0.0 110.44 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.88 91.1 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.55 45.21 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 110.273 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -146.22 -37.75 0.24 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.887 . . . . 0.0 110.153 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.492 ' CG1' ' OE1' ' A' ' 120' ' ' GLU . 11.5 t 60.29 80.08 0.27 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.08 54.61 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.029 1.542 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 118' ' ' VAL . 14.1 pt-20 -103.7 -175.41 2.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.8 75.48 0.65 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.184 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 112.71 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.995 1.524 . . . . 0.0 110.316 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 125' ' ' GLN . 45.6 Cg_endo -72.94 65.62 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.991 1.521 . . . . 0.0 110.413 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 55.79 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.958 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -98.68 110.62 23.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -125.29 178.71 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.136 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.442 ' HG ' ' HD2' ' A' ' 128' ' ' PRO . 8.4 tt -131.0 130.39 22.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.442 ' HD2' ' HG ' ' A' ' 127' ' ' LEU . 46.7 Cg_endo -73.1 -52.46 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.942 1.496 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.62 173.31 13.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -140.47 -85.59 0.21 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -1.142 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -86.88 114.83 60.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.89 -163.04 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.072 1.564 . . . . 0.0 110.474 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.13 36.15 1.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.21 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.768 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 8.5 mtp180 -152.38 150.41 29.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.88 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 162.49 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 109.874 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.132 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -106.73 125.52 51.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.977 ' N ' HG12 ' B' ' 167' ' ' VAL . 14.5 p90 -155.04 167.63 29.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.73 -1.231 . . . . 0.0 111.108 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.926 HG21 ' HD2' ' A' ' 62' ' ' LYS . 3.0 mp -101.93 149.07 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 110.933 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.713 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.9 m-85 -99.15 133.08 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 110.985 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER -89.91 -162.77 0.92 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.657 -0.652 . . . . 0.0 110.004 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -43.04 -45.93 6.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.0 18.31 0.23 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 145' ' ' ILE . 4.1 mm-40 -120.34 123.92 44.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.18 . . . . 0.0 110.403 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 23.5 mtpt -75.73 105.33 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.035 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.07 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -91.83 110.9 46.83 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.897 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -76.47 128.99 10.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.143 1.602 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.07 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -124.63 123.16 39.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.289 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.7 p -102.53 117.44 47.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.67 -1.269 . . . . 0.0 110.297 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.993 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.9 pp -108.65 132.29 54.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.875 . . . . 0.0 110.047 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.473 ' HA ' ' HB3' ' A' ' 100' ' ' PRO . 4.2 p -169.9 27.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.026 -1.046 . . . . 0.0 110.73 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.573 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -113.58 124.84 30.48 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 109.943 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 46.6 Cg_endo -73.76 129.82 13.95 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.988 1.52 . . . . 0.0 110.703 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.773 ' HB2' HG22 ' A' ' 38' ' ' THR . 36.7 tp -91.92 128.57 37.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.4 OUTLIER 59.97 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.105 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 153' ' ' LEU . 2.6 m 43.3 -93.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 110.253 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 154' ' ' SER . 5.9 t-20 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 7.3 t -122.75 165.55 16.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -167.39 -177.46 3.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.202 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.59 -157.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.681 HG22 ' O ' ' B' ' 161' ' ' THR . 93.9 m -94.5 30.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.169 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.809 HG12 ' O ' ' B' ' 162' ' ' VAL . 40.5 t -131.09 59.89 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.543 ' O ' ' CD1' ' B' ' 164' ' ' PTR . 3.6 pm0 -58.6 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.779 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.581 ' HD1' ' HA ' ' A' ' 64' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.998 ' O ' HD11 ' A' ' 64' ' ' LEU . 4.7 t -134.09 96.25 3.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.857 . . . . 0.0 109.955 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.536 ' C ' ' O ' ' B' ' 165' ' ' SER . 46.3 p -30.34 123.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.568 -0.707 . . . . 0.0 110.44 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.132 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -92.53 84.16 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 110.268 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 135' ' ' ALA . 32.8 t 59.1 138.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' B' ' 170' ' ' SER . 16.0 m170 -102.26 -67.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' B' ' 169' ' ' HIS . 0.2 OUTLIER 173.16 123.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.259 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.592 ' CA ' HD12 ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.652 ' O ' HG23 ' A' ' 6' ' ' VAL . 29.8 p90 -61.19 -35.86 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.6 tt0 -55.0 -37.39 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.172 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.2 mt -60.9 -47.34 86.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 50' ' ' PHE . 55.5 t -70.38 -42.72 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.746 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 2' ' ' TYR . 73.2 t -58.78 -50.73 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.954 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.83 -41.87 87.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.93 -41.49 98.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.817 . . . . 0.0 109.659 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.15 HG22 ' CE2' ' A' ' 18' ' ' TYR . 2.9 t -56.97 -39.53 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.147 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -48.11 75.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -78.18 -38.94 42.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.14 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -65.3 -31.9 73.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.316 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.449 ' OE1' HG12 ' A' ' 9' ' ' VAL . 39.5 mt-30 -66.93 -39.86 87.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -34.28 71.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.262 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 p -72.02 -37.78 69.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 154' ' ' SER . . . 94.04 -5.18 71.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 9.0 t80 -93.54 6.04 49.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -1.111 . . . . 0.0 110.007 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 1.15 ' CE2' HG22 ' A' ' 9' ' ' VAL . 2.2 t80 -90.92 131.9 36.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 40' ' ' LEU . 29.1 m95 -124.15 104.18 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 111.146 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -122.44 17.73 10.53 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.873 0.845 . . . . 0.0 108.883 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.98 47.95 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.393 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.638 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -113.63 -157.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.889 -1.132 . . . . 0.0 109.974 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.599 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 1.2 p -95.96 176.1 6.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.555 ' HA3' ' CB ' ' A' ' 45' ' ' SER . . . -52.83 -69.51 1.18 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.584 ' HA3' HG22 ' B' ' 162' ' ' VAL . . . -79.66 -40.94 13.77 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.087 -1.243 . . . . 0.0 110.94 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 4.6 tp10 -59.59 -28.12 66.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.721 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.026 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -77.95 -42.92 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.084 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.952 HD21 HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.28 -44.97 70.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 111.277 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.952 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -70.32 -31.92 69.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.155 -0.966 . . . . 0.0 111.851 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.026 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.6 pp -55.43 -23.8 27.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.824 -1.173 . . . . 0.0 110.223 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.767 HD13 ' O ' ' A' ' 38' ' ' THR . 2.8 pp -78.47 -38.47 40.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.715 ' OG ' HG21 ' A' ' 61' ' ' THR . 12.7 p -70.09 -32.71 70.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.85 -20.57 42.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.299 -0.876 . . . . 0.0 110.973 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.715 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 11.8 mm-40 -116.29 -75.08 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.9 -1.125 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.715 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 45.2 Cg_endo -71.64 72.58 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.302 1.159 . . . . 0.0 110.564 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -57.62 141.25 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.952 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' H ' ' CE ' ' A' ' 56' ' ' LYS . . . 77.64 19.45 75.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -133.56 148.09 51.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -1.026 . . . . 0.0 109.928 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.905 ' HB3' HG23 ' A' ' 55' ' ' VAL . 21.9 p90 -121.84 159.44 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.937 . . . . 0.0 109.945 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.816 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -152.64 159.86 43.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 110.704 -178.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.679 HG12 ' OH ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -114.45 134.76 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 13.9 tpt180 -112.71 129.93 56.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.058 -1.026 . . . . 0.0 110.033 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.6 ' OD1' ' CG ' ' A' ' 51' ' ' PHE . 15.0 m-20 -98.59 138.1 36.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER 71.85 152.51 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.281 -0.887 . . . . 0.0 110.494 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.555 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 33.9 t -163.95 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.093 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -135.91 -138.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 110.182 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -86.04 -29.11 23.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -69.17 -31.29 69.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 48' ' ' ARG . 9.1 t60 58.03 143.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.826 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER 171.01 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.705 ' CD1' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -115.81 139.88 49.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.36 -0.838 . . . . 0.0 109.88 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 16.1 p -123.12 146.63 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.97 -1.081 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' B' ' 167' ' ' VAL . 0.2 OUTLIER -120.82 122.72 40.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 109.818 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.621 ' CB ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -143.52 155.94 44.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.726 -1.234 . . . . 0.0 112.812 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 39' ' ' PHE . 5.3 p -143.66 174.48 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.166 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 2.1 ttpt -115.72 125.45 52.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.862 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -153.88 -162.62 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.985 . . . . 0.0 110.498 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 57' ' ' THR . 5.1 mt-30 -79.77 -23.21 42.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -81.73 13.38 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.166 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.06 138.72 3.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.924 ' O ' HD11 ' A' ' 29' ' ' LEU . 2.9 t -78.85 108.76 12.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -1.139 . . . . 0.0 109.951 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 54' ' ' SER . 6.9 mmtt -109.17 157.94 18.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.213 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 64' ' ' LEU . 59.8 t30 -111.97 152.28 28.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.877 . . . . 0.0 110.028 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.98 ' CD1' HG23 ' B' ' 167' ' ' VAL . 15.1 mt -138.52 117.52 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 0.0 110.233 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -81.8 155.71 25.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 0.0 110.586 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.006 HD11 ' SG ' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -77.28 141.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 110.014 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.3 mt-30 -93.48 132.55 37.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' SER . 30.0 t -109.42 118.82 37.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 72' ' ' SER . 7.0 mm-40 -133.15 104.77 6.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.442 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.68 36.32 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.18 -0.01 55.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -103.75 163.3 12.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -1.127 . . . . 0.0 109.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.4 m-30 -110.87 148.06 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.851 ' O ' HD13 ' A' ' 66' ' ' ILE . 19.5 m -144.43 138.59 27.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.808 . . . . 0.0 110.079 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.956 ' CD1' HD11 ' A' ' 94' ' ' LEU . 10.0 tp -115.35 -3.46 12.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' B' ' 169' ' ' HIS . 2.8 mp0 -71.85 -145.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.133 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.904 ' OG ' HG21 ' B' ' 166' ' ' THR . 1.8 t -179.39 30.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . 1.3 m-20 -120.04 125.04 27.51 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.18 53.93 2.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.947 1.498 . . . . 0.0 110.432 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 78' ' ' ASP . 15.0 mtp180 -87.46 19.01 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.143 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 80' ' ' ARG . 3.9 p 43.81 42.28 4.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 14.1 t -81.85 10.22 6.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.566 ' CG ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 61.96 -179.24 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 110.193 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 83' ' ' GLN . 46.9 Cg_endo -72.84 -179.77 4.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.965 1.508 . . . . 0.0 110.38 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.52 143.02 27.29 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 47.1 Cg_endo -72.88 138.39 28.54 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.011 1.532 . . . . 0.0 110.418 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.597 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 69.22 28.46 4.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.365 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 40.0 p90 35.82 45.42 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.603 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -72.31 110.11 6.51 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.02 -1.05 . . . . 0.0 109.909 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 1.006 ' SG ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -177.44 -75.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.625 -0.672 . . . . 0.0 110.044 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 92' ' ' LEU . 8.6 m -54.88 -51.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.016 . . . . 0.0 109.696 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 13.3 mt -63.41 -46.12 87.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 108.829 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -64.95 -29.42 70.35 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.576 0.703 . . . . 0.0 109.543 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.956 HD11 ' CD1' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.51 -34.55 69.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 110.739 -178.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.872 HG12 HD11 ' A' ' 12' ' ' LEU . 3.7 m -54.19 -39.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.928 -1.108 . . . . 0.0 108.825 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.59 ' CE1' ' HD2' ' A' ' 101' ' ' PRO . 1.0 OUTLIER -68.62 -30.01 68.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 178.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.668 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -56.73 -38.82 72.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 110.276 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.864 ' HA ' HD13 ' A' ' 149' ' ' LEU . 36.3 m-85 -73.8 -0.65 16.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.602 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 178.52 110.47 0.16 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.035 -1.041 . . . . 0.0 110.471 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HG3' ' HG3' ' A' ' 134' ' ' ARG . 47.5 Cg_endo -74.83 138.53 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.905 1.476 . . . . 0.0 110.313 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.67 164.92 33.6 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.002 1.528 . . . . 0.0 110.428 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.88 169.5 21.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.985 1.519 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.51 -54.85 0.77 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 100.55 1.25 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.25 -1.147 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -53.46 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.12 1.59 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.2 -74.12 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.89 . . . . 0.0 110.245 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.621 ' O ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -72.02 124.31 24.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 m -88.63 81.4 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.942 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -110.82 147.41 36.42 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 112' ' ' THR . 46.8 Cg_endo -72.96 137.03 26.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.016 1.535 . . . . 0.0 110.452 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.87 76.8 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.062 1.559 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 110' ' ' PRO . 21.1 p -78.59 121.15 24.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -142.9 117.62 6.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.31 -44.42 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.381 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 p -63.07 153.75 33.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.3 t -98.96 30.44 3.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -46.75 -53.79 11.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.1 p -164.79 78.96 1.36 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 46.1 Cg_endo -72.78 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.066 1.561 . . . . 0.0 110.427 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER 65.89 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.836 . . . . 0.0 110.233 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 120' ' ' GLU . 22.8 tp60 -162.54 105.45 1.07 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.19 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.98 128.13 12.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.044 1.55 . . . . 0.0 110.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 124' ' ' ALA . 46.4 Cg_endo -73.4 54.18 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 123' ' ' PRO . . . 42.72 -154.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 8.3 mt-30 -93.01 -35.01 13.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 110.228 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 125' ' ' GLN . . . 66.68 50.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' N ' ' HD2' ' A' ' 128' ' ' PRO . 0.1 OUTLIER -67.86 -55.74 13.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 127' ' ' LEU . 45.5 Cg_endo -73.05 -89.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.923 1.486 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.01 -166.41 38.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 131' ' ' THR . 0.6 OUTLIER -59.17 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 130' ' ' SER . 25.2 p 42.96 88.19 0.11 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 172.97 14.26 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -98.45 77.48 2.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.761 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 2.8 ttt180 -120.8 101.59 7.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.0 110.222 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.13 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.844 . . . . 0.0 109.997 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.904 ' CD1' ' O ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -102.59 124.86 48.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.018 . . . . 0.0 108.993 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.931 ' N ' HG13 ' B' ' 167' ' ' VAL . 6.7 p90 -156.02 166.34 33.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.804 -1.185 . . . . 0.0 111.016 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.889 ' H ' HD13 ' A' ' 147' ' ' LEU . 5.6 mt -102.43 149.53 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.778 0.799 . . . . 0.0 111.377 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -97.79 133.46 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.639 0.733 . . . . 0.0 110.969 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.972 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -121.43 119.53 32.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.566 -0.709 . . . . 0.0 110.52 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 42.58 63.41 1.91 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.3 13.84 23.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 140' ' ' SER . 8.3 tp10 -109.97 121.73 45.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 18.2 mttt -79.4 105.65 10.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.833 . . . . 0.0 110.561 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 147' ' ' LEU . 1.2 mp -97.22 109.67 50.71 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.846 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.59 129.38 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.139 1.599 . . . . 0.0 111.838 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.002 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.28 134.96 53.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.493 -0.755 . . . . 0.0 109.87 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.93 118.41 53.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER -76.06 157.83 32.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.87 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.4 -74.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 0.0 110.999 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 38' ' ' THR . 2.8 mtt180 -105.19 132.54 20.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.038 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 49.9 Cg_endo -78.04 148.01 24.33 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.02 1.537 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -85.26 115.9 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.54 142.37 42.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.346 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.582 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -136.74 167.92 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 110.233 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.252 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.218 0.532 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 2.5 m -128.3 157.16 41.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -175.33 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 2.0 t -110.05 88.44 2.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.208 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER -105.5 159.79 15.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.776 HG12 ' O ' ' B' ' 162' ' ' VAL . 41.1 t 56.65 67.68 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.394 -0.816 . . . . 0.0 110.319 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 5.2 mt-10 -88.48 154.45 20.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.57 ' CD2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.723 ' C ' HD22 ' A' ' 64' ' ' LEU . 6.9 t -144.54 -96.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.904 HG21 ' OG ' ' A' ' 77' ' ' SER . 2.2 t -178.32 147.41 0.42 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.98 HG23 ' CD1' ' A' ' 64' ' ' LEU . 5.0 t -86.03 145.38 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 137' ' ' TYR . 7.7 p -54.5 162.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -101.64 -148.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.327 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.476 ' N ' ' CG ' ' B' ' 169' ' ' HIS . 30.0 m -124.46 -68.43 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 110.195 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.1 mt-10 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.237 0.542 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.577 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 t80 -66.8 -51.51 54.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.219 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -67.3 -40.8 86.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.899 HD23 ' HA ' ' A' ' 90' ' ' CYS . 3.0 mt -56.99 -45.89 82.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.158 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.887 HG21 ' HA ' ' A' ' 50' ' ' PHE . 17.0 t -71.97 -47.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 2' ' ' TYR . 81.0 t -58.75 -32.77 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.358 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -70.88 -38.68 73.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 91' ' ' VAL . . . -76.14 -44.61 37.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.485 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.696 HG12 ' HE2' ' A' ' 18' ' ' TYR . 24.5 m -57.62 -39.81 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.323 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 mmt180 -55.75 -44.44 77.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 109.82 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.09 -41.32 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.921 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.88 -41.93 95.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 19.6 mt-30 -67.75 -35.27 78.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -69.7 -49.57 52.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -58.53 -28.75 65.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.23 15.84 29.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . 4.0 m-85 -101.85 -0.94 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.144 . . . . 0.0 110.13 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.696 ' HE2' HG12 ' A' ' 9' ' ' VAL . 4.3 t80 -90.77 136.05 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.639 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.861 ' HE1' HD13 ' A' ' 153' ' ' LEU . 45.9 m95 -117.35 148.07 42.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 109.651 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -150.66 108.18 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 110.444 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.737 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . . . 176.16 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -119.42 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 110.421 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -85.61 176.14 8.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.338 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.7 -69.38 1.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.638 ' HA3' HG21 ' B' ' 162' ' ' VAL . . . -77.64 -36.04 34.52 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 3.1 tt0 -59.66 -24.57 64.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 0.0 109.603 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.002 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -74.35 -46.47 40.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.474 -0.766 . . . . 0.0 110.364 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.904 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -67.96 -36.68 80.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.765 HD11 ' HB ' ' A' ' 61' ' ' THR . 0.4 OUTLIER -57.71 -32.31 67.27 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.004 -1.06 . . . . 0.0 110.282 -178.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -56.39 -23.88 40.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 108.765 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.965 HD11 ' CB ' ' A' ' 56' ' ' LYS . 1.7 pp -68.06 -33.67 75.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 m -69.56 -33.03 72.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.758 . . . . 0.0 109.777 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.01 41.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 109.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.788 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 45.1 mm-40 -125.93 -86.87 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.788 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.4 Cg_endo -74.46 68.57 5.25 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 122.831 0.911 . . . . 0.0 110.267 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 141.47 48.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 0.0 110.64 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.27 18.65 66.34 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.866 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -131.28 148.21 52.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.482 -1.01 . . . . 0.0 110.103 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.758 ' CZ ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -121.72 138.74 54.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 110.068 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.13 161.09 28.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.45 -0.781 . . . . 0.0 110.286 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -113.12 128.69 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.108 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 1.002 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -129.14 136.51 50.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.831 . . . . 0.0 109.655 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 2.3 t0 -73.77 127.57 33.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 45' ' ' SER . 85.8 p -117.05 -177.85 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.299 -0.876 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 4.2 t 42.51 65.23 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 66.44 135.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.891 . . . . 0.0 110.07 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ARG . 7.4 pt20 -66.29 -7.88 21.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -42.37 -47.81 4.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.246 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER 177.74 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.887 ' HA ' HG21 ' A' ' 5' ' ' VAL . 18.4 t80 55.04 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.878 ' HD2' HG13 ' A' ' 5' ' ' VAL . 7.3 p90 -126.24 148.79 49.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.034 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.3 m -126.42 155.03 42.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -126.93 136.52 52.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.004 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.71 154.29 45.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 109.55 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 149' ' ' LEU . 6.6 m -118.02 174.36 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.563 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.965 ' CB ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -103.91 138.98 39.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.39 -0.819 . . . . 0.0 110.28 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.724 HG23 HD11 ' A' ' 147' ' ' LEU . 21.1 m -127.32 158.14 38.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 57' ' ' THR . 43.9 mt-30 -38.92 -28.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.0 t -173.55 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.2 62.4 0.46 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.765 ' HB ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -78.95 108.94 12.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -1.194 . . . . 0.0 109.514 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -137.46 178.0 7.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 0.0 110.67 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.56 ' CA ' ' HB3' ' A' ' 54' ' ' SER . 32.5 p-10 -137.56 156.17 48.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.491 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 52' ' ' THR . 34.5 mt -131.04 152.19 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.11 156.79 18.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 110.178 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.83 HD13 ' HB2' ' A' ' 94' ' ' LEU . 3.5 tp -76.76 134.75 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.96 151.04 20.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.8 t -116.72 116.92 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.6 mm-40 -107.41 102.79 12.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.009 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.38 -79.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -143.7 45.67 0.87 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.477 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 1.2 t -142.92 163.03 33.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -1.155 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -133.14 126.8 32.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 109.823 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.787 ' N ' HD11 ' A' ' 66' ' ' ILE . 4.1 p -155.24 146.03 22.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.018 . . . . 0.0 110.435 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.863 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -82.9 -9.84 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.001 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.534 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 0.7 OUTLIER -141.91 -135.13 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.469 ' N ' ' CG ' ' A' ' 76' ' ' GLN . 88.9 p -151.17 64.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 32.8 p-10 -119.61 115.0 34.04 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.124 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.13 52.54 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.008 1.531 . . . . 0.0 110.705 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' SER . 22.4 mmm180 -90.11 20.13 4.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -52.1 -172.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.823 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -112.11 18.28 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.302 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.823 ' CB ' ' O ' ' A' ' 82' ' ' THR . 9.8 tt0 113.54 -28.8 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 122.132 -0.355 . . . . 0.0 111.635 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.739 ' HD2' ' N ' ' A' ' 83' ' ' GLN . 45.5 Cg_endo -73.41 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.047 1.025 . . . . 0.0 110.61 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.919 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -92.82 168.49 12.28 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 0.0 109.616 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.919 ' HD2' HG22 ' A' ' 85' ' ' VAL . 42.9 Cg_endo -70.06 132.56 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.912 1.48 . . . . 0.0 109.874 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.585 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.2 mtt-85 60.8 -75.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.846 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 163.83 121.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.322 -0.862 . . . . 0.0 109.631 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.658 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 11.3 t70 -84.72 109.26 17.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 110.052 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.899 ' HA ' HD23 ' A' ' 4' ' ' LEU . 0.8 OUTLIER 151.75 134.5 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.037 0.446 . . . . 0.0 109.9 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.853 HG23 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -49.71 -25.4 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.348 179.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.965 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -56.47 -35.37 67.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.485 -0.759 . . . . 0.0 110.154 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.501 ' HG3' ' HB2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -58.25 -38.57 77.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.266 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.959 HD21 ' CD2' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -68.16 -35.14 77.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.418 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 94' ' ' LEU . 93.4 t -55.37 -37.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.749 . . . . 0.0 110.404 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.09 -45.51 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.58 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.534 ' ND1' ' NE2' ' A' ' 76' ' ' GLN . 1.5 t60 -78.12 -36.74 47.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.84 . . . . 0.0 109.533 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.959 ' CD2' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -69.32 -12.15 61.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 12.5 ttt -177.77 79.12 0.24 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.27 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.45 166.86 28.76 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.004 1.529 . . . . 0.0 110.322 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HG2' ' HG2' ' A' ' 132' ' ' PRO . 45.6 Cg_endo -72.61 116.82 4.86 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.039 1.547 . . . . 0.0 110.424 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.84 -174.99 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.925 1.487 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.95 60.77 0.39 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.545 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.63 -58.33 7.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.247 -1.149 . . . . 0.0 110.168 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 46.3 Cg_endo -73.25 165.92 31.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.459 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.507 ' C ' ' CG ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -66.87 -159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.196 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.507 ' CG ' ' C ' ' A' ' 106' ' ' SER . 39.3 m-85 -150.49 174.29 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.453 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -136.94 52.09 1.95 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.149 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 108' ' ' SER . 3.8 mp -125.22 170.43 9.25 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.195 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.03 155.25 52.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.981 1.516 . . . . 0.0 110.438 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 112' ' ' THR . 46.1 Cg_endo -73.01 156.96 51.75 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.438 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 111' ' ' PRO . 7.6 p 43.26 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.21 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -107.06 137.07 19.43 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.243 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.9 -159.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.0 1.526 . . . . 0.0 110.471 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 116' ' ' SER . 11.1 m -152.3 109.55 3.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -42.98 133.13 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.893 . . . . 0.0 110.221 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.896 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.6 mm-40 -163.2 -36.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 117' ' ' GLU . 2.5 t -165.91 -61.45 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 118' ' ' VAL . 45.5 Cg_endo -71.49 -2.8 11.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.719 1.378 . . . . 0.0 110.465 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' CG ' ' A' ' 121' ' ' GLN . 4.3 mt-10 -123.15 -167.76 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.897 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.536 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 176.18 -58.14 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 45.9 Cg_endo -73.07 136.38 24.62 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 47.8 Cg_endo -73.6 -49.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.979 1.515 . . . . 0.0 110.464 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 123' ' ' PRO . . . 175.63 -29.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 13.3 mt-30 59.07 -147.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.297 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 125' ' ' GLN . . . -42.54 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 128' ' ' PRO . 1.7 tt -61.48 132.46 92.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' HD23 ' A' ' 127' ' ' LEU . 45.9 Cg_endo -73.4 161.5 42.41 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.059 1.557 . . . . 0.0 110.396 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.95 -31.12 7.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 0.8 OUTLIER -74.0 133.61 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -1.148 . . . . 0.0 110.223 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 131' ' ' THR . 72.9 p -42.73 102.32 0.27 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.248 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.485 ' HG2' ' HG2' ' A' ' 101' ' ' PRO . 46.4 Cg_endo -73.02 107.29 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.026 1.54 . . . . 0.0 110.418 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.04 81.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mmt-85 -76.69 -146.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.908 . . . . 0.0 110.213 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' HG21 ' B' ' 168' ' ' VAL . . . -160.89 132.85 5.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' B' ' 167' ' ' VAL . 1.5 t80 -119.42 123.53 44.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.838 ' H ' HG22 ' B' ' 167' ' ' VAL . 3.8 p90 -155.23 166.74 32.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.857 -1.152 . . . . 0.0 111.285 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.663 ' H ' HD23 ' A' ' 147' ' ' LEU . 3.0 mt -102.44 149.11 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.388 -0.82 . . . . 0.0 111.207 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.711 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 14.8 m-85 -98.72 133.19 43.39 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.692 0.758 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.72 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -94.88 -162.07 0.91 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.68 . . . . 0.0 110.134 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.37 60.7 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 101.6 2.46 53.12 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -119.97 121.92 40.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.644 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -80.74 105.33 11.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.485 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.996 HG22 HD21 ' A' ' 147' ' ' LEU . 1.5 mp -82.77 109.13 14.82 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -74.93 129.42 12.38 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.193 1.628 . . . . 0.0 112.811 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.996 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -125.25 135.86 52.96 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 148' ' ' VAL . 13.0 p -97.43 117.15 41.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.265 -1.522 . . . . 0.0 110.428 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 98' ' ' TYR . 9.5 tp -91.88 114.8 27.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 t -161.77 10.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.892 -1.13 . . . . 0.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 2.9 mtt85 -108.93 123.93 35.62 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.679 -1.263 . . . . 0.0 109.991 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 50.1 Cg_endo -78.65 148.35 22.84 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.98 1.516 . . . . 0.0 111.039 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.861 HD13 ' HE1' ' A' ' 19' ' ' TRP . 4.4 pp -83.73 135.63 34.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.914 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.531 ' HB3' HD12 ' A' ' 153' ' ' LEU . 12.7 t 41.64 -89.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 110.36 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 153' ' ' LEU . 23.0 t -59.24 156.17 12.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 110.169 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.466 ' OXT' ' ND2' ' A' ' 156' ' ' ASN . 9.9 p-10 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.223 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' SER . . . . . 0.502 ' O ' ' N ' ' B' ' 159' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.303 0.573 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' B' ' 157' ' ' SER . 43.8 m 55.98 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 157' ' ' SER . . . -165.32 -161.12 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' B' ' 159' ' ' ALA . 16.2 t -177.06 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 160' ' ' SER . 4.7 t -42.04 155.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.638 HG21 ' HA3' ' A' ' 25' ' ' GLY . 17.4 m -78.97 150.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.468 ' C ' ' CD2' ' B' ' 164' ' ' PTR . 0.6 OUTLIER -75.97 177.46 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.532 ' N ' ' CD2' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -169.54 102.35 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.73 159.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -113.47 170.61 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 135' ' ' ALA . 46.8 t -6.28 115.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.195 0.521 . . . . 0.0 111.314 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -99.46 179.6 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 11.6 m -153.57 122.63 6.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.153 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.595 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.779 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.3 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 6' ' ' VAL . 55.1 p90 -57.55 -36.04 71.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.9 tt0 -55.03 -37.98 67.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 1' ' ' GLU . 1.5 mt -58.87 -45.8 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.995 HG22 ' CE2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -71.16 -37.34 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.189 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 2' ' ' TYR . 94.9 t -58.02 -39.43 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.923 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -70.69 -34.67 72.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.797 ' HB2' HD11 ' A' ' 92' ' ' LEU . . . -76.27 -44.17 38.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.785 . . . . 0.0 110.119 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.656 HG23 ' CE2' ' A' ' 51' ' ' PHE . 47.3 t -57.4 -39.85 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.47 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.8 ttm180 -55.91 -45.46 78.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.947 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -38.61 43.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.862 . . . . 0.0 109.992 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 41' ' ' ILE . 18.0 tp -71.0 -40.7 71.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 110.013 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 15.4 pt20 -68.12 -34.94 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.303 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -57.95 -27.92 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.54 -27.27 69.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.865 . . . . 0.0 110.168 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.3 25.11 24.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -130.11 7.83 5.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.041 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.558 ' HD2' HD23 ' A' ' 12' ' ' LEU . 4.3 t80 -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.813 ' CG ' HD11 ' A' ' 40' ' ' LEU . 17.2 m95 -121.1 148.56 44.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.416 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -151.41 24.83 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.02 8.97 20.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.661 -0.649 . . . . 0.0 110.924 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.785 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -116.35 -160.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.049 . . . . 0.0 109.925 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.54 ' CB ' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -97.31 176.16 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.319 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.58 -85.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.622 ' N ' HG11 ' B' ' 162' ' ' VAL . . . -70.74 -31.63 67.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -59.09 -39.17 81.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.129 -1.218 . . . . 0.0 109.958 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -64.44 -47.03 80.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.627 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.713 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 m-80 -68.91 -43.66 74.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -0.94 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.468 ' O ' ' OG ' ' A' ' 32' ' ' SER . 1.6 mp -70.53 -32.29 69.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 112.072 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -55.17 -24.42 26.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.709 -1.244 . . . . 0.0 111.032 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.016 HD13 ' O ' ' A' ' 38' ' ' THR . 4.4 pp -77.56 -37.86 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 0.0 109.584 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.884 ' N ' HD12 ' A' ' 31' ' ' LEU . 21.8 p -69.74 -32.57 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 0.0 110.28 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.65 43.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.615 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.731 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 5.3 mm-40 -115.76 -76.41 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.92 -1.112 . . . . 0.0 110.489 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.731 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.2 Cg_endo -72.69 70.37 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.286 1.151 . . . . 0.0 110.509 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 141.23 13.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 73.46 20.77 79.92 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 1.016 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.3 m -129.59 147.7 51.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -1.074 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.782 ' CD1' HG12 ' A' ' 55' ' ' VAL . 9.7 m-85 -122.9 158.46 30.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.382 -0.824 . . . . 0.0 109.454 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.006 ' HB2' HD13 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -152.38 160.57 43.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.008 -1.058 . . . . 0.0 111.195 -178.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.704 HG21 ' CD2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -113.89 129.18 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.541 -0.724 . . . . 0.0 109.906 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -117.36 161.12 20.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.282 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.486 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 7.5 t70 -100.05 138.06 37.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 109.991 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' ASP . 53.1 p -44.97 170.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 t -89.01 -25.05 22.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -166.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -65.07 -26.26 68.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 50' ' ' PHE . 1.9 mtm-85 -176.8 -65.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 51.75 -89.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.248 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.939 ' CA ' HG21 ' A' ' 5' ' ' VAL . 12.2 p90 -163.8 -165.01 0.96 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 1.107 ' CE1' HG22 ' A' ' 91' ' ' VAL . 13.0 p90 -134.33 139.6 45.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 110.628 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.59 ' CG2' ' HA ' ' A' ' 65' ' ' ARG . 2.2 p -126.31 155.29 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.474 -0.767 . . . . 0.0 109.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.18 HD12 ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -134.37 142.58 47.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.064 -1.023 . . . . 0.0 110.688 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.18 ' N ' HD12 ' A' ' 53' ' ' LEU . 1.3 p -124.5 154.17 40.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.097 HG11 HD22 ' A' ' 149' ' ' LEU . 21.2 m -117.63 174.01 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.114 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.99 130.79 51.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.465 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 80.5 p -141.11 156.6 45.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.76 82.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.2 t -63.0 -10.86 15.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 124.07 153.64 8.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -78.91 140.47 38.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' SER . 69.6 mmtt -139.16 133.18 31.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.585 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 11.2 p30 -111.91 128.85 56.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 HG23 ' B' ' 167' ' ' VAL . 2.9 mp -102.43 118.14 36.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.972 . . . . 0.0 110.252 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 0.1 OUTLIER -84.52 152.26 24.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.02 HD11 ' HB2' ' A' ' 90' ' ' CYS . 4.5 tp -84.93 149.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -114.58 115.65 27.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.855 . . . . 0.0 110.504 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 27.5 p -92.04 123.15 35.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 14.9 tt0 -133.19 103.5 6.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.5 32.93 85.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.81 -11.67 69.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 82.9 p -94.74 143.1 26.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.989 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.667 ' HE2' HG23 ' A' ' 5' ' ' VAL . 3.4 m-30 -110.82 157.36 19.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.243 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -155.56 138.65 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.153 -0.967 . . . . 0.0 110.486 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.06 ' CD2' HD21 ' A' ' 94' ' ' LEU . 1.2 tp -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.681 HE21 HD23 ' A' ' 75' ' ' LEU . 3.1 mt-30 -113.48 94.28 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 t 44.75 -146.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -103.5 120.47 51.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.551 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 46.8 Cg_endo -73.36 59.86 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 1.1 ttm-85 -70.32 -4.0 20.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.42 -64.66 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 83' ' ' GLN . 14.9 t -131.49 27.6 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 43.06 89.62 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.155 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.619 ' O ' ' C ' ' A' ' 85' ' ' VAL . 47.8 Cg_endo -74.06 1.41 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.037 1.546 . . . . 0.0 110.678 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.619 ' C ' ' O ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -22.61 -59.6 0.1 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.611 ' CD ' HG23 ' A' ' 85' ' ' VAL . 44.3 Cg_endo -71.54 132.95 21.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.859 1.452 . . . . 0.0 109.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.621 ' O ' ' C ' ' A' ' 88' ' ' PHE . 5.6 mtp85 49.15 26.79 1.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.079 -1.013 . . . . 0.0 109.518 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.621 ' C ' ' O ' ' A' ' 87' ' ' ARG . 11.9 p90 -17.09 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.476 0.655 . . . . 0.0 111.585 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -96.87 110.81 23.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.009 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 1.02 ' HB2' HD11 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -171.28 -88.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 0.0 110.454 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.107 HG22 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -59.71 -51.19 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.051 -1.03 . . . . 0.0 109.469 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 8' ' ' ALA . 4.9 mp -66.36 -46.2 77.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 108.841 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.482 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 32.4 ttpt -65.79 -29.22 69.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.784 0.802 . . . . 0.0 108.869 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.145 HD22 ' CZ ' ' A' ' 98' ' ' TYR . 5.0 mt -57.48 -34.23 68.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 0.0 110.096 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -54.27 -38.66 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.879 -1.138 . . . . 0.0 108.686 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.478 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 7.7 m170 -68.64 -51.89 37.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 108.862 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -63.81 -36.95 85.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.358 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 3.7 m-30 -73.38 -9.16 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.642 -0.661 . . . . 0.0 110.013 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 171.28 160.33 0.23 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 110.2 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.94 160.83 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.009 1.531 . . . . 0.0 110.452 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.06 154.7 52.62 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.058 1.557 . . . . 0.0 110.422 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.9 136.42 25.09 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.02 1.537 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.05 -150.52 12.42 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 8.8 t -140.86 48.54 1.34 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.195 -1.179 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 104' ' ' THR . 46.7 Cg_endo -72.94 111.51 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.369 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 69.25 -57.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.204 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.5 OUTLIER 68.91 -65.88 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 26.4 t 179.04 34.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.515 HD13 ' C ' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -94.26 114.05 62.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.472 ' N ' HD13 ' A' ' 109' ' ' LEU . 45.5 Cg_endo -72.92 111.35 3.25 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.048 1.552 . . . . 0.0 110.407 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 109' ' ' LEU . 46.0 Cg_endo -72.63 55.99 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.03 1.542 . . . . 0.0 110.435 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 16.9 m -82.37 -49.82 9.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 4.6 mt-10 -164.31 52.63 0.31 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.271 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 46.6 Cg_endo -72.96 157.69 50.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.042 1.549 . . . . 0.0 110.452 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 116' ' ' SER . 53.5 p -86.17 -21.62 27.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.227 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 117' ' ' GLU . 37.6 t -177.58 -138.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 116' ' ' SER . 2.0 tt0 67.8 -138.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 118' ' ' VAL . 16.0 m -41.89 146.42 0.62 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.89 156.83 52.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.89 1.468 . . . . 0.0 110.419 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 121' ' ' GLN . 66.6 tt0 -92.65 29.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.952 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' GLU . 34.9 tt0 57.96 122.6 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.35 -0.844 . . . . 0.0 110.313 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.81 128.65 13.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.89 1.468 . . . . 0.0 110.424 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.08 140.63 31.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.001 1.527 . . . . 0.0 110.418 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' GLN . . . -167.13 69.92 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 11.6 mm100 58.93 174.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.1 60.96 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 127' ' ' LEU . 0.5 OUTLIER -175.68 71.54 0.27 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.148 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.69 -17.66 25.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.012 1.533 . . . . 0.0 110.505 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' SER . . . -148.5 -79.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER 61.69 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.206 -1.173 . . . . 0.0 110.161 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 131' ' ' THR . 54.4 m 47.64 47.76 5.0 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 131' ' ' THR . 47.2 Cg_endo -73.06 170.8 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.495 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -71.41 -24.32 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 ptm180 -109.44 120.9 43.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.137 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG11 ' B' ' 168' ' ' VAL . . . 172.23 130.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.023 ' CD2' HG11 ' B' ' 167' ' ' VAL . 1.2 t80 -116.55 122.54 44.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.984 -1.072 . . . . 0.0 109.306 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.042 ' CD2' HG12 ' B' ' 168' ' ' VAL . 5.4 p90 -156.32 166.95 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.952 -1.092 . . . . 0.0 110.66 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.33 149.17 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.061 . . . . 0.0 111.356 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.71 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.7 m-30 -86.44 107.88 18.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.591 -0.693 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.947 ' HB2' HD13 ' A' ' 145' ' ' ILE . 23.0 t -55.78 84.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.018 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 66.9 -64.79 0.19 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -144.7 13.08 1.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 145' ' ' ILE . 2.8 tt0 -120.45 123.43 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.093 . . . . 0.0 109.797 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -75.5 105.57 6.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 140' ' ' SER . 0.9 OUTLIER -103.38 112.86 65.94 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.8 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.8 Cg_endo -72.79 127.47 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.76 1.4 . . . . 0.0 111.791 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.66 ' O ' ' O ' ' A' ' 136' ' ' TYR . 1.1 mp -126.42 135.24 51.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.689 ' O ' HG23 ' A' ' 148' ' ' VAL . 15.0 m -97.88 116.58 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.187 -1.571 . . . . 0.0 109.945 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.097 HD22 HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -109.5 123.34 49.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.7 m -158.61 61.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -134.37 124.92 17.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 46.4 Cg_endo -73.7 144.17 34.92 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.922 1.485 . . . . 0.0 110.472 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 1.006 HD13 ' HB2' ' A' ' 40' ' ' LEU . 1.3 tt -92.03 153.74 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.885 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 155' ' ' SER . 1.8 t 44.81 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER -107.84 173.25 6.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 152' ' ' PRO . 29.7 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.22 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.29 0.567 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 53.1 p -61.07 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.02 77.85 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.28 -62.69 1.4 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.469 ' O ' ' C ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER -131.71 164.89 24.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 110.163 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.622 HG11 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -38.89 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.474 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 81.2 mt-10 -79.07 173.57 12.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.561 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 64' ' ' LEU . 50.9 m -130.85 172.98 11.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.407 -0.808 . . . . 0.0 110.074 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.742 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -89.61 139.55 30.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.023 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -91.77 106.92 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.067 -1.021 . . . . 0.0 109.829 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.042 HG12 ' CD2' ' A' ' 137' ' ' TYR . 1.3 m 50.03 -171.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.771 ' N ' HG23 ' B' ' 168' ' ' VAL . 0.3 OUTLIER 66.37 121.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' B' ' 169' ' ' HIS . 2.6 m 63.61 86.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.576 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.791 ' O ' HG12 ' A' ' 5' ' ' VAL . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.224 0.535 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.0 p90 -60.49 -37.17 80.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.18 -41.46 77.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.341 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' SG ' ' A' ' 68' ' ' CYS . 1.1 mt -67.44 -47.21 70.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.123 HG23 ' CE2' ' A' ' 51' ' ' PHE . 3.5 p -64.95 -48.36 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.757 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 2' ' ' TYR . 12.4 p -58.7 -43.99 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 109.984 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.598 ' N ' HG13 ' A' ' 6' ' ' VAL . 6.5 m-80 -59.06 -42.16 89.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.0 109.618 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.859 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -68.34 -44.17 75.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.806 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 49.1 t -57.53 -39.8 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.387 -0.821 . . . . 0.0 109.25 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 tpt180 -55.66 -49.0 74.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -34.26 49.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.806 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 tp -72.16 -44.15 63.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 110.097 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 15.7 pt20 -60.82 -33.91 73.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 25.7 tt0 -57.82 -18.98 25.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.426 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 59.1 m -55.99 -43.01 77.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.044 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.2 34.37 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 12' ' ' LEU . 15.5 p90 -153.0 18.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.253 . . . . 0.0 110.56 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 3.0 t80 -90.84 119.86 31.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.756 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 1.044 ' CG ' HD12 ' A' ' 40' ' ' LEU . 31.6 m95 -72.69 148.12 45.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.631 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.804 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -62.15 -12.67 21.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.901 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 74.1 75.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 110.915 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -46.42 -92.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 109.091 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.595 ' H ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -106.63 165.81 11.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 178.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.526 ' HA2' ' NH1' ' A' ' 42' ' ' ARG . . . -43.51 -81.16 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.624 ' HA3' HG11 ' B' ' 162' ' ' VAL . . . -79.26 -30.15 47.1 Favored Glycine 0 N--CA 1.491 2.349 0 O-C-N 121.41 -1.053 . . . . 0.0 110.705 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.592 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -58.22 -24.46 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.378 . . . . 0.0 110.955 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 42' ' ' ARG . . . -77.63 -46.61 21.55 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 110.146 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.758 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -70.42 -46.85 63.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 111.2 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.758 HD13 ' OD1' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -70.61 -29.98 66.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 112.069 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.952 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -52.96 -23.25 6.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.64 -1.288 . . . . 0.0 109.8 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 40' ' ' LEU . 45.0 mt -64.05 -41.33 97.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.992 -1.068 . . . . 0.0 109.219 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 55.9 p -69.1 -31.6 70.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 -20.13 47.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.787 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 17.8 mm-40 -126.15 -81.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.901 -1.124 . . . . 0.0 110.607 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 55.4 Cg_endo -77.71 68.43 7.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 122.902 0.949 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.39 135.5 33.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.625 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 87.04 7.9 76.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 35' ' ' PRO . 27.4 p -116.11 147.71 41.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -1.136 . . . . 0.0 110.608 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.957 ' CD1' HD11 ' A' ' 53' ' ' LEU . 7.2 p90 -122.3 147.3 46.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 0.0 110.374 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.044 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -147.21 160.24 42.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.481 -0.762 . . . . 0.0 109.548 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 1.4 tt -113.56 128.47 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 110.001 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.564 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 5.7 ppt_? -112.77 122.11 46.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 110.31 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.773 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 4.9 t70 -73.82 114.97 12.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -44.77 146.81 0.71 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.239 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -73.65 -52.9 11.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.54 135.89 8.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -67.24 -18.18 65.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -97.35 50.18 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.237 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 44' ' ' SER . 2.2 m80 -147.7 -160.86 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.755 ' CB ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -143.6 -150.82 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.162 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 1.123 ' CE2' HG23 ' A' ' 5' ' ' VAL . 25.6 p90 -115.56 142.79 46.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 110.104 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.638 HG22 ' CG ' ' A' ' 63' ' ' ASN . 2.4 m -126.28 143.5 51.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.089 HD22 ' CD1' ' A' ' 98' ' ' TYR . 7.2 tt -124.21 135.1 53.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.655 ' CB ' ' OD1' ' A' ' 28' ' ' ASN . 23.1 p -139.26 155.42 47.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 61' ' ' THR . 10.3 p -140.94 158.9 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 110.481 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.76 137.48 41.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 147' ' ' LEU . 25.8 p -137.73 -74.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 59' ' ' SER . 2.3 mt-30 -147.43 -78.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 58' ' ' GLN . 9.8 t -42.69 -53.17 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.32 47.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 55' ' ' VAL . 5.5 m -99.56 141.02 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.17 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.9 145.86 51.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.25 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.638 ' CG ' HG22 ' A' ' 52' ' ' THR . 13.6 t-20 -111.13 132.34 54.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.92 ' CD1' HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -110.97 152.13 27.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.621 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -140.91 148.05 39.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.258 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.727 HD11 ' CB ' ' A' ' 90' ' ' CYS . 10.0 tp -76.83 128.29 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 74' ' ' SER . 2.7 tp-100 -96.54 151.1 19.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.216 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.708 ' SG ' HD13 ' A' ' 4' ' ' LEU . 36.5 t -93.01 139.12 30.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -130.08 102.94 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 44.82 -111.19 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.73 28.11 15.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.552 ' OG ' ' CB ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -136.72 163.18 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 110.145 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.759 ' O ' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -124.54 144.96 49.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.505 ' OG ' HG11 ' A' ' 85' ' ' VAL . 47.4 t -155.54 167.12 31.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.571 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 ' CD1' ' A' ' 94' ' ' LEU . 6.1 tp -107.42 -45.04 4.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.769 ' HG3' HG22 ' B' ' 166' ' ' THR . 0.3 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.89 155.57 30.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.283 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -115.34 132.81 22.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.08 -3.07 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.935 1.492 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -56.43 -40.51 74.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.206 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.436 ' OG ' ' HG3' ' A' ' 83' ' ' GLN . 79.0 p -162.96 -160.4 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.03 27.95 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.436 ' HG3' ' OG ' ' A' ' 81' ' ' SER . 3.7 mt-30 -82.57 126.71 72.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.182 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.552 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 47.0 Cg_endo -73.35 -158.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.759 HG21 ' O ' ' A' ' 73' ' ' PHE . 31.3 m -109.52 148.81 38.85 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.202 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 45.7 Cg_endo -73.08 133.48 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.965 1.508 . . . . 0.0 110.493 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER 66.54 41.36 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.633 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 23.4 p90 34.54 50.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 0.0 110.835 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' SER . 91.5 m-20 -71.87 110.01 6.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.986 -1.071 . . . . 0.0 109.195 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.727 ' CB ' HD11 ' A' ' 66' ' ' ILE . 7.1 p -148.31 -117.53 0.06 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.533 -0.729 . . . . 0.0 110.477 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG11 ' HB1' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -49.91 -45.56 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.168 -0.958 . . . . 0.0 110.046 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 91' ' ' VAL . 7.4 mp -59.52 -47.1 86.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.045 . . . . 0.0 108.974 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -31.86 72.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -59.73 -35.03 73.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.697 -0.627 . . . . 0.0 110.261 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 91' ' ' VAL . 62.9 t -54.5 -38.01 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.574 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 51.7 m170 -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.284 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.649 ' NE2' HG23 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.15 -50.51 11.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.932 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.089 ' CD1' HD22 ' A' ' 53' ' ' LEU . 10.0 m-85 -63.79 -11.73 29.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 4.4 tpt 71.21 103.69 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.138 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 95' ' ' VAL . 46.4 Cg_endo -74.04 159.39 44.58 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.043 1.549 . . . . 0.0 110.374 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HB3' ' CB ' ' A' ' 152' ' ' PRO . 46.7 Cg_endo -73.16 151.38 49.26 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.16 1.61 . . . . 0.0 110.423 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.62 91.96 0.78 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.073 1.565 . . . . 0.0 110.472 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.42 -115.82 0.57 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -112.7 100.32 50.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.253 -1.145 . . . . 0.0 110.263 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 106' ' ' SER . 47.2 Cg_endo -73.0 -40.1 1.93 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.489 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 62.28 51.37 3.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -146.98 -52.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 0.2 OUTLIER 174.56 -44.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 110.11 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -43.09 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 108' ' ' SER . 46.7 Cg_endo -73.54 114.87 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.962 1.506 . . . . 0.0 110.353 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' THR . 47.2 Cg_endo -72.64 -92.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 73.2 p 40.79 -139.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.08 161.19 53.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 115' ' ' SER . 45.2 Cg_endo -72.82 173.81 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.977 1.514 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' PRO . 12.8 p -42.98 135.14 3.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.222 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.43 149.61 46.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 mt-10 -67.32 -140.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 61.64 117.19 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 44.3 Cg_endo -73.04 -88.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.946 1.498 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 3.3 tt0 69.15 -67.96 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' PRO . 0.6 OUTLIER -167.62 124.52 0.91 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.07 119.26 5.94 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.894 1.47 . . . . 0.0 110.474 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 46.5 Cg_endo -72.94 126.36 11.21 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.022 1.538 . . . . 0.0 110.473 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 59.72 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -106.33 95.75 5.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.203 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 125' ' ' GLN . . . 56.52 23.2 7.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 110.225 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.541 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 1.5 mt -132.24 50.03 5.28 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 127' ' ' LEU . 46.6 Cg_endo -73.0 55.98 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.06 1.558 . . . . 0.0 110.413 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.91 -174.82 45.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.3 162.95 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.262 -1.14 . . . . 0.0 110.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -43.71 110.4 0.95 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.31 53.71 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.532 . . . . 0.0 110.431 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.85 47.17 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.83 171.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.851 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.83 143.98 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.208 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.8 t80 -138.21 121.65 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.579 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.121 ' CD2' HG12 ' B' ' 168' ' ' VAL . 6.7 p90 -156.11 166.72 32.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.737 -1.227 . . . . 0.0 110.843 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.721 ' H ' HD23 ' A' ' 147' ' ' LEU . 2.5 mt -102.14 149.61 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.289 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.699 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.6 m-85 -99.4 133.37 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.637 0.732 . . . . 0.0 111.007 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -88.31 54.23 3.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.526 -0.734 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.63 31.41 1.73 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.87 -29.56 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 140' ' ' SER . 6.1 mp0 -116.06 121.91 43.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.12 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.66 105.39 8.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.096 HG22 HD21 ' A' ' 147' ' ' LEU . 1.3 mp -87.56 110.64 35.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.711 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 48.9 Cg_endo -75.72 128.12 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.026 1.54 . . . . 0.0 112.728 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.096 HD21 HG22 ' A' ' 145' ' ' ILE . 2.0 mm? -125.49 135.32 52.18 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 148' ' ' VAL . 5.6 m -98.68 116.38 41.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.006 -1.684 . . . . 0.0 111.218 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.961 HD12 ' CD2' ' A' ' 136' ' ' TYR . 1.6 mt -91.05 125.89 35.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.022 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 90.9 p -151.23 -24.39 0.21 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.774 -1.204 . . . . 0.0 111.985 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 38' ' ' THR . 47.5 mtp180 -85.85 124.5 70.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.627 -1.296 . . . . 0.0 110.328 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.522 ' CB ' ' HB3' ' A' ' 101' ' ' PRO . 49.5 Cg_endo -77.57 148.23 25.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.104 1.581 . . . . 0.0 110.397 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.941 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.54 158.13 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.357 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 153' ' ' LEU . 7.7 t -133.91 98.88 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -107.72 -30.81 8.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 155' ' ' SER . 4.7 m-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.218 0.532 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.448 ' H ' HG22 ' B' ' 158' ' ' THR . 6.3 t -81.99 -146.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.136 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' OG1' ' B' ' 158' ' ' THR . . . -56.89 127.84 33.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.48 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.464 ' OG1' ' N ' ' B' ' 162' ' ' VAL . 4.4 t -176.19 -143.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.624 HG11 ' HA3' ' A' ' 25' ' ' GLY . 13.1 m -117.7 159.48 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.246 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -152.85 175.75 12.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.76 -168.16 2.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.769 HG22 ' HG3' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -94.04 151.43 19.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.291 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.208 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.2 t -87.59 -160.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 1.121 HG12 ' CD2' ' A' ' 137' ' ' TYR . 21.4 m -42.36 153.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.424 ' O ' ' C ' ' B' ' 170' ' ' SER . 16.7 t-160 -150.67 82.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.424 ' C ' ' O ' ' B' ' 169' ' ' HIS . 4.8 p 42.42 -153.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.294 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.215 0.531 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.478 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.18 -35.74 79.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 43.4 tp60 -54.79 -33.85 61.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.168 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.098 HD22 ' CD1' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -57.0 -47.02 81.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.035 HG22 ' CD2' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -59.89 -44.41 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 73.7 t -58.73 -51.14 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 48.3 m-20 -59.83 -46.08 90.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -63.08 -43.51 98.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -0.801 . . . . 0.0 109.655 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 18' ' ' TYR . 25.6 t -57.29 -39.31 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.72 . . . . 0.0 109.311 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.7 tpt180 -55.42 -40.92 72.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.445 -0.784 . . . . 0.0 109.887 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -42.15 32.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 41' ' ' ILE . 1.2 tp -72.0 -38.87 69.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 8.6 pt20 -65.77 -33.97 77.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.84 -18.96 25.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -56.6 -43.49 80.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 110.081 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.97 30.9 2.02 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.662 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 15' ' ' SER . 1.6 p90 -159.93 33.79 0.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.43 . . . . 0.0 111.134 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.786 ' CE2' HG13 ' A' ' 9' ' ' VAL . 1.7 t80 -90.89 134.66 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.725 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.727 ' CB ' HD11 ' A' ' 40' ' ' LEU . 24.8 m95 -124.5 148.55 47.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.13 23.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.01 0.15 13.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.546 -0.721 . . . . 0.0 111.004 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -107.24 -158.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.9 -1.125 . . . . 0.0 109.721 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.54 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -101.56 170.76 7.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.093 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.75 -79.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.705 ' CA ' HG11 ' B' ' 162' ' ' VAL . . . -79.32 -30.92 43.75 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.4 tp10 -58.27 -37.78 75.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -1.225 . . . . 0.0 110.069 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.47 -50.69 71.76 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.031 -1.043 . . . . 0.0 108.825 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.547 HD21 HD23 ' A' ' 40' ' ' LEU . 5.2 m120 -69.79 -49.04 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 61' ' ' THR . 1.6 mp -59.77 -31.76 69.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 111.237 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.93 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.25 -22.49 11.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.998 -1.064 . . . . 0.0 109.555 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 38' ' ' THR . 80.4 mt -60.13 -35.3 74.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.087 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.672 ' HB2' ' CD ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -69.56 -32.48 71.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.112 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.2 -20.8 43.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.96 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.754 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.6 mt-10 -131.07 -84.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.515 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.754 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.1 Cg_endo -76.77 68.31 7.17 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 122.77 0.879 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.27 141.74 14.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -0.978 . . . . 0.0 110.717 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' ' CD ' ' A' ' 151' ' ' ARG . . . 72.32 25.66 73.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.855 ' O ' HD13 ' A' ' 31' ' ' LEU . 79.1 m -119.82 149.19 42.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.933 . . . . 0.0 110.692 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.845 ' CB ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.72 138.81 53.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.795 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -134.08 160.53 37.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.442 -0.786 . . . . 0.0 110.959 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.763 HG13 HD21 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -114.07 134.09 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 1.1 ttp-105 -129.32 146.35 51.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.327 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 8.2 t0 -99.08 138.0 36.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -45.27 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 1.2 t -52.43 -86.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' N ' ' OG ' ' A' ' 45' ' ' SER . 2.3 t0 -43.3 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -14.22 39.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.19 21.5 2.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 21.6 m170 -116.26 170.92 8.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.013 ' HA ' HG21 ' A' ' 5' ' ' VAL . 27.6 p90 -89.78 -177.77 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.197 -0.939 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 1.035 ' CD2' HG22 ' A' ' 5' ' ' VAL . 6.8 p90 -116.0 155.72 27.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.53 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.2 m -126.16 154.65 42.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.028 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -135.0 130.86 36.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 1.028 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.43 153.9 50.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.583 -0.698 . . . . 0.0 109.665 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.845 HG23 ' CB ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -127.59 171.18 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 110.447 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -119.38 135.42 54.74 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 0.0 110.1 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 4.4 t -127.51 61.34 1.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER 67.37 -57.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -145.84 47.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.208 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' HG22 ' A' ' 57' ' ' THR . . . -153.57 74.42 0.24 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.749 HG23 HD11 ' A' ' 29' ' ' LEU . 2.7 m -96.17 108.87 21.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.672 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.7 OUTLIER -128.97 155.29 45.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 1.049 ' O ' HD23 ' A' ' 64' ' ' LEU . 4.0 m-20 -140.07 149.22 42.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 63' ' ' ASN . 17.4 mt -134.87 147.17 49.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -108.38 153.62 23.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.313 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.087 ' CD1' HD12 ' A' ' 75' ' ' LEU . 20.0 mm -89.06 145.59 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.43 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 66' ' ' ILE . 51.5 mm-40 -122.09 132.96 54.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 72' ' ' SER . 28.1 p -88.61 125.24 34.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.11 112.27 11.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 53.5 65.82 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.36 18.02 9.22 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.8 OUTLIER -122.29 163.15 20.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -1.174 . . . . 0.0 109.882 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 1.098 ' CD1' HD22 ' A' ' 4' ' ' LEU . 5.3 m-85 -131.94 139.8 48.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 110.47 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 77' ' ' SER . 8.3 t -147.23 138.98 24.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.0 110.101 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.087 HD12 ' CD1' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -83.2 71.45 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER 56.53 21.01 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 110.261 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.455 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 57.8 m -84.71 170.87 12.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.197 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.39 149.39 38.21 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.196 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 54.61 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.055 1.555 . . . . 0.0 110.444 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 81' ' ' SER . 3.0 mtt180 -62.77 -47.94 81.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER 65.18 66.64 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.17 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' GLN . 9.7 t -92.41 -12.76 31.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.586 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -175.61 -60.84 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 46.2 Cg_endo -72.57 -170.16 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.887 1.467 . . . . 0.0 110.419 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.762 HG13 ' HD2' ' A' ' 86' ' ' PRO . 54.6 t -97.31 148.6 34.65 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.762 ' HD2' HG13 ' A' ' 85' ' ' VAL . 43.4 Cg_endo -70.04 132.97 23.97 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.939 1.494 . . . . 0.0 110.088 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 4.3 mtt180 75.25 -48.78 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.634 ' CG ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER 74.38 -174.84 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.431 -0.793 . . . . 0.0 110.536 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.687 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 1.5 t70 -101.96 113.94 27.61 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.449 -0.782 . . . . 0.0 109.78 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.687 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 27.8 m 89.6 123.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.709 0.766 . . . . 0.0 110.362 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 51' ' ' PHE . 2.8 p -48.45 -20.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.655 0.74 . . . . 0.0 109.385 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.766 ' O ' HG12 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -54.03 -35.07 61.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 110.932 -178.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.634 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 1.5 tptt -58.28 -35.65 72.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.54 -1.35 . . . . 0.0 109.06 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.887 ' O ' ' HD2' ' A' ' 97' ' ' HIS . 63.1 mt -62.86 -34.86 78.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -54.6 -37.07 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.448 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -53.76 -31.54 48.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.02 . . . . 0.0 109.121 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.916 ' NE2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -65.86 -35.94 82.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 0.0 109.411 179.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.841 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.9 m-85 -63.05 -10.54 14.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.612 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 78.69 78.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.703 -0.623 . . . . 0.0 110.211 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.469 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 45.5 Cg_endo -72.32 173.97 12.24 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.976 1.514 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 100' ' ' PRO . 46.1 Cg_endo -72.75 122.86 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.456 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.57 135.13 21.5 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.998 1.525 . . . . 0.0 110.364 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.5 141.61 3.84 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -45.14 118.85 3.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 106' ' ' SER . 46.3 Cg_endo -72.93 -55.02 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.91 1.479 . . . . 0.0 110.416 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER 172.96 -62.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 106' ' ' SER . 1.9 m-85 60.5 126.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 p -49.98 -28.49 6.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.153 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.69 126.81 30.3 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 140.76 31.57 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.972 1.512 . . . . 0.0 110.431 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.12 -89.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.063 1.56 . . . . 0.0 110.383 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -74.7 0.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 116.43 51.08 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 110.195 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -1.78 11.02 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.43 103.73 4.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.72 46.88 1.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 110.233 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 118' ' ' VAL . 4.5 pt-20 -78.76 -139.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.562 HG23 ' HG3' ' A' ' 117' ' ' GLU . 39.3 t 55.66 97.55 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.16 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 73.8 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.038 1.546 . . . . 0.0 110.469 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' GLN . 4.5 tp10 -152.03 132.99 14.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER 55.65 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.252 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 123.57 8.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.951 1.5 . . . . 0.0 110.45 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.725 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 45.4 Cg_endo -73.01 -87.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.99 1.521 . . . . 0.0 110.461 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 68.82 126.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.177 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' ALA . 81.1 mt-30 -43.09 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.21 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . -162.43 54.25 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.938 . . . . 0.0 110.178 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.9 83.52 3.67 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.21 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 126' ' ' ALA . 46.4 Cg_endo -73.0 57.37 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 110.404 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.46 104.12 0.85 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -44.64 127.25 6.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -1.144 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.66 -55.29 12.8 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.266 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 131' ' ' THR . 45.3 Cg_endo -73.01 -30.43 10.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.917 1.483 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 132' ' ' PRO . 27.2 tttt 61.16 133.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.774 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 29.3 mmt-85 -79.02 -165.57 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 163.27 75.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.913 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.867 ' HB2' HG11 ' B' ' 167' ' ' VAL . 0.2 OUTLIER -102.7 124.72 48.76 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 109.321 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.972 ' N ' HG13 ' B' ' 167' ' ' VAL . 5.6 p90 -155.6 167.06 31.62 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.085 -1.009 . . . . 0.0 110.983 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.672 HD13 ' CB ' ' A' ' 62' ' ' LYS . 2.2 mp -102.75 149.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 111.11 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.694 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 17.5 m-85 -97.31 133.3 42.1 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.697 0.76 . . . . 0.0 111.096 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 3.2 t -86.48 51.92 2.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.17 27.53 1.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.42 -32.78 0.24 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 14.2 tp10 -120.19 121.98 39.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.234 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 3.9 ptmt -72.03 105.46 3.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.397 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.833 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -85.11 110.54 29.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.0 Cg_endo -75.38 129.65 12.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.124 1.591 . . . . 0.0 111.828 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 138' ' ' ILE . 1.0 OUTLIER -124.02 134.2 53.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.392 -0.818 . . . . 0.0 109.396 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 148' ' ' VAL . 13.5 m -107.61 117.53 53.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.96 -1.087 . . . . 0.0 110.604 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 55' ' ' VAL . 6.6 tt -125.08 114.82 19.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.78 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.8 t -168.1 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.038 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.589 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -111.9 124.83 31.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 109.996 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.38 138.26 29.7 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.93 1.49 . . . . 0.0 110.693 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 154' ' ' SER . 4.8 tp -91.77 145.66 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.868 ' H ' HD12 ' A' ' 153' ' ' LEU . 1.2 p -83.07 92.05 7.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 154' ' ' SER . 2.1 m -42.79 -36.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 0.0 110.211 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.189 -179.967 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.175 0.512 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 158' ' ' THR . . . . . 0.579 HG22 ' N ' ' B' ' 159' ' ' ALA . 22.4 m -88.05 170.74 10.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.579 ' N ' HG22 ' B' ' 158' ' ' THR . . . -179.19 120.3 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' B' ' 161' ' ' THR . 30.9 m -94.86 156.75 16.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.244 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 161' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' B' ' 160' ' ' SER . 1.1 t 176.94 137.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.222 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.705 HG11 ' CA ' ' A' ' 25' ' ' GLY . 2.6 m -117.72 104.62 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 163' ' ' GLU . . . . . 0.523 ' CG ' ' H ' ' B' ' 164' ' ' PTR . 28.8 tt0 -43.7 155.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.629 ' CE2' HG23 ' B' ' 162' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.636 ' CB ' HG23 ' A' ' 138' ' ' ILE . 57.9 m -128.56 12.56 6.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.775 ' H ' HD22 ' A' ' 64' ' ' LEU . 1.3 m 58.52 152.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 64' ' ' LEU . 2.9 t -108.9 151.08 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.008 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.956 HG12 ' H ' ' A' ' 137' ' ' TYR . 6.5 p -51.92 -16.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.955 . . . . 0.0 110.931 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' HIS . . . . . 0.978 ' H ' HG12 ' B' ' 167' ' ' VAL . 1.1 m80 58.14 119.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 0.0 110.318 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 134' ' ' ARG . 1.5 p -84.88 -49.24 8.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.543 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.53 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.235 0.54 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 49' ' ' HIS . 3.6 t80 -63.29 -52.06 63.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.542 ' O ' HG12 ' A' ' 6' ' ' VAL . 5.5 tm0? -68.57 -35.77 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.655 HD21 ' O ' ' A' ' 87' ' ' ARG . 2.3 mt -67.13 -42.0 85.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.067 HG13 ' CD2' ' A' ' 51' ' ' PHE . 56.0 t -72.06 -46.29 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.581 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.609 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 14.2 p -58.33 -32.7 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.309 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 t-20 -68.1 -37.88 81.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 110.309 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.799 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . . . -76.25 -45.05 34.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 110.593 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 33.6 m -57.91 -39.65 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' VAL . 2.9 ttt180 -55.75 -46.77 77.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.538 -0.726 . . . . 0.0 109.92 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.06 -35.87 49.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.883 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' CD2' HG21 ' A' ' 41' ' ' ILE . 52.0 tp -71.99 -44.32 63.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 110.058 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 10.9 pt20 -68.48 -34.16 75.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.4 mt-10 -57.91 -45.0 87.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -55.91 -26.87 49.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.88 40.4 3.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 152' ' ' PRO . 1.1 m-85 -141.98 44.46 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.17 . . . . 0.0 110.609 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.589 ' HE2' HG12 ' A' ' 9' ' ' VAL . 2.8 t80 -126.59 130.36 50.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.945 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.3 m95 -102.86 147.66 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 m -44.64 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 167.78 79.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.659 HG21 ' CD2' ' A' ' 30' ' ' LEU . 2.6 t -56.03 -118.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.29 -0.881 . . . . 0.0 109.647 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.11 168.93 10.79 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.786 -1.196 . . . . 0.0 109.347 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.561 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.32 -85.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.885 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -79.37 -30.12 46.78 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.384 -1.068 . . . . 0.0 110.465 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -57.59 -42.9 84.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.242 . . . . 0.0 110.049 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -58.91 -49.28 78.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 109.046 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 52' ' ' THR . 34.8 m-80 -68.75 -44.17 74.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.425 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -70.68 -31.71 68.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 112.091 -178.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.0 pp -54.71 -24.07 20.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.712 -1.243 . . . . 0.0 110.692 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.924 HD23 HD22 ' A' ' 40' ' ' LEU . 4.0 pp -78.5 -35.64 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.004 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.665 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.87 -32.84 71.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.74 41.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.629 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 24.6 mm-40 -113.64 -76.71 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.004 -1.06 . . . . 0.0 110.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.3 Cg_endo -72.03 65.36 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.287 1.151 . . . . 0.0 110.261 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 141.25 13.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 74.85 20.17 79.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.869 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.78 146.62 49.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -1.1 . . . . 0.0 110.224 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 5.3 p90 -123.39 155.92 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 110.311 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.945 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -149.48 159.01 44.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.962 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.74 HD12 ' CD2' ' A' ' 53' ' ' LEU . 5.5 tt -115.06 128.56 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.069 -1.019 . . . . 0.0 110.324 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.89 149.72 32.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.778 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' CG ' ' HA ' ' A' ' 48' ' ' ARG . 5.2 t0 -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 50' ' ' PHE . 28.2 m -53.77 -49.77 67.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -174.04 -153.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.142 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 51.4 -140.57 0.86 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 0.8 OUTLIER -91.0 -38.11 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 110.226 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' NH1' ' HG2' ' A' ' 47' ' ' GLN . 8.0 ptp85 -177.02 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.555 ' C ' HG11 ' A' ' 5' ' ' VAL . 2.3 m-70 -92.48 151.9 19.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.048 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 48.12 107.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.395 -0.816 . . . . 0.0 110.898 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 1.067 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.7 p90 -120.47 140.31 51.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 28' ' ' ASN . 8.2 t -126.85 155.25 43.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.383 -0.823 . . . . 0.0 109.916 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.145 HD11 ' CD1' ' A' ' 98' ' ' TYR . 2.0 pp -143.99 127.24 16.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.025 -1.047 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.743 ' O ' HD21 ' A' ' 31' ' ' LEU . 6.6 t -112.83 154.1 26.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.454 -0.779 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.977 HG11 ' HG ' ' A' ' 149' ' ' LEU . 14.9 p -127.86 173.78 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.13 -0.981 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' N ' HG22 ' A' ' 55' ' ' VAL . 4.6 tptt -117.55 139.05 51.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 0.0 110.018 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.778 HG21 ' CB ' ' A' ' 147' ' ' LEU . 4.9 p -135.7 -94.08 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.294 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.3 mm-40 -80.02 -29.17 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER 162.8 -18.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.735 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.56 100.81 2.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 56' ' ' LYS . 2.2 t -100.43 121.46 41.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -1.13 . . . . 0.0 109.925 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -139.71 171.81 13.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.076 -1.015 . . . . 0.0 110.518 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 1.4 p-10 -123.6 152.68 41.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 167' ' ' VAL . 1.0 OUTLIER -110.44 117.79 34.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.936 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HB3' ' CE1' ' B' ' 164' ' ' PTR . 9.2 ptm180 -83.13 151.76 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.903 HG21 ' CD2' ' A' ' 73' ' ' PHE . 6.9 mm -84.84 144.2 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.5 OUTLIER -96.08 121.37 37.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 26.8 p -88.07 118.16 27.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -133.04 121.15 22.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.221 -0.924 . . . . 0.0 110.244 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.51 95.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 4' ' ' LEU . . . 61.82 13.06 38.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 69' ' ' GLU . 13.7 p -108.8 163.21 13.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.296 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.903 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.78 128.38 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -155.17 138.98 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.997 ' CD2' HD11 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -91.9 -51.19 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.639 ' HG3' HD23 ' A' ' 75' ' ' LEU . 65.4 mt-30 -135.49 128.41 31.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 t -57.18 82.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 76' ' ' GLN . 59.2 t0 -120.04 114.0 33.92 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.875 . . . . 0.0 110.215 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.09 61.51 3.98 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.562 ' NH1' ' HB3' ' A' ' 93' ' ' LYS . 4.8 ptp180 -65.07 -9.04 19.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.191 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 82' ' ' THR . 0.3 OUTLIER 71.71 96.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.286 -0.884 . . . . 0.0 110.423 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -167.76 -52.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.881 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' THR . 10.3 mt-30 41.12 84.85 0.18 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 47.6 Cg_endo -73.52 -92.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 110.298 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.927 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -120.99 170.06 7.92 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 85' ' ' VAL . 42.0 Cg_endo -69.0 132.78 25.3 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.633 1.333 . . . . 0.0 109.698 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.655 ' O ' HD21 ' A' ' 4' ' ' LEU . 0.8 OUTLIER 54.75 39.68 31.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.545 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.624 ' CD2' ' N ' ' A' ' 89' ' ' ASP . 1.2 p90 -74.68 -175.18 2.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.436 -0.79 . . . . 0.0 110.236 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.799 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 3.1 t0 -107.71 110.84 22.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.631 ' SG ' HD23 ' A' ' 94' ' ' LEU . 11.8 t -71.7 -20.5 61.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 110.488 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 5.4 t -49.88 -36.25 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.046 -1.033 . . . . 0.0 109.795 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.9 mp -58.06 -47.03 84.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 109.308 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.562 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 5.0 mtpp -67.86 -31.46 71.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 108.891 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -59.39 -33.71 71.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.49 -37.21 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.733 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.446 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 5.0 m-70 -53.65 -50.44 65.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.62 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 135' ' ' ALA . 7.3 t60 -78.28 -36.95 46.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.518 -0.739 . . . . 0.0 109.09 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CD1' HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.11 -12.0 46.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.887 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 149' ' ' LEU . 1.9 ttt 178.7 68.53 0.12 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.456 -0.778 . . . . 0.0 110.079 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.543 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 45.9 Cg_endo -72.66 111.92 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.903 1.475 . . . . 0.0 110.467 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.673 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.6 Cg_endo -72.22 -29.77 13.9 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.038 1.546 . . . . 0.0 112.212 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 48.5 Cg_endo -74.58 95.26 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 122.879 0.936 . . . . 0.0 110.337 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 104' ' ' THR . . . -43.79 -28.77 1.21 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -178.24 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.251 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 45.5 Cg_endo -72.54 -167.86 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.935 1.492 . . . . 0.0 110.4 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.59 ' C ' ' CG ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER 66.19 -63.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.167 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.59 ' CG ' ' C ' ' A' ' 106' ' ' SER . 17.4 p90 34.17 57.96 0.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.493 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' PHE . 1.2 m 65.09 141.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.19 123.94 89.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.174 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.12 138.75 28.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.884 1.466 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.07 -41.62 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.009 1.531 . . . . 0.0 110.466 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.467 ' OG1' ' N ' ' A' ' 113' ' ' GLU . 4.4 t -175.44 -147.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.467 ' N ' ' OG1' ' A' ' 112' ' ' THR . 0.2 OUTLIER -118.88 110.27 38.56 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' O ' ' OG ' ' A' ' 115' ' ' SER . 46.0 Cg_endo -72.84 56.25 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.031 1.543 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 114' ' ' PRO . 54.1 p 42.77 89.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -121.58 104.33 9.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.14 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 116' ' ' SER . 1.7 mm-40 55.72 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.185 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 116' ' ' SER . 33.5 m -138.77 160.65 62.28 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.04 56.71 3.12 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.049 1.552 . . . . 0.0 110.46 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 118' ' ' VAL . 2.3 mm-40 -110.99 -163.25 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.501 ' N ' ' CD ' ' A' ' 122' ' ' PRO . 0.9 OUTLIER -138.25 52.32 4.68 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 121' ' ' GLN . 46.4 Cg_endo -73.09 113.59 3.81 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.1 1.579 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' ALA . 46.3 Cg_endo -73.12 -54.99 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.018 1.536 . . . . 0.0 110.389 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 123' ' ' PRO . . . 42.79 63.92 1.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 110.253 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 175.43 52.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.166 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.812 ' O ' HD12 ' A' ' 127' ' ' LEU . . . -136.33 14.85 3.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER 176.22 -57.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 46.0 Cg_endo -72.95 -37.46 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.117 1.588 . . . . 0.0 110.398 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.76 -150.41 1.7 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 p -94.74 111.45 23.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.556 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -59.86 -55.09 49.14 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 131' ' ' THR . 46.4 Cg_endo -73.13 -177.05 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.861 1.453 . . . . 0.0 110.419 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 134' ' ' ARG . 23.4 tttp -153.81 -132.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -47.63 176.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 166.2 147.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.416 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 1.048 ' CD2' HD11 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -100.58 162.41 12.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.851 ' C ' HD21 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -152.27 151.6 31.13 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 116.74 -1.984 . . . . 0.0 115.118 -176.215 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.852 ' N ' HD21 ' A' ' 147' ' ' LEU . 13.4 mt -142.17 120.57 8.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 7.7 m-85 -84.09 107.96 16.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 143' ' ' GLU . 1.6 t -72.94 66.98 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.341 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.12 89.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.94 2.15 57.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.658 ' HB3' HD11 ' A' ' 145' ' ' ILE . 1.5 mt-10 -120.04 121.86 39.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -1.147 . . . . 0.0 110.31 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.727 ' C ' HD12 ' A' ' 145' ' ' ILE . 1.1 ttpp -98.23 105.72 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.808 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.8 mp -112.7 119.02 44.06 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.778 . . . . 0.0 109.098 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 137' ' ' TYR . 48.1 Cg_endo -75.13 127.2 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.731 1.385 . . . . 0.0 111.021 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.852 HD21 ' N ' ' A' ' 138' ' ' ILE . 0.4 OUTLIER -125.59 134.33 51.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.221 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 p -120.72 118.85 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.752 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.048 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mp -76.36 150.62 36.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.218 -0.926 . . . . 0.0 109.886 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -36.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.462 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 6.9 mtp85 -104.78 124.32 37.21 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 51.2 Cg_endo -78.21 147.29 23.21 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.024 1.539 . . . . 0.0 110.198 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 40' ' ' LEU . 4.3 tp -92.18 115.84 28.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.132 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' PHE . 81.0 p -100.01 151.96 20.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 0.9 OUTLIER -95.96 -46.54 6.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.222 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.263 0.554 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 53.0 m -120.07 -26.03 5.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 0.0 110.176 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.4 155.07 17.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.55 -56.62 4.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 110.179 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.53 160.12 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.184 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.731 HG23 ' CA ' ' A' ' 25' ' ' GLY . 12.3 p -59.97 123.61 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.2 129.12 42.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 164' ' ' PTR . . . . . 0.59 ' N ' ' CD2' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.5 t -109.21 158.79 17.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.13 -0.982 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 45.1 p -65.94 -162.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' VAL . . . . . 0.781 HG13 ' N ' ' A' ' 137' ' ' TYR . 55.4 t -143.06 167.61 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.703 HG22 HG12 ' B' ' 167' ' ' VAL . 18.7 m -38.98 135.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.454 -0.779 . . . . 0.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -121.02 -29.93 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 31.1 t -124.03 22.88 8.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.644 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.9 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.204 0.526 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -54.96 -45.24 74.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 109.956 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.628 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -54.94 -39.82 69.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.847 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.0 OUTLIER -63.75 -47.2 82.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.836 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.16 HG22 ' CE2' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -65.84 -48.35 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 110.012 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.631 ' N ' HG12 ' A' ' 5' ' ' VAL . 39.5 t -59.54 -47.17 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.2 m120 -58.74 -28.07 65.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -74.13 -44.13 54.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG12 HE21 ' A' ' 13' ' ' GLN . 50.4 t -57.38 -39.72 70.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.357 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -55.87 -49.35 73.58 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.73 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.53 -36.1 45.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 41' ' ' ILE . 46.2 tp -69.48 -42.01 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.537 HE21 HG12 ' A' ' 9' ' ' VAL . 5.9 pt20 -67.99 -34.2 76.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.8 tt0 -57.91 -23.7 54.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 110.269 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 1.2 t -70.57 -27.0 63.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.23 -14.12 63.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -76.92 -10.67 59.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -1.108 . . . . 0.0 110.004 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -93.41 121.08 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.061 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 1.017 ' CD1' HD12 ' A' ' 40' ' ' LEU . 9.0 m95 -110.3 101.86 10.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 110.005 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.23 109.04 20.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 164.98 -4.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.426 -0.796 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.85 -159.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 0.0 109.982 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -99.19 176.2 5.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 110.228 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.597 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.76 -78.25 0.1 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' OD1' ' A' ' 63' ' ' ASN . . . -79.26 -34.49 32.64 Favored Glycine 0 N--CA 1.492 2.398 0 O-C-N 121.193 -1.18 . . . . 0.0 110.424 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 2.7 mt-10 -59.51 -30.17 68.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.272 . . . . 0.0 110.098 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' O ' HD23 ' A' ' 30' ' ' LEU . . . -69.62 -47.3 63.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.665 ' O ' HD23 ' A' ' 31' ' ' LEU . 38.6 m-80 -68.01 -42.38 80.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.172 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' A' ' 61' ' ' THR . 3.4 mp -59.18 -32.01 69.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.799 . . . . 0.0 111.043 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -55.42 -23.81 27.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.973 -1.08 . . . . 0.0 109.943 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 38' ' ' THR . 4.0 pp -61.85 -37.01 82.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.096 -1.002 . . . . 0.0 109.042 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.875 ' N ' HD12 ' A' ' 31' ' ' LEU . 96.6 p -69.6 -32.27 70.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -20.6 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.3 mm-40 -122.12 -79.8 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.5 Cg_endo -75.89 69.77 6.1 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.064 1.034 . . . . 0.0 110.184 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.96 141.33 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.21 78.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 1.061 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.4 m -131.0 147.9 52.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -1.04 . . . . 0.0 110.173 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.92 ' HA ' HD22 ' A' ' 31' ' ' LEU . 3.0 m-85 -122.64 141.49 51.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 110.072 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -135.49 159.51 41.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.512 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.558 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 9.7 tt -115.05 138.56 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 2.6 tmt_? -112.86 160.71 17.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.0 110.261 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' CZ ' ' A' ' 42' ' ' ARG . 11.6 t0 -85.43 106.47 16.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.346 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.535 ' O ' HG11 ' A' ' 5' ' ' VAL . 54.4 m170 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -163.58 147.73 10.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 1.16 ' CE2' HG22 ' A' ' 5' ' ' VAL . 12.4 p90 -132.11 146.72 52.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.95 . . . . 0.0 110.533 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -126.08 140.87 52.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.507 -0.746 . . . . 0.0 109.521 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.153 HD22 ' CD1' ' A' ' 98' ' ' TYR . 8.3 tt -120.93 145.32 47.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 111.039 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.63 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -139.17 153.82 47.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.715 . . . . 0.0 109.453 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.055 HG11 HD22 ' A' ' 149' ' ' LEU . 33.5 m -121.35 174.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.662 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.918 ' HB2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -112.43 139.22 48.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.565 ' OG1' ' CD2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -153.17 175.87 12.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.94 4.72 15.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.035 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -13.48 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 110.176 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 57' ' ' THR . . . 130.7 150.3 6.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -79.96 132.04 35.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -1.123 . . . . 0.0 110.227 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.868 ' HE3' HG23 ' A' ' 138' ' ' ILE . 10.6 ttmt -122.41 146.54 47.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.495 ' OD1' ' ND2' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -115.8 145.73 42.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.123 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.973 HD21 ' HA ' ' B' ' 166' ' ' THR . 0.4 OUTLIER -138.23 152.74 48.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.506 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 52' ' ' THR . 30.9 ptt85 -126.48 159.79 32.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 110.398 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.847 ' HB ' HD22 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -86.55 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -113.19 129.22 56.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.068 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 28.1 p -88.03 119.67 28.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.455 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.3 tm-20 -108.7 103.24 12.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.2 -0.937 . . . . 0.0 110.1 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.95 -84.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -138.23 21.95 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 58.6 p -123.08 156.79 34.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HZ ' HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -110.96 131.55 54.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 0.0 110.178 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.85 146.86 22.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.057 -1.027 . . . . 0.0 110.514 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.883 HD12 ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.611 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.743 HG22 HD23 ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.727 ' O ' HG12 ' A' ' 95' ' ' VAL . 6.1 mp -53.81 -46.2 71.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.527 -1.358 . . . . 0.0 110.342 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -37.36 83.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 108.498 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.883 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.0 tp -68.31 -34.81 76.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.913 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -54.43 -36.95 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.905 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 99' ' ' MET . 20.2 t-160 -53.16 -33.65 53.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 0.0 109.042 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.537 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -78.18 -37.07 46.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.153 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.3 m-85 -78.7 -21.22 48.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.915 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.511 ' CE ' ' HB3' ' A' ' 152' ' ' PRO . 1.3 mtp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 109.992 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.223 0.535 . . . . 0.0 110.296 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 169.98 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -121.85 123.52 41.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.978 -1.076 . . . . 0.0 109.539 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.916 ' H ' HG22 ' B' ' 167' ' ' VAL . 8.3 p90 -154.99 167.74 29.32 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.894 -1.129 . . . . 0.0 111.392 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.868 HG23 ' HE3' ' A' ' 62' ' ' LYS . 3.3 mt -102.69 143.24 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.656 0.741 . . . . 0.0 111.05 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.716 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 12.5 m-85 -92.89 132.63 36.86 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.637 0.732 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -84.01 52.59 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.641 -0.662 . . . . 0.0 110.22 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.53 27.06 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 162.95 -30.87 0.28 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mt-10 -116.47 121.8 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.02 105.51 11.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.341 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -93.01 105.23 14.24 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.817 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.8 Cg_endo -73.55 129.64 13.94 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.052 1.554 . . . . 0.0 112.358 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.804 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 mp -125.64 135.28 51.99 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -98.27 116.98 42.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.365 -1.46 . . . . 0.0 109.954 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.055 HD22 HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -121.86 135.52 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.066 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.0 t -167.6 54.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.697 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.87 123.88 22.19 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.077 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 50.7 Cg_endo -78.75 148.32 22.51 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.143 1.602 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.977 HD13 ' HB2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -85.83 133.78 33.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.823 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.828 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.465 ' O ' HG23 ' B' ' 166' ' ' THR . 43.3 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.105 0.478 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.973 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.4 p -152.58 -179.54 7.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.921 HG12 HG22 ' B' ' 168' ' ' VAL . 1.0 OUTLIER -127.85 143.48 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.921 HG22 HG12 ' B' ' 167' ' ' VAL . 4.4 m . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.4 0.619 . . . . 0.0 111.126 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.596 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.254 0.55 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.9 p90 -55.79 -39.02 70.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.578 ' O ' HG12 ' A' ' 6' ' ' VAL . 40.0 tp60 -61.16 -42.27 98.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.123 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.1 mt -67.27 -47.23 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.987 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.4 m -72.56 -44.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.667 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 3' ' ' GLN . 5.2 p -58.35 -32.55 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -67.98 -40.92 83.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.096 -1.003 . . . . 0.0 109.78 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . . . -76.36 -44.99 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 5' ' ' VAL . 4.3 m -57.93 -39.7 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.9 ttt180 -55.44 -45.9 76.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 109.69 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -32.94 50.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.687 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 5.9 tp -68.23 -43.98 76.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.455 -0.778 . . . . 0.0 110.286 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 3.4 pt20 -64.65 -33.83 76.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.187 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 2.9 mt-10 -57.84 -31.03 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -67.29 -41.3 85.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.034 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.75 36.62 3.19 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.903 ' HB2' HD21 ' A' ' 153' ' ' LEU . 5.6 p90 -145.39 28.17 1.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -1.166 . . . . 0.0 110.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 20' ' ' SER . 3.0 t80 -90.76 136.29 33.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.831 ' HE1' HD23 ' A' ' 153' ' ' LEU . 69.4 m95 -117.51 149.23 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 89.7 p 178.98 -15.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -13.26 4.36 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.714 -0.616 . . . . 0.0 110.533 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.39 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.599 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.588 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -89.16 175.82 7.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.791 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' CD ' ' A' ' 42' ' ' ARG . . . -46.03 -83.77 0.02 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.34 -30.51 45.32 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 121.398 -1.06 . . . . 0.0 110.681 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.588 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.4 mm-40 -58.27 -26.69 63.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.338 . . . . 0.0 110.422 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.87 -49.97 47.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.016 -1.053 . . . . 0.0 109.117 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.927 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -69.99 -46.39 65.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.0 110.747 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.883 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -59.08 -31.34 68.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.445 -0.784 . . . . 0.0 111.602 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 pp -54.63 -23.62 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.789 -1.194 . . . . 0.0 109.442 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.996 HD13 ' O ' ' A' ' 38' ' ' THR . 3.6 pp -68.95 -34.11 74.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.155 -0.966 . . . . 0.0 108.567 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.684 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t -69.97 -32.81 71.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.67 -0.643 . . . . 0.0 110.234 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.66 -20.72 42.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.85 . . . . 0.0 110.488 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.74 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -122.9 -80.59 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.972 -1.08 . . . . 0.0 110.922 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.74 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 53.1 Cg_endo -75.24 68.46 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.015 1.008 . . . . 0.0 110.703 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.92 141.43 10.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.023 . . . . 0.0 110.399 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 78.93 20.58 70.16 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 53.7 m -117.55 148.3 42.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.984 . . . . 0.0 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 8.3 p90 -121.86 138.94 54.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.005 -1.06 . . . . 0.0 109.787 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -138.95 156.71 47.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.388 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.569 HD11 ' CD1' ' A' ' 51' ' ' PHE . 4.3 tt -115.37 133.75 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.376 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -112.89 141.43 46.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.856 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 49.3 t0 -82.08 132.77 35.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.106 -0.996 . . . . 0.0 110.247 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . 59.4 p . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.363 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.563 ' O ' HG11 ' A' ' 5' ' ' VAL . 80.9 m-70 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.301 0.572 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' HA ' ' CB ' ' A' ' 5' ' ' VAL . 16.3 p90 -177.45 175.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 38.0 p90 -125.73 141.64 51.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.039 -1.038 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.604 ' CG2' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -125.33 144.34 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.104 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -121.99 133.6 54.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.104 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -139.1 154.28 48.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 110.087 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 149' ' ' LEU . 10.7 p -132.98 174.9 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.667 ' HG3' HG22 ' A' ' 61' ' ' THR . 2.0 ttpp -103.36 135.2 45.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -97.7 -154.02 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -24.46 66.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 m -177.02 29.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.65 109.8 0.56 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.667 HG22 ' HG3' ' A' ' 56' ' ' LYS . 32.2 p -98.2 108.94 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.155 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.523 ' HD3' HG21 ' A' ' 138' ' ' ILE . 2.4 mptp? -116.93 159.28 22.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.994 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.81 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 38.6 m-20 -112.01 134.22 53.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.2 mm? -109.4 117.99 35.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -117.0 148.38 41.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.258 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.931 HG21 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -76.74 130.57 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.0 OUTLIER -94.74 151.18 19.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.43 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 72' ' ' SER . 27.6 p -97.89 139.08 34.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' SER . 70.5 mt-10 -131.56 113.04 13.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.342 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 46.65 24.27 1.72 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.29 -2.19 40.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -95.01 153.63 17.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.931 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -113.39 126.78 55.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.8 OUTLIER -155.53 147.59 23.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.521 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.872 HD13 HD12 ' A' ' 94' ' ' LEU . 14.7 tp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.948 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 4.6 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.836 ' O ' HG22 ' A' ' 95' ' ' VAL . 10.9 mp -59.24 -46.08 89.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 108.681 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.57 ' HA ' ' CD2' ' A' ' 96' ' ' HIS . 7.8 tptt -67.23 -30.7 70.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -58.57 -34.56 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.612 -0.68 . . . . 0.0 109.879 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.026 ' N ' HD23 ' A' ' 94' ' ' LEU . 3.0 m -54.83 -37.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CD2' ' HA ' ' A' ' 93' ' ' LYS . 18.8 m-70 -55.38 -47.26 76.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.063 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -61.21 -36.74 80.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.476 -0.765 . . . . 0.0 109.258 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.955 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.6 m-30 -65.12 -9.38 22.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 109.975 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 99' ' ' MET . 2.7 ptt? . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.3 mtm180 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.297 0.57 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.075 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 172.93 112.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.116 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 0.5 OUTLIER -104.66 122.76 46.33 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.152 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.2 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -156.94 156.39 32.95 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.322 -0.861 . . . . 0.0 110.091 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.132 ' N ' HD23 ' A' ' 147' ' ' LEU . 2.0 mt -103.37 149.4 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.339 -0.851 . . . . 0.0 109.796 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.589 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 81.4 m-85 -85.37 132.05 34.3 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.264 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.714 ' HB3' HD13 ' A' ' 145' ' ' ILE . 2.7 t -95.25 59.06 2.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.245 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.33 54.07 40.31 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.15 1.0 58.33 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 6.4 mm-40 -120.01 123.49 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 145' ' ' ILE . 12.9 mtmt -70.86 119.13 14.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -118.31 115.27 36.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.035 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.905 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 42.7 Cg_endo -69.33 125.23 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.808 1.425 . . . . 0.0 111.349 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.132 HD23 ' N ' ' A' ' 138' ' ' ILE . 1.9 pp -127.03 101.93 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.6 p -102.45 118.58 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.814 -1.179 . . . . 0.0 111.034 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 98' ' ' TYR . 0.9 OUTLIER -76.66 114.88 15.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 -30.25 6.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 110.935 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.87 124.47 70.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.987 -1.07 . . . . 0.0 110.203 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.584 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 50.0 Cg_endo -78.0 141.09 18.56 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.03 1.542 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.931 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.55 158.13 15.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.508 ' N ' HD22 ' A' ' 153' ' ' LEU . 45.0 m . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 5.3 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.192 0.52 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.459 ' O ' ' O ' ' B' ' 165' ' ' SER . 0.2 OUTLIER 53.5 169.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.116 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.8 t -126.82 102.64 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.2 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.3 t . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.091 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.699 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.0 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.258 0.551 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.489 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.5 p90 -54.85 -36.6 65.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.659 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.8 tt0 -54.89 -32.69 61.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.962 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 1' ' ' GLU . 6.4 mt -59.56 -47.43 85.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.4 t -64.55 -44.77 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.865 . . . . 0.0 110.775 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -58.03 -33.5 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.299 -0.876 . . . . 0.0 110.575 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -71.44 -40.35 70.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.1 -44.46 38.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.249 -0.907 . . . . 0.0 110.75 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 5' ' ' VAL . 7.4 m -57.2 -38.37 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -54.23 -49.12 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.862 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -78.44 -40.19 36.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -0.999 . . . . 0.0 109.925 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -72.27 -31.22 65.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.399 -0.813 . . . . 0.0 111.032 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.74 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 22.3 mt-30 -59.44 -41.45 89.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 0.0 111.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.48 -52.56 8.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.889 -1.132 . . . . 0.0 110.598 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 t -73.68 -42.4 61.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 111.746 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' C ' ' A' ' 17' ' ' PHE . . . -90.23 67.57 2.57 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.36 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.702 ' C ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 2.21 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.742 -0.858 . . . . 0.0 110.8 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.74 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 3.8 t80 -90.87 136.23 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.756 ' CG ' HD11 ' A' ' 40' ' ' LEU . 15.9 m95 -116.59 148.24 41.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -142.26 23.73 1.99 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.07 0.13 31.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.784 . . . . 0.0 110.949 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.53 -158.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 110.343 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.577 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.26 166.97 11.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 110.334 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.49 ' CA ' ' HG2' ' A' ' 42' ' ' ARG . . . -39.73 -84.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.555 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.05 -31.7 42.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 7.7 tt0 -59.53 -24.85 64.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.283 . . . . 0.0 109.938 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -72.95 -48.42 36.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.587 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.797 HD21 HD13 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -68.44 -36.16 78.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.326 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.815 HD11 ' OG1' ' A' ' 61' ' ' THR . 0.6 OUTLIER -58.24 -31.71 67.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 110.976 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp -55.49 -23.84 28.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.875 -1.141 . . . . 0.0 109.223 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 38' ' ' THR . 2.7 pp -70.33 -32.95 70.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 108.648 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 61.2 m -69.85 -33.09 71.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.578 -0.701 . . . . 0.0 110.08 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -21.19 41.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.068 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.766 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.4 mm-40 -122.31 -83.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.564 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.766 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.17 69.27 4.87 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 122.923 0.959 . . . . 0.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.59 141.53 37.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.225 -0.922 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 83.31 19.44 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.926 ' O ' HD13 ' A' ' 31' ' ' LEU . 4.0 m -122.43 148.33 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.505 -0.997 . . . . 0.0 110.204 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HB2' HG12 ' A' ' 55' ' ' VAL . 4.5 p90 -122.21 138.97 54.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.852 -1.155 . . . . 0.0 109.981 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.35 159.31 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 0.0 110.276 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.838 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.4 tt -117.01 149.21 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 3.0 tpt180 -121.62 152.89 38.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.445 -0.784 . . . . 0.0 109.612 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.573 ' CA ' ' OH ' ' A' ' 18' ' ' TYR . 8.8 t0 -90.76 104.31 16.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.956 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 8.3 t . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 0.0 110.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.158 0.504 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.871 ' HD1' HG21 ' A' ' 5' ' ' VAL . 20.0 t80 -155.82 156.06 34.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.855 ' CD2' HG13 ' A' ' 5' ' ' VAL . 8.7 p90 -115.96 151.79 34.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.5 ' C ' HG13 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -126.41 147.62 49.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.916 HD12 ' N ' ' A' ' 54' ' ' SER . 0.3 OUTLIER -131.1 125.07 32.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.39 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.916 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -122.8 153.74 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.02 HG11 HD22 ' A' ' 149' ' ' LEU . 10.2 m -121.39 174.56 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.372 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HA ' HG22 ' A' ' 61' ' ' THR . 14.5 tttm -103.47 126.48 50.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.986 ' HB ' HD22 ' A' ' 147' ' ' LEU . 21.4 p -128.9 169.87 14.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.86 -27.11 67.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 t -86.41 -28.31 23.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.161 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 147.36 156.78 7.12 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 56' ' ' LYS . 17.3 p -80.13 138.08 36.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' CB ' HG12 ' A' ' 138' ' ' ILE . 23.2 mmtm -137.15 160.45 38.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.506 ' HB3' ' CB ' ' A' ' 54' ' ' SER . 5.5 p30 -138.28 154.64 49.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.704 HD11 ' CA ' ' B' ' 166' ' ' THR . 8.0 mt -137.45 148.41 46.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 110.01 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HA ' ' HZ ' ' A' ' 50' ' ' PHE . 4.7 mtt180 -98.25 152.29 19.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.33 139.6 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -96.4 151.0 19.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.403 ' HA ' ' CD1' ' A' ' 73' ' ' PHE . 18.5 p -99.36 137.03 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 mt-10 -130.63 102.89 6.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 43.24 -95.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -120.53 32.75 4.73 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 5.0 p -139.58 150.91 45.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.292 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -124.29 144.83 49.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 66' ' ' ILE . 2.2 t -155.18 141.3 18.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.119 -0.988 . . . . 0.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 94' ' ' LEU . 17.8 tp . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.282 -0.886 . . . . 0.0 110.455 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.786 HG21 HG22 ' A' ' 5' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.074 0.464 . . . . 0.0 111.125 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -54.19 -35.77 62.7 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.907 -1.121 . . . . 0.0 110.058 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.565 ' NZ ' ' CD2' ' A' ' 96' ' ' HIS . 0.3 OUTLIER -62.39 -36.4 82.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.991 -1.068 . . . . 0.0 109.437 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.82 -35.87 75.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.595 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' MET . 78.0 t -56.02 -38.31 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.78 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.565 ' CD2' ' NZ ' ' A' ' 93' ' ' LYS . 26.7 t60 -54.79 -46.55 74.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -71.78 -42.95 66.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.069 ' O ' HD11 ' A' ' 149' ' ' LEU . 2.0 m-30 -69.31 -22.11 63.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.571 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 6.9 ppt_? . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.23 0.538 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.854 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 169.5 129.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.431 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.122 ' CD1' HG11 ' B' ' 167' ' ' VAL . 2.5 t80 -116.18 121.78 43.12 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.807 -1.183 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.904 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.7 p90 -156.99 167.97 28.88 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.878 -1.139 . . . . 0.0 111.185 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.468 HG12 ' CB ' ' A' ' 62' ' ' LYS . 2.8 mp -121.62 149.54 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.95 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.76 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.1 m-30 -84.85 110.47 18.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.729 . . . . 0.0 110.119 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 3.9 m -66.32 56.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.53 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 65.84 82.9 0.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.25 -10.42 49.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.8 tt0 -120.01 121.6 39.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.269 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 2.4 ptpt -89.8 105.5 17.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.02 109.14 52.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.823 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.3 Cg_endo -72.57 128.95 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.996 1.524 . . . . 0.0 111.938 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.986 HD22 ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -125.83 135.88 52.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 148' ' ' VAL . 25.3 m -98.04 117.12 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.382 -1.449 . . . . 0.0 110.079 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.069 HD11 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -117.38 137.91 52.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.047 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.502 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -176.02 41.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.583 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -111.56 124.96 31.31 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.148 -0.97 . . . . 0.0 110.046 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.632 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 45.7 Cg_endo -73.08 147.32 42.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 111.059 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.795 HD22 HG21 ' A' ' 38' ' ' THR . 0.3 OUTLIER -89.7 128.66 36.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.742 . . . . 0.0 109.778 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.759 ' N ' HD13 ' A' ' 153' ' ' LEU . 49.4 m . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.443 ' C ' HD21 ' A' ' 64' ' ' LEU . 56.6 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.214 0.53 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.745 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.5 OUTLIER 176.87 155.82 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.192 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.122 HG11 ' CD1' ' A' ' 136' ' ' TYR . 15.3 t -118.62 132.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 135' ' ' ALA . 5.8 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.188 0.518 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 6' ' ' VAL . 33.7 p90 -65.31 -37.55 87.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.5 OUTLIER -69.32 -33.65 73.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.218 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.09 -47.3 71.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.516 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 49' ' ' HIS . 34.8 m -72.18 -37.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.449 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 2' ' ' TYR . 24.8 t -58.45 -32.97 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.33 -45.65 92.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -67.0 -43.11 83.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.724 HG13 ' CE2' ' A' ' 18' ' ' TYR . 60.1 t -56.93 -39.39 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 15.3 ttt180 -55.47 -48.81 73.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.855 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.37 -33.02 49.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.64 -44.08 71.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.267 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 6.5 pt20 -65.59 -33.77 76.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 1.2 tt0 -66.01 -32.26 73.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.312 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.6 p -69.68 -27.5 65.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.28 19.97 21.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CD2' ' CD1' ' A' ' 153' ' ' LEU . 3.0 m-85 -108.5 4.22 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -1.129 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.724 ' CE2' HG13 ' A' ' 9' ' ' VAL . 21.6 t80 -90.86 136.07 33.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.355 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.94 ' CG ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -92.23 148.34 22.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.667 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 2.6 t -40.68 -92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.783 . . . . 0.0 110.321 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.91 61.72 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -59.53 -137.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -85.32 166.19 16.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 109.551 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . -39.89 -83.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.29 -30.18 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 17.0 tt0 -57.78 -34.79 69.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.982 -1.305 . . . . 0.0 110.517 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -66.84 -48.73 67.96 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.94 -1.1 . . . . 0.0 109.025 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.657 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 29.1 m-80 -69.3 -43.15 74.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.463 -0.773 . . . . 0.0 110.728 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -70.28 -31.78 69.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 111.686 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.756 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.76 -41.15 70.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.88 -1.138 . . . . 0.0 110.352 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.063 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.1 pp -61.02 -34.69 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 108.964 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.79 -32.82 71.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -20.62 42.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.504 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.8 mt-10 -114.89 -76.75 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.2 Cg_endo -72.85 65.53 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.299 1.157 . . . . 0.0 110.118 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.91 140.62 11.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 80.15 -2.44 76.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.916 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 m -104.41 146.38 28.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.432 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.787 ' HB2' HD23 ' A' ' 149' ' ' LEU . 39.9 p90 -123.79 138.88 54.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.985 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.063 HD23 ' HB3' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -141.4 159.4 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.145 -0.972 . . . . 0.0 110.619 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.919 ' N ' HD12 ' A' ' 40' ' ' LEU . 1.7 tt -115.16 130.58 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.945 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' NH2' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -112.72 160.5 17.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.032 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' CB ' ' OH ' ' A' ' 18' ' ' TYR . 12.4 t70 -74.0 126.28 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.137 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.602 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 9.4 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 110.101 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.667 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.6 m-70 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.225 0.536 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 44' ' ' SER . 42.7 p90 -177.78 -158.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 35.5 p90 -133.26 149.14 51.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.377 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 64' ' ' LEU . 74.7 m -126.22 155.13 42.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.18 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -137.24 146.44 44.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.697 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 25.1 p -139.43 153.99 47.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' CG2' ' HG ' ' A' ' 149' ' ' LEU . 8.8 p -120.13 172.24 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 1.6 tmtp? -123.01 139.19 54.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.537 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -151.65 -173.35 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.66 24.23 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.511 ' HB3' HG21 ' A' ' 145' ' ' ILE . 1.7 p -126.98 -2.62 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.25 139.55 5.6 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 61' ' ' THR . 15.3 t -95.31 109.56 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.308 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -110.65 155.18 22.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 110.04 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 6.7 t-20 -111.53 128.68 56.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.019 HD13 ' CG2' ' B' ' 167' ' ' VAL . 0.9 OUTLIER -130.23 152.06 50.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -0.971 . . . . 0.0 110.33 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.58 ' CA ' HG23 ' A' ' 52' ' ' THR . 3.0 ptm180 -121.68 -145.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.777 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 94' ' ' LEU . 1.4 tp -116.75 149.02 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 0.0 110.341 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -110.76 124.71 52.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.575 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 29.4 p -87.81 126.89 35.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.65 103.02 7.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.47 -102.15 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.6 36.19 3.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.06 160.39 40.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -1.18 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.644 ' CD1' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.16 138.44 46.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.855 . . . . 0.0 110.033 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.3 t -155.32 150.15 26.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.052 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.662 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.8 p . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.223 0.535 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.872 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.29 -34.08 63.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 110.073 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -57.53 -31.76 66.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.799 ' HB2' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -59.83 -35.4 74.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.246 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.7 m -55.33 -37.32 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.316 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.54 ' HB2' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -53.83 -34.71 60.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.023 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.614 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -78.07 -36.77 47.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 109.986 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.741 ' CE1' HD23 ' A' ' 53' ' ' LEU . 3.3 m-85 -63.55 -22.02 66.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 0.0 110.319 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.257 0.551 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -175.42 111.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.154 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 2.1 t80 -103.0 121.42 42.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.936 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.18 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.9 165.89 33.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.0 . . . . 0.0 110.423 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.096 HD12 ' CD2' ' A' ' 147' ' ' LEU . 6.1 mt -123.5 126.73 73.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.012 . . . . 0.0 109.758 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.781 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -83.36 107.63 16.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.832 0.825 . . . . 0.0 109.717 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' TYR . 56.1 p -42.45 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.774 -0.579 . . . . 0.0 110.411 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.84 80.3 0.36 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.38 82.31 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 145' ' ' ILE . 39.8 tt0 -114.06 121.28 43.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.281 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 21.9 mtmm -76.94 108.45 9.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 110.949 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.834 HG22 HD11 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -104.31 132.47 20.94 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.927 ' C ' HD12 ' A' ' 147' ' ' LEU . 45.2 Cg_endo -71.56 128.16 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.79 1.416 . . . . 0.0 112.111 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.096 ' CD2' HD12 ' A' ' 138' ' ' ILE . 8.3 mp -123.69 101.5 7.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.71 117.81 44.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.874 -1.142 . . . . 0.0 111.207 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 39' ' ' PHE . 8.8 mp -79.73 114.83 18.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.283 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.18 -23.93 2.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -85.91 124.9 70.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 110.271 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.581 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 47.9 Cg_endo -74.74 128.26 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.055 1.555 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.937 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.76 158.22 16.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.519 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.556 ' N ' HD22 ' A' ' 153' ' ' LEU . 47.8 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.104 -0.997 . . . . 0.0 110.264 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.1 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.174 0.512 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.607 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 31.0 m -145.16 147.71 32.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.154 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.6 t -87.67 102.39 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.18 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.405 -0.81 . . . . 0.0 110.231 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.522 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.336 0.588 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 38.0 p90 -63.38 -36.08 82.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.479 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -55.57 -36.21 66.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 4.2 mt -64.29 -44.46 91.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 51' ' ' PHE . 12.1 t -66.63 -48.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.8 t -58.82 -41.75 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -71.22 -31.26 67.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 109.833 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' HG12 ' A' ' 91' ' ' VAL . . . -76.05 -44.28 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.458 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 6' ' ' VAL . 29.9 m -57.11 -38.71 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.241 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 4.6 mtp180 -55.04 -40.63 70.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -71.36 -42.39 68.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.959 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -72.04 -40.18 68.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 5.3 pt20 -68.19 -33.73 74.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 4.0 tm-20 -57.65 -21.45 39.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 110.261 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -26.95 62.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.17 37.8 3.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 25.5 t80 -142.13 7.15 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -1.142 . . . . 0.0 110.235 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 6.3 t80 -96.28 136.21 37.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 1.102 ' CG ' HD12 ' A' ' 40' ' ' LEU . 28.6 m95 -110.6 148.31 32.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.478 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -148.41 109.74 4.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 176.59 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 111.089 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' CG2' ' CZ ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -120.88 -160.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.862 -1.149 . . . . 0.0 110.277 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -86.09 166.04 16.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -52.19 -76.45 0.18 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.718 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -60.74 -43.72 98.79 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.457 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 29.9 tt0 -59.78 -24.83 64.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 110.01 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.676 ' HB1' ' HE ' ' A' ' 42' ' ' ARG . . . -78.12 -45.55 23.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.32 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.718 HD22 ' HA2' ' A' ' 25' ' ' GLY . 1.6 m-80 -69.04 -41.8 77.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.389 -0.819 . . . . 0.0 110.755 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 1.4 mp -59.43 -32.14 69.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.766 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.751 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -55.21 -23.58 22.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.982 -1.074 . . . . 0.0 109.352 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 38' ' ' THR . 70.9 mt -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 109.096 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.549 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 26.9 p -69.19 -32.43 71.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.716 . . . . 0.0 109.888 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.48 -20.62 43.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.371 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.762 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 12.5 mm-40 -134.06 -83.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.762 ' HD3' ' CB ' ' A' ' 34' ' ' GLU . 50.3 Cg_endo -78.01 67.67 8.01 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 122.812 0.901 . . . . 0.0 110.152 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -63.67 141.47 58.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 88.98 15.74 58.88 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.754 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -130.63 147.17 52.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -1.05 . . . . 0.0 110.142 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 149' ' ' LEU . 4.0 p90 -123.11 146.22 47.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 0.0 110.678 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.102 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.08 160.31 43.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 12' ' ' LEU . 3.3 tt -114.0 128.84 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.924 -1.11 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.676 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -117.68 150.44 39.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.755 . . . . 0.0 110.122 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 44' ' ' SER . 9.8 t70 -73.87 127.56 33.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 44' ' ' SER . 25.5 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.324 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 59.4 m170 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.1 0.476 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.617 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.4 p90 -152.7 -160.99 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.838 ' CD2' HG13 ' A' ' 5' ' ' VAL . 27.1 p90 -115.9 148.72 39.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' CA ' ' A' ' 24' ' ' GLY . 88.6 m -126.13 139.76 53.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.055 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -126.92 124.97 40.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.918 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -133.9 154.29 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.476 -0.765 . . . . 0.0 110.049 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 149' ' ' LEU . 12.4 p -130.58 174.08 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -118.86 139.02 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.204 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.796 HG21 ' HB3' ' A' ' 147' ' ' LEU . 26.6 m -115.21 -43.3 3.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 57' ' ' THR . 2.8 pt20 -177.99 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.59 29.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.626 ' O ' HD13 ' A' ' 138' ' ' ILE . . . -155.76 65.46 0.31 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 61' ' ' THR . 3.8 t -84.96 111.85 20.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -1.144 . . . . 0.0 110.138 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HG3' HG21 ' A' ' 138' ' ' ILE . 14.3 mmtt -123.53 166.08 16.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -134.32 154.12 51.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.027 HD21 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.01 118.15 13.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 110.53 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.555 ' HD2' ' CZ ' ' A' ' 50' ' ' PHE . 10.7 ptm180 -75.32 162.21 28.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.864 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.914 ' CG1' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -78.27 148.78 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 110.263 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -107.53 136.75 46.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 1' ' ' GLU . 27.9 p -87.83 119.97 28.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.28 103.09 8.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.64 -78.27 0.02 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -148.25 30.35 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.44 163.09 33.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.956 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -115.7 141.18 48.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 109.977 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.631 ' C ' HD13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -148.15 138.89 23.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.94 -1.1 . . . . 0.0 110.616 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.702 HD21 ' CB ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 109.793 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.956 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.703 0.763 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.0 pp -54.41 -33.87 60.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.565 -0.709 . . . . 0.0 111.545 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -57.31 -30.41 64.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.596 -1.315 . . . . 0.0 109.741 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.914 HD22 ' CG1' ' A' ' 66' ' ' ILE . 1.1 pp -58.78 -33.02 69.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.3 m -53.39 -34.85 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.429 -0.794 . . . . 0.0 110.353 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' N ' HG23 ' A' ' 95' ' ' VAL . 8.3 m80 -51.29 -30.06 16.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 109.51 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.508 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 2.0 t60 -73.17 -36.3 66.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.166 -0.959 . . . . 0.0 108.825 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.055 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.8 m-85 -63.57 -22.12 66.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.568 -0.707 . . . . 0.0 109.674 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.569 ' HE1' ' HA ' ' A' ' 135' ' ' ALA . 10.8 ttm . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.465 -0.772 . . . . 0.0 110.301 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.195 0.521 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.889 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.97 126.34 0.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 110.058 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.921 ' CD2' HG11 ' B' ' 167' ' ' VAL . 3.7 t80 -128.59 121.81 29.56 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.408 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.029 ' CD2' HG22 ' B' ' 168' ' ' VAL . 12.6 p90 -156.83 167.33 30.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.203 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.705 HD12 HD21 ' A' ' 147' ' ' LEU . 2.6 mp -106.05 149.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.635 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 29.5 m-85 -96.18 133.05 40.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.76 . . . . 0.0 110.992 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.48 ' OG ' HD13 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -87.46 48.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.636 -0.665 . . . . 0.0 110.217 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 52.49 65.73 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.07 -22.48 15.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.53 121.97 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -1.174 . . . . 0.0 110.162 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.4 ptmt -88.48 105.72 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.27 102.98 10.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.791 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.2 Cg_endo -76.18 126.68 9.37 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.681 1.358 . . . . 0.0 111.981 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.796 ' HB3' HG21 ' A' ' 57' ' ' THR . 0.4 OUTLIER -126.76 136.0 51.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 148' ' ' VAL . 30.2 m -97.08 117.18 41.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.136 -1.603 . . . . 0.0 110.624 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 39' ' ' PHE . 6.3 tt -90.11 114.93 26.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.65 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.1 OUTLIER -148.94 19.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.021 -1.05 . . . . 0.0 110.821 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -105.6 124.49 36.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.03 -1.044 . . . . 0.0 109.976 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.5 Cg_endo -76.57 148.22 29.14 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.954 1.502 . . . . 0.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.709 HD21 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -79.07 152.87 30.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 110.089 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.677 ' H ' HD13 ' A' ' 153' ' ' LEU . 17.0 m . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 1.027 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.158 0.504 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.638 ' CA ' HD11 ' A' ' 64' ' ' LEU . 2.6 t -146.82 175.47 10.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 110.26 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.921 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -128.73 112.36 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.976 . . . . 0.0 110.272 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 137' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.238 0.542 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.08 -36.14 80.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -55.2 -34.21 63.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.167 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -67.26 -45.17 77.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 110.205 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.94 ' O ' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -64.94 -48.4 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -58.42 -32.62 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.311 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.11 -42.52 80.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 91' ' ' VAL . . . -76.12 -44.91 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.94 HG13 ' O ' ' A' ' 5' ' ' VAL . 5.4 m -59.01 -39.58 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -55.54 -49.01 73.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -35.94 65.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 109.513 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 12' ' ' LEU . 14.0 tp -72.13 -44.09 63.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 16.7 pt20 -68.21 -33.87 75.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.6 -26.48 61.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.112 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -26.89 62.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.024 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.19 1.61 56.93 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HD2' HD12 ' A' ' 153' ' ' LEU . 1.6 t80 -88.96 -8.33 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 110.187 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 41' ' ' ILE . 5.7 t80 -90.91 136.23 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.812 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 1.034 ' CD1' HD13 ' A' ' 40' ' ' LEU . 46.3 m95 -99.79 148.42 24.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.795 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -53.07 -18.7 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.855 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 75.54 93.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.659 . . . . 0.0 111.16 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 23' ' ' THR . 1.8 m -66.41 -90.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.284 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.678 ' H ' HG23 ' A' ' 22' ' ' VAL . 1.1 m -103.5 172.99 6.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.003 -1.061 . . . . 0.0 109.219 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.599 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.23 -94.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -71.25 -29.5 68.43 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.485 -1.009 . . . . 0.0 110.651 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.594 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -57.56 -24.95 59.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.25 . . . . 0.0 111.204 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.918 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -76.46 -47.04 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.825 -1.172 . . . . 0.0 109.66 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.669 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.7 m-80 -70.34 -44.86 67.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 111.066 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' OG1' ' A' ' 61' ' ' THR . 15.1 mt -70.7 -31.53 68.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.7 pp -54.28 -27.41 35.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.535 -1.353 . . . . 0.0 110.561 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.033 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.4 pp -74.05 -33.75 63.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.81 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -69.89 -32.72 71.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 110.296 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.07 41.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.352 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.744 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 3.7 mm-40 -113.95 -77.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.057 -1.027 . . . . 0.0 110.063 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.744 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.0 Cg_endo -72.49 71.09 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.271 1.143 . . . . 0.0 110.142 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.09 137.18 47.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.04 0.6 89.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -111.23 147.41 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -1.181 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -122.79 148.75 45.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.0 110.716 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' CD1' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -147.65 160.02 43.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 109.91 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.021 ' N ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -113.95 148.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.973 . . . . 0.0 110.46 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.599 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 5.7 ppt_? -127.38 127.59 44.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.705 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 24.7 t70 -75.27 138.24 41.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.483 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.568 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 12.9 m . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.228 0.537 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.843 ' CB ' HG21 ' A' ' 5' ' ' VAL . 17.2 p90 -154.42 -156.13 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.857 ' CE1' HG22 ' A' ' 5' ' ' VAL . 14.2 p90 -116.01 152.71 33.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 24.3 m -118.13 155.54 30.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.904 HD13 ' N ' ' A' ' 54' ' ' SER . 1.2 tm? -142.17 129.68 21.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.301 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.904 ' N ' HD13 ' A' ' 53' ' ' LEU . 3.1 p -138.32 154.13 49.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.642 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG11 HD21 ' A' ' 149' ' ' LEU . 2.8 m -127.03 173.99 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 110.835 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 14.5 tptm -113.04 129.58 56.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.887 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.965 ' HB ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.63 -165.76 1.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.387 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' GLY . 8.4 tt0 -77.93 -59.12 2.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.473 ' OG ' ' HB ' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -42.24 -27.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' GLN . . . 130.66 151.92 7.24 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 61' ' ' THR . 2.4 t -78.87 108.89 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.181 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -110.37 153.2 25.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.942 . . . . 0.0 110.099 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 15.0 p30 -121.06 125.84 48.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -118.65 151.93 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.633 ' C ' HD12 ' A' ' 75' ' ' LEU . 1.4 ptt180 -140.36 152.99 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 110.437 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.73 HD13 ' C ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -76.62 117.86 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 74' ' ' SER . 16.2 tt0 -91.95 151.14 20.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 110.484 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 20.0 p -101.62 127.84 48.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -133.14 117.01 16.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.31 34.15 87.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.22 -14.22 54.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 51.2 p -94.99 162.81 13.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -1.14 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.7 m-30 -110.92 152.01 27.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.73 ' C ' HD13 ' A' ' 66' ' ' ILE . 19.3 m -155.63 138.7 15.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.031 HD13 ' HG ' ' A' ' 94' ' ' LEU . 2.6 tt . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.076 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 92' ' ' LEU . 7.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.722 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.6 mt -61.64 -42.07 98.38 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -57.86 -34.41 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 110.43 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.7 m -54.35 -37.67 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.94 -1.1 . . . . 0.0 109.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.471 ' N ' HG23 ' A' ' 95' ' ' VAL . 80.1 m-70 -68.16 -37.34 80.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.247 -0.908 . . . . 0.0 109.188 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.582 ' CD2' ' CD1' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -77.57 -36.87 51.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 109.749 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.913 ' OH ' HD11 ' A' ' 75' ' ' LEU . 5.6 m-85 -77.1 -22.33 52.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.824 . . . . 0.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.336 -179.777 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.244 0.545 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.068 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -176.31 102.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.143 ' CE2' HG21 ' B' ' 167' ' ' VAL . 3.0 t80 -102.62 122.51 44.55 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.903 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.165 ' CD2' HG22 ' B' ' 168' ' ' VAL . 3.5 p90 -155.73 167.9 28.89 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.927 -1.108 . . . . 0.0 110.781 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.566 HG12 ' CB ' ' A' ' 62' ' ' LYS . 3.0 mp -121.09 149.58 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 111.055 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.752 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.0 OUTLIER -84.71 107.94 17.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 110.057 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.851 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -91.82 122.02 33.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 110.286 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.14 65.68 2.59 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 51.35 20.59 5.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 140' ' ' SER . 12.8 tt0 -120.38 121.86 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.135 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.16 105.36 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 110.63 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.851 HD13 ' HB3' ' A' ' 140' ' ' SER . 0.9 OUTLIER -99.98 109.04 54.79 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.831 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.5 Cg_endo -72.53 128.72 13.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.954 1.502 . . . . 0.0 112.277 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -125.89 135.21 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 148' ' ' VAL . 35.7 m -103.83 117.72 49.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.273 -1.517 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.823 HD21 HG11 ' A' ' 55' ' ' VAL . 12.8 mt -76.17 123.5 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -0.963 . . . . 0.0 108.969 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -137.84 -7.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.82 -1.175 . . . . 0.0 111.647 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 ttm-85 -100.23 124.63 42.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.718 -1.239 . . . . 0.0 110.104 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 147.96 32.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.981 1.516 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 1.119 HD13 ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -67.13 159.14 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.964 ' N ' HD22 ' A' ' 153' ' ' LEU . 5.0 m . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.558 -0.713 . . . . 0.0 111.231 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.511 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -125.95 163.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.191 -0.943 . . . . 0.0 110.134 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.143 HG21 ' CE2' ' A' ' 136' ' ' TYR . 37.8 t -114.47 112.89 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.165 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.225 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.61 ' N ' HD12 ' A' ' 4' ' ' LEU . 85.3 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.34 0.591 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 22.1 p90 -64.52 -35.88 82.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.564 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 28.1 pt20 -62.88 -40.22 96.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.1 mt -67.0 -47.46 71.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 50' ' ' PHE . 7.1 p -68.94 -47.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.318 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.608 ' N ' HG13 ' A' ' 5' ' ' VAL . 41.9 t -58.68 -50.23 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.82 -38.42 78.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.724 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.59 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -72.34 -38.26 68.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.791 HG13 ' CE2' ' A' ' 18' ' ' TYR . 3.0 t -56.94 -39.39 65.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.3 mtp85 -58.45 -49.42 77.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.568 -0.708 . . . . 0.0 110.104 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -78.57 -33.25 47.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.323 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' CG2' ' A' ' 95' ' ' VAL . 2.2 tt -72.0 -44.15 63.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.758 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 4.6 pt20 -61.28 -40.94 96.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 110.371 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 8.3 tt0 -77.16 -51.64 10.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -72.79 -43.18 63.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 17' ' ' PHE . . . -99.98 33.99 5.85 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.221 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 3.1 p90 29.75 44.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -1.039 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.791 ' CE2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -92.79 122.92 35.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.721 ' CE2' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -125.61 145.94 49.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 110.126 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 107.31 14.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.29 12.82 0.12 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.472 -0.767 . . . . 0.0 110.016 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.54 -159.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.693 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.19 176.17 7.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 42' ' ' ARG . . . -55.21 -75.3 0.25 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -79.39 -31.77 40.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.564 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 1.9 tp10 -59.0 -36.47 74.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.032 -1.275 . . . . 0.0 109.509 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.938 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -60.92 -51.43 69.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.729 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 4.1 m-80 -69.82 -42.88 73.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.968 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.99 -32.75 69.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -0.842 . . . . 0.0 112.321 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.938 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.7 pp -55.4 -35.12 64.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.704 -1.247 . . . . 0.0 110.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.043 HD13 ' O ' ' A' ' 38' ' ' THR . 4.6 pp -66.27 -36.24 82.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.826 -1.171 . . . . 0.0 109.265 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.922 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.53 -32.72 71.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 110.324 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.55 -20.71 42.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.67 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -116.84 -76.03 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.9 Cg_endo -73.18 70.9 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.292 1.154 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 141.28 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 79.91 18.21 73.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 1.043 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.42 147.31 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -1.079 . . . . 0.0 110.023 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.763 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.02 163.08 21.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.016 . . . . 0.0 110.202 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.97 ' HB2' HD23 ' A' ' 153' ' ' LEU . 7.6 tt -151.96 159.18 43.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.96 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.858 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -119.24 129.28 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 24' ' ' GLY . 6.3 ppt_? -112.16 155.06 24.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.34 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 30.3 t0 -100.05 132.14 45.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 36.2 m80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.155 0.502 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.911 ' HA ' HG21 ' A' ' 5' ' ' VAL . 12.1 p90 175.44 178.02 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.878 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.894 ' CD2' HG23 ' A' ' 5' ' ' VAL . 3.3 p90 -115.88 148.66 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.987 . . . . 0.0 110.3 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 65' ' ' ARG . 2.1 p -126.84 155.33 43.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.865 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.12 HD22 ' CD1' ' A' ' 98' ' ' TYR . 1.9 tt -124.22 154.09 40.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.796 ' N ' HD23 ' A' ' 53' ' ' LEU . 3.2 p -139.03 153.63 48.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' HB3' ' A' ' 39' ' ' PHE . 2.8 m -130.13 174.11 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.794 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.8 139.14 52.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.471 -0.768 . . . . 0.0 110.086 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -175.6 146.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.3 OUTLIER 66.82 -60.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.184 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER 165.89 -22.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 109.817 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' C ' ' NZ ' ' A' ' 62' ' ' LYS . . . -105.77 117.1 5.38 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' THR . 9.7 t -97.61 116.52 29.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.142 -1.211 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -106.71 161.37 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.132 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' C ' HD22 ' A' ' 64' ' ' LEU . 1.1 m-80 -118.98 135.82 54.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.904 ' HB3' HD11 ' A' ' 75' ' ' LEU . 2.1 mm? -104.05 127.09 51.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.587 ' CB ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -118.02 138.28 52.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 91' ' ' VAL . 1.1 tp -82.95 148.42 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 27.3 tp60 -112.88 151.06 30.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 67' ' ' GLN . 45.2 t -102.04 127.84 48.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 110.231 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.4 tt0 -121.26 103.0 8.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.76 -68.95 0.12 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -157.02 28.03 0.52 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 p -136.45 161.31 36.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 110.161 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 5' ' ' VAL . 1.3 m-30 -112.95 149.96 32.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 67' ' ' GLN . 16.4 t -150.99 138.82 19.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD21 ' A' ' 94' ' ' LEU . 27.0 tp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.141 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.734 ' CA ' HD13 ' A' ' 66' ' ' ILE . 4.0 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.171 0.51 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 8' ' ' ALA . 16.3 mt -63.51 -46.06 87.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 108.434 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -60.26 -29.9 69.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.033 HD21 HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.92 -34.24 69.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.785 -0.572 . . . . 0.0 110.095 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 42.0 t -54.05 -42.15 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.089 -1.007 . . . . 0.0 108.948 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.0 OUTLIER -68.26 -31.37 70.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.915 . . . . 0.0 108.735 178.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.12 -43.29 29.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.684 -0.635 . . . . 0.0 109.503 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.12 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.2 m-85 -64.05 -22.15 66.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.475 -0.766 . . . . 0.0 110.055 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.249 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.239 0.542 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . -173.25 152.82 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.124 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CG ' HG11 ' B' ' 167' ' ' VAL . 1.3 t80 -131.11 122.94 27.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.329 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.113 ' CE2' HG12 ' B' ' 168' ' ' VAL . 9.4 p90 -155.15 168.03 28.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.583 -1.323 . . . . 0.0 111.64 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.737 HG21 ' HD3' ' A' ' 62' ' ' LYS . 4.2 mp -102.16 143.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.624 0.726 . . . . 0.0 110.744 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.721 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.2 m-85 -93.3 132.76 37.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.718 0.771 . . . . 0.0 110.925 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.531 ' HB2' HD13 ' A' ' 145' ' ' ILE . 12.1 t -101.8 -163.55 1.02 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.088 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.504 ' N ' ' OG ' ' A' ' 140' ' ' SER . . . -55.67 85.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 63.77 12.43 47.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mm-40 -120.2 121.93 39.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -87.22 105.26 17.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.471 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.948 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -89.52 108.6 26.01 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.828 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.6 Cg_endo -76.35 129.44 11.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.059 1.558 . . . . 0.0 113.35 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.948 HD21 HG22 ' A' ' 145' ' ' ILE . 2.1 mm? -125.12 134.96 52.25 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 148' ' ' VAL . 17.2 m -101.16 116.45 44.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 119.878 -1.764 . . . . 0.0 110.921 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.762 ' CD1' HG11 ' A' ' 55' ' ' VAL . 56.4 mt -84.79 114.96 22.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.135 -0.978 . . . . 0.0 109.241 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.5 p -147.69 28.55 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 111.375 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 1.2 mtt180 -134.11 123.22 16.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.789 -1.195 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 50.7 Cg_endo -79.3 135.45 12.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.069 1.562 . . . . 0.0 110.822 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 ' HB2' ' A' ' 40' ' ' LEU . 16.3 tp -92.39 146.5 23.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.865 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.479 ' H ' HD12 ' A' ' 153' ' ' LEU . 19.0 m . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 110.339 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.272 0.558 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.581 ' HA ' HD11 ' A' ' 64' ' ' LEU . 41.7 p -131.25 -173.15 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.992 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.88 -160.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.106 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.113 HG12 ' CE2' ' A' ' 137' ' ' TYR . 2.3 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.775 ' HA ' HD12 ' A' ' 4' ' ' LEU . 6.1 pt-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.602 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 30.0 p90 -66.67 -35.9 81.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.4 tt0 -65.18 -44.13 89.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 1' ' ' GLU . 2.4 mt -67.12 -47.5 70.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.937 HG21 ' HA ' ' A' ' 50' ' ' PHE . 6.8 p -65.32 -47.85 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 0.0 110.353 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' HG13 ' A' ' 5' ' ' VAL . 24.9 t -58.64 -36.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.05 -33.21 70.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -76.05 -44.36 39.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.04 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.596 HG12 HE21 ' A' ' 13' ' ' GLN . 82.0 t -57.45 -39.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.446 -0.784 . . . . 0.0 109.295 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.4 mtm180 -55.86 -48.33 75.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.721 . . . . 0.0 109.893 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -34.75 50.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.984 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.941 HD23 HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.04 -43.29 65.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 110.055 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.596 HE21 HG12 ' A' ' 9' ' ' VAL . 4.8 pt20 -65.74 -33.73 76.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 2.3 mt-10 -57.61 -33.7 68.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.095 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.461 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 3.7 m -56.02 -27.5 53.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.8 42.71 5.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 9.2 p90 -152.59 14.5 0.57 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -1.18 . . . . 0.0 110.452 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.677 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -94.93 126.26 40.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.251 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.981 ' CD1' HD12 ' A' ' 40' ' ' LEU . 16.9 m95 -106.04 148.09 28.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 3.6 m -39.12 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.821 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 166.99 81.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.451 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.1 t -47.22 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -108.23 173.07 6.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.811 -1.181 . . . . 0.0 109.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.87 -89.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.44 -30.31 45.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -57.82 -34.93 70.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.268 . . . . 0.0 110.445 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -66.48 -49.06 67.89 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.012 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.0 m-80 -69.29 -39.87 78.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 110.535 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.39 -31.41 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 111.712 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -54.68 -24.02 20.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.825 -1.172 . . . . 0.0 110.794 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 38' ' ' THR . 4.2 pp -75.41 -36.13 60.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.937 -1.102 . . . . 0.0 109.322 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.85 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -69.69 -32.91 71.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.61 41.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.938 . . . . 0.0 110.72 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.737 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.6 mt-10 -114.34 -76.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.737 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 47.3 Cg_endo -72.12 71.31 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.224 1.118 . . . . 0.0 110.268 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.57 141.28 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.497 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.86 20.76 79.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.963 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.21 146.93 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 110.178 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.995 ' CG ' HD12 ' A' ' 149' ' ' LEU . 4.3 m-85 -123.42 157.41 33.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.916 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.981 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.23 159.18 43.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 110.592 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.017 HD11 ' CD1' ' A' ' 51' ' ' PHE . 13.1 tt -116.33 144.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.81 136.07 52.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 20' ' ' SER . 1.5 p30 -89.58 121.72 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 10.8 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.464 ' HB2' ' CB ' ' A' ' 44' ' ' SER . 13.7 m-70 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.228 0.537 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.937 ' HA ' HG21 ' A' ' 5' ' ' VAL . 20.9 p90 -177.44 -159.5 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 110.194 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 1.017 ' CD1' HD11 ' A' ' 41' ' ' ILE . 8.5 p90 -126.96 155.79 42.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 74.9 m -126.24 138.38 53.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -0.953 . . . . 0.0 110.267 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.03 HD23 ' CG ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -120.93 124.89 46.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.084 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.956 ' N ' HD12 ' A' ' 53' ' ' LEU . 2.5 p -126.02 154.14 43.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.971 HG11 HD13 ' A' ' 149' ' ' LEU . 2.2 m -122.34 174.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.85 . . . . 0.0 110.717 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 25.7 tttt -107.12 124.23 49.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.707 HG21 ' CD1' ' A' ' 138' ' ' ILE . 8.9 p -127.4 157.13 40.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 110.332 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.73 -24.24 64.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -79.72 -23.13 42.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 152.82 143.47 3.69 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.3 p -78.93 110.52 14.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 138' ' ' ILE . 5.3 mmtt -111.99 161.72 16.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.214 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.486 ' CB ' ' HB2' ' A' ' 54' ' ' SER . 12.7 p30 -140.12 125.98 19.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.609 HD12 ' OH ' ' A' ' 136' ' ' TYR . 12.9 mt -104.73 152.08 22.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -125.11 143.13 51.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.647 HD13 HD22 ' A' ' 94' ' ' LEU . 3.5 tp -78.58 136.65 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.077 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -102.79 145.31 29.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 1' ' ' GLU . 42.6 t -108.57 127.5 54.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.0 tt0 -124.17 104.29 8.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.04 -71.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -154.22 23.58 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.89 163.26 24.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 110.182 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.6 m-30 -119.42 157.87 27.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.634 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.12 138.68 15.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.14 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.887 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 73' ' ' PHE . 15.5 m . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.018 0.437 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.7 mt -65.11 -46.56 80.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -67.5 -31.14 71.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.069 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.887 HD21 ' CB ' ' A' ' 75' ' ' LEU . 3.7 mp -59.36 -33.85 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.84 -0.538 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.2 m -52.47 -37.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.98 -1.075 . . . . 0.0 109.651 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.461 ' N ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -57.15 -52.49 65.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.909 -1.119 . . . . 0.0 109.161 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.58 ' CE1' HD22 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -79.21 -40.14 31.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 110.097 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.03 ' CG ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -64.43 -22.36 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.0 109.64 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 17' ' ' PHE . 2.6 ttp . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 0.0 109.816 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.743 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.27 0.557 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 167.44 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CD1' HG21 ' B' ' 167' ' ' VAL . 3.2 t80 -102.47 122.57 44.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.484 -1.286 . . . . 0.0 109.697 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.786 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.6 p90 -156.08 167.18 31.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.707 ' CD1' HG21 ' A' ' 57' ' ' THR . 2.5 mp -120.25 149.29 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 111.42 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.67 108.08 17.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.986 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.627 ' HB2' HD13 ' A' ' 145' ' ' ILE . 2.8 m -66.84 56.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.572 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 67.31 81.8 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.89 -8.59 49.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -120.23 121.8 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.239 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -89.57 105.25 17.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.095 -1.003 . . . . 0.0 110.62 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.786 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.53 110.51 51.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.78 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.1 Cg_endo -71.94 129.47 15.36 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.569 . . . . 0.0 112.107 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.784 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.2 mt -125.74 135.83 52.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.46 117.36 42.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.336 -1.478 . . . . 0.0 109.791 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.996 HD21 ' C ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -116.2 114.88 25.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.061 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -155.13 41.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.23 125.37 24.63 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.286 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.83 148.11 40.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.009 1.531 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.39 150.69 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.207 0.527 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.27 174.38 12.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.032 HG12 HG22 ' B' ' 168' ' ' VAL . 2.4 t -135.87 146.1 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.032 HG22 HG12 ' B' ' 167' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.738 -0.601 . . . . 0.0 110.945 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 68' ' ' CYS . 2.7 tm-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 40.1 p90 -64.36 -35.8 82.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.1 tp60 -54.85 -41.08 70.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.683 HD13 ' CE1' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -66.14 -47.4 74.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.08 HG11 ' HA ' ' A' ' 50' ' ' PHE . 38.9 t -65.31 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.1 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.74 -49.32 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -58.97 -38.23 78.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.895 . . . . 0.0 109.89 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.019 ' O ' HD12 ' A' ' 12' ' ' LEU . . . -76.29 -44.69 35.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.04 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 75.4 t -57.77 -39.87 72.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.404 -0.81 . . . . 0.0 109.163 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -56.05 -41.66 75.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.869 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -76.87 -44.85 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.019 HD12 ' O ' ' A' ' 8' ' ' ALA . 1.1 mt -62.11 -44.37 96.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 110.013 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.593 HE21 HG12 ' A' ' 9' ' ' VAL . 6.0 pt20 -68.27 -33.82 75.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.252 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.86 -45.13 86.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.534 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.554 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 5.6 m -55.9 -38.42 70.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.967 . . . . 0.0 110.096 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.06 35.64 2.7 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HZ ' HD23 ' A' ' 12' ' ' LEU . 23.3 p90 -139.22 10.72 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -1.137 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 9' ' ' VAL . 5.2 t80 -90.87 117.45 29.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.6 m95 -82.02 141.58 33.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -162.86 108.65 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.045 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 159.62 -2.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.53 -0.731 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.16 -156.65 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.097 . . . . 0.0 110.001 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -95.57 175.99 6.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -47.98 -86.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.595 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -76.48 -31.76 53.35 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 3.5 tt0 -59.63 -24.97 64.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.129 -1.218 . . . . 0.0 110.219 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -74.65 -49.96 19.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.8 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -70.09 -44.96 67.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.252 -0.905 . . . . 0.0 110.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.4 mp -59.89 -32.26 70.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.744 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp -55.39 -30.67 60.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.928 -1.107 . . . . 0.0 109.383 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.224 HD13 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.81 -33.99 73.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 1.224 ' N ' HD13 ' A' ' 31' ' ' LEU . 19.7 p -70.44 -32.84 70.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.557 -0.715 . . . . 0.0 110.288 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.78 -20.89 41.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.75 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.9 mt-10 -120.99 -79.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.943 -1.098 . . . . 0.0 110.391 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.1 Cg_endo -75.42 54.83 3.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.072 1.038 . . . . 0.0 110.105 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB1' ' HE2' ' A' ' 56' ' ' LYS . . . -53.03 141.61 22.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.377 -0.827 . . . . 0.0 110.736 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 92.67 15.29 53.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.64 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.44 148.8 43.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.977 . . . . 0.0 110.141 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 1.102 ' CG ' HD21 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -121.59 149.4 43.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.017 . . . . 0.0 110.514 -179.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -150.37 160.73 43.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.565 -0.709 . . . . 0.0 109.588 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.1 tt -113.47 145.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.796 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 tmt_? -112.28 151.22 29.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.628 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.571 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 9.6 t0 -94.38 133.69 37.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.086 -1.008 . . . . 0.0 110.661 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.527 -0.733 . . . . 0.0 110.635 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.255 0.55 . . . . 0.0 110.33 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 1.08 ' HA ' HG11 ' A' ' 5' ' ' VAL . 54.3 p90 -179.52 -176.79 0.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.089 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.931 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.2 p90 -115.85 155.15 28.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 110.089 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -126.07 150.68 47.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 110.047 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.091 HD22 ' CG ' ' A' ' 98' ' ' TYR . 1.4 tt -139.26 131.02 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 111.158 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.73 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -139.71 154.11 47.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.483 -0.761 . . . . 0.0 109.959 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 39' ' ' PHE . 1.5 p -129.08 174.2 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 110.585 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.808 ' HE2' ' HB1' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -111.74 139.1 47.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.198 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 58' ' ' GLN . 2.3 m -160.33 148.94 16.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 110.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' THR . 7.5 pt20 -41.92 -27.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -66.93 -53.46 31.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.253 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.64 146.55 4.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.43 HG21 ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -83.32 129.06 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -1.098 . . . . 0.0 110.133 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.797 ' NZ ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -142.08 140.92 32.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.9 OUTLIER -111.05 141.35 44.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.992 HD22 HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -138.18 152.42 48.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 110.834 -179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -121.07 165.0 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.813 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.676 HD13 ' CB ' ' A' ' 94' ' ' LEU . 5.0 tp -78.11 131.23 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -97.84 140.33 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 1' ' ' GLU . 31.0 p -92.32 128.09 38.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 72' ' ' SER . 3.3 tt0 -133.07 104.53 6.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.335 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 54.55 65.42 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.36 24.0 15.03 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 70' ' ' GLY . 0.7 OUTLIER -124.12 157.7 34.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 0.0 110.048 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -124.22 128.91 49.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.089 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -153.97 139.01 17.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.898 . . . . 0.0 110.34 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.943 HD22 ' NE2' ' A' ' 97' ' ' HIS . 1.8 tt . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 109.885 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.741 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 t . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.281 0.562 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -56.04 -38.07 70.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.273 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 -40.56 83.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -68.17 -35.39 77.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.555 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 24.8 t -55.49 -37.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 110.268 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -54.27 -35.77 62.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.943 ' NE2' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.17 -41.85 33.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.061 -1.024 . . . . 0.0 110.412 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.091 ' CG ' HD22 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -64.68 -22.15 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.205 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.522 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.91 . . . . 0.0 110.29 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.767 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 59.1 mmt-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.165 0.507 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.982 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.32 82.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 110.17 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.984 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.83 125.96 49.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.478 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.037 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -154.11 167.21 30.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.089 . . . . 0.0 110.511 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 62' ' ' LYS . 3.0 mt -101.57 149.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 111.298 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.723 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.0 m-85 -98.97 132.82 44.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.709 0.766 . . . . 0.0 110.984 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 145' ' ' ILE . 45.0 t -97.06 48.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.618 -0.676 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.02 82.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.61 -22.07 39.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 1.5 mp0 -117.05 122.02 42.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 1.2 pttm -91.68 105.29 17.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.219 -0.926 . . . . 0.0 110.312 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.732 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -87.73 108.24 19.58 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.2 Cg_endo -76.07 128.8 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.994 1.523 . . . . 0.0 112.346 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' NZ ' ' A' ' 62' ' ' LYS . 1.2 mp -125.06 134.19 52.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -117.87 117.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.596 -1.315 . . . . 0.0 111.249 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 39' ' ' PHE . 3.8 tt -92.45 114.86 27.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.11 -15.14 1.51 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 111.063 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.85 124.91 70.2 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.958 -1.088 . . . . 0.0 110.017 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.06 147.88 43.85 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.945 1.497 . . . . 0.0 110.592 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.902 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.48 158.56 14.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 0.0 110.567 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.509 ' N ' HD22 ' A' ' 153' ' ' LEU . 46.2 t . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.315 -0.866 . . . . 0.0 110.815 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.68 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.197 0.522 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.8 p -112.29 144.64 41.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.852 . . . . 0.0 110.05 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.037 HG12 ' N ' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -100.24 114.49 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.982 HG21 ' O ' ' A' ' 135' ' ' ALA . 99.6 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.559 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . 7.9 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 6' ' ' VAL . 11.8 t80 -66.9 -52.39 43.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.907 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -61.09 -39.44 89.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.476 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . 1.2 mt -67.09 -47.25 71.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.063 HG23 HG21 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -69.58 -47.92 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.245 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 2' ' ' TYR . 72.9 t -61.83 -41.27 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -58.93 -41.44 87.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.934 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.936 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -62.01 -44.16 97.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.78 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 ' HE2' ' A' ' 18' ' ' TYR . 41.3 t -57.55 -39.8 71.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.88 78.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.737 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -32.86 56.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -61.91 -43.7 98.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 110.092 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.626 ' NE2' HG12 ' A' ' 9' ' ' VAL . 40.2 mt-30 -67.2 -35.89 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -63.42 -39.27 94.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.222 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -38.81 75.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.37 1.17 23.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 1.027 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.6 t80 -94.99 21.85 7.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.659 ' HE2' HG22 ' A' ' 9' ' ' VAL . 36.3 t80 -121.25 136.03 55.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 110.258 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.704 ' CE3' ' NH2' ' A' ' 42' ' ' ARG . 9.4 m95 -104.67 148.64 26.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 110.333 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 42.1 m -31.91 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 163.81 69.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG23 HH11 ' A' ' 42' ' ' ARG . 0.5 OUTLIER -60.9 -135.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.329 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.621 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -88.34 176.16 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.76 -1.213 . . . . 0.0 109.205 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.1 -81.75 0.03 OUTLIER Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.332 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.595 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -79.9 -31.12 40.6 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.439 -1.036 . . . . 0.0 111.643 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.621 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 21.2 tp10 -58.63 -24.9 62.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.451 . . . . 0.0 110.955 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.012 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -77.15 -48.19 18.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.992 -1.067 . . . . 0.0 109.544 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.962 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.8 m-80 -70.62 -49.57 46.16 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.686 0.755 . . . . 0.0 111.142 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.465 HD11 HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -61.88 -31.59 71.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.698 . . . . 0.0 112.162 -178.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.2 pp -55.18 -35.15 64.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.75 -1.219 . . . . 0.0 109.853 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -81.25 -36.18 30.26 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 108.622 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 1.046 ' N ' HD23 ' A' ' 31' ' ' LEU . 52.0 m -70.03 -32.88 71.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.555 -0.716 . . . . 0.0 110.129 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.02 41.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.512 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 10.4 mt-10 -113.87 -76.77 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.041 . . . . 0.0 110.05 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.741 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.8 Cg_endo -73.08 61.32 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.277 1.146 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.73 141.24 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.421 ' C ' ' HG ' ' A' ' 150' ' ' SER . . . 89.34 13.45 61.66 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.883 ' C ' HD11 ' A' ' 31' ' ' LEU . 21.2 m -132.66 146.08 51.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.554 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.747 ' CG ' HD23 ' A' ' 149' ' ' LEU . 30.5 p90 -126.97 138.84 53.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.838 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -131.4 161.01 33.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.913 HG12 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.41 128.56 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.789 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 1.012 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 78.5 mtt-85 -135.73 153.43 51.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.739 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -73.94 122.79 23.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 109.7 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.338 -0.852 . . . . 0.0 110.562 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 50' ' ' PHE . 28.5 p80 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.271 0.558 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.763 ' CB ' HG21 ' A' ' 5' ' ' VAL . 35.9 p90 -92.55 -166.74 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.916 ' CE2' HG22 ' A' ' 5' ' ' VAL . 5.9 p90 -130.82 158.21 40.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.84 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 14.5 t -126.28 139.2 53.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.067 HD22 ' CD1' ' A' ' 98' ' ' TYR . 6.9 tt -121.03 139.45 53.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.698 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -139.33 154.39 47.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.839 HG11 ' CG ' ' A' ' 149' ' ' LEU . 2.4 m -130.12 174.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.392 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' SER . 18.4 tptt -105.93 130.49 53.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.715 HG21 ' HA ' ' A' ' 147' ' ' LEU . 33.7 p -134.86 -169.27 2.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -77.48 -34.95 54.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.3 t -81.73 -22.79 37.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.18 -0.95 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.48 14.62 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 1.8 t -101.04 126.4 47.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -1.123 . . . . 0.0 110.27 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.524 ' CG ' HG12 ' A' ' 138' ' ' ILE . 8.7 mmpt? -114.07 147.3 38.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.235 -0.916 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' CB ' ' OG ' ' A' ' 54' ' ' SER . 10.7 p30 -112.02 144.07 41.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 110.706 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.995 HD22 HG23 ' B' ' 167' ' ' VAL . 1.2 mp -138.93 152.26 47.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.594 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 50' ' ' PHE . 3.3 ptt180 -123.49 164.04 19.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.063 HG21 HG23 ' A' ' 5' ' ' VAL . 6.6 tp -76.78 143.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -113.05 144.66 42.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.559 ' CB ' ' HB3' ' A' ' 1' ' ' GLU . 13.7 t -101.99 118.85 37.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 110.368 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 71' ' ' GLY . 22.9 tt0 -105.21 102.89 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.037 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.21 -83.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -139.87 37.69 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.64 163.07 32.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -1.107 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.617 ' CE1' ' CB ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -122.4 127.97 50.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 3.4 m -155.55 159.91 40.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.856 HD13 HD12 ' A' ' 94' ' ' LEU . 10.5 tp . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.844 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB1' ' A' ' 8' ' ' ALA . 7.8 p . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.091 0.472 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.8 mt -55.64 -35.98 66.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.723 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -62.53 -46.36 88.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.865 -1.147 . . . . 0.0 109.209 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -68.25 -34.82 76.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.44 -0.787 . . . . 0.0 109.58 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 91' ' ' VAL . 56.0 t -54.74 -36.43 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 110.438 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -52.61 -33.12 44.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -78.18 -36.79 47.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.156 -0.965 . . . . 0.0 109.476 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.067 ' CD1' HD22 ' A' ' 53' ' ' LEU . 6.9 m-85 -73.59 -22.05 60.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.316 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.0 mtt85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.237 0.542 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 173.85 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.13 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.3 t80 -102.81 121.52 42.63 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.719 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.158 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.24 148.67 20.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 110.137 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.013 HD13 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -102.65 150.18 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.977 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.594 ' CZ ' ' OH ' ' A' ' 137' ' ' TYR . 76.2 m-85 -86.19 132.71 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 110.435 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.641 ' HB3' HD13 ' A' ' 145' ' ' ILE . 1.3 t -98.49 69.23 1.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.65 41.93 75.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.56 2.76 29.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 140' ' ' SER . 2.8 mt-10 -117.8 121.97 42.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -70.92 105.93 3.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.463 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.75 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -101.5 120.1 55.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.866 . . . . 0.0 109.555 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.876 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 43.6 Cg_endo -69.64 129.42 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.349 1.71 . . . . 0.0 112.786 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.013 ' CD2' HD13 ' A' ' 138' ' ' ILE . 6.1 mp -121.1 101.29 7.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.3 p -102.85 117.64 48.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.624 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.945 HD22 ' O ' ' A' ' 98' ' ' TYR . 3.5 mp -76.02 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 37' ' ' GLY . 2.7 p -172.62 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.74 -1.225 . . . . 0.0 111.495 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -85.68 124.93 70.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.855 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 48.5 Cg_endo -75.7 148.06 32.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.106 1.582 . . . . 0.0 110.093 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 1.027 HD21 ' O ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -63.21 144.37 56.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.227 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.465 ' N ' HD12 ' A' ' 153' ' ' LEU . 1.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.097 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.553 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.152 0.501 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.686 ' HA ' HD21 ' A' ' 64' ' ' LEU . 2.7 t -105.87 137.52 43.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.13 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -84.63 95.49 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.114 -0.991 . . . . 0.0 109.589 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.158 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.893 . . . . 0.0 109.983 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 4' ' ' LEU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.266 0.555 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 30.2 p90 -55.72 -36.48 67.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.7 tt0 -55.03 -32.88 62.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.215 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.887 HD13 ' CD1' ' A' ' 73' ' ' PHE . 10.2 mt -62.33 -44.04 97.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.867 HG13 ' HD2' ' A' ' 51' ' ' PHE . 61.1 t -63.14 -48.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.158 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 6' ' ' VAL . 15.5 t -61.5 -50.53 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.884 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 2.0 t-20 -62.36 -44.1 97.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -67.01 -44.52 80.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.771 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.782 HG12 HE21 ' A' ' 13' ' ' GLN . 23.1 t -57.93 -40.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.823 . . . . 0.0 109.136 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -55.89 -47.86 76.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.613 -0.68 . . . . 0.0 109.867 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -36.56 63.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.918 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD22 ' CZ ' ' A' ' 17' ' ' PHE . 4.2 mt -71.77 -44.05 64.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 110.003 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.782 HE21 HG12 ' A' ' 9' ' ' VAL . 6.0 pt20 -67.89 -33.87 75.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -57.9 -34.49 69.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.07 -34.7 66.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.845 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.57 29.19 6.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.997 ' C ' HD11 ' A' ' 153' ' ' LEU . 6.7 p90 -145.97 40.24 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 110.631 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 4.9 t80 -120.38 115.81 24.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.853 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CD1' HD13 ' A' ' 153' ' ' LEU . 63.5 m95 -77.26 144.08 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 110.329 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 18.6 t -45.77 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.722 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 165.64 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.859 . . . . 0.0 110.568 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 27' ' ' ALA . 1.4 m -47.04 -97.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.069 -1.02 . . . . 0.0 109.41 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.606 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -108.05 165.88 11.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 109.199 178.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -43.3 -79.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' HA2' ' OD1' ' A' ' 28' ' ' ASN . . . -79.5 -30.47 44.79 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.369 -1.077 . . . . 0.0 111.254 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.9 mm-40 -58.49 -24.79 61.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.344 . . . . 0.0 110.954 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 22' ' ' VAL . . . -76.04 -49.78 16.6 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 109.24 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -71.18 -49.68 41.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 111.244 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.673 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -63.37 -31.09 72.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.583 -0.698 . . . . 0.0 111.797 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.924 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -53.77 -23.39 11.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.835 -1.166 . . . . 0.0 109.689 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 40' ' ' LEU . 62.6 mt -61.73 -39.51 91.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 109.191 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 93.1 p -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.6 -0.688 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.95 -20.39 45.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.7 mm-40 -125.27 -81.16 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.998 -1.064 . . . . 0.0 110.404 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.6 Cg_endo -77.17 68.38 7.41 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 122.92 0.958 . . . . 0.0 110.175 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.67 141.48 9.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.0 110.614 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 71.65 24.0 77.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.586 ' CB ' ' HB2' ' A' ' 35' ' ' PRO . 7.9 m -125.81 147.14 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -1.048 . . . . 0.0 110.474 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.784 ' CE2' HD21 ' A' ' 149' ' ' LEU . 1.2 p90 -122.83 147.1 46.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.995 HD23 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -145.29 159.71 42.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.493 -0.754 . . . . 0.0 109.72 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.645 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 5.3 tt -114.31 137.9 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.105 -0.997 . . . . 0.0 110.118 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -112.63 131.82 55.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.0 110.438 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 35.9 t0 -89.28 118.22 28.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.55 ' CB ' ' CD2' ' A' ' 49' ' ' HIS . 5.7 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.202 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.55 ' CD2' ' CB ' ' A' ' 44' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.214 0.531 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.851 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.2 p90 176.77 -151.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.114 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.867 ' HD2' HG13 ' A' ' 5' ' ' VAL . 25.8 p90 -115.37 151.92 33.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -1.0 . . . . 0.0 109.869 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' LEU . 36.2 m -125.9 135.74 52.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.945 . . . . 0.0 110.499 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.949 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -120.75 123.32 42.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.871 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -140.34 155.72 46.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.483 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.743 HG12 ' OH ' ' A' ' 136' ' ' TYR . 2.7 p -134.53 174.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 0.0 110.689 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.42 133.69 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.82 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.849 HG21 ' HG ' ' A' ' 147' ' ' LEU . 8.8 t -132.93 -156.96 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.58 -58.36 2.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.899 ' HB2' HG23 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -44.63 -61.43 1.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 57' ' ' THR . . . -179.05 172.84 45.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 56' ' ' LYS . 49.2 p -99.37 108.97 21.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -1.119 . . . . 0.0 110.238 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.843 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -108.43 177.83 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.945 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 1.091 ' O ' HD23 ' A' ' 64' ' ' LEU . 23.8 m-20 -128.42 132.47 48.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 110.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.091 HD23 ' O ' ' A' ' 63' ' ' ASN . 8.2 mt -131.69 152.12 51.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -147.9 168.43 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.0 110.516 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.0 HG21 ' CD2' ' A' ' 73' ' ' PHE . 44.0 mm -76.82 146.74 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -114.41 150.82 34.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.513 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 54.1 t -89.01 132.85 34.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.317 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 71' ' ' GLY . 10.3 tm-20 -123.86 102.94 8.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.02 -89.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -133.61 24.62 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -132.93 162.92 30.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 1.0 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -110.91 136.38 50.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -155.23 150.29 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.299 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.808 ' CB ' HD22 ' A' ' 94' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.972 0.415 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -65.16 -47.25 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 109.537 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 0.2 OUTLIER -68.21 -33.47 74.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 0.0 108.851 178.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.984 HD13 ' CD1' ' A' ' 66' ' ' ILE . 7.5 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.828 -0.545 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -53.04 -36.8 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.399 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 99' ' ' MET . 7.4 m170 -53.42 -45.47 69.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.999 -1.063 . . . . 0.0 108.22 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -78.73 -38.43 38.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.774 . . . . 0.0 108.92 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.949 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.77 -22.11 66.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.689 ' HG3' HD23 ' A' ' 149' ' ' LEU . 3.2 ttp . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.898 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.785 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.217 0.532 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.41 78.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.175 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.8 125.02 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.049 -1.032 . . . . 0.0 109.463 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.992 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -155.01 167.62 29.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 110.622 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 mt -101.43 147.43 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.0 110.958 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.703 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -96.66 133.31 41.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -96.64 67.54 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.703 -0.623 . . . . 0.0 110.26 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.54 -65.11 0.17 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -133.25 3.97 4.84 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.3 121.96 40.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -1.196 . . . . 0.0 110.289 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 9.7 mttt -82.25 105.53 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 147' ' ' LEU . 1.1 mp -89.45 108.94 28.03 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 0.0 108.947 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.3 Cg_endo -71.72 129.53 15.68 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.206 1.635 . . . . 0.0 112.191 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.64 135.12 52.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.595 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 5.7 p -118.51 117.48 54.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.939 -1.1 . . . . 0.0 110.822 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.792 ' C ' HD23 ' A' ' 149' ' ' LEU . 5.2 tt -113.73 115.07 27.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.519 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -146.05 11.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.026 -1.046 . . . . 0.0 111.352 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.69 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -118.43 124.62 28.4 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.256 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.72 145.85 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.895 1.471 . . . . 0.0 110.719 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 1.094 HD13 ' CD1' ' A' ' 19' ' ' TRP . 4.2 pp -82.11 139.86 34.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.563 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 3.9 m . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.392 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.945 ' O ' HD22 ' A' ' 64' ' ' LEU . 6.4 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.235 0.54 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -82.21 -175.3 5.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.872 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.175 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -107.64 -158.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.028 . . . . 0.0 110.215 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.942 HG21 ' O ' ' A' ' 135' ' ' ALA . 37.5 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 110.29 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.584 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.7 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 17.9 p90 -67.08 -35.71 80.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.571 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -54.78 -32.97 60.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.103 -0.998 . . . . 0.0 110.523 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.1 mt -67.32 -48.13 68.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 110.616 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 49' ' ' HIS . 2.0 m -72.76 -44.46 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 0.0 110.53 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 9' ' ' VAL . 95.7 t -58.47 -32.46 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -33.06 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.93 -1.106 . . . . 0.0 110.807 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.688 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . . . -76.19 -33.59 59.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.153 -0.967 . . . . 0.0 111.143 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 6' ' ' VAL . 1.5 m -56.49 -37.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 108.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 71.2 mtt180 -55.57 -42.82 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.854 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -46.86 19.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -65.46 -39.44 92.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.9 mt-30 -59.97 -33.96 72.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -72.0 -29.8 64.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 110.027 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 1.4 t -59.17 -43.05 92.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.97 20.11 22.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 12' ' ' LEU . 4.1 p90 -130.08 -4.69 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.267 . . . . 0.0 110.472 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -95.46 119.36 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 0.0 109.919 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CD1' HD12 ' A' ' 40' ' ' LEU . 5.7 m95 -109.22 148.1 31.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.385 -0.822 . . . . 0.0 109.911 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.488 ' C ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -134.95 25.13 3.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.381 -0.824 . . . . 0.0 109.268 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.96 1.13 14.6 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.102 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.6 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.43 -157.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.923 -1.111 . . . . 0.0 109.469 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.593 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -97.5 169.53 9.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 110.074 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -42.67 -81.45 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.15 -31.6 42.12 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.26 -1.141 . . . . 0.0 110.705 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 7.4 mt-10 -58.82 -36.78 75.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.007 -1.29 . . . . 0.0 109.865 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 42' ' ' ARG . . . -61.65 -50.57 71.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.035 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.596 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 m-80 -68.99 -38.96 79.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.371 -0.831 . . . . 0.0 110.669 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.3 mp -70.51 -31.44 68.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.523 -0.735 . . . . 0.0 112.135 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.713 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.35 -43.34 71.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.261 . . . . 0.0 110.474 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -72.01 -34.99 69.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.77 -1.207 . . . . 0.0 108.636 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.859 ' OG ' HG21 ' A' ' 61' ' ' THR . 17.2 p -70.05 -32.4 70.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.671 -0.643 . . . . 0.0 110.286 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.19 -20.98 43.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.948 . . . . 0.0 110.142 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.7 mm-40 -115.52 -77.51 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -75.28 62.14 6.02 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.213 1.112 . . . . 0.0 109.818 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.6 141.42 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . 100.03 15.95 29.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.674 ' C ' HG23 ' A' ' 55' ' ' VAL . 16.7 p -134.98 147.27 49.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.659 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.573 ' CG ' HD13 ' A' ' 149' ' ' LEU . 47.9 p90 -122.76 141.11 52.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -134.49 158.16 44.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 110.099 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.88 HD12 HD23 ' A' ' 53' ' ' LEU . 2.7 tt -114.46 130.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 5.3 tpt180 -112.75 144.06 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' OG ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -92.29 115.67 28.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.832 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.222 0.534 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' HIS . 31.8 p90 -178.63 154.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.12 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.605 ' O ' ' CD1' ' A' ' 51' ' ' PHE . 9.3 p90 -124.15 141.44 52.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.507 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -127.01 148.13 50.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 109.631 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.038 HD11 ' CD1' ' A' ' 98' ' ' TYR . 4.3 pp -120.94 153.12 37.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.793 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.615 ' HB2' ' CA ' ' A' ' 63' ' ' ASN . 4.0 t -139.12 153.9 48.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 109.969 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG23 ' C ' ' A' ' 38' ' ' THR . 3.3 p -127.03 174.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -103.53 136.57 43.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -168.57 169.41 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -44.51 -44.43 8.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.628 ' CB ' HG21 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -54.16 -46.18 72.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.177 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.92 161.89 9.59 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.859 HG21 ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -80.13 111.78 16.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 110.195 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -142.0 152.87 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.487 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.615 ' CA ' ' HB2' ' A' ' 54' ' ' SER . 7.7 p30 -120.51 156.28 31.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.967 HD22 ' HA ' ' B' ' 166' ' ' THR . 23.8 mt -134.34 141.99 47.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -104.29 -177.55 3.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.295 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -105.46 149.04 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.248 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -95.65 132.24 41.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.154 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -106.27 136.84 45.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 71' ' ' GLY . 4.0 tt0 -132.0 102.91 6.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.47 -78.44 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -147.84 34.97 1.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.15 146.61 33.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.108 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 9.1 m-30 -110.97 155.85 22.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.15 165.92 32.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.975 . . . . 0.0 110.586 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 109.689 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' A' ' 8' ' ' ALA . 5.2 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.462 0.649 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -55.71 -34.87 65.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -57.66 -31.72 66.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.975 -1.078 . . . . 0.0 109.224 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.97 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -68.01 -34.62 76.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.603 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.97 ' N ' HD23 ' A' ' 94' ' ' LEU . 54.7 t -54.71 -37.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.155 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -53.8 -29.88 42.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.787 ' CE1' HD12 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -67.56 -40.86 84.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.038 ' CD1' HD11 ' A' ' 53' ' ' LEU . 38.1 m-85 -70.87 -15.74 62.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 97' ' ' HIS . 15.4 mmt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 27.2 mtp85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.287 0.565 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.41 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.083 ' CZ ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -102.72 124.65 48.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.083 -1.01 . . . . 0.0 109.065 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.901 ' H ' HG12 ' B' ' 168' ' ' VAL . 7.8 p90 -155.44 167.36 30.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.828 -1.17 . . . . 0.0 111.48 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.809 HD12 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -104.21 149.27 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.624 0.726 . . . . 0.0 111.0 -178.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.765 ' OH ' HG23 ' B' ' 168' ' ' VAL . 16.9 m-85 -96.42 133.34 40.96 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.494 0.664 . . . . 0.0 110.644 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.609 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -125.95 126.45 44.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 110.568 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 41.18 68.54 0.63 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.74 22.7 2.0 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 140' ' ' SER . 5.1 tp10 -117.7 121.97 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -1.208 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -84.64 105.62 15.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.663 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -99.17 98.78 6.98 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.893 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.7 Cg_endo -73.08 127.27 11.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 111.792 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.809 ' CD2' HD12 ' A' ' 138' ' ' ILE . 0.5 OUTLIER -126.14 133.2 51.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.1 p -107.53 117.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.765 -1.209 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.083 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.7 pp -102.34 123.17 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.2 OUTLIER -154.88 14.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.824 -179.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 37' ' ' GLY . 1.5 tpt180 -101.34 124.22 41.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.987 -1.071 . . . . 0.0 109.976 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.14 138.11 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.946 1.498 . . . . 0.0 110.591 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 40' ' ' LEU . 21.6 tp -91.22 123.55 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.187 0.518 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.967 ' HA ' HD22 ' A' ' 64' ' ' LEU . 8.8 t -149.78 154.83 39.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.945 HG21 ' CD2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -93.17 173.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.132 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.901 HG12 ' H ' ' A' ' 137' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.246 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 4' ' ' LEU . 1.5 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.232 0.539 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.4 p90 -56.73 -35.95 69.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.508 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 2.6 tm0? -67.95 -42.84 80.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.3 mt -67.1 -47.48 71.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.72 HG12 ' CZ ' ' A' ' 73' ' ' PHE . 25.7 m -61.4 -38.64 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.055 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 2' ' ' TYR . 25.6 t -58.72 -51.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.47 -45.51 91.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.04 97.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.683 HG23 ' CD2' ' A' ' 51' ' ' PHE . 13.8 t -57.44 -39.82 70.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.351 -0.843 . . . . 0.0 109.327 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.89 72.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.712 . . . . 0.0 109.936 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -41.03 46.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 21.4 tp -72.1 -43.99 63.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 9' ' ' VAL . 12.2 mt-30 -60.12 -33.5 72.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.56 -27.65 62.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.595 ' OG ' ' CD2' ' A' ' 17' ' ' PHE . 96.2 p -60.76 -43.09 98.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 109.843 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.35 26.99 7.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.91 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.9 p90 -132.39 -5.06 3.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 0.0 110.606 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.68 ' CD1' ' CG2' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -106.42 114.91 29.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.014 -1.054 . . . . 0.0 110.004 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.788 ' CE2' HD11 ' A' ' 40' ' ' LEU . 1.7 p-90 -126.46 148.24 49.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 110.025 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.01 107.49 14.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.98 10.19 0.17 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.551 -0.718 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -120.41 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -93.32 175.34 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.881 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.42 -81.99 0.04 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.734 ' HA2' ' ND2' ' A' ' 28' ' ' ASN . . . -79.35 -31.57 41.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.575 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.7 tt0 -59.22 -24.82 63.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.238 . . . . 0.0 109.94 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 23' ' ' THR . . . -69.16 -48.58 61.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.885 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.734 ' ND2' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -68.8 -47.26 66.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.396 -0.815 . . . . 0.0 110.899 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 1.5 mp -59.27 -31.92 69.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.797 . . . . 0.0 111.472 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -55.8 -46.08 78.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.9 -1.125 . . . . 0.0 109.665 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.023 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -73.08 -36.2 66.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 108.579 178.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 1.023 ' N ' HD23 ' A' ' 31' ' ' LEU . 1.9 m -69.8 -32.73 71.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 110.018 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.58 -20.95 42.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.6 mt-10 -113.15 -77.11 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.7 Cg_endo -72.11 64.11 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.33 1.174 . . . . 0.0 110.199 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 141.48 10.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.219 -0.926 . . . . 0.0 110.538 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 90.53 15.74 56.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.873 ' O ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -135.07 147.23 49.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -1.026 . . . . 0.0 110.252 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 149' ' ' LEU . 10.4 p90 -122.76 142.22 50.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 0.0 110.094 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 41' ' ' ILE . 5.5 tt -131.26 151.56 51.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.426 -0.796 . . . . 0.0 110.394 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.885 HD12 HD23 ' A' ' 53' ' ' LEU . 9.0 tt -114.77 128.07 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.446 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 5.5 tpt180 -119.56 139.56 51.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 1.4 t0 -73.89 138.06 44.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.443 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.311 0.577 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.55 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.3 p90 -79.71 168.57 19.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.922 . . . . 0.0 110.182 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.843 ' CE1' HG21 ' A' ' 91' ' ' VAL . 7.8 p90 -123.1 139.26 54.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 7.1 t -128.22 154.47 45.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.155 HD21 ' CG ' ' A' ' 98' ' ' TYR . 3.9 pp -139.47 151.38 46.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.941 -1.099 . . . . 0.0 110.456 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.579 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 0.8 OUTLIER -139.29 153.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.0 110.262 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 56' ' ' LYS . 10.7 p -129.01 173.47 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.333 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HB2' ' CA ' ' A' ' 32' ' ' SER . 9.6 tttm -116.92 139.14 50.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.606 HG21 HD22 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -146.26 -171.76 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.147 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.99 62.44 3.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 p -175.54 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.856 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.97 135.51 2.89 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 t -79.12 125.49 29.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.211 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' SER . 14.6 mmtt -123.8 141.96 51.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 110.175 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 5.1 p30 -116.73 138.87 51.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.574 HD13 HG22 ' B' ' 167' ' ' VAL . 0.7 OUTLIER -132.16 131.01 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.419 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.504 ' HG3' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -96.29 157.08 16.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -100.6 136.3 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.152 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -119.91 150.98 39.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.276 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 72' ' ' SER . 19.9 p -87.95 130.26 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.56 124.37 48.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.4 -74.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -158.53 20.91 0.32 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 24.2 p -134.03 163.41 29.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.72 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.56 130.68 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.819 ' HA ' HD11 ' A' ' 94' ' ' LEU . 9.5 p -145.52 167.08 23.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.777 HD11 ' CE1' ' A' ' 97' ' ' HIS . 2.7 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' A' ' 51' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.197 0.522 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 9.3 mp -57.6 -46.64 83.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.565 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -38.38 84.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.024 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.819 HD11 ' HA ' ' A' ' 74' ' ' SER . 7.4 mt -68.09 -34.82 77.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.622 -0.673 . . . . 0.0 109.836 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 91' ' ' VAL . 26.9 t -54.66 -37.71 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 110.042 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -53.49 -35.53 60.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.029 . . . . 0.0 109.339 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.777 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -78.16 -34.19 49.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.714 . . . . 0.0 109.776 179.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.155 ' CG ' HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -61.88 -22.21 65.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.456 -0.778 . . . . 0.0 111.314 -178.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.865 ' HB2' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 120.913 -1.117 . . . . 0.0 111.554 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.741 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 5.9 tmm_? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 167.17 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.932 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.916 ' CD2' HG11 ' B' ' 167' ' ' VAL . 5.8 t80 -114.44 120.69 41.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.876 -1.14 . . . . 0.0 109.623 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.962 ' H ' HG12 ' B' ' 167' ' ' VAL . 1.8 p90 -157.15 166.89 31.99 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.954 -1.091 . . . . 0.0 109.998 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 147' ' ' LEU . 1.8 mp -119.24 147.41 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 120.88 -1.137 . . . . 0.0 111.51 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.833 ' CE2' HG23 ' B' ' 166' ' ' THR . 1.2 m-30 -84.65 107.77 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.705 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.762 ' HB3' HD13 ' A' ' 145' ' ' ILE . 10.3 t -92.47 124.82 36.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.68 61.54 3.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 57.09 20.28 34.28 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -120.23 121.73 39.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.942 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.62 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.06 105.44 11.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.005 -1.059 . . . . 0.0 110.704 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.863 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -97.71 115.09 65.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.2 Cg_endo -71.81 128.73 14.52 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 112.204 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.774 ' O ' ' O ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -126.1 136.46 52.93 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.4 t -97.41 116.45 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.062 -1.649 . . . . 0.0 109.852 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 98' ' ' TYR . 1.2 tt -91.47 125.31 36.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 6.9 p -165.55 46.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.78 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 4.4 mtp180 -134.08 124.54 17.53 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.06 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.0 Cg_endo -76.55 148.13 29.12 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.875 1.461 . . . . 0.0 110.771 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.91 HD21 ' O ' ' A' ' 17' ' ' PHE . 4.4 pp -88.18 158.04 18.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.589 ' C ' ' O ' ' A' ' 153' ' ' LEU . 14.0 t . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.704 -0.622 . . . . 0.0 111.067 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.573 ' C ' HG22 ' B' ' 166' ' ' THR . 36.6 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.236 0.541 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.833 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.2 OUTLIER 171.67 166.95 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -0.885 . . . . 0.0 110.311 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.962 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.58 -162.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.384 -0.823 . . . . 0.0 110.274 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.936 HG22 ' CE2' ' A' ' 137' ' ' TYR . 3.6 t . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.271 -0.893 . . . . 0.0 110.296 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.514 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.515 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -61.46 -47.91 83.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 110.053 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -67.53 -32.96 74.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.368 -0.832 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 71' ' ' GLY . 63.4 mt -57.01 -47.39 80.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.868 HG21 ' CA ' ' A' ' 50' ' ' PHE . 3.0 t -61.07 -47.24 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.092 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -43.19 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.134 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -65.0 -39.8 93.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.032 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.28 -44.45 52.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.895 . . . . 0.0 110.026 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.798 HG12 HE21 ' A' ' 13' ' ' GLN . 94.8 t -57.83 -39.91 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 0.0 109.391 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -55.74 -43.74 76.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.482 -0.762 . . . . 0.0 110.054 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -77.97 -44.33 27.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' HG21 ' A' ' 41' ' ' ILE . 44.9 tp -65.98 -42.1 90.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.798 HE21 HG12 ' A' ' 9' ' ' VAL . 3.5 pt20 -68.18 -38.86 82.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.257 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.4 tm-20 -57.79 -44.91 86.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -26.91 51.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.48 31.2 8.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.703 ' CZ ' ' CE1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -129.76 8.38 5.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -1.141 . . . . 0.0 110.266 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.785 ' HE2' HG22 ' A' ' 9' ' ' VAL . 2.6 t80 -90.81 136.18 33.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.972 ' CG ' HD12 ' A' ' 40' ' ' LEU . 12.9 m95 -108.48 143.42 37.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.334 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.687 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -149.78 110.99 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.892 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.36 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.66 -161.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 0.0 110.145 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -93.7 165.81 12.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.639 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.51 -84.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.669 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -60.66 -41.93 99.12 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.1 mt-10 -59.56 -27.12 65.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.973 -1.31 . . . . 0.0 110.212 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -78.3 -44.55 25.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 110.023 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.689 ' O ' HD23 ' A' ' 31' ' ' LEU . 8.8 m-80 -68.78 -48.27 64.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.465 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.6 mp -59.19 -32.32 69.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.832 . . . . 0.0 111.038 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -55.98 -26.19 47.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 38' ' ' THR . 2.4 pp -68.52 -33.17 73.65 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.396 -0.921 . . . . 0.0 108.599 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.535 ' CA ' ' HD2' ' A' ' 56' ' ' LYS . 7.5 t -69.78 -32.93 71.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.611 -0.681 . . . . 0.0 110.056 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.61 -20.99 41.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 110.013 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.769 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 22.2 mt-10 -122.85 -83.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 110.552 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.769 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.5 69.5 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.894 0.944 . . . . 0.0 110.44 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.34 141.38 41.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 110.287 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 78.6 20.68 70.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.985 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.5 m -124.99 147.88 48.71 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -1.041 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.715 ' HB2' HG12 ' A' ' 55' ' ' VAL . 13.0 p90 -122.42 145.71 48.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.542 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.972 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.03 159.47 43.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.466 -0.772 . . . . 0.0 109.964 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.578 HG21 ' CD2' ' A' ' 12' ' ' LEU . 3.1 tt -114.79 143.74 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.283 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.1 tpm_? -129.71 132.04 46.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' A' ' 42' ' ' ARG . 1.9 t0 -77.09 103.95 7.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.515 ' HB2' ' N ' ' A' ' 24' ' ' GLY . 64.2 m . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.133 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.513 ' NE2' ' CE1' ' A' ' 2' ' ' TYR . 35.4 m80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.279 0.561 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.868 ' CA ' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 59.95 108.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.099 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 14.6 p90 -115.88 143.5 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.4 m -126.08 155.29 41.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.89 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -130.84 128.43 40.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.519 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -139.26 154.09 47.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.45 -0.781 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.815 ' HA ' HD21 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -135.17 174.22 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HD2' ' CA ' ' A' ' 32' ' ' SER . 6.7 tttt -111.03 139.24 46.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.171 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.958 ' HB ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -131.97 -142.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 110.163 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 59' ' ' SER . 5.4 tt0 -46.09 -27.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.066 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER 163.46 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.522 -0.736 . . . . 0.0 109.77 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 80.5 1.53 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 56' ' ' LYS . 13.3 p -94.49 108.88 20.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 0.0 109.872 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.926 ' HD2' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -137.11 172.79 12.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -140.16 155.33 47.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.998 HD11 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.31 129.94 27.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 110.655 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -80.22 156.35 26.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' CE2' ' A' ' 73' ' ' PHE . 6.8 tp -76.77 140.54 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 110.413 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.8 OUTLIER -91.81 117.77 30.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.658 ' SG ' HD12 ' A' ' 4' ' ' LEU . 42.0 t -98.93 117.15 32.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.02 102.95 14.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.861 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.34 -81.37 0.59 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.733 ' O ' HD11 ' A' ' 4' ' ' LEU . . . -141.45 6.79 2.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.4 OUTLIER -104.02 163.61 12.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 110.299 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.42 141.33 43.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.404 -0.81 . . . . 0.0 110.202 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 67' ' ' GLN . 4.0 p -155.41 139.99 16.94 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.935 . . . . 0.0 110.753 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.084 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 1.5 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.904 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -57.58 -47.35 82.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.999 -1.063 . . . . 0.0 108.899 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 93' ' ' LYS . 26.0 mmtt -68.44 -34.06 75.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 108.714 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.084 HD13 ' CB ' ' A' ' 75' ' ' LEU . 19.6 mt -59.82 -33.13 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.201 0.524 . . . . 0.0 110.297 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.19 -36.43 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.5 OUTLIER -53.68 -52.71 59.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.584 -1.322 . . . . 0.0 108.906 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.682 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 19.9 t60 -79.58 -53.12 7.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -0.865 . . . . 0.0 109.692 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.89 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.02 -22.25 65.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.726 -0.609 . . . . 0.0 110.344 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.733 ' HA ' HD11 ' A' ' 149' ' ' LEU . 2.3 mtp . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.768 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 8.5 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.253 0.549 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.88 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 162.49 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 109.874 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.132 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -106.73 125.52 51.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.977 ' N ' HG12 ' B' ' 167' ' ' VAL . 14.5 p90 -155.04 167.63 29.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.73 -1.231 . . . . 0.0 111.108 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.926 HG21 ' HD2' ' A' ' 62' ' ' LYS . 3.0 mp -101.93 149.07 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 110.933 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.713 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.9 m-85 -99.15 133.08 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 110.985 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER -89.91 -162.77 0.92 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.657 -0.652 . . . . 0.0 110.004 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -43.04 -45.93 6.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.0 18.31 0.23 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 145' ' ' ILE . 4.1 mm-40 -120.34 123.92 44.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.18 . . . . 0.0 110.403 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 23.5 mtpt -75.73 105.33 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.035 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.07 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -91.83 110.9 46.83 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.897 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -76.47 128.99 10.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.143 1.602 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.07 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -124.63 123.16 39.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.289 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.7 p -102.53 117.44 47.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.67 -1.269 . . . . 0.0 110.297 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.993 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.9 pp -108.65 132.29 54.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.875 . . . . 0.0 110.047 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.2 p -169.9 27.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.026 -1.046 . . . . 0.0 110.73 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.573 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -113.58 124.84 30.48 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 109.943 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 46.6 Cg_endo -73.76 129.82 13.95 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.988 1.52 . . . . 0.0 110.703 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.773 ' HB2' HG22 ' A' ' 38' ' ' THR . 36.7 tp -91.92 128.57 37.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.105 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.998 ' O ' HD11 ' A' ' 64' ' ' LEU . 4.7 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.06 0.457 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.536 ' C ' ' O ' ' B' ' 165' ' ' SER . 46.3 p -30.34 123.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.568 -0.707 . . . . 0.0 110.44 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.132 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -92.53 84.16 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 110.268 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 135' ' ' ALA . 32.8 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.592 ' CA ' HD12 ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.652 ' O ' HG23 ' A' ' 6' ' ' VAL . 29.8 p90 -61.19 -35.86 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -55.0 -37.39 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.2 mt -60.9 -47.34 86.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 50' ' ' PHE . 55.5 t -70.38 -42.72 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.746 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 2' ' ' TYR . 73.2 t -58.78 -50.73 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.954 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.83 -41.87 87.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.93 -41.49 98.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.817 . . . . 0.0 109.659 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.15 HG22 ' CE2' ' A' ' 18' ' ' TYR . 2.9 t -56.97 -39.53 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.147 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -48.11 75.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -78.18 -38.94 42.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.14 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -65.3 -31.9 73.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.316 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.637 HE21 HG12 ' A' ' 9' ' ' VAL . 26.7 mt-30 -66.93 -39.86 87.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -34.28 71.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.262 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 p -72.02 -37.78 69.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 154' ' ' SER . . . 94.04 -5.18 71.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 9.0 t80 -93.54 6.04 49.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -1.111 . . . . 0.0 110.007 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 1.15 ' CE2' HG22 ' A' ' 9' ' ' VAL . 2.2 t80 -90.92 131.9 36.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 40' ' ' LEU . 29.1 m95 -124.15 104.18 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 111.146 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -122.44 17.73 10.53 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.873 0.845 . . . . 0.0 108.883 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.98 47.95 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.393 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.638 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -113.63 -157.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.889 -1.132 . . . . 0.0 109.974 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.599 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 1.2 p -95.96 176.1 6.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 42' ' ' ARG . . . -52.83 -69.51 1.18 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.66 -40.94 13.77 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.087 -1.243 . . . . 0.0 110.94 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 4.6 tp10 -59.59 -28.12 66.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.721 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.026 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -77.95 -42.92 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.084 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.952 HD21 HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.28 -44.97 70.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 111.277 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.952 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -70.32 -31.92 69.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.155 -0.966 . . . . 0.0 111.851 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.026 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.6 pp -55.43 -23.8 27.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.824 -1.173 . . . . 0.0 110.223 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.767 HD13 ' O ' ' A' ' 38' ' ' THR . 2.8 pp -78.47 -38.47 40.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.715 ' OG ' HG21 ' A' ' 61' ' ' THR . 12.7 p -70.09 -32.71 70.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.85 -20.57 42.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.299 -0.876 . . . . 0.0 110.973 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.715 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 11.8 mm-40 -116.29 -75.08 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.9 -1.125 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.715 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 45.2 Cg_endo -71.64 72.58 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.302 1.159 . . . . 0.0 110.564 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -57.62 141.25 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.952 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' H ' ' CE ' ' A' ' 56' ' ' LYS . . . 77.64 19.45 75.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -133.56 148.09 51.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -1.026 . . . . 0.0 109.928 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.905 ' HB3' HG23 ' A' ' 55' ' ' VAL . 21.9 p90 -121.84 159.44 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.937 . . . . 0.0 109.945 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.816 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -152.64 159.86 43.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 110.704 -178.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.679 HG12 ' OH ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -114.45 134.76 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 13.9 tpt180 -112.71 129.93 56.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.058 -1.026 . . . . 0.0 110.033 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.6 ' OD1' ' CG ' ' A' ' 51' ' ' PHE . 15.0 m-20 -98.59 138.1 36.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.281 -0.887 . . . . 0.0 110.494 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' O ' ' HB3' ' A' ' 50' ' ' PHE . 9.1 t60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.175 0.512 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.826 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER 171.01 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.705 ' CD1' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -115.81 139.88 49.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.36 -0.838 . . . . 0.0 109.88 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 16.1 p -123.12 146.63 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.97 -1.081 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' B' ' 167' ' ' VAL . 0.2 OUTLIER -120.82 122.72 40.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 109.818 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.621 ' CB ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -143.52 155.94 44.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.726 -1.234 . . . . 0.0 112.812 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 39' ' ' PHE . 5.3 p -143.66 174.48 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.166 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 2.1 ttpt -115.72 125.45 52.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.862 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -153.88 -162.62 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.985 . . . . 0.0 110.498 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 57' ' ' THR . 5.1 mt-30 -79.77 -23.21 42.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -81.73 13.38 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.166 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.06 138.72 3.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.924 ' O ' HD11 ' A' ' 29' ' ' LEU . 2.9 t -78.85 108.76 12.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -1.139 . . . . 0.0 109.951 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 54' ' ' SER . 6.9 mmtt -109.17 157.94 18.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.213 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 64' ' ' LEU . 1.7 t-20 -111.97 152.28 28.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.877 . . . . 0.0 110.028 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.98 ' CD1' HG23 ' B' ' 167' ' ' VAL . 15.1 mt -138.52 117.52 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 0.0 110.233 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -81.8 155.71 25.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 0.0 110.586 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.851 HD13 ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -77.28 141.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 110.014 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.3 mt-30 -93.48 132.55 37.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' SER . 30.0 t -109.42 118.82 37.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 72' ' ' SER . 7.0 mm-40 -133.15 104.77 6.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.442 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.68 36.32 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.18 -0.01 55.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -103.75 163.3 12.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -1.127 . . . . 0.0 109.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.4 m-30 -110.87 148.06 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.851 ' O ' HD13 ' A' ' 66' ' ' ILE . 19.5 m -144.43 138.59 27.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.808 . . . . 0.0 110.079 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.956 ' CD1' HD11 ' A' ' 94' ' ' LEU . 10.0 tp . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 109.94 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 92' ' ' LEU . 8.6 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 13.3 mt -63.41 -46.12 87.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 108.829 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -64.95 -29.42 70.35 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.576 0.703 . . . . 0.0 109.543 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.956 HD11 ' CD1' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.51 -34.55 69.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 110.739 -178.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.872 HG12 HD11 ' A' ' 12' ' ' LEU . 3.7 m -54.19 -39.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.928 -1.108 . . . . 0.0 108.825 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -68.62 -30.01 68.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 178.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.668 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -56.73 -38.82 72.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 110.276 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.864 ' HA ' HD13 ' A' ' 149' ' ' LEU . 36.3 m-85 -73.8 -0.65 16.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.602 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.035 -1.041 . . . . 0.0 110.471 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.761 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 2.8 ttt180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.13 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.844 . . . . 0.0 109.997 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.904 ' CD1' ' O ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -102.59 124.86 48.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.018 . . . . 0.0 108.993 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.931 ' N ' HG13 ' B' ' 167' ' ' VAL . 6.7 p90 -156.02 166.34 33.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.804 -1.185 . . . . 0.0 111.016 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.889 ' H ' HD13 ' A' ' 147' ' ' LEU . 5.6 mt -102.43 149.53 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.778 0.799 . . . . 0.0 111.377 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -97.79 133.46 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.639 0.733 . . . . 0.0 110.969 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.972 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -121.43 119.53 32.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.566 -0.709 . . . . 0.0 110.52 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 42.58 63.41 1.91 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.3 13.84 23.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 140' ' ' SER . 8.3 tp10 -109.97 121.73 45.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 18.2 mttt -79.4 105.65 10.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.833 . . . . 0.0 110.561 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 147' ' ' LEU . 1.2 mp -97.22 109.67 50.71 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.846 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.59 129.38 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.139 1.599 . . . . 0.0 111.838 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.002 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.28 134.96 53.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.493 -0.755 . . . . 0.0 109.87 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.93 118.41 53.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER -76.06 157.83 32.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.87 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.4 -74.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 0.0 110.999 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 38' ' ' THR . 2.8 mtt180 -105.19 132.54 20.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.038 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 49.9 Cg_endo -78.04 148.01 24.33 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.02 1.537 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -85.26 115.9 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.346 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.723 ' C ' HD22 ' A' ' 64' ' ' LEU . 6.9 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.15 0.5 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.854 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.2 t -178.32 147.41 0.42 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.98 HG23 ' CD1' ' A' ' 64' ' ' LEU . 5.0 t -86.03 145.38 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 137' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.1 mt-10 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.237 0.542 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.577 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 t80 -66.8 -51.51 54.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.219 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -67.3 -40.8 86.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.723 HD12 ' HA ' ' A' ' 1' ' ' GLU . 3.0 mt -56.99 -45.89 82.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.158 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.887 HG21 ' HA ' ' A' ' 50' ' ' PHE . 17.0 t -71.97 -47.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 2' ' ' TYR . 81.0 t -58.75 -32.77 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.358 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -70.88 -38.68 73.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 91' ' ' VAL . . . -76.14 -44.61 37.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.485 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.696 HG12 ' HE2' ' A' ' 18' ' ' TYR . 24.5 m -57.62 -39.81 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.323 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 mmt180 -55.75 -44.44 77.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 109.82 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.09 -41.32 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.921 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.88 -41.93 95.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 19.6 mt-30 -67.75 -35.27 78.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -69.7 -49.57 52.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -58.53 -28.75 65.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.23 15.84 29.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . 4.0 m-85 -101.85 -0.94 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.144 . . . . 0.0 110.13 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.696 ' HE2' HG12 ' A' ' 9' ' ' VAL . 4.3 t80 -90.77 136.05 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.639 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.861 ' HE1' HD13 ' A' ' 153' ' ' LEU . 45.9 m95 -117.35 148.07 42.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 109.651 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -150.66 108.18 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 110.444 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.737 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . . . 176.16 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -119.42 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 110.421 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -85.61 176.14 8.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.338 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.7 -69.38 1.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -77.64 -36.04 34.52 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 3.1 tt0 -59.66 -24.57 64.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 0.0 109.603 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.002 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -74.35 -46.47 40.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.474 -0.766 . . . . 0.0 110.364 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.904 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -67.96 -36.68 80.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.845 HD13 HD21 ' A' ' 28' ' ' ASN . 0.4 OUTLIER -57.71 -32.31 67.27 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.004 -1.06 . . . . 0.0 110.282 -178.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -56.39 -23.88 40.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 108.765 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.965 HD11 ' CB ' ' A' ' 56' ' ' LYS . 1.7 pp -68.06 -33.67 75.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 m -69.56 -33.03 72.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.758 . . . . 0.0 109.777 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.01 41.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 109.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.788 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 45.1 mm-40 -125.93 -86.87 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.788 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.4 Cg_endo -74.46 68.57 5.25 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 122.831 0.911 . . . . 0.0 110.267 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 141.47 48.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 0.0 110.64 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.27 18.65 66.34 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.866 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -131.28 148.21 52.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.482 -1.01 . . . . 0.0 110.103 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.758 ' CZ ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -121.72 138.74 54.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 110.068 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.13 161.09 28.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.45 -0.781 . . . . 0.0 110.286 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -113.12 128.69 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.108 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 1.002 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -129.14 136.51 50.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.831 . . . . 0.0 109.655 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 2.3 t0 -73.77 127.57 33.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.299 -0.876 . . . . 0.0 110.184 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.23 0.538 . . . . 0.0 110.248 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.887 ' HA ' HG21 ' A' ' 5' ' ' VAL . 18.4 t80 55.04 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.878 ' HD2' HG13 ' A' ' 5' ' ' VAL . 7.3 p90 -126.24 148.79 49.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.034 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.3 m -126.42 155.03 42.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -126.93 136.52 52.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.004 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.71 154.29 45.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 109.55 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 149' ' ' LEU . 6.6 m -118.02 174.36 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.563 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.965 ' CB ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -103.91 138.98 39.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.39 -0.819 . . . . 0.0 110.28 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.724 HG23 HD11 ' A' ' 147' ' ' LEU . 21.1 m -127.32 158.14 38.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 57' ' ' THR . 43.9 mt-30 -38.92 -28.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.0 t -173.55 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.2 62.4 0.46 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.765 ' HB ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -78.95 108.94 12.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -1.194 . . . . 0.0 109.514 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -137.46 178.0 7.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 0.0 110.67 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.56 ' CA ' ' HB3' ' A' ' 54' ' ' SER . 32.5 p-10 -137.56 156.17 48.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.491 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 52' ' ' THR . 34.5 mt -131.04 152.19 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.11 156.79 18.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 110.178 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.83 HD13 ' HB2' ' A' ' 94' ' ' LEU . 3.5 tp -76.76 134.75 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.96 151.04 20.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.8 t -116.72 116.92 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.6 mm-40 -107.41 102.79 12.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.009 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.38 -79.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -143.7 45.67 0.87 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 t -142.92 163.03 33.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -1.155 . . . . 0.0 110.393 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -133.14 126.8 32.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 109.823 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.787 ' N ' HD11 ' A' ' 66' ' ' ILE . 4.1 p -155.24 146.03 22.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.018 . . . . 0.0 110.435 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.863 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.001 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.853 HG23 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.427 0.632 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.965 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -56.47 -35.37 67.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.485 -0.759 . . . . 0.0 110.154 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -58.25 -38.57 77.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.266 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.959 HD21 ' CD2' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -68.16 -35.14 77.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.418 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 94' ' ' LEU . 93.4 t -55.37 -37.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.749 . . . . 0.0 110.404 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.09 -45.51 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.58 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.419 ' CD2' ' HD1' ' A' ' 136' ' ' TYR . 1.5 t60 -78.12 -36.74 47.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.84 . . . . 0.0 109.533 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.959 ' CD2' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -69.32 -12.15 61.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 12.5 ttt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.27 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mmt-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.172 0.511 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' HG21 ' B' ' 168' ' ' VAL . . . -160.89 132.85 5.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' B' ' 167' ' ' VAL . 1.5 t80 -119.42 123.53 44.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.838 ' H ' HG22 ' B' ' 167' ' ' VAL . 3.8 p90 -155.23 166.74 32.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.857 -1.152 . . . . 0.0 111.285 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.663 ' H ' HD23 ' A' ' 147' ' ' LEU . 3.0 mt -102.44 149.11 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.388 -0.82 . . . . 0.0 111.207 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.711 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 14.8 m-85 -98.72 133.19 43.39 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.692 0.758 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.72 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -94.88 -162.07 0.91 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.68 . . . . 0.0 110.134 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.37 60.7 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 101.6 2.46 53.12 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -119.97 121.92 40.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.644 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -80.74 105.33 11.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.485 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.996 HG22 HD21 ' A' ' 147' ' ' LEU . 1.5 mp -82.77 109.13 14.82 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -74.93 129.42 12.38 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.193 1.628 . . . . 0.0 112.811 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.996 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -125.25 135.86 52.96 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 148' ' ' VAL . 13.0 p -97.43 117.15 41.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.265 -1.522 . . . . 0.0 110.428 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 98' ' ' TYR . 9.5 tp -91.88 114.8 27.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 t -161.77 10.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.892 -1.13 . . . . 0.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 2.9 mtt85 -108.93 123.93 35.62 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.679 -1.263 . . . . 0.0 109.991 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 50.1 Cg_endo -78.65 148.35 22.84 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.98 1.516 . . . . 0.0 111.039 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.861 HD13 ' HE1' ' A' ' 19' ' ' TRP . 4.4 pp -83.73 135.63 34.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.914 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.531 ' HB3' HD12 ' A' ' 153' ' ' LEU . 12.7 t . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 110.36 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.235 0.54 . . . . 0.0 110.139 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.73 159.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -113.47 170.61 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 135' ' ' ALA . 46.8 t . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.195 0.521 . . . . 0.0 111.314 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.779 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.3 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 6' ' ' VAL . 55.1 p90 -57.55 -36.04 71.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.9 tt0 -55.03 -37.98 67.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 1' ' ' GLU . 1.5 mt -58.87 -45.8 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.995 HG22 ' CE2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -71.16 -37.34 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.189 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 2' ' ' TYR . 94.9 t -58.02 -39.43 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.923 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -70.69 -34.67 72.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.797 ' HB2' HD11 ' A' ' 92' ' ' LEU . . . -76.27 -44.17 38.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.785 . . . . 0.0 110.119 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.794 HG12 HE21 ' A' ' 13' ' ' GLN . 47.3 t -57.4 -39.85 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.47 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.8 ttm180 -55.91 -45.46 78.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.947 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -38.61 43.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.862 . . . . 0.0 109.992 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 41' ' ' ILE . 18.0 tp -71.0 -40.7 71.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 110.013 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.794 HE21 HG12 ' A' ' 9' ' ' VAL . 4.6 pt20 -68.12 -34.94 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.303 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -57.95 -27.92 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.54 -27.27 69.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.865 . . . . 0.0 110.168 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.3 25.11 24.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -130.11 7.83 5.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.041 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.558 ' HD2' HD23 ' A' ' 12' ' ' LEU . 4.3 t80 -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.813 ' CG ' HD11 ' A' ' 40' ' ' LEU . 17.2 m95 -121.1 148.56 44.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.416 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -151.41 24.83 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.02 8.97 20.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.661 -0.649 . . . . 0.0 110.924 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.785 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -116.35 -160.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.049 . . . . 0.0 109.925 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.54 ' CB ' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -97.31 176.16 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.319 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.58 -85.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.593 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -70.74 -31.63 67.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -59.09 -39.17 81.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.129 -1.218 . . . . 0.0 109.958 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -64.44 -47.03 80.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.627 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.713 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 m-80 -68.91 -43.66 74.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -0.94 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.468 ' O ' ' OG ' ' A' ' 32' ' ' SER . 1.6 mp -70.53 -32.29 69.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 112.072 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -55.17 -24.42 26.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.709 -1.244 . . . . 0.0 111.032 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.016 HD13 ' O ' ' A' ' 38' ' ' THR . 4.4 pp -77.56 -37.86 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 0.0 109.584 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.884 ' N ' HD12 ' A' ' 31' ' ' LEU . 21.8 p -69.74 -32.57 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 0.0 110.28 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.65 43.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.615 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.731 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 5.3 mm-40 -115.76 -76.41 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.92 -1.112 . . . . 0.0 110.489 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.731 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.2 Cg_endo -72.69 70.37 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.286 1.151 . . . . 0.0 110.509 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 141.23 13.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 73.46 20.77 79.92 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 1.016 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.3 m -129.59 147.7 51.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -1.074 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.782 ' CD1' HG12 ' A' ' 55' ' ' VAL . 9.7 m-85 -122.9 158.46 30.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.382 -0.824 . . . . 0.0 109.454 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.006 ' HB2' HD13 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -152.38 160.57 43.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.008 -1.058 . . . . 0.0 111.195 -178.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.704 HG21 ' CD2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -113.89 129.18 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.541 -0.724 . . . . 0.0 109.906 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -117.36 161.12 20.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.282 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.486 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 7.5 t70 -100.05 138.06 37.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 109.991 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' ASP . 53.1 p . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.291 0.567 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.939 ' CA ' HG21 ' A' ' 5' ' ' VAL . 12.2 p90 -163.8 -165.01 0.96 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 1.107 ' CE1' HG22 ' A' ' 91' ' ' VAL . 13.0 p90 -134.33 139.6 45.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 110.628 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.59 ' CG2' ' HA ' ' A' ' 65' ' ' ARG . 2.2 p -126.31 155.29 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.474 -0.767 . . . . 0.0 109.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.18 HD12 ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -134.37 142.58 47.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.064 -1.023 . . . . 0.0 110.688 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.18 ' N ' HD12 ' A' ' 53' ' ' LEU . 1.3 p -124.5 154.17 40.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.097 HG11 HD22 ' A' ' 149' ' ' LEU . 21.2 m -117.63 174.01 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.114 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.99 130.79 51.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.465 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 80.5 p -141.11 156.6 45.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.76 82.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.2 t -63.0 -10.86 15.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 124.07 153.64 8.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -78.91 140.47 38.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' SER . 69.6 mmtt -139.16 133.18 31.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.585 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 1.5 p-10 -111.91 128.85 56.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 HG23 ' B' ' 167' ' ' VAL . 2.9 mp -102.43 118.14 36.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.972 . . . . 0.0 110.252 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 0.1 OUTLIER -84.52 152.26 24.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.664 HG22 ' CD1' ' A' ' 50' ' ' PHE . 4.5 tp -84.93 149.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -114.58 115.65 27.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.855 . . . . 0.0 110.504 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 27.5 p -92.04 123.15 35.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 14.9 tt0 -133.19 103.5 6.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.5 32.93 85.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.81 -11.67 69.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 82.9 p -94.74 143.1 26.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.989 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.667 ' HE2' HG23 ' A' ' 5' ' ' VAL . 3.4 m-30 -110.82 157.36 19.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.243 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -155.56 138.65 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.153 -0.967 . . . . 0.0 110.486 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.06 ' CD2' HD21 ' A' ' 94' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.107 HG22 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 8' ' ' ALA . 4.9 mp -66.36 -46.2 77.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 108.841 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -29.22 69.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.784 0.802 . . . . 0.0 108.869 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.145 HD22 ' CZ ' ' A' ' 98' ' ' TYR . 5.0 mt -57.48 -34.23 68.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 0.0 110.096 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -54.27 -38.66 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.879 -1.138 . . . . 0.0 108.686 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.478 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 7.7 m170 -68.64 -51.89 37.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 108.862 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -63.81 -36.95 85.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.358 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 3.7 m-30 -73.38 -9.16 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.642 -0.661 . . . . 0.0 110.013 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 110.2 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 ptm180 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.338 0.59 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG11 ' B' ' 168' ' ' VAL . . . 172.23 130.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.023 ' CD2' HG11 ' B' ' 167' ' ' VAL . 1.2 t80 -116.55 122.54 44.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.984 -1.072 . . . . 0.0 109.306 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.042 ' CD2' HG12 ' B' ' 168' ' ' VAL . 5.4 p90 -156.32 166.95 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.952 -1.092 . . . . 0.0 110.66 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.33 149.17 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.061 . . . . 0.0 111.356 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.71 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.7 m-30 -86.44 107.88 18.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.591 -0.693 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.947 ' HB2' HD13 ' A' ' 145' ' ' ILE . 23.0 t -55.78 84.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.018 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 66.9 -64.79 0.19 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -144.7 13.08 1.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 145' ' ' ILE . 2.8 tt0 -120.45 123.43 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.093 . . . . 0.0 109.797 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -75.5 105.57 6.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 140' ' ' SER . 0.9 OUTLIER -103.38 112.86 65.94 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.8 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.8 Cg_endo -72.79 127.47 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.76 1.4 . . . . 0.0 111.791 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.66 ' O ' ' O ' ' A' ' 136' ' ' TYR . 1.1 mp -126.42 135.24 51.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.689 ' O ' HG23 ' A' ' 148' ' ' VAL . 15.0 m -97.88 116.58 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.187 -1.571 . . . . 0.0 109.945 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.097 HD22 HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -109.5 123.34 49.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.7 m -158.61 61.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -134.37 124.92 17.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.7 144.17 34.92 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.922 1.485 . . . . 0.0 110.472 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 1.006 HD13 ' HB2' ' A' ' 40' ' ' LEU . 1.3 tt -92.03 153.74 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.885 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 64' ' ' LEU . 50.9 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.742 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -89.61 139.55 30.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.023 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -91.77 106.92 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.067 -1.021 . . . . 0.0 109.829 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.042 HG12 ' CD2' ' A' ' 137' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.791 ' O ' HG12 ' A' ' 5' ' ' VAL . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.224 0.535 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.0 p90 -60.49 -37.17 80.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.18 -41.46 77.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.341 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' SG ' ' A' ' 68' ' ' CYS . 1.1 mt -67.44 -47.21 70.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.123 HG23 ' CE2' ' A' ' 51' ' ' PHE . 3.5 p -64.95 -48.36 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.757 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 2' ' ' TYR . 12.4 p -58.7 -43.99 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 109.984 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.598 ' N ' HG13 ' A' ' 6' ' ' VAL . 1.9 m120 -59.06 -42.16 89.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.0 109.618 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.859 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -68.34 -44.17 75.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.806 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.455 HG12 HE21 ' A' ' 13' ' ' GLN . 49.1 t -57.53 -39.8 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.387 -0.821 . . . . 0.0 109.25 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 tpt180 -55.66 -49.0 74.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -34.26 49.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.806 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 tp -72.16 -44.15 63.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 110.097 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 4.9 pt20 -60.82 -33.91 73.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 25.7 tt0 -57.82 -18.98 25.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.426 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 59.1 m -55.99 -43.01 77.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.044 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.2 34.37 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 12' ' ' LEU . 15.5 p90 -153.0 18.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.253 . . . . 0.0 110.56 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 3.0 t80 -90.84 119.86 31.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.756 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 1.044 ' CG ' HD12 ' A' ' 40' ' ' LEU . 31.6 m95 -72.69 148.12 45.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.631 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.804 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -62.15 -12.67 21.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.901 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 74.1 75.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 110.915 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -46.42 -92.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 109.091 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.595 ' H ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -106.63 165.81 11.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 178.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.526 ' HA2' ' NH1' ' A' ' 42' ' ' ARG . . . -43.51 -81.16 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.614 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.26 -30.15 47.1 Favored Glycine 0 N--CA 1.491 2.349 0 O-C-N 121.41 -1.053 . . . . 0.0 110.705 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.592 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -58.22 -24.46 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.378 . . . . 0.0 110.955 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 42' ' ' ARG . . . -77.63 -46.61 21.55 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 110.146 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.758 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -70.42 -46.85 63.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 111.2 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.758 HD13 ' OD1' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -70.61 -29.98 66.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 112.069 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.952 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -52.96 -23.25 6.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.64 -1.288 . . . . 0.0 109.8 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 40' ' ' LEU . 45.0 mt -64.05 -41.33 97.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.992 -1.068 . . . . 0.0 109.219 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 55.9 p -69.1 -31.6 70.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 -20.13 47.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.787 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 17.8 mm-40 -126.15 -81.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.901 -1.124 . . . . 0.0 110.607 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 55.4 Cg_endo -77.71 68.43 7.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 122.902 0.949 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.39 135.5 33.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.625 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 87.04 7.9 76.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 35' ' ' PRO . 27.4 p -116.11 147.71 41.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -1.136 . . . . 0.0 110.608 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.957 ' CD1' HD11 ' A' ' 53' ' ' LEU . 7.2 p90 -122.3 147.3 46.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 0.0 110.374 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.044 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -147.21 160.24 42.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.481 -0.762 . . . . 0.0 109.548 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 1.4 tt -113.56 128.47 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 110.001 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.564 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 5.7 ppt_? -112.77 122.11 46.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 110.31 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.773 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 4.9 t70 -73.82 114.97 12.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.239 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 44' ' ' SER . 7.6 m-70 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.187 0.518 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.755 ' CB ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -143.6 -150.82 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.162 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 1.123 ' CE2' HG23 ' A' ' 5' ' ' VAL . 25.6 p90 -115.56 142.79 46.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 110.104 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.638 HG22 ' CG ' ' A' ' 63' ' ' ASN . 2.4 m -126.28 143.5 51.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.089 HD22 ' CD1' ' A' ' 98' ' ' TYR . 7.2 tt -124.21 135.1 53.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.655 ' CB ' ' OD1' ' A' ' 28' ' ' ASN . 23.1 p -139.26 155.42 47.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 61' ' ' THR . 10.3 p -140.94 158.9 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 110.481 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.76 137.48 41.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 147' ' ' LEU . 25.8 p -137.73 -74.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 59' ' ' SER . 2.3 mt-30 -147.43 -78.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 58' ' ' GLN . 9.8 t -42.69 -53.17 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.32 47.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 55' ' ' VAL . 5.5 m -99.56 141.02 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.17 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.9 145.86 51.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.25 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.638 ' CG ' HG22 ' A' ' 52' ' ' THR . 13.6 t-20 -111.13 132.34 54.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.92 ' CD1' HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -110.97 152.13 27.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.621 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -140.91 148.05 39.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.258 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.576 HG12 ' CD2' ' A' ' 73' ' ' PHE . 10.0 tp -76.83 128.29 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 74' ' ' SER . 2.7 tp-100 -96.54 151.1 19.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.216 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.708 ' SG ' HD13 ' A' ' 4' ' ' LEU . 36.5 t -93.01 139.12 30.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -130.08 102.94 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 44.82 -111.19 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.73 28.11 15.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.18 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 110.145 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.576 ' CD2' HG12 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -124.54 144.96 49.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 67' ' ' GLN . 47.4 t -155.54 167.12 31.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.571 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 ' CD1' ' A' ' 94' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 109.892 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG11 ' HB1' ' A' ' 8' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 91' ' ' VAL . 7.4 mp -59.52 -47.1 86.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.045 . . . . 0.0 108.974 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -31.86 72.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -59.73 -35.03 73.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.697 -0.627 . . . . 0.0 110.261 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 91' ' ' VAL . 62.9 t -54.5 -38.01 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.574 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.284 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.649 ' NE2' HG23 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.15 -50.51 11.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.932 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.089 ' CD1' HD22 ' A' ' 53' ' ' LEU . 10.0 m-85 -63.79 -11.73 29.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 4.4 tpt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.138 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.242 0.544 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.851 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.83 143.98 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.208 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.8 t80 -138.21 121.65 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.579 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.121 ' CD2' HG12 ' B' ' 168' ' ' VAL . 6.7 p90 -156.11 166.72 32.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.737 -1.227 . . . . 0.0 110.843 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.721 ' H ' HD23 ' A' ' 147' ' ' LEU . 2.5 mt -102.14 149.61 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.289 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.699 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.6 m-85 -99.4 133.37 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.637 0.732 . . . . 0.0 111.007 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -88.31 54.23 3.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.526 -0.734 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.63 31.41 1.73 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.87 -29.56 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 140' ' ' SER . 6.1 mp0 -116.06 121.91 43.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.12 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.66 105.39 8.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.096 HG22 HD21 ' A' ' 147' ' ' LEU . 1.3 mp -87.56 110.64 35.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.711 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 48.9 Cg_endo -75.72 128.12 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.026 1.54 . . . . 0.0 112.728 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.096 HD21 HG22 ' A' ' 145' ' ' ILE . 2.0 mm? -125.49 135.32 52.18 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 148' ' ' VAL . 5.6 m -98.68 116.38 41.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.006 -1.684 . . . . 0.0 111.218 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.961 HD12 ' CD2' ' A' ' 136' ' ' TYR . 1.6 mt -91.05 125.89 35.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.022 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 90.9 p -151.23 -24.39 0.21 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.774 -1.204 . . . . 0.0 111.985 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 38' ' ' THR . 47.5 mtp180 -85.85 124.5 70.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.627 -1.296 . . . . 0.0 110.328 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.57 148.23 25.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.104 1.581 . . . . 0.0 110.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.941 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.54 158.13 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.357 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 153' ' ' LEU . 7.7 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.264 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.31 0.576 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.436 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -94.04 151.43 19.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.291 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.208 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.2 t -87.59 -160.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 1.121 HG12 ' CD2' ' A' ' 137' ' ' TYR . 21.4 m . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.215 0.531 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.478 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.18 -35.74 79.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 43.4 tp60 -54.79 -33.85 61.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.168 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.098 HD22 ' CD1' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -57.0 -47.02 81.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.035 HG22 ' CD2' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -59.89 -44.41 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 73.7 t -58.73 -51.14 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 48.3 m-20 -59.83 -46.08 90.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -63.08 -43.51 98.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -0.801 . . . . 0.0 109.655 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 18' ' ' TYR . 25.6 t -57.29 -39.31 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.72 . . . . 0.0 109.311 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.7 tpt180 -55.42 -40.92 72.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.445 -0.784 . . . . 0.0 109.887 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -42.15 32.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 41' ' ' ILE . 1.2 tp -72.0 -38.87 69.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.681 HE21 HG12 ' A' ' 9' ' ' VAL . 2.6 pt20 -65.77 -33.97 77.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.84 -18.96 25.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -56.6 -43.49 80.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 110.081 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.97 30.9 2.02 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.662 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 15' ' ' SER . 1.6 p90 -159.93 33.79 0.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.43 . . . . 0.0 111.134 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.786 ' CE2' HG13 ' A' ' 9' ' ' VAL . 1.7 t80 -90.89 134.66 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.725 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.727 ' CB ' HD11 ' A' ' 40' ' ' LEU . 24.8 m95 -124.5 148.55 47.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.13 23.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.01 0.15 13.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.546 -0.721 . . . . 0.0 111.004 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -107.24 -158.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.9 -1.125 . . . . 0.0 109.721 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.54 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -101.56 170.76 7.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.093 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.75 -79.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.564 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -79.32 -30.92 43.75 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.4 tp10 -58.27 -37.78 75.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -1.225 . . . . 0.0 110.069 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.47 -50.69 71.76 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.031 -1.043 . . . . 0.0 108.825 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.564 HD22 ' HA2' ' A' ' 25' ' ' GLY . 8.4 m-80 -69.79 -49.04 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 61' ' ' THR . 1.6 mp -59.77 -31.76 69.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 111.237 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.93 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.25 -22.49 11.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.998 -1.064 . . . . 0.0 109.555 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 38' ' ' THR . 80.4 mt -60.13 -35.3 74.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.087 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.672 ' HB2' ' CD ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -69.56 -32.48 71.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.112 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.2 -20.8 43.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.96 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.754 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.6 mt-10 -131.07 -84.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.515 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.754 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.1 Cg_endo -76.77 68.31 7.17 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 122.77 0.879 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.27 141.74 14.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -0.978 . . . . 0.0 110.717 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' ' CD ' ' A' ' 151' ' ' ARG . . . 72.32 25.66 73.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.855 ' O ' HD13 ' A' ' 31' ' ' LEU . 79.1 m -119.82 149.19 42.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.933 . . . . 0.0 110.692 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.845 ' CB ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.72 138.81 53.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.795 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -134.08 160.53 37.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.442 -0.786 . . . . 0.0 110.959 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.763 HG13 HD21 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -114.07 134.09 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 1.1 ttp-105 -129.32 146.35 51.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.327 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 8.2 t0 -99.08 138.0 36.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 21.6 m170 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.184 0.516 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 1.013 ' HA ' HG21 ' A' ' 5' ' ' VAL . 27.6 p90 -89.78 -177.77 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.197 -0.939 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 1.035 ' CD2' HG22 ' A' ' 5' ' ' VAL . 6.8 p90 -116.0 155.72 27.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.53 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.2 m -126.16 154.65 42.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.028 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -135.0 130.86 36.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 1.028 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.43 153.9 50.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.583 -0.698 . . . . 0.0 109.665 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.845 HG23 ' CB ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -127.59 171.18 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 110.447 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -119.38 135.42 54.74 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 0.0 110.1 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 4.4 t -127.51 61.34 1.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER 67.37 -57.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -145.84 47.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.208 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' HG22 ' A' ' 57' ' ' THR . . . -153.57 74.42 0.24 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.749 HG23 HD11 ' A' ' 29' ' ' LEU . 2.7 m -96.17 108.87 21.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.672 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.7 OUTLIER -128.97 155.29 45.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 1.049 ' O ' HD23 ' A' ' 64' ' ' LEU . 4.0 m-20 -140.07 149.22 42.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 63' ' ' ASN . 17.4 mt -134.87 147.17 49.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -108.38 153.62 23.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.313 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.087 ' CD1' HD12 ' A' ' 75' ' ' LEU . 20.0 mm -89.06 145.59 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.43 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 66' ' ' ILE . 51.5 mm-40 -122.09 132.96 54.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 72' ' ' SER . 28.1 p -88.61 125.24 34.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.11 112.27 11.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 53.5 65.82 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.36 18.02 9.22 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.8 OUTLIER -122.29 163.15 20.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -1.174 . . . . 0.0 109.882 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 1.098 ' CD1' HD22 ' A' ' 4' ' ' LEU . 5.3 m-85 -131.94 139.8 48.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 110.47 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.422 ' CA ' HD11 ' A' ' 94' ' ' LEU . 8.3 t -147.23 138.98 24.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.0 110.101 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.11 HD22 ' CE1' ' A' ' 97' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 51' ' ' PHE . 2.8 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.655 0.74 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.766 ' O ' HG12 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -54.03 -35.07 61.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 110.932 -178.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.62 ' N ' ' HG ' ' A' ' 92' ' ' LEU . 1.5 tptt -58.28 -35.65 72.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.54 -1.35 . . . . 0.0 109.06 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.624 HD12 HD12 ' A' ' 66' ' ' ILE . 63.1 mt -62.86 -34.86 78.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -54.6 -37.07 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.448 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -53.76 -31.54 48.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.02 . . . . 0.0 109.121 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 1.11 ' CE1' HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -65.86 -35.94 82.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 0.0 109.411 179.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.841 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.9 m-85 -63.05 -10.54 14.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.612 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.703 -0.623 . . . . 0.0 110.211 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.774 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 29.3 mmt-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.188 0.518 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 163.27 75.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.913 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.867 ' HB2' HG11 ' B' ' 167' ' ' VAL . 0.2 OUTLIER -102.7 124.72 48.76 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 109.321 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.972 ' N ' HG13 ' B' ' 167' ' ' VAL . 5.6 p90 -155.6 167.06 31.62 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.085 -1.009 . . . . 0.0 110.983 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.672 HD13 ' CB ' ' A' ' 62' ' ' LYS . 2.2 mp -102.75 149.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 111.11 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.694 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 17.5 m-85 -97.31 133.3 42.1 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.697 0.76 . . . . 0.0 111.096 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 3.2 t -86.48 51.92 2.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.17 27.53 1.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.42 -32.78 0.24 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 14.2 tp10 -120.19 121.98 39.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.234 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 3.9 ptmt -72.03 105.46 3.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.397 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.833 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -85.11 110.54 29.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.0 Cg_endo -75.38 129.65 12.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.124 1.591 . . . . 0.0 111.828 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 138' ' ' ILE . 1.0 OUTLIER -124.02 134.2 53.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.392 -0.818 . . . . 0.0 109.396 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 148' ' ' VAL . 13.5 m -107.61 117.53 53.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.96 -1.087 . . . . 0.0 110.604 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 55' ' ' VAL . 6.6 tt -125.08 114.82 19.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.78 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.8 t -168.1 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.038 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.589 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -111.9 124.83 31.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 109.996 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.38 138.26 29.7 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.93 1.49 . . . . 0.0 110.693 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 154' ' ' SER . 4.8 tp -91.77 145.66 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.868 ' H ' HD12 ' A' ' 153' ' ' LEU . 1.2 p . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.636 ' CB ' HG23 ' A' ' 138' ' ' ILE . 57.9 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.241 0.543 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.775 ' H ' HD22 ' A' ' 64' ' ' LEU . 1.3 m 58.52 152.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 64' ' ' LEU . 2.9 t -108.9 151.08 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.008 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.956 HG12 ' H ' ' A' ' 137' ' ' TYR . 6.5 p . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.955 . . . . 0.0 110.931 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.53 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.235 0.54 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 49' ' ' HIS . 3.6 t80 -63.29 -52.06 63.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.542 ' O ' HG12 ' A' ' 6' ' ' VAL . 5.5 tm0? -68.57 -35.77 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 73' ' ' PHE . 2.3 mt -67.13 -42.0 85.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.067 HG13 ' CD2' ' A' ' 51' ' ' PHE . 56.0 t -72.06 -46.29 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.581 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.609 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 14.2 p -58.33 -32.7 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.309 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 t-20 -68.1 -37.88 81.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 110.309 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.476 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . . . -76.25 -45.05 34.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 110.593 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 33.6 m -57.91 -39.65 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' VAL . 2.9 ttt180 -55.75 -46.77 77.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.538 -0.726 . . . . 0.0 109.92 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.06 -35.87 49.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.883 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.548 ' CD2' HG21 ' A' ' 41' ' ' ILE . 52.0 tp -71.99 -44.32 63.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 110.058 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 1.9 pt20 -68.48 -34.16 75.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.4 mt-10 -57.91 -45.0 87.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -55.91 -26.87 49.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.88 40.4 3.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 152' ' ' PRO . 1.1 m-85 -141.98 44.46 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.17 . . . . 0.0 110.609 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.589 ' HE2' HG12 ' A' ' 9' ' ' VAL . 2.8 t80 -126.59 130.36 50.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.945 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.3 m95 -102.86 147.66 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 m -44.64 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 167.78 79.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.659 HG21 ' CD2' ' A' ' 30' ' ' LEU . 2.6 t -56.03 -118.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.29 -0.881 . . . . 0.0 109.647 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.11 168.93 10.79 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.786 -1.196 . . . . 0.0 109.347 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.561 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.32 -85.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.885 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -79.37 -30.12 46.78 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.384 -1.068 . . . . 0.0 110.465 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -57.59 -42.9 84.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.242 . . . . 0.0 110.049 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -58.91 -49.28 78.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 109.046 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 52' ' ' THR . 34.8 m-80 -68.75 -44.17 74.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.425 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -70.68 -31.71 68.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 112.091 -178.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.0 pp -54.71 -24.07 20.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.712 -1.243 . . . . 0.0 110.692 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.924 HD23 HD22 ' A' ' 40' ' ' LEU . 4.0 pp -78.5 -35.64 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.004 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.665 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.87 -32.84 71.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.74 41.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.629 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 24.6 mm-40 -113.64 -76.71 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.004 -1.06 . . . . 0.0 110.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.3 Cg_endo -72.03 65.36 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.287 1.151 . . . . 0.0 110.261 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 141.25 13.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 74.85 20.17 79.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.869 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.78 146.62 49.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -1.1 . . . . 0.0 110.224 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 5.3 p90 -123.39 155.92 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 110.311 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.945 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -149.48 159.01 44.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.962 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.74 HD12 ' CD2' ' A' ' 53' ' ' LEU . 5.5 tt -115.06 128.56 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.069 -1.019 . . . . 0.0 110.324 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.89 149.72 32.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.778 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 49' ' ' HIS . 5.2 t0 -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 50' ' ' PHE . 28.2 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.555 ' C ' HG11 ' A' ' 5' ' ' VAL . 2.3 m-70 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.23 0.538 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 1.048 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 48.12 107.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.395 -0.816 . . . . 0.0 110.898 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 1.067 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.7 p90 -120.47 140.31 51.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 28' ' ' ASN . 8.2 t -126.85 155.25 43.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.383 -0.823 . . . . 0.0 109.916 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.145 HD11 ' CD1' ' A' ' 98' ' ' TYR . 2.0 pp -143.99 127.24 16.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.025 -1.047 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.743 ' O ' HD21 ' A' ' 31' ' ' LEU . 6.6 t -112.83 154.1 26.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.454 -0.779 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.977 HG11 ' HG ' ' A' ' 149' ' ' LEU . 14.9 p -127.86 173.78 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.13 -0.981 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' N ' HG22 ' A' ' 55' ' ' VAL . 4.6 tptt -117.55 139.05 51.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 0.0 110.018 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.778 HG21 ' CB ' ' A' ' 147' ' ' LEU . 4.9 p -135.7 -94.08 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.294 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.3 mm-40 -80.02 -29.17 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER 162.8 -18.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.735 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.56 100.81 2.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 56' ' ' LYS . 2.2 t -100.43 121.46 41.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -1.13 . . . . 0.0 109.925 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -139.71 171.81 13.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.076 -1.015 . . . . 0.0 110.518 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 1.4 p-10 -123.6 152.68 41.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 167' ' ' VAL . 1.0 OUTLIER -110.44 117.79 34.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.936 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.479 ' NH2' ' CZ ' ' A' ' 50' ' ' PHE . 9.2 ptm180 -83.13 151.76 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.903 HG21 ' CD2' ' A' ' 73' ' ' PHE . 6.9 mm -84.84 144.2 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.5 OUTLIER -96.08 121.37 37.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 26.8 p -88.07 118.16 27.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -133.04 121.15 22.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.221 -0.924 . . . . 0.0 110.244 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.51 95.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 4' ' ' LEU . . . 61.82 13.06 38.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 69' ' ' GLU . 13.7 p -108.8 163.21 13.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.296 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.903 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.78 128.38 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -155.17 138.98 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.997 ' CD2' HD11 ' A' ' 94' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 5.4 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.073 0.463 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.9 mp -58.06 -47.03 84.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 109.308 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 5.0 mtpp -67.86 -31.46 71.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 108.891 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -59.39 -33.71 71.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.49 -37.21 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.733 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.446 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 5.0 m-70 -53.65 -50.44 65.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.62 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 135' ' ' ALA . 7.3 t60 -78.28 -36.95 46.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.518 -0.739 . . . . 0.0 109.09 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CD1' HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.11 -12.0 46.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.887 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 149' ' ' LEU . 1.9 ttt . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.456 -0.778 . . . . 0.0 110.079 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.254 0.55 . . . . 0.0 110.336 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 166.2 147.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.416 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 1.048 ' CD2' HD11 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -100.58 162.41 12.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.851 ' C ' HD21 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -152.27 151.6 31.13 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 116.74 -1.984 . . . . 0.0 115.118 -176.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.852 ' N ' HD21 ' A' ' 147' ' ' LEU . 13.4 mt -142.17 120.57 8.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 7.7 m-85 -84.09 107.96 16.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 143' ' ' GLU . 1.6 t -72.94 66.98 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.341 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.12 89.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.94 2.15 57.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.658 ' HB3' HD11 ' A' ' 145' ' ' ILE . 1.5 mt-10 -120.04 121.86 39.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -1.147 . . . . 0.0 110.31 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.727 ' C ' HD12 ' A' ' 145' ' ' ILE . 1.1 ttpp -98.23 105.72 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.808 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.8 mp -112.7 119.02 44.06 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.778 . . . . 0.0 109.098 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 137' ' ' TYR . 48.1 Cg_endo -75.13 127.2 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.731 1.385 . . . . 0.0 111.021 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.852 HD21 ' N ' ' A' ' 138' ' ' ILE . 0.4 OUTLIER -125.59 134.33 51.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 p -120.72 118.85 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.752 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.048 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mp -76.36 150.62 36.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.218 -0.926 . . . . 0.0 109.886 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -36.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.462 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 6.9 mtp85 -104.78 124.32 37.21 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 51.2 Cg_endo -78.21 147.29 23.21 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.024 1.539 . . . . 0.0 110.198 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 40' ' ' LEU . 4.3 tp -92.18 115.84 28.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.132 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' PHE . 81.0 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.312 0.577 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 45.1 p -65.94 -162.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' VAL . . . . . 0.781 HG13 ' N ' ' A' ' 137' ' ' TYR . 55.4 t -143.06 167.61 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' VAL . . . . . 0.703 HG22 HG12 ' B' ' 167' ' ' VAL . 18.7 m . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.454 -0.779 . . . . 0.0 110.385 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.644 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.9 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.204 0.526 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.628 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -54.96 -45.24 74.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 109.956 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.628 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -54.94 -39.82 69.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.847 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.931 HD23 ' SG ' ' A' ' 90' ' ' CYS . 1.0 OUTLIER -63.75 -47.2 82.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.836 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.16 HG22 ' CE2' ' A' ' 51' ' ' PHE . 0.8 OUTLIER -65.84 -48.35 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 110.012 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.631 ' N ' HG12 ' A' ' 5' ' ' VAL . 39.5 t -59.54 -47.17 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 1.2 m120 -58.74 -28.07 65.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.704 ' HB1' ' HB ' ' A' ' 91' ' ' VAL . . . -74.13 -44.13 54.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG12 HE21 ' A' ' 13' ' ' GLN . 50.4 t -57.38 -39.72 70.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.417 -0.802 . . . . 0.0 109.357 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -55.87 -49.35 73.58 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.73 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -78.53 -36.1 45.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 41' ' ' ILE . 46.2 tp -69.48 -42.01 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.537 HE21 HG12 ' A' ' 9' ' ' VAL . 5.9 pt20 -67.99 -34.2 76.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.8 tt0 -57.91 -23.7 54.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 110.269 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 1.2 t -70.57 -27.0 63.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.23 -14.12 63.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -76.92 -10.67 59.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -1.108 . . . . 0.0 110.004 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -93.41 121.08 34.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.061 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 1.017 ' CD1' HD12 ' A' ' 40' ' ' LEU . 9.0 m95 -110.3 101.86 10.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 110.005 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -92.23 109.04 20.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 164.98 -4.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.426 -0.796 . . . . 0.0 111.088 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.618 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.85 -159.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 0.0 109.982 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -99.19 176.2 5.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 110.228 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.597 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.76 -78.25 0.1 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.761 ' N ' HG22 ' B' ' 162' ' ' VAL . . . -79.26 -34.49 32.64 Favored Glycine 0 N--CA 1.492 2.398 0 O-C-N 121.193 -1.18 . . . . 0.0 110.424 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 2.7 mt-10 -59.51 -30.17 68.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.037 -1.272 . . . . 0.0 110.098 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' O ' HD23 ' A' ' 30' ' ' LEU . . . -69.62 -47.3 63.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.665 ' O ' HD23 ' A' ' 31' ' ' LEU . 38.6 m-80 -68.01 -42.38 80.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.172 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' A' ' 61' ' ' THR . 3.4 mp -59.18 -32.01 69.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.799 . . . . 0.0 111.043 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -55.42 -23.81 27.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.973 -1.08 . . . . 0.0 109.943 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.061 HD13 ' O ' ' A' ' 38' ' ' THR . 4.0 pp -61.85 -37.01 82.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.096 -1.002 . . . . 0.0 109.042 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.875 ' N ' HD12 ' A' ' 31' ' ' LEU . 96.6 p -69.6 -32.27 70.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -20.6 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.3 mm-40 -122.12 -79.8 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.5 Cg_endo -75.89 69.77 6.1 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.064 1.034 . . . . 0.0 110.184 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.96 141.33 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.21 78.32 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 1.061 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.4 m -131.0 147.9 52.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.431 -1.04 . . . . 0.0 110.173 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.92 ' HA ' HD22 ' A' ' 31' ' ' LEU . 3.0 m-85 -122.64 141.49 51.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.063 -1.023 . . . . 0.0 110.072 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -135.49 159.51 41.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.512 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.558 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 9.7 tt -115.05 138.56 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 2.6 tmt_? -112.86 160.71 17.75 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.0 110.261 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' ' CZ ' ' A' ' 42' ' ' ARG . 11.6 t0 -85.43 106.47 16.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 t -44.43 145.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.346 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 23.2 t -64.88 -145.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.202 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 45' ' ' SER . 2.5 t70 67.27 -138.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' O ' ' CB ' ' A' ' 48' ' ' ARG . 26.8 mt-30 -67.06 -6.36 16.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.495 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 69.88 19.18 7.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 110.148 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.535 ' O ' HG11 ' A' ' 5' ' ' VAL . 54.4 m170 -102.83 39.54 1.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.117 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -163.58 147.73 10.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 1.16 ' CE2' HG22 ' A' ' 5' ' ' VAL . 12.4 p90 -132.11 146.72 52.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.95 . . . . 0.0 110.533 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -126.08 140.87 52.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.507 -0.746 . . . . 0.0 109.521 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.153 HD22 ' CD1' ' A' ' 98' ' ' TYR . 8.3 tt -120.93 145.32 47.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 111.039 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.63 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -139.17 153.82 47.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.715 . . . . 0.0 109.453 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.055 HG11 HD22 ' A' ' 149' ' ' LEU . 33.5 m -121.35 174.15 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.662 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.918 ' HB2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -112.43 139.22 48.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.565 ' OG1' ' CD2' ' A' ' 147' ' ' LEU . 0.4 OUTLIER -153.17 175.87 12.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.94 4.72 15.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.035 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -13.48 14.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 110.176 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 57' ' ' THR . . . 130.7 150.3 6.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -79.96 132.04 35.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -1.123 . . . . 0.0 110.227 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.868 ' HE3' HG23 ' A' ' 138' ' ' ILE . 10.6 ttmt -122.41 146.54 47.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.541 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -115.8 145.73 42.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.123 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.973 HD21 ' HA ' ' B' ' 166' ' ' THR . 0.4 OUTLIER -138.23 152.74 48.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.506 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 52' ' ' THR . 30.9 ptt85 -126.48 159.79 32.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 110.398 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.847 ' HB ' HD22 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -86.55 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -113.19 129.22 56.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.068 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 28.1 p -88.03 119.67 28.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.455 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.3 tm-20 -108.7 103.24 12.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.2 -0.937 . . . . 0.0 110.1 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.95 -84.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -138.23 21.95 3.1 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 58.6 p -123.08 156.79 34.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HZ ' HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -110.96 131.55 54.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 0.0 110.178 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.85 146.86 22.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.057 -1.027 . . . . 0.0 110.514 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.883 HD12 ' CD1' ' A' ' 94' ' ' LEU . 2.1 tt -76.93 2.27 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.611 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 -157.34 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 0.0 110.079 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.65 4.08 8.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.097 -1.002 . . . . 0.0 110.499 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -98.47 121.99 54.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.072 -1.017 . . . . 0.0 110.278 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.67 52.0 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.952 1.501 . . . . 0.0 110.621 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 15.98 9.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.23 56.02 1.3 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.333 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.6 t -86.31 13.05 8.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.581 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -43.81 -53.55 12.5 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 83' ' ' GLN . 44.9 Cg_endo -72.38 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.82 1.432 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.562 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 3.5 m -102.69 168.38 8.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.965 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.8 Cg_endo -70.7 134.78 26.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.933 1.491 . . . . 0.0 110.152 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.8 ptt180 73.05 21.41 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.859 . . . . 0.0 109.865 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.652 ' CE1' ' CB ' ' A' ' 93' ' ' LYS . 49.5 p90 -58.66 -154.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.826 ' HB3' HD22 ' A' ' 92' ' ' LEU . 1.1 m-20 -72.69 110.42 7.03 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 109.187 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.931 ' SG ' HD23 ' A' ' 4' ' ' LEU . 61.8 m -37.66 -109.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.667 0.746 . . . . 0.0 112.433 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.743 HG22 HD23 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -49.39 -22.8 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 112.155 -178.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.826 HD22 ' HB3' ' A' ' 89' ' ' ASP . 6.1 mp -53.81 -46.2 71.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.527 -1.358 . . . . 0.0 110.342 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -67.06 -37.36 83.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 108.498 178.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.883 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.0 tp -68.31 -34.81 76.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.913 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -54.43 -36.95 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.905 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 99' ' ' MET . 20.2 t-160 -53.16 -33.65 53.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 0.0 109.042 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.537 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -78.18 -37.07 46.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.153 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.3 m-85 -78.7 -21.22 48.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.915 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.566 ' CB ' ' HD2' ' A' ' 100' ' ' PRO . 1.3 mtp -161.86 -177.23 0.68 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.0 109.992 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 99' ' ' MET . 45.4 Cg_endo -72.4 175.33 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.858 1.452 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 100' ' ' PRO . 43.9 Cg_endo -71.37 160.81 47.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.992 1.522 . . . . 0.0 110.541 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.13 -157.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.075 1.566 . . . . 0.0 110.417 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 104' ' ' THR . . . 80.43 85.05 0.66 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.3 OUTLIER -42.43 159.87 0.19 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -1.13 . . . . 0.0 110.131 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.9 -13.09 26.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.996 1.524 . . . . 0.0 110.281 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.4 p -75.51 157.62 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' LEU . 25.7 t80 -161.62 92.82 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.12 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 2.9 m 57.81 -81.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.126 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.583 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 5.3 tp 173.49 -56.28 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 109' ' ' LEU . 45.1 Cg_endo -71.65 142.63 40.32 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.898 1.473 . . . . 0.0 110.425 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.93 94.13 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.947 1.499 . . . . 0.0 110.438 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.56 -35.59 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.286 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -136.26 106.44 9.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.301 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.18 152.57 50.72 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.028 1.541 . . . . 0.0 110.377 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -128.36 44.86 2.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.946 ' O ' HG22 ' A' ' 118' ' ' VAL . 92.3 p -70.28 -145.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 118' ' ' VAL . 5.3 tm-20 -55.94 104.53 0.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.946 HG22 ' O ' ' A' ' 116' ' ' SER . 9.7 m -154.25 75.64 5.88 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 110.275 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.04 165.26 33.25 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.997 1.525 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 53.3 71.85 0.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.224 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -151.39 134.18 8.71 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.32 112.08 3.44 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.38 66.79 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.81 91.49 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.25 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -91.48 -81.09 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.155 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.76 68.66 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 8.2 tp -155.97 52.68 0.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 127' ' ' LEU . 45.9 Cg_endo -73.0 59.28 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.032 1.543 . . . . 0.0 110.411 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 62.18 47.57 88.9 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -154.78 108.35 2.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 131' ' ' THR . 1.3 t -155.38 105.65 2.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 46.2 Cg_endo -73.25 -1.02 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.913 1.48 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER 61.99 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.97 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -131.59 161.01 33.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.296 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 169.98 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -121.85 123.52 41.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.978 -1.076 . . . . 0.0 109.539 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.916 ' H ' HG22 ' B' ' 167' ' ' VAL . 8.3 p90 -154.99 167.74 29.32 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.894 -1.129 . . . . 0.0 111.392 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.868 HG23 ' HE3' ' A' ' 62' ' ' LYS . 3.3 mt -102.69 143.24 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.656 0.741 . . . . 0.0 111.05 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.716 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 12.5 m-85 -92.89 132.63 36.86 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.637 0.732 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -84.01 52.59 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.641 -0.662 . . . . 0.0 110.22 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.53 27.06 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 162.95 -30.87 0.28 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mt-10 -116.47 121.8 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.02 105.51 11.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.341 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -93.01 105.23 14.24 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.817 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.8 Cg_endo -73.55 129.64 13.94 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.052 1.554 . . . . 0.0 112.358 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.804 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 mp -125.64 135.28 51.99 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -98.27 116.98 42.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 120.365 -1.46 . . . . 0.0 109.954 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.055 HD22 HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -121.86 135.52 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.066 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 29.0 t -167.6 54.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.87 123.88 22.19 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.082 -1.011 . . . . 0.0 110.077 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.511 ' HB3' ' CE ' ' A' ' 99' ' ' MET . 50.7 Cg_endo -78.75 148.32 22.51 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.143 1.602 . . . . 0.0 110.79 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.977 HD13 ' HB2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -85.83 133.78 33.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.823 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 155' ' ' SER . 36.9 t -117.79 78.77 1.27 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.63 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 10.0 m 42.65 -166.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -0.935 . . . . 0.0 110.219 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' A' ' 155' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.297 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' B' ' 159' ' ' ALA . 95.5 m -94.45 74.33 3.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.263 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' B' ' 158' ' ' THR . . . 179.63 -88.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.947 . . . . 0.0 110.265 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.16 114.1 9.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.89 -36.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.349 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.975 HG12 ' HE1' ' B' ' 164' ' ' PTR . 97.2 t -73.25 55.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 2.6 mt-10 -96.6 159.17 15.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.975 ' HE1' HG12 ' B' ' 162' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.465 ' O ' HG23 ' B' ' 166' ' ' THR . 43.3 t -139.47 -105.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.263 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.973 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.4 p -152.58 -179.54 7.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 110.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.921 HG12 HG22 ' B' ' 168' ' ' VAL . 1.0 OUTLIER -127.85 143.48 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.921 HG22 HG12 ' B' ' 167' ' ' VAL . 4.4 m 22.23 76.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.4 0.619 . . . . 0.0 111.126 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.555 ' N ' ' OH ' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -44.72 -78.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' B' ' 171' ' ' GLY . 83.5 p -128.64 -76.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.43 ' N ' ' OG ' ' B' ' 170' ' ' SER . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.585 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.254 0.55 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.9 p90 -55.79 -39.02 70.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' O ' HG12 ' A' ' 6' ' ' VAL . 40.0 tp60 -61.16 -42.27 98.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.123 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 89' ' ' ASP . 1.1 mt -67.27 -47.23 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.987 ' O ' HG13 ' A' ' 9' ' ' VAL . 2.4 m -72.56 -44.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.667 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 3' ' ' GLN . 5.2 p -58.35 -32.55 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -67.98 -40.92 83.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.096 -1.003 . . . . 0.0 109.78 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . . . -76.36 -44.99 34.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.987 HG13 ' O ' ' A' ' 5' ' ' VAL . 4.3 m -57.93 -39.7 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.399 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.9 ttt180 -55.44 -45.9 76.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 109.69 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -32.94 50.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.687 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 5.9 tp -68.23 -43.98 76.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.455 -0.778 . . . . 0.0 110.286 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 14' ' ' GLU . 3.4 pt20 -64.65 -33.83 76.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.96 . . . . 0.0 110.187 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 2.9 mt-10 -57.84 -31.03 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -67.29 -41.3 85.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.034 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.75 36.62 3.19 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.903 ' HB2' HD21 ' A' ' 153' ' ' LEU . 5.6 p90 -145.39 28.17 1.21 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -1.166 . . . . 0.0 110.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 20' ' ' SER . 3.0 t80 -90.76 136.29 33.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.831 ' HE1' HD23 ' A' ' 153' ' ' LEU . 69.4 m95 -117.51 149.23 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.449 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 89.7 p 178.98 -15.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -13.26 4.36 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.714 -0.616 . . . . 0.0 110.533 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -99.39 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.599 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.588 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -89.16 175.82 7.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.057 -1.027 . . . . 0.0 109.791 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' CD ' ' A' ' 42' ' ' ARG . . . -46.03 -83.77 0.02 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.34 -30.51 45.32 Favored Glycine 0 N--CA 1.491 2.307 0 O-C-N 121.398 -1.06 . . . . 0.0 110.681 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.588 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.4 mm-40 -58.27 -26.69 63.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.338 . . . . 0.0 110.422 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.87 -49.97 47.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.016 -1.053 . . . . 0.0 109.117 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.927 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -69.99 -46.39 65.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.0 110.747 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.883 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -59.08 -31.34 68.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.445 -0.784 . . . . 0.0 111.602 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 pp -54.63 -23.62 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.789 -1.194 . . . . 0.0 109.442 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.996 HD13 ' O ' ' A' ' 38' ' ' THR . 3.6 pp -68.95 -34.11 74.82 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.155 -0.966 . . . . 0.0 108.567 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.684 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t -69.97 -32.81 71.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.67 -0.643 . . . . 0.0 110.234 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.66 -20.72 42.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.85 . . . . 0.0 110.488 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.74 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.7 OUTLIER -122.9 -80.59 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.972 -1.08 . . . . 0.0 110.922 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.74 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 53.1 Cg_endo -75.24 68.46 5.94 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.015 1.008 . . . . 0.0 110.703 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.92 141.43 10.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.023 . . . . 0.0 110.399 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 78.93 20.58 70.16 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 53.7 m -117.55 148.3 42.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.984 . . . . 0.0 110.367 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 8.3 p90 -121.86 138.94 54.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.005 -1.06 . . . . 0.0 109.787 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -138.95 156.71 47.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.388 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.569 HD11 ' CD1' ' A' ' 51' ' ' PHE . 4.3 tt -115.37 133.75 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.376 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -112.89 141.43 46.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.856 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 49.3 t0 -82.08 132.77 35.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.106 -0.996 . . . . 0.0 110.247 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . 59.4 p -56.54 -63.81 1.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.363 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 69.56 7.43 6.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 0.0 109.93 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 3.9 t70 -102.3 -135.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.575 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -90.71 -26.45 19.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 110.345 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -75.33 -21.98 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.237 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 47' ' ' GLN . 80.9 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.255 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 48' ' ' ARG . 16.3 p90 -177.45 175.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 38.0 p90 -125.73 141.64 51.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.039 -1.038 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.604 ' CG2' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -125.33 144.34 50.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.104 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -121.99 133.6 54.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.872 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.104 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -139.1 154.28 48.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.445 -0.784 . . . . 0.0 110.087 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.851 ' HB ' HD23 ' A' ' 149' ' ' LEU . 10.7 p -132.98 174.9 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.284 -0.885 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.667 ' HG3' HG22 ' A' ' 61' ' ' THR . 2.0 ttpp -103.36 135.2 45.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -97.7 -154.02 0.44 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -24.46 66.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 m -177.02 29.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.65 109.8 0.56 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.667 HG22 ' HG3' ' A' ' 56' ' ' LYS . 32.2 p -98.2 108.94 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.155 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' B' ' 163' ' ' GLU . 2.4 mptp? -116.93 159.28 22.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.994 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.81 ' HA ' ' HB2' ' A' ' 54' ' ' SER . 38.6 m-20 -112.01 134.22 53.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.2 mm? -109.4 117.99 35.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' CE2' ' B' ' 164' ' ' PTR . 0.2 OUTLIER -117.0 148.38 41.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.258 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.931 HG21 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -76.74 130.57 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.0 OUTLIER -94.74 151.18 19.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.43 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 72' ' ' SER . 27.6 p -97.89 139.08 34.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' SER . 70.5 mt-10 -131.56 113.04 13.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.342 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 46.65 24.27 1.72 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.29 -2.19 40.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -95.01 153.63 17.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.931 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -113.39 126.78 55.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.8 OUTLIER -155.53 147.59 23.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.521 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.872 HD13 HD12 ' A' ' 94' ' ' LEU . 14.7 tp -77.48 -13.04 60.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.78 -139.83 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 110.117 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.46 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 45.5 t -164.49 44.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.151 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.05 111.89 35.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.4 61.77 4.29 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.022 1.538 . . . . 0.0 110.343 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' SER . 2.9 tpt180 -67.27 -48.06 68.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.251 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER 174.96 169.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 83' ' ' GLN . 1.9 p -104.75 71.7 0.99 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -42.18 -56.72 5.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.443 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.652 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 47.3 Cg_endo -71.4 -99.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.979 1.515 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.004 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -135.59 172.51 7.04 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 109.541 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 1.004 ' HD2' HG22 ' A' ' 85' ' ' VAL . 42.0 Cg_endo -69.93 132.56 23.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.526 1.277 . . . . 0.0 109.547 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 2.6 mtt180 67.42 34.12 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 0.0 109.77 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.652 ' CG ' ' HG2' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -86.21 -176.29 5.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.615 ' N ' ' CD2' ' A' ' 88' ' ' PHE . 17.8 p-10 -112.42 110.97 21.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 110.091 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' PHE . 7.3 t -82.6 -5.63 58.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.923 . . . . 0.0 110.476 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.948 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 4.6 p -49.84 -31.53 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.111 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.836 ' O ' HG22 ' A' ' 95' ' ' VAL . 10.9 mp -59.24 -46.08 89.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 108.681 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.57 ' HA ' ' CD2' ' A' ' 96' ' ' HIS . 7.8 tptt -67.23 -30.7 70.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -58.57 -34.56 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.612 -0.68 . . . . 0.0 109.879 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.026 ' N ' HD23 ' A' ' 94' ' ' LEU . 3.0 m -54.83 -37.41 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CD2' ' HA ' ' A' ' 93' ' ' LYS . 18.8 m-70 -55.38 -47.26 76.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.063 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.615 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -61.21 -36.74 80.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.476 -0.765 . . . . 0.0 109.258 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.955 ' CD2' HD23 ' A' ' 53' ' ' LEU . 2.6 m-30 -65.12 -9.38 22.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.788 . . . . 0.0 109.975 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.563 ' C ' ' HD2' ' A' ' 101' ' ' PRO . 2.7 ptt? -167.16 114.99 0.68 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 110.173 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.681 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 41.8 Cg_endo -72.09 -29.55 14.55 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.954 1.502 . . . . 0.0 112.22 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 100' ' ' PRO . 48.2 Cg_endo -74.33 159.93 42.81 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.888 0.941 . . . . 0.0 110.312 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.76 126.87 11.75 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.038 1.546 . . . . 0.0 110.41 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.13 -66.11 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.5 p -139.85 160.5 60.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -1.113 . . . . 0.0 110.182 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -91.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.513 . . . . 0.0 110.456 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.21 -41.36 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.477 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 30.5 p90 -122.59 130.49 53.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -88.34 -63.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 1.4 pp -131.1 119.4 17.79 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.74 150.63 50.54 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.942 1.496 . . . . 0.0 110.44 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 112' ' ' THR . 46.0 Cg_endo -72.93 -51.02 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 21.1 m 53.79 99.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . 9.0 tp10 172.34 -55.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.19 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 45.6 Cg_endo -71.54 89.37 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.899 1.473 . . . . 0.0 110.469 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 114' ' ' PRO . 8.6 t 60.47 -178.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 6.4 t -66.9 -63.29 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.536 ' C ' HG23 ' A' ' 118' ' ' VAL . 6.1 tp10 55.74 94.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.194 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.556 ' N ' ' CD ' ' A' ' 119' ' ' PRO . 23.1 t -151.57 49.48 0.57 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 118' ' ' VAL . 46.1 Cg_endo -73.17 118.91 5.74 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.953 1.502 . . . . 0.0 110.407 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 0.0 OUTLIER 61.69 147.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 6.5 mm-40 -147.58 115.9 4.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.04 142.18 34.12 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.946 1.498 . . . . 0.0 110.51 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.08 -89.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.965 1.508 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.31 -145.45 0.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.151 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -130.11 -70.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 0.0 110.089 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.59 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.201 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 129' ' ' GLY . 1.1 pp -75.42 161.89 74.88 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.94 -50.95 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.961 1.506 . . . . 0.0 110.411 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' N ' HD12 ' A' ' 127' ' ' LEU . . . 103.5 126.23 5.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 72.9 p -178.58 -168.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 110.234 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.18 65.3 69.44 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.94 70.87 3.54 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.122 1.59 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt 48.06 71.26 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.152 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.3 mtm180 -159.39 139.31 11.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.19 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.075 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 172.93 112.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.116 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 0.5 OUTLIER -104.66 122.76 46.33 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.152 178.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.2 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -156.94 156.39 32.95 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.322 -0.861 . . . . 0.0 110.091 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.132 ' N ' HD23 ' A' ' 147' ' ' LEU . 2.0 mt -103.37 149.4 7.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.339 -0.851 . . . . 0.0 109.796 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.589 ' CE2' ' OH ' ' A' ' 137' ' ' TYR . 81.4 m-85 -85.37 132.05 34.3 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.264 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.714 ' HB3' HD13 ' A' ' 145' ' ' ILE . 2.7 t -95.25 59.06 2.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.245 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.33 54.07 40.31 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.15 1.0 58.33 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 6.4 mm-40 -120.01 123.49 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 145' ' ' ILE . 12.9 mtmt -70.86 119.13 14.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -118.31 115.27 36.13 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.035 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.905 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 42.7 Cg_endo -69.33 125.23 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.808 1.425 . . . . 0.0 111.349 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.132 HD23 ' N ' ' A' ' 138' ' ' ILE . 1.9 pp -127.03 101.93 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.6 p -102.45 118.58 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.814 -1.179 . . . . 0.0 111.034 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 98' ' ' TYR . 0.9 OUTLIER -76.66 114.88 15.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 -30.25 6.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 110.935 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.87 124.47 70.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.987 -1.07 . . . . 0.0 110.203 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.584 ' HA ' ' CE2' ' A' ' 39' ' ' PHE . 50.0 Cg_endo -78.0 141.09 18.56 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.03 1.542 . . . . 0.0 110.461 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.931 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.55 158.13 15.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.206 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.508 ' N ' HD22 ' A' ' 153' ' ' LEU . 45.0 m -126.93 92.92 3.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.601 ' HB2' ' CE2' ' A' ' 19' ' ' TRP . 4.1 t -114.06 34.21 4.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.241 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.329 0.585 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 3.2 p -134.79 80.58 1.85 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.272 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' B' ' 161' ' ' THR . . . -126.46 23.09 6.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.195 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 1.7 t 66.2 -63.86 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.518 ' N ' ' O ' ' B' ' 159' ' ' ALA . 0.7 OUTLIER 61.23 48.94 5.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.174 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.653 HG12 ' O ' ' B' ' 162' ' ' VAL . 78.5 t -82.72 50.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 9.6 pt-20 -73.74 -162.26 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.22 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 65' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 5.3 m -137.19 10.29 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.459 ' O ' ' O ' ' B' ' 165' ' ' SER . 0.2 OUTLIER 53.5 169.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.116 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.8 t -126.82 102.64 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.2 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.3 t 67.17 142.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.483 ' O ' ' CG ' ' B' ' 169' ' ' HIS . 6.8 t60 -131.22 14.61 5.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.193 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.416 ' O ' ' O ' ' B' ' 171' ' ' GLY . 85.4 p -150.22 23.94 0.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.189 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' B' ' 170' ' ' SER . . . . . . . . 0 N--CA 1.49 2.268 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.535 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.699 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.0 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.258 0.551 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.489 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 30.5 p90 -54.85 -36.6 65.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.659 ' O ' HG12 ' A' ' 6' ' ' VAL . 1.8 tt0 -54.89 -32.69 61.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.962 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.892 HD22 ' HB3' ' A' ' 90' ' ' CYS . 6.4 mt -59.56 -47.43 85.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.4 t -64.55 -44.77 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.865 . . . . 0.0 110.775 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.3 OUTLIER -58.03 -33.5 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.299 -0.876 . . . . 0.0 110.575 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -71.44 -40.35 70.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 0.0 110.589 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 12' ' ' LEU . . . -76.1 -44.46 38.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.249 -0.907 . . . . 0.0 110.75 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 5' ' ' VAL . 7.4 m -57.2 -38.37 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -54.23 -49.12 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.862 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -78.44 -40.19 36.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -0.999 . . . . 0.0 109.925 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -72.27 -31.22 65.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.399 -0.813 . . . . 0.0 111.032 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.74 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 22.3 mt-30 -59.44 -41.45 89.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 0.0 111.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.48 -52.56 8.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.889 -1.132 . . . . 0.0 110.598 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 t -73.68 -42.4 61.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 111.746 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' C ' ' A' ' 17' ' ' PHE . . . -90.23 67.57 2.57 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.36 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.702 ' C ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 2.21 72.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.742 -0.858 . . . . 0.0 110.8 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.74 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 3.8 t80 -90.87 136.23 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.756 ' CG ' HD11 ' A' ' 40' ' ' LEU . 15.9 m95 -116.59 148.24 41.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -142.26 23.73 1.99 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.07 0.13 31.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.784 . . . . 0.0 110.949 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.53 -158.15 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 110.343 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.577 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -95.26 166.97 11.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 110.334 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.49 ' CA ' ' HG2' ' A' ' 42' ' ' ARG . . . -39.73 -84.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.555 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -79.05 -31.7 42.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 7.7 tt0 -59.53 -24.85 64.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.283 . . . . 0.0 109.938 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -72.95 -48.42 36.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.587 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.797 HD21 HD13 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -68.44 -36.16 78.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 110.326 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.815 HD11 ' OG1' ' A' ' 61' ' ' THR . 0.6 OUTLIER -58.24 -31.71 67.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 110.976 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp -55.49 -23.84 28.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.875 -1.141 . . . . 0.0 109.223 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 38' ' ' THR . 2.7 pp -70.33 -32.95 70.89 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 108.648 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 61.2 m -69.85 -33.09 71.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.578 -0.701 . . . . 0.0 110.08 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.68 -21.19 41.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.068 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.766 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.4 mm-40 -122.31 -83.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.564 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.766 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.17 69.27 4.87 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 122.923 0.959 . . . . 0.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.59 141.53 37.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.225 -0.922 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 83.31 19.44 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.926 ' O ' HD13 ' A' ' 31' ' ' LEU . 4.0 m -122.43 148.33 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.505 -0.997 . . . . 0.0 110.204 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HB2' HG12 ' A' ' 55' ' ' VAL . 4.5 p90 -122.21 138.97 54.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.852 -1.155 . . . . 0.0 109.981 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.35 159.31 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.347 -0.846 . . . . 0.0 110.276 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.838 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.4 tt -117.01 149.21 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.897 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 3.0 tpt180 -121.62 152.89 38.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.445 -0.784 . . . . 0.0 109.612 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.573 ' CA ' ' OH ' ' A' ' 18' ' ' TYR . 8.8 t0 -90.76 104.31 16.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.956 . . . . 0.0 110.314 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' PHE . 8.3 t -53.94 168.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 0.0 110.139 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 p -115.99 5.41 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.48 173.36 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -14.68 58.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -82.16 4.38 23.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER 43.34 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.167 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.871 ' HD1' HG21 ' A' ' 5' ' ' VAL . 20.0 t80 -155.82 156.06 34.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 110.499 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.855 ' CD2' HG13 ' A' ' 5' ' ' VAL . 8.7 p90 -115.96 151.79 34.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.5 ' C ' HG13 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -126.41 147.62 49.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.297 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.916 HD12 ' N ' ' A' ' 54' ' ' SER . 0.3 OUTLIER -131.1 125.07 32.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.39 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.916 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -122.8 153.74 39.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.02 HG11 HD22 ' A' ' 149' ' ' LEU . 10.2 m -121.39 174.56 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.372 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HA ' HG22 ' A' ' 61' ' ' THR . 14.5 tttm -103.47 126.48 50.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.986 ' HB ' HD22 ' A' ' 147' ' ' LEU . 21.4 p -128.9 169.87 14.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.86 -27.11 67.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.4 t -86.41 -28.31 23.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.161 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 147.36 156.78 7.12 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 56' ' ' LYS . 17.3 p -80.13 138.08 36.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -1.115 . . . . 0.0 110.127 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' CB ' HG12 ' A' ' 138' ' ' ILE . 23.2 mmtm -137.15 160.45 38.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 5.5 p30 -138.28 154.64 49.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.704 HD11 ' CA ' ' B' ' 166' ' ' THR . 8.0 mt -137.45 148.41 46.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 110.01 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.404 ' HA ' ' HZ ' ' A' ' 50' ' ' PHE . 4.7 mtt180 -98.25 152.29 19.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -79.33 139.6 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 110.554 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -96.4 151.0 19.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.403 ' HA ' ' CD1' ' A' ' 73' ' ' PHE . 18.5 p -99.36 137.03 38.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 mt-10 -130.63 102.89 6.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.106 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 43.24 -95.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -120.53 32.75 4.73 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 69' ' ' GLU . 5.0 p -139.58 150.91 45.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.292 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.634 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -124.29 144.83 49.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 66' ' ' ILE . 2.2 t -155.18 141.3 18.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.119 -0.988 . . . . 0.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 94' ' ' LEU . 17.8 tp -76.77 1.3 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.282 -0.886 . . . . 0.0 110.455 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 77' ' ' SER . 18.6 pt20 -139.5 -155.43 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 76' ' ' GLN . 93.1 p -60.0 -142.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 80' ' ' ARG . 17.7 p-10 -74.46 126.14 89.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.63 58.93 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.994 1.523 . . . . 0.0 110.366 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' O ' ' OG1' ' A' ' 82' ' ' THR . 0.0 OUTLIER -71.62 -2.79 18.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.283 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 82' ' ' THR . 1.0 OUTLIER -50.1 -34.16 21.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 110.19 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 69.26 6.35 5.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.582 ' HB3' ' HD3' ' A' ' 84' ' ' PRO . 8.7 tt0 -57.53 -59.94 11.38 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 83' ' ' GLN . 46.4 Cg_endo -71.68 -155.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.818 1.43 . . . . 0.0 110.219 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -118.82 178.3 1.11 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.136 -0.978 . . . . 0.0 109.682 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 40.8 Cg_endo -67.89 132.65 27.05 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.798 1.42 . . . . 0.0 109.434 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 71' ' ' GLY . 1.7 mpp_? 52.91 65.91 1.38 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.147 -0.971 . . . . 0.0 109.248 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG ' ' A' ' 93' ' ' LYS . 53.1 p90 -100.3 -155.97 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.162 -0.961 . . . . 0.0 109.647 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.674 ' CB ' ' HB2' ' A' ' 92' ' ' LEU . 72.8 m-20 -72.9 109.77 6.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.057 -1.027 . . . . 0.0 108.716 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.892 ' HB3' HD22 ' A' ' 4' ' ' LEU . 1.3 p -39.94 -93.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.786 HG21 HG22 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -48.09 -22.6 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.272 -0.892 . . . . 0.0 111.125 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.674 ' HB2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -54.19 -35.77 62.7 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.907 -1.121 . . . . 0.0 110.058 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.604 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -62.39 -36.4 82.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.991 -1.068 . . . . 0.0 109.437 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.82 -35.87 75.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.595 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 99' ' ' MET . 78.0 t -56.02 -38.31 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 109.78 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.565 ' CD2' ' NZ ' ' A' ' 93' ' ' LYS . 26.7 t60 -54.79 -46.55 74.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.774 ' HB3' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -71.78 -42.95 66.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.069 ' O ' HD11 ' A' ' 149' ' ' LEU . 2.0 m-30 -69.31 -22.11 63.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.571 ' HG3' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -166.12 167.57 8.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.211 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 99' ' ' MET . 44.8 Cg_endo -72.57 170.81 18.51 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.017 1.535 . . . . 0.0 110.462 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 145.68 41.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.046 1.55 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 -12.68 25.48 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.99 1.521 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -165.78 41.18 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.55 75.87 0.42 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.15 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.412 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 t -172.88 133.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.238 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 9.2 t80 -126.64 58.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 109' ' ' LEU . 6.8 m 49.9 -137.95 1.0 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 110' ' ' PRO . 2.1 tp -42.17 143.02 1.1 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.45 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 46.5 Cg_endo -72.96 118.7 5.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.948 1.499 . . . . 0.0 110.442 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.03 -159.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.467 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 113' ' ' GLU . 1.4 m 57.62 174.41 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.229 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 112' ' ' THR . 14.5 mt-10 56.85 159.85 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.06 99.88 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -143.83 19.83 1.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.44 -76.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -142.66 -46.43 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.313 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.5 t 51.78 86.33 0.16 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.76 -89.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.033 1.544 . . . . 0.0 110.494 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.83 178.81 6.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.255 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 134.09 25.64 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.17 135.66 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.998 1.525 . . . . 0.0 110.464 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 56.68 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 -28.06 16.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.74 54.89 6.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.422 ' C ' ' HG ' ' A' ' 127' ' ' LEU . . . -147.43 19.34 1.2 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 126' ' ' ALA . 10.8 mt -134.66 95.74 15.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.245 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.77 -166.34 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.072 1.564 . . . . 0.0 110.359 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.96 85.67 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 131' ' ' THR . 40.9 t -99.01 -96.86 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -179.92 -61.01 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 131' ' ' THR . 45.8 Cg_endo -72.26 67.45 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.967 1.509 . . . . 0.0 110.499 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -44.63 -38.08 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 110.12 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.701 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 6.9 ppt_? -140.1 176.21 8.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.032 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.854 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 169.5 129.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.431 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.122 ' CD1' HG11 ' B' ' 167' ' ' VAL . 2.5 t80 -116.18 121.78 43.12 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.807 -1.183 . . . . 0.0 108.69 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.904 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.7 p90 -156.99 167.97 28.88 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.878 -1.139 . . . . 0.0 111.185 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.468 HG12 ' CB ' ' A' ' 62' ' ' LYS . 2.8 mp -121.62 149.54 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.95 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.76 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.1 m-30 -84.85 110.47 18.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.534 -0.729 . . . . 0.0 110.119 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 143' ' ' GLU . 3.9 m -66.32 56.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.53 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 65.84 82.9 0.11 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.25 -10.42 49.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.8 tt0 -120.01 121.6 39.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.269 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 2.4 ptpt -89.8 105.5 17.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -99.02 109.14 52.94 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.823 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.3 Cg_endo -72.57 128.95 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.996 1.524 . . . . 0.0 111.938 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.986 HD22 ' HB ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -125.83 135.88 52.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 148' ' ' VAL . 25.3 m -98.04 117.12 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.382 -1.449 . . . . 0.0 110.079 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.069 HD11 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -117.38 137.91 52.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.047 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.502 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -176.02 41.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.583 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -111.56 124.96 31.31 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.148 -0.97 . . . . 0.0 110.046 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.632 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 45.7 Cg_endo -73.08 147.32 42.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.931 1.49 . . . . 0.0 111.059 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.795 HD22 HG21 ' A' ' 38' ' ' THR . 0.3 OUTLIER -89.7 128.66 36.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.742 . . . . 0.0 109.778 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.759 ' N ' HD13 ' A' ' 153' ' ' LEU . 49.4 m -73.09 88.67 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.329 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.589 ' HB2' ' CE2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -119.23 -38.4 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.152 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.256 0.55 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 8.9 t -124.72 145.92 49.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.72 1.89 11.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.103 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' B' ' 161' ' ' THR . 32.1 m -165.45 -171.66 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.247 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER 66.83 70.67 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.248 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.65 HG12 ' O ' ' B' ' 162' ' ' VAL . 84.4 t 56.93 54.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.28 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.536 ' CG ' ' N ' ' B' ' 164' ' ' PTR . 42.3 tt0 -89.12 172.08 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.549 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.443 ' C ' HD21 ' A' ' 64' ' ' LEU . 56.6 m -160.67 -60.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.386 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.745 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.5 OUTLIER 176.87 155.82 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.192 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.122 HG11 ' CD1' ' A' ' 136' ' ' TYR . 15.3 t -118.62 132.63 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.854 HG21 ' O ' ' A' ' 135' ' ' ALA . 5.8 t 40.68 94.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.351 -0.843 . . . . 0.0 110.336 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.434 ' HB2' ' OH ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -91.19 91.54 8.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -72.92 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.922 -1.488 . . . . 0.0 109.497 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.188 0.518 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 6' ' ' VAL . 33.7 p90 -65.31 -37.55 87.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.5 OUTLIER -69.32 -33.65 73.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.218 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.928 HD23 ' SG ' ' A' ' 90' ' ' CYS . 3.3 mt -67.09 -47.3 71.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.516 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 49' ' ' HIS . 34.8 m -72.18 -37.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.285 -0.884 . . . . 0.0 110.449 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 2' ' ' TYR . 24.8 t -58.45 -32.97 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.33 -45.65 92.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -67.0 -43.11 83.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 0.0 110.216 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.724 HG13 ' CE2' ' A' ' 18' ' ' TYR . 60.1 t -56.93 -39.39 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 15.3 ttt180 -55.47 -48.81 73.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.855 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.37 -33.02 49.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.964 . . . . 0.0 110.235 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.64 -44.08 71.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.201 -0.937 . . . . 0.0 110.267 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 6.5 pt20 -65.59 -33.77 76.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 1.2 tt0 -66.01 -32.26 73.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.312 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.6 p -69.68 -27.5 65.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.28 19.97 21.78 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CD2' ' CD1' ' A' ' 153' ' ' LEU . 3.0 m-85 -108.5 4.22 23.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -1.129 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.724 ' CE2' HG13 ' A' ' 9' ' ' VAL . 21.6 t80 -90.86 136.07 33.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.355 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.94 ' CG ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -92.23 148.34 22.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.667 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 2.6 t -40.68 -92.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.783 . . . . 0.0 110.321 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.91 61.72 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -59.53 -137.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -85.32 166.19 16.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 109.551 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . -39.89 -83.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.827 ' CA ' HG21 ' B' ' 162' ' ' VAL . . . -79.29 -30.18 46.88 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 17.0 tt0 -57.78 -34.79 69.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.982 -1.305 . . . . 0.0 110.517 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -66.84 -48.73 67.96 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.94 -1.1 . . . . 0.0 109.025 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.657 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 29.1 m-80 -69.3 -43.15 74.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.463 -0.773 . . . . 0.0 110.728 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -70.28 -31.78 69.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 111.686 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.756 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.76 -41.15 70.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.88 -1.138 . . . . 0.0 110.352 -178.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.063 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.1 pp -61.02 -34.69 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 108.964 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -69.79 -32.82 71.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -20.62 42.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.504 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.8 mt-10 -114.89 -76.75 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.2 Cg_endo -72.85 65.53 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.299 1.157 . . . . 0.0 110.118 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.91 140.62 11.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 80.15 -2.44 76.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.916 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 m -104.41 146.38 28.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.432 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.787 ' HB2' HD23 ' A' ' 149' ' ' LEU . 39.9 p90 -123.79 138.88 54.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.985 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.063 HD23 ' HB3' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -141.4 159.4 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.145 -0.972 . . . . 0.0 110.619 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.919 ' N ' HD12 ' A' ' 40' ' ' LEU . 1.7 tt -115.16 130.58 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.945 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' NH2' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -112.72 160.5 17.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.032 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' CB ' ' OH ' ' A' ' 18' ' ' TYR . 12.4 t70 -74.0 126.28 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.159 -0.963 . . . . 0.0 110.137 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.602 ' HA ' ' NH2' ' A' ' 42' ' ' ARG . 9.4 t -57.47 -87.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 110.101 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.576 ' HB3' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -119.78 67.76 0.82 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.993 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER 69.28 -168.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.091 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -1.93 32.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -92.28 16.54 11.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.893 . . . . 0.0 110.247 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.667 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.6 m-70 -143.25 -93.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 44' ' ' SER . 42.7 p90 -177.78 -158.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 35.5 p90 -133.26 149.14 51.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.377 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 64' ' ' LEU . 74.7 m -126.22 155.13 42.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.18 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -137.24 146.44 44.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.697 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 25.1 p -139.43 153.99 47.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' CG2' ' HG ' ' A' ' 149' ' ' LEU . 8.8 p -120.13 172.24 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' CG ' ' CB ' ' A' ' 32' ' ' SER . 1.6 tmtp? -123.01 139.19 54.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.179 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.537 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -151.65 -173.35 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.215 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.66 24.23 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.92 . . . . 0.0 110.227 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.511 ' HB3' HG21 ' A' ' 145' ' ' ILE . 1.7 p -126.98 -2.62 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.25 139.55 5.6 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 61' ' ' THR . 15.3 t -95.31 109.56 21.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.308 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -110.65 155.18 22.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 110.04 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 6.7 t-20 -111.53 128.68 56.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.019 HD13 ' CG2' ' B' ' 167' ' ' VAL . 0.9 OUTLIER -130.23 152.06 50.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -0.971 . . . . 0.0 110.33 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.58 ' CA ' HG23 ' A' ' 52' ' ' THR . 3.0 ptm180 -121.68 -145.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.777 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 94' ' ' LEU . 1.4 tp -116.75 149.02 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.373 -0.829 . . . . 0.0 110.341 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -110.76 124.71 52.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.575 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 29.4 p -87.81 126.89 35.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.65 103.02 7.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.47 -102.15 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.6 36.19 3.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.06 160.39 40.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -1.18 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.644 ' CD1' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -133.16 138.44 46.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.855 . . . . 0.0 110.033 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.3 t -155.32 150.15 26.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -80.02 49.37 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.052 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.522 ' NE2' ' OG1' ' B' ' 166' ' ' THR . 2.1 tt0 66.71 74.7 0.33 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -136.52 -169.17 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' HB3' ' CA ' ' B' ' 171' ' ' GLY . 18.3 p-10 -120.04 149.95 50.06 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.19 54.64 2.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.077 1.567 . . . . 0.0 110.356 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -69.98 -4.27 19.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER 67.83 40.23 2.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.177 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.509 ' N ' ' OE1' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -106.31 33.82 3.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.193 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.509 ' OE1' ' N ' ' A' ' 82' ' ' THR . 8.8 mp0 -131.49 163.7 47.79 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.174 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.619 ' HD2' ' CE1' ' A' ' 88' ' ' PHE . 40.5 Cg_endo -66.77 -53.1 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 111.211 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.768 HG13 ' HD2' ' A' ' 86' ' ' PRO . 55.3 t -116.88 149.34 43.91 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.766 -1.209 . . . . 0.0 110.23 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.768 ' HD2' HG13 ' A' ' 85' ' ' VAL . 41.3 Cg_endo -68.21 132.87 27.02 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.922 1.485 . . . . 0.0 109.051 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.608 ' O ' ' O ' ' A' ' 88' ' ' PHE . 14.3 mtm180 54.65 85.93 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.955 -1.091 . . . . 0.0 108.513 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.619 ' CE1' ' HD2' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -51.72 -153.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 110.649 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 90' ' ' CYS . 64.1 m-20 -88.47 109.97 20.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.965 -1.085 . . . . 0.0 110.694 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.928 ' SG ' HD23 ' A' ' 4' ' ' LEU . 13.7 m 20.81 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.641 0.734 . . . . 0.0 112.14 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.662 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.8 p -49.63 -24.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 110.633 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.872 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -55.29 -34.08 63.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.958 . . . . 0.0 110.073 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.609 ' HB2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -57.53 -31.76 66.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.799 ' HB2' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -59.83 -35.4 74.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 110.246 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.7 m -55.33 -37.32 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.316 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.54 ' HB2' ' HE3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -53.83 -34.71 60.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.023 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.614 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -78.07 -36.77 47.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 109.986 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.741 ' CE1' HD23 ' A' ' 53' ' ' LEU . 3.3 m-85 -63.55 -22.02 66.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.321 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.32 124.73 4.6 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 0.0 110.319 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.97 162.56 40.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.925 1.487 . . . . 0.0 110.305 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HD3' ' HG2' ' A' ' 134' ' ' ARG . 45.7 Cg_endo -72.99 130.89 16.07 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.004 1.528 . . . . 0.0 110.373 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 55.61 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.985 1.518 . . . . 0.0 110.361 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.492 ' C ' HG23 ' A' ' 104' ' ' THR . . . 70.64 -174.71 38.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 103' ' ' GLY . 21.5 p -149.54 164.45 20.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -1.16 . . . . 0.0 110.205 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 45.9 Cg_endo -73.1 -159.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.961 1.506 . . . . 0.0 110.395 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' SER . 3.3 m -170.87 153.96 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 52.81 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 110.216 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' SER . 0.8 OUTLIER -138.73 164.38 29.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.224 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.544 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 1.4 tp -61.14 -55.46 43.91 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.895 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 109' ' ' LEU . 45.8 Cg_endo -72.86 134.91 22.55 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.942 1.496 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 117' ' ' GLU . 46.6 Cg_endo -73.16 83.63 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.984 1.518 . . . . 0.0 110.432 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PRO . 0.2 OUTLIER 48.41 -178.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 2.1 mm-40 -58.7 -57.73 24.56 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.226 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 46.6 Cg_endo -72.93 -177.58 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.991 1.521 . . . . 0.0 110.431 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.2 p -123.89 58.32 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.883 . . . . 0.0 110.163 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.1 m -150.38 17.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.24 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -74.15 61.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 118' ' ' VAL . 17.4 m -123.18 52.38 4.53 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.945 . . . . 0.0 110.157 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 118' ' ' VAL . 45.7 Cg_endo -72.92 -164.31 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.961 1.506 . . . . 0.0 110.383 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -150.0 56.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.53 ' CB ' ' HD3' ' A' ' 122' ' ' PRO . 10.5 mm-40 -71.59 -57.7 4.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.89 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 121' ' ' GLN . 47.4 Cg_endo -73.08 159.01 48.56 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.983 1.517 . . . . 0.0 110.458 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.22 -6.94 19.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.054 1.555 . . . . 0.0 110.419 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.14 -163.04 1.41 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -110.76 -59.07 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.61 -50.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 110.311 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.433 HD21 ' HG3' ' A' ' 132' ' ' PRO . 0.5 OUTLIER -139.8 102.2 7.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.297 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.31 -16.36 24.85 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.977 1.514 . . . . 0.0 110.363 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.46 -21.7 41.73 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 m -76.87 -30.13 56.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -1.128 . . . . 0.0 110.143 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.527 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -57.75 -57.61 24.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 131' ' ' THR . 46.6 Cg_endo -73.08 152.58 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.0 1.526 . . . . 0.0 110.408 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 134' ' ' ARG . 1.2 mmpt? -78.24 -13.14 59.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.467 ' HG2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -42.68 116.73 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -175.42 111.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.154 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 2.1 t80 -103.0 121.42 42.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.936 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.18 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.9 165.89 33.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.0 . . . . 0.0 110.423 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.096 HD12 ' CD2' ' A' ' 147' ' ' LEU . 6.1 mt -123.5 126.73 73.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.012 . . . . 0.0 109.758 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.781 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -83.36 107.63 16.0 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.832 0.825 . . . . 0.0 109.717 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' TYR . 56.1 p -42.45 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.774 -0.579 . . . . 0.0 110.411 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.84 80.3 0.36 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.38 82.31 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 145' ' ' ILE . 39.8 tt0 -114.06 121.28 43.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.281 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 21.9 mtmm -76.94 108.45 9.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 110.949 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.834 HG22 HD11 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -104.31 132.47 20.94 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.927 ' C ' HD12 ' A' ' 147' ' ' LEU . 45.2 Cg_endo -71.56 128.16 14.06 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.79 1.416 . . . . 0.0 112.111 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.096 ' CD2' HD12 ' A' ' 138' ' ' ILE . 8.3 mp -123.69 101.5 7.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.71 117.81 44.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.874 -1.142 . . . . 0.0 111.207 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 39' ' ' PHE . 8.8 mp -79.73 114.83 18.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.283 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.18 -23.93 2.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -85.91 124.9 70.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 110.271 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.581 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 47.9 Cg_endo -74.74 128.26 11.55 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.055 1.555 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.937 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.76 158.22 16.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.519 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.556 ' N ' HD22 ' A' ' 153' ' ' LEU . 47.8 t -113.03 82.47 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.104 -0.997 . . . . 0.0 110.264 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.2 m -71.29 95.2 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 156' ' ' ASN . 27.5 p30 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.23 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.276 0.56 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.8 145.87 18.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.494 ' O ' HG23 ' B' ' 161' ' ' THR . . . -126.13 -47.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.412 ' C ' HG23 ' B' ' 161' ' ' THR . 3.7 t 45.7 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.219 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.494 HG23 ' O ' ' B' ' 159' ' ' ALA . 69.5 p -145.75 92.64 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.827 HG21 ' CA ' ' A' ' 25' ' ' GLY . 7.2 p -119.97 92.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' B' ' 164' ' ' PTR . 0.4 OUTLIER -71.56 162.84 28.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.561 ' N ' ' CD2' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 64' ' ' LEU . 3.1 t -120.45 -134.87 0.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.607 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 31.0 m -145.16 147.71 32.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.18 -0.95 . . . . 0.0 110.158 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.154 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.6 t -87.67 102.39 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.18 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t 72.7 120.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.405 -0.81 . . . . 0.0 110.231 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' B' ' 168' ' ' VAL . 0.1 OUTLIER -42.26 153.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.15 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' GLN . 4.4 t -102.77 93.84 5.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.509 ' CA ' ' HB3' ' A' ' 78' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.522 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.336 0.588 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 38.0 p90 -63.38 -36.08 82.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.479 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 1.0 OUTLIER -55.57 -36.21 66.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 4.2 mt -64.29 -44.46 91.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 51' ' ' PHE . 12.1 t -66.63 -48.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.8 t -58.82 -41.75 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -71.22 -31.26 67.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 109.833 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.918 ' HB1' HG12 ' A' ' 91' ' ' VAL . . . -76.05 -44.28 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.458 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 6' ' ' VAL . 29.9 m -57.11 -38.71 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.241 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 4.6 mtp180 -55.04 -40.63 70.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.639 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -71.36 -42.39 68.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.959 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -72.04 -40.18 68.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 5.3 pt20 -68.19 -33.73 74.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 4.0 tm-20 -57.65 -21.45 39.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 110.261 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -26.95 62.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.17 37.8 3.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 25.5 t80 -142.13 7.15 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -1.142 . . . . 0.0 110.235 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 6.3 t80 -96.28 136.21 37.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.121 -0.987 . . . . 0.0 110.194 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 1.102 ' CG ' HD12 ' A' ' 40' ' ' LEU . 28.6 m95 -110.6 148.31 32.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.478 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -148.41 109.74 4.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 176.59 -27.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 111.089 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' CG2' ' CZ ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -120.88 -160.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.862 -1.149 . . . . 0.0 110.277 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -86.09 166.04 16.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.084 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -52.19 -76.45 0.18 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.718 ' HA2' HD22 ' A' ' 28' ' ' ASN . . . -60.74 -43.72 98.79 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.457 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 29.9 tt0 -59.78 -24.83 64.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 110.01 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.676 ' HB1' ' HE ' ' A' ' 42' ' ' ARG . . . -78.12 -45.55 23.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.32 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.718 HD22 ' HA2' ' A' ' 25' ' ' GLY . 1.6 m-80 -69.04 -41.8 77.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.389 -0.819 . . . . 0.0 110.755 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 1.4 mp -59.43 -32.14 69.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.766 . . . . 0.0 110.951 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.751 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -55.21 -23.58 22.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.982 -1.074 . . . . 0.0 109.352 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 38' ' ' THR . 70.9 mt -64.38 -37.31 87.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 109.096 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.549 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 26.9 p -69.19 -32.43 71.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.554 -0.716 . . . . 0.0 109.888 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.48 -20.62 43.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.89 . . . . 0.0 110.371 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.762 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 12.5 mm-40 -134.06 -83.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.762 ' HD3' ' CB ' ' A' ' 34' ' ' GLU . 50.3 Cg_endo -78.01 67.67 8.01 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 122.812 0.901 . . . . 0.0 110.152 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 31' ' ' LEU . . . -63.67 141.47 58.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 88.98 15.74 58.88 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.754 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -130.63 147.17 52.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -1.05 . . . . 0.0 110.142 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 1.07 ' CD1' HD21 ' A' ' 149' ' ' LEU . 4.0 p90 -123.11 146.22 47.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 0.0 110.678 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.102 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -152.08 160.31 43.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 12' ' ' LEU . 3.3 tt -114.0 128.84 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.924 -1.11 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.676 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -117.68 150.44 39.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.755 . . . . 0.0 110.122 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 44' ' ' SER . 9.8 t70 -73.87 127.56 33.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 44' ' ' SER . 25.5 m -41.26 -34.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.324 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.43 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 0.0 110.258 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -177.25 -172.12 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.184 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -64.97 -10.02 26.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 110.224 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' N ' ' OE1' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -67.86 -32.53 73.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.261 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 59.4 m170 -115.29 -123.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.104 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.617 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.4 p90 -152.7 -160.99 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.838 ' CD2' HG13 ' A' ' 5' ' ' VAL . 27.1 p90 -115.9 148.72 39.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' CA ' ' A' ' 24' ' ' GLY . 88.6 m -126.13 139.76 53.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.055 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -126.92 124.97 40.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.918 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -133.9 154.29 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.476 -0.765 . . . . 0.0 110.049 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 149' ' ' LEU . 12.4 p -130.58 174.08 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -118.86 139.02 52.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.204 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.796 HG21 ' HB3' ' A' ' 147' ' ' LEU . 26.6 m -115.21 -43.3 3.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 57' ' ' THR . 2.8 pt20 -177.99 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.59 29.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.254 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.626 ' O ' HD13 ' A' ' 138' ' ' ILE . . . -155.76 65.46 0.31 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 61' ' ' THR . 3.8 t -84.96 111.85 20.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -1.144 . . . . 0.0 110.138 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HG3' HG21 ' A' ' 138' ' ' ILE . 14.3 mmtt -123.53 166.08 16.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.804 ' OD1' HG13 ' B' ' 162' ' ' VAL . 0.5 OUTLIER -134.32 154.12 51.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.027 HD21 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.01 118.15 13.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 110.53 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.555 ' HD2' ' CZ ' ' A' ' 50' ' ' PHE . 10.7 ptm180 -75.32 162.21 28.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.864 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.914 ' CG1' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -78.27 148.78 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 110.263 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -107.53 136.75 46.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 1' ' ' GLU . 27.9 p -87.83 119.97 28.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.28 103.09 8.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.64 -78.27 0.02 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -148.25 30.35 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.44 163.09 33.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.956 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -115.7 141.18 48.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.285 -0.884 . . . . 0.0 109.977 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.631 ' C ' HD13 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -148.15 138.89 23.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.94 -1.1 . . . . 0.0 110.616 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.702 HD21 ' CB ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -86.06 -1.14 57.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 109.793 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.67 HE21 HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -121.12 -130.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.097 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.21 -87.86 0.53 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.386 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' OD1' ' HG3' ' A' ' 80' ' ' ARG . 6.0 t0 -81.28 113.21 39.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HB3' ' HB2' ' A' ' 74' ' ' SER . 47.3 Cg_endo -74.35 -12.64 22.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.043 1.549 . . . . 0.0 110.379 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.42 ' HG3' ' OD1' ' A' ' 78' ' ' ASP . 13.7 mtm-85 -67.79 -6.17 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.309 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 82' ' ' THR . 34.3 t -142.81 -143.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.223 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.698 HG22 ' HE1' ' A' ' 97' ' ' HIS . 0.2 OUTLIER 70.38 -55.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 0.0 110.315 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 177.02 -57.11 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.314 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 83' ' ' GLN . 45.1 Cg_endo -72.01 162.0 43.12 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.905 1.476 . . . . 0.0 110.452 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' HB ' ' HD2' ' A' ' 86' ' ' PRO . 20.9 m -97.81 167.08 12.33 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.2 Cg_endo -70.46 132.85 23.02 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.952 1.501 . . . . 0.0 110.122 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 3.5 mtt180 63.36 43.11 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.915 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 93' ' ' LYS . 14.4 p90 -61.43 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.037 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 90' ' ' CYS . 74.2 m-20 -103.9 109.97 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.76 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.779 ' CB ' HD23 ' A' ' 92' ' ' LEU . 0.6 OUTLIER 50.92 156.13 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.962 0.887 . . . . 0.0 111.588 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.956 HG23 ' CD2' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -49.05 -21.11 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.703 0.763 . . . . 0.0 109.32 178.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.0 pp -54.41 -33.87 60.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.565 -0.709 . . . . 0.0 111.545 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.583 ' HB2' ' CD1' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -57.31 -30.41 64.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.596 -1.315 . . . . 0.0 109.741 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.914 HD22 ' CG1' ' A' ' 66' ' ' ILE . 1.1 pp -58.78 -33.02 69.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.3 m -53.39 -34.85 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.429 -0.794 . . . . 0.0 110.353 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' N ' HG23 ' A' ' 95' ' ' VAL . 8.3 m80 -51.29 -30.06 16.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.0 109.51 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.698 ' HE1' HG22 ' A' ' 82' ' ' THR . 2.0 t60 -73.17 -36.3 66.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.166 -0.959 . . . . 0.0 108.825 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.055 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.8 m-85 -63.57 -22.12 66.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.568 -0.707 . . . . 0.0 109.674 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.569 ' HE1' ' HA ' ' A' ' 135' ' ' ALA . 10.8 ttm 71.57 63.31 0.41 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.465 -0.772 . . . . 0.0 110.301 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 42.1 Cg_endo -72.67 -29.41 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.915 1.481 . . . . 0.0 112.284 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 100' ' ' PRO . 48.3 Cg_endo -74.36 162.76 37.74 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 122.821 0.906 . . . . 0.0 110.415 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' HA ' ' HG ' ' A' ' 150' ' ' SER . 45.8 Cg_endo -73.26 -90.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.004 1.528 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 119.93 12.14 6.65 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.6 p -56.16 142.69 66.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 110.237 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.35 -44.28 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.05 1.553 . . . . 0.0 110.412 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.8 t -159.06 -161.92 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.269 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 43.91 75.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -107.86 -174.02 2.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.226 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.499 ' N ' ' OG ' ' A' ' 108' ' ' SER . 0.1 OUTLIER -130.83 75.42 78.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.89 139.91 31.02 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.496 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.02 147.45 43.29 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.034 1.544 . . . . 0.0 110.463 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -80.67 91.96 5.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.216 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 8.2 pt-20 -64.42 143.18 98.49 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.191 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.99 -18.69 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.988 1.52 . . . . 0.0 110.419 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.72 150.58 21.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 3.4 t -140.7 -136.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 2.5 mt-10 65.6 9.71 6.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 t -54.6 117.98 15.29 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.101 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 45.9 Cg_endo -72.6 -48.95 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.982 1.517 . . . . 0.0 110.504 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 119' ' ' PRO . 2.1 tt0 177.18 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.238 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 6.6 mt-30 -43.32 127.34 3.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.75 110.56 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 121' ' ' GLN . 46.4 Cg_endo -73.08 -159.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.996 1.524 . . . . 0.0 110.406 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 125' ' ' GLN . . . -92.25 -17.73 24.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 124' ' ' ALA . 7.5 tp60 42.35 62.44 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.915 . . . . 0.0 110.202 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . 43.31 -99.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.0 110.09 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER 40.21 81.5 0.25 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.935 . . . . 0.0 110.287 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' SER . 46.1 Cg_endo -73.08 -54.63 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.002 1.527 . . . . 0.0 110.443 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 48.08 -94.11 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 128' ' ' PRO . 0.1 OUTLIER -116.66 105.21 12.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -1.124 . . . . 0.0 110.244 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.43 123.13 68.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 133' ' ' LYS . 46.0 Cg_endo -72.7 104.23 1.7 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.961 1.506 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 134' ' ' ARG . 2.3 tptt -42.81 -58.61 2.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 110.319 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 133' ' ' LYS . 1.7 mtp180 57.57 113.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.889 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.97 126.34 0.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 110.058 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.921 ' CD2' HG11 ' B' ' 167' ' ' VAL . 3.7 t80 -128.59 121.81 29.56 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.408 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.029 ' CD2' HG22 ' B' ' 168' ' ' VAL . 12.6 p90 -156.83 167.33 30.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.203 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.705 HD12 HD21 ' A' ' 147' ' ' LEU . 2.6 mp -106.05 149.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.635 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 29.5 m-85 -96.18 133.05 40.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.76 . . . . 0.0 110.992 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.48 ' OG ' HD13 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -87.46 48.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.636 -0.665 . . . . 0.0 110.217 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 52.49 65.73 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.07 -22.48 15.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.53 121.97 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -1.174 . . . . 0.0 110.162 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.4 ptmt -88.48 105.72 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.27 102.98 10.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.791 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.2 Cg_endo -76.18 126.68 9.37 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.681 1.358 . . . . 0.0 111.981 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.796 ' HB3' HG21 ' A' ' 57' ' ' THR . 0.4 OUTLIER -126.76 136.0 51.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 148' ' ' VAL . 30.2 m -97.08 117.18 41.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.136 -1.603 . . . . 0.0 110.624 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.07 HD21 ' CD1' ' A' ' 39' ' ' PHE . 6.3 tt -90.11 114.93 26.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.65 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.52 ' HG ' ' HA ' ' A' ' 102' ' ' PRO . 0.1 OUTLIER -148.94 19.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.021 -1.05 . . . . 0.0 110.821 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -105.6 124.49 36.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.03 -1.044 . . . . 0.0 109.976 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.5 Cg_endo -76.57 148.22 29.14 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.954 1.502 . . . . 0.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.709 HD21 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -79.07 152.87 30.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 110.089 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.677 ' H ' HD13 ' A' ' 153' ' ' LEU . 17.0 m -91.55 57.57 3.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 110.192 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.561 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 38.0 t -41.21 -60.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 110.27 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . 0.659 ' O ' HG23 ' B' ' 158' ' ' THR . 37.3 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.228 0.537 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.659 HG23 ' O ' ' B' ' 157' ' ' SER . 0.7 OUTLIER -159.64 28.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.237 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 158' ' ' THR . . . -176.16 60.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.269 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 12.0 t -115.18 174.55 5.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.42 ' O ' ' C ' ' B' ' 162' ' ' VAL . 12.9 m -121.22 42.8 2.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.804 HG13 ' OD1' ' A' ' 63' ' ' ASN . 43.2 t 42.44 64.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.265 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -87.87 153.56 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.638 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 1.027 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 p -149.03 -98.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.368 -0.833 . . . . 0.0 110.318 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.638 ' CA ' HD11 ' A' ' 64' ' ' LEU . 2.6 t -146.82 175.47 10.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 110.26 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.921 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -128.73 112.36 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.976 . . . . 0.0 110.272 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 137' ' ' TYR . 0.2 OUTLIER 41.46 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -116.53 170.43 8.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.54 -73.34 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.238 0.542 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.505 ' HB2' ' HD2' ' A' ' 48' ' ' ARG . 36.8 p90 -62.08 -36.14 80.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -55.2 -34.21 63.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.167 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -67.26 -45.17 77.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 110.205 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.94 ' O ' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -64.94 -48.4 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER -58.42 -32.62 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.311 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -68.11 -42.52 80.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 91' ' ' VAL . . . -76.12 -44.91 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.94 HG13 ' O ' ' A' ' 5' ' ' VAL . 5.4 m -59.01 -39.58 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -55.54 -49.01 73.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 -35.94 65.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 109.513 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 12' ' ' LEU . 14.0 tp -72.13 -44.09 63.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 10' ' ' ARG . 16.7 pt20 -68.21 -33.87 75.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.6 -26.48 61.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 110.112 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -26.89 62.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.024 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' ' 155' ' ' SER . . . 99.19 1.61 56.93 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HD2' HD12 ' A' ' 153' ' ' LEU . 1.6 t80 -88.96 -8.33 54.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -1.059 . . . . 0.0 110.187 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 41' ' ' ILE . 5.7 t80 -90.91 136.23 33.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.812 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 1.034 ' CD1' HD13 ' A' ' 40' ' ' LEU . 46.3 m95 -99.79 148.42 24.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.383 -0.823 . . . . 0.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.795 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -53.07 -18.7 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.855 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 75.54 93.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.659 . . . . 0.0 111.16 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 23' ' ' THR . 1.8 m -66.41 -90.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 0.0 109.284 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.678 ' H ' HG23 ' A' ' 22' ' ' VAL . 1.1 m -103.5 172.99 6.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.003 -1.061 . . . . 0.0 109.219 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.599 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.23 -94.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.644 ' CA ' HG21 ' B' ' 162' ' ' VAL . . . -71.25 -29.5 68.43 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.485 -1.009 . . . . 0.0 110.651 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.594 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -57.56 -24.95 59.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.076 -1.25 . . . . 0.0 111.204 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.918 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -76.46 -47.04 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.825 -1.172 . . . . 0.0 109.66 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.669 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.7 m-80 -70.34 -44.86 67.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 111.066 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' OG1' ' A' ' 61' ' ' THR . 15.1 mt -70.7 -31.53 68.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 27' ' ' ALA . 3.7 pp -54.28 -27.41 35.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.535 -1.353 . . . . 0.0 110.561 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.033 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.4 pp -74.05 -33.75 63.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 108.557 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.81 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -69.89 -32.72 71.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 110.296 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.65 -21.07 41.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 110.352 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.744 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 3.7 mm-40 -113.95 -77.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.057 -1.027 . . . . 0.0 110.063 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.744 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.0 Cg_endo -72.49 71.09 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.271 1.143 . . . . 0.0 110.142 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.09 137.18 47.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.04 0.6 89.76 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.996 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -111.23 147.41 35.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -1.181 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -122.79 148.75 45.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.0 110.716 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' CD1' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -147.65 160.02 43.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 109.91 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.021 ' N ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -113.95 148.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.973 . . . . 0.0 110.46 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.599 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 5.7 ppt_? -127.38 127.59 44.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.705 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 24.7 t70 -75.27 138.24 41.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.483 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.568 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 12.9 m -69.86 64.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -47.98 -24.89 1.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.172 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 45' ' ' SER . 52.5 t0 -49.78 -101.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 13.1 mt-30 -78.11 -1.89 34.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.991 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER 68.77 23.72 6.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -58.66 -70.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.368 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.843 ' CB ' HG21 ' A' ' 5' ' ' VAL . 17.2 p90 -154.42 -156.13 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.857 ' CE1' HG22 ' A' ' 5' ' ' VAL . 14.2 p90 -116.01 152.71 33.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 24.3 m -118.13 155.54 30.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.885 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.904 HD13 ' N ' ' A' ' 54' ' ' SER . 1.2 tm? -142.17 129.68 21.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.301 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.904 ' N ' HD13 ' A' ' 53' ' ' LEU . 3.1 p -138.32 154.13 49.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.124 -0.985 . . . . 0.0 109.642 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG11 HD21 ' A' ' 149' ' ' LEU . 2.8 m -127.03 173.99 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 110.835 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 14.5 tptm -113.04 129.58 56.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.401 -0.812 . . . . 0.0 109.887 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.965 ' HB ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.63 -165.76 1.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.387 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 60' ' ' GLY . 8.4 tt0 -77.93 -59.12 2.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.473 ' OG ' ' HB ' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -42.24 -27.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' GLN . . . 130.66 151.92 7.24 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 61' ' ' THR . 2.4 t -78.87 108.89 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -1.151 . . . . 0.0 110.181 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -110.37 153.2 25.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.942 . . . . 0.0 110.099 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 164' ' ' PTR . 15.0 p30 -121.06 125.84 48.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -118.65 151.93 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.633 ' C ' HD12 ' A' ' 75' ' ' LEU . 1.4 ptt180 -140.36 152.99 46.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.127 -0.983 . . . . 0.0 110.437 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.911 HD11 ' HB2' ' A' ' 90' ' ' CYS . 0.3 OUTLIER -76.62 117.86 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 74' ' ' SER . 16.2 tt0 -91.95 151.14 20.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 110.484 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 20.0 p -101.62 127.84 48.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.268 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -133.14 117.01 16.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.31 34.15 87.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.22 -14.22 54.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 51.2 p -94.99 162.81 13.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -1.14 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.7 m-30 -110.92 152.01 27.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.254 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.73 ' C ' HD13 ' A' ' 66' ' ' ILE . 19.3 m -155.63 138.7 15.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.031 HD13 ' HG ' ' A' ' 94' ' ' LEU . 2.6 tt -123.74 -1.86 8.39 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.076 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 77' ' ' SER . 13.7 mt-30 -131.37 -136.06 0.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.089 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 76' ' ' GLN . 5.3 t -42.56 139.82 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 110.163 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 80' ' ' ARG . 3.8 p30 -81.56 130.15 62.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.2 -0.938 . . . . 0.0 110.164 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 54.41 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.52 . . . . 0.0 110.416 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' HB2' ' OD1' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -85.88 16.08 4.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -108.84 44.26 1.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.876 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 43.79 39.97 2.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.471 ' HG2' ' OG ' ' A' ' 81' ' ' SER . 3.2 pt20 -134.2 70.97 73.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.23 -179.16 4.12 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.979 1.515 . . . . 0.0 110.357 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.74 141.61 40.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.452 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 46.7 Cg_endo -72.95 137.66 27.11 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.011 1.532 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.649 ' O ' ' O ' ' A' ' 88' ' ' PHE . 4.3 mtt180 57.54 37.22 27.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 110.15 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.2 p90 36.16 109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.727 0.775 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.504 ' C ' ' SG ' ' A' ' 90' ' ' CYS . 0.9 OUTLIER -113.56 110.1 19.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.914 -1.116 . . . . 0.0 109.349 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.911 ' HB2' HD11 ' A' ' 66' ' ' ILE . 0.8 OUTLIER 172.79 -65.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.642 -179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 92' ' ' LEU . 7.3 p -49.79 -48.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.82 -1.175 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.722 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.6 mt -61.64 -42.07 98.38 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -57.86 -34.41 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 110.43 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.7 m -54.35 -37.67 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.94 -1.1 . . . . 0.0 109.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.525 ' ND1' ' HB3' ' A' ' 101' ' ' PRO . 80.1 m-70 -68.16 -37.34 80.91 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.247 -0.908 . . . . 0.0 109.188 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.582 ' CD2' ' CD1' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -77.57 -36.87 51.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 109.749 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.913 ' OH ' HD11 ' A' ' 75' ' ' LEU . 5.6 m-85 -77.1 -22.33 52.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.824 . . . . 0.0 110.413 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' HD2' ' A' ' 100' ' ' PRO . 2.5 mtp -156.89 167.96 13.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.336 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.498 ' HG3' ' HA ' ' A' ' 150' ' ' SER . 48.9 Cg_endo -76.01 133.96 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.0 110.451 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.525 ' HB3' ' ND1' ' A' ' 96' ' ' HIS . 45.4 Cg_endo -73.03 111.8 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.977 1.514 . . . . 0.0 110.344 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 46.3 Cg_endo -72.87 55.12 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.985 1.518 . . . . 0.0 110.383 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.71 117.38 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.5 m -140.73 88.92 10.43 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.264 -1.139 . . . . 0.0 110.214 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.24 -176.7 2.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.026 1.54 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 t -72.73 -176.26 1.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -83.78 82.03 8.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 109' ' ' LEU . 19.2 t 50.84 -157.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.84 HD23 ' H ' ' A' ' 109' ' ' LEU . 2.5 pt? -149.87 158.57 37.03 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.236 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HB2' ' HB2' ' A' ' 113' ' ' GLU . 46.7 Cg_endo -73.0 148.43 45.07 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.09 -90.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.967 1.509 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.35 67.33 1.42 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.211 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -155.81 77.09 4.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.205 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 115' ' ' SER . 46.7 Cg_endo -72.83 -53.57 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.477 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 114' ' ' PRO . 0.7 OUTLIER 63.3 20.95 12.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' GLU . 5.7 t 57.95 21.36 7.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' SER . 18.7 mt-10 43.28 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.262 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 118' ' ' VAL . 50.6 t -127.57 62.12 53.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -35.01 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.045 1.55 . . . . 0.0 110.458 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 52.68 87.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -150.12 49.26 0.62 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.199 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 121' ' ' GLN . 47.0 Cg_endo -73.42 134.39 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.944 1.497 . . . . 0.0 110.531 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 56.1 3.42 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.974 1.513 . . . . 0.0 110.4 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.56 18.29 3.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.343 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -135.08 151.88 51.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.04 129.2 9.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.536 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 3.2 mm? -63.36 -57.56 19.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 46.2 Cg_endo -73.1 119.3 5.96 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.542 . . . . 0.0 110.435 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 131' ' ' THR . . . 159.29 -90.29 0.11 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -57.45 84.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -1.146 . . . . 0.0 110.231 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.571 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -127.53 48.29 3.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.228 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 131' ' ' THR . 47.1 Cg_endo -73.42 -0.18 8.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.99 1.521 . . . . 0.0 110.562 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 35.64 3.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.248 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.425 ' HB3' HG22 ' A' ' 131' ' ' THR . 0.1 OUTLIER -162.96 52.25 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.068 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -176.31 102.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.143 ' CE2' HG21 ' B' ' 167' ' ' VAL . 3.0 t80 -102.62 122.51 44.55 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.903 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.165 ' CD2' HG22 ' B' ' 168' ' ' VAL . 3.5 p90 -155.73 167.9 28.89 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.927 -1.108 . . . . 0.0 110.781 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.566 HG12 ' CB ' ' A' ' 62' ' ' LYS . 3.0 mp -121.09 149.58 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 111.055 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.752 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.0 OUTLIER -84.71 107.94 17.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 110.057 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.851 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -91.82 122.02 33.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 110.286 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.14 65.68 2.59 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 51.35 20.59 5.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 140' ' ' SER . 12.8 tt0 -120.38 121.86 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -1.135 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.16 105.36 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 110.63 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.851 HD13 ' HB3' ' A' ' 140' ' ' SER . 0.9 OUTLIER -99.98 109.04 54.79 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.831 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.5 Cg_endo -72.53 128.72 13.84 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.954 1.502 . . . . 0.0 112.277 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 137' ' ' TYR . 0.9 OUTLIER -125.89 135.21 51.65 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 148' ' ' VAL . 35.7 m -103.83 117.72 49.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 120.273 -1.517 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.823 HD21 HG11 ' A' ' 55' ' ' VAL . 12.8 mt -76.17 123.5 25.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.159 -0.963 . . . . 0.0 108.969 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.498 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 11.0 t -137.84 -7.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.82 -1.175 . . . . 0.0 111.647 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 ttm-85 -100.23 124.63 42.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.718 -1.239 . . . . 0.0 110.104 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.7 147.96 32.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.981 1.516 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 1.119 HD13 ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -67.13 159.14 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 110.207 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.964 ' N ' HD22 ' A' ' 153' ' ' LEU . 5.0 m -14.09 -86.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.558 -0.713 . . . . 0.0 111.231 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 20.0 m -41.09 139.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.218 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.203 0.525 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.73 49.77 6.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -163.82 -51.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.91 148.62 0.52 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -0.871 . . . . 0.0 110.175 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -97.56 -51.9 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.644 HG21 ' CA ' ' A' ' 25' ' ' GLY . 2.6 p -171.03 121.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 110.014 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 0.0 OUTLIER -120.81 -176.5 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.189 -0.944 . . . . 0.0 110.28 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.552 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.488 ' O ' ' CD2' ' B' ' 164' ' ' PTR . 1.4 m -134.83 -138.67 0.17 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.511 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -125.95 163.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.191 -0.943 . . . . 0.0 110.134 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.143 HG21 ' CE2' ' A' ' 136' ' ' TYR . 37.8 t -114.47 112.89 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.165 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.5 t 58.48 155.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -172.37 128.34 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 5.6 t -131.05 109.19 10.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.26 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.57 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.61 ' N ' HD12 ' A' ' 4' ' ' LEU . 85.3 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.34 0.591 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 22.1 p90 -64.52 -35.88 82.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.16 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.564 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 28.1 pt20 -62.88 -40.22 96.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 1' ' ' GLU . 1.1 mt -67.0 -47.46 71.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 50' ' ' PHE . 7.1 p -68.94 -47.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.318 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.608 ' N ' HG13 ' A' ' 5' ' ' VAL . 41.9 t -58.68 -50.23 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.181 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.82 -38.42 78.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.724 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.59 ' CB ' HD21 ' A' ' 92' ' ' LEU . . . -72.34 -38.26 68.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.415 -0.803 . . . . 0.0 109.937 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.791 HG13 ' CE2' ' A' ' 18' ' ' TYR . 3.0 t -56.94 -39.39 65.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.3 mtp85 -58.45 -49.42 77.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.568 -0.708 . . . . 0.0 110.104 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -78.57 -33.25 47.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.323 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' CG2' ' A' ' 95' ' ' VAL . 2.2 tt -72.0 -44.15 63.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.758 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 14' ' ' GLU . 4.6 pt20 -61.28 -40.94 96.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 110.371 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 8.3 tt0 -77.16 -51.64 10.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 p -72.79 -43.18 63.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.975 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.587 ' O ' ' CD1' ' A' ' 17' ' ' PHE . . . -99.98 33.99 5.85 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.221 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 3.1 p90 29.75 44.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -1.039 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.791 ' CE2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -92.79 122.92 35.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.721 ' CE2' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -125.61 145.94 49.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 110.126 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 107.31 14.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.29 12.82 0.12 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.472 -0.767 . . . . 0.0 110.016 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.54 -159.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.693 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -87.19 176.17 7.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 42' ' ' ARG . . . -55.21 -75.3 0.25 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.742 ' CA ' HG11 ' B' ' 162' ' ' VAL . . . -79.39 -31.77 40.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.564 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 1.9 tp10 -59.0 -36.47 74.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.032 -1.275 . . . . 0.0 109.509 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.938 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -60.92 -51.43 69.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.497 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.729 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 4.1 m-80 -69.82 -42.88 73.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.968 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.99 -32.75 69.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.352 -0.842 . . . . 0.0 112.321 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.938 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.7 pp -55.4 -35.12 64.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.704 -1.247 . . . . 0.0 110.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.043 HD13 ' O ' ' A' ' 38' ' ' THR . 4.6 pp -66.27 -36.24 82.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.826 -1.171 . . . . 0.0 109.265 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.922 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.53 -32.72 71.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 110.324 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.55 -20.71 42.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.67 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -116.84 -76.03 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.0 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.9 Cg_endo -73.18 70.9 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.292 1.154 . . . . 0.0 110.42 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.57 141.28 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 79.91 18.21 73.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 1.043 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.42 147.31 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -1.079 . . . . 0.0 110.023 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.763 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -123.02 163.08 21.14 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.016 . . . . 0.0 110.202 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.97 ' HB2' HD23 ' A' ' 153' ' ' LEU . 7.6 tt -151.96 159.18 43.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.96 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.858 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -119.24 129.28 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 24' ' ' GLY . 6.3 ppt_? -112.16 155.06 24.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.34 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 30.3 t0 -100.05 132.14 45.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.48 ' HA ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -55.82 153.98 7.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m -48.17 -51.28 25.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.168 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -79.56 146.14 32.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -90.91 -2.0 57.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.212 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -93.94 44.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 48' ' ' ARG . 36.2 m80 -146.35 -93.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.911 ' HA ' HG21 ' A' ' 5' ' ' VAL . 12.1 p90 175.44 178.02 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.878 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.894 ' CD2' HG23 ' A' ' 5' ' ' VAL . 3.3 p90 -115.88 148.66 39.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.987 . . . . 0.0 110.3 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 65' ' ' ARG . 2.1 p -126.84 155.33 43.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.301 -0.874 . . . . 0.0 110.865 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.12 HD22 ' CD1' ' A' ' 98' ' ' TYR . 1.9 tt -124.22 154.09 40.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.796 ' N ' HD23 ' A' ' 53' ' ' LEU . 3.2 p -139.03 153.63 48.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' HB3' ' A' ' 39' ' ' PHE . 2.8 m -130.13 174.11 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.794 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.8 139.14 52.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.471 -0.768 . . . . 0.0 110.086 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -175.6 146.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.546 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.3 OUTLIER 66.82 -60.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.184 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER 165.89 -22.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 109.817 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' C ' ' NZ ' ' A' ' 62' ' ' LYS . . . -105.77 117.1 5.38 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' THR . 9.7 t -97.61 116.52 29.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.142 -1.211 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -106.71 161.37 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.132 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' C ' HD22 ' A' ' 64' ' ' LEU . 1.1 m-80 -118.98 135.82 54.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.449 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.904 ' HB3' HD11 ' A' ' 75' ' ' LEU . 2.1 mm? -104.05 127.09 51.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.587 ' CB ' ' CG2' ' A' ' 52' ' ' THR . 0.0 OUTLIER -118.02 138.28 52.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 91' ' ' VAL . 1.1 tp -82.95 148.42 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 68' ' ' CYS . 27.3 tp60 -112.88 151.06 30.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 110.247 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 67' ' ' GLN . 45.2 t -102.04 127.84 48.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 110.231 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 71' ' ' GLY . 3.4 tt0 -121.26 103.0 8.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.76 -68.95 0.12 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -157.02 28.03 0.52 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 4.5 p -136.45 161.31 36.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 110.161 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 90' ' ' CYS . 1.3 m-30 -112.95 149.96 32.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.485 ' HA ' ' SG ' ' A' ' 90' ' ' CYS . 16.4 t -150.99 138.82 19.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.033 HD13 HD21 ' A' ' 94' ' ' LEU . 27.0 tp -96.41 -23.24 16.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -102.07 142.89 32.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 110.213 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.5 m -92.45 83.48 4.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 40.7 p-10 -109.44 139.86 21.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.18 56.11 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.996 1.524 . . . . 0.0 110.457 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 81' ' ' SER . 0.0 OUTLIER -85.9 -38.96 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 110.234 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.666 ' O ' HG22 ' A' ' 82' ' ' THR . 12.7 m 55.79 -163.0 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 110.147 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.666 HG22 ' O ' ' A' ' 81' ' ' SER . 12.6 t 37.79 35.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.297 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.2 tp60 69.66 125.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.65 -62.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.94 1.495 . . . . 0.0 110.524 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.64 HG21 ' O ' ' A' ' 89' ' ' ASP . 2.9 m -126.91 168.13 15.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 110.017 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 85' ' ' VAL . 43.4 Cg_endo -70.46 132.87 23.04 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.863 1.454 . . . . 0.0 110.116 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.552 ' O ' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 67.95 -77.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.904 . . . . 0.0 109.938 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB3' ' O ' ' A' ' 87' ' ' ARG . 10.5 p90 176.39 50.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.858 . . . . 0.0 109.84 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.64 ' O ' HG21 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -72.64 110.09 6.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.158 -0.963 . . . . 0.0 109.896 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HB3' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER 168.89 -71.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.734 ' CA ' HD13 ' A' ' 66' ' ' ILE . 4.0 p -53.43 -50.06 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 8' ' ' ALA . 16.3 mt -63.51 -46.06 87.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 108.434 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -60.26 -29.9 69.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.033 HD21 HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.92 -34.24 69.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.785 -0.572 . . . . 0.0 110.095 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 42.0 t -54.05 -42.15 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.089 -1.007 . . . . 0.0 108.948 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.0 OUTLIER -68.26 -31.37 70.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.915 . . . . 0.0 108.735 178.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.12 -43.29 29.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.684 -0.635 . . . . 0.0 109.503 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.12 ' CD1' HD22 ' A' ' 53' ' ' LEU . 4.2 m-85 -64.05 -22.15 66.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.475 -0.766 . . . . 0.0 110.055 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.523 ' CB ' ' HD2' ' A' ' 100' ' ' PRO . 0.2 OUTLIER -129.61 -179.04 0.91 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.249 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 150' ' ' SER . 48.0 Cg_endo -75.41 127.57 10.5 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.04 1.547 . . . . 0.0 110.38 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.404 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 46.3 Cg_endo -73.26 110.44 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.998 1.525 . . . . 0.0 110.42 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 46.7 Cg_endo -73.56 -90.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.019 1.536 . . . . 0.0 110.49 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.74 26.46 7.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.8 t -174.4 140.91 0.75 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.206 -1.173 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.99 -89.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.976 1.513 . . . . 0.0 110.427 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 88.5 p -175.61 102.47 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -121.08 -164.81 1.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 0.0 110.195 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.73 108.02 5.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.947 . . . . 0.0 110.251 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.96 121.82 86.06 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 132.76 18.64 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.955 1.503 . . . . 0.0 110.492 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 113' ' ' GLU . 46.8 Cg_endo -73.52 -0.51 9.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.974 1.513 . . . . 0.0 110.452 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 111' ' ' PRO . 16.6 p -42.31 -26.82 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 110.251 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 111' ' ' PRO . 2.9 mm-40 -96.87 129.97 31.3 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.131 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.25 170.92 18.73 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.932 1.491 . . . . 0.0 110.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.6 t -160.46 101.93 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 116' ' ' SER . 27.8 p -96.78 100.52 12.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.34 111.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 118' ' ' VAL . 30.6 m -139.0 81.27 21.95 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.24 109.86 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.059 1.557 . . . . 0.0 110.336 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 121' ' ' GLN . 21.0 pt-20 -61.27 -176.81 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 120' ' ' GLU . 8.8 mt-30 44.7 91.05 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.11 154.13 52.14 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.035 1.545 . . . . 0.0 110.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.18 132.86 18.59 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.047 1.551 . . . . 0.0 110.343 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 125' ' ' GLN . . . -135.56 84.05 2.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 7.1 mt-30 56.43 98.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.138 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 125' ' ' GLN . . . 176.23 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.251 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.52 153.09 85.64 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.0 113.39 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.044 1.549 . . . . 0.0 110.476 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.77 -135.48 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 131' ' ' THR . 0.1 OUTLIER 55.44 28.13 11.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -1.154 . . . . 0.0 110.212 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.62 ' O ' HG22 ' A' ' 131' ' ' THR . 10.7 m 44.27 80.99 0.26 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.85 53.22 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.059 1.557 . . . . 0.0 110.422 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -102.73 -89.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.404 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -71.49 146.07 48.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . -173.25 152.82 2.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.124 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CG ' HG11 ' B' ' 167' ' ' VAL . 1.3 t80 -131.11 122.94 27.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.329 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.113 ' CE2' HG12 ' B' ' 168' ' ' VAL . 9.4 p90 -155.15 168.03 28.38 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.583 -1.323 . . . . 0.0 111.64 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.737 HG21 ' HD3' ' A' ' 62' ' ' LYS . 4.2 mp -102.16 143.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.624 0.726 . . . . 0.0 110.744 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.721 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.2 m-85 -93.3 132.76 37.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.718 0.771 . . . . 0.0 110.925 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.531 ' HB2' HD13 ' A' ' 145' ' ' ILE . 12.1 t -101.8 -163.55 1.02 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.088 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.504 ' N ' ' OG ' ' A' ' 140' ' ' SER . . . -55.67 85.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 63.77 12.43 47.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 2.7 mm-40 -120.2 121.93 39.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 110.197 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.619 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -87.22 105.26 17.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.471 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.948 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -89.52 108.6 26.01 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.828 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.6 Cg_endo -76.35 129.44 11.16 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.059 1.558 . . . . 0.0 113.35 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.948 HD21 HG22 ' A' ' 145' ' ' ILE . 2.1 mm? -125.12 134.96 52.25 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 148' ' ' VAL . 17.2 m -101.16 116.45 44.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 119.878 -1.764 . . . . 0.0 110.921 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.762 ' CD1' HG11 ' A' ' 55' ' ' VAL . 56.4 mt -84.79 114.96 22.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.135 -0.978 . . . . 0.0 109.241 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 1.5 p -147.69 28.55 0.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 111.375 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 1.2 mtt180 -134.11 123.22 16.69 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.789 -1.195 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 50.7 Cg_endo -79.3 135.45 12.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.069 1.562 . . . . 0.0 110.822 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 ' HB2' ' A' ' 40' ' ' LEU . 16.3 tp -92.39 146.5 23.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.865 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.479 ' H ' HD12 ' A' ' 153' ' ' LEU . 19.0 m -61.91 114.03 3.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -0.99 . . . . 0.0 110.339 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.63 ' HA ' ' CD1' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -45.39 -24.36 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.22 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.18 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.183 0.516 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.76 38.53 30.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' B' ' 160' ' ' SER . . . -111.0 -67.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.182 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' B' ' 159' ' ' ALA . 3.4 t 65.06 137.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.275 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.13 155.99 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.786 HG23 ' O3P' ' B' ' 164' ' ' PTR . 2.8 m -52.55 120.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.49 ' C ' ' CD2' ' B' ' 164' ' ' PTR . 17.2 pt-20 -115.66 174.0 6.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.786 ' O3P' HG23 ' B' ' 162' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 t -116.72 -141.17 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.337 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.581 ' HA ' HD11 ' A' ' 64' ' ' LEU . 41.7 p -131.25 -173.15 3.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.992 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.88 -160.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.106 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.113 HG12 ' CE2' ' A' ' 137' ' ' TYR . 2.3 m -69.87 -157.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.126 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.593 ' N ' HG23 ' B' ' 168' ' ' VAL . 1.8 p-80 -133.73 174.06 10.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 110.184 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 1.4 t -176.16 151.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.035 -1.425 . . . . 0.0 109.578 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.775 ' HA ' HD12 ' A' ' 4' ' ' LEU . 6.1 pt-20 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.602 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 30.0 p90 -66.67 -35.9 81.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.4 tt0 -65.18 -44.13 89.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.888 HD22 ' CB ' ' A' ' 88' ' ' PHE . 2.4 mt -67.12 -47.5 70.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.937 HG21 ' HA ' ' A' ' 50' ' ' PHE . 6.8 p -65.32 -47.85 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.161 -0.962 . . . . 0.0 110.353 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.602 ' N ' HG13 ' A' ' 5' ' ' VAL . 24.9 t -58.64 -36.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.029 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.05 -33.21 70.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.744 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -76.05 -44.36 39.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.04 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.596 HG12 HE21 ' A' ' 13' ' ' GLN . 82.0 t -57.45 -39.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.446 -0.784 . . . . 0.0 109.295 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.4 mtm180 -55.86 -48.33 75.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.547 -0.721 . . . . 0.0 109.893 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -34.75 50.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.984 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.941 HD23 HG21 ' A' ' 41' ' ' ILE . 1.2 tp -72.04 -43.29 65.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 110.055 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.596 HE21 HG12 ' A' ' 9' ' ' VAL . 4.8 pt20 -65.74 -33.73 76.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 2.3 mt-10 -57.61 -33.7 68.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.095 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.461 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 3.7 m -56.02 -27.5 53.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.022 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 155' ' ' SER . . . 87.8 42.71 5.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 9.2 p90 -152.59 14.5 0.57 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -1.18 . . . . 0.0 110.452 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.677 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -94.93 126.26 40.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 110.251 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.981 ' CD1' HD12 ' A' ' 40' ' ' LEU . 16.9 m95 -106.04 148.09 28.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 3.6 m -39.12 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.821 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 166.99 81.93 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.566 -0.709 . . . . 0.0 110.451 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.1 t -47.22 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -108.23 173.07 6.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.811 -1.181 . . . . 0.0 109.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.87 -89.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.584 ' CA ' HG11 ' B' ' 162' ' ' VAL . . . -79.44 -30.31 45.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -57.82 -34.93 70.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.268 . . . . 0.0 110.445 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -66.48 -49.06 67.89 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.012 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.0 m-80 -69.29 -39.87 78.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 110.535 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.1 mp -70.39 -31.41 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -0.862 . . . . 0.0 111.712 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -54.68 -24.02 20.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.825 -1.172 . . . . 0.0 110.794 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.963 HD13 ' O ' ' A' ' 38' ' ' THR . 4.2 pp -75.41 -36.13 60.88 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.937 -1.102 . . . . 0.0 109.322 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.85 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -69.69 -32.91 71.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.61 41.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.938 . . . . 0.0 110.72 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.737 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.6 mt-10 -114.34 -76.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.017 -1.052 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.737 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 47.3 Cg_endo -72.12 71.31 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.224 1.118 . . . . 0.0 110.268 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.57 141.28 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.497 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.86 20.76 79.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.963 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.21 146.93 50.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -1.087 . . . . 0.0 110.178 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.995 ' CG ' HD12 ' A' ' 149' ' ' LEU . 4.3 m-85 -123.42 157.41 33.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.916 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.981 HD12 ' CD1' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.23 159.18 43.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 110.592 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.017 HD11 ' CD1' ' A' ' 51' ' ' PHE . 13.1 tt -116.33 144.76 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.81 136.07 52.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 20' ' ' SER . 1.5 p30 -89.58 121.72 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 10.8 t -48.05 124.63 7.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.108 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 8.53 8.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.582 ' CB ' ' CD2' ' A' ' 49' ' ' HIS . 9.6 m-20 -67.21 -143.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 48' ' ' ARG . 3.9 pt20 -90.99 -37.52 13.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -173.54 37.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.31 -0.869 . . . . 0.0 110.144 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.582 ' CD2' ' CB ' ' A' ' 46' ' ' ASP . 13.7 m-70 -64.48 -93.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.913 . . . . 0.0 110.269 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.937 ' HA ' HG21 ' A' ' 5' ' ' VAL . 20.9 p90 -177.44 -159.5 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 110.194 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 1.017 ' CD1' HD11 ' A' ' 41' ' ' ILE . 8.5 p90 -126.96 155.79 42.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 74.9 m -126.24 138.38 53.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -0.953 . . . . 0.0 110.267 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.03 HD23 ' CG ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -120.93 124.89 46.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.084 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.956 ' N ' HD12 ' A' ' 53' ' ' LEU . 2.5 p -126.02 154.14 43.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.971 HG11 HD13 ' A' ' 149' ' ' LEU . 2.2 m -122.34 174.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.85 . . . . 0.0 110.717 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 25.7 tttt -107.12 124.23 49.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.707 HG21 ' CD1' ' A' ' 138' ' ' ILE . 8.9 p -127.4 157.13 40.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 110.332 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.73 -24.24 64.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -79.72 -23.13 42.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 152.82 143.47 3.69 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.3 p -78.93 110.52 14.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 110.159 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 138' ' ' ILE . 5.3 mmtt -111.99 161.72 16.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.214 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.486 ' CB ' ' HB2' ' A' ' 54' ' ' SER . 12.7 p30 -140.12 125.98 19.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.609 HD12 ' OH ' ' A' ' 136' ' ' TYR . 12.9 mt -104.73 152.08 22.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -125.11 143.13 51.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.705 HD11 ' SG ' ' A' ' 90' ' ' CYS . 3.5 tp -78.58 136.65 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.077 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -102.79 145.31 29.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 1' ' ' GLU . 42.6 t -108.57 127.5 54.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 110.251 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' GLY . 13.0 tt0 -124.17 104.29 8.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.04 -71.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -154.22 23.58 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -126.89 163.26 24.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 110.182 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.6 m-30 -119.42 157.87 27.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.634 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.12 138.68 15.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.14 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.887 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -127.0 -17.46 4.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.54 ' NE2' HD23 ' A' ' 75' ' ' LEU . 1.1 tp-100 -86.69 -148.14 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.942 ' HB3' HG21 ' B' ' 166' ' ' THR . 22.7 t -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.249 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -112.62 117.14 47.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -45.01 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.983 1.517 . . . . 0.0 110.463 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -55.97 -46.33 78.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.66 165.57 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' GLN . 0.0 OUTLIER -45.12 -41.7 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.241 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 82' ' ' THR . 8.4 mt-30 42.2 84.67 0.18 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.74 -164.07 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.096 1.577 . . . . 0.0 110.516 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 89' ' ' ASP . 8.5 m -130.9 154.31 81.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 110.206 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 46.3 Cg_endo -73.44 135.64 22.59 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.943 1.496 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.608 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 59.38 49.44 8.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.622 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.888 ' CB ' HD22 ' A' ' 4' ' ' LEU . 26.3 p90 35.19 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.402 -0.811 . . . . 0.0 110.535 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 87' ' ' ARG . 15.4 t0 -72.12 109.83 6.17 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.915 -1.116 . . . . 0.0 109.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.896 ' O ' HD13 ' A' ' 94' ' ' LEU . 9.1 t -175.21 -74.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.669 -0.644 . . . . 0.0 110.211 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 73' ' ' PHE . 15.5 m -50.63 -51.12 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.7 mt -65.11 -46.56 80.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -67.5 -31.14 71.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.069 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 90' ' ' CYS . 3.7 mp -59.36 -33.85 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.84 -0.538 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.2 m -52.47 -37.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.98 -1.075 . . . . 0.0 109.651 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -57.15 -52.49 65.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.909 -1.119 . . . . 0.0 109.161 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.58 ' CE1' HD22 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -79.21 -40.14 31.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 110.097 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.03 ' CG ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -64.43 -22.36 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.0 109.64 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 17' ' ' PHE . 2.6 ttp 165.63 89.42 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 0.0 109.816 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 149' ' ' LEU . 47.5 Cg_endo -76.06 129.59 11.53 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.848 1.446 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HG2' ' HD3' ' A' ' 102' ' ' PRO . 41.4 Cg_endo -72.24 -29.76 13.85 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.025 1.54 . . . . 0.0 112.241 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.671 ' HD3' ' HG2' ' A' ' 101' ' ' PRO . 48.3 Cg_endo -74.96 149.49 36.95 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.824 0.907 . . . . 0.0 110.476 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.29 7.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.682 HG21 HD22 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -44.39 108.27 0.71 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' SER . 47.2 Cg_endo -73.23 -174.55 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 59.12 -163.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 110.19 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -126.63 21.93 7.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 -165.85 1.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.94 . . . . 0.0 110.251 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 104' ' ' THR . 2.5 tp 49.32 85.34 0.18 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.91 125.06 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.059 1.557 . . . . 0.0 110.469 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.87 -6.19 18.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.965 1.508 . . . . 0.0 110.393 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -52.84 124.86 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 110.222 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -69.83 -57.23 6.7 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 46.2 Cg_endo -73.21 148.18 43.61 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.082 1.569 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 63.1 m -68.01 149.41 49.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 118' ' ' VAL . 15.3 m -158.86 150.47 20.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.53 24.76 7.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 116' ' ' SER . 17.5 t -96.47 123.18 55.32 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.883 . . . . 0.0 110.214 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.03 -90.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.0 110.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -135.4 -37.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.288 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.88 143.83 29.07 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . 46.5 Cg_endo -73.38 173.64 13.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.984 1.518 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 122' ' ' PRO . 46.0 Cg_endo -73.28 -20.11 21.61 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.469 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.29 138.97 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.182 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -168.62 -43.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -104.08 100.39 10.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 127' ' ' LEU . 2.2 pp -168.73 125.82 0.84 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.8 -58.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.006 1.529 . . . . 0.0 110.495 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -88.11 -134.07 4.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.0 t -115.94 103.23 10.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -1.125 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' A' ' 132' ' ' PRO . 1.3 m -67.6 -54.22 18.92 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 131' ' ' THR . 45.6 Cg_endo -71.83 105.57 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.879 1.463 . . . . 0.0 110.485 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.638 ' O ' HG21 ' B' ' 168' ' ' VAL . 0.0 OUTLIER -145.2 -46.2 0.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.256 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.743 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -63.28 106.4 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' B' ' 168' ' ' VAL . . . 167.44 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.929 ' CD1' HG21 ' B' ' 167' ' ' VAL . 3.2 t80 -102.47 122.57 44.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.484 -1.286 . . . . 0.0 109.697 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.786 ' HB2' ' O ' ' A' ' 145' ' ' ILE . 1.6 p90 -156.08 167.18 31.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.066 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.707 ' CD1' HG21 ' A' ' 57' ' ' THR . 2.5 mp -120.25 149.29 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 111.42 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.2 m-30 -84.67 108.08 17.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.986 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.627 ' HB2' HD13 ' A' ' 145' ' ' ILE . 2.8 m -66.84 56.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.867 . . . . 0.0 110.572 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 67.31 81.8 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.89 -8.59 49.6 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -120.23 121.8 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.239 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -89.57 105.25 17.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.095 -1.003 . . . . 0.0 110.62 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.786 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -95.53 110.51 51.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.78 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.1 Cg_endo -71.94 129.47 15.36 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.569 . . . . 0.0 112.107 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.784 ' H ' ' HB3' ' A' ' 137' ' ' TYR . 1.2 mt -125.74 135.83 52.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.46 117.36 42.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.336 -1.478 . . . . 0.0 109.791 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.996 HD21 ' C ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -116.2 114.88 25.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.061 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -155.13 41.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.23 125.37 24.63 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.286 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.83 148.11 40.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.009 1.531 . . . . 0.0 110.635 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.39 150.69 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.34 109.57 6.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -171.47 96.71 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.257 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.207 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.232 0.539 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.705 HG23 ' O ' ' B' ' 158' ' ' THR . 8.1 t -65.13 91.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 160' ' ' SER . . . 49.02 61.61 3.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.287 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.462 ' O ' ' O ' ' B' ' 159' ' ' ALA . 0.2 OUTLIER 60.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 110.24 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.438 HG22 ' N ' ' B' ' 162' ' ' VAL . 16.6 m -167.29 163.43 15.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 110.246 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.584 HG11 ' CA ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -132.85 134.69 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.13 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 0.1 OUTLIER -82.22 -178.09 6.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.162 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.533 ' CG ' ' O ' ' B' ' 163' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 15.5 m -92.11 -139.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.942 HG21 ' HB3' ' A' ' 77' ' ' SER . 0.9 OUTLIER -148.27 174.38 12.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.032 HG12 HG22 ' B' ' 168' ' ' VAL . 2.4 t -135.87 146.1 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.032 HG22 HG12 ' B' ' 167' ' ' VAL . 6.7 m 20.62 93.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.738 -0.601 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' B' ' 170' ' ' SER . 11.5 t-160 -94.37 -76.4 0.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.249 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' B' ' 169' ' ' HIS . 17.5 t -177.12 88.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 68' ' ' CYS . 2.7 tm-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 40.1 p90 -64.36 -35.8 82.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.1 tp60 -54.85 -41.08 70.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.193 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.683 HD13 ' CE1' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -66.14 -47.4 74.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.08 HG11 ' HA ' ' A' ' 50' ' ' PHE . 38.9 t -65.31 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.1 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.74 -49.32 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -58.97 -38.23 78.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.895 . . . . 0.0 109.89 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.019 ' O ' HD12 ' A' ' 12' ' ' LEU . . . -76.29 -44.69 35.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.04 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 75.4 t -57.77 -39.87 72.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.404 -0.81 . . . . 0.0 109.163 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -56.05 -41.66 75.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.869 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -76.87 -44.85 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.019 HD12 ' O ' ' A' ' 8' ' ' ALA . 1.1 mt -62.11 -44.37 96.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 110.013 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.593 HE21 HG12 ' A' ' 9' ' ' VAL . 6.0 pt20 -68.27 -33.82 75.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.252 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.86 -45.13 86.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.534 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.554 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 5.6 m -55.9 -38.42 70.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.967 . . . . 0.0 110.096 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.06 35.64 2.7 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HZ ' HD23 ' A' ' 12' ' ' LEU . 23.3 p90 -139.22 10.72 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -1.137 . . . . 0.0 110.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 9' ' ' VAL . 5.2 t80 -90.87 117.45 29.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CG ' HD12 ' A' ' 40' ' ' LEU . 58.6 m95 -82.02 141.58 33.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -162.86 108.65 1.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.045 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 159.62 -2.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.53 -0.731 . . . . 0.0 110.7 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -108.16 -156.65 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.097 . . . . 0.0 110.001 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -95.57 175.99 6.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -47.98 -86.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.595 ' HA2' HD21 ' A' ' 28' ' ' ASN . . . -76.48 -31.76 53.35 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 3.5 tt0 -59.63 -24.97 64.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.129 -1.218 . . . . 0.0 110.219 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -74.65 -49.96 19.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.8 ' HA ' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -70.09 -44.96 67.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.252 -0.905 . . . . 0.0 110.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.4 mp -59.89 -32.26 70.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.744 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 pp -55.39 -30.67 60.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.928 -1.107 . . . . 0.0 109.383 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.224 HD13 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.81 -33.99 73.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 1.224 ' N ' HD13 ' A' ' 31' ' ' LEU . 19.7 p -70.44 -32.84 70.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.557 -0.715 . . . . 0.0 110.288 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.78 -20.89 41.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.75 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 2.9 mt-10 -120.99 -79.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.943 -1.098 . . . . 0.0 110.391 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.1 Cg_endo -75.42 54.83 3.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.072 1.038 . . . . 0.0 110.105 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.808 ' HB1' ' HE2' ' A' ' 56' ' ' LYS . . . -53.03 141.61 22.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.377 -0.827 . . . . 0.0 110.736 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 92.67 15.29 53.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.64 ' O ' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.44 148.8 43.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.977 . . . . 0.0 110.141 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 1.102 ' CG ' HD21 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -121.59 149.4 43.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.017 . . . . 0.0 110.514 -179.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -150.37 160.73 43.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.565 -0.709 . . . . 0.0 109.588 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 51' ' ' PHE . 2.1 tt -113.47 145.59 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.001 . . . . 0.0 110.796 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HG3' ' CB ' ' A' ' 27' ' ' ALA . 1.7 tmt_? -112.28 151.22 29.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.628 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.571 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 9.6 t0 -94.38 133.69 37.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.086 -1.008 . . . . 0.0 110.661 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER 74.15 135.63 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.527 -0.733 . . . . 0.0 110.635 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 7.5 t -150.35 -43.85 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.731 . . . . 0.0 109.668 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.519 ' OD1' ' HA ' ' B' ' 161' ' ' THR . 8.7 m-20 -132.86 -152.96 0.52 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.925 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -91.05 -1.88 57.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 110.091 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 6.8 mtt180 -78.75 -15.16 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.498 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER 68.58 98.53 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.33 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.08 ' HA ' HG11 ' A' ' 5' ' ' VAL . 54.3 p90 -179.52 -176.79 0.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.089 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.931 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.2 p90 -115.85 155.15 28.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 110.089 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -126.07 150.68 47.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.858 . . . . 0.0 110.047 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.091 HD22 ' CG ' ' A' ' 98' ' ' TYR . 1.4 tt -139.26 131.02 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 111.158 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.73 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -139.71 154.11 47.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.483 -0.761 . . . . 0.0 109.959 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 39' ' ' PHE . 1.5 p -129.08 174.2 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 110.585 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.808 ' HE2' ' HB1' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -111.74 139.1 47.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.198 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 58' ' ' GLN . 2.3 m -160.33 148.94 16.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -0.996 . . . . 0.0 110.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' THR . 7.5 pt20 -41.92 -27.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -66.93 -53.46 31.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.253 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 158.64 146.55 4.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.43 HG21 ' CB ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -83.32 129.06 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -1.098 . . . . 0.0 110.133 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.797 ' NZ ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -142.08 140.92 32.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.241 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' OD1' ' CB ' ' A' ' 54' ' ' SER . 0.9 OUTLIER -111.05 141.35 44.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.992 HD22 HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -138.18 152.42 48.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 110.834 -179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -121.07 165.0 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.813 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.676 HD13 ' CB ' ' A' ' 94' ' ' LEU . 5.0 tp -78.11 131.23 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.952 . . . . 0.0 110.379 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -97.84 140.33 32.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 1' ' ' GLU . 31.0 p -92.32 128.09 38.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HG2' ' NE ' ' A' ' 87' ' ' ARG . 3.3 tt0 -133.07 104.53 6.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.335 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 54.55 65.42 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.36 24.0 15.03 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 70' ' ' GLY . 0.7 OUTLIER -124.12 157.7 34.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -1.169 . . . . 0.0 110.048 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -124.22 128.91 49.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.896 . . . . 0.0 110.089 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.4 t -153.97 139.01 17.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.898 . . . . 0.0 110.34 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.943 HD22 ' NE2' ' A' ' 97' ' ' HIS . 1.8 tt -116.29 -17.82 10.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 109.885 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.596 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -178.57 141.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.064 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.47 ' HB3' ' OE1' ' A' ' 76' ' ' GLN . 0.1 OUTLIER 60.78 139.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.19 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -120.0 113.79 34.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HG3' ' HD3' ' A' ' 93' ' ' LYS . 47.4 Cg_endo -73.21 57.9 3.47 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.978 1.515 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 20.08 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' OE1' ' A' ' 83' ' ' GLN . 31.3 p -115.48 134.88 54.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.441 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.486 ' O ' ' NE2' ' A' ' 83' ' ' GLN . 2.9 p 42.35 40.34 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.354 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.508 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -133.99 177.28 2.32 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' HG3' ' A' ' 83' ' ' GLN . 45.6 Cg_endo -72.89 -57.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.093 1.575 . . . . 0.0 110.305 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -144.83 153.2 53.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 110.111 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 44.4 Cg_endo -72.37 152.19 54.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.03 1.542 . . . . 0.0 110.332 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.568 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 75.33 -42.36 0.47 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.788 . . . . 0.0 110.429 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' CD2' ' HD2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 71.48 103.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.705 ' O ' ' HB2' ' A' ' 90' ' ' CYS . 5.1 t0 -72.83 109.21 6.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.705 ' HB2' ' O ' ' A' ' 89' ' ' ASP . 10.7 t 149.72 121.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.741 ' HB ' ' HB2' ' A' ' 8' ' ' ALA . 1.2 t -49.56 -25.06 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -56.04 -38.07 70.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.273 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.569 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -58.57 -40.56 83.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -68.17 -35.39 77.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.555 ' N ' ' HG ' ' A' ' 94' ' ' LEU . 24.8 t -55.49 -37.66 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 110.268 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -54.27 -35.77 62.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.943 ' NE2' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.17 -41.85 33.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.061 -1.024 . . . . 0.0 110.412 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.091 ' CG ' HD22 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -64.68 -22.15 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 110.205 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.522 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -124.55 164.23 31.82 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.91 . . . . 0.0 110.29 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 45.5 Cg_endo -73.25 174.45 12.05 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.019 1.537 . . . . 0.0 110.282 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HB3' HG22 ' A' ' 131' ' ' THR . 44.4 Cg_endo -72.1 166.83 28.48 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.005 1.529 . . . . 0.0 110.395 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 107.46 2.3 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.072 1.564 . . . . 0.0 110.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.39 2.26 7.12 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.475 ' OG1' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -130.33 156.95 78.69 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' OG1' ' A' ' 104' ' ' THR . 43.8 Cg_endo -72.27 -73.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.022 1.538 . . . . 0.0 110.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 107' ' ' PHE . 28.7 t 44.35 -144.66 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.513 ' N ' ' OG ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -135.97 101.66 4.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 t -140.67 176.63 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp 52.25 90.85 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.916 . . . . 0.0 110.189 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.97 148.3 45.07 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.963 1.507 . . . . 0.0 110.388 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 78.75 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.967 1.509 . . . . 0.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 t -163.35 151.1 13.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.167 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.5 138.79 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.154 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.15 116.54 4.75 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.089 1.573 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 117' ' ' GLU . 70.6 m -121.11 152.63 38.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 115' ' ' SER . 7.9 m 56.73 -86.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -156.98 138.0 13.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 118' ' ' VAL . 35.7 t -46.0 104.71 0.41 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 117' ' ' GLU . 46.6 Cg_endo -73.09 132.69 18.48 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.045 1.55 . . . . 0.0 110.455 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -109.06 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.141 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.526 ' N ' ' HD2' ' A' ' 122' ' ' PRO . 1.2 mt-30 -64.12 -56.37 24.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 121' ' ' GLN . 46.5 Cg_endo -73.36 173.99 12.86 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.944 1.497 . . . . 0.0 110.386 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 46.6 Cg_endo -72.95 156.36 52.38 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.017 1.535 . . . . 0.0 110.478 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 123' ' ' PRO . . . 178.78 -30.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.676 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -59.68 -15.33 18.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.186 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.676 ' HB3' ' O ' ' A' ' 125' ' ' GLN . . . 66.76 23.38 10.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.129 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER 64.54 131.43 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.231 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' SER . 46.2 Cg_endo -73.09 -7.93 21.36 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.972 1.512 . . . . 0.0 110.514 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.61 89.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' PRO . 0.9 OUTLIER -153.62 65.35 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 110.127 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -64.24 126.11 89.66 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 110.238 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 Cg_endo -74.12 -63.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.978 1.515 . . . . 0.0 110.582 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.7 tttp -178.11 66.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.767 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 59.1 mmt-85 -59.42 133.58 56.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.982 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.32 82.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 110.17 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.984 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.83 125.96 49.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.478 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.037 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -154.11 167.21 30.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.089 . . . . 0.0 110.511 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 62' ' ' LYS . 3.0 mt -101.57 149.15 6.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 111.298 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.723 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.0 m-85 -98.97 132.82 44.0 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.709 0.766 . . . . 0.0 110.984 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.715 ' HB2' HD13 ' A' ' 145' ' ' ILE . 45.0 t -97.06 48.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.618 -0.676 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.02 82.79 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.61 -22.07 39.59 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 1.5 mp0 -117.05 122.02 42.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.629 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 1.2 pttm -91.68 105.29 17.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.219 -0.926 . . . . 0.0 110.312 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.732 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -87.73 108.24 19.58 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.2 Cg_endo -76.07 128.8 10.91 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.994 1.523 . . . . 0.0 112.346 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' NZ ' ' A' ' 62' ' ' LYS . 1.2 mp -125.06 134.19 52.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 148' ' ' VAL . 16.3 m -117.87 117.65 55.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.596 -1.315 . . . . 0.0 111.249 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 39' ' ' PHE . 3.8 tt -92.45 114.86 27.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.443 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 1.0 OUTLIER -137.11 -15.14 1.51 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 111.063 -179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -85.85 124.91 70.2 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.958 -1.088 . . . . 0.0 110.017 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.06 147.88 43.85 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.945 1.497 . . . . 0.0 110.592 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.902 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.48 158.56 14.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 0.0 110.567 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.509 ' N ' HD22 ' A' ' 153' ' ' LEU . 46.2 t -38.04 -76.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.315 -0.866 . . . . 0.0 110.815 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.3 OUTLIER 61.32 -84.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.491 ' N ' ' OG ' ' A' ' 155' ' ' SER . 4.0 t-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.17 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.173 0.511 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 1.8 t -163.47 64.04 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . 48.23 -142.04 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.162 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.08 -158.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.519 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 p -89.94 118.84 29.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 110.293 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.52 HG22 ' HA3' ' A' ' 24' ' ' GLY . 16.5 t -46.14 149.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.954 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.481 ' C ' ' HD1' ' B' ' 164' ' ' PTR . 0.4 OUTLIER -93.81 122.38 36.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.585 ' HD2' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.68 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -142.92 -149.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.362 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.733 ' HA ' HD21 ' A' ' 64' ' ' LEU . 1.8 p -112.29 144.64 41.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.852 . . . . 0.0 110.05 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.037 HG12 ' N ' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -100.24 114.49 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.982 HG21 ' O ' ' A' ' 135' ' ' ALA . 99.6 t 40.23 83.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.43 -0.794 . . . . 0.0 110.492 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -126.08 107.54 10.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.28 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 3.4 t -167.52 77.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.316 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 CA-C-O 118.036 -1.424 . . . . 0.0 109.548 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.559 ' HB3' ' CB ' ' A' ' 68' ' ' CYS . 7.9 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.286 0.565 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 6' ' ' VAL . 11.8 t80 -66.9 -52.39 43.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.907 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -61.09 -39.44 89.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.476 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CB ' ' CE1' ' A' ' 73' ' ' PHE . 1.2 mt -67.09 -47.25 71.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.063 HG23 HG21 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -69.58 -47.92 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.245 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 2' ' ' TYR . 72.9 t -61.83 -41.27 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -58.93 -41.44 87.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.934 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.936 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -62.01 -44.16 97.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.78 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 ' HE2' ' A' ' 18' ' ' TYR . 41.3 t -57.55 -39.8 71.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.375 -0.828 . . . . 0.0 109.083 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.88 78.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.737 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -32.86 56.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -61.91 -43.7 98.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 110.092 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.626 ' NE2' HG12 ' A' ' 9' ' ' VAL . 40.2 mt-30 -67.2 -35.89 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -63.42 -39.27 94.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.222 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -38.81 75.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.37 1.17 23.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 1.027 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.6 t80 -94.99 21.85 7.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.659 ' HE2' HG22 ' A' ' 9' ' ' VAL . 36.3 t80 -121.25 136.03 55.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 110.258 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.704 ' CE3' ' NH2' ' A' ' 42' ' ' ARG . 9.4 m95 -104.67 148.64 26.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 110.333 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 42.1 m -31.91 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.66 -0.65 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 163.81 69.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG23 HH11 ' A' ' 42' ' ' ARG . 0.5 OUTLIER -60.9 -135.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.127 -0.983 . . . . 0.0 109.329 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.621 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -88.34 176.16 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.76 -1.213 . . . . 0.0 109.205 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.1 -81.75 0.03 OUTLIER Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.332 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.758 ' H ' HG21 ' B' ' 162' ' ' VAL . . . -79.9 -31.12 40.6 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.439 -1.036 . . . . 0.0 111.643 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.621 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 21.2 tp10 -58.63 -24.9 62.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.451 . . . . 0.0 110.955 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.012 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -77.15 -48.19 18.34 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.992 -1.067 . . . . 0.0 109.544 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.962 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.8 m-80 -70.62 -49.57 46.16 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.686 0.755 . . . . 0.0 111.142 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.465 HD11 HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -61.88 -31.59 71.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.583 -0.698 . . . . 0.0 112.162 -178.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.772 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.2 pp -55.18 -35.15 64.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.75 -1.219 . . . . 0.0 109.853 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -81.25 -36.18 30.26 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 108.622 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 1.046 ' N ' HD23 ' A' ' 31' ' ' LEU . 52.0 m -70.03 -32.88 71.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.555 -0.716 . . . . 0.0 110.129 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.02 41.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.512 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 10.4 mt-10 -113.87 -76.77 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.041 . . . . 0.0 110.05 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.741 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 48.8 Cg_endo -73.08 61.32 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.277 1.146 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.73 141.24 10.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.421 ' C ' ' HG ' ' A' ' 150' ' ' SER . . . 89.34 13.45 61.66 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.883 ' C ' HD11 ' A' ' 31' ' ' LEU . 21.2 m -132.66 146.08 51.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.554 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.747 ' CG ' HD23 ' A' ' 149' ' ' LEU . 30.5 p90 -126.97 138.84 53.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.838 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.021 ' HG ' HD13 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -131.4 161.01 33.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.913 HG12 HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.41 128.56 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.789 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 1.012 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 78.5 mtt-85 -135.73 153.43 51.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.739 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' SER . 0.4 OUTLIER -73.94 122.79 23.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 109.7 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -36.35 -72.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.338 -0.852 . . . . 0.0 110.562 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.45 ' H ' ' CE1' ' A' ' 49' ' ' HIS . 60.5 m -109.42 -31.85 7.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 49' ' ' HIS . 16.0 t0 -178.08 -178.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 110.252 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.43 -1.97 36.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.149 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -71.16 -2.47 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.295 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 50' ' ' PHE . 28.5 p80 -144.07 -144.42 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 110.271 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.763 ' CB ' HG21 ' A' ' 5' ' ' VAL . 35.9 p90 -92.55 -166.74 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.916 ' CE2' HG22 ' A' ' 5' ' ' VAL . 5.9 p90 -130.82 158.21 40.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.84 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 14.5 t -126.28 139.2 53.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.067 HD22 ' CD1' ' A' ' 98' ' ' TYR . 6.9 tt -121.03 139.45 53.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.391 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.698 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -139.33 154.39 47.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.839 HG11 ' CG ' ' A' ' 149' ' ' LEU . 2.4 m -130.12 174.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.392 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' SER . 18.4 tptt -105.93 130.49 53.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.715 HG21 ' HA ' ' A' ' 147' ' ' LEU . 33.7 p -134.86 -169.27 2.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -77.48 -34.95 54.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.3 t -81.73 -22.79 37.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.18 -0.95 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.48 14.62 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 1.8 t -101.04 126.4 47.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -1.123 . . . . 0.0 110.27 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.524 ' CG ' HG12 ' A' ' 138' ' ' ILE . 8.7 mmpt? -114.07 147.3 38.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.235 -0.916 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.595 ' O ' ' CD1' ' B' ' 164' ' ' PTR . 10.7 p30 -112.02 144.07 41.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 110.706 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.995 HD22 HG23 ' B' ' 167' ' ' VAL . 1.2 mp -138.93 152.26 47.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.594 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 50' ' ' PHE . 3.3 ptt180 -123.49 164.04 19.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.063 HG21 HG23 ' A' ' 5' ' ' VAL . 6.6 tp -76.78 143.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -113.05 144.66 42.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.559 ' CB ' ' HB3' ' A' ' 1' ' ' GLU . 13.7 t -101.99 118.85 37.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 110.368 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 71' ' ' GLY . 22.9 tt0 -105.21 102.89 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.037 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.21 -83.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -139.87 37.69 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.64 163.07 32.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -1.107 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.617 ' CE1' ' CB ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -122.4 127.97 50.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 3.4 m -155.55 159.91 40.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.856 HD13 HD12 ' A' ' 94' ' ' LEU . 10.5 tp -94.1 17.15 13.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.844 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 64.05 93.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.184 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.2 t -162.77 -69.01 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.33 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 78' ' ' ASP . 18.5 p-10 -93.96 114.08 62.22 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.265 -0.897 . . . . 0.0 110.297 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.04 -56.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.009 1.531 . . . . 0.0 110.439 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' O ' ' CB ' ' A' ' 81' ' ' SER . 15.4 tpt180 -56.21 -48.02 77.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.901 . . . . 0.0 110.249 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER 66.1 53.79 1.04 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.194 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 m -96.89 -43.87 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 110.219 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -55.25 -58.12 16.68 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 110.19 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 46.5 Cg_endo -73.07 -157.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.062 1.559 . . . . 0.0 110.277 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.729 HG13 ' HD2' ' A' ' 86' ' ' PRO . 88.9 t -125.17 149.31 63.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.729 ' HD2' HG13 ' A' ' 85' ' ' VAL . 40.7 Cg_endo -67.69 132.06 25.93 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.718 1.378 . . . . 0.0 109.821 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 72.82 47.5 0.22 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.418 -179.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.543 ' CB ' ' HG3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -57.68 -149.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.53 -0.732 . . . . 0.0 110.187 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.628 ' O ' ' C ' ' A' ' 90' ' ' CYS . 47.7 m-20 -100.44 110.34 22.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.957 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.628 ' C ' ' O ' ' A' ' 89' ' ' ASP . 78.8 m 4.07 -121.29 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.499 0.666 . . . . 0.0 112.083 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB1' ' A' ' 8' ' ' ALA . 7.8 p -57.07 -24.8 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 89' ' ' ASP . 3.8 mt -55.64 -35.98 66.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.723 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.543 ' HG3' ' CB ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -62.53 -46.36 88.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.865 -1.147 . . . . 0.0 109.209 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -68.25 -34.82 76.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.44 -0.787 . . . . 0.0 109.58 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 91' ' ' VAL . 56.0 t -54.74 -36.43 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 110.438 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -52.61 -33.12 44.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -78.18 -36.79 47.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.156 -0.965 . . . . 0.0 109.476 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.067 ' CD1' HD22 ' A' ' 53' ' ' LEU . 6.9 m-85 -73.59 -22.05 60.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.98 78.88 34.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.316 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 45.0 Cg_endo -73.01 142.01 33.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.02 1.537 . . . . 0.0 110.226 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.63 110.22 2.95 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.988 1.52 . . . . 0.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 100' ' ' PRO . 47.1 Cg_endo -73.43 -55.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.028 1.541 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 106' ' ' SER . . . 157.36 67.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.553 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.36 -58.74 2.91 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.165 -1.197 . . . . 0.0 110.119 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 46.4 Cg_endo -72.64 60.09 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.468 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 103' ' ' GLY . 0.8 OUTLIER -120.16 -62.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER 63.17 77.24 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 110.155 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 0.4 OUTLIER 61.38 -79.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -76.87 130.06 77.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.255 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 170.56 19.42 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.436 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.04 150.13 47.89 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.069 1.563 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 17.8 m -74.55 -53.23 9.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 112' ' ' THR . 2.9 mt-10 58.25 93.63 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.04 118.57 5.61 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.978 1.515 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 116' ' ' SER . 29.3 t -114.84 -153.96 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.45 ' N ' ' OG ' ' A' ' 115' ' ' SER . 57.8 m 46.33 64.44 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 1.3 tt0 -94.59 73.45 3.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 61.4 t 57.04 92.33 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.22 -161.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.015 1.534 . . . . 0.0 110.406 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -146.17 -70.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.227 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.609 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -91.13 -63.48 0.19 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 110.35 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 46.2 Cg_endo -73.3 120.15 6.38 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.825 1.434 . . . . 0.0 110.385 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.97 -89.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.965 1.508 . . . . 0.0 110.409 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 125' ' ' GLN . . . -70.56 -62.32 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 122' ' ' PRO . 7.4 tp60 54.46 102.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 127' ' ' LEU . . . -102.61 -89.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.184 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER 56.7 110.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 129' ' ' GLY . 45.8 Cg_endo -72.98 67.46 4.03 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.397 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 128' ' ' PRO . . . -45.1 134.55 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -45.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -1.127 . . . . 0.0 110.147 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.541 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -55.62 -56.65 27.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 131' ' ' THR . 45.5 Cg_endo -72.86 -19.69 23.32 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.346 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -175.74 1.68 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 110.19 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.621 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.0 mtt85 -44.51 129.88 6.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.094 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 173.85 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.13 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.3 t80 -102.81 121.52 42.63 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.719 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.158 ' CD2' HG22 ' B' ' 168' ' ' VAL . 0.7 OUTLIER -158.24 148.67 20.31 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 110.137 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.013 HD13 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -102.65 150.18 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.977 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.594 ' CZ ' ' OH ' ' A' ' 137' ' ' TYR . 76.2 m-85 -86.19 132.71 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 110.435 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.641 ' HB3' HD13 ' A' ' 145' ' ' ILE . 1.3 t -98.49 69.23 1.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 54.65 41.93 75.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.56 2.76 29.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 140' ' ' SER . 2.8 mt-10 -117.8 121.97 42.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -70.92 105.93 3.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.463 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.75 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.3 mp -101.5 120.1 55.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.866 . . . . 0.0 109.555 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.876 ' HA ' ' HB2' ' A' ' 137' ' ' TYR . 43.6 Cg_endo -69.64 129.42 17.69 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.349 1.71 . . . . 0.0 112.786 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.013 ' CD2' HD13 ' A' ' 138' ' ' ILE . 6.1 mp -121.1 101.29 7.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.3 p -102.85 117.64 48.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.624 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.945 HD22 ' O ' ' A' ' 98' ' ' TYR . 3.5 mp -76.02 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 37' ' ' GLY . 2.7 p -172.62 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.74 -1.225 . . . . 0.0 111.495 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -85.68 124.93 70.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 110.855 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 39' ' ' PHE . 48.5 Cg_endo -75.7 148.06 32.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.106 1.582 . . . . 0.0 110.093 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 1.027 HD21 ' O ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -63.21 144.37 56.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.227 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.465 ' N ' HD12 ' A' ' 153' ' ' LEU . 1.1 t -130.88 81.2 1.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.097 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -133.18 151.18 51.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.264 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.237 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.256 0.55 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.433 ' O ' ' N ' ' B' ' 160' ' ' SER . 0.2 OUTLIER 47.69 27.55 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.195 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' B' ' 160' ' ' SER . . . 54.53 -91.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 0.7 OUTLIER 170.31 127.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.277 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -43.92 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 110.024 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.834 HG12 ' O ' ' B' ' 162' ' ' VAL . 4.3 t -122.66 74.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 110.058 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.33 116.53 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.875 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.595 ' CD1' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.553 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.6 m -157.78 -137.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 110.173 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.686 ' HA ' HD21 ' A' ' 64' ' ' LEU . 2.7 t -105.87 137.52 43.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.13 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 0.8 OUTLIER -84.63 95.49 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.114 -0.991 . . . . 0.0 109.589 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.158 HG22 ' CD2' ' A' ' 137' ' ' TYR . 2.2 t 70.66 104.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.893 . . . . 0.0 109.983 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.624 ' CD2' ' N ' ' B' ' 170' ' ' SER . 5.3 p-80 -100.5 -29.36 12.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.21 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.624 ' N ' ' CD2' ' B' ' 169' ' ' HIS . 93.0 p -78.0 125.72 29.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 132' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 4' ' ' LEU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.266 0.555 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 30.2 p90 -55.72 -36.48 67.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.121 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 3.7 tt0 -55.03 -32.88 62.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.215 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.887 HD13 ' CD1' ' A' ' 73' ' ' PHE . 10.2 mt -62.33 -44.04 97.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.867 HG13 ' HD2' ' A' ' 51' ' ' PHE . 61.1 t -63.14 -48.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.158 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 6' ' ' VAL . 15.5 t -61.5 -50.53 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.884 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 2.0 t-20 -62.36 -44.1 97.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -67.01 -44.52 80.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.771 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.782 HG12 HE21 ' A' ' 13' ' ' GLN . 23.1 t -57.93 -40.14 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.823 . . . . 0.0 109.136 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -55.89 -47.86 76.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.613 -0.68 . . . . 0.0 109.867 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -36.56 63.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 109.918 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD22 ' CZ ' ' A' ' 17' ' ' PHE . 4.2 mt -71.77 -44.05 64.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 110.003 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.782 HE21 HG12 ' A' ' 9' ' ' VAL . 6.0 pt20 -67.89 -33.87 75.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.126 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -57.9 -34.49 69.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.07 -34.7 66.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.845 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 155' ' ' SER . . . 100.57 29.19 6.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.997 ' C ' HD11 ' A' ' 153' ' ' LEU . 6.7 p90 -145.97 40.24 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 110.631 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 4.9 t80 -120.38 115.81 24.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.853 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 1.094 ' CD1' HD13 ' A' ' 153' ' ' LEU . 63.5 m95 -77.26 144.08 38.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 110.329 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.788 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 18.6 t -45.77 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 109.722 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 165.64 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.859 . . . . 0.0 110.568 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 27' ' ' ALA . 1.4 m -47.04 -97.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.069 -1.02 . . . . 0.0 109.41 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.606 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -108.05 165.88 11.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 109.199 178.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -43.3 -79.15 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.865 ' CA ' HG21 ' B' ' 162' ' ' VAL . . . -79.5 -30.47 44.79 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 121.369 -1.077 . . . . 0.0 111.254 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.9 mm-40 -58.49 -24.79 61.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.344 . . . . 0.0 110.954 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 22' ' ' VAL . . . -76.04 -49.78 16.6 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 109.24 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -71.18 -49.68 41.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 111.244 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.673 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -63.37 -31.09 72.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.583 -0.698 . . . . 0.0 111.797 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.924 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -53.77 -23.39 11.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.835 -1.166 . . . . 0.0 109.689 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.774 HD11 ' HB3' ' A' ' 40' ' ' LEU . 62.6 mt -61.73 -39.51 91.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 109.191 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 93.1 p -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.6 -0.688 . . . . 0.0 110.314 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.95 -20.39 45.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.7 mm-40 -125.27 -81.16 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.998 -1.064 . . . . 0.0 110.404 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 54.6 Cg_endo -77.17 68.38 7.41 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 122.92 0.958 . . . . 0.0 110.175 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.67 141.48 9.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.0 110.614 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 71.65 24.0 77.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.586 ' CB ' ' HB2' ' A' ' 35' ' ' PRO . 7.9 m -125.81 147.14 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -1.048 . . . . 0.0 110.474 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.784 ' CE2' HD21 ' A' ' 149' ' ' LEU . 1.2 p90 -122.83 147.1 46.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.995 HD23 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -145.29 159.71 42.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.493 -0.754 . . . . 0.0 109.72 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.645 ' CG2' ' CE2' ' A' ' 18' ' ' TYR . 5.3 tt -114.31 137.9 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.105 -0.997 . . . . 0.0 110.118 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 0.1 OUTLIER -112.63 131.82 55.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.0 110.438 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 35.9 t0 -89.28 118.22 28.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.55 ' CB ' ' CD2' ' A' ' 49' ' ' HIS . 5.7 t -69.8 -22.05 63.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.202 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 45' ' ' SER . 26.7 p 43.8 81.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.526 ' CB ' ' HB2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -144.82 -156.66 0.72 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.259 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 2' ' ' TYR . 19.9 mm-40 -91.19 -35.27 14.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 110.245 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' O ' ' OE2' ' A' ' 1' ' ' GLU . 7.5 mtt-85 -136.06 4.3 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.55 ' CD2' ' CB ' ' A' ' 44' ' ' SER . 0.9 OUTLIER -74.43 -144.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.16 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.851 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.2 p90 176.77 -151.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.114 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.867 ' HD2' HG13 ' A' ' 5' ' ' VAL . 25.8 p90 -115.37 151.92 33.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.101 -1.0 . . . . 0.0 109.869 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' LEU . 36.2 m -125.9 135.74 52.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.945 . . . . 0.0 110.499 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.949 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -120.75 123.32 42.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.292 -0.88 . . . . 0.0 109.548 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.871 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -140.34 155.72 46.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.483 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.743 HG12 ' OH ' ' A' ' 136' ' ' TYR . 2.7 p -134.53 174.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 0.0 110.689 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.42 133.69 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.82 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.849 HG21 ' HG ' ' A' ' 147' ' ' LEU . 8.8 t -132.93 -156.96 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.29 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.58 -58.36 2.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.899 ' HB2' HG23 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -44.63 -61.43 1.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 57' ' ' THR . . . -179.05 172.84 45.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 56' ' ' LYS . 49.2 p -99.37 108.97 21.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -1.119 . . . . 0.0 110.238 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.843 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -108.43 177.83 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.945 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 1.091 ' O ' HD23 ' A' ' 64' ' ' LEU . 23.8 m-20 -128.42 132.47 48.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.101 -0.999 . . . . 0.0 110.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.091 HD23 ' O ' ' A' ' 63' ' ' ASN . 8.2 mt -131.69 152.12 51.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.46 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -147.9 168.43 22.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.0 110.516 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.0 HG21 ' CD2' ' A' ' 73' ' ' PHE . 44.0 mm -76.82 146.74 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -114.41 150.82 34.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.513 ' SG ' ' CG ' ' A' ' 1' ' ' GLU . 54.1 t -89.01 132.85 34.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.317 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 71' ' ' GLY . 10.3 tm-20 -123.86 102.94 8.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.02 -89.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -133.61 24.62 3.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -132.93 162.92 30.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -1.16 . . . . 0.0 110.189 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 1.0 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -110.91 136.38 50.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -155.23 150.29 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.299 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.808 ' CB ' HD22 ' A' ' 94' ' ' LEU . 0.9 OUTLIER -89.75 -29.83 18.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.096 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HG2' ' HB3' ' B' ' 169' ' ' HIS . 31.6 mt-30 -97.93 -165.24 1.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.9 p -95.6 -0.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.145 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -107.23 112.19 62.99 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.23 -38.46 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.995 1.523 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.8 18.18 4.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.893 . . . . 0.0 110.21 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -72.05 -62.98 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.106 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.586 HG23 ' HD3' ' A' ' 84' ' ' PRO . 9.0 t -73.05 -4.08 30.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.43 ' N ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 57.54 56.98 7.55 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.365 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 82' ' ' THR . 48.1 Cg_endo -75.01 -163.42 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.955 1.503 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.839 HG12 ' CD ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -128.88 -167.94 0.15 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.237 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.839 ' CD ' HG12 ' A' ' 85' ' ' VAL . 43.7 Cg_endo -73.55 132.69 17.82 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.33 1.173 . . . . 0.0 109.813 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 57.36 45.72 19.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.749 ' CG ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -116.17 131.74 56.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.366 -0.834 . . . . 0.0 110.726 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.8 m-20 -88.09 110.47 20.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.294 -0.878 . . . . 0.0 109.263 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.757 ' C ' HD12 ' A' ' 94' ' ' LEU . 87.3 m -67.21 -4.06 9.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.343 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 3.3 p -58.44 -45.87 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.036 -1.04 . . . . 0.0 110.099 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -65.16 -47.25 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 109.537 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 0.2 OUTLIER -68.21 -33.47 74.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 0.0 108.851 178.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.984 HD13 ' CD1' ' A' ' 66' ' ' ILE . 7.5 mt -60.01 -33.39 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.828 -0.545 . . . . 0.0 110.376 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -53.04 -36.8 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.399 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 99' ' ' MET . 7.4 m170 -53.42 -45.47 69.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.999 -1.063 . . . . 0.0 108.22 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -78.73 -38.43 38.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.774 . . . . 0.0 108.92 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.949 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -63.77 -22.11 66.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.689 ' HG3' HD23 ' A' ' 149' ' ' LEU . 3.2 ttp -152.46 142.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.898 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 149' ' ' LEU . 48.3 Cg_endo -75.82 125.05 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.868 1.457 . . . . 0.0 110.497 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.681 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.7 Cg_endo -72.16 -29.57 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.92 1.484 . . . . 0.0 112.154 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 48.4 Cg_endo -74.42 177.67 8.04 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.924 0.96 . . . . 0.0 110.397 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.42 -74.23 2.4 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.0 p -132.42 88.38 39.62 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.262 -1.14 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.72 153.7 54.01 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 107' ' ' PHE . 3.3 m -106.71 146.54 30.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.463 ' O ' ' CB ' ' A' ' 108' ' ' SER . 1.5 p90 -175.93 177.62 1.61 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.194 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 107' ' ' PHE . 0.4 OUTLIER 171.68 -43.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.207 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 109' ' ' LEU . 4.0 pp -107.74 159.59 29.83 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 121.58 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.977 1.514 . . . . 0.0 110.427 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.96 142.37 34.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.95 1.5 . . . . 0.0 110.403 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -131.37 134.23 46.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.191 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -166.81 57.91 0.44 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.14 177.87 7.27 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.008 1.531 . . . . 0.0 110.396 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 115' ' ' SER . 3.4 p 57.43 48.98 13.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 110.217 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -167.11 127.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.868 . . . . 0.0 110.147 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.95 108.95 13.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 m -135.45 142.25 40.57 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.85 -4.57 15.62 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.098 1.578 . . . . 0.0 110.43 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 121' ' ' GLN . 2.4 mt-10 55.51 170.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 120' ' ' GLU . 2.7 mp0 56.23 166.76 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.58 139.98 32.1 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.031 1.543 . . . . 0.0 110.431 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 46.2 Cg_endo -72.88 -16.4 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.033 1.544 . . . . 0.0 110.485 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 61.81 23.52 13.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 110.228 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -175.22 130.77 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -145.2 -38.06 0.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.932 . . . . 0.0 110.179 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 127' ' ' LEU . 7.1 mt -117.66 117.02 36.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 129' ' ' GLY . 45.1 Cg_endo -72.94 158.52 49.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.946 1.498 . . . . 0.0 110.39 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' O ' ' OG ' ' A' ' 130' ' ' SER . . . 62.61 133.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 129' ' ' GLY . 28.2 p 42.54 -165.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER 42.47 75.52 0.62 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.11 -57.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.106 1.582 . . . . 0.0 110.457 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -138.97 -53.23 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 110.187 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.785 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -155.89 142.74 18.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.223 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 164.41 78.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.175 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.3 OUTLIER -102.8 125.02 49.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.049 -1.032 . . . . 0.0 109.463 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.992 ' N ' HG12 ' B' ' 167' ' ' VAL . 8.2 p90 -155.01 167.62 29.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 110.622 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 mt -101.43 147.43 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.0 110.958 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.703 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -96.66 133.31 41.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.626 0.727 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -96.64 67.54 2.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.703 -0.623 . . . . 0.0 110.26 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.54 -65.11 0.17 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -133.25 3.97 4.84 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -119.3 121.96 40.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -1.196 . . . . 0.0 110.289 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 9.7 mttt -82.25 105.53 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.434 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 147' ' ' LEU . 1.1 mp -89.45 108.94 28.03 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.401 -0.812 . . . . 0.0 108.947 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.779 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.3 Cg_endo -71.72 129.53 15.68 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.206 1.635 . . . . 0.0 112.191 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.64 135.12 52.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.595 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 5.7 p -118.51 117.48 54.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.939 -1.1 . . . . 0.0 110.822 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.792 ' C ' HD23 ' A' ' 149' ' ' LEU . 5.2 tt -113.73 115.07 27.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 109.653 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.519 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -146.05 11.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.026 -1.046 . . . . 0.0 111.352 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.69 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -118.43 124.62 28.4 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 0.0 110.256 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.72 145.85 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.895 1.471 . . . . 0.0 110.719 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 1.094 HD13 ' CD1' ' A' ' 19' ' ' TRP . 4.2 pp -82.11 139.86 34.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.563 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 3.9 m 38.95 -92.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.392 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER 68.12 124.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.928 . . . . 0.0 110.228 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.205 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.186 0.517 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.654 ' O ' ' HB3' ' B' ' 159' ' ' ALA . 14.5 t -88.01 -159.38 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.167 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' B' ' 158' ' ' THR . . . 64.8 -173.43 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.166 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 59.6 p -167.69 -145.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -73.93 -63.6 1.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.865 HG21 ' CA ' ' A' ' 25' ' ' GLY . 3.2 p -151.86 130.53 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.309 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.448 ' C ' ' HD1' ' B' ' 164' ' ' PTR . 1.2 pp20? -109.56 162.43 14.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.157 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.533 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.945 ' O ' HD22 ' A' ' 64' ' ' LEU . 6.4 m -145.65 -174.47 4.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 110.328 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -82.21 -175.3 5.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.872 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.175 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -107.64 -158.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.028 . . . . 0.0 110.215 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.942 HG21 ' O ' ' A' ' 135' ' ' ALA . 37.5 t -57.93 103.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 110.29 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.507 ' CD2' ' HB2' ' B' ' 170' ' ' SER . 54.3 p-80 -135.19 -39.04 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.033 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.507 ' HB2' ' CD2' ' B' ' 169' ' ' HIS . 9.1 m -145.67 133.04 20.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.13 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.553 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.584 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.7 pt-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 3' ' ' GLN . 17.9 p90 -67.08 -35.71 80.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.571 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -54.78 -32.97 60.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.103 -0.998 . . . . 0.0 110.523 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.1 mt -67.32 -48.13 68.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 110.616 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 49' ' ' HIS . 2.0 m -72.76 -44.46 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 0.0 110.53 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 9' ' ' VAL . 95.7 t -58.47 -32.46 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -0.948 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -33.06 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.93 -1.106 . . . . 0.0 110.807 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.688 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . . . -76.19 -33.59 59.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.153 -0.967 . . . . 0.0 111.143 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 6' ' ' VAL . 1.5 m -56.49 -37.89 53.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.198 -0.939 . . . . 0.0 108.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 71.2 mtt180 -55.57 -42.82 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.854 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -46.86 19.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.211 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -65.46 -39.44 92.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.9 mt-30 -59.97 -33.96 72.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -72.0 -29.8 64.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 110.027 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.593 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 1.4 t -59.17 -43.05 92.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.97 20.11 22.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.598 ' CZ ' ' HG ' ' A' ' 12' ' ' LEU . 4.1 p90 -130.08 -4.69 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.267 . . . . 0.0 110.472 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -95.46 119.36 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 0.0 109.919 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CD1' HD12 ' A' ' 40' ' ' LEU . 5.7 m95 -109.22 148.1 31.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.385 -0.822 . . . . 0.0 109.911 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.488 ' C ' ' NH1' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -134.95 25.13 3.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.381 -0.824 . . . . 0.0 109.268 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.96 1.13 14.6 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.102 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.6 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -104.43 -157.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.923 -1.111 . . . . 0.0 109.469 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.593 ' CB ' ' HB2' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -97.5 169.53 9.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.09 -1.006 . . . . 0.0 110.074 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -42.67 -81.45 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.684 ' N ' HG21 ' B' ' 162' ' ' VAL . . . -79.15 -31.6 42.12 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.26 -1.141 . . . . 0.0 110.705 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 7.4 mt-10 -58.82 -36.78 75.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.007 -1.29 . . . . 0.0 109.865 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 42' ' ' ARG . . . -61.65 -50.57 71.99 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.035 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.596 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 m-80 -68.99 -38.96 79.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.371 -0.831 . . . . 0.0 110.669 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 1.3 mp -70.51 -31.44 68.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.523 -0.735 . . . . 0.0 112.135 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.713 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.35 -43.34 71.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.683 -1.261 . . . . 0.0 110.474 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.634 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -72.01 -34.99 69.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.77 -1.207 . . . . 0.0 108.636 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.859 ' OG ' HG21 ' A' ' 61' ' ' THR . 17.2 p -70.05 -32.4 70.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.671 -0.643 . . . . 0.0 110.286 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.19 -20.98 43.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.182 -0.948 . . . . 0.0 110.142 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 14.7 mm-40 -115.52 -77.51 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.734 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -75.28 62.14 6.02 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.213 1.112 . . . . 0.0 109.818 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.6 141.42 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.156 -0.965 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 151' ' ' ARG . . . 100.03 15.95 29.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.674 ' C ' HG23 ' A' ' 55' ' ' VAL . 16.7 p -134.98 147.27 49.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.659 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.573 ' CG ' HD13 ' A' ' 149' ' ' LEU . 47.9 p90 -122.76 141.11 52.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -134.49 158.16 44.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 110.099 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.88 HD12 HD23 ' A' ' 53' ' ' LEU . 2.7 tt -114.46 130.4 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 5.3 tpt180 -112.75 144.06 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' OG ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -92.29 115.67 28.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.99 123.07 34.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.3 81.82 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.181 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -110.54 -163.45 0.85 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.41 -8.53 50.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.231 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 1' ' ' GLU . 5.6 mtt85 -107.7 -14.91 14.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.254 -0.904 . . . . 0.0 110.114 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.832 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER 60.86 112.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.314 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' HIS . 31.8 p90 -178.63 154.94 0.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.12 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.605 ' O ' ' CD1' ' A' ' 51' ' ' PHE . 9.3 p90 -124.15 141.44 52.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.507 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -127.01 148.13 50.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.462 -0.774 . . . . 0.0 109.631 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.038 HD11 ' CD1' ' A' ' 98' ' ' TYR . 4.3 pp -120.94 153.12 37.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.793 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.615 ' HB2' ' CA ' ' A' ' 63' ' ' ASN . 4.0 t -139.12 153.9 48.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 109.969 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG23 ' C ' ' A' ' 38' ' ' THR . 3.3 p -127.03 174.47 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.695 ' O ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -103.53 136.57 43.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -168.57 169.41 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -44.51 -44.43 8.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.628 ' CB ' HG21 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -54.16 -46.18 72.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.177 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.92 161.89 9.59 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.859 HG21 ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -80.13 111.78 16.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 110.195 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -142.0 152.87 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.487 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.615 ' CA ' ' HB2' ' A' ' 54' ' ' SER . 7.7 p30 -120.51 156.28 31.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.967 HD22 ' HA ' ' B' ' 166' ' ' THR . 23.8 mt -134.34 141.99 47.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HD3' ' OH ' ' B' ' 164' ' ' PTR . 2.2 ptm180 -104.29 -177.55 3.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -105.46 149.04 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.183 -0.948 . . . . 0.0 110.248 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -95.65 132.24 41.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.154 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.0 p -106.27 136.84 45.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 71' ' ' GLY . 4.0 tt0 -132.0 102.91 6.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.47 -78.44 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 89' ' ' ASP . . . -147.84 34.97 1.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.488 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -143.15 146.61 33.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.108 . . . . 0.0 110.034 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 9.1 m-30 -110.97 155.85 22.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.47 ' HB3' ' HG3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -151.15 165.92 32.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.975 . . . . 0.0 110.586 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.3 tp 179.03 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 109.689 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.571 ' CG ' ' HA ' ' B' ' 169' ' ' HIS . 0.0 OUTLIER 172.09 -173.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.437 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.56 ' HB3' ' CD2' ' A' ' 96' ' ' HIS . 0.2 OUTLIER 55.84 157.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.443 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -120.1 150.06 50.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.275 -0.891 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.48 54.84 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.046 1.551 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -24.79 59.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 82' ' ' THR . 78.6 p -49.57 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.221 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 1.1 p -113.4 -29.8 7.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.124 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 65.85 48.5 0.6 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.885 . . . . 0.0 110.189 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 46.0 Cg_endo -73.18 -53.51 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.072 1.564 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 88' ' ' PHE . 9.9 m -125.54 150.59 68.43 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.622 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 46.3 Cg_endo -72.76 132.95 19.37 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.963 1.507 . . . . 0.0 110.445 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.622 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 78.55 -32.12 0.16 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 0.0 110.566 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.568 ' CB ' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 73.33 94.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.231 -0.918 . . . . 0.0 109.972 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 19.3 p-10 -72.83 109.15 6.21 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.153 -0.967 . . . . 0.0 109.423 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.663 ' HA ' HD23 ' A' ' 4' ' ' LEU . 0.5 OUTLIER 157.42 124.3 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.206 0.526 . . . . 0.0 109.862 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.688 ' CG1' ' HB2' ' A' ' 8' ' ' ALA . 5.2 p -49.52 -24.88 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.759 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -55.71 -34.87 65.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -57.66 -31.72 66.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.975 -1.078 . . . . 0.0 109.224 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.97 HD23 ' N ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -68.01 -34.62 76.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.603 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.97 ' N ' HD23 ' A' ' 94' ' ' LEU . 54.7 t -54.71 -37.54 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.155 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.56 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 1.6 t-80 -53.8 -29.88 42.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.787 ' CE1' HD12 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -67.56 -40.86 84.93 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.038 ' CD1' HD11 ' A' ' 53' ' ' LEU . 38.1 m-85 -70.87 -15.74 62.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 110.112 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 97' ' ' HIS . 15.4 mmt 62.93 85.09 0.18 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.546 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 44.8 Cg_endo -72.29 133.92 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.07 1.563 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 41.7 Cg_endo -72.36 -29.76 13.48 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.094 1.576 . . . . 0.0 112.247 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 48.9 Cg_endo -74.6 155.08 44.91 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 122.809 0.899 . . . . 0.0 110.445 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 104' ' ' THR . . . -122.63 -50.59 0.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 103' ' ' GLY . 41.8 p 43.36 72.7 1.1 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.285 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 106' ' ' SER . 45.9 Cg_endo -73.14 -91.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 107' ' ' PHE . 3.7 t 171.06 -105.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 110.107 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.511 ' N ' ' OG ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 41.54 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.304 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.67 -68.39 0.72 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.901 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 109' ' ' LEU . 3.3 tt -173.99 85.36 0.36 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.03 122.37 8.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.965 1.508 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.95 175.83 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.944 1.497 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' THR . 18.7 m -62.71 90.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 110.177 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.72 155.29 75.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.254 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.91 165.35 33.04 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.956 1.503 . . . . 0.0 110.434 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER 46.4 51.83 11.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m 53.82 -86.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.248 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 115' ' ' SER . 4.7 mp0 -147.13 -167.2 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.894 . . . . 0.0 110.193 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 10.6 t -115.47 100.82 54.03 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.126 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 120' ' ' GLU . 46.6 Cg_endo -72.77 54.44 2.53 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.561 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 119' ' ' PRO . 2.5 tt0 42.61 -159.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.543 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -74.92 -58.19 1.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.183 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 45.8 Cg_endo -73.26 116.07 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.005 1.529 . . . . 0.0 110.35 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.88 115.26 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.97 1.51 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -166.44 158.27 13.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -146.24 90.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.23 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -166.59 -143.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.199 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -90.87 126.06 56.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.6 -45.16 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.909 1.478 . . . . 0.0 110.467 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.45 44.54 0.26 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 131' ' ' THR . 0.5 OUTLIER -63.9 -55.83 19.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 130' ' ' SER . 66.4 p 42.86 75.88 0.59 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.249 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 115.06 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.04 1.547 . . . . 0.0 110.335 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' B' ' 169' ' ' HIS . 22.6 tttt -73.11 -72.42 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 27.2 mtp85 59.21 107.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.153 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.41 74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.091 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.083 ' CZ ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -102.72 124.65 48.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.083 -1.01 . . . . 0.0 109.065 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.901 ' H ' HG12 ' B' ' 168' ' ' VAL . 7.8 p90 -155.44 167.36 30.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.828 -1.17 . . . . 0.0 111.48 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.809 HD12 ' CD2' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -104.21 149.27 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.624 0.726 . . . . 0.0 111.0 -178.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.765 ' OH ' HG23 ' B' ' 168' ' ' VAL . 16.9 m-85 -96.42 133.34 40.96 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.494 0.664 . . . . 0.0 110.644 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.609 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -125.95 126.45 44.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.553 -0.717 . . . . 0.0 110.568 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 41.18 68.54 0.63 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.74 22.7 2.0 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 140' ' ' SER . 5.1 tp10 -117.7 121.97 42.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -1.208 . . . . 0.0 109.989 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 139' ' ' TYR . 0.1 OUTLIER -84.64 105.62 15.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.663 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -99.17 98.78 6.98 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.893 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 47.7 Cg_endo -73.08 127.27 11.92 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.845 1.445 . . . . 0.0 111.792 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.809 ' CD2' HD12 ' A' ' 138' ' ' ILE . 0.5 OUTLIER -126.14 133.2 51.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.1 p -107.53 117.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.765 -1.209 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.083 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.7 pp -102.34 123.17 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -154.88 14.09 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.824 -179.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 37' ' ' GLY . 1.5 tpt180 -101.34 124.22 41.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.987 -1.071 . . . . 0.0 109.976 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.14 138.11 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.946 1.498 . . . . 0.0 110.591 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.7 HD23 HD12 ' A' ' 40' ' ' LEU . 21.6 tp -91.22 123.55 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.97 90.23 3.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.566 ' O ' ' CH2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.79 155.41 44.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.188 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' B' ' 160' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.172 0.511 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 3.4 m -68.65 -26.63 65.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.42 -29.22 47.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.181 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' B' ' 157' ' ' SER . 4.5 m -51.07 -89.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 1.2 t -138.59 173.25 11.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.684 HG21 ' N ' ' A' ' 25' ' ' GLY . 7.8 p -97.9 123.25 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 15.4 pt-20 -69.05 156.9 37.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.564 ' HD2' HD23 ' A' ' 64' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 11.2 m -139.89 -132.27 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.967 ' HA ' HD22 ' A' ' 64' ' ' LEU . 8.8 t -149.78 154.83 39.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.945 HG21 ' CD2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -93.17 173.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.132 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.901 HG12 ' H ' ' A' ' 137' ' ' TYR . 2.8 p -62.88 97.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.246 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.571 ' HA ' ' CG ' ' A' ' 76' ' ' GLN . 14.6 p80 -53.5 -41.81 66.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' B' ' 169' ' ' HIS . 0.1 OUTLIER -168.52 163.35 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.885 . . . . 0.0 110.243 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.529 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.706 ' H2 ' HD12 ' A' ' 4' ' ' LEU . 1.5 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.232 0.539 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 6' ' ' VAL . 11.4 p90 -56.73 -35.95 69.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.149 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.508 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 2.6 tm0? -67.95 -42.84 80.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.706 HD12 ' H2 ' ' A' ' 1' ' ' GLU . 1.3 mt -67.1 -47.48 71.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.72 HG12 ' CZ ' ' A' ' 73' ' ' PHE . 25.7 m -61.4 -38.64 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 110.055 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 2' ' ' TYR . 25.6 t -58.72 -51.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.959 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.47 -45.51 91.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.684 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . . . -61.91 -44.04 97.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.683 HG23 ' CD2' ' A' ' 51' ' ' PHE . 13.8 t -57.44 -39.82 70.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.351 -0.843 . . . . 0.0 109.327 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.89 72.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.712 . . . . 0.0 109.936 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -41.03 46.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 ' HZ ' ' A' ' 17' ' ' PHE . 21.4 tp -72.1 -43.99 63.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 9' ' ' VAL . 12.2 mt-30 -60.12 -33.5 72.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.56 -27.65 62.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.595 ' OG ' ' CD2' ' A' ' 17' ' ' PHE . 96.2 p -60.76 -43.09 98.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 109.843 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.35 26.99 7.9 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.91 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.9 p90 -132.39 -5.06 3.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 0.0 110.606 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.68 ' CD1' ' CG2' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -106.42 114.91 29.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.014 -1.054 . . . . 0.0 110.004 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.788 ' CE2' HD11 ' A' ' 40' ' ' LEU . 1.7 p-90 -126.46 148.24 49.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 110.025 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.01 107.49 14.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.98 10.19 0.17 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.551 -0.718 . . . . 0.0 110.192 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -120.41 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -93.32 175.34 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.881 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -49.42 -81.99 0.04 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.734 ' HA2' ' ND2' ' A' ' 28' ' ' ASN . . . -79.35 -31.57 41.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.575 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.7 tt0 -59.22 -24.82 63.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.095 -1.238 . . . . 0.0 109.94 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 23' ' ' THR . . . -69.16 -48.58 61.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.885 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.734 ' ND2' ' HA2' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -68.8 -47.26 66.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.396 -0.815 . . . . 0.0 110.899 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 32' ' ' SER . 1.5 mp -59.27 -31.92 69.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.797 . . . . 0.0 111.472 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -55.8 -46.08 78.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.9 -1.125 . . . . 0.0 109.665 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.023 HD23 ' N ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -73.08 -36.2 66.78 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 108.579 178.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 1.023 ' N ' HD23 ' A' ' 31' ' ' LEU . 1.9 m -69.8 -32.73 71.35 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 110.018 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -80.58 -20.95 42.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.738 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.6 mt-10 -113.15 -77.11 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 109.969 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.7 Cg_endo -72.11 64.11 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.33 1.174 . . . . 0.0 110.199 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 141.48 10.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.219 -0.926 . . . . 0.0 110.538 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 90.53 15.74 56.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.873 ' O ' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -135.07 147.23 49.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -1.026 . . . . 0.0 110.252 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 149' ' ' LEU . 10.4 p90 -122.76 142.22 50.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 0.0 110.094 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 41' ' ' ILE . 5.5 tt -131.26 151.56 51.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.426 -0.796 . . . . 0.0 110.394 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.885 HD12 HD23 ' A' ' 53' ' ' LEU . 9.0 tt -114.77 128.07 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.446 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 5.5 tpt180 -119.56 139.56 51.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 1.4 t0 -73.89 138.06 44.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -38.35 -70.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.37 -72.96 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.67 -170.28 1.92 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.118 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -67.09 -7.31 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.154 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -95.48 26.41 3.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 110.113 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.443 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.9 177.42 7.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.55 ' HA ' HG11 ' A' ' 5' ' ' VAL . 12.3 p90 -79.71 168.57 19.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.922 . . . . 0.0 110.182 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.843 ' CE1' HG21 ' A' ' 91' ' ' VAL . 7.8 p90 -123.1 139.26 54.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.401 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 7.1 t -128.22 154.47 45.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.585 -0.697 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.155 HD21 ' CG ' ' A' ' 98' ' ' TYR . 3.9 pp -139.47 151.38 46.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.941 -1.099 . . . . 0.0 110.456 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.579 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 0.8 OUTLIER -139.29 153.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.0 110.262 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 56' ' ' LYS . 10.7 p -129.01 173.47 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.333 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' HB2' ' CA ' ' A' ' 32' ' ' SER . 9.6 tttm -116.92 139.14 50.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.606 HG21 HD22 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -146.26 -171.76 3.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.147 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.99 62.44 3.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 p -175.54 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.856 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.97 135.51 2.89 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 t -79.12 125.49 29.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.211 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' SER . 14.6 mmtt -123.8 141.96 51.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 110.175 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 164' ' ' PTR . 5.1 p30 -116.73 138.87 51.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.574 HD13 HG22 ' B' ' 167' ' ' VAL . 0.7 OUTLIER -132.16 131.01 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 110.419 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.504 ' HG3' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -96.29 157.08 16.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 110.03 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -100.6 136.3 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.152 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' NE2' ' HD3' ' A' ' 79' ' ' PRO . 52.0 mt-30 -119.91 150.98 39.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.276 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 72' ' ' SER . 19.9 p -87.95 130.26 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.56 124.37 48.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.659 ' O ' HG11 ' A' ' 85' ' ' VAL . . . 65.4 -74.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.766 ' HA2' HG11 ' A' ' 85' ' ' VAL . . . -158.53 20.91 0.32 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 24.2 p -134.03 163.41 29.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.72 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -110.56 130.68 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.819 ' HA ' HD11 ' A' ' 94' ' ' LEU . 9.5 p -145.52 167.08 23.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.268 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.777 HD11 ' CE1' ' A' ' 97' ' ' HIS . 2.7 mt -67.08 117.12 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 64.37 122.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 110.212 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -176.63 -164.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 110.263 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' A' ' 77' ' ' SER . 0.8 OUTLIER -112.41 112.0 52.02 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.194 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HD3' ' NE2' ' A' ' 67' ' ' GLN . 46.1 Cg_endo -73.5 53.87 2.76 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.992 1.522 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.03 17.02 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.294 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.426 ' C ' ' OG1' ' A' ' 82' ' ' THR . 1.9 t -108.17 -58.51 1.98 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.219 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 41.9 33.25 0.33 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.237 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.551 ' CG ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -150.39 -179.3 0.97 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 83' ' ' GLN . 45.6 Cg_endo -72.8 125.92 10.92 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.962 1.507 . . . . 0.0 110.35 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.766 HG11 ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -132.91 -177.89 0.77 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 109.709 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.584 ' HD2' ' CB ' ' A' ' 85' ' ' VAL . 40.2 Cg_endo -67.31 153.25 77.62 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.571 1.3 . . . . 0.0 109.544 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.581 ' O ' ' HB3' ' A' ' 88' ' ' PHE . 54.4 mtt180 65.09 -118.94 0.4 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' HB3' ' O ' ' A' ' 87' ' ' ARG . 4.8 p90 165.68 -148.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.171 -0.955 . . . . 0.0 109.748 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.684 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 5.7 p-10 -73.24 110.18 7.33 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.067 -1.021 . . . . 0.0 109.596 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.84 6.85 26.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 110.66 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -50.08 -26.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 109.78 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 9.3 mp -57.6 -46.64 83.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.565 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -38.38 84.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.024 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.819 HD11 ' HA ' ' A' ' 74' ' ' SER . 7.4 mt -68.09 -34.82 77.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.622 -0.673 . . . . 0.0 109.836 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 91' ' ' VAL . 26.9 t -54.66 -37.71 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 110.042 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 100' ' ' PRO . 34.3 m170 -53.49 -35.53 60.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.029 . . . . 0.0 109.339 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.777 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -78.16 -34.19 49.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.714 . . . . 0.0 109.776 179.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.155 ' CG ' HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -61.88 -22.21 65.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.456 -0.778 . . . . 0.0 111.314 -178.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.865 ' HB2' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER 177.63 -56.88 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.913 -1.117 . . . . 0.0 111.554 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.657 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 40.5 Cg_endo -65.77 110.08 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.619 1.326 . . . . 0.0 111.256 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 99' ' ' MET . 48.9 Cg_endo -75.84 168.99 23.14 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.94 1.495 . . . . 0.0 110.257 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 134' ' ' ARG . 47.5 Cg_endo -73.87 -5.56 17.22 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.953 1.501 . . . . 0.0 110.275 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.59 149.95 5.08 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 105' ' ' PRO . 1.1 m -179.25 -58.59 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.224 -1.162 . . . . 0.0 110.171 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 104' ' ' THR . 44.6 Cg_endo -71.0 158.55 55.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.862 1.453 . . . . 0.0 110.462 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 107' ' ' PHE . 26.7 t -69.09 -92.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 108' ' ' SER . 53.2 m-85 41.86 64.44 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.247 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 4.2 m 56.05 174.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.182 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.514 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 16.8 mt 61.51 51.88 2.24 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 109' ' ' LEU . 46.7 Cg_endo -72.95 118.33 5.52 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.996 1.524 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -9.21 23.15 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.941 1.495 . . . . 0.0 110.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.411 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 8.3 t -117.2 167.34 11.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.271 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.536 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . 2.1 mt-10 173.72 -57.58 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 113' ' ' GLU . 45.9 Cg_endo -73.13 -10.0 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.049 1.552 . . . . 0.0 110.485 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.8 t -114.33 170.95 7.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.0 110.189 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.2 171.82 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.78 27.94 1.23 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.582 ' HB ' ' HD3' ' A' ' 119' ' ' PRO . 2.8 t -48.52 -54.62 24.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.286 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 118' ' ' VAL . 44.8 Cg_endo -71.42 152.53 60.57 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.881 1.463 . . . . 0.0 110.474 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.6 pt-20 -114.59 112.07 22.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.554 ' C ' ' HD2' ' A' ' 123' ' ' PRO . 7.8 mt-30 56.51 107.46 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.245 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 42.0 Cg_endo -72.26 -29.56 14.02 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.05 1.553 . . . . 0.0 112.242 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 48.7 Cg_endo -74.4 -32.11 6.67 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 122.851 0.922 . . . . 0.0 110.342 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -95.17 89.04 5.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.914 . . . . 0.0 110.162 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -127.9 -56.51 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 0.0 110.292 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.47 -157.06 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.544 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -59.25 -58.11 21.97 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 45.5 Cg_endo -72.71 127.56 12.48 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 130' ' ' SER . . . -101.97 -1.5 51.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 129' ' ' GLY . 4.8 m 62.49 -164.29 0.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 130' ' ' SER . 27.3 p 42.48 81.27 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 61.39 3.94 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -125.63 -87.99 0.59 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.741 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 5.9 tmm_? -76.95 144.76 38.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.29 -0.881 . . . . 0.0 110.149 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 167.17 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.932 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.916 ' CD2' HG11 ' B' ' 167' ' ' VAL . 5.8 t80 -114.44 120.69 41.15 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.876 -1.14 . . . . 0.0 109.623 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.962 ' H ' HG12 ' B' ' 167' ' ' VAL . 1.8 p90 -157.15 166.89 31.99 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.954 -1.091 . . . . 0.0 109.998 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 147' ' ' LEU . 1.8 mp -119.24 147.41 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 120.88 -1.137 . . . . 0.0 111.51 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.833 ' CE2' HG23 ' B' ' 166' ' ' THR . 1.2 m-30 -84.65 107.77 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.705 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.762 ' HB3' HD13 ' A' ' 145' ' ' ILE . 10.3 t -92.47 124.82 36.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.68 61.54 3.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 57.09 20.28 34.28 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -120.23 121.73 39.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.942 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.62 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -80.06 105.44 11.34 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.005 -1.059 . . . . 0.0 110.704 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.863 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.1 mp -97.71 115.09 65.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.731 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 46.2 Cg_endo -71.81 128.73 14.52 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 112.204 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.774 ' O ' ' O ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -126.1 136.46 52.93 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.4 t -97.41 116.45 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 120.062 -1.649 . . . . 0.0 109.852 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 98' ' ' TYR . 1.2 tt -91.47 125.31 36.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 6.9 p -165.55 46.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.78 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 4.4 mtp180 -134.08 124.54 17.53 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.06 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' CG2' ' A' ' 38' ' ' THR . 49.0 Cg_endo -76.55 148.13 29.12 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.875 1.461 . . . . 0.0 110.771 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.91 HD21 ' O ' ' A' ' 17' ' ' PHE . 4.4 pp -88.18 158.04 18.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.589 ' C ' ' O ' ' A' ' 153' ' ' LEU . 14.0 t 22.04 -90.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.704 -0.622 . . . . 0.0 111.067 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 153' ' ' LEU . 5.7 t 55.21 -85.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 110.219 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 154' ' ' SER . 2.3 t30 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.234 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.33 86.28 7.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.95 39.54 1.04 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 57.8 m -95.71 71.13 3.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 110.215 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.605 ' O ' HG23 ' B' ' 162' ' ' VAL . 68.4 p -68.08 117.64 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.778 HG12 ' O ' ' B' ' 162' ' ' VAL . 1.8 t -158.67 92.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 24.7 mt-10 -119.32 -173.1 2.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 109.955 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.58 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.573 ' C ' HG22 ' B' ' 166' ' ' THR . 36.6 m -123.58 -91.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.438 -0.789 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.833 HG23 ' CE2' ' A' ' 139' ' ' TYR . 0.2 OUTLIER 171.67 166.95 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -0.885 . . . . 0.0 110.311 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.962 HG12 ' H ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -123.58 -162.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.384 -0.823 . . . . 0.0 110.274 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.936 HG22 ' CE2' ' A' ' 137' ' ' TYR . 3.6 t -77.19 132.94 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.271 -0.893 . . . . 0.0 110.296 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -67.17 149.56 50.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 97' ' ' HIS . 3.8 m -97.81 40.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.499 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.514 ' CG ' ' SG ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.515 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 0.1 OUTLIER -61.46 -47.91 83.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 110.053 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -67.53 -32.96 74.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.368 -0.832 . . . . 0.0 110.529 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.733 HD11 ' O ' ' A' ' 71' ' ' GLY . 63.4 mt -57.01 -47.39 80.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.868 HG21 ' CA ' ' A' ' 50' ' ' PHE . 3.0 t -61.07 -47.24 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.092 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -43.19 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.134 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -65.0 -39.8 93.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.032 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.28 -44.45 52.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.895 . . . . 0.0 110.026 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.798 HG12 HE21 ' A' ' 13' ' ' GLN . 94.8 t -57.83 -39.91 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 0.0 109.391 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -55.74 -43.74 76.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.482 -0.762 . . . . 0.0 110.054 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -77.97 -44.33 27.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' HG21 ' A' ' 41' ' ' ILE . 44.9 tp -65.98 -42.1 90.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.798 HE21 HG12 ' A' ' 9' ' ' VAL . 3.5 pt20 -68.18 -38.86 82.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.257 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 13' ' ' GLN . 3.4 tm-20 -57.79 -44.91 86.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -26.91 51.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.48 31.2 8.04 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.703 ' CZ ' ' CE1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -129.76 8.38 5.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -1.141 . . . . 0.0 110.266 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.785 ' HE2' HG22 ' A' ' 9' ' ' VAL . 2.6 t80 -90.81 136.18 33.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.972 ' CG ' HD12 ' A' ' 40' ' ' LEU . 12.9 m95 -108.48 143.42 37.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.334 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.687 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -149.78 110.99 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.892 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 171.36 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.571 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -118.66 -161.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.992 -1.067 . . . . 0.0 110.145 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -93.7 165.81 12.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.639 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -44.51 -84.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.73 ' HA3' HG22 ' B' ' 162' ' ' VAL . . . -60.66 -41.93 99.12 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 23' ' ' THR . 3.1 mt-10 -59.56 -27.12 65.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.973 -1.31 . . . . 0.0 110.212 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -78.3 -44.55 25.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 110.023 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.689 ' O ' HD23 ' A' ' 31' ' ' LEU . 8.8 m-80 -68.78 -48.27 64.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.465 HD13 ' OD1' ' A' ' 63' ' ' ASN . 1.6 mp -59.19 -32.32 69.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.832 . . . . 0.0 111.038 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -55.98 -26.19 47.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 38' ' ' THR . 2.4 pp -68.52 -33.17 73.65 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.396 -0.921 . . . . 0.0 108.599 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.535 ' CA ' ' HD2' ' A' ' 56' ' ' LYS . 7.5 t -69.78 -32.93 71.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.611 -0.681 . . . . 0.0 110.056 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.61 -20.99 41.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 110.013 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.769 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 22.2 mt-10 -122.85 -83.01 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 110.552 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.769 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.8 Cg_endo -74.5 69.5 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 122.894 0.944 . . . . 0.0 110.44 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.34 141.38 41.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 110.287 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 78.6 20.68 70.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.985 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.5 m -124.99 147.88 48.71 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -1.041 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.715 ' HB2' HG12 ' A' ' 55' ' ' VAL . 13.0 p90 -122.42 145.71 48.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.542 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.972 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -152.03 159.47 43.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.466 -0.772 . . . . 0.0 109.964 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.578 HG21 ' CD2' ' A' ' 12' ' ' LEU . 3.1 tt -114.79 143.74 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.283 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.1 tpm_? -129.71 132.04 46.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' A' ' 42' ' ' ARG . 1.9 t0 -77.09 103.95 7.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.129 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.515 ' HB2' ' N ' ' A' ' 24' ' ' GLY . 64.2 m -166.69 -155.73 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.133 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 67.54 29.68 7.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.079 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.2 -153.89 0.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' A' ' 48' ' ' ARG . 29.9 mt-30 -85.41 -12.94 50.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 110.359 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 47' ' ' GLN . 2.8 mtm180 170.68 -27.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.943 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.513 ' NE2' ' CE1' ' A' ' 2' ' ' TYR . 35.4 m80 -103.85 -147.59 0.39 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.868 ' CA ' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 59.95 108.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.099 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 91' ' ' VAL . 14.6 p90 -115.88 143.5 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.4 m -126.08 155.29 41.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.89 HD23 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -130.84 128.43 40.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.519 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -139.26 154.09 47.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.45 -0.781 . . . . 0.0 109.796 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.815 ' HA ' HD21 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -135.17 174.22 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HD2' ' CA ' ' A' ' 32' ' ' SER . 6.7 tttt -111.03 139.24 46.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.171 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.958 ' HB ' HD12 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -131.97 -142.91 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 110.163 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 59' ' ' SER . 5.4 tt0 -46.09 -27.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.066 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER 163.46 -18.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.522 -0.736 . . . . 0.0 109.77 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 80.5 1.53 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 56' ' ' LYS . 13.3 p -94.49 108.88 20.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 0.0 109.872 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.926 ' HD2' HG21 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -137.11 172.79 12.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -140.16 155.33 47.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.385 -0.822 . . . . 0.0 109.991 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.998 HD11 ' O ' ' B' ' 165' ' ' SER . 0.3 OUTLIER -138.31 129.94 27.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 110.655 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -80.22 156.35 26.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' CE2' ' A' ' 73' ' ' PHE . 6.8 tp -76.77 140.54 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 110.413 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.8 OUTLIER -91.81 117.77 30.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.912 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.658 ' SG ' HD12 ' A' ' 4' ' ' LEU . 42.0 t -98.93 117.15 32.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 110.566 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.02 102.95 14.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.861 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.34 -81.37 0.59 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.733 ' O ' HD11 ' A' ' 4' ' ' LEU . . . -141.45 6.79 2.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.4 OUTLIER -104.02 163.61 12.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 110.299 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.42 141.33 43.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.404 -0.81 . . . . 0.0 110.202 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 67' ' ' GLN . 4.0 p -155.41 139.99 16.94 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.205 -0.935 . . . . 0.0 110.753 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.084 ' CB ' HD13 ' A' ' 94' ' ' LEU . 2.1 tt -128.33 57.69 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.502 ' NE2' ' HB ' ' B' ' 166' ' ' THR . 0.0 OUTLIER 62.56 -149.97 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.081 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 62.91 -171.77 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.176 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' N ' ' OG ' ' A' ' 77' ' ' SER . 0.5 OUTLIER -89.8 121.62 68.8 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 0.0 110.201 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.03 59.26 3.6 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.965 1.508 . . . . 0.0 110.585 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.34 20.01 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.14 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' HG3' ' A' ' 93' ' ' LYS . 12.4 m -68.46 -5.73 20.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 82' ' ' THR . 33.5 m 59.42 13.41 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 46.31 92.09 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.617 ' HD2' ' CE1' ' A' ' 88' ' ' PHE . 44.8 Cg_endo -73.68 -81.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.002 1.528 . . . . 0.0 110.479 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.97 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -110.71 170.22 5.51 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.083 -1.01 . . . . 0.0 109.547 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.97 ' HD2' HG22 ' A' ' 85' ' ' VAL . 41.3 Cg_endo -68.46 132.67 26.07 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.734 1.387 . . . . 0.0 109.66 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.609 ' O ' HD21 ' A' ' 4' ' ' LEU . 31.7 mtm180 53.57 39.42 30.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 109.316 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.617 ' CE1' ' HD2' ' A' ' 84' ' ' PRO . 9.7 p90 -77.21 164.99 25.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.402 -0.811 . . . . 0.0 110.493 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.666 ' OD1' HD11 ' A' ' 92' ' ' LEU . 32.5 p-10 -83.91 110.65 18.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.319 -0.863 . . . . 0.0 109.497 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' PHE . 4.4 t -88.73 -18.79 27.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.682 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 1.5 t -49.64 -25.88 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.025 -1.047 . . . . 0.0 109.925 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.904 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -57.58 -47.35 82.33 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.999 -1.063 . . . . 0.0 108.899 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.482 ' HG3' ' OG ' ' A' ' 81' ' ' SER . 26.0 mmtt -68.44 -34.06 75.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 108.714 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.084 HD13 ' CB ' ' A' ' 75' ' ' LEU . 19.6 mt -59.82 -33.13 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.201 0.524 . . . . 0.0 110.297 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.19 -36.43 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 99' ' ' MET . 0.5 OUTLIER -53.68 -52.71 59.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.584 -1.322 . . . . 0.0 108.906 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.682 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 19.9 t60 -79.58 -53.12 7.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -0.865 . . . . 0.0 109.692 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.89 ' CD2' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.02 -22.25 65.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.726 -0.609 . . . . 0.0 110.344 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.733 ' HA ' HD11 ' A' ' 149' ' ' LEU . 2.3 mtp -137.03 -176.39 0.57 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.104 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.602 ' HD3' ' CZ ' ' A' ' 39' ' ' PHE . 46.5 Cg_endo -74.38 136.88 22.42 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.689 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 42.1 Cg_endo -72.32 -29.79 13.57 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.972 1.512 . . . . 0.0 112.307 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 101' ' ' PRO . 47.6 Cg_endo -73.74 78.6 2.41 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.797 0.893 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.95 -159.59 0.13 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -176.44 86.11 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.246 -1.149 . . . . 0.0 110.286 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 107' ' ' PHE . 46.1 Cg_endo -73.05 55.03 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.997 1.525 . . . . 0.0 110.35 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.91 52.31 9.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.865 . . . . 0.0 110.176 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 107' ' ' PHE . 1.8 p90 -134.2 128.76 34.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.88 . . . . 0.0 110.271 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p -59.13 -163.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.555 ' C ' ' HD2' ' A' ' 111' ' ' PRO . 0.8 OUTLIER -141.29 86.83 10.94 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.326 -0.859 . . . . 0.0 110.221 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 111' ' ' PRO . 41.7 Cg_endo -72.18 -29.75 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.983 1.517 . . . . 0.0 112.257 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 110' ' ' PRO . 47.7 Cg_endo -74.54 130.64 13.98 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 122.881 0.937 . . . . 0.0 110.387 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -86.64 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 110.162 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 110.75 2.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.71 64.76 3.9 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.975 1.513 . . . . 0.0 110.44 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.88 91.1 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.55 45.21 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 110.273 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -146.22 -37.75 0.24 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.887 . . . . 0.0 110.153 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.492 ' CG1' ' OE1' ' A' ' 120' ' ' GLU . 11.5 t 60.29 80.08 0.27 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.08 54.61 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.029 1.542 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE1' ' CG1' ' A' ' 118' ' ' VAL . 14.1 pt-20 -103.7 -175.41 2.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.8 75.48 0.65 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.184 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 112.71 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.995 1.524 . . . . 0.0 110.316 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 125' ' ' GLN . 45.6 Cg_endo -72.94 65.62 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.991 1.521 . . . . 0.0 110.413 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 55.79 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.958 . . . . 0.0 110.232 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -98.68 110.62 23.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -125.29 178.71 5.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.136 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.442 ' HG ' ' HD2' ' A' ' 128' ' ' PRO . 8.4 tt -131.0 130.39 22.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.929 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.442 ' HD2' ' HG ' ' A' ' 127' ' ' LEU . 46.7 Cg_endo -73.1 -52.46 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.942 1.496 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.62 173.31 13.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -140.47 -85.59 0.21 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -1.142 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -86.88 114.83 60.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.169 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.89 -163.04 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.072 1.564 . . . . 0.0 110.474 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.13 36.15 1.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.21 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.768 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 8.5 mtp180 -152.38 150.41 29.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.88 ' O ' HG21 ' B' ' 168' ' ' VAL . . . 162.49 75.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 109.874 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.132 ' CD2' HG11 ' B' ' 167' ' ' VAL . 0.1 OUTLIER -106.73 125.52 51.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.977 ' N ' HG12 ' B' ' 167' ' ' VAL . 14.5 p90 -155.04 167.63 29.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.73 -1.231 . . . . 0.0 111.108 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.926 HG21 ' HD2' ' A' ' 62' ' ' LYS . 3.0 mp -101.93 149.07 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 110.933 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.713 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 16.9 m-85 -99.15 133.08 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 110.985 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 141' ' ' GLY . 0.4 OUTLIER -89.91 -162.77 0.92 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.657 -0.652 . . . . 0.0 110.004 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -43.04 -45.93 6.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.0 18.31 0.23 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 145' ' ' ILE . 4.1 mm-40 -120.34 123.92 44.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -1.18 . . . . 0.0 110.403 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 23.5 mtpt -75.73 105.33 6.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.035 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.07 HG22 HD21 ' A' ' 147' ' ' LEU . 1.1 mp -91.83 110.9 46.83 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.897 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -76.47 128.99 10.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.143 1.602 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.07 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -124.63 123.16 39.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.289 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 148' ' ' VAL . 7.7 p -102.53 117.44 47.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.67 -1.269 . . . . 0.0 110.297 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.993 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.9 pp -108.65 132.29 54.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.875 . . . . 0.0 110.047 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.473 ' HA ' ' HB3' ' A' ' 100' ' ' PRO . 4.2 p -169.9 27.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.026 -1.046 . . . . 0.0 110.73 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.573 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -113.58 124.84 30.48 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 109.943 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 46.6 Cg_endo -73.76 129.82 13.95 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.988 1.52 . . . . 0.0 110.703 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.773 ' HB2' HG22 ' A' ' 38' ' ' THR . 36.7 tp -91.92 128.57 37.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.4 OUTLIER 59.97 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.105 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 153' ' ' LEU . 2.6 m 43.3 -93.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 110.253 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 154' ' ' SER . 5.9 t-20 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 7.3 t -122.75 165.55 16.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -167.39 -177.46 3.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.202 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.59 -157.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.681 HG22 ' O ' ' B' ' 161' ' ' THR . 93.9 m -94.5 30.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.169 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.809 HG12 ' O ' ' B' ' 162' ' ' VAL . 40.5 t -131.09 59.89 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.222 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.543 ' O ' ' CD1' ' B' ' 164' ' ' PTR . 3.6 pm0 -58.6 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.779 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.581 ' HD1' ' HA ' ' A' ' 64' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.998 ' O ' HD11 ' A' ' 64' ' ' LEU . 4.7 t -134.09 96.25 3.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.857 . . . . 0.0 109.955 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.536 ' C ' ' O ' ' B' ' 165' ' ' SER . 46.3 p -30.34 123.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.568 -0.707 . . . . 0.0 110.44 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.132 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.2 OUTLIER -92.53 84.16 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 110.268 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 135' ' ' ALA . 32.8 t 59.1 138.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' B' ' 170' ' ' SER . 16.0 m170 -102.26 -67.42 0.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' B' ' 169' ' ' HIS . 0.2 OUTLIER 173.16 123.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.259 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.592 ' CA ' HD12 ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.298 0.57 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.652 ' O ' HG23 ' A' ' 6' ' ' VAL . 29.8 p90 -61.19 -35.86 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -55.0 -37.39 66.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.649 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . 1.2 mt -60.9 -47.34 86.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.826 HG21 ' HA ' ' A' ' 50' ' ' PHE . 55.5 t -70.38 -42.72 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.746 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 2' ' ' TYR . 73.2 t -58.78 -50.73 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.954 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -58.83 -41.87 87.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -61.93 -41.49 98.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.817 . . . . 0.0 109.659 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.15 HG22 ' CE2' ' A' ' 18' ' ' TYR . 2.9 t -56.97 -39.53 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.147 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -48.11 75.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -78.18 -38.94 42.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 110.14 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -65.3 -31.9 73.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 110.316 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.637 HE21 HG12 ' A' ' 9' ' ' VAL . 26.7 mt-30 -66.93 -39.86 87.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -34.28 71.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.262 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 p -72.02 -37.78 69.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 154' ' ' SER . . . 94.04 -5.18 71.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 9.0 t80 -93.54 6.04 49.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -1.111 . . . . 0.0 110.007 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 1.15 ' CE2' HG22 ' A' ' 9' ' ' VAL . 2.2 t80 -90.92 131.9 36.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 40' ' ' LEU . 29.1 m95 -124.15 104.18 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 111.146 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -122.44 17.73 10.53 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.873 0.845 . . . . 0.0 108.883 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.98 47.95 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.393 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.638 HG23 ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -113.63 -157.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.889 -1.132 . . . . 0.0 109.974 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.599 ' OG1' ' CB ' ' A' ' 26' ' ' GLU . 1.2 p -95.96 176.1 6.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.555 ' HA3' ' CB ' ' A' ' 45' ' ' SER . . . -52.83 -69.51 1.18 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.584 ' HA3' HG22 ' B' ' 162' ' ' VAL . . . -79.66 -40.94 13.77 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.087 -1.243 . . . . 0.0 110.94 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' CB ' ' OG1' ' A' ' 23' ' ' THR . 4.6 tp10 -59.59 -28.12 66.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.721 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.026 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -77.95 -42.92 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.084 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.952 HD21 HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.28 -44.97 70.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 111.277 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.952 HD13 HD21 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -70.32 -31.92 69.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.155 -0.966 . . . . 0.0 111.851 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.026 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.6 pp -55.43 -23.8 27.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.824 -1.173 . . . . 0.0 110.223 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.767 HD13 ' O ' ' A' ' 38' ' ' THR . 2.8 pp -78.47 -38.47 40.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.548 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.715 ' OG ' HG21 ' A' ' 61' ' ' THR . 12.7 p -70.09 -32.71 70.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.85 -20.57 42.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.299 -0.876 . . . . 0.0 110.973 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.715 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 11.8 mm-40 -116.29 -75.08 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.9 -1.125 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.715 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 45.2 Cg_endo -71.64 72.58 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.302 1.159 . . . . 0.0 110.564 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . . . -57.62 141.25 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.952 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' H ' ' CE ' ' A' ' 56' ' ' LYS . . . 77.64 19.45 75.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -133.56 148.09 51.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.455 -1.026 . . . . 0.0 109.928 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.905 ' HB3' HG23 ' A' ' 55' ' ' VAL . 21.9 p90 -121.84 159.44 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.202 -0.937 . . . . 0.0 109.945 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.816 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -152.64 159.86 43.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 110.704 -178.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.679 HG12 ' OH ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -114.45 134.76 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 109.664 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HD3' ' CB ' ' A' ' 27' ' ' ALA . 13.9 tpt180 -112.71 129.93 56.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.058 -1.026 . . . . 0.0 110.033 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.6 ' OD1' ' CG ' ' A' ' 51' ' ' PHE . 15.0 m-20 -98.59 138.1 36.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER 71.85 152.51 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.281 -0.887 . . . . 0.0 110.494 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.555 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 33.9 t -163.95 -36.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.093 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -135.91 -138.83 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.372 -0.83 . . . . 0.0 110.182 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -86.04 -29.11 23.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -69.17 -31.29 69.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 48' ' ' ARG . 9.1 t60 58.03 143.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.826 ' HA ' HG21 ' A' ' 5' ' ' VAL . 1.0 OUTLIER 171.01 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.705 ' CD1' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -115.81 139.88 49.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.36 -0.838 . . . . 0.0 109.88 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 16.1 p -123.12 146.63 47.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.97 -1.081 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' B' ' 167' ' ' VAL . 0.2 OUTLIER -120.82 122.72 40.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 109.818 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.621 ' CB ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -143.52 155.94 44.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.726 -1.234 . . . . 0.0 112.812 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 39' ' ' PHE . 5.3 p -143.66 174.48 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.166 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 32' ' ' SER . 2.1 ttpt -115.72 125.45 52.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 109.862 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -153.88 -162.62 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.985 . . . . 0.0 110.498 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 57' ' ' THR . 5.1 mt-30 -79.77 -23.21 42.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -81.73 13.38 3.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.166 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.06 138.72 3.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.924 ' O ' HD11 ' A' ' 29' ' ' LEU . 2.9 t -78.85 108.76 12.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.263 -1.139 . . . . 0.0 109.951 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 54' ' ' SER . 6.9 mmtt -109.17 157.94 18.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 110.213 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 64' ' ' LEU . 1.7 t-20 -111.97 152.28 28.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.877 . . . . 0.0 110.028 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.98 ' CD1' HG23 ' B' ' 167' ' ' VAL . 15.1 mt -138.52 117.52 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.991 -1.068 . . . . 0.0 110.233 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -81.8 155.71 25.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.345 -0.847 . . . . 0.0 110.586 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.006 HD11 ' SG ' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -77.28 141.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 110.014 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.3 mt-30 -93.48 132.55 37.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' SER . 30.0 t -109.42 118.82 37.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 72' ' ' SER . 7.0 mm-40 -133.15 104.77 6.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.442 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.68 36.32 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.18 -0.01 55.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -103.75 163.3 12.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -1.127 . . . . 0.0 109.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 4' ' ' LEU . 1.4 m-30 -110.87 148.06 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.851 ' O ' HD13 ' A' ' 66' ' ' ILE . 19.5 m -144.43 138.59 27.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.808 . . . . 0.0 110.079 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.956 ' CD1' HD11 ' A' ' 94' ' ' LEU . 10.0 tp -115.35 -3.46 12.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.577 ' CG ' ' HB3' ' B' ' 169' ' ' HIS . 2.8 mp0 -71.85 -145.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.133 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.904 ' OG ' HG21 ' B' ' 166' ' ' THR . 1.8 t -179.39 30.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . 1.3 m-20 -120.04 125.04 27.51 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.18 53.93 2.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.947 1.498 . . . . 0.0 110.432 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 78' ' ' ASP . 15.0 mtp180 -87.46 19.01 3.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.143 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 80' ' ' ARG . 3.9 p 43.81 42.28 4.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 14.1 t -81.85 10.22 6.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.566 ' CG ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER 61.96 -179.24 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 110.193 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 83' ' ' GLN . 46.9 Cg_endo -72.84 -179.77 4.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.965 1.508 . . . . 0.0 110.38 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.52 143.02 27.29 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 47.1 Cg_endo -72.88 138.39 28.54 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.011 1.532 . . . . 0.0 110.418 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.597 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 69.22 28.46 4.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.365 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 87' ' ' ARG . 40.0 p90 35.82 45.42 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.417 -0.802 . . . . 0.0 110.603 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -72.31 110.11 6.51 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.02 -1.05 . . . . 0.0 109.909 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 1.006 ' SG ' HD11 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -177.44 -75.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.625 -0.672 . . . . 0.0 110.044 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' H ' ' A' ' 92' ' ' LEU . 8.6 m -54.88 -51.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.016 . . . . 0.0 109.696 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 13.3 mt -63.41 -46.12 87.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 108.829 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -64.95 -29.42 70.35 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.576 0.703 . . . . 0.0 109.543 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.956 HD11 ' CD1' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -57.51 -34.55 69.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 110.739 -178.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.872 HG12 HD11 ' A' ' 12' ' ' LEU . 3.7 m -54.19 -39.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.928 -1.108 . . . . 0.0 108.825 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.59 ' CE1' ' HD2' ' A' ' 101' ' ' PRO . 1.0 OUTLIER -68.62 -30.01 68.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 178.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.668 ' CD2' ' HB2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -56.73 -38.82 72.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 110.276 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.864 ' HA ' HD13 ' A' ' 149' ' ' LEU . 36.3 m-85 -73.8 -0.65 16.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.602 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 178.52 110.47 0.16 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.035 -1.041 . . . . 0.0 110.471 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HG3' ' HG3' ' A' ' 134' ' ' ARG . 47.5 Cg_endo -74.83 138.53 23.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.905 1.476 . . . . 0.0 110.313 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.67 164.92 33.6 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.002 1.528 . . . . 0.0 110.428 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.88 169.5 21.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.985 1.519 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.51 -54.85 0.77 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 100.55 1.25 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.25 -1.147 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -53.46 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.12 1.59 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.2 -74.12 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.89 . . . . 0.0 110.245 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.621 ' O ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -72.02 124.31 24.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 m -88.63 81.4 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.942 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -110.82 147.41 36.42 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 112' ' ' THR . 46.8 Cg_endo -72.96 137.03 26.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.016 1.535 . . . . 0.0 110.452 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.87 76.8 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.062 1.559 . . . . 0.0 110.403 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 110' ' ' PRO . 21.1 p -78.59 121.15 24.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -142.9 117.62 6.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.31 -44.42 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.381 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 p -63.07 153.75 33.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.3 t -98.96 30.44 3.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -46.75 -53.79 11.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.1 p -164.79 78.96 1.36 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 46.1 Cg_endo -72.78 -160.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.066 1.561 . . . . 0.0 110.427 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER 65.89 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.363 -0.836 . . . . 0.0 110.233 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 120' ' ' GLU . 22.8 tp60 -162.54 105.45 1.07 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.19 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.98 128.13 12.84 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.044 1.55 . . . . 0.0 110.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 124' ' ' ALA . 46.4 Cg_endo -73.4 54.18 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 123' ' ' PRO . . . 42.72 -154.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.251 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 8.3 mt-30 -93.01 -35.01 13.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 110.228 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 125' ' ' GLN . . . 66.68 50.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' N ' ' HD2' ' A' ' 128' ' ' PRO . 0.1 OUTLIER -67.86 -55.74 13.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 127' ' ' LEU . 45.5 Cg_endo -73.05 -89.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.923 1.486 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.01 -166.41 38.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 131' ' ' THR . 0.6 OUTLIER -59.17 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -1.125 . . . . 0.0 110.251 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 130' ' ' SER . 25.2 p 42.96 88.19 0.11 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.25 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 172.97 14.26 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.049 1.552 . . . . 0.0 110.481 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -98.45 77.48 2.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.761 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 2.8 ttt180 -120.8 101.59 7.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.0 110.222 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 165.13 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.844 . . . . 0.0 109.997 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.904 ' CD1' ' O ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -102.59 124.86 48.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.018 . . . . 0.0 108.993 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.931 ' N ' HG13 ' B' ' 167' ' ' VAL . 6.7 p90 -156.02 166.34 33.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.804 -1.185 . . . . 0.0 111.016 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.889 ' H ' HD13 ' A' ' 147' ' ' LEU . 5.6 mt -102.43 149.53 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.778 0.799 . . . . 0.0 111.377 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 19.9 m-85 -97.79 133.46 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.639 0.733 . . . . 0.0 110.969 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.972 ' HB3' HD13 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -121.43 119.53 32.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.566 -0.709 . . . . 0.0 110.52 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 42.58 63.41 1.91 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.3 13.84 23.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 140' ' ' SER . 8.3 tp10 -109.97 121.73 45.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 18.2 mttt -79.4 105.65 10.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.833 . . . . 0.0 110.561 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 147' ' ' LEU . 1.2 mp -97.22 109.67 50.71 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.846 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.2 Cg_endo -71.59 129.38 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.139 1.599 . . . . 0.0 111.838 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.002 HD11 HG22 ' A' ' 145' ' ' ILE . 5.6 mp -124.28 134.96 53.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.493 -0.755 . . . . 0.0 109.87 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.93 118.41 53.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER -76.06 157.83 32.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.87 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.4 -74.04 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 0.0 110.999 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 38' ' ' THR . 2.8 mtt180 -105.19 132.54 20.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.038 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 49.9 Cg_endo -78.04 148.01 24.33 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.02 1.537 . . . . 0.0 110.246 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -85.26 115.9 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -110.54 142.37 42.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.346 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.582 ' OG ' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -136.74 167.92 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 110.233 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.252 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.218 0.532 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 2.5 m -128.3 157.16 41.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -175.33 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 2.0 t -110.05 88.44 2.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.208 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER -105.5 159.79 15.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.776 HG12 ' O ' ' B' ' 162' ' ' VAL . 41.1 t 56.65 67.68 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.394 -0.816 . . . . 0.0 110.319 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 5.2 mt-10 -88.48 154.45 20.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.024 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.57 ' CD2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.723 ' C ' HD22 ' A' ' 64' ' ' LEU . 6.9 t -144.54 -96.02 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.904 HG21 ' OG ' ' A' ' 77' ' ' SER . 2.2 t -178.32 147.41 0.42 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.219 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.98 HG23 ' CD1' ' A' ' 64' ' ' LEU . 5.0 t -86.03 145.38 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.153 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 137' ' ' TYR . 7.7 p -54.5 162.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -101.64 -148.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.327 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.476 ' N ' ' CG ' ' B' ' 169' ' ' HIS . 30.0 m -124.46 -68.43 0.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 0.0 110.195 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.723 ' HA ' HD12 ' A' ' 4' ' ' LEU . 5.1 mt-10 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.237 0.542 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.577 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 t80 -66.8 -51.51 54.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.219 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -67.3 -40.8 86.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.899 HD23 ' HA ' ' A' ' 90' ' ' CYS . 3.0 mt -56.99 -45.89 82.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.158 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.887 HG21 ' HA ' ' A' ' 50' ' ' PHE . 17.0 t -71.97 -47.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 2' ' ' TYR . 81.0 t -58.75 -32.77 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.358 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -70.88 -38.68 73.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' HB2' HG12 ' A' ' 91' ' ' VAL . . . -76.14 -44.61 37.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.485 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.696 HG12 ' HE2' ' A' ' 18' ' ' TYR . 24.5 m -57.62 -39.81 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.323 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 mmt180 -55.75 -44.44 77.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 0.0 109.82 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.09 -41.32 35.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.921 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.88 -41.93 95.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 18' ' ' TYR . 19.6 mt-30 -67.75 -35.27 78.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -69.7 -49.57 52.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -58.53 -28.75 65.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.23 15.84 29.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . 4.0 m-85 -101.85 -0.94 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.144 . . . . 0.0 110.13 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.696 ' HE2' HG12 ' A' ' 9' ' ' VAL . 4.3 t80 -90.77 136.05 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.639 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.861 ' HE1' HD13 ' A' ' 153' ' ' LEU . 45.9 m95 -117.35 148.07 42.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 109.651 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -150.66 108.18 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 110.444 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.737 ' HB3' ' NH2' ' A' ' 42' ' ' ARG . . . 176.16 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -119.42 -158.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 110.421 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -85.61 176.14 8.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.338 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.7 -69.38 1.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.638 ' HA3' HG21 ' B' ' 162' ' ' VAL . . . -77.64 -36.04 34.52 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 3.1 tt0 -59.66 -24.57 64.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 0.0 109.603 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.002 ' HB1' ' HD3' ' A' ' 42' ' ' ARG . . . -74.35 -46.47 40.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.474 -0.766 . . . . 0.0 110.364 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.904 ' HA ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -67.96 -36.68 80.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.845 HD13 HD21 ' A' ' 28' ' ' ASN . 0.4 OUTLIER -57.71 -32.31 67.27 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.004 -1.06 . . . . 0.0 110.282 -178.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 pp -56.39 -23.88 40.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 108.765 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.965 HD11 ' CB ' ' A' ' 56' ' ' LYS . 1.7 pp -68.06 -33.67 75.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.553 ' CB ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 m -69.56 -33.03 72.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.758 . . . . 0.0 109.777 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 -21.01 41.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 109.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.788 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 45.1 mm-40 -125.93 -86.87 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.788 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.4 Cg_endo -74.46 68.57 5.25 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 122.831 0.911 . . . . 0.0 110.267 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 141.47 48.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 0.0 110.64 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 82.27 18.65 66.34 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.866 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -131.28 148.21 52.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.482 -1.01 . . . . 0.0 110.103 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.758 ' CZ ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -121.72 138.74 54.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 110.068 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.13 161.09 28.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.45 -0.781 . . . . 0.0 110.286 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -113.12 128.69 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 110.108 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 1.002 ' HD3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -129.14 136.51 50.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.831 . . . . 0.0 109.655 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 2.3 t0 -73.77 127.57 33.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 45' ' ' SER . 85.8 p -117.05 -177.85 3.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.299 -0.876 . . . . 0.0 110.184 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 4.2 t 42.51 65.23 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER 66.44 135.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.891 . . . . 0.0 110.07 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ARG . 7.4 pt20 -66.29 -7.88 21.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -42.37 -47.81 4.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.246 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 49' ' ' HIS . 0.3 OUTLIER 177.74 -160.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.248 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.887 ' HA ' HG21 ' A' ' 5' ' ' VAL . 18.4 t80 55.04 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.878 ' HD2' HG13 ' A' ' 5' ' ' VAL . 7.3 p90 -126.24 148.79 49.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.034 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.3 m -126.42 155.03 42.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -126.93 136.52 52.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.004 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.71 154.29 45.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 0.0 109.55 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 149' ' ' LEU . 6.6 m -118.02 174.36 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.563 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.965 ' CB ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -103.91 138.98 39.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.39 -0.819 . . . . 0.0 110.28 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.724 HG23 HD11 ' A' ' 147' ' ' LEU . 21.1 m -127.32 158.14 38.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 57' ' ' THR . 43.9 mt-30 -38.92 -28.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.0 t -173.55 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.2 62.4 0.46 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.765 ' HB ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -78.95 108.94 12.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -1.194 . . . . 0.0 109.514 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -137.46 178.0 7.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.011 -1.056 . . . . 0.0 110.67 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.56 ' CA ' ' HB3' ' A' ' 54' ' ' SER . 32.5 p-10 -137.56 156.17 48.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.869 . . . . 0.0 110.491 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 52' ' ' THR . 34.5 mt -131.04 152.19 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.11 156.79 18.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 110.178 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.83 HD13 ' HB2' ' A' ' 94' ' ' LEU . 3.5 tp -76.76 134.75 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.96 151.04 20.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.8 t -116.72 116.92 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.6 mm-40 -107.41 102.79 12.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.009 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.38 -79.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . -143.7 45.67 0.87 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.477 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 1.2 t -142.92 163.03 33.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -1.155 . . . . 0.0 110.393 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CD2' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -133.14 126.8 32.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 109.823 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.787 ' N ' HD11 ' A' ' 66' ' ' ILE . 4.1 p -155.24 146.03 22.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.018 . . . . 0.0 110.435 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.863 HD12 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -82.9 -9.84 59.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.001 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -141.91 -135.13 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.469 ' N ' ' CG ' ' A' ' 76' ' ' GLN . 88.9 p -151.17 64.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 32.8 p-10 -119.61 115.0 34.04 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.124 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.13 52.54 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.008 1.531 . . . . 0.0 110.705 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' SER . 22.4 mmm180 -90.11 20.13 4.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -52.1 -172.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.823 ' O ' ' CB ' ' A' ' 83' ' ' GLN . 0.2 OUTLIER -112.11 18.28 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.302 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.823 ' CB ' ' O ' ' A' ' 82' ' ' THR . 9.8 tt0 113.54 -28.8 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 122.132 -0.355 . . . . 0.0 111.635 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.739 ' HD2' ' N ' ' A' ' 83' ' ' GLN . 45.5 Cg_endo -73.41 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.047 1.025 . . . . 0.0 110.61 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.919 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -92.82 168.49 12.28 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 0.0 109.616 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.919 ' HD2' HG22 ' A' ' 85' ' ' VAL . 42.9 Cg_endo -70.06 132.56 23.1 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.912 1.48 . . . . 0.0 109.874 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.585 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 8.2 mtt-85 60.8 -75.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.846 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 163.83 121.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.322 -0.862 . . . . 0.0 109.631 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.658 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 11.3 t70 -84.72 109.26 17.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 110.052 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.899 ' HA ' HD23 ' A' ' 4' ' ' LEU . 0.8 OUTLIER 151.75 134.5 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.037 0.446 . . . . 0.0 109.9 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.853 HG23 ' CD2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -49.71 -25.4 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 109.348 179.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.965 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -56.47 -35.37 67.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.485 -0.759 . . . . 0.0 110.154 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.501 ' HG3' ' HB2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -58.25 -38.57 77.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.266 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.959 HD21 ' CD2' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -68.16 -35.14 77.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.418 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.809 ' N ' HD23 ' A' ' 94' ' ' LEU . 93.4 t -55.37 -37.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.749 . . . . 0.0 110.404 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.09 -45.51 68.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 109.58 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.419 ' CD2' ' HD1' ' A' ' 136' ' ' TYR . 1.5 t60 -78.12 -36.74 47.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.84 . . . . 0.0 109.533 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.959 ' CD2' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -69.32 -12.15 61.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 12.5 ttt -177.77 79.12 0.24 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.27 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.45 166.86 28.76 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.004 1.529 . . . . 0.0 110.322 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HG2' ' HG2' ' A' ' 132' ' ' PRO . 45.6 Cg_endo -72.61 116.82 4.86 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.039 1.547 . . . . 0.0 110.424 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.84 -174.99 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.925 1.487 . . . . 0.0 110.369 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.95 60.77 0.39 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.545 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.63 -58.33 7.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.247 -1.149 . . . . 0.0 110.168 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 46.3 Cg_endo -73.25 165.92 31.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.99 1.521 . . . . 0.0 110.459 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.507 ' C ' ' CG ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -66.87 -159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.196 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.507 ' CG ' ' C ' ' A' ' 106' ' ' SER . 39.3 m-85 -150.49 174.29 13.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.453 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -136.94 52.09 1.95 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.149 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 108' ' ' SER . 3.8 mp -125.22 170.43 9.25 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.195 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.03 155.25 52.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.981 1.516 . . . . 0.0 110.438 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 112' ' ' THR . 46.1 Cg_endo -73.01 156.96 51.75 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.438 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 111' ' ' PRO . 7.6 p 43.26 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.21 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -107.06 137.07 19.43 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.243 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.9 -159.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.0 1.526 . . . . 0.0 110.471 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 116' ' ' SER . 11.1 m -152.3 109.55 3.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -42.98 133.13 3.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.893 . . . . 0.0 110.221 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.896 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.6 mm-40 -163.2 -36.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 117' ' ' GLU . 2.5 t -165.91 -61.45 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.841 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 118' ' ' VAL . 45.5 Cg_endo -71.49 -2.8 11.86 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.719 1.378 . . . . 0.0 110.465 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' CG ' ' A' ' 121' ' ' GLN . 4.3 mt-10 -123.15 -167.76 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.897 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.536 ' CB ' ' CD ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 176.18 -58.14 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.332 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 121' ' ' GLN . 45.9 Cg_endo -73.07 136.38 24.62 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 47.8 Cg_endo -73.6 -49.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.979 1.515 . . . . 0.0 110.464 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 123' ' ' PRO . . . 175.63 -29.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 13.3 mt-30 59.07 -147.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.297 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 125' ' ' GLN . . . -42.54 -83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 128' ' ' PRO . 1.7 tt -61.48 132.46 92.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' HD23 ' A' ' 127' ' ' LEU . 45.9 Cg_endo -73.4 161.5 42.41 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.059 1.557 . . . . 0.0 110.396 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -96.95 -31.12 7.12 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 0.8 OUTLIER -74.0 133.61 42.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -1.148 . . . . 0.0 110.223 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 131' ' ' THR . 72.9 p -42.73 102.32 0.27 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.248 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.485 ' HG2' ' HG2' ' A' ' 101' ' ' PRO . 46.4 Cg_endo -73.02 107.29 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.026 1.54 . . . . 0.0 110.418 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.04 81.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mmt-85 -76.69 -146.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.908 . . . . 0.0 110.213 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' HG21 ' B' ' 168' ' ' VAL . . . -160.89 132.85 5.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' B' ' 167' ' ' VAL . 1.5 t80 -119.42 123.53 44.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.838 ' H ' HG22 ' B' ' 167' ' ' VAL . 3.8 p90 -155.23 166.74 32.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.857 -1.152 . . . . 0.0 111.285 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.663 ' H ' HD23 ' A' ' 147' ' ' LEU . 3.0 mt -102.44 149.11 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.388 -0.82 . . . . 0.0 111.207 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.711 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 14.8 m-85 -98.72 133.19 43.39 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.692 0.758 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.72 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -94.88 -162.07 0.91 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.68 . . . . 0.0 110.134 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.37 60.7 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' SER . . . 101.6 2.46 53.12 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -119.97 121.92 40.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.644 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -80.74 105.33 11.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.919 . . . . 0.0 110.485 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.996 HG22 HD21 ' A' ' 147' ' ' LEU . 1.5 mp -82.77 109.13 14.82 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 50.1 Cg_endo -74.93 129.42 12.38 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.193 1.628 . . . . 0.0 112.811 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.996 HD21 HG22 ' A' ' 145' ' ' ILE . 1.8 mm? -125.25 135.86 52.96 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 148' ' ' VAL . 13.0 p -97.43 117.15 41.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.265 -1.522 . . . . 0.0 110.428 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 98' ' ' TYR . 9.5 tp -91.88 114.8 27.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 t -161.77 10.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.892 -1.13 . . . . 0.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 2.9 mtt85 -108.93 123.93 35.62 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.679 -1.263 . . . . 0.0 109.991 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 50.1 Cg_endo -78.65 148.35 22.84 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.98 1.516 . . . . 0.0 111.039 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.861 HD13 ' HE1' ' A' ' 19' ' ' TRP . 4.4 pp -83.73 135.63 34.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.914 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.531 ' HB3' HD12 ' A' ' 153' ' ' LEU . 12.7 t 41.64 -89.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 110.36 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 153' ' ' LEU . 23.0 t -59.24 156.17 12.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 110.169 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.466 ' OXT' ' ND2' ' A' ' 156' ' ' ASN . 9.9 p-10 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.223 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . 0.502 ' O ' ' N ' ' B' ' 159' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.303 0.573 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' B' ' 157' ' ' SER . 43.8 m 55.98 -85.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 157' ' ' SER . . . -165.32 -161.12 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' B' ' 159' ' ' ALA . 16.2 t -177.06 -31.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 160' ' ' SER . 4.7 t -42.04 155.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.638 HG21 ' HA3' ' A' ' 25' ' ' GLY . 17.4 m -78.97 150.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.468 ' C ' ' CD2' ' B' ' 164' ' ' PTR . 0.6 OUTLIER -75.97 177.46 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.532 ' N ' ' CD2' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.77 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -169.54 102.35 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.73 159.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 110.221 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 137' ' ' TYR . 1.0 OUTLIER -113.47 170.61 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 135' ' ' ALA . 46.8 t -6.28 115.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.195 0.521 . . . . 0.0 111.314 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.46 179.6 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 11.6 m -153.57 122.63 6.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.153 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.595 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.779 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.3 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 6' ' ' VAL . 55.1 p90 -57.55 -36.04 71.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 20.9 tt0 -55.03 -37.98 67.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 1' ' ' GLU . 1.5 mt -58.87 -45.8 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.995 HG22 ' CE2' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -71.16 -37.34 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.189 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 2' ' ' TYR . 94.9 t -58.02 -39.43 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.923 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -70.69 -34.67 72.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.582 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.797 ' HB2' HD11 ' A' ' 92' ' ' LEU . . . -76.27 -44.17 38.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.785 . . . . 0.0 110.119 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.794 HG12 HE21 ' A' ' 13' ' ' GLN . 47.3 t -57.4 -39.85 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.47 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.8 ttm180 -55.91 -45.46 78.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.947 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -38.61 43.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.862 . . . . 0.0 109.992 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 41' ' ' ILE . 18.0 tp -71.0 -40.7 71.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 110.013 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.794 HE21 HG12 ' A' ' 9' ' ' VAL . 4.6 pt20 -68.12 -34.94 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.303 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -57.95 -27.92 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.54 -27.27 69.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.865 . . . . 0.0 110.168 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.3 25.11 24.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -130.11 7.83 5.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.041 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.558 ' HD2' HD23 ' A' ' 12' ' ' LEU . 4.3 t80 -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 110.293 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.813 ' CG ' HD11 ' A' ' 40' ' ' LEU . 17.2 m95 -121.1 148.56 44.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.416 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -151.41 24.83 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.02 8.97 20.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.661 -0.649 . . . . 0.0 110.924 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.785 HG11 HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -116.35 -160.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.049 . . . . 0.0 109.925 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.54 ' CB ' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -97.31 176.16 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.319 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -49.58 -85.1 0.02 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.622 ' N ' HG11 ' B' ' 162' ' ' VAL . . . -70.74 -31.63 67.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -59.09 -39.17 81.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.129 -1.218 . . . . 0.0 109.958 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.003 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -64.44 -47.03 80.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.627 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.713 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 m-80 -68.91 -43.66 74.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -0.94 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.468 ' O ' ' OG ' ' A' ' 32' ' ' SER . 1.6 mp -70.53 -32.29 69.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 112.072 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 27' ' ' ALA . 1.8 pp -55.17 -24.42 26.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.709 -1.244 . . . . 0.0 111.032 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.016 HD13 ' O ' ' A' ' 38' ' ' THR . 4.4 pp -77.56 -37.86 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 0.0 109.584 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.884 ' N ' HD12 ' A' ' 31' ' ' LEU . 21.8 p -69.74 -32.57 71.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.382 -0.824 . . . . 0.0 110.28 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.65 43.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.615 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.731 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 5.3 mm-40 -115.76 -76.41 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.92 -1.112 . . . . 0.0 110.489 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.731 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 49.2 Cg_endo -72.69 70.37 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.286 1.151 . . . . 0.0 110.509 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 141.23 13.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 151' ' ' ARG . . . 73.46 20.77 79.92 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 1.016 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.3 m -129.59 147.7 51.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -1.074 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.782 ' CD1' HG12 ' A' ' 55' ' ' VAL . 9.7 m-85 -122.9 158.46 30.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.382 -0.824 . . . . 0.0 109.454 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.006 ' HB2' HD13 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -152.38 160.57 43.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.008 -1.058 . . . . 0.0 111.195 -178.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.704 HG21 ' CD2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -113.89 129.18 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.541 -0.724 . . . . 0.0 109.906 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -117.36 161.12 20.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.282 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.486 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 7.5 t70 -100.05 138.06 37.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 109.991 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' ASP . 53.1 p -44.97 170.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 t -89.01 -25.05 22.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.59 -166.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -65.07 -26.26 68.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 50' ' ' PHE . 1.9 mtm-85 -176.8 -65.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 m80 51.75 -89.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 110.248 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.939 ' CA ' HG21 ' A' ' 5' ' ' VAL . 12.2 p90 -163.8 -165.01 0.96 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 1.107 ' CE1' HG22 ' A' ' 91' ' ' VAL . 13.0 p90 -134.33 139.6 45.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.121 -0.987 . . . . 0.0 110.628 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.59 ' CG2' ' HA ' ' A' ' 65' ' ' ARG . 2.2 p -126.31 155.29 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.474 -0.767 . . . . 0.0 109.909 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.18 HD12 ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -134.37 142.58 47.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.064 -1.023 . . . . 0.0 110.688 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.18 ' N ' HD12 ' A' ' 53' ' ' LEU . 1.3 p -124.5 154.17 40.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.097 HG11 HD22 ' A' ' 149' ' ' LEU . 21.2 m -117.63 174.01 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.114 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 32' ' ' SER . 0.3 OUTLIER -103.99 130.79 51.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.29 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.465 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 80.5 p -141.11 156.6 45.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.76 82.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.223 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.2 t -63.0 -10.86 15.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.198 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 57' ' ' THR . . . 124.07 153.64 8.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -78.91 140.47 38.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -1.146 . . . . 0.0 110.179 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' SER . 69.6 mmtt -139.16 133.18 31.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.585 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 1.5 p-10 -111.91 128.85 56.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 HG23 ' B' ' 167' ' ' VAL . 2.9 mp -102.43 118.14 36.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.972 . . . . 0.0 110.252 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 0.1 OUTLIER -84.52 152.26 24.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.02 HD11 ' HB2' ' A' ' 90' ' ' CYS . 4.5 tp -84.93 149.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' SER . 1.6 tt0 -114.58 115.65 27.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.331 -0.855 . . . . 0.0 110.504 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 27.5 p -92.04 123.15 35.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 14.9 tt0 -133.19 103.5 6.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 110.489 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.5 32.93 85.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.81 -11.67 69.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 82.9 p -94.74 143.1 26.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.989 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.667 ' HE2' HG23 ' A' ' 5' ' ' VAL . 3.4 m-30 -110.82 157.36 19.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.243 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -155.56 138.65 15.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.153 -0.967 . . . . 0.0 110.486 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.06 ' CD2' HD21 ' A' ' 94' ' ' LEU . 1.2 tp -112.41 -22.74 10.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.681 HE21 HD23 ' A' ' 75' ' ' LEU . 3.1 mt-30 -113.48 94.28 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 t 44.75 -146.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 110.373 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -103.5 120.47 51.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.551 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 46.8 Cg_endo -73.36 59.86 3.95 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.015 1.534 . . . . 0.0 110.452 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 1.1 ttm-85 -70.32 -4.0 20.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.42 -64.66 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 83' ' ' GLN . 14.9 t -131.49 27.6 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.24 -0.913 . . . . 0.0 110.321 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 43.06 89.62 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.155 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.619 ' O ' ' C ' ' A' ' 85' ' ' VAL . 47.8 Cg_endo -74.06 1.41 7.21 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.037 1.546 . . . . 0.0 110.678 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.619 ' C ' ' O ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -22.61 -59.6 0.1 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.611 ' CD ' HG23 ' A' ' 85' ' ' VAL . 44.3 Cg_endo -71.54 132.95 21.4 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.859 1.452 . . . . 0.0 109.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.621 ' O ' ' C ' ' A' ' 88' ' ' PHE . 5.6 mtp85 49.15 26.79 1.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.079 -1.013 . . . . 0.0 109.518 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.621 ' C ' ' O ' ' A' ' 87' ' ' ARG . 11.9 p90 -17.09 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.476 0.655 . . . . 0.0 111.585 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -96.87 110.81 23.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.009 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 1.02 ' HB2' HD11 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -171.28 -88.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.974 . . . . 0.0 110.454 -178.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.107 HG22 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -59.71 -51.19 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.051 -1.03 . . . . 0.0 109.469 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 8' ' ' ALA . 4.9 mp -66.36 -46.2 77.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 108.841 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.482 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 32.4 ttpt -65.79 -29.22 69.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.784 0.802 . . . . 0.0 108.869 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.145 HD22 ' CZ ' ' A' ' 98' ' ' TYR . 5.0 mt -57.48 -34.23 68.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 0.0 110.096 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.4 m -54.27 -38.66 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.879 -1.138 . . . . 0.0 108.686 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.478 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 7.7 m170 -68.64 -51.89 37.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 108.862 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -63.81 -36.95 85.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.358 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 3.7 m-30 -73.38 -9.16 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.642 -0.661 . . . . 0.0 110.013 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 171.28 160.33 0.23 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.398 -0.814 . . . . 0.0 110.2 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.94 160.83 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.009 1.531 . . . . 0.0 110.452 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.06 154.7 52.62 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.058 1.557 . . . . 0.0 110.422 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.9 136.42 25.09 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.02 1.537 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.05 -150.52 12.42 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 8.8 t -140.86 48.54 1.34 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.195 -1.179 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 104' ' ' THR . 46.7 Cg_endo -72.94 111.51 3.29 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.369 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 69.25 -57.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.204 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.5 OUTLIER 68.91 -65.88 0.27 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 107' ' ' PHE . 26.4 t 179.04 34.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.515 HD13 ' C ' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -94.26 114.05 62.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.472 ' N ' HD13 ' A' ' 109' ' ' LEU . 45.5 Cg_endo -72.92 111.35 3.25 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.048 1.552 . . . . 0.0 110.407 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 109' ' ' LEU . 46.0 Cg_endo -72.63 55.99 2.75 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.03 1.542 . . . . 0.0 110.435 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 16.9 m -82.37 -49.82 9.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 4.6 mt-10 -164.31 52.63 0.31 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.271 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 113' ' ' GLU . 46.6 Cg_endo -72.96 157.69 50.89 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.042 1.549 . . . . 0.0 110.452 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 116' ' ' SER . 53.5 p -86.17 -21.62 27.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.227 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 117' ' ' GLU . 37.6 t -177.58 -138.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 116' ' ' SER . 2.0 tt0 67.8 -138.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 118' ' ' VAL . 16.0 m -41.89 146.42 0.62 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.276 -0.89 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.89 156.83 52.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.89 1.468 . . . . 0.0 110.419 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 121' ' ' GLN . 66.6 tt0 -92.65 29.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.952 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' GLU . 34.9 tt0 57.96 122.6 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.35 -0.844 . . . . 0.0 110.313 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.81 128.65 13.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.89 1.468 . . . . 0.0 110.424 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.08 140.63 31.5 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.001 1.527 . . . . 0.0 110.418 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' GLN . . . -167.13 69.92 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 11.6 mm100 58.93 174.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.18 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.1 60.96 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.214 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 127' ' ' LEU . 0.5 OUTLIER -175.68 71.54 0.27 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.148 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.69 -17.66 25.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.012 1.533 . . . . 0.0 110.505 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' SER . . . -148.5 -79.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER 61.69 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.206 -1.173 . . . . 0.0 110.161 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 131' ' ' THR . 54.4 m 47.64 47.76 5.0 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 131' ' ' THR . 47.2 Cg_endo -73.06 170.8 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.989 1.521 . . . . 0.0 110.495 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -71.41 -24.32 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 ptm180 -109.44 120.9 43.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.137 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.942 ' O ' HG11 ' B' ' 168' ' ' VAL . . . 172.23 130.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.023 ' CD2' HG11 ' B' ' 167' ' ' VAL . 1.2 t80 -116.55 122.54 44.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.984 -1.072 . . . . 0.0 109.306 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.042 ' CD2' HG12 ' B' ' 168' ' ' VAL . 5.4 p90 -156.32 166.95 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.952 -1.092 . . . . 0.0 110.66 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.33 149.17 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.003 -1.061 . . . . 0.0 111.356 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.71 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 1.7 m-30 -86.44 107.88 18.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.591 -0.693 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.947 ' HB2' HD13 ' A' ' 145' ' ' ILE . 23.0 t -55.78 84.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.018 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 139' ' ' TYR . . . 66.9 -64.79 0.19 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' SER . . . -144.7 13.08 1.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 145' ' ' ILE . 2.8 tt0 -120.45 123.43 42.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.093 . . . . 0.0 109.797 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -75.5 105.57 6.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.145 -0.972 . . . . 0.0 110.713 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 140' ' ' SER . 0.9 OUTLIER -103.38 112.86 65.94 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.8 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 45.8 Cg_endo -72.79 127.47 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.76 1.4 . . . . 0.0 111.791 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.66 ' O ' ' O ' ' A' ' 136' ' ' TYR . 1.1 mp -126.42 135.24 51.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.689 ' O ' HG23 ' A' ' 148' ' ' VAL . 15.0 m -97.88 116.58 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 120.187 -1.571 . . . . 0.0 109.945 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.097 HD22 HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -109.5 123.34 49.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.265 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.7 m -158.61 61.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -134.37 124.92 17.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.0 110.063 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HB2' ' HB2' ' A' ' 156' ' ' ASN . 46.4 Cg_endo -73.7 144.17 34.92 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.922 1.485 . . . . 0.0 110.472 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 1.006 HD13 ' HB2' ' A' ' 40' ' ' LEU . 1.3 tt -92.03 153.74 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.885 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 155' ' ' SER . 1.8 t 44.81 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.937 . . . . 0.0 110.26 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.4 OUTLIER -107.84 173.25 6.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 152' ' ' PRO . 3.3 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.22 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.29 0.567 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 53.1 p -61.07 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.02 77.85 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.28 -62.69 1.4 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.112 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.469 ' O ' ' C ' ' B' ' 162' ' ' VAL . 0.2 OUTLIER -131.71 164.89 24.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 110.163 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.622 HG11 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -38.89 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.474 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' B' ' 164' ' ' PTR . 81.2 mt-10 -79.07 173.57 12.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 109.915 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.561 ' CG ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 64' ' ' LEU . 50.9 m -130.85 172.98 11.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.407 -0.808 . . . . 0.0 110.074 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.742 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -89.61 139.55 30.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.023 HG11 ' CD2' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -91.77 106.92 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.067 -1.021 . . . . 0.0 109.829 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.042 HG12 ' CD2' ' A' ' 137' ' ' TYR . 1.3 m 50.03 -171.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.771 ' N ' HG23 ' B' ' 168' ' ' VAL . 0.3 OUTLIER 66.37 121.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' B' ' 169' ' ' HIS . 2.6 m 63.61 86.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.576 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.791 ' O ' HG12 ' A' ' 5' ' ' VAL . 13.2 pt-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.224 0.535 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.0 p90 -60.49 -37.17 80.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.18 -41.46 77.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.341 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' SG ' ' A' ' 68' ' ' CYS . 1.1 mt -67.44 -47.21 70.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.123 HG23 ' CE2' ' A' ' 51' ' ' PHE . 3.5 p -64.95 -48.36 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.757 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 2' ' ' TYR . 12.4 p -58.7 -43.99 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 109.984 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.598 ' N ' HG13 ' A' ' 6' ' ' VAL . 1.9 m120 -59.06 -42.16 89.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.0 109.618 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.859 ' HB1' HG11 ' A' ' 91' ' ' VAL . . . -68.34 -44.17 75.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.806 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.455 HG12 HE21 ' A' ' 13' ' ' GLN . 49.1 t -57.53 -39.8 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.387 -0.821 . . . . 0.0 109.25 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 3.6 tpt180 -55.66 -49.0 74.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.497 -0.752 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -34.26 49.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.806 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.752 HD11 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 tp -72.16 -44.15 63.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 110.097 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 4.9 pt20 -60.82 -33.91 73.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 25.7 tt0 -57.82 -18.98 25.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.426 ' CB ' ' CE2' ' A' ' 17' ' ' PHE . 59.1 m -55.99 -43.01 77.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.044 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.2 34.37 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.752 ' CZ ' HD11 ' A' ' 12' ' ' LEU . 15.5 p90 -153.0 18.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.253 . . . . 0.0 110.56 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 43' ' ' ASP . 3.0 t80 -90.84 119.86 31.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.756 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 1.044 ' CG ' HD12 ' A' ' 40' ' ' LEU . 31.6 m95 -72.69 148.12 45.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.631 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.804 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -62.15 -12.67 21.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.901 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 20' ' ' SER . . . 74.1 75.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 110.915 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -46.42 -92.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 0.0 109.091 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.595 ' H ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -106.63 165.81 11.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 178.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.526 ' HA2' ' NH1' ' A' ' 42' ' ' ARG . . . -43.51 -81.16 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.624 ' HA3' HG11 ' B' ' 162' ' ' VAL . . . -79.26 -30.15 47.1 Favored Glycine 0 N--CA 1.491 2.349 0 O-C-N 121.41 -1.053 . . . . 0.0 110.705 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.592 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -58.22 -24.46 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.378 . . . . 0.0 110.955 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 42' ' ' ARG . . . -77.63 -46.61 21.55 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 110.146 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.758 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -70.42 -46.85 63.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 111.2 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.758 HD13 ' OD1' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -70.61 -29.98 66.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 112.069 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.952 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -52.96 -23.25 6.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.64 -1.288 . . . . 0.0 109.8 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 40' ' ' LEU . 45.0 mt -64.05 -41.33 97.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.992 -1.068 . . . . 0.0 109.219 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 55.9 p -69.1 -31.6 70.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.64 -20.13 47.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.787 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.749 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 17.8 mm-40 -126.15 -81.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.901 -1.124 . . . . 0.0 110.607 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.749 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 55.4 Cg_endo -77.71 68.43 7.66 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 122.902 0.949 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.39 135.5 33.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.625 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 87.04 7.9 76.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.587 HG21 ' HB2' ' A' ' 35' ' ' PRO . 27.4 p -116.11 147.71 41.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -1.136 . . . . 0.0 110.608 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.957 ' CD1' HD11 ' A' ' 53' ' ' LEU . 7.2 p90 -122.3 147.3 46.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.859 . . . . 0.0 110.374 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.044 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -147.21 160.24 42.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.481 -0.762 . . . . 0.0 109.548 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 1.4 tt -113.56 128.47 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 110.001 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.564 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 5.7 ppt_? -112.77 122.11 46.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 110.31 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.773 ' N ' ' HB2' ' A' ' 21' ' ' ALA . 4.9 t70 -73.82 114.97 12.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -44.77 146.81 0.71 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.239 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -73.65 -52.9 11.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.54 135.89 8.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -67.24 -18.18 65.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -97.35 50.18 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.237 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.551 ' HB3' ' CB ' ' A' ' 44' ' ' SER . 7.6 m-70 -147.7 -160.86 1.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.755 ' CB ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -143.6 -150.82 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.162 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 1.123 ' CE2' HG23 ' A' ' 5' ' ' VAL . 25.6 p90 -115.56 142.79 46.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 110.104 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.638 HG22 ' CG ' ' A' ' 63' ' ' ASN . 2.4 m -126.28 143.5 51.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.089 HD22 ' CD1' ' A' ' 98' ' ' TYR . 7.2 tt -124.21 135.1 53.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.655 ' CB ' ' OD1' ' A' ' 28' ' ' ASN . 23.1 p -139.26 155.42 47.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 61' ' ' THR . 10.3 p -140.94 158.9 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 110.481 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -103.76 137.48 41.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 147' ' ' LEU . 25.8 p -137.73 -74.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 59' ' ' SER . 2.3 mt-30 -147.43 -78.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 58' ' ' GLN . 9.8 t -42.69 -53.17 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.32 47.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 55' ' ' VAL . 5.5 m -99.56 141.02 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -1.122 . . . . 0.0 110.17 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.9 145.86 51.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 0.0 110.25 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.638 ' CG ' HG22 ' A' ' 52' ' ' THR . 13.6 t-20 -111.13 132.34 54.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.92 ' CD1' HG23 ' B' ' 167' ' ' VAL . 0.4 OUTLIER -110.97 152.13 27.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.621 -179.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -140.91 148.05 39.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.258 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.727 HD11 ' CB ' ' A' ' 90' ' ' CYS . 10.0 tp -76.83 128.29 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.98 . . . . 0.0 110.348 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 74' ' ' SER . 2.7 tp-100 -96.54 151.1 19.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.348 -0.845 . . . . 0.0 110.216 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.708 ' SG ' HD13 ' A' ' 4' ' ' LEU . 36.5 t -93.01 139.12 30.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -130.08 102.94 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 69' ' ' GLU . . . 44.82 -111.19 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.73 28.11 15.31 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.552 ' OG ' ' CB ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -136.72 163.18 31.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 110.145 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.759 ' O ' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -124.54 144.96 49.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.505 ' OG ' HG11 ' A' ' 85' ' ' VAL . 47.4 t -155.54 167.12 31.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.571 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 ' CD1' ' A' ' 94' ' ' LEU . 6.1 tp -107.42 -45.04 4.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -0.882 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.769 ' HG3' HG22 ' B' ' 166' ' ' THR . 0.2 OUTLIER -110.63 80.0 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.89 155.57 30.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.283 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -115.34 132.81 22.9 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.08 -3.07 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.935 1.492 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -56.43 -40.51 74.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 110.206 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.436 ' OG ' ' HG3' ' A' ' 83' ' ' GLN . 79.0 p -162.96 -160.4 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 110.279 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.03 27.95 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.436 ' HG3' ' OG ' ' A' ' 81' ' ' SER . 3.7 mt-30 -82.57 126.71 72.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.182 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.552 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 47.0 Cg_endo -73.35 -158.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.955 1.503 . . . . 0.0 110.398 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.759 HG21 ' O ' ' A' ' 73' ' ' PHE . 31.3 m -109.52 148.81 38.85 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.202 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 45.7 Cg_endo -73.08 133.48 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.965 1.508 . . . . 0.0 110.493 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER 66.54 41.36 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.807 . . . . 0.0 110.633 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 23.4 p90 34.54 50.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 0.0 110.835 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' SER . 91.5 m-20 -71.87 110.01 6.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.986 -1.071 . . . . 0.0 109.195 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.727 ' CB ' HD11 ' A' ' 66' ' ' ILE . 7.1 p -148.31 -117.53 0.06 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.533 -0.729 . . . . 0.0 110.477 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG11 ' HB1' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -49.91 -45.56 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.168 -0.958 . . . . 0.0 110.046 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.618 HD12 ' CG1' ' A' ' 91' ' ' VAL . 7.4 mp -59.52 -47.1 86.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.045 . . . . 0.0 108.974 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -31.86 72.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -59.73 -35.03 73.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.697 -0.627 . . . . 0.0 110.261 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 91' ' ' VAL . 62.9 t -54.5 -38.01 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 109.574 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.284 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.649 ' NE2' HG23 ' B' ' 168' ' ' VAL . 0.4 OUTLIER -78.15 -50.51 11.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.932 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.089 ' CD1' HD22 ' A' ' 53' ' ' LEU . 10.0 m-85 -63.79 -11.73 29.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 4.4 tpt 71.21 103.69 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.138 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 95' ' ' VAL . 46.4 Cg_endo -74.04 159.39 44.58 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.043 1.549 . . . . 0.0 110.374 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HB3' ' CB ' ' A' ' 152' ' ' PRO . 46.7 Cg_endo -73.16 151.38 49.26 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.16 1.61 . . . . 0.0 110.423 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.62 91.96 0.78 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.073 1.565 . . . . 0.0 110.472 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.42 -115.82 0.57 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -112.7 100.32 50.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.253 -1.145 . . . . 0.0 110.263 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 106' ' ' SER . 47.2 Cg_endo -73.0 -40.1 1.93 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.489 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 62.28 51.37 3.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -146.98 -52.07 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.921 . . . . 0.0 110.174 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 0.2 OUTLIER 174.56 -44.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 110.11 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -43.09 102.58 0.28 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 108' ' ' SER . 46.7 Cg_endo -73.54 114.87 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.962 1.506 . . . . 0.0 110.353 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 112' ' ' THR . 47.2 Cg_endo -72.64 -92.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 0.0 110.435 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 111' ' ' PRO . 73.2 p 40.79 -139.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.08 161.19 53.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.141 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 115' ' ' SER . 45.2 Cg_endo -72.82 173.81 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.977 1.514 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' PRO . 12.8 p -42.98 135.14 3.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.222 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.43 149.61 46.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 2.9 mt-10 -67.32 -140.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 110.191 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 61.64 117.19 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 44.3 Cg_endo -73.04 -88.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.946 1.498 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 3.3 tt0 69.15 -67.96 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' PRO . 0.6 OUTLIER -167.62 124.52 0.91 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.206 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.07 119.26 5.94 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.894 1.47 . . . . 0.0 110.474 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 46.5 Cg_endo -72.94 126.36 11.21 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.022 1.538 . . . . 0.0 110.473 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 59.72 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.257 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -106.33 95.75 5.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.203 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 125' ' ' GLN . . . 56.52 23.2 7.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 110.225 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.541 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 1.5 mt -132.24 50.03 5.28 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 127' ' ' LEU . 46.6 Cg_endo -73.0 55.98 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.06 1.558 . . . . 0.0 110.413 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.91 -174.82 45.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.3 162.95 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.262 -1.14 . . . . 0.0 110.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -43.71 110.4 0.95 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.31 53.71 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.012 1.532 . . . . 0.0 110.431 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.85 47.17 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -48.83 171.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.851 ' O ' HG21 ' B' ' 168' ' ' VAL . . . -171.83 143.98 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.208 ' CZ ' HG21 ' B' ' 167' ' ' VAL . 1.8 t80 -138.21 121.65 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.579 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.121 ' CD2' HG12 ' B' ' 168' ' ' VAL . 6.7 p90 -156.11 166.72 32.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.737 -1.227 . . . . 0.0 110.843 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.721 ' H ' HD23 ' A' ' 147' ' ' LEU . 2.5 mt -102.14 149.61 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 111.289 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.699 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 15.6 m-85 -99.4 133.37 43.81 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.637 0.732 . . . . 0.0 111.007 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -88.31 54.23 3.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.526 -0.734 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 43.63 31.41 1.73 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.87 -29.56 0.6 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 140' ' ' SER . 6.1 mp0 -116.06 121.91 43.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.12 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.66 105.39 8.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.096 HG22 HD21 ' A' ' 147' ' ' LEU . 1.3 mp -87.56 110.64 35.98 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.711 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 48.9 Cg_endo -75.72 128.12 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.026 1.54 . . . . 0.0 112.728 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.096 HD21 HG22 ' A' ' 145' ' ' ILE . 2.0 mm? -125.49 135.32 52.18 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 148' ' ' VAL . 5.6 m -98.68 116.38 41.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.006 -1.684 . . . . 0.0 111.218 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.961 HD12 ' CD2' ' A' ' 136' ' ' TYR . 1.6 mt -91.05 125.89 35.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.022 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 99' ' ' MET . 90.9 p -151.23 -24.39 0.21 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.774 -1.204 . . . . 0.0 111.985 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 38' ' ' THR . 47.5 mtp180 -85.85 124.5 70.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.627 -1.296 . . . . 0.0 110.328 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.522 ' CB ' ' HB3' ' A' ' 101' ' ' PRO . 49.5 Cg_endo -77.57 148.23 25.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.104 1.581 . . . . 0.0 110.397 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.941 HD22 ' C ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -61.54 158.13 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 110.357 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 153' ' ' LEU . 7.7 t -133.91 98.88 4.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.977 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER -107.72 -30.81 8.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 155' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.213 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.218 0.532 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.448 ' H ' HG22 ' B' ' 158' ' ' THR . 6.3 t -81.99 -146.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.136 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' OG1' ' B' ' 158' ' ' THR . . . -56.89 127.84 33.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.48 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.464 ' OG1' ' N ' ' B' ' 162' ' ' VAL . 4.4 t -176.19 -143.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.624 HG11 ' HA3' ' A' ' 25' ' ' GLY . 13.1 m -117.7 159.48 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.246 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -152.85 175.75 12.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 63' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.76 -168.16 2.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.769 HG22 ' HG3' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -94.04 151.43 19.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.291 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.208 HG21 ' CZ ' ' A' ' 136' ' ' TYR . 1.2 t -87.59 -160.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 1.121 HG12 ' CD2' ' A' ' 137' ' ' TYR . 21.4 m -42.36 153.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.424 ' O ' ' C ' ' B' ' 170' ' ' SER . 16.7 t-160 -150.67 82.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.424 ' C ' ' O ' ' B' ' 169' ' ' HIS . 4.8 p 42.42 -153.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.367 -0.833 . . . . 0.0 110.294 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.215 0.531 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.478 ' CG ' ' N ' ' A' ' 3' ' ' GLN . 36.8 p90 -62.18 -35.74 79.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CG ' ' A' ' 2' ' ' TYR . 43.4 tp60 -54.79 -33.85 61.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.168 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.098 HD22 ' CD1' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -57.0 -47.02 81.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.035 HG22 ' CD2' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -59.89 -44.41 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 73.7 t -58.73 -51.14 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.833 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 48.3 m-20 -59.83 -46.08 90.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -63.08 -43.51 98.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -0.801 . . . . 0.0 109.655 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 18' ' ' TYR . 25.6 t -57.29 -39.31 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.72 . . . . 0.0 109.311 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.7 tpt180 -55.42 -40.92 72.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.445 -0.784 . . . . 0.0 109.887 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -42.15 32.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 41' ' ' ILE . 1.2 tp -72.0 -38.87 69.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.681 HE21 HG12 ' A' ' 9' ' ' VAL . 2.6 pt20 -65.77 -33.97 77.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -57.84 -18.96 25.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -56.6 -43.49 80.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 110.081 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.97 30.9 2.02 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.662 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 15' ' ' SER . 1.6 p90 -159.93 33.79 0.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.43 . . . . 0.0 111.134 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.786 ' CE2' HG13 ' A' ' 9' ' ' VAL . 1.7 t80 -90.89 134.66 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.725 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.727 ' CB ' HD11 ' A' ' 40' ' ' LEU . 24.8 m95 -124.5 148.55 47.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.341 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.13 23.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.01 0.15 13.57 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.546 -0.721 . . . . 0.0 111.004 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -107.24 -158.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.9 -1.125 . . . . 0.0 109.721 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.54 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -101.56 170.76 7.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.093 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 42' ' ' ARG . . . -42.75 -79.02 0.06 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.705 ' CA ' HG11 ' B' ' 162' ' ' VAL . . . -79.32 -30.92 43.75 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 5.4 tp10 -58.27 -37.78 75.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -1.225 . . . . 0.0 110.069 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -61.47 -50.69 71.76 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.031 -1.043 . . . . 0.0 108.825 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.564 HD22 ' HA2' ' A' ' 25' ' ' GLY . 8.4 m-80 -69.79 -49.04 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 110.546 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 61' ' ' THR . 1.6 mp -59.77 -31.76 69.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 111.237 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.93 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.25 -22.49 11.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.998 -1.064 . . . . 0.0 109.555 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 38' ' ' THR . 80.4 mt -60.13 -35.3 74.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 109.087 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.672 ' HB2' ' CD ' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -69.56 -32.48 71.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.112 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.2 -20.8 43.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.96 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.754 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 4.6 mt-10 -131.07 -84.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.515 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.754 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 51.1 Cg_endo -76.77 68.31 7.17 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 122.77 0.879 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.27 141.74 14.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -0.978 . . . . 0.0 110.717 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' O ' ' CD ' ' A' ' 151' ' ' ARG . . . 72.32 25.66 73.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.855 ' O ' HD13 ' A' ' 31' ' ' LEU . 79.1 m -119.82 149.19 42.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.933 . . . . 0.0 110.692 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.845 ' CB ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -120.72 138.81 53.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.795 HD23 ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -134.08 160.53 37.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.442 -0.786 . . . . 0.0 110.959 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.763 HG13 HD21 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -114.07 134.09 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.507 -0.746 . . . . 0.0 109.678 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 1.1 ttp-105 -129.32 146.35 51.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.327 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' OH ' ' A' ' 18' ' ' TYR . 8.2 t0 -99.08 138.0 36.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -45.27 165.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 110.183 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 1.2 t -52.43 -86.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' N ' ' OG ' ' A' ' 45' ' ' SER . 2.3 t0 -43.3 160.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -14.22 39.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.19 21.5 2.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 21.6 m170 -116.26 170.92 8.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.013 ' HA ' HG21 ' A' ' 5' ' ' VAL . 27.6 p90 -89.78 -177.77 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.197 -0.939 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 1.035 ' CD2' HG22 ' A' ' 5' ' ' VAL . 6.8 p90 -116.0 155.72 27.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.53 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 64' ' ' LEU . 3.2 m -126.16 154.65 42.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.028 HD12 ' N ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -135.0 130.86 36.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 1.028 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.43 153.9 50.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.583 -0.698 . . . . 0.0 109.665 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.845 HG23 ' CB ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -127.59 171.18 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 110.447 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -119.38 135.42 54.74 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.422 -0.799 . . . . 0.0 110.1 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 4.4 t -127.51 61.34 1.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER 67.37 -57.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -145.84 47.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.208 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' HG22 ' A' ' 57' ' ' THR . . . -153.57 74.42 0.24 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.749 HG23 HD11 ' A' ' 29' ' ' LEU . 2.7 m -96.17 108.87 21.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 110.07 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.672 ' CB ' HD13 ' A' ' 138' ' ' ILE . 0.7 OUTLIER -128.97 155.29 45.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 1.049 ' O ' HD23 ' A' ' 64' ' ' LEU . 4.0 m-20 -140.07 149.22 42.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 63' ' ' ASN . 17.4 mt -134.87 147.17 49.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -108.38 153.62 23.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.976 . . . . 0.0 110.313 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.087 ' CD1' HD12 ' A' ' 75' ' ' LEU . 20.0 mm -89.06 145.59 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.43 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 66' ' ' ILE . 51.5 mm-40 -122.09 132.96 54.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 72' ' ' SER . 28.1 p -88.61 125.24 34.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -133.11 112.27 11.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 53.5 65.82 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.36 18.02 9.22 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.8 OUTLIER -122.29 163.15 20.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -1.174 . . . . 0.0 109.882 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 1.098 ' CD1' HD22 ' A' ' 4' ' ' LEU . 5.3 m-85 -131.94 139.8 48.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 110.47 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 77' ' ' SER . 8.3 t -147.23 138.98 24.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.0 110.101 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.11 HD22 ' CE1' ' A' ' 97' ' ' HIS . 0.5 OUTLIER -83.2 71.45 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.173 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.499 ' NE2' ' HB3' ' B' ' 164' ' ' PTR . 8.2 mm-40 56.53 21.01 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 110.261 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.455 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 57.8 m -84.71 170.87 12.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.197 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.39 149.39 38.21 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.196 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 54.61 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.055 1.555 . . . . 0.0 110.444 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 81' ' ' SER . 3.0 mtt180 -62.77 -47.94 81.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER 65.18 66.64 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.17 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' GLN . 9.7 t -92.41 -12.76 31.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.586 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -175.61 -60.84 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 46.2 Cg_endo -72.57 -170.16 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.887 1.467 . . . . 0.0 110.419 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.762 HG13 ' HD2' ' A' ' 86' ' ' PRO . 54.6 t -97.31 148.6 34.65 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.762 ' HD2' HG13 ' A' ' 85' ' ' VAL . 43.4 Cg_endo -70.04 132.97 23.97 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.939 1.494 . . . . 0.0 110.088 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 4.3 mtt180 75.25 -48.78 0.63 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.634 ' CG ' ' HG2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER 74.38 -174.84 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.431 -0.793 . . . . 0.0 110.536 179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.687 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 1.5 t70 -101.96 113.94 27.61 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.449 -0.782 . . . . 0.0 109.78 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.687 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 27.8 m 89.6 123.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.709 0.766 . . . . 0.0 110.362 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 51' ' ' PHE . 2.8 p -48.45 -20.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.655 0.74 . . . . 0.0 109.385 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.766 ' O ' HG12 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -54.03 -35.07 61.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 110.932 -178.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.634 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 1.5 tptt -58.28 -35.65 72.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.54 -1.35 . . . . 0.0 109.06 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.624 HD12 HD12 ' A' ' 66' ' ' ILE . 63.1 mt -62.86 -34.86 78.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -54.6 -37.07 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.448 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -53.76 -31.54 48.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.02 . . . . 0.0 109.121 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 1.11 ' CE1' HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -65.86 -35.94 82.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 0.0 109.411 179.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.841 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.9 m-85 -63.05 -10.54 14.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.612 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 78.69 78.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.703 -0.623 . . . . 0.0 110.211 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.469 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 45.5 Cg_endo -72.32 173.97 12.24 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.976 1.514 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 100' ' ' PRO . 46.1 Cg_endo -72.75 122.86 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.456 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.57 135.13 21.5 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.998 1.525 . . . . 0.0 110.364 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.5 141.61 3.84 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -45.14 118.85 3.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 106' ' ' SER . 46.3 Cg_endo -72.93 -55.02 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.91 1.479 . . . . 0.0 110.416 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER 172.96 -62.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 106' ' ' SER . 1.9 m-85 60.5 126.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 p -49.98 -28.49 6.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.153 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.69 126.81 30.3 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.182 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 140.76 31.57 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.972 1.512 . . . . 0.0 110.431 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.12 -89.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.063 1.56 . . . . 0.0 110.383 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -74.7 0.59 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 116.43 51.08 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 110.195 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -1.78 11.02 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.43 103.73 4.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.72 46.88 1.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 110.233 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 118' ' ' VAL . 4.5 pt-20 -78.76 -139.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.562 HG23 ' HG3' ' A' ' 117' ' ' GLU . 39.3 t 55.66 97.55 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.16 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 73.8 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.038 1.546 . . . . 0.0 110.469 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' GLN . 4.5 tp10 -152.03 132.99 14.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER 55.65 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.252 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 123.57 8.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.951 1.5 . . . . 0.0 110.45 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.725 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 45.4 Cg_endo -73.01 -87.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.99 1.521 . . . . 0.0 110.461 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 123' ' ' PRO . . . 68.82 126.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.177 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' ALA . 81.1 mt-30 -43.09 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.21 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . -162.43 54.25 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.938 . . . . 0.0 110.178 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.9 83.52 3.67 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.21 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 126' ' ' ALA . 46.4 Cg_endo -73.0 57.37 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 110.404 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 133.46 104.12 0.85 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -44.64 127.25 6.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -1.144 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.66 -55.29 12.8 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.266 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 131' ' ' THR . 45.3 Cg_endo -73.01 -30.43 10.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.917 1.483 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 132' ' ' PRO . 27.2 tttt 61.16 133.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.774 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 29.3 mmt-85 -79.02 -165.57 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 163.27 75.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.913 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.867 ' HB2' HG11 ' B' ' 167' ' ' VAL . 0.2 OUTLIER -102.7 124.72 48.76 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.119 -0.988 . . . . 0.0 109.321 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.972 ' N ' HG13 ' B' ' 167' ' ' VAL . 5.6 p90 -155.6 167.06 31.62 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.085 -1.009 . . . . 0.0 110.983 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.672 HD13 ' CB ' ' A' ' 62' ' ' LYS . 2.2 mp -102.75 149.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 111.11 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.694 ' CZ ' ' CZ ' ' A' ' 137' ' ' TYR . 17.5 m-85 -97.31 133.3 42.1 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.697 0.76 . . . . 0.0 111.096 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 3.2 t -86.48 51.92 2.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.615 -0.678 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 140' ' ' SER . . . 44.17 27.53 1.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.42 -32.78 0.24 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 140' ' ' SER . 14.2 tp10 -120.19 121.98 39.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.234 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 3.9 ptmt -72.03 105.46 3.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.397 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.833 ' O ' ' HB2' ' A' ' 137' ' ' TYR . 1.5 mp -85.11 110.54 29.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.757 ' HA ' ' CB ' ' A' ' 137' ' ' TYR . 49.0 Cg_endo -75.38 129.65 12.2 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.124 1.591 . . . . 0.0 111.828 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 138' ' ' ILE . 1.0 OUTLIER -124.02 134.2 53.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.392 -0.818 . . . . 0.0 109.396 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 148' ' ' VAL . 13.5 m -107.61 117.53 53.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.96 -1.087 . . . . 0.0 110.604 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 55' ' ' VAL . 6.6 tt -125.08 114.82 19.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.78 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.8 t -168.1 20.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.038 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.589 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -111.9 124.83 31.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 109.996 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.38 138.26 29.7 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.93 1.49 . . . . 0.0 110.693 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 154' ' ' SER . 4.8 tp -91.77 145.66 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.868 ' H ' HD12 ' A' ' 153' ' ' LEU . 1.2 p -83.07 92.05 7.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 154' ' ' SER . 2.1 m -42.79 -36.41 1.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 0.0 110.211 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.189 -179.967 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.175 0.512 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . 0.579 HG22 ' N ' ' B' ' 159' ' ' ALA . 22.4 m -88.05 170.74 10.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.579 ' N ' HG22 ' B' ' 158' ' ' THR . . . -179.19 120.3 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.275 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' B' ' 161' ' ' THR . 30.9 m -94.86 156.75 16.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 110.244 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' B' ' 160' ' ' SER . 1.1 t 176.94 137.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.222 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.705 HG11 ' CA ' ' A' ' 25' ' ' GLY . 2.6 m -117.72 104.62 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . 0.523 ' CG ' ' H ' ' B' ' 164' ' ' PTR . 28.8 tt0 -43.7 155.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.629 ' CE2' HG23 ' B' ' 162' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.636 ' CB ' HG23 ' A' ' 138' ' ' ILE . 57.9 m -128.56 12.56 6.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.775 ' H ' HD22 ' A' ' 64' ' ' LEU . 1.3 m 58.52 152.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 64' ' ' LEU . 2.9 t -108.9 151.08 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.008 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.956 HG12 ' H ' ' A' ' 137' ' ' TYR . 6.5 p -51.92 -16.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.955 . . . . 0.0 110.931 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . 0.978 ' H ' HG12 ' B' ' 167' ' ' VAL . 7.2 m170 58.14 119.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 0.0 110.318 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 134' ' ' ARG . 1.5 p -84.88 -49.24 8.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.543 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.53 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.9 pt-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.235 0.54 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 49' ' ' HIS . 3.6 t80 -63.29 -52.06 63.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.542 ' O ' HG12 ' A' ' 6' ' ' VAL . 5.5 tm0? -68.57 -35.77 77.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.655 HD21 ' O ' ' A' ' 87' ' ' ARG . 2.3 mt -67.13 -42.0 85.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.067 HG13 ' CD2' ' A' ' 51' ' ' PHE . 56.0 t -72.06 -46.29 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.581 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.609 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 14.2 p -58.33 -32.7 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.309 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 6' ' ' VAL . 32.2 t-20 -68.1 -37.88 81.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 110.309 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.799 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . . . -76.25 -45.05 34.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 110.593 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' CG2' ' HA ' ' A' ' 6' ' ' VAL . 33.6 m -57.91 -39.65 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' VAL . 2.9 ttt180 -55.75 -46.77 77.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.538 -0.726 . . . . 0.0 109.92 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.06 -35.87 49.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.883 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' CD2' HG21 ' A' ' 41' ' ' ILE . 52.0 tp -71.99 -44.32 63.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 110.058 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 9' ' ' VAL . 1.9 pt20 -68.48 -34.16 75.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.092 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.4 mt-10 -57.91 -45.0 87.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -55.91 -26.87 49.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.88 40.4 3.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 152' ' ' PRO . 1.1 m-85 -141.98 44.46 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.17 . . . . 0.0 110.609 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.589 ' HE2' HG12 ' A' ' 9' ' ' VAL . 2.8 t80 -126.59 130.36 50.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.945 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.3 m95 -102.86 147.66 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 110.202 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.74 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 m -44.64 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 20' ' ' SER . . . 167.78 79.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.659 HG21 ' CD2' ' A' ' 30' ' ' LEU . 2.6 t -56.03 -118.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.29 -0.881 . . . . 0.0 109.647 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.604 ' HB ' ' CB ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.11 168.93 10.79 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.786 -1.196 . . . . 0.0 109.347 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.561 ' O ' ' ND2' ' A' ' 28' ' ' ASN . . . -41.32 -85.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.885 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -79.37 -30.12 46.78 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.384 -1.068 . . . . 0.0 110.465 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.604 ' CB ' ' HB ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -57.59 -42.9 84.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.242 . . . . 0.0 110.049 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.023 ' HA ' HD23 ' A' ' 30' ' ' LEU . . . -58.91 -49.28 78.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 109.046 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 52' ' ' THR . 34.8 m-80 -68.75 -44.17 74.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 110.425 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -70.68 -31.71 68.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 112.091 -178.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.023 HD23 ' HA ' ' A' ' 27' ' ' ALA . 2.0 pp -54.71 -24.07 20.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.712 -1.243 . . . . 0.0 110.692 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.924 HD23 HD22 ' A' ' 40' ' ' LEU . 4.0 pp -78.5 -35.64 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.004 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.665 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.87 -32.84 71.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.9 -20.74 41.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.629 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.743 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 24.6 mm-40 -113.64 -76.71 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.004 -1.06 . . . . 0.0 110.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 34' ' ' GLU . 46.3 Cg_endo -72.03 65.36 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.287 1.151 . . . . 0.0 110.261 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 141.25 13.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 151' ' ' ARG . . . 74.85 20.17 79.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.869 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -134.78 146.62 49.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -1.1 . . . . 0.0 110.224 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' PHE . 5.3 p90 -123.39 155.92 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 110.311 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.945 HD12 ' CG ' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -149.48 159.01 44.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.962 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.74 HD12 ' CD2' ' A' ' 53' ' ' LEU . 5.5 tt -115.06 128.56 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.069 -1.019 . . . . 0.0 110.324 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -112.89 149.72 32.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.778 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' CG ' ' HA ' ' A' ' 48' ' ' ARG . 5.2 t0 -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 50' ' ' PHE . 28.2 m -53.77 -49.77 67.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -174.04 -153.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.142 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 51.4 -140.57 0.86 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 0.8 OUTLIER -91.0 -38.11 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 110.226 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' NH1' ' HG2' ' A' ' 47' ' ' GLN . 8.0 ptp85 -177.02 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.555 ' C ' HG11 ' A' ' 5' ' ' VAL . 2.3 m-70 -92.48 151.9 19.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.048 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER 48.12 107.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.395 -0.816 . . . . 0.0 110.898 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 1.067 ' CD2' HG13 ' A' ' 5' ' ' VAL . 5.7 p90 -120.47 140.31 51.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 28' ' ' ASN . 8.2 t -126.85 155.25 43.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.383 -0.823 . . . . 0.0 109.916 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.145 HD11 ' CD1' ' A' ' 98' ' ' TYR . 2.0 pp -143.99 127.24 16.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.025 -1.047 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.743 ' O ' HD21 ' A' ' 31' ' ' LEU . 6.6 t -112.83 154.1 26.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.454 -0.779 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.977 HG11 ' HG ' ' A' ' 149' ' ' LEU . 14.9 p -127.86 173.78 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.13 -0.981 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' N ' HG22 ' A' ' 55' ' ' VAL . 4.6 tptt -117.55 139.05 51.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 0.0 110.018 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.778 HG21 ' CB ' ' A' ' 147' ' ' LEU . 4.9 p -135.7 -94.08 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.294 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.3 mm-40 -80.02 -29.17 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER 162.8 -18.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.73 . . . . 0.0 109.735 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.56 100.81 2.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 56' ' ' LYS . 2.2 t -100.43 121.46 41.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -1.13 . . . . 0.0 109.925 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -139.71 171.81 13.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.076 -1.015 . . . . 0.0 110.518 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 1.4 p-10 -123.6 152.68 41.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 167' ' ' VAL . 1.0 OUTLIER -110.44 117.79 34.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.936 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HB3' ' CE1' ' B' ' 164' ' ' PTR . 9.2 ptm180 -83.13 151.76 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.903 HG21 ' CD2' ' A' ' 73' ' ' PHE . 6.9 mm -84.84 144.2 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 74' ' ' SER . 0.5 OUTLIER -96.08 121.37 37.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 26.8 p -88.07 118.16 27.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG3' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -133.04 121.15 22.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.221 -0.924 . . . . 0.0 110.244 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.51 95.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 4' ' ' LEU . . . 61.82 13.06 38.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 69' ' ' GLU . 13.7 p -108.8 163.21 13.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.296 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.903 ' CD2' HG21 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -110.78 128.38 55.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -155.17 138.98 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.181 -0.949 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.997 ' CD2' HD11 ' A' ' 94' ' ' LEU . 0.8 OUTLIER -91.9 -51.19 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.639 ' HG3' HD23 ' A' ' 75' ' ' LEU . 65.4 mt-30 -135.49 128.41 31.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 t -57.18 82.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.221 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 76' ' ' GLN . 59.2 t0 -120.04 114.0 33.92 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.875 . . . . 0.0 110.215 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.09 61.51 3.98 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.562 ' NH1' ' HB3' ' A' ' 93' ' ' LYS . 4.8 ptp180 -65.07 -9.04 19.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.191 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 82' ' ' THR . 0.3 OUTLIER 71.71 96.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.286 -0.884 . . . . 0.0 110.423 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -167.76 -52.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 109.881 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' THR . 5.2 mt-30 41.12 84.85 0.18 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' HG2' ' CG ' ' A' ' 88' ' ' PHE . 47.6 Cg_endo -73.52 -92.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 110.298 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.927 HG22 ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -120.99 170.06 7.92 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 109.533 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 85' ' ' VAL . 42.0 Cg_endo -69.0 132.78 25.3 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.633 1.333 . . . . 0.0 109.698 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.655 ' O ' HD21 ' A' ' 4' ' ' LEU . 0.8 OUTLIER 54.75 39.68 31.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.14 -0.975 . . . . 0.0 109.545 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.624 ' CD2' ' N ' ' A' ' 89' ' ' ASP . 1.2 p90 -74.68 -175.18 2.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.436 -0.79 . . . . 0.0 110.236 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.799 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 3.1 t0 -107.71 110.84 22.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.631 ' SG ' HD23 ' A' ' 94' ' ' LEU . 11.8 t -71.7 -20.5 61.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 110.488 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG21 ' CZ ' ' A' ' 51' ' ' PHE . 5.4 t -49.88 -36.25 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.046 -1.033 . . . . 0.0 109.795 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.9 mp -58.06 -47.03 84.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 109.308 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.562 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 5.0 mtpp -67.86 -31.46 71.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 108.891 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.997 HD11 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -59.39 -33.71 71.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.3 m -53.49 -37.21 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.733 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.446 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 5.0 m-70 -53.65 -50.44 65.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.62 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 135' ' ' ALA . 7.3 t60 -78.28 -36.95 46.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.518 -0.739 . . . . 0.0 109.09 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 1.145 ' CD1' HD11 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.11 -12.0 46.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.514 -0.741 . . . . 0.0 109.887 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 149' ' ' LEU . 1.9 ttt 178.7 68.53 0.12 Allowed Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.456 -0.778 . . . . 0.0 110.079 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.543 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 45.9 Cg_endo -72.66 111.92 3.36 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.903 1.475 . . . . 0.0 110.467 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.673 ' N ' ' CD ' ' A' ' 102' ' ' PRO . 41.6 Cg_endo -72.22 -29.77 13.9 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.038 1.546 . . . . 0.0 112.212 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 101' ' ' PRO . 48.5 Cg_endo -74.58 95.26 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 122.879 0.936 . . . . 0.0 110.337 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 104' ' ' THR . . . -43.79 -28.77 1.21 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -178.24 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.251 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 104' ' ' THR . 45.5 Cg_endo -72.54 -167.86 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.935 1.492 . . . . 0.0 110.4 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.59 ' C ' ' CG ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER 66.19 -63.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.167 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.59 ' CG ' ' C ' ' A' ' 106' ' ' SER . 17.4 p90 34.17 57.96 0.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.493 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' PHE . 1.2 m 65.09 141.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 mp -74.19 123.94 89.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.174 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.12 138.75 28.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.884 1.466 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.07 -41.62 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.009 1.531 . . . . 0.0 110.466 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.467 ' OG1' ' N ' ' A' ' 113' ' ' GLU . 4.4 t -175.44 -147.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.467 ' N ' ' OG1' ' A' ' 112' ' ' THR . 0.2 OUTLIER -118.88 110.27 38.56 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' O ' ' OG ' ' A' ' 115' ' ' SER . 46.0 Cg_endo -72.84 56.25 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.031 1.543 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 114' ' ' PRO . 54.1 p 42.77 89.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -121.58 104.33 9.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.14 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 116' ' ' SER . 1.7 mm-40 55.72 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.185 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 116' ' ' SER . 33.5 m -138.77 160.65 62.28 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.04 56.71 3.12 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.049 1.552 . . . . 0.0 110.46 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 118' ' ' VAL . 2.3 mm-40 -110.99 -163.25 0.84 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.501 ' N ' ' CD ' ' A' ' 122' ' ' PRO . 0.9 OUTLIER -138.25 52.32 4.68 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 121' ' ' GLN . 46.4 Cg_endo -73.09 113.59 3.81 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.1 1.579 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 124' ' ' ALA . 46.3 Cg_endo -73.12 -54.99 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.018 1.536 . . . . 0.0 110.389 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 123' ' ' PRO . . . 42.79 63.92 1.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 110.253 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 175.43 52.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.166 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.812 ' O ' HD12 ' A' ' 127' ' ' LEU . . . -136.33 14.85 3.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER 176.22 -57.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 127' ' ' LEU . 46.0 Cg_endo -72.95 -37.46 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.117 1.588 . . . . 0.0 110.398 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.76 -150.41 1.7 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 p -94.74 111.45 23.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.556 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -59.86 -55.09 49.14 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 131' ' ' THR . 46.4 Cg_endo -73.13 -177.05 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.861 1.453 . . . . 0.0 110.419 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 134' ' ' ARG . 23.4 tttp -153.81 -132.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -47.63 176.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 134' ' ' ARG . . . 166.2 147.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.416 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 1.048 ' CD2' HD11 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -100.58 162.41 12.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 177.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.851 ' C ' HD21 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -152.27 151.6 31.13 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 116.74 -1.984 . . . . 0.0 115.118 -176.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.852 ' N ' HD21 ' A' ' 147' ' ' LEU . 13.4 mt -142.17 120.57 8.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 143' ' ' GLU . 7.7 m-85 -84.09 107.96 16.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 143' ' ' GLU . 1.6 t -72.94 66.98 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 110.341 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.12 89.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.94 2.15 57.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.658 ' HB3' HD11 ' A' ' 145' ' ' ILE . 1.5 mt-10 -120.04 121.86 39.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -1.147 . . . . 0.0 110.31 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.727 ' C ' HD12 ' A' ' 145' ' ' ILE . 1.1 ttpp -98.23 105.72 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.808 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.8 mp -112.7 119.02 44.06 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.778 . . . . 0.0 109.098 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 137' ' ' TYR . 48.1 Cg_endo -75.13 127.2 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.731 1.385 . . . . 0.0 111.021 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.852 HD21 ' N ' ' A' ' 138' ' ' ILE . 0.4 OUTLIER -125.59 134.33 51.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.221 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.2 p -120.72 118.85 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.752 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.048 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mp -76.36 150.62 36.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.218 -0.926 . . . . 0.0 109.886 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -36.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.462 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 6.9 mtp85 -104.78 124.32 37.21 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 51.2 Cg_endo -78.21 147.29 23.21 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.024 1.539 . . . . 0.0 110.198 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 40' ' ' LEU . 4.3 tp -92.18 115.84 28.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.132 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' PHE . 81.0 p -100.01 151.96 20.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 19' ' ' TRP . 0.9 OUTLIER -95.96 -46.54 6.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.222 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.263 0.554 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' THR . . . . . . . . . . . . . 53.0 m -120.07 -26.03 5.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.276 -0.89 . . . . 0.0 110.176 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.4 155.07 17.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.55 -56.62 4.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 110.179 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.53 160.12 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.184 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.731 HG23 ' CA ' ' A' ' 25' ' ' GLY . 12.3 p -59.97 123.61 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.159 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.2 129.12 42.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' PTR . . . . . 0.59 ' N ' ' CD2' ' B' ' 164' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.5 t -109.21 158.79 17.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.13 -0.982 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 45.1 p -65.94 -162.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' VAL . . . . . 0.781 HG13 ' N ' ' A' ' 137' ' ' TYR . 55.4 t -143.06 167.61 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.703 HG22 HG12 ' B' ' 167' ' ' VAL . 18.7 m -38.98 135.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.454 -0.779 . . . . 0.0 110.385 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -121.02 -29.93 4.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' SER . . . . . . . . . . . . . 31.1 t -124.03 22.88 8.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.95 . . . . . . . . 0 0 . 1 stop_ save_